<?xml version="1.0"?>
<!DOCTYPE BlastOutput PUBLIC "-//NCBI//NCBI BlastOutput/EN" "http://www.ncbi.nlm.nih.gov/dtd/NCBI_BlastOutput.dtd">
<BlastOutput>
  <BlastOutput_program>blastp</BlastOutput_program>
  <BlastOutput_version>BLASTP 2.12.0+</BlastOutput_version>
  <BlastOutput_reference>Stephen F. Altschul, Thomas L. Madden, Alejandro A. Sch&amp;auml;ffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), &quot;Gapped BLAST and PSI-BLAST: a new generation of protein database search programs&quot;, Nucleic Acids Res. 25:3389-3402.</BlastOutput_reference>
  <BlastOutput_db>/project/bowmanlab/borowsky.jonathan/installations/pdbaa</BlastOutput_db>
  <BlastOutput_query-ID>Query_1</BlastOutput_query-ID>
  <BlastOutput_query-def>1AFQ_1|Chain A|BOVINE GAMMA-CHYMOTRYPSIN|Bos taurus (9913)</BlastOutput_query-def>
  <BlastOutput_query-len>13</BlastOutput_query-len>
  <BlastOutput_param>
    <Parameters>
      <Parameters_matrix>BLOSUM62</Parameters_matrix>
      <Parameters_expect>10</Parameters_expect>
      <Parameters_gap-open>11</Parameters_gap-open>
      <Parameters_gap-extend>1</Parameters_gap-extend>
      <Parameters_filter>F</Parameters_filter>
    </Parameters>
  </BlastOutput_param>
<BlastOutput_iterations>
<Iteration>
  <Iteration_iter-num>1</Iteration_iter-num>
  <Iteration_query-ID>Query_1</Iteration_query-ID>
  <Iteration_query-def>1AFQ_1|Chain A|BOVINE GAMMA-CHYMOTRYPSIN|Bos taurus (9913)</Iteration_query-def>
  <Iteration_query-len>13</Iteration_query-len>
<Iteration_hits>
<Hit>
  <Hit_num>1</Hit_num>
  <Hit_id>pdb|1AB9|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1AFQ|A CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR [Bos taurus] &gt;pdb|1CA0|A Bovine Chymotrypsin Complexed To Appi &gt;pdb|1CA0|F Bovine Chymotrypsin Complexed To Appi &gt;pdb|1CBW|A BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI [Bos taurus] &gt;pdb|1CBW|F BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI [Bos taurus] &gt;pdb|1CHO|E CRYSTAL AND MOLECULAR STRUCTURES OF THE COMPLEX OF ALPHA-*CHYMOTRYPSIN WITH ITS INHIBITOR TURKEY OVOMUCOID THIRD DOMAIN AT 1.8 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|1DLK|A CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR [Bos taurus] &gt;pdb|1DLK|C CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR [Bos taurus] &gt;pdb|1GCT|A Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of Gamma- Chymotrypsin? [Bos taurus] &gt;pdb|1GHA|E A Second Active Site In Chymotrypsin? The X-Ray Crystal Structure Of N-Acetyl-D-Tryptophan Bound To Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GHB|E A Second Active Site In Chymotrypsin? The X-Ray Crystal Structure Of N-Acetyl-D-Tryptophan Bound To Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GMC|E The X-Ray Crystal Structure Of The Tetrahedral Intermediate Of Gamma- Chymotrypsin In Hexane [Bos taurus] &gt;pdb|1GMD|E X-ray crystal structure of gamma-chymotrypsin in hexane [Bos taurus] &gt;pdb|1GMH|E REFINED CRYSTAL STRUCTURE OF &quot;AGED&quot; AND &quot;NON-AGED&quot; ORGANOPHOSPHORYL CONJUGATES OF GAMMA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1HJA|A LYS 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH ALPHA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1MTN|A BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION [Bos taurus] &gt;pdb|1MTN|E BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION [Bos taurus] &gt;pdb|1N8O|A Crystal structure of a complex between bovine chymotrypsin and ecotin [Bos taurus] &gt;pdb|1VGC|A Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|1YPH|A High resolution structure of bovine alpha-chymotrypsin [Bos taurus] &gt;pdb|1YPH|B High resolution structure of bovine alpha-chymotrypsin [Bos taurus] &gt;pdb|2CHA|A The Structure Of Crystalline Alpha-Chymotrypsin, v.The Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2 Angstroms Resolution [Bos taurus] &gt;pdb|2CHA|E The Structure Of Crystalline Alpha-Chymotrypsin, v.The Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2 Angstroms Resolution [Bos taurus] &gt;pdb|2GCH|E Refined Crystal Structure Of Gamma-chymotrypsin At 1.9 Angstroms Resolution [Bos taurus] &gt;pdb|2GCT|A Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph 10.5 Suggests That Gamma-Chymotrypsin Is A Covalent Acyl-Enzyme Adduct At Low Ph [Bos taurus] &gt;pdb|2GMT|A Three-Dimensional Structure Of Chymotrypsin Inactivated With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl Ketone: Implications For The Mechanism Of Inactivation Of Serine Proteases By Chloroketones [Bos taurus] &gt;pdb|2P8O|A Crystal Structure of a Benzohydroxamic Acid/Vanadate complex bound to chymotrypsin A [Bos taurus] &gt;pdb|2VGC|A Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|3BG4|A The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor [Bos taurus] &gt;pdb|3GCH|A Chemistry Of Caged Enzymes. Binding Of Photoreversible Cinnamates To Chymotrypsin [Bos taurus] &gt;pdb|3GCT|E Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH 10.5 Suggests That Gamma-Chymotrypsin Is A Covalent Acyl-Enzyme Adduct At Low pH [Bos taurus] &gt;pdb|3VGC|A Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid Acid Inhibitor Complex [Bos taurus] &gt;pdb|4CHA|A Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms Resolution [Bos taurus] &gt;pdb|4CHA|E Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms Resolution [Bos taurus] &gt;pdb|4GCH|E Structure And Activity Of Two Photoreversible Cinnamates Bound To Chymotrypsin [Bos taurus] &gt;pdb|4VGC|A Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|5CHA|A The Refinement And The Structure Of The Dimer Of Alpha- Chymotrypsin At 1.67-Angstroms Resolution [Bos taurus] &gt;pdb|5CHA|E The Refinement And The Structure Of The Dimer Of Alpha- Chymotrypsin At 1.67-Angstroms Resolution [Bos taurus] &gt;pdb|5GCH|E Chemistry Of Caged Enzymes II. Photoactivation Of Inhibited Chymotrypsin [Bos taurus] &gt;pdb|6CHA|A STRUCTURE OF A TETRAHEDRAL TRANSITION STATE COMPLEX OF ALPHA-*CHYMOTRYPSIN AT 1.8-*ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|6CHA|E STRUCTURE OF A TETRAHEDRAL TRANSITION STATE COMPLEX OF ALPHA-*CHYMOTRYPSIN AT 1.8-*ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|6DI8|A Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|D Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|G Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|J Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6GCH|E Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor Complexes. Comparison Of Slowly And Rapidly Equilibrating Inhibitors [Bos taurus] &gt;pdb|7GCH|E Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor Complexes. Comparison Of Slowly And Rapidly Equilibrating Inhibitors [Bos taurus] &gt;pdb|7JRX|A Chain A, Chymotrypsin A chain A [Bos taurus] &gt;pdb|7JRX|a Chain a, Chymotrypsin A chain A [Bos taurus] &gt;pdb|8GCH|E Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With Its Own Autolysis Products [Bos taurus]</Hit_def>
  <Hit_accession>1AB9_A</Hit_accession>
  <Hit_len>13</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>28.4906</Hsp_bit-score>
      <Hsp_score>62</Hsp_score>
      <Hsp_evalue>0.0134896</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>13</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>13</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>13</Hsp_identity>
      <Hsp_positive>13</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>13</Hsp_align-len>
      <Hsp_qseq>CGVPAIQPVLSGL</Hsp_qseq>
      <Hsp_hseq>CGVPAIQPVLSGL</Hsp_hseq>
      <Hsp_midline>CGVPAIQPVLSGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>2</Hit_num>
  <Hit_id>pdb|1ACB|E</Hit_id>
  <Hit_def>CRYSTAL AND MOLECULAR STRUCTURE OF THE BOVINE ALPHA-CHYMOTRYPSIN-EGLIN C COMPLEX AT 2.0 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|1CGI|E Three-Dimensional Structure Of The Complexes Between Bovine ChymotrypsinogenA And Two Recombinant Variants Of Human Pancreatic Secretory Trypsin Inhibitor (Kazal-Type) [Bos taurus] &gt;pdb|1CGJ|E Three-Dimensional Structure Of The Complexes Between Bovine ChymotrypsinogenA And Two Recombinant Variants Of Human Pancreatic Secretory Trypsin Inhibitor (Kazal-Type) [Bos taurus] &gt;pdb|1CHG|A Chymotrypsinogen,2.5 Angstroms Crystal Structure, Comparison With Alpha-Chymotrypsin,And Implications For Zymogen Activation [Bos taurus] &gt;pdb|1EX3|A Crystal Structure Of Bovine Chymotrypsinogen A (tetragonal) [Bos taurus] &gt;pdb|1GCD|A Refined Crystal Structure Of &quot;aged&quot; And &quot;non-Aged&quot; Organophosphoryl Conjugates Of Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GL0|E structure of the complex between bovine alpha-chymotrypsin and PMP-D2v, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|A structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|B structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|C structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1K2I|1 Crystal Structure of Gamma-Chymotrypsin in Complex with 7-Hydroxycoumarin [Bos taurus] &gt;pdb|1OXG|A Crystal structure of a complex formed between organic solvent treated bovine alpha-chymotrypsin and its autocatalytically produced highly potent 14-residue peptide at 2.2 resolution [Bos taurus] &gt;pdb|1P2M|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2M|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2N|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2N|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2O|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2O|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2Q|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2Q|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1T7C|A Crystal Structure Of The P1 Glu Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T7C|C Crystal Structure Of The P1 Glu Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8L|A Crystal Structure Of The P1 Met Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8L|C Crystal Structure Of The P1 Met Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8M|A Crystal Structure Of The P1 His Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8M|C Crystal Structure Of The P1 His Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8N|A Crystal Structure Of The P1 Thr Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8N|C Crystal Structure Of The P1 Thr Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8O|A Crystal Structure Of The P1 Trp Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8O|C Crystal Structure Of The P1 Trp Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|2CGA|A Bovine Chymotrypsinogen A. X-Ray Crystal Structure Analysis And Refinement Of A New Crystal Form At 1.8 Angstroms Resolution [Bos taurus] &gt;pdb|2CGA|B Bovine Chymotrypsinogen A. X-Ray Crystal Structure Analysis And Refinement Of A New Crystal Form At 1.8 Angstroms Resolution [Bos taurus] &gt;pdb|2Y6T|A Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|B Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|C Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|D Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|3T62|A Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|3T62|B Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|3T62|C Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|4Q2K|A Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|B Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|C Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|D Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|5J4Q|A alpha-chymotrypsin from bovine pancreas in complex with Bowman-Birk inhibitor from soybean [Bos taurus] &gt;pdb|5J4S|A alpha-chymotrypsin from bovine pancreas in complex with a modified Bowman-Birk inhibitor from soybean [Bos taurus] &gt;pdb|7KTY|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KTZ|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU0|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU1|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU2|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU3|A Chain A, Chymotrypsinogen A [Bos taurus]</Hit_def>
  <Hit_accession>1ACB_E</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>30.0314</Hsp_bit-score>
      <Hsp_score>66</Hsp_score>
      <Hsp_evalue>0.0142751</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>13</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>13</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>13</Hsp_identity>
      <Hsp_positive>13</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>13</Hsp_align-len>
      <Hsp_qseq>CGVPAIQPVLSGL</Hsp_qseq>
      <Hsp_hseq>CGVPAIQPVLSGL</Hsp_hseq>
      <Hsp_midline>CGVPAIQPVLSGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>3</Hit_num>
  <Hit_id>pdb|3RU4|C</Hit_id>
  <Hit_def>Crystal structure of the Bowman-Birk serine protease inhibitor BTCI in complex with trypsin and chymotrypsin [Bos taurus]</Hit_def>
  <Hit_accession>3RU4_C</Hit_accession>
  <Hit_len>11</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>25.0238</Hsp_bit-score>
      <Hsp_score>53</Hsp_score>
      <Hsp_evalue>0.307388</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>11</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>11</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>11</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>11</Hsp_align-len>
      <Hsp_qseq>CGVPAIQPVLS</Hsp_qseq>
      <Hsp_hseq>CGVPAIQPVLS</Hsp_hseq>
      <Hsp_midline>CGVPAIQPVLS</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>4</Hit_num>
  <Hit_id>pdb|1GG6|A</Hit_id>
  <Hit_def>Crystal Structure Of Gamma Chymotrypsin With N-acetyl-phenylalanine Trifluoromethyl Ketone Bound At The Active Site [Bos taurus] &gt;pdb|1GGD|A CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-LEUCIL-PHENYLALANINE ALDEHYDE BOUND AT THE ACTIVE SITE [Bos taurus]</Hit_def>
  <Hit_accession>1GG6_A</Hit_accession>
  <Hit_len>10</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>23.483</Hsp_bit-score>
      <Hsp_score>49</Hsp_score>
      <Hsp_evalue>1.4209</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>10</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>10</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>10</Hsp_identity>
      <Hsp_positive>10</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>10</Hsp_align-len>
      <Hsp_qseq>CGVPAIQPVL</Hsp_qseq>
      <Hsp_hseq>CGVPAIQPVL</Hsp_hseq>
      <Hsp_midline>CGVPAIQPVL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>5</Hit_num>
  <Hit_id>pdb|2JET|A</Hit_id>
  <Hit_def>Crystal structure of a trypsin-like mutant (S189D, A226G) chymotrypsin. [Rattus norvegicus]</Hit_def>
  <Hit_accession>2JET_A</Hit_accession>
  <Hit_len>15</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>22.3274</Hsp_bit-score>
      <Hsp_score>46</Hsp_score>
      <Hsp_evalue>2.84517</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>10</Hsp_query-to>
      <Hsp_hit-from>6</Hsp_hit-from>
      <Hsp_hit-to>15</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>9</Hsp_identity>
      <Hsp_positive>9</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>10</Hsp_align-len>
      <Hsp_qseq>CGVPAIQPVL</Hsp_qseq>
      <Hsp_hseq>CGVPTIQPVL</Hsp_hseq>
      <Hsp_midline>CGVP IQPVL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
</Iteration_hits>
  <Iteration_stat>
    <Statistics>
      <Statistics_db-num>130881</Statistics_db-num>
      <Statistics_db-len>34844698</Statistics_db-len>
      <Statistics_hsp-len>0</Statistics_hsp-len>
      <Statistics_eff-space>452981074</Statistics_eff-space>
      <Statistics_kappa>0.041</Statistics_kappa>
      <Statistics_lambda>0.267</Statistics_lambda>
      <Statistics_entropy>0.14</Statistics_entropy>
    </Statistics>
  </Iteration_stat>
</Iteration>
<Iteration>
  <Iteration_iter-num>2</Iteration_iter-num>
  <Iteration_query-ID>Query_2</Iteration_query-ID>
  <Iteration_query-def>1AFQ_2|Chain B|BOVINE GAMMA-CHYMOTRYPSIN|Bos taurus (9913)</Iteration_query-def>
  <Iteration_query-len>131</Iteration_query-len>
<Iteration_hits>
<Hit>
  <Hit_num>1</Hit_num>
  <Hit_id>pdb|1AB9|B</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1AFQ|B CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR [Bos taurus] &gt;pdb|1CA0|B Bovine Chymotrypsin Complexed To Appi [Bos taurus] &gt;pdb|1CA0|G Bovine Chymotrypsin Complexed To Appi [Bos taurus] &gt;pdb|1CBW|B BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI [Bos taurus] &gt;pdb|1CBW|G BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI [Bos taurus] &gt;pdb|1CHO|F CRYSTAL AND MOLECULAR STRUCTURES OF THE COMPLEX OF ALPHA-*CHYMOTRYPSIN WITH ITS INHIBITOR TURKEY OVOMUCOID THIRD DOMAIN AT 1.8 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|1GCT|B Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of Gamma- Chymotrypsin? [Bos taurus] &gt;pdb|1GG6|B Crystal Structure Of Gamma Chymotrypsin With N-acetyl-phenylalanine Trifluoromethyl Ketone Bound At The Active Site [Bos taurus] &gt;pdb|1GGD|B CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-LEUCIL-PHENYLALANINE ALDEHYDE BOUND AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GHA|F A Second Active Site In Chymotrypsin? The X-Ray Crystal Structure Of N-Acetyl-D-Tryptophan Bound To Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GHB|F A Second Active Site In Chymotrypsin? The X-Ray Crystal Structure Of N-Acetyl-D-Tryptophan Bound To Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GMC|F The X-Ray Crystal Structure Of The Tetrahedral Intermediate Of Gamma- Chymotrypsin In Hexane [Bos taurus] &gt;pdb|1GMD|F X-ray crystal structure of gamma-chymotrypsin in hexane [Bos taurus] &gt;pdb|1GMH|F REFINED CRYSTAL STRUCTURE OF &quot;AGED&quot; AND &quot;NON-AGED&quot; ORGANOPHOSPHORYL CONJUGATES OF GAMMA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1HJA|B LYS 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH ALPHA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1MTN|B BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION [Bos taurus] &gt;pdb|1MTN|F BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION [Bos taurus] &gt;pdb|1N8O|B Crystal structure of a complex between bovine chymotrypsin and ecotin [Bos taurus] &gt;pdb|1VGC|B Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|1YPH|C High resolution structure of bovine alpha-chymotrypsin [Bos taurus] &gt;pdb|1YPH|D High resolution structure of bovine alpha-chymotrypsin [Bos taurus] &gt;pdb|2CHA|B The Structure Of Crystalline Alpha-Chymotrypsin, v.The Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2 Angstroms Resolution [Bos taurus] &gt;pdb|2CHA|F The Structure Of Crystalline Alpha-Chymotrypsin, v.The Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2 Angstroms Resolution [Bos taurus] &gt;pdb|2GCH|F Refined Crystal Structure Of Gamma-chymotrypsin At 1.9 Angstroms Resolution [Bos taurus] &gt;pdb|2GCT|B Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph 10.5 Suggests That Gamma-Chymotrypsin Is A Covalent Acyl-Enzyme Adduct At Low Ph [Bos taurus] &gt;pdb|2GMT|B Three-Dimensional Structure Of Chymotrypsin Inactivated With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl Ketone: Implications For The Mechanism Of Inactivation Of Serine Proteases By Chloroketones [Bos taurus] &gt;pdb|2P8O|B Crystal Structure of a Benzohydroxamic Acid/Vanadate complex bound to chymotrypsin A [Bos taurus] &gt;pdb|2VGC|B Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|3BG4|B The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor [Bos taurus] &gt;pdb|3GCH|B Chemistry Of Caged Enzymes. Binding Of Photoreversible Cinnamates To Chymotrypsin [Bos taurus] &gt;pdb|3GCT|F Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH 10.5 Suggests That Gamma-Chymotrypsin Is A Covalent Acyl-Enzyme Adduct At Low pH [Bos taurus] &gt;pdb|3RU4|D Crystal structure of the Bowman-Birk serine protease inhibitor BTCI in complex with trypsin and chymotrypsin [Bos taurus] &gt;pdb|3VGC|B Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid Acid Inhibitor Complex [Bos taurus] &gt;pdb|4CHA|B Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms Resolution [Bos taurus] &gt;pdb|4CHA|F Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms Resolution [Bos taurus] &gt;pdb|4GCH|F Structure And Activity Of Two Photoreversible Cinnamates Bound To Chymotrypsin [Bos taurus] &gt;pdb|4VGC|B Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|5CHA|B The Refinement And The Structure Of The Dimer Of Alpha- Chymotrypsin At 1.67-Angstroms Resolution [Bos taurus] &gt;pdb|5CHA|F The Refinement And The Structure Of The Dimer Of Alpha- Chymotrypsin At 1.67-Angstroms Resolution [Bos taurus] &gt;pdb|5GCH|F Chemistry Of Caged Enzymes II. Photoactivation Of Inhibited Chymotrypsin [Bos taurus] &gt;pdb|6CHA|B STRUCTURE OF A TETRAHEDRAL TRANSITION STATE COMPLEX OF ALPHA-*CHYMOTRYPSIN AT 1.8-*ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|6CHA|F STRUCTURE OF A TETRAHEDRAL TRANSITION STATE COMPLEX OF ALPHA-*CHYMOTRYPSIN AT 1.8-*ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|6DI8|B Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|E Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|H Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|K Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6GCH|F Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor Complexes. Comparison Of Slowly And Rapidly Equilibrating Inhibitors [Bos taurus] &gt;pdb|7GCH|F Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor Complexes. Comparison Of Slowly And Rapidly Equilibrating Inhibitors [Bos taurus] &gt;pdb|7JRX|B Chain B, Chymotrypsin A chain B [Bos taurus] &gt;pdb|7JRX|b Chain b, Chymotrypsin A chain B [Bos taurus] &gt;pdb|8GCH|F Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With Its Own Autolysis Products [Bos taurus]</Hit_def>
  <Hit_accession>1AB9_B</Hit_accession>
  <Hit_len>131</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>267.7</Hsp_bit-score>
      <Hsp_score>683</Hsp_score>
      <Hsp_evalue>6.76533e-94</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>131</Hsp_identity>
      <Hsp_positive>131</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_hseq>
      <Hsp_midline>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>2</Hit_num>
  <Hit_id>pdb|1DLK|B</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR [Bos taurus] &gt;pdb|1DLK|D CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR [Bos taurus]</Hit_def>
  <Hit_accession>1DLK_B</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>267.7</Hsp_bit-score>
      <Hsp_score>683</Hsp_score>
      <Hsp_evalue>1.55682e-92</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>131</Hsp_identity>
      <Hsp_positive>131</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_hseq>
      <Hsp_midline>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>3</Hit_num>
  <Hit_id>pdb|1ACB|E</Hit_id>
  <Hit_def>CRYSTAL AND MOLECULAR STRUCTURE OF THE BOVINE ALPHA-CHYMOTRYPSIN-EGLIN C COMPLEX AT 2.0 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|1CGI|E Three-Dimensional Structure Of The Complexes Between Bovine ChymotrypsinogenA And Two Recombinant Variants Of Human Pancreatic Secretory Trypsin Inhibitor (Kazal-Type) [Bos taurus] &gt;pdb|1CGJ|E Three-Dimensional Structure Of The Complexes Between Bovine ChymotrypsinogenA And Two Recombinant Variants Of Human Pancreatic Secretory Trypsin Inhibitor (Kazal-Type) [Bos taurus] &gt;pdb|1CHG|A Chymotrypsinogen,2.5 Angstroms Crystal Structure, Comparison With Alpha-Chymotrypsin,And Implications For Zymogen Activation [Bos taurus] &gt;pdb|1EX3|A Crystal Structure Of Bovine Chymotrypsinogen A (tetragonal) [Bos taurus] &gt;pdb|1GCD|A Refined Crystal Structure Of &quot;aged&quot; And &quot;non-Aged&quot; Organophosphoryl Conjugates Of Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GL0|E structure of the complex between bovine alpha-chymotrypsin and PMP-D2v, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|A structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|B structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|C structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1K2I|1 Crystal Structure of Gamma-Chymotrypsin in Complex with 7-Hydroxycoumarin [Bos taurus] &gt;pdb|1OXG|A Crystal structure of a complex formed between organic solvent treated bovine alpha-chymotrypsin and its autocatalytically produced highly potent 14-residue peptide at 2.2 resolution [Bos taurus] &gt;pdb|1P2M|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2M|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2N|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2N|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2O|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2O|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2Q|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2Q|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1T7C|A Crystal Structure Of The P1 Glu Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T7C|C Crystal Structure Of The P1 Glu Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8L|A Crystal Structure Of The P1 Met Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8L|C Crystal Structure Of The P1 Met Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8M|A Crystal Structure Of The P1 His Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8M|C Crystal Structure Of The P1 His Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8N|A Crystal Structure Of The P1 Thr Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8N|C Crystal Structure Of The P1 Thr Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8O|A Crystal Structure Of The P1 Trp Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8O|C Crystal Structure Of The P1 Trp Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|2CGA|A Bovine Chymotrypsinogen A. X-Ray Crystal Structure Analysis And Refinement Of A New Crystal Form At 1.8 Angstroms Resolution [Bos taurus] &gt;pdb|2CGA|B Bovine Chymotrypsinogen A. X-Ray Crystal Structure Analysis And Refinement Of A New Crystal Form At 1.8 Angstroms Resolution [Bos taurus] &gt;pdb|2Y6T|A Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|B Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|C Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|D Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|3T62|A Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|3T62|B Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|3T62|C Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|4Q2K|A Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|B Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|C Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|D Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|5J4Q|A alpha-chymotrypsin from bovine pancreas in complex with Bowman-Birk inhibitor from soybean [Bos taurus] &gt;pdb|5J4S|A alpha-chymotrypsin from bovine pancreas in complex with a modified Bowman-Birk inhibitor from soybean [Bos taurus] &gt;pdb|7KTY|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KTZ|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU0|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU1|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU2|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU3|A Chain A, Chymotrypsinogen A [Bos taurus]</Hit_def>
  <Hit_accession>1ACB_E</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>267.7</Hsp_bit-score>
      <Hsp_score>683</Hsp_score>
      <Hsp_evalue>2.62594e-92</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>131</Hsp_identity>
      <Hsp_positive>131</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_hseq>
      <Hsp_midline>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>4</Hit_num>
  <Hit_id>pdb|1KDQ|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of the Mutant S189D Rat Chymotrypsin [Rattus norvegicus]</Hit_def>
  <Hit_accession>1KDQ_A</Hit_accession>
  <Hit_len>131</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>216.853</Hsp_bit-score>
      <Hsp_score>551</Hsp_score>
      <Hsp_evalue>7.83972e-74</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>101</Hsp_identity>
      <Hsp_positive>112</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVNGEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDVVVAGEFDQGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVSLPNVDDDFPPGTVCATTGWGKTKY</Hsp_hseq>
      <Hsp_midline>IVNGE+A+PGSWPWQVSLQDKTGFHFCGGSLI+E+WVVTAAHCGV TSDVVVAGEFDQGS  E IQ LKIA+VFKN K+N  T+ NDITLLKL+T A FS+TVSAV LP+  DDF  GT C TTGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>5</Hit_num>
  <Hit_id>pdb|2JET|B</Hit_id>
  <Hit_def>Crystal structure of a trypsin-like mutant (S189D, A226G) chymotrypsin. [Rattus norvegicus]</Hit_def>
  <Hit_accession>2JET_B</Hit_accession>
  <Hit_len>128</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>214.927</Hsp_bit-score>
      <Hsp_score>546</Hsp_score>
      <Hsp_evalue>5.17391e-73</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>99</Hsp_identity>
      <Hsp_positive>110</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>128</Hsp_align-len>
      <Hsp_qseq>GEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>GEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDVVVAGEFDQGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPNVDDDFPPGTVCATTGWGKTKY</Hsp_hseq>
      <Hsp_midline>GE+A+PGSWPWQVSLQDKTGFHFCGGSLI+E+WVVTAAHCGV TSDVVVAGEFDQGS  E IQ LKIA+VFKN K+N  T+ NDITLLKL+T A FS+TVSAVCLP+  DDF  GT C TTGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>6</Hit_num>
  <Hit_id>pdb|4IS5|A</Hit_id>
  <Hit_def>Crystal Structure of the ligand-free inactive Matriptase [Homo sapiens] &gt;pdb|4ISL|A Crystal Structure of the inactive Matriptase in complex with its inhibitor HAI-1 [Homo sapiens]</Hit_def>
  <Hit_accession>4IS5_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>104.375</Hsp_bit-score>
      <Hsp_score>259</Hsp_score>
      <Hsp_evalue>3.09048e-28</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-----GVTTSD----VVVAGEFDQGS-SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQY</Hsp_hseq>
      <Hsp_midline>+V G +A  G WPWQVSL      H CG SLI+ NW+V+AAHC     G   SD        G  DQ   S+  +Q+ ++ ++  +  +N  T + DI LL+L   A +S  V  +CLP AS  F AG     TGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>7</Hit_num>
  <Hit_id>pdb|3P8F|A</Hit_id>
  <Hit_def>Crystal Structure of MT-SP1 in complex with SFTI-1 [Homo sapiens] &gt;pdb|3P8G|A Crystal Structure of MT-SP1 in complex with benzamidine [Homo sapiens] &gt;pdb|4ISN|A Crystal Structure of Matriptase in complex with its inhibitor HAI-1 [Homo sapiens] &gt;pdb|4ISO|A Crystal Structure of Matriptase in complex with its inhibitor HAI-1 [Homo sapiens]</Hit_def>
  <Hit_accession>3P8F_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>104.375</Hsp_bit-score>
      <Hsp_score>259</Hsp_score>
      <Hsp_evalue>3.2257e-28</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-----GVTTSD----VVVAGEFDQGS-SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQY</Hsp_hseq>
      <Hsp_midline>+V G +A  G WPWQVSL      H CG SLI+ NW+V+AAHC     G   SD        G  DQ   S+  +Q+ ++ ++  +  +N  T + DI LL+L   A +S  V  +CLP AS  F AG     TGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>8</Hit_num>
  <Hit_id>pdb|1EAW|A</Hit_id>
  <Hit_def>Crystal structure of the MTSP1 (matriptase)-BPTI (aprotinin) complex [Homo sapiens] &gt;pdb|1EAW|C Crystal structure of the MTSP1 (matriptase)-BPTI (aprotinin) complex [Homo sapiens] &gt;pdb|1EAX|A Crystal structure of MTSP1 (matriptase) [Homo sapiens] &gt;pdb|2GV6|A Chain A, Suppressor of tumorigenicity 14 [Homo sapiens] &gt;pdb|2GV7|A Structure of Matriptase in Complex with Inhibitor CJ-672 [Homo sapiens] &gt;pdb|4JYT|A Crystal Structure of Matriptase in complex with Inhibitor [Homo sapiens] &gt;pdb|4JZ1|A Crystal Structure of Matriptase in complex with Inhibitor [Homo sapiens] &gt;pdb|4JZI|A Crystal Structure of Matriptase in complex with Inhibitor&apos;. [Homo sapiens] &gt;pdb|4O97|A Crystal structure of matriptase in complex with inhibitor [Homo sapiens] &gt;pdb|4O9V|A Crystal structure of matriptase in complex with inhibitor [Homo sapiens] &gt;pdb|4R0I|A CRYSTAL STRUCTURE of MATRIPTASE in COMPLEX WITH INHIBITOR [Homo sapiens] &gt;pdb|6N4T|A Crystal structure of Matriptase1 in complex with a peptidomimetic benzothiazole [Homo sapiens]</Hit_def>
  <Hit_accession>1EAW_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>104.375</Hsp_bit-score>
      <Hsp_score>259</Hsp_score>
      <Hsp_evalue>3.29552e-28</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-----GVTTSD----VVVAGEFDQGS-SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQY</Hsp_hseq>
      <Hsp_midline>+V G +A  G WPWQVSL      H CG SLI+ NW+V+AAHC     G   SD        G  DQ   S+  +Q+ ++ ++  +  +N  T + DI LL+L   A +S  V  +CLP AS  F AG     TGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>9</Hit_num>
  <Hit_id>pdb|5LYO|A</Hit_id>
  <Hit_def>Crystal structure of the zymogen matriptase catalytic domain [Homo sapiens] &gt;pdb|5LYO|B Crystal structure of the zymogen matriptase catalytic domain [Homo sapiens] &gt;pdb|5LYO|C Crystal structure of the zymogen matriptase catalytic domain [Homo sapiens]</Hit_def>
  <Hit_accession>5LYO_A</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>104.375</Hsp_bit-score>
      <Hsp_score>259</Hsp_score>
      <Hsp_evalue>5.38103e-28</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>165</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-----GVTTSD----VVVAGEFDQGS-SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQY</Hsp_hseq>
      <Hsp_midline>+V G +A  G WPWQVSL      H CG SLI+ NW+V+AAHC     G   SD        G  DQ   S+  +Q+ ++ ++  +  +N  T + DI LL+L   A +S  V  +CLP AS  F AG     TGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>10</Hit_num>
  <Hit_id>pdb|4DG4|A</Hit_id>
  <Hit_def>Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|4DG4|B Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|4DG4|D Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|4DG4|G Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens]</Hit_def>
  <Hit_accession>4DG4_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>102.064</Hsp_bit-score>
      <Hsp_score>253</Hsp_score>
      <Hsp_evalue>2.08091e-27</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>59</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCEENSLPYQVSLN--SGYHFCGGSLISEQWVVSAAHCYKTRIQVRL-GEHNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPP--AAGTECLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLI+E WVV+AAHC  T   V + GE +        Q +  AK+ ++ KYN  T++NDI L+KLS+ A  +  VS + LP+A    AAGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>11</Hit_num>
  <Hit_id>pdb|1BZX|E</Hit_id>
  <Hit_def>The Crystal Structure Of Anionic Salmon Trypsin In Complex With Bovine Pancreatic Trypsin Inhibitor [Salmo salar] &gt;pdb|2STA|E Anionic Salmon Trypsin In Complex With Squash Seed Inhibitor (Cucurbita Maxima Trypsin Inhibitor I) [Salmo salar] &gt;pdb|2STB|E Anionic Salmon Trypsin In Complex With Squash Seed Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii) [Salmo salar]</Hit_def>
  <Hit_accession>1BZX_E</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>101.293</Hsp_bit-score>
      <Hsp_score>251</Hsp_score>
      <Hsp_evalue>3.32954e-27</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>57</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKPYSQPHQVSLN--SGYHFCGGSLVNENWVVSAAHCYKSRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E  P S P QVSL   +G+HFCGGSL+NENWVV+AAHC  +  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LP++     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>12</Hit_num>
  <Hit_id>pdb|1UTK|A</Hit_id>
  <Hit_def>Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Salmo salar] &gt;pdb|1UTL|M Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Salmo salar] &gt;pdb|1UTM|A Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Salmo salar]</Hit_def>
  <Hit_accession>1UTK_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>101.293</Hsp_bit-score>
      <Hsp_score>251</Hsp_score>
      <Hsp_evalue>5.31679e-27</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>144</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>57</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKPYSQPHQVSLN--SGYHFCGGSLVNENWVVSAAHCYKSRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E  P S P QVSL   +G+HFCGGSL+NENWVV+AAHC  +  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LP++     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>13</Hit_num>
  <Hit_id>pdb|3BN9|A</Hit_id>
  <Hit_def>Crystal Structure of MT-SP1 in complex with Fab Inhibitor E2 [Homo sapiens] &gt;pdb|3BN9|B Crystal Structure of MT-SP1 in complex with Fab Inhibitor E2 [Homo sapiens] &gt;pdb|3NCL|A Crystal Structure of MT-SP1 bound to Benzamidine Phosphonate Inhibitor [Homo sapiens] &gt;pdb|3NPS|A Crystal structure of membrane-type serine protease 1 (MT-SP1) in complex with the Fab Inhibitor S4 [Homo sapiens] &gt;pdb|3SO3|A Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition. [Homo sapiens] &gt;pdb|6T9T|A Chain A, Suppressor of tumorigenicity 14 protein [Homo sapiens]</Hit_def>
  <Hit_accession>3BN9_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>100.523</Hsp_bit-score>
      <Hsp_score>249</Hsp_score>
      <Hsp_evalue>1.00971e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-----GVTTSD----VVVAGEFDQGS-SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPISLPDASHVFPAGKAIWVTGWGHTQY</Hsp_hseq>
      <Hsp_midline>+V G +A  G WPWQVSL      H CG SLI+ NW+V+AAHC     G   SD        G  DQ   S+  +Q+ ++ ++  +  +N  T + DI LL+L   A +S  V  + LP AS  F AG     TGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>14</Hit_num>
  <Hit_id>pdb|2ZPS|A</Hit_id>
  <Hit_def>Crystal structure of anionic trypsin isoform 3 from chum salmon [Oncorhynchus keta]</Hit_def>
  <Hit_accession>2ZPS_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>100.138</Hsp_bit-score>
      <Hsp_score>248</Hsp_score>
      <Hsp_evalue>1.18051e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKAYSQPHQVSLN--SGYHFCGGSLVNENWVVSAAHCYKTRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E    S P QVSL   +G+HFCGGSL+NENWVV+AAHC  T  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LPS+     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>15</Hit_num>
  <Hit_id>pdb|1RJX|B</Hit_id>
  <Hit_def>Human PLASMINOGEN CATALYTIC DOMAIN, K698M MUTANT [Homo sapiens]</Hit_def>
  <Hit_accession>1RJX_B</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>100.138</Hsp_bit-score>
      <Hsp_score>248</Hsp_score>
      <Hsp_evalue>1.67928e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>16</Hit_num>
  <Hit_id>pdb|2R9P|A</Hit_id>
  <Hit_def>Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) [Homo sapiens] &gt;pdb|2R9P|B Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) [Homo sapiens] &gt;pdb|2R9P|C Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) [Homo sapiens] &gt;pdb|2R9P|D Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) [Homo sapiens] &gt;pdb|3L33|A Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) [Homo sapiens] &gt;pdb|3L33|B Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) [Homo sapiens] &gt;pdb|3L33|C Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) [Homo sapiens] &gt;pdb|3L33|D Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) [Homo sapiens] &gt;pdb|3L3T|A Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K) [Homo sapiens] &gt;pdb|3L3T|B Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K) [Homo sapiens] &gt;pdb|3L3T|C Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K) [Homo sapiens] &gt;pdb|3L3T|D Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K) [Homo sapiens] &gt;pdb|3P92|A Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (BPTI-K15R/R17G) [Homo sapiens] &gt;pdb|3P95|A Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (BPTI-K15R/R17D) [Homo sapiens] &gt;pdb|4U30|A Human mesotrypsin complexed with bikunin Kunitz domain 2 [Homo sapiens] &gt;pdb|4U30|B Human mesotrypsin complexed with bikunin Kunitz domain 2 [Homo sapiens] &gt;pdb|4U30|C Human mesotrypsin complexed with bikunin Kunitz domain 2 [Homo sapiens] &gt;pdb|4U30|D Human mesotrypsin complexed with bikunin Kunitz domain 2 [Homo sapiens] &gt;pdb|4U32|A Human mesotrypsin complexed with HAI-2 Kunitz domain 1 [Homo sapiens] &gt;pdb|5C67|A Human Mesotrypsin in complex with amyloid precursor protein inhibitor variant APPI-M17G/I18F/F34V [Homo sapiens] &gt;pdb|5C67|B Human Mesotrypsin in complex with amyloid precursor protein inhibitor variant APPI-M17G/I18F/F34V [Homo sapiens] &gt;pdb|5JBT|A Mesotrypsin in complex with cleaved amyloid precursor like protein 2 inhibitor (APLP2) [Homo sapiens] &gt;pdb|6BX8|A Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C) [Homo sapiens] &gt;pdb|6BX8|C Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C) [Homo sapiens] &gt;pdb|6BX8|E Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C) [Homo sapiens] &gt;pdb|6BX8|G Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C) [Homo sapiens] &gt;pdb|6GFI|A Structure of Human Mesotrypsin in complex with APPI variant T11V/M17R/I18F/F34V [Homo sapiens] &gt;pdb|6GFI|B Structure of Human Mesotrypsin in complex with APPI variant T11V/M17R/I18F/F34V [Homo sapiens] &gt;pdb|6HAR|A Crystal structure of Mesotrypsin in complex with APPI-M17C/I18F/F34C [Homo sapiens]</Hit_def>
  <Hit_accession>2R9P_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>2.02035e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>59</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCEENSLPYQVSLN--SGSHFCGGSLISEQWVVSAAHCYKTRIQVRL-GEHNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPP--AAGTECLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLI+E WVV+AAHC  T   V + GE +        Q +  AK+ ++ KYN  T++NDI L+KLS+ A  +  VS + LP+A    AAGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>17</Hit_num>
  <Hit_id>pdb|5TP0|A</Hit_id>
  <Hit_def>Human mesotrypsin in complex with diminazene [Homo sapiens]</Hit_def>
  <Hit_accession>5TP0_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>2.04211e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>59</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCEENSLPYQVSLN--SGSHFCGGSLISEQWVVSAAHCYKTRIQVRL-GEHNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPP--AAGTECLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLI+E WVV+AAHC  T   V + GE +        Q +  AK+ ++ KYN  T++NDI L+KLS+ A  +  VS + LP+A    AAGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>18</Hit_num>
  <Hit_id>pdb|1UTJ|A</Hit_id>
  <Hit_def>Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Salmo salar]</Hit_def>
  <Hit_accession>1UTJ_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.7525</Hsp_bit-score>
      <Hsp_score>247</Hsp_score>
      <Hsp_evalue>2.39686e-26</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>144</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>128</Hsp_align-len>
      <Hsp_qseq>VNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>VGGYECKPYSQPHQVSLN--SGYHFCGGSLVNENWVVSAAHCYKSRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>V G E  P S P QVSL   +G+HFCGGSL+NENWVV+AAHC  +  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LP++     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>19</Hit_num>
  <Hit_id>pdb|1MBQ|A</Hit_id>
  <Hit_def>Anionic Trypsin from Pacific Chum Salmon [Oncorhynchus keta]</Hit_def>
  <Hit_accession>1MBQ_A</Hit_accession>
  <Hit_len>220</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>98.9821</Hsp_bit-score>
      <Hsp_score>245</Hsp_score>
      <Hsp_evalue>2.57808e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>57</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKAYSQPHQVSLN--SGYHFCGGSLVNENWVVSAAHCYKSRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKSATLNTYVQPVALPSSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E    S P QVSL   +G+HFCGGSL+NENWVV+AAHC  +  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS +A+ +  V  V LPS+     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>20</Hit_num>
  <Hit_id>pdb|6D40|A</Hit_id>
  <Hit_def>Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma [Homo sapiens]</Hit_def>
  <Hit_accession>6D40_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.24938e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>21</Hit_num>
  <Hit_id>pdb|2F9N|A</Hit_id>
  <Hit_def>Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9N|B Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9N|C Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9N|D Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin [Homo sapiens]</Hit_def>
  <Hit_accession>2F9N_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.36478e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+  D+   HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++  +    DI LL+L    + S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>22</Hit_num>
  <Hit_id>pdb|2ZPQ|A</Hit_id>
  <Hit_def>Crystal structure of anionic trypsin isoform 1 from chum salmon [Oncorhynchus keta] &gt;pdb|2ZPQ|B Crystal structure of anionic trypsin isoform 1 from chum salmon [Oncorhynchus keta]</Hit_def>
  <Hit_accession>2ZPQ_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>98.9821</Hsp_bit-score>
      <Hsp_score>245</Hsp_score>
      <Hsp_evalue>3.37504e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>57</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKAYSQPHQVSLN--SGYHFCGGSLVNENWVVSAAHCYKSRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E    S P QVSL   +G+HFCGGSL+NENWVV+AAHC  +  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LPS+     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>23</Hit_num>
  <Hit_id>pdb|3UIR|A</Hit_id>
  <Hit_def>Crystal structure of the plasmin-textilinin-1 complex [Homo sapiens] &gt;pdb|3UIR|B Crystal structure of the plasmin-textilinin-1 complex [Homo sapiens] &gt;pdb|6D3Y|A Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma [Homo sapiens]</Hit_def>
  <Hit_accession>3UIR_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.46759e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>24</Hit_num>
  <Hit_id>pdb|2F9O|A</Hit_id>
  <Hit_def>Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G [Homo sapiens] &gt;pdb|2F9O|B Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G [Homo sapiens] &gt;pdb|2F9O|C Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G [Homo sapiens] &gt;pdb|2F9O|D Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G [Homo sapiens] &gt;pdb|2F9P|A Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9P|B Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9P|C Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9P|D Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin [Homo sapiens]</Hit_def>
  <Hit_accession>2F9O_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.51143e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+  D+   HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++  +    DI LL+L    + S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>25</Hit_num>
  <Hit_id>pdb|1LTO|A</Hit_id>
  <Hit_def>Human alpha1-tryptase [Homo sapiens] &gt;pdb|1LTO|B Human alpha1-tryptase [Homo sapiens] &gt;pdb|1LTO|C Human alpha1-tryptase [Homo sapiens] &gt;pdb|1LTO|D Human alpha1-tryptase [Homo sapiens]</Hit_def>
  <Hit_accession>1LTO_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.51143e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPDVKDLATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+  D+   HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++  +    DI LL+L    + S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>26</Hit_num>
  <Hit_id>pdb|1L4Z|A</Hit_id>
  <Hit_def>X-Ray Crystal Structure Of The Complex Of Microplasminogen With Alpha Domain Of Streptokinase In The Presence Cadmium Ions [Homo sapiens]</Hit_def>
  <Hit_accession>1L4Z_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.61483e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>27</Hit_num>
  <Hit_id>pdb|6Q1U|A</Hit_id>
  <Hit_def>Structure of plasmin and peptide complex [Homo sapiens] &gt;pdb|6Q1U|B Structure of plasmin and peptide complex [Homo sapiens]</Hit_def>
  <Hit_accession>6Q1U_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.64946e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>147</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>28</Hit_num>
  <Hit_id>pdb|1BML|A</Hit_id>
  <Hit_def>COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE [Homo sapiens] &gt;pdb|1BML|B COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE [Homo sapiens]</Hit_def>
  <Hit_accession>1BML_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.68417e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>148</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>29</Hit_num>
  <Hit_id>pdb|1L4D|A</Hit_id>
  <Hit_def>Crystal Structure Of Microplasminogen-streptokinase Alpha Domain Complex [Homo sapiens]</Hit_def>
  <Hit_accession>1L4D_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.68856e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>147</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>30</Hit_num>
  <Hit_id>pdb|5UGD|A</Hit_id>
  <Hit_def>Protease Inhibitor [Homo sapiens] &gt;pdb|5UGG|A Protease Inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>5UGD_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.75876e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>31</Hit_num>
  <Hit_id>pdb|6D3Z|A</Hit_id>
  <Hit_def>Protease SFTI complex [Homo sapiens]</Hit_def>
  <Hit_accession>6D3Z_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.78007e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>17</Hsp_hit-from>
      <Hsp_hit-to>144</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>32</Hit_num>
  <Hit_id>pdb|1BUI|A</Hit_id>
  <Hit_def>Structure of the ternary microplasmin-staphylokinase-microplasmin complex: a proteinase-cofactor-substrate complex in action [Homo sapiens] &gt;pdb|1BUI|B Structure of the ternary microplasmin-staphylokinase-microplasmin complex: a proteinase-cofactor-substrate complex in action [Homo sapiens]</Hit_def>
  <Hit_accession>1BUI_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.96939e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>148</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>33</Hit_num>
  <Hit_id>pdb|1DDJ|A</Hit_id>
  <Hit_def>Crystal Structure Of Human Plasminogen Catalytic Domain [Homo sapiens] &gt;pdb|1DDJ|B Crystal Structure Of Human Plasminogen Catalytic Domain [Homo sapiens] &gt;pdb|1DDJ|C Crystal Structure Of Human Plasminogen Catalytic Domain [Homo sapiens] &gt;pdb|1DDJ|D Crystal Structure Of Human Plasminogen Catalytic Domain [Homo sapiens]</Hit_def>
  <Hit_accession>1DDJ_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>99.3673</Hsp_bit-score>
      <Hsp_score>246</Hsp_score>
      <Hsp_evalue>3.98301e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>34</Hit_num>
  <Hit_id>pdb|6D3X|A</Hit_id>
  <Hit_def>Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma [Homo sapiens] &gt;pdb|6D3X|B Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma [Homo sapiens]</Hit_def>
  <Hit_accession>6D3X_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>98.9821</Hsp_bit-score>
      <Hsp_score>245</Hsp_score>
      <Hsp_evalue>4.11663e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>17</Hsp_hit-from>
      <Hsp_hit-to>144</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>35</Hit_num>
  <Hit_id>pdb|1TRN|A</Hit_id>
  <Hit_def>Crystal Structure Of Human Trypsin 1: Unexpected Phosphorylation Of Tyrosine 151 [Homo sapiens] &gt;pdb|1TRN|B Crystal Structure Of Human Trypsin 1: Unexpected Phosphorylation Of Tyrosine 151 [Homo sapiens]</Hit_def>
  <Hit_accession>1TRN_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>98.2117</Hsp_bit-score>
      <Hsp_score>243</Hsp_score>
      <Hsp_evalue>5.29793e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYNCEENSVPYQVSLN--SGYHFCGGSLINEQWVVSAGHCYKSRIQVRL-GEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPP--ATGTKCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLINE WVV+A HC  +   V + GE +        Q +  AK+ ++ +Y+  T+NNDI L+KLS+ A  +  VS + LP+A    A GT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>36</Hit_num>
  <Hit_id>pdb|4WWY|A</Hit_id>
  <Hit_def>human cationic trypsin G193R mutant in complex with bovine pancreatic trypsin inhibitor [Homo sapiens] &gt;pdb|4WWY|B human cationic trypsin G193R mutant in complex with bovine pancreatic trypsin inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>4WWY_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>98.2117</Hsp_bit-score>
      <Hsp_score>243</Hsp_score>
      <Hsp_evalue>5.6495e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYNCEENSVPYQVSLN--SGYHFCGGSLINEQWVVSAGHCYKSRIQVRL-GEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPTAPP--ATGTKCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLINE WVV+A HC  +   V + GE +        Q +  AK+ ++ +Y+  T+NNDI L+KLS+ A  +  VS + LP+A    A GT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>37</Hit_num>
  <Hit_id>pdb|2RA3|A</Hit_id>
  <Hit_def>Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|2RA3|B Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens]</Hit_def>
  <Hit_accession>2RA3_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>98.2117</Hsp_bit-score>
      <Hsp_score>243</Hsp_score>
      <Hsp_evalue>6.92409e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYNCEENSVPYQVSLN--SGYHFCGGSLINEQWVVSAGHCYKSRIQVRL-GEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPTAPP--ATGTKCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLINE WVV+A HC  +   V + GE +        Q +  AK+ ++ +Y+  T+NNDI L+KLS+ A  +  VS + LP+A    A GT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>38</Hit_num>
  <Hit_id>pdb|2ZPR|A</Hit_id>
  <Hit_def>Crystal structure of anionic trypsin isoform 2 from chum salmon [Oncorhynchus keta] &gt;pdb|2ZPR|B Crystal structure of anionic trypsin isoform 2 from chum salmon [Oncorhynchus keta]</Hit_def>
  <Hit_accession>2ZPR_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.8265</Hsp_bit-score>
      <Hsp_score>242</Hsp_score>
      <Hsp_evalue>7.22137e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>57</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKAYSQPHQVSLN--SGYHFCGGSLVNENWVVSAAHC-YKSRVAVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E    S P QVSL   +G+HFCGGSL+NENWVV+AAHC   +   V  GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LPS+     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>39</Hit_num>
  <Hit_id>pdb|1H4W|A</Hit_id>
  <Hit_def>Structure of human trypsin IV (brain trypsin) [Homo sapiens]</Hit_def>
  <Hit_accession>1H4W_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.8265</Hsp_bit-score>
      <Hsp_score>242</Hsp_score>
      <Hsp_evalue>8.85729e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCEENSLPYQVSLN--SGSHFCGGSLISEQWVVSAAHCYKTRIQVRL-GEHNIKVLEGNEQFINAVKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPP--AAGTECLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLI+E WVV+AAHC  T   V + GE +        Q +   K+ ++ KYN  T++NDI L+KLS+ A  +  VS + LP+A    AAGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>40</Hit_num>
  <Hit_id>pdb|1HJ8|A</Hit_id>
  <Hit_def>Chain A, TRYPSIN I [Salmo salar]</Hit_def>
  <Hit_accession>1HJ8_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>9.54004e-26</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKAYSQPHQVSLN--SGYHFCGGSLVNENWVVSAAHCYKSRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E    S P QVSL   +G+HFCGGSL+NENWVV+AAHC  +  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LP++     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>41</Hit_num>
  <Hit_id>pdb|4WXV|A</Hit_id>
  <Hit_def>Human cationic trypsin K97D mutant in complex with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|4WXV|B Human cationic trypsin K97D mutant in complex with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens]</Hit_def>
  <Hit_accession>4WXV_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>1.0855e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYNCEENSVPYQVSL--NSGYHFCGGSLINEQWVVSAGHCYKSRIQVRL-GEHNIEVLEGNEQFINAAKIIRHPQYDRDTLNNDIMLIKLSSRAVINAHVSTISLPTAPP--ATGTKCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLINE WVV+A HC  +   V + GE +        Q +  AK+ ++ +Y+  T+NNDI L+KLS+ A  +  VS + LP+A    A GT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>42</Hit_num>
  <Hit_id>pdb|1QRZ|A</Hit_id>
  <Hit_def>Catalytic Domain Of Plasminogen [Homo sapiens] &gt;pdb|1QRZ|B Catalytic Domain Of Plasminogen [Homo sapiens] &gt;pdb|1QRZ|C Catalytic Domain Of Plasminogen [Homo sapiens] &gt;pdb|1QRZ|D Catalytic Domain Of Plasminogen [Homo sapiens]</Hit_def>
  <Hit_accession>1QRZ_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>98.2117</Hsp_bit-score>
      <Hsp_score>243</Hsp_score>
      <Hsp_evalue>1.09741e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>17</Hsp_hit-from>
      <Hsp_hit-to>144</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP------TRKDIALLKLSSPAVITDKVIPACLPSPNYMVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>43</Hit_num>
  <Hit_id>pdb|1ELT|A</Hit_id>
  <Hit_def>STRUCTURE OF NATIVE PANCREATIC ELASTASE FROM NORTH ATLANTIC SALMON AT 1.61 ANGSTROMS RESOLUTION [Salmo salar]</Hit_def>
  <Hit_accession>1ELT_A</Hit_accession>
  <Hit_len>236</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.8265</Hsp_bit-score>
      <Hsp_score>242</Hsp_score>
      <Hsp_evalue>1.1677e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>135</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>57</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHCGVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI--NNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHC-VDSARTWRVVLGEHNLNTNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLAALPPSNQILPNNNPCYITGWGKT</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQ+SLQ K+G   +H CGGSLI + WV+TAAHC V ++    VV GE +  ++  K Q + +  VF +S +NS  +    DI LL+L+T AS +  V    LP ++        C  TGWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>44</Hit_num>
  <Hit_id>pdb|1PYT|C</Hit_id>
  <Hit_def>Ternary Complex Of Procarboxypeptidase A, Proproteinase E, And Chymotrypsinogen C [Bos taurus]</Hit_def>
  <Hit_accession>1PYT_C</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.8265</Hsp_bit-score>
      <Hsp_score>242</Hsp_score>
      <Hsp_evalue>1.69831e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>59</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ---DKTGFHFCGGSLINENWVVTAAHCGVTTSDV--VVAGEFDQG--SSSEKIQKLKIAKVFKNSKYNS--LTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHC-ISTSRTYQVVLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLPPAGDILPNEAPCYISGWG</Hsp_hseq>
      <Hsp_midline>+VNGE+AVP SW WQVSLQ   D    H CGGSLI  +WVVTA HC ++TS    VV GE+D+     SE++  +    +F +  +NS  +   NDI L+KLS +A     V    LP A D       C  +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>45</Hit_num>
  <Hit_id>pdb|2ZEB|A</Hit_id>
  <Hit_def>Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEB|B Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEB|C Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEB|D Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEC|A Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEC|B Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEC|C Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEC|D Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens]</Hit_def>
  <Hit_accession>2ZEB_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>3.16218e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF--HFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+    +  HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++ +  I  DI LL+L      S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>46</Hit_num>
  <Hit_id>pdb|2BM2|A</Hit_id>
  <Hit_def>human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone [Homo sapiens] &gt;pdb|2BM2|B human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone [Homo sapiens] &gt;pdb|2BM2|C human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone [Homo sapiens] &gt;pdb|2BM2|D human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone [Homo sapiens] &gt;pdb|2FPZ|A Human tryptase with 2-amino benzimidazole [Homo sapiens] &gt;pdb|2FPZ|B Human tryptase with 2-amino benzimidazole [Homo sapiens] &gt;pdb|2FPZ|C Human tryptase with 2-amino benzimidazole [Homo sapiens] &gt;pdb|2FPZ|D Human tryptase with 2-amino benzimidazole [Homo sapiens] &gt;pdb|2FS8|A Human beta-tryptase II with inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FS8|B Human beta-tryptase II with inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FS8|C Human beta-tryptase II with inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FS8|D Human beta-tryptase II with inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FS9|A Human beta tryptase II with inhibitor CRA-28427 [Homo sapiens] &gt;pdb|2FS9|B Human beta tryptase II with inhibitor CRA-28427 [Homo sapiens] &gt;pdb|2FS9|C Human beta tryptase II with inhibitor CRA-28427 [Homo sapiens] &gt;pdb|2FS9|D Human beta tryptase II with inhibitor CRA-28427 [Homo sapiens] &gt;pdb|2FWW|A human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme [Homo sapiens] &gt;pdb|2FWW|B human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme [Homo sapiens] &gt;pdb|2FWW|C human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme [Homo sapiens] &gt;pdb|2FWW|D human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme [Homo sapiens] &gt;pdb|2FXR|A human beta tryptase II complexed with activated ketone inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FXR|B human beta tryptase II complexed with activated ketone inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FXR|C human beta tryptase II complexed with activated ketone inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FXR|D human beta tryptase II complexed with activated ketone inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2GDD|A Human beta II tryptase with inhibitor CRA-27592 [Homo sapiens] &gt;pdb|2GDD|B Human beta II tryptase with inhibitor CRA-27592 [Homo sapiens] &gt;pdb|2GDD|C Human beta II tryptase with inhibitor CRA-27592 [Homo sapiens] &gt;pdb|2GDD|D Human beta II tryptase with inhibitor CRA-27592 [Homo sapiens] &gt;pdb|2ZA5|A Crystal Structure of human tryptase with potent non-peptide inhibitor [Homo sapiens] &gt;pdb|2ZA5|B Crystal Structure of human tryptase with potent non-peptide inhibitor [Homo sapiens] &gt;pdb|2ZA5|C Crystal Structure of human tryptase with potent non-peptide inhibitor [Homo sapiens] &gt;pdb|2ZA5|D Crystal Structure of human tryptase with potent non-peptide inhibitor [Homo sapiens] &gt;pdb|3V7T|A Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold [Homo sapiens] &gt;pdb|3V7T|B Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold [Homo sapiens] &gt;pdb|3V7T|C Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold [Homo sapiens] &gt;pdb|3V7T|D Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold [Homo sapiens] &gt;pdb|4A6L|A beta-tryptase inhibitor [Homo sapiens] &gt;pdb|4A6L|B beta-tryptase inhibitor [Homo sapiens] &gt;pdb|4A6L|C beta-tryptase inhibitor [Homo sapiens] &gt;pdb|4A6L|D beta-tryptase inhibitor [Homo sapiens] &gt;pdb|4MPU|A Human beta-tryptase co-crystal structure with (6S,8R)-N,N&apos;-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-8-hydroxy-6-(1-hydroxycyclobutyl)-5,7-dioxaspiro[3.4]octane-6,8-dicarboxamide [Homo sapiens] &gt;pdb|4MPU|B Human beta-tryptase co-crystal structure with (6S,8R)-N,N&apos;-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-8-hydroxy-6-(1-hydroxycyclobutyl)-5,7-dioxaspiro[3.4]octane-6,8-dicarboxamide [Homo sapiens] &gt;pdb|4MPV|A Human beta-tryptase co-crystal structure with (2R,4S)-N,N&apos;-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-4-hydroxy-2-(2-hydroxypropan-2-yl)-5,5-dimethyl-1,3-dioxolane-2,4-dicarboxamide [Homo sapiens] &gt;pdb|4MPV|B Human beta-tryptase co-crystal structure with (2R,4S)-N,N&apos;-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-4-hydroxy-2-(2-hydroxypropan-2-yl)-5,5-dimethyl-1,3-dioxolane-2,4-dicarboxamide [Homo sapiens] &gt;pdb|4MPW|A Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzofuran-3,5-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MPW|B Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzofuran-3,5-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MPX|A Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzothiene-4,2-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MPX|B Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzothiene-4,2-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MQA|A Human beta-tryptase co-crystal structure with {(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bis[5-(methylsulfanyl)benzene-3,1-diyl]}bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MQA|B Human beta-tryptase co-crystal structure with {(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bis[5-(methylsulfanyl)benzene-3,1-diyl]}bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|5F03|A TRYPTASE B2 IN COMPLEX WITH 5-(3-Aminomethyl-phenoxymethyl)-3-[3-(2-chloro-pyridin-3-ylethynyl)-phenyl]-oxazolidin-2-one; compound with trifluoro-acetic acid [Homo sapiens] &gt;pdb|5F03|B TRYPTASE B2 IN COMPLEX WITH 5-(3-Aminomethyl-phenoxymethyl)-3-[3-(2-chloro-pyridin-3-ylethynyl)-phenyl]-oxazolidin-2-one; compound with trifluoro-acetic acid [Homo sapiens]</Hit_def>
  <Hit_accession>2BM2_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>3.36203e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF--HFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+    +  HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++ +  I  DI LL+L      S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>47</Hit_num>
  <Hit_id>pdb|1A0L|A</Hit_id>
  <Hit_def>Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites Facing A Central Pore [Homo sapiens] &gt;pdb|1A0L|B Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites Facing A Central Pore [Homo sapiens] &gt;pdb|1A0L|C Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites Facing A Central Pore [Homo sapiens] &gt;pdb|1A0L|D Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites Facing A Central Pore [Homo sapiens]</Hit_def>
  <Hit_accession>1A0L_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>3.51308e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF--HFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+    +  HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++ +  I  DI LL+L      S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>48</Hit_num>
  <Hit_id>pdb|6VVU|A</Hit_id>
  <Hit_def>Chain A, Tryptase alpha/beta-1 [Homo sapiens] &gt;pdb|6VVU|B Chain B, Tryptase alpha/beta-1 [Homo sapiens] &gt;pdb|6VVU|C Chain C, Tryptase alpha/beta-1 [Homo sapiens] &gt;pdb|6VVU|D Chain D, Tryptase alpha/beta-1 [Homo sapiens]</Hit_def>
  <Hit_accession>6VVU_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>3.99216e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>161</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF--HFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVNVSSHVHTVTLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+    +  HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++ +  I  DI LL+L    + S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>49</Hit_num>
  <Hit_id>pdb|6O1F|A</Hit_id>
  <Hit_def>Complex between soybean trypsin inhibitor beta1-tryptase and a humanized fab [Homo sapiens]</Hit_def>
  <Hit_accession>6O1F_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>4.49342e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF--HFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVNVSSHVHTVTLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+    +  HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++ +  I  DI LL+L    + S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>50</Hit_num>
  <Hit_id>pdb|6P0P|A</Hit_id>
  <Hit_def>Human beta-tryptase co-crystal structure with 5-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-2-(3&apos;-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-[1,1&apos;-biphenyl]-3-yl)-2-hydroxy-2H-1,3,2-benzodioxaborol-2-uide [Homo sapiens] &gt;pdb|6P0P|B Human beta-tryptase co-crystal structure with 5-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-2-(3&apos;-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-[1,1&apos;-biphenyl]-3-yl)-2-hydroxy-2H-1,3,2-benzodioxaborol-2-uide [Homo sapiens]</Hit_def>
  <Hit_accession>6P0P_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>4.67801e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>161</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF--HFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+    +  HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++ +  I  DI LL+L      S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>51</Hit_num>
  <Hit_id>pdb|1AKS|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF THE FIRST ACTIVE AUTOLYSATE FORM OF THE PORCINE ALPHA TRYPSIN [Sus scrofa] &gt;pdb|1UHB|A Crystal structure of porcine alpha trypsin bound with auto catalyticaly produced native peptide at 2.15 A resolution [Sus scrofa]</Hit_def>
  <Hit_accession>1AKS_A</Hit_accession>
  <Hit_len>125</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>4.74055e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCAANSIPYQVSLN--SGSHFCGGSLINSQWVVSAAHCYKSRIQVRL-GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCA--AAGTECLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLIN  WVV+AAHC  +   V + GE +        Q +  AK+  +  +N  T++NDI L+KLS+ A+ +  V+ V LP +    AAGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>52</Hit_num>
  <Hit_id>pdb|1PYT|D</Hit_id>
  <Hit_def>Ternary Complex Of Procarboxypeptidase A, Proproteinase E, And Chymotrypsinogen C [Bos taurus]</Hit_def>
  <Hit_accession>1PYT_D</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>4.98802e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>52</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ---DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIA--KVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTLTYRVALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVELGDTIQVACLPSEGSLLPQDYPCFVTGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A+P SWPWQ+SLQ   D T  H CGG+LI  N V+TAAHC   T    VA   +     ++   L +    +F + K+NS  + NDI L+KL+       T+   CLPS          C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>53</Hit_num>
  <Hit_id>pdb|5XW1|A</Hit_id>
  <Hit_def>Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRN, at pH10 [Sus scrofa] &gt;pdb|5XW8|A Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRN, at pH 7 [Sus scrofa] &gt;pdb|5XW9|A Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRY, at pH 7 [Sus scrofa] &gt;pdb|5XWA|A Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRY, at pH 10 [Sus scrofa]</Hit_def>
  <Hit_accession>5XW1_A</Hit_accession>
  <Hit_len>133</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.33943e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCAANSIPYQVSLN--SGSHFCGGSLINSQWVVSAAHCYKSRIQVRL-GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC--AAAGTECLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLIN  WVV+AAHC  +   V + GE +        Q +  AK+  +  +N  T++NDI L+KLS+ A+ +  V+ V LP +    AAGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>54</Hit_num>
  <Hit_id>pdb|1SLU|B</Hit_id>
  <Hit_def>Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin [Rattus norvegicus] &gt;pdb|1SLV|B Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin; Copper- Bound [Rattus norvegicus] &gt;pdb|1SLX|B Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin; Zinc-Bound [Rattus norvegicus]</Hit_def>
  <Hit_accession>1SLU_B</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.5153</Hsp_bit-score>
      <Hsp_score>236</Hsp_score>
      <Hsp_evalue>7.05783e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGHT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>55</Hit_num>
  <Hit_id>pdb|1SLW|B</Hit_id>
  <Hit_def>Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin; Nickel- Bound [Rattus norvegicus]</Hit_def>
  <Hit_accession>1SLW_B</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.1301</Hsp_bit-score>
      <Hsp_score>235</Hsp_score>
      <Hsp_evalue>9.41978e-25</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>54</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALPSSC--APAGTQCLISGWGHT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ + LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>56</Hit_num>
  <Hit_id>pdb|3TGJ|E</Hit_id>
  <Hit_def>S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin Inhibitor (Bpti) [Rattus norvegicus]</Hit_def>
  <Hit_accession>3TGJ_E</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.1301</Hsp_bit-score>
      <Hsp_score>235</Hsp_score>
      <Hsp_evalue>1.0543e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>57</Hit_num>
  <Hit_id>pdb|1BRA|A</Hit_id>
  <Hit_def>RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN [Rattus rattus] &gt;pdb|1BRB|E CRYSTAL STRUCTURES OF RAT ANIONIC TRYPSIN COMPLEXED WITH THE PROTEIN INHIBITORS APPI AND BPTI [Rattus norvegicus] &gt;pdb|1BRC|E RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN [Rattus norvegicus]</Hit_def>
  <Hit_accession>1BRA_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.1301</Hsp_bit-score>
      <Hsp_score>235</Hsp_score>
      <Hsp_evalue>1.05952e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>58</Hit_num>
  <Hit_id>pdb|1ANE|A</Hit_id>
  <Hit_def>Anionic Trypsin Wild Type [Rattus rattus] &gt;pdb|3FP6|E Anionic trypsin in complex with bovine pancreatic trypsin inhibitor (BPTI) determined to the 1.49 A resolution limit [Rattus norvegicus] &gt;pdb|3TGI|E Wild-Type Rat Anionic Trypsin Complexed With Bovine Pancreatic Trypsin Inhibitor (Bpti) [Rattus norvegicus]</Hit_def>
  <Hit_accession>1ANE_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.1301</Hsp_bit-score>
      <Hsp_score>235</Hsp_score>
      <Hsp_evalue>1.05952e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>59</Hit_num>
  <Hit_id>pdb|1K9O|E</Hit_id>
  <Hit_def>Crystal Structure Of Michaelis Serpin-Trypsin Complex [Rattus norvegicus] &gt;pdb|1YKT|A Trypsin/Bpti complex mutant [Rattus norvegicus] &gt;pdb|1YLC|A Trypsin/BPTI complex mutant [Rattus norvegicus] &gt;pdb|1YLD|A Trypsin/BPTI complex mutant [Rattus norvegicus] &gt;pdb|3FP7|E Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) cleaved at the scissile bond (LYS15-ALA16) determined to the 1.46 A resolution limit [Rattus norvegicus] &gt;pdb|3FP8|E Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) determined to the 1.46 A resolution limit [Rattus norvegicus]</Hit_def>
  <Hit_accession>1K9O_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.11769e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>60</Hit_num>
  <Hit_id>pdb|1ANB|A</Hit_id>
  <Hit_def>Anionic Trypsin Mutant With Ser 214 Replaced By Glu [Rattus rattus]</Hit_def>
  <Hit_accession>1ANB_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.1297e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>61</Hit_num>
  <Hit_id>pdb|1ANC|A</Hit_id>
  <Hit_def>Anionic Trypsin Mutant With Ser 214 Replaced By Lys [Rattus rattus]</Hit_def>
  <Hit_accession>1ANC_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.14184e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>62</Hit_num>
  <Hit_id>pdb|1DPO|A</Hit_id>
  <Hit_def>Structure Of Rat Trypsin [Rattus rattus]</Hit_def>
  <Hit_accession>1DPO_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.20453e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>63</Hit_num>
  <Hit_id>pdb|1AMH|A</Hit_id>
  <Hit_def>Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With Ser (D189s) [Rattus rattus] &gt;pdb|1AMH|B Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With Ser (D189s) [Rattus rattus]</Hit_def>
  <Hit_accession>1AMH_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.20453e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>64</Hit_num>
  <Hit_id>pdb|1F7Z|A</Hit_id>
  <Hit_def>Rat Trypsinogen K15a Complexed With Bovine Pancreatic Trypsin Inhibitor [Rattus norvegicus]</Hit_def>
  <Hit_accession>1F7Z_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.1301</Hsp_bit-score>
      <Hsp_score>235</Hsp_score>
      <Hsp_evalue>1.22409e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>65</Hit_num>
  <Hit_id>pdb|1AND|A</Hit_id>
  <Hit_def>Anionic Trypsin Mutant With Arg 96 Replaced By His [Rattus rattus]</Hit_def>
  <Hit_accession>1AND_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.29811e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>66</Hit_num>
  <Hit_id>pdb|1BRU|P</Hit_id>
  <Hit_def>STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH THE ELASTASE INHIBITOR GR143783 [Sus scrofa]</Hit_def>
  <Hit_accession>1BRU_P</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.1301</Hsp_bit-score>
      <Hsp_score>235</Hsp_score>
      <Hsp_evalue>1.3069e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>54</Hsp_identity>
      <Hsp_positive>80</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ-DKTG--FHFCGGSLINENWVVTAAHCGVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNS--LTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHC-ISSSRTYRVVLGRHSLSTNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGCLPAAGTILPNNYVCYVTGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A P SWPWQVSLQ D +G   H CGG+L++++WV+TAAHC +++S    VV G     ++      +K++K+  +  +NS  L+  NDI LLKL++  S +  +   CLP+A         C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>67</Hit_num>
  <Hit_id>pdb|1FON|A</Hit_id>
  <Hit_def>Crystal Structure Of Bovine Procarboxypeptidase A-S6 Subunit Iii, A Highly Structured Truncated Zymogen E [Bos taurus] &gt;pdb|1FON|B Crystal Structure Of Bovine Procarboxypeptidase A-S6 Subunit Iii, A Highly Structured Truncated Zymogen E [Bos taurus]</Hit_def>
  <Hit_accession>1FON_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.67184e-24</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>NGEEAVPGSWPWQVSLQ---DKTGFHFCGGSLINENWVVTAAHCGVTTSDV--VVAGEFDQG--SSSEKIQKLKIAKVFKNSKYNS--LTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>NGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHC-ISTSRTYQVVLGEYDRSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLPPAGDILPNEAPCYISGWG</Hsp_hseq>
      <Hsp_midline>NGE+AVP SW WQVSLQ   D    H CGGSLI  +WVVTA HC ++TS    VV GE+D+     SE++  +    +F +  +NS  +   NDI L+KLS +A     V    LP A D       C  +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>68</Hit_num>
  <Hit_id>pdb|1CO7|E</Hit_id>
  <Hit_def>R117H mutant rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) [Rattus norvegicus]</Hit_def>
  <Hit_accession>1CO7_E</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.73079e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>69</Hit_num>
  <Hit_id>pdb|1YM0|A</Hit_id>
  <Hit_def>Chain A, fibrinotic enzyme component B [Eisenia fetida]</Hit_def>
  <Hit_accession>1YM0_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>1.84497e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG-FHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQGEAPALVSLVVGEHDSSAASTVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPANDYVYRKS-QCSGWG</Hsp_hseq>
      <Hsp_midline>IV G EA P  +PWQVS++ K+   HFCGGS+IN+ WVV AAHC    +  +V+   GE D  ++S   Q   +  +F N  Y+  T+ ND++++K + A +F   V  +C P  ++D+    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>70</Hit_num>
  <Hit_id>pdb|5WI6|A</Hit_id>
  <Hit_def>Human beta-1 tryptase mutant Ile99Cys [Homo sapiens] &gt;pdb|5WI6|B Human beta-1 tryptase mutant Ile99Cys [Homo sapiens] &gt;pdb|5WI6|C Human beta-1 tryptase mutant Ile99Cys [Homo sapiens] &gt;pdb|5WI6|D Human beta-1 tryptase mutant Ile99Cys [Homo sapiens]</Hit_def>
  <Hit_accession>5WI6_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.3597</Hsp_bit-score>
      <Hsp_score>233</Hsp_score>
      <Hsp_evalue>2.4065e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF--HFCGGSLINENWVVTAAHC-GVTTSDVV-VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQCGADIALLELEEPVNVSSHVHTVTLPPASETFPPGMPCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G+EA    WPWQVSL+    +  HFCGGSLI+  WV+TAAHC G    D+  +  +  +     + Q L ++++  + ++ +     DI LL+L    + S  V  V LP AS+ F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>71</Hit_num>
  <Hit_id>pdb|2TBS|A</Hit_id>
  <Hit_def>Cold-Adaption Of Enzymes: Structural Comparison Between Salmon And Bovine Trypsins [Salmo salar]</Hit_def>
  <Hit_accession>2TBS_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.9745</Hsp_bit-score>
      <Hsp_score>232</Hsp_score>
      <Hsp_evalue>2.57309e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKAYSQAHQVSL--NSGYHFCGGSLVNENWVVSAAHCYKSRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E    S   QVSL   +G+HFCGGSL+NENWVV+AAHC  +  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LP++     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>72</Hit_num>
  <Hit_id>pdb|1J14|A</Hit_id>
  <Hit_def>Benzamidine In Complex With Rat Trypsin Mutant X99rt [Rattus norvegicus] &gt;pdb|1QL9|A Factor Xa Specific Inhibitor In Complex With Rat Trypsin Mutant X99rt [Rattus norvegicus]</Hit_def>
  <Hit_accession>1J14_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.5893</Hsp_bit-score>
      <Hsp_score>231</Hsp_score>
      <Hsp_evalue>3.25372e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>73</Hit_num>
  <Hit_id>pdb|1J15|A</Hit_id>
  <Hit_def>Benzamidine In Complex With Rat Trypsin Mutant X99175190RT [Rattus norvegicus] &gt;pdb|1J16|A Benzamidine In Complex With Rat Trypsin Mutant X99175190RT [Rattus norvegicus] &gt;pdb|1J17|T Factor Xa Specific Inhibitor In Complex With Rat Trypsin Mutant X99175190RT [Rattus norvegicus]</Hit_def>
  <Hit_accession>1J15_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.5893</Hsp_bit-score>
      <Hsp_score>231</Hsp_score>
      <Hsp_evalue>3.39575e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>74</Hit_num>
  <Hit_id>pdb|1BIT|A</Hit_id>
  <Hit_def>THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN A SECOND CRYSTAL FORM [Salmo salar]</Hit_def>
  <Hit_accession>1BIT_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.9745</Hsp_bit-score>
      <Hsp_score>232</Hsp_score>
      <Hsp_evalue>3.49983e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>139</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECKAYSQAHQVSLN--SGYHFCGGSLVNENWVVSAAHCYKSRVEVRL-GEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCA--PAGTMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E    S   QVSL   +G+HFCGGSL+NENWVV+AAHC  +  +V + GE +   +    Q +  ++V ++  Y+S  I+NDI L+KLS  A+ +  V  V LP++     AGT C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>75</Hit_num>
  <Hit_id>pdb|3VEQ|B</Hit_id>
  <Hit_def>A binary complex betwwen bovine pancreatic trypsin and a engineered mutant trypsin inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3VEQ_B</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.5893</Hsp_bit-score>
      <Hsp_score>231</Hsp_score>
      <Hsp_evalue>3.50632e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVSLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V++V LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>76</Hit_num>
  <Hit_id>pdb|2D8W|A</Hit_id>
  <Hit_def>Structure of HYPER-VIL-trypsin [Bos taurus]</Hit_def>
  <Hit_accession>2D8W_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.5893</Hsp_bit-score>
      <Hsp_score>231</Hsp_score>
      <Hsp_evalue>3.54397e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHCXKSGIQVRL-GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC  +   V + GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>77</Hit_num>
  <Hit_id>pdb|4NIV|A</Hit_id>
  <Hit_def>Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) trigonal form [Bos taurus] &gt;pdb|4NIW|A Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) orthorhombic form [Bos taurus] &gt;pdb|4NIX|A Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) orthorhombic form, zinc-bound [Bos taurus] &gt;pdb|4NIY|A Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin) [Bos taurus] &gt;pdb|4NIY|B Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin) [Bos taurus] &gt;pdb|4NIY|C Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin) [Bos taurus] &gt;pdb|4NIY|D Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin) [Bos taurus]</Hit_def>
  <Hit_accession>4NIV_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.5893</Hsp_bit-score>
      <Hsp_score>231</Hsp_score>
      <Hsp_evalue>3.69866e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YESGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGHTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>78</Hit_num>
  <Hit_id>pdb|1BTP|A</Hit_id>
  <Hit_def>Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4- (Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-N- Allylglycine Methanesulfonate To Bovine Trypsin, Revealed By The Crystal Structure Of The Complex [Bos taurus] &gt;pdb|1BTW|A Episelection: novel KI ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface [Bos taurus] &gt;pdb|1BTX|A Episelection: Novel Ki ~Nanomolar Inhibitors of Serine Proteases Selected by Binding or Chemistry on an Enzyme Surface [Bos taurus] &gt;pdb|1BTY|A Crystal structure of beta-trypsin in complex with benzamidine [Bos taurus] &gt;pdb|1BTZ|A Episelection: novel KI ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface [Bos taurus] &gt;pdb|1TGB|A Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms Resolution. Ii. Crystallographic Refinement, Refined Crystal Structure And Comparison With Bovine Trypsin [Bos taurus] &gt;pdb|1TGC|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|1TGN|A STRUCTURE OF BOVINE TRYPSINOGEN AT 1.9 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|1TGS|Z Three-Dimensional Structure Of The Complex Between Pancreatic Secretory Inhibitor (Kazal Type) And Trypsinogen At 1.8 Angstroms Resolution. Structure Solution, Crystallographic Refinement And Preliminary Structural Interpretation [Bos taurus] &gt;pdb|1TGT|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|1TNG|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNH|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNI|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNJ|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNK|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNL|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|2TGA|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|2TGD|A LACK OF THE TRANSITION STATE STABILIZATION SITE IS A FACTOR IN THE INACTIVITY OF TRYPSINOGEN, A SERINE PROTEASE ZYMOGEN. STRUCTURE OF DFP INHIBITED BOVINE TRYPSINOGEN AT 2.1 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|2TGP|Z The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|2TGT|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|2TPI|Z On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|3TPI|Z The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|4TPI|Z The Refined 2.2-angstroms (0.22-nm) X-ray Crystal Structure Of The Ternary Complex Formed By Bovine Trypsinogen, Valine-valine And The Arg15 Analogue Of Bovine Pancreatic Trypsin Inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>1BTP_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.5893</Hsp_bit-score>
      <Hsp_score>231</Hsp_score>
      <Hsp_evalue>4.65903e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>79</Hit_num>
  <Hit_id>pdb|1G3B|A</Hit_id>
  <Hit_def>BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE MAGNESIUM(II) CHELATE [Bos taurus] &gt;pdb|1G3C|A BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF BASE IRON(III) CHELATE [Bos taurus] &gt;pdb|1G3D|A BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE COPPER (II) CHELATE [Bos taurus] &gt;pdb|1G3E|A BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF-BASE COPPER (II) CHELATE [Bos taurus]</Hit_def>
  <Hit_accession>1G3B_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>4.66302e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>6</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>80</Hit_num>
  <Hit_id>pdb|5PTP|A</Hit_id>
  <Hit_def>STRUCTURE OF HYDROLASE (SERINE PROTEINASE) [Bos taurus]</Hit_def>
  <Hit_accession>5PTP_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>4.93478e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>81</Hit_num>
  <Hit_id>pdb|1V2O|T</Hit_id>
  <Hit_def>Trypsin inhibitor in complex with bovine trypsin variant X(SSYI)bT.B4 [Bos taurus] &gt;pdb|1V2P|T Trypsin inhibitor in complex with bovine trypsin variant X(SSYI)bT.A4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2O_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>4.93478e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>82</Hit_num>
  <Hit_id>pdb|1V2J|T</Hit_id>
  <Hit_def>BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)bT.C1 [Bos taurus] &gt;pdb|1V2R|T Trypsin inhibitor in complex with bovine trypsin variant X(SSRI)bT.B4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2J_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>4.98775e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>83</Hit_num>
  <Hit_id>pdb|1TAW|A</Hit_id>
  <Hit_def>BOVINE TRYPSIN COMPLEXED TO APPI [Bos taurus] &gt;pdb|1ZR0|A Crystal Structure of Kunitz Domain 1 of Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin [Bos taurus] &gt;pdb|1ZR0|C Crystal Structure of Kunitz Domain 1 of Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin [Bos taurus]</Hit_def>
  <Hit_accession>1TAW_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.0413e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>84</Hit_num>
  <Hit_id>pdb|2TLD|E</Hit_id>
  <Hit_def>Crystal Structure Of An Engineered Subtilisin Inhibitor Complexed With Bovine Trypsin [Bos taurus]</Hit_def>
  <Hit_accession>2TLD_E</Hit_accession>
  <Hit_len>220</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.10149e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>85</Hit_num>
  <Hit_id>pdb|1F5R|A</Hit_id>
  <Hit_def>Rat Trypsinogen Mutant Complexed With Bovine Pancreatic Trypsin Inhibitor [Rattus norvegicus]</Hit_def>
  <Hit_accession>1F5R_A</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.11831e-24</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>52</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>119</Hsp_align-len>
      <Hsp_qseq>SWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>SVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>86</Hit_num>
  <Hit_id>pdb|1FY8|E</Hit_id>
  <Hit_def>Crystal Structure Of The Deltaile16val17 Rat Anionic Trypsinogen-bpti Complex [Rattus rattus]</Hit_def>
  <Hit_accession>1FY8_E</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.17316e-24</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>52</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>119</Hsp_align-len>
      <Hsp_qseq>SWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>SVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>87</Hit_num>
  <Hit_id>pdb|3TGK|E</Hit_id>
  <Hit_def>TRYPSINOGEN MUTANT D194N AND DELETION OF ILE 16-VAL 17 COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) [Rattus norvegicus]</Hit_def>
  <Hit_accession>3TGK_E</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.22859e-24</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>52</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>119</Hsp_align-len>
      <Hsp_qseq>SWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>SVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NNDI L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>88</Hit_num>
  <Hit_id>pdb|1HJ9|A</Hit_id>
  <Hit_def>Atomic resolution structures of trypsin provide insight into structural radiation damage [Bos taurus]</Hit_def>
  <Hit_accession>1HJ9_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.26128e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIXLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>89</Hit_num>
  <Hit_id>pdb|1V2U|T</Hit_id>
  <Hit_def>Benzamidine in complex with bovine trypsin varinat X(SSAI)bT.D1 [Bos taurus] &gt;pdb|1V2V|T Benzamidine in complex with bovine trypsin variant X(SSAI)bT.C1 [Bos taurus] &gt;pdb|1V2W|T Trypsin inhibitor in complex with bovine trypsin variant X(SSAI)bT.B4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2U_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.26128e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>90</Hit_num>
  <Hit_id>pdb|1AQ7|A</Hit_id>
  <Hit_def>Trypsin With Inhibitor Aeruginosin 98-b [Bos taurus] &gt;pdb|1AUJ|A Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor [Bos taurus] &gt;pdb|1AZ8|A Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor [Bos taurus] &gt;pdb|1BJU|A Beta-Trypsin Complexed With Acpu [Bos taurus] &gt;pdb|1BJV|A Beta-Trypsin Complexed With Appu [Bos taurus] &gt;pdb|1C1N|A Chain A, TRYPSIN [Bos taurus] &gt;pdb|1C1O|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1P|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1Q|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1R|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1S|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1T|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2D|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2E|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2F|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2G|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2H|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2I|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2J|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2K|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2L|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2M|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C5P|A Chain A, PROTEIN (TRYPSIN) [Bos taurus] &gt;pdb|1C5Q|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5R|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5S|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5T|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5U|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5V|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C9T|A Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|B Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|C Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|D Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|E Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|F Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1CE5|A BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE [Bos taurus] &gt;pdb|1D6R|A Crystal Structure Of Cancer Chemopreventive Bowman-birk Inhibitor In Ternary Complex With Bovine Trypsin At 2.3 A Resolution. Structural Basis Of Janus-faced Serine Protease Inhibitor Specificity [Bos taurus] &gt;pdb|1EB2|A Trypsin inhibitor complex (BPO) [Bos taurus] &gt;pdb|1EJM|A CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN [Bos taurus] &gt;pdb|1EJM|C CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN [Bos taurus] &gt;pdb|1EJM|E CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN [Bos taurus] &gt;pdb|1F2S|E Crystal Structure Of The Complex Formed Between Bovine Beta-trypsin And Mcti-a, A Trypsin Inhibitor Of Squash Family At 1.8 A Resolution [Bos taurus] &gt;pdb|1G36|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1G9I|E CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE [Bos taurus] &gt;pdb|1GBT|A Structure Of An Acyl-Enzyme Intermediate During Catalysis: (Guanidinobenzoyl) Trypsin [Bos taurus] &gt;pdb|1GHZ|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI0|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI1|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI2|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI3|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI4|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI5|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI6|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GJ6|A ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Bos taurus] &gt;pdb|1J8A|A Crystal Structure Of Benzamidine Inhibited Bovine Pancreatic Trypsin At 105k To 1.21a Resolution From Laboratory Source With High Number Of Waters Modelled [Bos taurus] &gt;pdb|1JIR|A Crystal Structure of Trypsin Complex with Amylamine in Cyclohexane [Bos taurus] &gt;pdb|1JRS|A HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN [Bos taurus] &gt;pdb|1JRT|A HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN [Bos taurus] &gt;pdb|1K1I|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1J|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1L|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1M|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1N|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1O|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1P|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1MAX|A Beta-Trypsin Phosphonate Inhibited [Bos taurus] &gt;pdb|1MAY|A Beta-Trypsin Phosphonate Inhibited [Bos taurus] &gt;pdb|1MTS|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1MTU|A FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN [Bos taurus] &gt;pdb|1MTV|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1MTW|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1N6X|A RIP-phasing on Bovine Trypsin [Bos taurus] &gt;pdb|1N6Y|A RIP-phasing on Bovine Trypsin [Bos taurus] &gt;pdb|1NC6|A Potent, small molecule inhibitors of human mast cell tryptase. Anti-asthmatic action of a dipeptide-based transition state analogue containing benzothiazole ketone [Bos taurus] &gt;pdb|1O2H|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2I|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2J|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2K|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2L|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2M|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2N|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2O|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2P|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2Q|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2R|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2S|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2T|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2U|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2V|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2W|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2X|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2Y|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2Z|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O30|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O31|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O32|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O33|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O34|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O35|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O36|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O37|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O38|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O39|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3A|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3B|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3C|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3D|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3E|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3F|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3G|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3H|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3I|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3J|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3K|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3L|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3M|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3N|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3O|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1OX1|A crystal structure of the bovine trypsin complex with a synthetic 11 peptide inhibitor [Bos taurus] &gt;pdb|1OYQ|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1P2I|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2J|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2K|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1PPC|E Geometry Of Binding Of The Benzamidine-and Arginine-based Inhibitors N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-amidinophenylalanyl- Piperidine (napap) And (2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4- Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray Crystallographic Determination Of The Napap-trypsin Complex And Modeling Of Napap- Thrombin And Mqpa-thrombin [Bos taurus] &gt;pdb|1PPE|E The Refined 2.0 Angstroms X-Ray Crystal Structure Of The Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima): Topological Similarity Of The Squash Seed Inhibitors With The Carboxypeptidase A Inhibitor From Potatoes [Bos taurus] &gt;pdb|1PPH|E Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To Thrombin And Trypsin: X- Ray Crystal Structures Of Their Trypsin Complexes And Modeling Of Their Thrombin Complexes [Sus scrofa] &gt;pdb|1QA0|A BOVINE TRYPSIN 2-AMINOBENZIMIDAZOLE COMPLEX [Bos taurus] &gt;pdb|1QB1|A Bovine Trypsin with 1-[2-[5-[amino(imino)methyl]-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid (ZK-806974) [Bos taurus] &gt;pdb|1QB6|A Bovine Trypsin 3,3&apos;-[3,5-Difluoro-4-Methyl-2, 6- Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk- 805623) Complex [Bos taurus] &gt;pdb|1QB9|A Bovine Trypsin 7-[[2-[[1-(1-iminoethyl)piperidin-4-yl]oxy]-9h- Carbozol-9-yl] Methyl]naphthalene-2-carboximidamide (zk-806450) Complex [Bos taurus] &gt;pdb|1QBN|A Bovine Trypsin 2-[amino(imino)methyl]-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridine-4-carboxylic Acid (ZK-806688) Complex [Bos taurus] &gt;pdb|1QBO|A Bovine Trypsin 7-[[6-[[1-(1-iminoethyl)piperidin-4-yl]oxy]-2-methyl- Benzimidazol-1-yl]methyl]naphthalene-2-carboximidamid Zk-806711 Inhibitor Complex [Bos taurus] &gt;pdb|1QCP|A Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta- Trypsin At 1.8 A [Bos taurus] &gt;pdb|1QL7|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1QL8|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1RXP|A Structure Of Trypsin (Orthorhombic) With 1-(4-Tert- Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino- Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid [Bos taurus] &gt;pdb|1S0Q|A Native Bovine Pancreatic Trypsin [Bos taurus] &gt;pdb|1S0R|A Bovine Pancreatic Trypsin inhibited with Benzamidine at Atomic resolution [Bos taurus] &gt;pdb|1SBW|A Crystal Structure Of Mung Bean Inhibitor Lysine Active Fragment Complex With Bovine Beta-Trypsin At 1.8a Resolution [Bos taurus] &gt;pdb|1SFI|A High resolution structure of a potent, cyclic protease inhibitor from sunflower seeds [Bos taurus] &gt;pdb|1SMF|E Studies on an artificial trypsin inhibitor peptide derived from the mung bean inhibitor [Bos taurus] &gt;pdb|1TAB|E Structure Of The Trypsin-Binding Domain Of Bowman-Birk Type Protease Inhibitor And Its Interaction With Trypsin [Bos taurus] &gt;pdb|1TIO|A Chain A, PROTEIN (BETA-TRYPSIN) [Bos taurus] &gt;pdb|1TLD|A Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms Resolution In A Crystal Form With Low Molecular Packing Density. Active Site Geometry, Ion Pairs And Solvent Structure [Bos taurus] &gt;pdb|1TPA|E The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|1TPO|A The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|1TPP|A The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|1TPS|A Atomic Structure Of The Trypsin-A90720a Complex: A Unified Approach To Structure And Function [Bos taurus] &gt;pdb|1TX7|A Bovine Trypsin complexed with p-amidinophenylmethylphosphinic acid (AMPA) [Bos taurus] &gt;pdb|1TX8|A Bovine Trypsin complexed with AMSO [Bos taurus] &gt;pdb|1TYN|A Atomic Structure Of The Trypsin-cyclotheonamide A Complex: Lessons For The Design Of Serine Protease Inhibitors [Bos taurus] &gt;pdb|1XUF|A TRYPSIN-BABIM-ZN+2, PH 8.2 [Bos taurus] &gt;pdb|1XUG|A TRYPSIN-BABIM-ZN+2, PH 8.2 [Bos taurus] &gt;pdb|1XUH|A TRYPSIN-KETO-BABIM-CO+2, PH 8.2 [Bos taurus] &gt;pdb|1XUI|A TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2 [Bos taurus] &gt;pdb|1XUJ|A TRYPSIN-KETO-BABIM-ZN+2, PH 8.2 [Bos taurus] &gt;pdb|1XUK|A TRYPSIN-BABIM-SULFATE, PH 5.9 [Bos taurus] &gt;pdb|1Y3U|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1Y3V|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1Y3W|A TRYPSIN INHIBITOR COMPLEX [Bos taurus] &gt;pdb|1Y3X|A TRYPSIN INHIBITOR COMPLEX [Bos taurus] &gt;pdb|1Y3Y|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1YP9|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1YYY|1 Trypsin inhibitors with rigid tripeptidyl aldehydes [Bos taurus] &gt;pdb|2A7H|A On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength [Bos taurus] &gt;pdb|2AGE|X Succinyl-AAPR-trypsin acyl-enzyme at 1.15 A resolution [Bos taurus] &gt;pdb|2AGG|X succinyl-AAPK-trypsin acyl-enzyme at 1.28 A resolution [Bos taurus] &gt;pdb|2AGI|X The leupeptin-trypsin covalent complex at 1.14 A resolution [Bos taurus] &gt;pdb|2AH4|X guanidinobenzoyl-trypsin acyl-enzyme at 1.13 A resolution [Bos taurus] &gt;pdb|2AYW|A Crystal Structure of the complex formed between trypsin and a designed synthetic highly potent inhibitor in the presence of benzamidine at 0.97 A resolution [Bos taurus] &gt;pdb|2BLV|A Trypsin before a high dose x-ray &apos;burn&apos; [Bos taurus] &gt;pdb|2BLW|A Trypsin after a high dose X-ray &apos;Burn&apos; [Bos taurus] &gt;pdb|2BTC|E Bovine Trypsin In Complex With Squash Seed Inhibitor (Cucurbita Pepo Trypsin Inhibitor Ii) [Bos taurus] &gt;pdb|2BZA|A BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZYLAMINE [Bos taurus] &gt;pdb|2CMY|A Crystal complex between bovine trypsin and Veronica hederifolia trypsin inhibitor [Bos taurus] &gt;pdb|2F3C|E Crystal structure of infestin 1, a Kazal-type serineprotease inhibitor, in complex with trypsin [Bos taurus] &gt;pdb|2FI3|E Crystal structure of a BPTI variant (Cys14-&gt;Ser, Cys38-&gt;Ser) in complex with trypsin [Bos taurus] &gt;pdb|2FX4|A Bovine trypsin bound by 4-piperidinebutyrate to make acylenzyme complex [Bos taurus] &gt;pdb|2FX6|A bovine trypsin complexed with 2-aminobenzamidazole [Bos taurus] &gt;pdb|2G55|A Anomalous substructure of trypsin (P3121) [Bos taurus] &gt;pdb|2G5N|A Indole-amidine Complexes with Bovine Trypsin [Bos taurus] &gt;pdb|2G5V|A Indole-amidine Complexes with Bovine Trypsin [Bos taurus] &gt;pdb|2G81|E Crystal Structure of the Bowman-Birk Inhibitor from Vigna unguiculata Seeds in Complex with Beta-trypsin at 1.55 Angstrons Resolution [Bos taurus] &gt;pdb|2G8T|A Indole-amidine Complexes with Bovine Trypsin [Bos taurus] &gt;pdb|2ILN|A Crystal structure of the Bowman-Birk inhibitor from snail medic seeds in complex with bovine trypsin [Bos taurus] &gt;pdb|2ILN|B Crystal structure of the Bowman-Birk inhibitor from snail medic seeds in complex with bovine trypsin [Bos taurus] &gt;pdb|2J9N|A Robotically harvested Trypsin complexed with Benzamidine containing polypeptide mediated crystal contacts [Bos taurus] &gt;pdb|2O9Q|A The crystal structure of Bovine Trypsin complexed with a small inhibition peptide ORB2K [Bos taurus] &gt;pdb|2OTV|A Crystal structure of the complex formed between bovine trypsin and nicotinamide at 1.56 A resolution [Bos taurus] &gt;pdb|2OXS|A Crystal Structure of the trypsin complex with benzamidine at high temperature (35 C) [Bos taurus] &gt;pdb|2PLX|A Trypsin complexed to a synthetic peptide from Veronica hederifolia [Bos taurus] &gt;pdb|2PTC|E The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|2PTN|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|2QN5|T Crystal Structure and Functional Study of the Bowman-Birk Inhibitor from Rice Bran in Complex with Bovine Trypsin [Bos taurus] &gt;pdb|2QYI|A Crystal structure of a binary complex between an engineered trypsin inhibitor and Bovine trypsin [Bos taurus] &gt;pdb|2QYI|C Crystal structure of a binary complex between an engineered trypsin inhibitor and Bovine trypsin [Bos taurus] &gt;pdb|2TIO|A Low Packing Density Form Of Bovine Beta-Trypsin In Cyclohexane [Bos taurus] &gt;pdb|2UUY|A Structure of a tick tryptase inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|2XTT|B Bovine trypsin in complex with evolutionary enhanced Schistocerca gregaria protease inhibitor 1 (SGPI-1-P02) [Bos taurus] &gt;pdb|2ZDK|A Exploring Trypsin S3 Pocket [Bos taurus] &gt;pdb|2ZDL|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZDM|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZDN|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZFS|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZFT|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZHD|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZQ1|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZQ2|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|3A7T|A Crystal Structure of Trypsin complexed with 4-formylbenzimidamide [Bos taurus] &gt;pdb|3A7V|A Crystal Structure of Trypsin complexed with 3-formylbenzimidamide [Bos taurus] &gt;pdb|3A7W|A Crystal Structure of Trypsin complexed with (E)-4-((tetrahydro-2H-pyran-2-yloxyimino)methyl)benzimidamide (soaking 4hours) [Bos taurus] &gt;pdb|3A7X|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 45seconds) [Bos taurus] &gt;pdb|3A7Y|A Crystal Structure of Trypsin complexed with (E)-4-((1-methylpiperidin-3-yloxyimino)methyl)benzimidamide (soaking 2hours) [Bos taurus] &gt;pdb|3A7Z|A Crystal Structure of Trypsin complexed with (E)-4-((1-methylpiperidin-4-yloxyimino)methyl)benzimidamide (soaking 3hours) [Bos taurus] &gt;pdb|3A80|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)-2-methylpropanoic acid (soaking 40seconds) [Bos taurus] &gt;pdb|3A81|A Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 8 hours) [Bos taurus] &gt;pdb|3A82|A Crystal Structure of Trypsin complexed with pre-synthesized (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid [Bos taurus] &gt;pdb|3A83|A Crystal Structure of Trypsin complexed with pre-synthesized (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide [Bos taurus] &gt;pdb|3A84|A Crystal Structure of Trypsin complexed with(E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 5 seconds) [Bos taurus] &gt;pdb|3A85|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 15 seconds) [Bos taurus] &gt;pdb|3A86|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 30 seconds) [Bos taurus] &gt;pdb|3A87|A Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 5 minutes) [Bos taurus] &gt;pdb|3A88|A Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 30 minutes) [Bos taurus] &gt;pdb|3A89|A Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 4 hours) [Bos taurus] &gt;pdb|3A8A|A Crystal Structure of Trypsin complexed with 4-formylbenzimidamide and aniline [Bos taurus] &gt;pdb|3A8B|A Crystal Structure of Trypsin complexed with (E)-4-((4-bromophenylimino)methyl)benzimidamide [Bos taurus] &gt;pdb|3A8C|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking with mixture of [(E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid] and [(E)-2-(4-carbamimidoylbenzylideneaminooxy)-2-methylpropanoic acid]) [Bos taurus] &gt;pdb|3A8D|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (under aniline-free condition) [Bos taurus] &gt;pdb|3AAS|A Bovine beta-trypsin bound to meta-guanidino schiff base copper (II) chelate [Bos taurus] &gt;pdb|3AAU|A Bovine beta-trypsin bound to meta-diguanidino schiff base copper (II) chelate [Bos taurus] &gt;pdb|3AAV|A Bovine beta-trypsin bound to meta-diamidino schiff base copper (II) chelate [Bos taurus] &gt;pdb|3AAV|B Bovine beta-trypsin bound to meta-diamidino schiff base copper (II) chelate [Bos taurus] &gt;pdb|3ATI|A Crystal structure of trypsin complexed with (3-methoxyphenyl)methanamine [Bos taurus] &gt;pdb|3ATK|A Crystal structure of trypsin complexed with cycloheptanamine [Bos taurus] &gt;pdb|3ATL|A Crystal structure of trypsin complexed with benzamidine [Bos taurus] &gt;pdb|3ATM|A Crystal structure of trypsin complexed with 2-(1H-indol-3-yl)ethanamine [Bos taurus] &gt;pdb|3BTD|E The Crystal Structures of the Complexes Between the Bovine Beta-Trypsin and Ten P1 Variants of BPTI. [Bos taurus] &gt;pdb|3BTE|E The Crystal Structures of the Complexes Between Bovine Beta-Trypsin and Ten P1 Variants of BPTI. [Bos taurus] &gt;pdb|3BTF|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI. [Bos taurus] &gt;pdb|3BTG|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTH|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTK|E The Crystal Structures Of The Complexes Between Bovine Beta- Trypsin And Ten P1 Variants Of Bpti [Bos taurus] &gt;pdb|3BTM|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTQ|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTT|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTW|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3D65|E Crystal structure of Textilinin-1, a Kunitz-type serine protease inhibitor from the Australian Common Brown snake venom, in complex with trypsin [Bos taurus] &gt;pdb|3E8L|A The Crystal Structure of the Double-headed Arrowhead Protease Inhibitor A in Complex with Two Trypsins [Bos taurus] &gt;pdb|3E8L|B The Crystal Structure of the Double-headed Arrowhead Protease Inhibitor A in Complex with Two Trypsins [Bos taurus] &gt;pdb|3GY2|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY3|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY4|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY5|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY6|A A comparative study on the inhibition of bovine beta-trypsin by the bis-benzamidines diminazene and pentamidine [Bos taurus] &gt;pdb|3GY7|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY8|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3I29|A Crystal structure of a binary complex between an mutant trypsin inhibitor with bovine trypsin [Bos taurus] &gt;pdb|3ITI|A Structure of bovine trypsin with the MAD triangle B3C [Bos taurus] &gt;pdb|3LJJ|A Bovine trypsin in complex with UB-THR 10 [Bos taurus] &gt;pdb|3LJO|A Bovine trypsin in complex with UB-THR 11 [Bos taurus] &gt;pdb|3M35|A Trypsin in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2&apos;-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423) [Bos taurus] &gt;pdb|3M7Q|A Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean sea anemone stichodactyla helianthus in complex with bovine pancreatic trypsin [Bos taurus] &gt;pdb|3MFJ|A Bovine trypsin at 0.8 A resolution, restrained refinement [Bos taurus] &gt;pdb|3MI4|A Bovine trypsin at 0.8 A resolution, non-restrained refinement [Bos taurus] &gt;pdb|3NK8|A Trypsin in complex with fluorine-containing fragment [Bos taurus] &gt;pdb|3NKK|A Trypsin in complex with fluorine containing fragment [Bos taurus] &gt;pdb|3OTJ|E A Crystal Structure of Trypsin Complexed with BPTI (Bovine Pancreatic Trypsin Inhibitor) by X-ray/Neutron Joint Refinement [Bos taurus] &gt;pdb|3PTB|A The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|3PTN|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|3RDZ|A Crystal Structure of rBTI-trypsin complex at 2.26 angstrom resolution [Bos taurus] &gt;pdb|3RDZ|B Crystal Structure of rBTI-trypsin complex at 2.26 angstrom resolution [Bos taurus] &gt;pdb|3RU4|T Crystal structure of the Bowman-Birk serine protease inhibitor BTCI in complex with trypsin and chymotrypsin [Bos taurus] &gt;pdb|3RXA|A Crystal structure of Trypsin complexed with cycloheptanamine [Bos taurus] &gt;pdb|3RXB|A Crystal structure of Trypsin complexed with 4-guanidinobutanoic acid [Bos taurus] &gt;pdb|3RXC|A Crystal structure of Trypsin complexed with 2-aminopyridine [Bos taurus] &gt;pdb|3RXD|A Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamine [Bos taurus] &gt;pdb|3RXE|A Crystal structure of Trypsin complexed with benzamide [Bos taurus] &gt;pdb|3RXF|A Crystal structure of Trypsin complexed with 4-aminopyridine [Bos taurus] &gt;pdb|3RXG|A Crystal structure of Trypsin complexed with 4-aminocyclohexanol [Bos taurus] &gt;pdb|3RXH|A Crystal structure of Trypsin complexed with 2-(1H-imidazol-4-yl)ethanamine [Bos taurus] &gt;pdb|3RXI|A Crystal structure of Trypsin complexed with 2-(1H-indol-3-yl)ethanamine [Bos taurus] &gt;pdb|3RXJ|A Crystal structure of Trypsin complexed with 4-guanidinobenzoic acid [Bos taurus] &gt;pdb|3RXK|A Crystal structure of Trypsin complexed with methyl 4-amino-1-methyl-pyrrolidine-2-carboxylate [Bos taurus] &gt;pdb|3RXL|A Crystal structure of Trypsin complexed with (2,5-dimethyl-3-furyl)methanamine [Bos taurus] &gt;pdb|3RXM|A Crystal structure of Trypsin complexed with [2-(2-thienyl)thiazol-4-yl]methanamine [Bos taurus] &gt;pdb|3RXO|A Crystal structure of Trypsin complexed with (3-pyrrol-1-ylphenyl)methanamine [Bos taurus] &gt;pdb|3RXP|A Crystal structure of Trypsin complexed with (1,5-dimethylpyrazol-3-yl)methanamine [Bos taurus] &gt;pdb|3RXQ|A Crystal structure of Trypsin complexed with benzamide (F01 and F05, cocktail experiment) [Bos taurus] &gt;pdb|3RXR|A Crystal structure of Trypsin complexed with cycloheptanamine (F01 and F03, cocktail experiment) [Bos taurus] &gt;pdb|3RXS|A Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamine (F04 and A06, cocktail experiment) [Bos taurus] &gt;pdb|3RXT|A Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamin (F04 and F03, cocktail experiment) [Bos taurus] &gt;pdb|3RXU|A Crystal structure of Trypsin complexed with benzamide (F05 and A06, cocktail experiment) [Bos taurus] &gt;pdb|3RXV|A Crystal structure of Trypsin complexed with benzamide (F05 and F03, cocktail experiment) [Bos taurus] &gt;pdb|3T25|A TMAO-grown orthorhombic trypsin (bovine) [Bos taurus] &gt;pdb|3T26|A Orthorhombic trypsin (bovine) in the presence of sarcosine [Bos taurus] &gt;pdb|3T27|A Orthorhombic trypsin (bovine) in the presence of betaine [Bos taurus] &gt;pdb|3T28|A TMAO-grown trypsin (bovine)-previously unreported tetragonal crystal form [Bos taurus] &gt;pdb|3T29|A TMAO-grown trigonal trypsin (bovine) [Bos taurus] &gt;pdb|3UNR|A Bond length analysis of asp, glu and his residues in trypsin at 1.2A resolution [Bos taurus] &gt;pdb|3VPK|A Crystal Structure of 6-Guanidinohexanoyl Trypsin [Bos taurus] &gt;pdb|4AB8|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4AB9|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABA|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABB|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABD|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABE|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABF|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABG|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABH|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABI|A Co-complex structure of bovine trypsin with a modified Bowman-Birk inhibitor (PtA)SFTI-1(1,14), that was 1,4-disubstituted with a 1,2,3- trizol to mimic a trans amide bond [Bos taurus] &gt;pdb|4ABJ|A Co-complex structure of bovine trypsin with a modified Bowman-Birk inhibitor (IcA)SFTI-1(1,14), that was 1,5-disubstituted with 1,2,3- trizol to mimic a cis amide bond [Bos taurus] &gt;pdb|4AOQ|A Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A) [Bos taurus] &gt;pdb|4AOQ|B Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A) [Bos taurus] &gt;pdb|4AOQ|C Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A) [Bos taurus] &gt;pdb|4AOR|A Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III) [Bos taurus] &gt;pdb|4AOR|B Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III) [Bos taurus] &gt;pdb|4AOR|C Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III) [Bos taurus] &gt;pdb|4HGC|A Crystal structure of bovine trypsin complexed with sfti-1 analog containing a peptoid residue at position p1 [Bos taurus] &gt;pdb|4I8G|A Bovine trypsin at 0.8 resolution [Bos taurus] &gt;pdb|4I8H|A Bovine trypsin at 0.75 resolution [Bos taurus] &gt;pdb|4I8J|A Bovine trypsin at 0.87 A resolution [Bos taurus] &gt;pdb|4I8K|A Bovine trypsin at 0.85 resolution [Bos taurus] &gt;pdb|4I8L|A Bovine trypsin at 0.87 resolution [Bos taurus] &gt;pdb|4J2Y|B Crystal structure of a plant trypsin inhibitor EcTI in complex with bovine trypsin. [Bos taurus] &gt;pdb|4KTS|A Bovine trypsin in complex with microviridin J at pH 8.5 [Bos taurus] &gt;pdb|4KTU|A Bovine trypsin in complex with microviridin J at pH 6.5 [Bos taurus] &gt;pdb|4MTB|A Bovine trypsin in complex with small molecule inhibitor [Bos taurus] &gt;pdb|4NCY|A In situ trypsin crystallized on a MiTeGen micromesh with imidazole ligand [Bos taurus] &gt;pdb|4TPY|A High throughput screening using acoustic droplet ejection to combine protein crystals and chemical libraries on crystallization plates at high density [Bos taurus] &gt;pdb|4U2W|A Atomic resolution crystal structure of HV-BBI protease inhibitor from amphibian skin in complex with bovine trypsin [Bos taurus] &gt;pdb|4Y0Y|E Trypsin in complex with with BPTI [Bos taurus] &gt;pdb|4Y0Z|E Trypsin in complex with with BPTI mutant AMINOBUTYRIC ACID [Bos taurus] &gt;pdb|4Y10|E Trypsin in complex with with BPTI mutant (2S)-2-amino-4,4-difluorobutanoic acid [Bos taurus] &gt;pdb|4Y11|E Trypsin in complex with with BPTI mutant (2S)-2-amino-4,4,4-trifluorobutanoic acid [Bos taurus] &gt;pdb|4YTA|A BOND LENGTH ANALYSIS OF ASP, GLU AND HIS RESIDUES IN TRYPSIN AT 1.2A RESOLUTION [Bos taurus] &gt;pdb|5EG4|A BOVINE TRYPSIN IN COMPLEX WITH CYCLIC INHIBITOR [Bos taurus] &gt;pdb|5F6M|A Isotropic Trypsin Model for Comparison of Diffuse Scattering [Bos taurus] &gt;pdb|5GIB|A Succinic acid bound trypsin crystallized as dimer [Bos taurus] &gt;pdb|5GIB|B Succinic acid bound trypsin crystallized as dimer [Bos taurus] &gt;pdb|5GXP|A Cationic Trypsin With GOL/PGE as Dimer at pH 4.6 [Bos taurus] &gt;pdb|5GXP|B Cationic Trypsin With GOL/PGE as Dimer at pH 4.6 [Bos taurus] &gt;pdb|5K7R|A MicroED structure of trypsin at 1.7 A resolution [Bos taurus] &gt;pdb|5LGO|A Trypsin inhibitors for the treatment of pancreatitis - cpd 15 [Bos taurus] &gt;pdb|5LH4|A Trypsin inhibitors for the treatment of pancreatitis - cpd 1 [Bos taurus] &gt;pdb|5LH8|A Trypsin inhibitors for the treatment of pancreatitis - cpd 8 [Bos taurus] &gt;pdb|5MN1|A Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNA|A Cationic trypsin in complex with aniline (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNB|A Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNC|A Cationic trypsin in complex with aniline (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNE|A Cationic trypsin in its apo form (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNF|A Cationic trypsin in its apo form (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNG|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|5MNH|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|5MNK|A Cationic trypsin in complex with benzylamine (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNL|A Cationic trypsin in complex with benzylamine (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNM|A Cationic trypsin in complex with benzylamine (at 295 K) [Bos taurus] &gt;pdb|5MNN|A Cationic trypsin in complex with N-amidinopiperidine (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNO|A Cationic trypsin in complex with N-amidinopiperidine (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNP|A Cationic trypsin in complex with N-amidinopiperidine (at 295 K) [Bos taurus] &gt;pdb|5MNQ|A Cationic trypsin in complex with a derivative of N-amidinopiperidine [Bos taurus] &gt;pdb|5MNX|A Neutron structure of cationic trypsin in complex with 2-aminopyridine [Bos taurus] &gt;pdb|5MNY|A Neutron structure of cationic trypsin in complex with aniline [Bos taurus] &gt;pdb|5MNZ|A Neutron structure of cationic trypsin in its apo form [Bos taurus] &gt;pdb|5MO0|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|5MO1|A Neutron structure of cationic trypsin in complex with benzylamine [Bos taurus] &gt;pdb|5MO2|A Neutron structure of cationic trypsin in complex with N-amidinopiperidine [Bos taurus] &gt;pdb|5MON|A Joint X-ray/neutron structure of cationic trypsin in complex with 2-aminopyridine [Bos taurus] &gt;pdb|5MOO|A Joint X-ray/neutron structure of cationic trypsin in complex with aniline [Bos taurus] &gt;pdb|5MOP|A Joint X-ray/neutron structure of cationic trypsin in its apo form [Bos taurus] &gt;pdb|5MOQ|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|5MOR|A Joint X-ray/neutron structure of cationic trypsin in complex with benzylamine [Bos taurus] &gt;pdb|5MOS|A Joint X-ray/neutron structure of cationic trypsin in complex with N-amidinopiperidine [Bos taurus] &gt;pdb|5T3H|A bovine trypsin soaked with selenourea for 5 min [Bos taurus] &gt;pdb|6AVL|A Orthorhombic Trypsin (295 K) in the presence of 50% xylose [Bos taurus] &gt;pdb|6B6N|A Orthorhombic trypsin (295 K) in the presence of 50% mpd [Bos taurus] &gt;pdb|6B6O|A Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant [Bos taurus] &gt;pdb|6B6P|A Orthorhombic trypsin cryocooled to 100 K with 30% xylose as cryoprotectant [Bos taurus] &gt;pdb|6B6Q|A Orthorhombic trypsin cryocooled to 100 K with 50% xylose as cryoprotectant [Bos taurus] &gt;pdb|6B6R|A Orthorhombic trypsin cryocooled to 100 K with 50% mpd as cryoprotectant [Bos taurus] &gt;pdb|6B6S|A Orthorhombic trypsin cryocooled to 100 K with 50% ethanol as cryoprotectant [Bos taurus] &gt;pdb|6B6T|A Orthorhombic trypsin cryocooled to 100 K with 50% methanol as cryoprotectant [Bos taurus] &gt;pdb|6BFP|A Bovine trypsin bound to potent inhibitor [Bos taurus] &gt;pdb|6BVH|A Trypsin complexed with a modified sunflower trypsin inhibitor, SFTI-TCTR(N12,N14) [Bos taurus] &gt;pdb|6DWF|A Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|B Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|C Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|D Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|E Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|F Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|A Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|B Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|C Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|D Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|E Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|F Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWU|AA Chain AA, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AC Chain AC, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AE Chain AE, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AG Chain AG, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AI Chain AI, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AK Chain AK, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AM Chain AM, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AO Chain AO, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AQ Chain AQ, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AS Chain AS, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AU Chain AU, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BA Chain BA, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BC Chain BC, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BE Chain BE, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BG Chain BG, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BI Chain BI, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BK Chain BK, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BM Chain BM, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BO Chain BO, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BQ Chain BQ, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BS Chain BS, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BU Chain BU, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CA Chain CA, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CC Chain CC, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CE Chain CE, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CG Chain CG, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CI Chain CI, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CK Chain CK, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CM Chain CM, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CO Chain CO, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CQ Chain CQ, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CS Chain CS, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CU Chain CU, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DA Chain DA, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DC Chain DC, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DE Chain DE, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DG Chain DG, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DI Chain DI, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DK Chain DK, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DM Chain DM, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DO Chain DO, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DQ Chain DQ, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DS Chain DS, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DU Chain DU, Cationic trypsin [Bos taurus] &gt;pdb|6DZF|A Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant [Bos taurus] &gt;pdb|6E5M|A Crystallographic structure of the cyclic nonapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 32 2 1 [Bos taurus] &gt;pdb|6EAT|A Crystallographic structure of the cyclic nonapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21. [Bos taurus] &gt;pdb|6EAU|A Crystallographic structure of the octapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21. [Bos taurus] &gt;pdb|6EAV|A Crystallographic structure of the cyclic heptapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 4(1) 2(1) 2 [Bos taurus] &gt;pdb|6EAW|A Crystallographic structure of the cyclic heptapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21 [Bos taurus] &gt;pdb|6EAX|A Crystallographic structure of the cyclic hexapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21 [Bos taurus] &gt;pdb|6FID|A Bovine trypsin solved by S-SAD on ID30B [Bos taurus] &gt;pdb|6QIH|A Pancreatic Bovine Trypsin with a boronic acid inhibitor [Bos taurus] &gt;pdb|6SUX|A Terahertz irradiated structure of bovine trypsin (even frames of crystal x37) [Bos taurus] &gt;pdb|6SV0|A Non-terahertz irradiated structure of bovine trypsin (odd frames of crystal x37) [Bos taurus] &gt;pdb|6SV6|A Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x38) [Bos taurus] &gt;pdb|6SV8|A Terahertz irradiated structure of bovine trypsin (odd frames of crystal x38) [Bos taurus] &gt;pdb|6SV9|A Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x40) [Bos taurus] &gt;pdb|6SVB|A Terahertz irradiated structure of bovine trypsin (odd frames of crystal x40) [Bos taurus] &gt;pdb|6SVD|A Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x41) [Bos taurus] &gt;pdb|6SVG|A Terahertz irradiated structure of bovine trypsin (odd frames of crystal x41) [Bos taurus] &gt;pdb|6SVI|A Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x42) [Bos taurus] &gt;pdb|6SVJ|A Terahertz irradiated structure of bovine trypsin (odd frames of crystal x42) [Bos taurus] &gt;pdb|6SVN|A Reference structure of bovine trypsin (even frames of crystal x28) [Bos taurus] &gt;pdb|6SVR|A Reference structure of bovine trypsin (odd frames of crystal x28) [Bos taurus] &gt;pdb|6SVU|A Reference structure of bovine trypsin (even frames of crystal x30) [Bos taurus] &gt;pdb|6SVV|A Reference structure of bovine trypsin (odd frames of crystal x30) [Bos taurus] &gt;pdb|6SVW|A Reference structure of bovine trypsin (even frames of crystal x33) [Bos taurus] &gt;pdb|6SVX|A Reference structure of bovine trypsin (odd frames of crystal x33) [Bos taurus] &gt;pdb|6SVZ|A Reference structure of bovine trypsin (even frames of crystal x34) [Bos taurus] &gt;pdb|6SW0|A Reference structure of bovine trypsin (odd frames of crystal x34) [Bos taurus] &gt;pdb|6U22|A Crystal structure of SFTI-triazole inhibitor in complex with beta-trypsin [Bos taurus] &gt;pdb|6VXY|A Triazole bridged SFTI1 inhibitor in complex with beta-trypsin [Bos taurus] &gt;pdb|6XYG|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6XYK|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6YIT|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YIU|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YIV|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YIW|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6YIX|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YIY|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6YZA|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YZC|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6ZFJ|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6ZFK|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6ZQ2|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7AYS|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRV|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRW|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRX|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRY|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRZ|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS0|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS1|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS2|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS3|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS4|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS5|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS6|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS7|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS8|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS9|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BSA|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|B Chain B, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|C Chain C, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|D Chain D, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|E Chain E, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|F Chain F, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|B Chain B, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|C Chain C, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|D Chain D, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|E Chain E, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|F Chain F, Cationic trypsin [Bos taurus] &gt;pdb|7JWX|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7JWX|B Chain B, Cationic trypsin [Bos taurus] &gt;pdb|7JWX|C Chain C, Cationic trypsin [Bos taurus] &gt;pdb|7JWX|D Chain D, Cationic trypsin [Bos taurus]</Hit_def>
  <Hit_accession>1AQ7_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.37485e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>91</Hit_num>
  <Hit_id>pdb|1V2S|T</Hit_id>
  <Hit_def>Benzamidine in complex with bovine trypsin variant X(SSFI.Glu)bT.D1 [Bos taurus] &gt;pdb|1V2T|T Trypsin inhibitor in complex with bovine trypsin variant X(SSFI.Glu)bT.B4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2S_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.37485e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>92</Hit_num>
  <Hit_id>pdb|6DWR|A</Hit_id>
  <Hit_def>Trypsin serine protease modified with the protease inhibitor cyanobenzylsulfonylfluoride [Bos taurus]</Hit_def>
  <Hit_accession>6DWR_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>5.66959e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNXRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>93</Hit_num>
  <Hit_id>pdb|1TRM|A</Hit_id>
  <Hit_def>THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS [Rattus rattus] &gt;pdb|1TRM|B THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS [Rattus rattus] &gt;pdb|2TRM|A THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS [Rattus norvegicus]</Hit_def>
  <Hit_accession>1TRM_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.8189</Hsp_bit-score>
      <Hsp_score>229</Hsp_score>
      <Hsp_evalue>6.24141e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>54</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NN+I L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>94</Hit_num>
  <Hit_id>pdb|2FI4|E</Hit_id>
  <Hit_def>Crystal structure of a BPTI variant (Cys14-&gt;Ser) in complex with trypsin [Bos taurus] &gt;pdb|2FTL|E Crystal structure of trypsin complexed with BPTI at 100K [Bos taurus]</Hit_def>
  <Hit_accession>2FI4_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.8189</Hsp_bit-score>
      <Hsp_score>229</Hsp_score>
      <Hsp_evalue>6.37611e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS    V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>95</Hit_num>
  <Hit_id>pdb|1EZS|C</Hit_id>
  <Hit_def>Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a, D70a Bound To Rat Anionic Trypsin Ii [Rattus norvegicus] &gt;pdb|1EZS|D Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a, D70a Bound To Rat Anionic Trypsin Ii [Rattus norvegicus] &gt;pdb|1EZU|C Ecotin Y69f, D70p Bound To D102n Trypsin [Rattus norvegicus] &gt;pdb|1EZU|D Ecotin Y69f, D70p Bound To D102n Trypsin [Rattus norvegicus]</Hit_def>
  <Hit_accession>1EZS_C</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.8189</Hsp_bit-score>
      <Hsp_score>229</Hsp_score>
      <Hsp_evalue>6.58363e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>54</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYTCQENSVPYQVSL--NSGYHFCGGSLINDQWVVSAAHCYKSRIQVRL-GEHNINVLEGDEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSC--APAGTQCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G+HFCGGSLIN+ WVV+AAHC  +   V + GE +        Q +  AK+ K+  ++  T+NN+I L+KLS+    +  V+ V LPS+     AGT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>96</Hit_num>
  <Hit_id>pdb|1ZZZ|A</Hit_id>
  <Hit_def>Trypsin inhibitors with rigid tripeptidyl aldehydes [Bos taurus]</Hit_def>
  <Hit_accession>1ZZZ_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>6.62853e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>139</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>97</Hit_num>
  <Hit_id>pdb|1V2Q|T</Hit_id>
  <Hit_def>Trypsin inhibitor in complex with bovine trypsin variant X(SSWI)bT.B4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2Q_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.8189</Hsp_bit-score>
      <Hsp_score>229</Hsp_score>
      <Hsp_evalue>7.01913e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>98</Hit_num>
  <Hit_id>pdb|4GUX|A</Hit_id>
  <Hit_def>Crystal structure of trypsin:MCoTi-II complex [Bos taurus] &gt;pdb|4GUX|B Crystal structure of trypsin:MCoTi-II complex [Bos taurus] &gt;pdb|4GUX|C Crystal structure of trypsin:MCoTi-II complex [Bos taurus] &gt;pdb|4XOJ|A Structure of bovine trypsin in complex with analogues of sunflower inhibitor 1 (SFTI-1) [Bos taurus] &gt;pdb|5FXL|A Structure of trypsin solved by MR from data collected by Direct Data Collection (DDC) using the ESRF RoboDiff goniometer [Bos taurus] &gt;pdb|5JYI|A Trypsin bound with succinic acid at 1.9A [Bos taurus] &gt;pdb|6QL0|A Cationic Trypsin in Complex with a D-Phe-Pro-p-aminopyridine derivative [Bos taurus] &gt;pdb|6SWV|AAA Chain AAA, Cationic trypsin [Bos taurus] &gt;pdb|6SY3|A Cationic Trypsin in Complex with a D-DiPhe-Pro-pyridine derivative [Bos taurus] &gt;pdb|6T0M|A Cationic Trypsin in Complex with a D-Phe-Pro-diaminopyridine derivative [Bos taurus] &gt;pdb|6T0P|A Cationic Trypsin in Complex with a D-Phe-Pro-2-aminopyridine derivative [Bos taurus] &gt;pdb|6T5W|A Cationic Trypsin in Complex with a D-Phe-Pro-p-aminopyridine Derivative (cocrystallizaton at 291 K) [Bos taurus] &gt;pdb|6T9U|A Chain A, Cationic Trypsin [Bos taurus] &gt;pdb|6T9V|A Chain A, Cationic Trypsin [Bos taurus] &gt;pdb|6YDY|A Chain A, Cationic Trypsin [Bos taurus] &gt;pdb|6YIS|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus]</Hit_def>
  <Hit_accession>4GUX_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>7.09848e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>148</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>99</Hit_num>
  <Hit_id>pdb|1OPH|B</Hit_id>
  <Hit_def>Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And S195a Trypsin [Bos taurus]</Hit_def>
  <Hit_accession>1OPH_B</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>7.53209e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>100</Hit_num>
  <Hit_id>pdb|1EZX|C</Hit_id>
  <Hit_def>Crystal Structure Of A Serpin:protease Complex [Bos taurus] &gt;pdb|1F0T|A Bovine Trypsin Complexed With Rpr131247 [Bos taurus] &gt;pdb|1F0U|A Bovine Trypsin Complexed With Rpr128515 [Bos taurus] &gt;pdb|1LQE|A Crystal Structure Of Trypsin In Complex With 79. [Bos taurus] &gt;pdb|2BY5|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BY6|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BY7|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BY8|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BY9|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BYA|X Chain X, CATIONIC TRYPSIN [Bos taurus]</Hit_def>
  <Hit_accession>1EZX_C</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.2041</Hsp_bit-score>
      <Hsp_score>230</Hsp_score>
      <Hsp_evalue>7.69387e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>101</Hit_num>
  <Hit_id>pdb|6MRQ|A</Hit_id>
  <Hit_def>Structure of ToPI1 inhibitor from Tityus obscurus scorpion venom in complex with trypsin [Bos taurus]</Hit_def>
  <Hit_accession>6MRQ_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.8189</Hsp_bit-score>
      <Hsp_score>229</Hsp_score>
      <Hsp_evalue>8.02788e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>102</Hit_num>
  <Hit_id>pdb|1A0J|A</Hit_id>
  <Hit_def>Crystal Structure Of A Non-Psychrophilic Trypsin From A Cold-Adapted Fish Species. [Salmo salar] &gt;pdb|1A0J|B Crystal Structure Of A Non-Psychrophilic Trypsin From A Cold-Adapted Fish Species. [Salmo salar] &gt;pdb|1A0J|C Crystal Structure Of A Non-Psychrophilic Trypsin From A Cold-Adapted Fish Species. [Salmo salar] &gt;pdb|1A0J|D Crystal Structure Of A Non-Psychrophilic Trypsin From A Cold-Adapted Fish Species. [Salmo salar]</Hit_def>
  <Hit_accession>1A0J_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>8.78287e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>122</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>127</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGYECRKNSASYQASLQ--SGYHFCGGSLISSTWVVSAAHCYKSRIQVRL-GEHNIAVNEGTEQFIDSVKVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALPSSCA--SSGTRCLVSGWG</Hsp_hseq>
      <Hsp_midline>IV G E    S  +Q SLQ  +G+HFCGGSLI+  WVV+AAHC  +   V + GE +   +    Q +   KV  +  YNS  ++NDI L+KLS  AS +  VS V LPS+    ++GT C+ +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>103</Hit_num>
  <Hit_id>pdb|1ZHM|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of the Coagulation Factor XIa in Complex with Benzamidine (S434A-T475A-K437 Mutant) [Homo sapiens]</Hit_def>
  <Hit_accession>1ZHM_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.8189</Hsp_bit-score>
      <Hsp_score>229</Hsp_score>
      <Hsp_evalue>9.10631e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q   +E      + ++  + +Y       DI LLKL T  +++ +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>104</Hit_num>
  <Hit_id>pdb|4B1T|A</Hit_id>
  <Hit_def>Structure of the factor Xa-like trypsin variant triple-Ala (TA) in complex with eglin C [Bos taurus] &gt;pdb|4B1T|C Structure of the factor Xa-like trypsin variant triple-Ala (TA) in complex with eglin C [Bos taurus]</Hit_def>
  <Hit_accession>4B1T_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>9.98296e-24</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>105</Hit_num>
  <Hit_id>pdb|1V2N|T</Hit_id>
  <Hit_def>Potent factor XA inhibitor in complex with bovine trypsin variant X(99/175/190)bT [Bos taurus]</Hit_def>
  <Hit_accession>1V2N_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.00901e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>106</Hit_num>
  <Hit_id>pdb|1Y59|T</Hit_id>
  <Hit_def>Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant [Bos taurus] &gt;pdb|1Y5A|T Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant [Bos taurus] &gt;pdb|1Y5B|T Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant [Bos taurus] &gt;pdb|1Y5U|T Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant [Bos taurus]</Hit_def>
  <Hit_accession>1Y59_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.01983e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>107</Hit_num>
  <Hit_id>pdb|3PWB|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PWC|A Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PYH|A Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3Q00|A Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3PWB_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.03078e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>108</Hit_num>
  <Hit_id>pdb|3PLB|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PLP|A Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PM3|A Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PMJ|A Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3PLB_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.03078e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>109</Hit_num>
  <Hit_id>pdb|1AVW|A</Hit_id>
  <Hit_def>Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN Inhibitor, Orthorhombic Crystal Form [Sus scrofa] &gt;pdb|1AVX|A Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN Inhibitor, Tetragonal Crystal Form [Sus scrofa] &gt;pdb|1EJA|A Structure Of Porcine Trypsin Complexed With Bdellastasin, An Antistasin-type Inhibitor [Sus scrofa] &gt;pdb|1H9H|E COMPLEX OF EETI-II WITH PORCINE TRYPSIN [Sus scrofa] &gt;pdb|1H9I|E COMPLEX OF EETI-II MUTANT WITH PORCINE TRYPSIN [Sus scrofa] &gt;pdb|1LDT|T COMPLEX OF LEECH-DERIVED TRYPTASE INHIBITOR WITH PORCINE TRYPSIN [Sus scrofa] &gt;pdb|1S5S|A Porcine trypsin complexed with guanidine-3-propanol inhibitor [Sus scrofa] &gt;pdb|1S6F|A PORCINE TRYPSIN COVALENT COMPLEX WITH BORATE AND GUANIDINE-3 INHIBITOR [Sus scrofa] &gt;pdb|1S6H|A PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR [Sus scrofa] &gt;pdb|1S81|A PORCINE TRYPSIN WITH NO INHIBITOR BOUND [Sus scrofa] &gt;pdb|1S82|A PORCINE TRYPSIN COMPLEXED WITH BORATE AND ETHYLENE GLYCOL [Sus scrofa] &gt;pdb|1S83|A PORCINE TRYPSIN COMPLEXED WITH 4-AMINO PROPANOL [Sus scrofa] &gt;pdb|1S84|A PORCINE TRYPSIN COVALENT COMPLEX WITH 4-AMINO BUTANOL, BORATE AND ETHYLENE GLYCOL [Sus scrofa] &gt;pdb|1S85|A PORCINE TRYPSIN COMPLEXED WITH P-HYDROXYMETHYL BENZAMIDINE AND BORATE [Sus scrofa] &gt;pdb|1TFX|A Complex Of The Second Kunitz Domain Of Tissue Factor Pathway Inhibitor With Porcine Trypsin [Sus scrofa] &gt;pdb|1TFX|B Complex Of The Second Kunitz Domain Of Tissue Factor Pathway Inhibitor With Porcine Trypsin [Sus scrofa] &gt;pdb|1TX6|A trypsin:BBI complex [Sus scrofa] &gt;pdb|1TX6|B trypsin:BBI complex [Sus scrofa] &gt;pdb|1TX6|C trypsin:BBI complex [Sus scrofa] &gt;pdb|1TX6|D trypsin:BBI complex [Sus scrofa] &gt;pdb|1V6D|A The crystal structure of the trypsin complex with synthetic heterochiral peptide [Sus scrofa] &gt;pdb|1YF4|A Crystal Structure of trypsin-vasopressin complex [Sus scrofa] &gt;pdb|1Z7K|A Crystal Structure of Trypsin- Ovomucoid turkey egg white inhibitor complex [Sus scrofa] &gt;pdb|2A31|A Trypsin in complex with borate [Sus scrofa] &gt;pdb|2A32|A Trypsin in complex with benzene boronic acid [Sus scrofa] &gt;pdb|4DOQ|A Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI [Sus scrofa] &gt;pdb|4DOQ|C Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI [Sus scrofa] &gt;pdb|4DOQ|E Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI [Sus scrofa]</Hit_def>
  <Hit_accession>1AVW_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.07573e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCAANSIPYQVSL--NSGSHFCGGSLINSQWVVSAAHCYKSRIQVRL-GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCA--AAGTECLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLIN  WVV+AAHC  +   V + GE +        Q +  AK+  +  +N  T++NDI L+KLS+ A+ +  V+ V LP +    AAGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>110</Hit_num>
  <Hit_id>pdb|4B2C|A</Hit_id>
  <Hit_def>Structure of the factor Xa-like trypsin variant triple-Ala (TPA) in complex with eglin C [Bos taurus] &gt;pdb|4B2C|C Structure of the factor Xa-like trypsin variant triple-Ala (TPA) in complex with eglin C [Bos taurus]</Hit_def>
  <Hit_accession>4B2C_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.08727e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>111</Hit_num>
  <Hit_id>pdb|1V2K|T</Hit_id>
  <Hit_def>Factor XA specific Inhibitor in complex with bovine trypsin variant X(triple.Glu)bT.D2 [Bos taurus] &gt;pdb|1V2L|T Benzamidine in complex with bovine trypsin variant X(triple.Glu)bT.D1 [Bos taurus] &gt;pdb|1V2M|T Benzamidine in complex with bovine trypsin variant X(triple.Glu)bT.A1 [Bos taurus]</Hit_def>
  <Hit_accession>1V2K_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.08727e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>112</Hit_num>
  <Hit_id>pdb|4AN7|A</Hit_id>
  <Hit_def>Kunitz type trypsin inhibitor complex with porcine trypsin [Sus scrofa] &gt;pdb|5XWJ|A Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 7 [Sus scrofa] &gt;pdb|5XWJ|B Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 7 [Sus scrofa] &gt;pdb|5XWL|A Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 10 [Sus scrofa] &gt;pdb|5XWL|B Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 10 [Sus scrofa]</Hit_def>
  <Hit_accession>4AN7_A</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.09066e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCAANSIPYQVSL--NSGSHFCGGSLINSQWVVSAAHCYKSRIQVRL-GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC--AAAGTECLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLIN  WVV+AAHC  +   V + GE +        Q +  AK+  +  +N  T++NDI L+KLS+ A+ +  V+ V LP +    AAGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>113</Hit_num>
  <Hit_id>pdb|4B2A|A</Hit_id>
  <Hit_def>Structure of the factor Xa-like trypsin variant triple-Ala (TGA) in complex with eglin C [Bos taurus] &gt;pdb|4B2A|C Structure of the factor Xa-like trypsin variant triple-Ala (TGA) in complex with eglin C [Bos taurus]</Hit_def>
  <Hit_accession>4B2A_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.09894e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>114</Hit_num>
  <Hit_id>pdb|4B2B|A</Hit_id>
  <Hit_def>Structure of the factor Xa-like trypsin variant triple-Ala (TGPA) in complex with eglin C [Bos taurus] &gt;pdb|4B2B|C Structure of the factor Xa-like trypsin variant triple-Ala (TGPA) in complex with eglin C [Bos taurus]</Hit_def>
  <Hit_accession>4B2B_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.11073e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>115</Hit_num>
  <Hit_id>pdb|1FMG|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.04% POLYDOCANOL [Sus scrofa] &gt;pdb|1FN6|A CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.1% POLYDOCANOL [Sus scrofa] &gt;pdb|1FNI|A CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.01% POLYDOCANOL [Sus scrofa] &gt;pdb|1MCT|A THE REFINED 1.6 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PORCINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY [Sus scrofa] &gt;pdb|1QQU|A Crystal Structure Of Porcine Beta Trypsin With Bound Acetate Ion [Sus scrofa]</Hit_def>
  <Hit_accession>1FMG_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.13469e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCAANSIPYQVSL--NSGSHFCGGSLINSQWVVSAAHCYKSRIQVRL-GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCA--AAGTECLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLIN  WVV+AAHC  +   V + GE +        Q +  AK+  +  +N  T++NDI L+KLS+ A+ +  V+ V LP +    AAGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>116</Hit_num>
  <Hit_id>pdb|4A5T|S</Hit_id>
  <Hit_def>Structural Basis For The Conformational Modulation [Homo sapiens] &gt;pdb|4DUR|A The X-ray Crystal Structure of Full-Length type II Human Plasminogen [Homo sapiens] &gt;pdb|4DUR|B The X-ray Crystal Structure of Full-Length type II Human Plasminogen [Homo sapiens] &gt;pdb|4DUU|A The X-ray Crystal Structure of Full-Length type I Human Plasminogen [Homo sapiens]</Hit_def>
  <Hit_accession>4A5T_S</Hit_accession>
  <Hit_len>791</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.9005</Hsp_bit-score>
      <Hsp_score>237</Hsp_score>
      <Hsp_evalue>1.14671e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>562</Hsp_hit-from>
      <Hsp_hit-to>689</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQ</Hsp_hseq>
      <Hsp_midline>+V G  A P SWPWQVSL+ + G HFCGG+LI+  WV+TAAHC       +S  V+ G   + +    +Q+++++++F            DI LLKLS+ A  +  V   CLPS +   A  T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>117</Hit_num>
  <Hit_id>pdb|3UNQ|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UPE|A Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UUZ|A Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UUZ|B Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3UNQ_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.18417e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>118</Hit_num>
  <Hit_id>pdb|3UNS|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UOP|A Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UQO|A Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3UNS_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.24907e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>119</Hit_num>
  <Hit_id>pdb|3UWI|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|A Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|B Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|C Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|D Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|E Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|F Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|G Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|H Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|I Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|J Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|K Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|L Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|M Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|N Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|O Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|P Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3V12|A Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3V13|A Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3UWI_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.24907e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>120</Hit_num>
  <Hit_id>pdb|3UQV|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3UQV_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.24907e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>121</Hit_num>
  <Hit_id>pdb|1XXD|A</Hit_id>
  <Hit_def>Crystal Structure of the FXIa Catalytic Domain in Complex with mutated Ecotin [Homo sapiens] &gt;pdb|1XXD|B Crystal Structure of the FXIa Catalytic Domain in Complex with mutated Ecotin [Homo sapiens] &gt;pdb|1XXF|A Crystal Structure of the FXIa Catalytic Domain in Complex with Ecotin Mutant (EcotinP) [Homo sapiens] &gt;pdb|1XXF|B Crystal Structure of the FXIa Catalytic Domain in Complex with Ecotin Mutant (EcotinP) [Homo sapiens]</Hit_def>
  <Hit_accession>1XXD_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.4337</Hsp_bit-score>
      <Hsp_score>228</Hsp_score>
      <Hsp_evalue>1.25287e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>122</Hit_num>
  <Hit_id>pdb|3MYW|A</Hit_id>
  <Hit_def>The Bowman-Birk type inhibitor from mung bean in ternary complex with porcine trypsin [Sus scrofa] &gt;pdb|3MYW|B The Bowman-Birk type inhibitor from mung bean in ternary complex with porcine trypsin [Sus scrofa]</Hit_def>
  <Hit_accession>3MYW_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.2897e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCAANSVPYQVSL--NSGSHFCGGSLINSQWVVSAAHCYKSRIQVRL-GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCA--AAGTECLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLIN  WVV+AAHC  +   V + GE +        Q +  AK+  +  +N  T++NDI L+KLS+ A+ +  V+ V LP +    AAGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>123</Hit_num>
  <Hit_id>pdb|1AN1|E</Hit_id>
  <Hit_def>Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX [Sus scrofa] &gt;pdb|1C9P|A Complex Of Bdellastasin With Porcine Trypsin [Sus scrofa]</Hit_def>
  <Hit_accession>1AN1_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.49749e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCAANSIPYQVSL--NSGSHFCGGSLINSQWVVSAAHCYKSRIQVRL-GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSLPRSCA--AAGTECLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLIN  WVV+AAHC  +   V + GE +        Q +  AK+  +  +N  T++NDI L+KLS+ A+    V+ V LP +    AAGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>124</Hit_num>
  <Hit_id>pdb|3V0X|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3V0X_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.54619e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLXSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS    V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>125</Hit_num>
  <Hit_id>pdb|1XX9|A</Hit_id>
  <Hit_def>Crystal Structure of the FXIa Catalytic Domain in Complex with EcotinM84R [Homo sapiens] &gt;pdb|1XX9|B Crystal Structure of the FXIa Catalytic Domain in Complex with EcotinM84R [Homo sapiens]</Hit_def>
  <Hit_accession>1XX9_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.65182e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>126</Hit_num>
  <Hit_id>pdb|4NA7|A</Hit_id>
  <Hit_def>Factor XIA in complex with the inhibitor 3&apos;-[(2S,4R)-6-carbamimidoyl-4-methyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]-4-carbamoyl-5&apos;-[(3-methylbutanoyl)amino]biphenyl-2-carboxylic acid [Homo sapiens] &gt;pdb|4NA8|A Factor XIa in complex with the inhibitor 5-aminocarbonyl-2-[3-[(2s,4r)-6-carbamimidoyl-4-methyl-4-phenyl-2,3-dihydro-1h-quinolin-2-yl]phenyl]benzoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>4NA7_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.85372e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>127</Hit_num>
  <Hit_id>pdb|1UTN|A</Hit_id>
  <Hit_def>Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Bos taurus] &gt;pdb|1UTO|A Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Bos taurus] &gt;pdb|1UTP|A Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Bos taurus]</Hit_def>
  <Hit_accession>1UTN_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>1.8977e-23</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>52</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>PYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>128</Hit_num>
  <Hit_id>pdb|1ZHP|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with Benzamidine (S434A-T475A-K505 Mutant) [Homo sapiens]</Hit_def>
  <Hit_accession>1ZHP_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.0485</Hsp_bit-score>
      <Hsp_score>227</Hsp_score>
      <Hsp_evalue>2.04313e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWG</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   +CLPS  D     T C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>129</Hit_num>
  <Hit_id>pdb|2QXG|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 7 in Complex with Ala-Ala-Phe-chloromethylketone [Homo sapiens] &gt;pdb|2QXG|B Crystal Structure of Human Kallikrein 7 in Complex with Ala-Ala-Phe-chloromethylketone [Homo sapiens] &gt;pdb|2QXH|A Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone [Homo sapiens] &gt;pdb|2QXI|A High resolution structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone [Homo sapiens] &gt;pdb|2QXJ|A Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone and Copper [Homo sapiens] &gt;pdb|5Y9L|A Human kallikrein 7 in complex with 1,3,6-trisubstituted 1,4-diazepane-7-one [Homo sapiens] &gt;pdb|5YJK|A Human kallikrein 7 in complex with 1,4-diazepane-7-one 1-acetamide derivative [Homo sapiens] &gt;pdb|6SHH|A Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|B Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|C Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|D Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|E Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|F Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|G Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|H Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|A Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|B Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|C Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|D Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|E Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|F Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|G Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|H Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|A Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|B Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|C Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|D Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|E Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|F Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|G Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|H Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6Y4S|A Human kallikrein-related peptidase 7 (KLK7) in the unliganded state [Homo sapiens] &gt;pdb|6Y4S|B Human kallikrein-related peptidase 7 (KLK7) in the unliganded state [Homo sapiens] &gt;pdb|6Y4S|C Human kallikrein-related peptidase 7 (KLK7) in the unliganded state [Homo sapiens]</Hit_def>
  <Hit_accession>2QXG_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>2.19672e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIDGAPCARGSHPWQVALLSGNQLH-CGGVLVNERWVLTAAHCKMNEYTVHLGSDT---LGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE--PPGTTCTVSGWGTT</Hsp_hseq>
      <Hsp_midline>I++G     GS PWQV+L      H CGG L+NE WV+TAAHC +    V +  +        + Q++K +K F++  Y++ T  ND+ L+KL++ A  S  V  V LPS  +    GTTC  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>130</Hit_num>
  <Hit_id>pdb|5FAH|A</Hit_id>
  <Hit_def>Kallikrein-7 In Complex With Compound1 [Homo sapiens]</Hit_def>
  <Hit_accession>5FAH_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>2.34186e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIDGAPCARGSHPWQVALLSGNQLH-CGGVLVNERWVLTAAHCKMNEYTVHLGSDT---LGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE--PPGTTCTVSGWGTT</Hsp_hseq>
      <Hsp_midline>I++G     GS PWQV+L      H CGG L+NE WV+TAAHC +    V +  +        + Q++K +K F++  Y++ T  ND+ L+KL++ A  S  V  V LPS  +    GTTC  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>131</Hit_num>
  <Hit_id>pdb|3PLK|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3PLK_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>2.5256e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>54</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLLNSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSL+N  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>132</Hit_num>
  <Hit_id>pdb|3BSQ|A</Hit_id>
  <Hit_def>Crystal structure of human kallikrein 7 produced as a secretion protein in E.coli [Homo sapiens] &gt;pdb|3BSQ|B Crystal structure of human kallikrein 7 produced as a secretion protein in E.coli [Homo sapiens] &gt;pdb|3BSQ|C Crystal structure of human kallikrein 7 produced as a secretion protein in E.coli [Homo sapiens]</Hit_def>
  <Hit_accession>3BSQ_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>2.85865e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIDGAPCARGSHPWQVALLSGNQLH-CGGVLVNERWVLTAAHCKMNEYTVHLGSDT---LGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE--PPGTTCTVSGWGTT</Hsp_hseq>
      <Hsp_midline>I++G     GS PWQV+L      H CGG L+NE WV+TAAHC +    V +  +        + Q++K +K F++  Y++ T  ND+ L+KL++ A  S  V  V LPS  +    GTTC  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>133</Hit_num>
  <Hit_id>pdb|4H4F|A</Hit_id>
  <Hit_def>Crystal structure of human chymotrypsin C (CTRC) bound to inhibitor eglin c from Hirudo medicinalis [Homo sapiens]</Hit_def>
  <Hit_accession>4H4F_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>3.38652e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ---DKTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTRTYRVAVGKNNLEVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVACLPEKDSLLPKDYPCYVTGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A P SWPWQ+SLQ   + T  H CGG+LI  N+V+TAAHC     T  V V     +    E    + +  +  + ++N+L + NDI L+KL+     S T+   CLP           C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>134</Hit_num>
  <Hit_id>pdb|4TY6|A</Hit_id>
  <Hit_def>Factor XIa in complex with the inhibitor 4-{2-[(1S)-1-({[trans-4-(aminomethyl)cyclohexyl]carbonyl}amino)-2-phenylethyl]-1H-imidazol-4-yl}benzamide [Homo sapiens] &gt;pdb|4TY7|A Factor XIa in complex with the inhibitor (2S)-6-amino-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl}-2-ethylhexanamide [Homo sapiens] &gt;pdb|4WXI|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR trans-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)pyridin-2-yl]-2-phenylethyl}-4-(aminomethyl)cyclohexanecarboxamide [Homo sapiens] &gt;pdb|4X6M|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl}-3-[2-(aminomethyl)-5-chlorobenzyl]urea [Homo sapiens] &gt;pdb|4X6N|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl}-3-[5-chloro-2-(1H-tetrazol-1-yl)benzyl]urea [Homo sapiens] &gt;pdb|4X6O|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl (4-{4-chloro-2-[(1S)-1-({3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]propanoyl}amino)-2-phenylethyl]-1H-imidazol-5-yl}phenyl)carbamate [Homo sapiens] &gt;pdb|4Y8X|A Factor XIa in complex with the inhibitor methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-phenylethyl]-1H-imidazol-5-yl}phenyl)carbamate [Homo sapiens] &gt;pdb|4Y8Y|A Factor XIa in complex with the inhibitor methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-3-(morpholin-4-yl)-3-oxopropyl]-1H-imidazol-5-yl}phenyl)carbamate [Homo sapiens] &gt;pdb|4Y8Z|A Factor XIa in complex with the inhibitor (2E)-N-[(1S)-1-[5-chloro-4-(4-hydroxy-2-oxo-1,2-dihydroquinolin-6-yl)-1H-imidazol-2-yl]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enamide [Homo sapiens] &gt;pdb|5E2O|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[(N-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}-L-phenylalanyl)amino]benzoic acid [Homo sapiens] &gt;pdb|5E2P|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR N-[(1S)-1-benzyl-2-[2-[5-chloro-2-(tetrazol-1-yl)phenyl]ethylamino]-2-oxo-ethyl]-4-hydroxy-2-oxo-1H-quinoline-6-carboxamide [Homo sapiens] &gt;pdb|5EXL|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-(aminomethyl)-~{N}-[(1~{S})-1-[4-(3-oxidanyl-1~{H}-indazol-5-yl)pyridin-2-yl]-2-phenyl-ethyl]cyclohexane-1-carboxamide [Homo sapiens] &gt;pdb|5EXM|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl ~{N}-[4-[2-[(1~{S})-1-[[4-(aminomethyl)cyclohexyl]carbonylamino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate [Homo sapiens] &gt;pdb|5Q0D|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-oxo-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecin-14-yl]carbamate [Homo sapiens] &gt;pdb|5Q0E|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(4S,8S)-8-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-4-methyl-2-oxo-1,3,4,5,6,7,8,10-octahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5Q0F|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(4R,5E,8S)-8-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-4-methyl-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5Q0G|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-3-ethyl-2-oxo-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecin-14-yl]carbamate [Homo sapiens] &gt;pdb|5Q0H|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(4R,5E,8S)-11-chloro-8-[(2,6-difluoro-4-methylbenzene-1-carbonyl)amino]-4-methyl-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QCK|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(2~{S},3~{R})-1-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3-phenyl-pyrrolidin-2-yl]carbonylamino]benzoic acid [Homo sapiens] &gt;pdb|5QCL|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid [Homo sapiens] &gt;pdb|5QCM|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl ~{N}-[4-[[(1~{S})-2-[(~{E})-3-[3-chloranyl-2-fluoranyl-6-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]phenyl]carbamate [Homo sapiens] &gt;pdb|5QCN|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-5-[(3~{S})-3-ethoxycarbonylpiperidin-1-yl]carbonyl-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid [Homo sapiens] &gt;pdb|5QQO|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(5E,8S)-8-[(6R)-6-(3-chlorophenyl)-2-oxo-1,3-oxazinan-3-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QQP|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(5E,8S)-8-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QTT|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-{[5-amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QTU|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QTV|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-(trifluoromethyl)-2,3,4,5,6,7-hexahydro-1H-8,11-epimino-1,9-benzodiazacyclotridecin-14-yl]carbamate [Homo sapiens] &gt;pdb|5QTW|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-14-[(methoxycarbonyl)amino]-2,3,4,5,6,7-hexahydro-1H-8,11-epimino-1,9-benzodiazacyclotridecine-2-carboxylate [Homo sapiens] &gt;pdb|5QTX|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR ethyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-14-[(methoxycarbonyl)amino]-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecine-2-carboxylate [Homo sapiens] &gt;pdb|5QTY|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR ethyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-15-[(methoxycarbonyl)amino]-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecine-2-carboxylate [Homo sapiens] &gt;pdb|5TKS|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR ((15S)-18-CHLORO- 15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2- PROPENOYL)AMINO)-17,19-DIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,16(19)-PENTAEN-5-YL)CARBAMATE [Homo sapiens] &gt;pdb|5TKT|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((12E,15S)-15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2-PROPENOYL)AMINO)-9-OXO-8,17,19-TRIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,12,16(19)-HEXAEN-5-YL)CARBAMATE [Homo sapiens] &gt;pdb|5TKU|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((15S)-15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2-PROPENOYL)AMINO)-9-OXO-8,17,19-TRIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,16(19)-PENTAEN-5-YL)CARBAMATE [Homo sapiens] &gt;pdb|5WB6|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(11S)-11-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-6-fluoro-2-oxo-1,3,4,10,11,13-hexahydro-2H-5,9:15,12-di(azeno)-1,13-benzodiazacycloheptadecin-18-yl]carbamate [Homo sapiens] &gt;pdb|6C0S|A Factor XIA in complex with the inhibitor methyl (4-{6-[(1S)-2-[(3R)-1-acetylpiperidin-3-yl]-1-({(2E)-3-[5-chloro-2- (1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)ethyl]-3-chloropyridazin-4-yl}phenyl) carbamate [Homo sapiens] &gt;pdb|6TWC|A Crystal Structure of the Catalytic Domain of the Coagulation Factor XIa in Complex with Double Bridged Peptide F21 [Homo sapiens] &gt;pdb|6W50|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((10R,14S)- 14-(4-(3-CHLORO-2,6-DIFLUOROPHENYL)-6-OXO-3,6-DIHYDRO- 1(2H)-PYRIDINYL)-10-METHYL-9-OXO-8,16- DIAZATRICYCLO[13.3.1.0~2,7~]NONADECA-1(19),2,4,6,15,17- HEXAEN-5-YL)CARBAMATE [Homo sapiens]</Hit_def>
  <Hit_accession>4TY6_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>3.89611e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T   +  +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>135</Hit_num>
  <Hit_id>pdb|6TWB|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of Coagulation Factor XIa in Complex with Double Bridged Peptide F19 [Homo sapiens] &gt;pdb|6TWB|H Crystal Structure of the Catalytic Domain of Coagulation Factor XIa in Complex with Double Bridged Peptide F19 [Homo sapiens]</Hit_def>
  <Hit_accession>6TWB_A</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>6.2509e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T   +  +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>136</Hit_num>
  <Hit_id>pdb|7MEQ|A</Hit_id>
  <Hit_def>Chain A, Transmembrane protease serine 2 [Homo sapiens]</Hit_def>
  <Hit_accession>7MEQ_A</Hit_accession>
  <Hit_len>395</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>92.8189</Hsp_bit-score>
      <Hsp_score>229</Hsp_score>
      <Hsp_evalue>7.49869e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>279</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>54</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGESALPGAWPWQVSLHVQN-VHVCGGSIITPEWIVTAAHCVEKPLNNPWHWTAFAGILRQ-SFMFYGAGYQVEKVISHPNYDSKTKNNDIALMKLQKPLTFNDLVKPVCLPNPGMMLQPEQLCWISGWGATE</Hsp_hseq>
      <Hsp_midline>IV GE A+PG+WPWQVSL  +   H CGGS+I   W+VTAAHC     +        AG   Q S        ++ KV  +  Y+S T NNDI L+KL    +F+  V  VCLP+          C  +GWG T </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>137</Hit_num>
  <Hit_id>pdb|1FUJ|A</Hit_id>
  <Hit_def>Pr3 (Myeloblastin) [Homo sapiens] &gt;pdb|1FUJ|B Pr3 (Myeloblastin) [Homo sapiens] &gt;pdb|1FUJ|C Pr3 (Myeloblastin) [Homo sapiens] &gt;pdb|1FUJ|D Pr3 (Myeloblastin) [Homo sapiens]</Hit_def>
  <Hit_accession>1FUJ_A</Hit_accession>
  <Hit_len>221</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>7.83474e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHCGVTTSDV------VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHC---LRDIPQRLVNVVLGAHNVRTQEPTQQHFSVAQVFLNN-YDAENKLNDILLIQLSSPANLSASVATVQLPQQDQPVPHGTQCLAMGWG</Hsp_hseq>
      <Hsp_midline>IV G EA P S P+  SLQ +   G HFCGG+LI+ ++V+TAAHC     D+      VV G  +  +     Q   +A+VF N+ Y++    NDI L++LS+ A+ S +V+ V LP        GT C+  GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>138</Hit_num>
  <Hit_id>pdb|1O5E|H</Hit_id>
  <Hit_def>Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1O5F|H Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1P57|B Extracellular domain of human hepsin [Homo sapiens]</Hit_def>
  <Hit_accession>1O5E_H</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.5077</Hsp_bit-score>
      <Hsp_score>223</Hsp_score>
      <Hsp_evalue>8.52677e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>139</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-----VVAGEFDQGSSSEKIQKLKIAKVFKNSKY------NSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVGGRDTSLGRWPWQVSLR-YDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAVAQ-ASPHGLQ-LGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQY</Hsp_hseq>
      <Hsp_midline>IV G +   G WPWQVSL+   G H CGGSL++ +WV+TAAHC    + V     V AG   Q +S   +Q L +  V  +  Y      NS   +NDI L+ LS+    ++ +  VCLP+A      G  C  TGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>139</Hit_num>
  <Hit_id>pdb|1UTQ|A</Hit_id>
  <Hit_def>Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Bos taurus]</Hit_def>
  <Hit_accession>1UTQ_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>1.08103e-22</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>PYQVSLN--SGYHFCGGSLINSQWVXSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>P+QVSL   +G+HFCGGSLIN  WV +AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>140</Hit_num>
  <Hit_id>pdb|5GVT|A</Hit_id>
  <Hit_def>Crystal structures of the serine protease domain of murine plasma kallikrein [Mus musculus] &gt;pdb|5GVT|B Crystal structures of the serine protease domain of murine plasma kallikrein [Mus musculus]</Hit_def>
  <Hit_accession>5GVT_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>1.10538e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAG-----EFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTNASLGEWPWQVSLQVKLVSQTHLCGGSIIGRQWVLTAAHCFDGIPYPDVWRIYGGILSLSEITKETPSSRIKELIIHQEYKVSEGNY-----DIALIKLQTPLNYTEFQKPISLPSKADTNTIYTNCWVTGWGYTK</Hsp_hseq>
      <Hsp_midline>IV G  A  G WPWQVSLQ K  +  H CGGS+I   WV+TAAHC  G+   DV  +  G     E  + + S +I++L I + +K S+ N      DI L+KL T  ++++    + LPS +D     T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>141</Hit_num>
  <Hit_id>pdb|6A8O|A</Hit_id>
  <Hit_def>Crystal structures of the serine protease domain of murine plasma kallikrein with peptide inhibitor mupain-1-16 [Mus musculus] &gt;pdb|6A8O|B Crystal structures of the serine protease domain of murine plasma kallikrein with peptide inhibitor mupain-1-16 [Mus musculus]</Hit_def>
  <Hit_accession>6A8O_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>1.1726e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAG-----EFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTNASLGEWPWQVSLQVKLVSQTHLCGGSIIGRQWVLTAAHCFDGIPYPDVWRIYGGILSLSEITKETPSSRIKELIIHQEYKVSEGNY-----DIALIKLQTPLNYTEFQKPISLPSKADTNTIYTNCWVTGWGYTK</Hsp_hseq>
      <Hsp_midline>IV G  A  G WPWQVSLQ K  +  H CGGS+I   WV+TAAHC  G+   DV  +  G     E  + + S +I++L I + +K S+ N      DI L+KL T  ++++    + LPS +D     T C  TGWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>142</Hit_num>
  <Hit_id>pdb|3DFJ|A</Hit_id>
  <Hit_def>Crystal structure of human Prostasin [Homo sapiens] &gt;pdb|3DFL|A Crystal structure of human Prostasin complexed to 4-guanidinobenzoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>3DFJ_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.5077</Hsp_bit-score>
      <Hsp_score>223</Hsp_score>
      <Hsp_evalue>1.22299e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV------VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>ITGGSSAVAGQWPWQVSITYE-GVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQLDSYSEDAKVSTLK--DIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASFPNGLHCTVTGWG</Hsp_hseq>
      <Hsp_midline>I  G  AV G WPWQVS+  + G H CGGSL++E WV++AAHC  +          + A + D  S   K+  LK   +  +  Y       DI LL+LS   +FS+ +  + LP+A+  F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>143</Hit_num>
  <Hit_id>pdb|3GYL|B</Hit_id>
  <Hit_def>Structure of Prostasin at 1.3 Angstroms resolution in complex with a Calcium Ion. [Homo sapiens] &gt;pdb|3GYM|A Structure of Prostasin in Complex with Aprotinin [Homo sapiens] &gt;pdb|3GYM|B Structure of Prostasin in Complex with Aprotinin [Homo sapiens]</Hit_def>
  <Hit_accession>3GYL_B</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>1.31337e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV------VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>ITGGSSAVAGQWPWQVSITYE-GVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQLDSYSEDAKVSTLK--DIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVTGWG</Hsp_hseq>
      <Hsp_midline>I  G  AV G WPWQVS+  + G H CGGSL++E WV++AAHC  +          + A + D  S   K+  LK   +  +  Y       DI LL+LS   +FS+ +  + LP+A   F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>144</Hit_num>
  <Hit_id>pdb|1NTP|A</Hit_id>
  <Hit_def>USE OF THE NEUTRON DIFFRACTION H/D EXCHANGE TECHNIQUE TO DETERMINE THE CONFORMATIONAL DYNAMICS OF TRYPSIN [Bos taurus]</Hit_def>
  <Hit_accession>1NTP_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.3521</Hsp_bit-score>
      <Hsp_score>220</Hsp_score>
      <Hsp_evalue>1.43491e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLIDSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISLPTSC--ASAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLI+  WVV+AAHC   +   V  GE +        Q +  +K   +  Y+S T+NNDI L+KL +AAS    V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>145</Hit_num>
  <Hit_id>pdb|3E0N|B</Hit_id>
  <Hit_def>The X-ray structure of Human Prostasin in complex with DFFR-chloromethyl ketone inhibitor [Homo sapiens] &gt;pdb|3E0P|B The X-ray structure of Human Prostasin in complex with a covalent benzoxazole inhibitor [Homo sapiens] &gt;pdb|3E16|B Chain B, Prostasin [Homo sapiens] &gt;pdb|3E1X|B The Crystal Structure of Apo Prostasin at 1.7 Angstroms Resolution [Homo sapiens] &gt;pdb|3FVF|B The Crystal Structure of Prostasin Complexed with Camostat at 1.6 Angstroms Resolution [Homo sapiens]</Hit_def>
  <Hit_accession>3E0N_B</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>1.55269e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV------VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>ITGGSSAVAGQWPWQVSITYE-GVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQLDSYSEDAKVSTLK--DIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVTGWG</Hsp_hseq>
      <Hsp_midline>I  G  AV G WPWQVS+  + G H CGGSL++E WV++AAHC  +          + A + D  S   K+  LK   +  +  Y       DI LL+LS   +FS+ +  + LP+A   F  G  C  TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>146</Hit_num>
  <Hit_id>pdb|3W94|A</Hit_id>
  <Hit_def>Structure of Oryzias latipes enteropeptidase light chain [Oryzias latipes] &gt;pdb|3W94|B Structure of Oryzias latipes enteropeptidase light chain [Oryzias latipes]</Hit_def>
  <Hit_accession>3W94_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.3521</Hsp_bit-score>
      <Hsp_score>220</Hsp_score>
      <Hsp_evalue>1.93361e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTS----DVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGVNAEKGAWPWMVSLHWR-GRHGCGASLIGRDWLLTAAHCVYGKNTHLQYWSAVLGLHAQSSMNSQEVQIRQVDRIIINKNYNRRTKEADIAMMHLQQPVNFTEWVLPVCLASEDQHFPAGRRCFIAGWG</Hsp_hseq>
      <Hsp_midline>+V G  A  G+WPW VSL  + G H CG SLI  +W++TAAHC  G  T       V+        +S+++Q  ++ ++  N  YN  T   DI ++ L    +F++ V  VCL S    F AG  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>147</Hit_num>
  <Hit_id>pdb|2FI5|E</Hit_id>
  <Hit_def>Crystal structure of a BPTI variant (Cys38-&gt;Ser) in complex with trypsin [Bos taurus] &gt;pdb|2FTM|A Crystal structure of trypsin complexed with the BPTI variant (Tyr35-&gt;Gly) [Bos taurus]</Hit_def>
  <Hit_accession>2FI5_E</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.9669</Hsp_bit-score>
      <Hsp_score>219</Hsp_score>
      <Hsp_evalue>2.17057e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>78</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQT-VSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YNS T+NNDI L+KL +AAS   + V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>148</Hit_num>
  <Hit_id>pdb|3QK1|A</Hit_id>
  <Hit_def>Crystal Structure of Enterokinase-like Trypsin Variant [Bos taurus]</Hit_def>
  <Hit_accession>3QK1_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.9669</Hsp_bit-score>
      <Hsp_score>219</Hsp_score>
      <Hsp_evalue>2.19944e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGYTCGANTVPYQVSLN--SGYHFCGGSLINSQWVVSAAHC-YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVASISLPTSCA--SAGTQCLISGWGNTK</Hsp_hseq>
      <Hsp_midline>IV G      + P+QVSL   +G+HFCGGSLIN  WVV+AAHC   +   V  GE +        Q +  +K   +  YN    NNDI L+KL +AAS +  V+++ LP++    +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>149</Hit_num>
  <Hit_id>pdb|2EEK|A</Hit_id>
  <Hit_def>Crystal structure of Atlantic cod trypsin complexed with benzamidine [Gadus morhua]</Hit_def>
  <Hit_accession>2EEK_A</Hit_accession>
  <Hit_len>220</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.5817</Hsp_bit-score>
      <Hsp_score>218</Hsp_score>
      <Hsp_evalue>2.58727e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>53</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYECTKHSQAHQVSL--NSGYHFCGGSLVSKDWVVSAAHCYKSVLRVRL-GEHHIRVNEGTEQYISSSSVIRHPNYSSYNINNDIMLIKLTKPATLNQYVHAVALP--TECAADATMCTVSGWGNT</Hsp_hseq>
      <Hsp_midline>IV G E    S   QVSL   +G+HFCGGSL++++WVV+AAHC  +   V + GE     +    Q +  + V ++  Y+S  INNDI L+KL+  A+ +Q V AV LP  ++  A  T C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>150</Hit_num>
  <Hit_id>pdb|1ZLR|A</Hit_id>
  <Hit_def>Factor XI catalytic domain complexed with 2-guanidino-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl nicotinate [Homo sapiens]</Hit_def>
  <Hit_accession>1ZLR_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.9669</Hsp_bit-score>
      <Hsp_score>219</Hsp_score>
      <Hsp_evalue>2.82015e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q   +E      + ++  + +Y       DI LLKL T  +++ +   + LPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>151</Hit_num>
  <Hit_id>pdb|6T7P|A</Hit_id>
  <Hit_def>human plasmakallikrein protease domain in complex with active site directed inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>6T7P_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.9669</Hsp_bit-score>
      <Hsp_score>219</Hsp_score>
      <Hsp_evalue>2.8735e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSK</Hsp_hseq>
      <Hsp_midline>IV G  +  G WPWQVSLQ K     H CGGSLI   WV+TAAHC  G+   DV  + +G  +    ++     +I ++  +  Y     N+DI L+KL    ++++    +CLPS  D     T C  TGWG ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>152</Hit_num>
  <Hit_id>pdb|5YJM|A</Hit_id>
  <Hit_def>Human chymase in complex with 7-oxo-3-(phenoxyimino)-1,4-diazepane derivative [Homo sapiens] &gt;pdb|5YJP|A Human chymase in complex with 3-(ethoxyimino)-7-oxo-1,4-diazepane derivative [Homo sapiens]</Hit_def>
  <Hit_accession>5YJM_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.5817</Hsp_bit-score>
      <Hsp_score>218</Hsp_score>
      <Hsp_evalue>2.91489e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHC-AGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E+ P S P+   L+  T      FCGG LI  N+V+TAAHC    S  V  G  +     +  QKL++ K F++ KYN+ T+++DI LLKL   AS +  V  +  PS  +    G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>153</Hit_num>
  <Hit_id>pdb|1ZHR|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with Benzamidine (S434A-T475A-C482S-K437A Mutant) [Homo sapiens] &gt;pdb|1ZMJ|A Crystal Structure of the Catalytic Domain of Factor XI in complex with 4-(guanidinomethyl)-phenylboronic acid [Homo sapiens] &gt;pdb|1ZML|A Crystal Structure of the Catalytic Domain of Factor XI in complex with (R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)phenethyl)guanidine [Homo sapiens] &gt;pdb|1ZMN|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with (R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)phenyl)guanidine [Homo sapiens] &gt;pdb|1ZOM|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in complex with a peptidomimetic Inhibitor [Homo sapiens] &gt;pdb|1ZPB|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 4-Methyl-pentanoic acid {1-[4-guanidino-1-(thiazole-2-carbonyl)-butylcarbamoyl]-2-methyl-propyl}-amide [Homo sapiens] &gt;pdb|1ZPC|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 2-[2-(3-Chloro-phenyl)-2-hydroxy-acetylamino]-N-[4-guanidino-1-(thiazole-2-carbonyl)-butyl]-3-methyl-butyramide [Homo sapiens] &gt;pdb|1ZSJ|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in complex with N-(7-Carbamimidoyl-naphthalen-1-yl)-3-hydroxy-2-methyl-benzamide [Homo sapiens] &gt;pdb|1ZSK|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester [Homo sapiens] &gt;pdb|1ZTJ|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 2-(5-Benzylamino-2-methylsulfanyl-6-oxo-6H-pyrimidin-1-yl)-N-[4-guanidino-1-(thiazole-2-carbonyl)-butyl]-acetamide [Homo sapiens] &gt;pdb|1ZTK|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 2-(5-Amino-6-oxo-2-m-tolyl-6H-pyrimidin-1-yl)-N-[4-guanidino-1-(thiazole-2-carbonyl)-butyl]-acetamide [Homo sapiens] &gt;pdb|1ZTL|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with N-[4-Guanidino-1-(thiazole-2-carbonyl)-butyl]-2-{6-oxo-5-[(quinolin-8-ylmethyl)-amino]-2-m-tolyl-6H-pyrimidin-1-yl}-acetamide [Homo sapiens] &gt;pdb|2FDA|A Crystal Structure of the Catalytic Domain of Human Coagulation Factor XIa in Complex with alpha-Ketothiazole Arginine Derived Ligand [Homo sapiens] &gt;pdb|4CR5|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CR9|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRA|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRB|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRD|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRF|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRG|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4D76|A Human FXIa in complex with small molecule inhibitors. [Homo sapiens] &gt;pdb|4D7F|A Human FXIa in complex with small molecule inhibitors. [Homo sapiens] &gt;pdb|4D7G|A Human FXIa in complex with small molecule inhibitors. [Homo sapiens]</Hit_def>
  <Hit_accession>1ZHR_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.9669</Hsp_bit-score>
      <Hsp_score>219</Hsp_score>
      <Hsp_evalue>3.12791e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q   +E      + ++  + +Y       DI LLKL T  +++ +   + LPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>154</Hit_num>
  <Hit_id>pdb|1Z8G|A</Hit_id>
  <Hit_def>Crystal structure of the extracellular region of the transmembrane serine protease hepsin with covalently bound preferred substrate. [Homo sapiens]</Hit_def>
  <Hit_accession>1Z8G_A</Hit_accession>
  <Hit_len>372</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.8929</Hsp_bit-score>
      <Hsp_score>224</Hsp_score>
      <Hsp_evalue>3.82431e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>118</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-----VVAGEFDQGSSSEKIQKLKIAKVFKNSKY------NSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVGGRDTSLGRWPWQVSLR-YDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAVAQ-ASPHGLQ-LGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQY</Hsp_hseq>
      <Hsp_midline>IV G +   G WPWQVSL+   G H CGGSL++ +WV+TAAHC    + V     V AG   Q +S   +Q L +  V  +  Y      NS   +NDI L+ LS+    ++ +  VCLP+A      G  C  TGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>155</Hit_num>
  <Hit_id>pdb|1ZJD|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with Kunitz Protease Inhibitor Domain of Protease Nexin II [Homo sapiens]</Hit_def>
  <Hit_accession>1ZJD_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.5817</Hsp_bit-score>
      <Hsp_score>218</Hsp_score>
      <Hsp_evalue>3.95969e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   + LPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>156</Hit_num>
  <Hit_id>pdb|1ZPZ|A</Hit_id>
  <Hit_def>Factor XI catalytic domain complexed with N-((R)-1-(4-bromophenyl)ethyl)urea-Asn-Val-Arg-alpha-ketothiazole [Homo sapiens] &gt;pdb|1ZRK|A Factor XI complexed with 3-hydroxypropyl 3-(7-amidinonaphthalene-1-carboxamido)benzenesulfonate [Homo sapiens] &gt;pdb|1ZSL|A Factor XI complexed with a pyrimidinone inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>1ZPZ_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.5817</Hsp_bit-score>
      <Hsp_score>218</Hsp_score>
      <Hsp_evalue>3.99169e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q   +E      + ++  + +Y       DI LLKL T  +++ +   + LPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>157</Hit_num>
  <Hit_id>pdb|3T2N|A</Hit_id>
  <Hit_def>Human hepsin protease in complex with the Fab fragment of an inhibitory antibody [Homo sapiens] &gt;pdb|3T2N|B Human hepsin protease in complex with the Fab fragment of an inhibitory antibody [Homo sapiens] &gt;pdb|5CE1|A Crystal Structure of Serine protease Hepsin in complex with Inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>3T2N_A</Hit_accession>
  <Hit_len>372</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.5077</Hsp_bit-score>
      <Hsp_score>223</Hsp_score>
      <Hsp_evalue>4.06525e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>118</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-----VVAGEFDQGSSSEKIQKLKIAKVFKNSKY------NSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVGGRDTSLGRWPWQVSLR-YDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAVAQ-ASPHGLQ-LGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQY</Hsp_hseq>
      <Hsp_midline>IV G +   G WPWQVSL+   G H CGGSL++ +WV+TAAHC    + V     V AG   Q +S   +Q L +  V  +  Y      NS   +NDI L+ LS+    ++ +  VCLP+A      G  C  TGWG T+Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>158</Hit_num>
  <Hit_id>pdb|3SOR|A</Hit_id>
  <Hit_def>Factor XIa in complex with a clorophenyl-tetrazole inhibitor [Homo sapiens] &gt;pdb|3SOS|A Benzothiazinone inhibitor in complex with FXIa [Homo sapiens] &gt;pdb|4X6P|A FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE INHIBITOR (2E)-N-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-1H-imidazol-2-yl]-2-phenylethyl}-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enamide [Homo sapiens] &gt;pdb|4X6P|B FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE INHIBITOR (2E)-N-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-1H-imidazol-2-yl]-2-phenylethyl}-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enamide [Homo sapiens] &gt;pdb|5EXN|A FACTOR XIA (C500S [C122S]) IN COMPLEX WITH THE INHIBITOR methyl ~{N}-[4-[2-[(1~{S})-1-[[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate [Homo sapiens] &gt;pdb|6HHC|A Allosteric Inhibition as a new mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated form of Coagulation Factor XI [Homo sapiens] &gt;pdb|6R8X|A COAGULATION FACTOR XI CATALYTIC DOMAIN IN COMPLEX WITH FAB-PORTION OF MAA868 [Homo sapiens] &gt;pdb|6TS5|A Coagulation factor XI protease domain in complex with active site inhibitor [Homo sapiens] &gt;pdb|6TS6|A Coagulation factor XI protease domain in complex with active site inhibitor [Homo sapiens] &gt;pdb|6TS7|A Coagulation factor XI protease domain in complex with active site inhibitor [Homo sapiens] &gt;pdb|6USY|A COAGULATION FACTOR XI CATALYTIC DOMAIN (C123S) IN COMPLEX WITH NVP-XIV936 [Homo sapiens] &gt;pdb|6VLU|A Factor XIa in complex with compound 7 [Homo sapiens] &gt;pdb|6VLV|A Factor XIa in complex with compound 11 [Homo sapiens]</Hit_def>
  <Hit_accession>3SOR_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.1965</Hsp_bit-score>
      <Hsp_score>217</Hsp_score>
      <Hsp_evalue>5.37093e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   + LPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>159</Hit_num>
  <Hit_id>pdb|6TS4|A</Hit_id>
  <Hit_def>Coagulation factor XI protease domain in complex with active site inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>6TS4_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.1965</Hsp_bit-score>
      <Hsp_score>217</Hsp_score>
      <Hsp_evalue>5.42815e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   + LPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>160</Hit_num>
  <Hit_id>pdb|5JBA|S</Hit_id>
  <Hit_def>Crystal structure of factor IXa variant V16I K98T Y177T I212V in complex with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>5JBA_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.1965</Hsp_bit-score>
      <Hsp_score>217</Hsp_score>
      <Hsp_evalue>5.70707e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>IV GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+   T N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>161</Hit_num>
  <Hit_id>pdb|5JBB|S</Hit_id>
  <Hit_def>Crystal structure of factor IXa variant V16I K98T Y177T I213V in complex with EGR-chloromethylketone [Homo sapiens] &gt;pdb|5JBC|S Crystal structure of factor IXa variant V16I K98T Y177T I213V in complex with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>5JBB_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.1965</Hsp_bit-score>
      <Hsp_score>217</Hsp_score>
      <Hsp_evalue>5.70707e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>IV GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+   T N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>162</Hit_num>
  <Hit_id>pdb|1PJP|A</Hit_id>
  <Hit_def>The 2.2 A Crystal Structure Of Human Chymase In Complex With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone [Homo sapiens] &gt;pdb|1T31|A A Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase with Therapeutic Efficacy in Animals Models of Inflammation [Homo sapiens] &gt;pdb|2HVX|A Discovery of Potent, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase by Using Structure-Based Drug Design [Homo sapiens] &gt;pdb|3S0N|A Crystal Structure of Human Chymase with Benzimidazolone Inhibitor [Homo sapiens] &gt;pdb|4K2Y|A Crystal Structure of Human Chymase in Complex with Fragment Inhibitor 6-chloro-1,3-dihydro-2H-indol-2-one [Homo sapiens] &gt;pdb|4K5Z|A Crystal Structure of Human Chymase in Complex with Fragment Inhibitor 6-chloro-2,3-dihydro-1H-isoindol-1-one [Homo sapiens] &gt;pdb|4K60|A Crystal Structure of Human Chymase in Complex with Fragment 6-bromo-1,3-dihydro-2H-indol-2-one [Homo sapiens] &gt;pdb|4K69|A Crystal Structure of Human Chymase in Complex with Fragment Linked Benzimidazolone Inhibitor: (3S)-3-{3-[(6-bromo-2-oxo-2,3-dihydro-1H-indol-4-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}hexanoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>1PJP_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.8113</Hsp_bit-score>
      <Hsp_score>216</Hsp_score>
      <Hsp_evalue>6.13566e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHC-AGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+   L+  T      FCGG LI  N+V+TAAHC    S  V  G  +     +  QKL++ K F++ KYN+ T+++DI LLKL   AS +  V  +  PS  +    G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>163</Hit_num>
  <Hit_id>pdb|2F83|A</Hit_id>
  <Hit_def>Crystal structure at 2.9 Angstroms resolution of human plasma coagulation factor XI zymogen [Homo sapiens]</Hit_def>
  <Hit_accession>2F83_A</Hit_accession>
  <Hit_len>625</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.8929</Hsp_bit-score>
      <Hsp_score>224</Hsp_score>
      <Hsp_evalue>6.5214e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>388</Hsp_hit-from>
      <Hsp_hit-to>523</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>164</Hit_num>
  <Hit_id>pdb|5EOD|A</Hit_id>
  <Hit_def>Human Plasma Coagulation FXI with peptide LP2 [Homo sapiens] &gt;pdb|5EOK|A Human Plasma Coagulation Factor XI in complex with peptide P39 [Homo sapiens]</Hit_def>
  <Hit_accession>5EOD_A</Hit_accession>
  <Hit_len>606</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.8929</Hsp_bit-score>
      <Hsp_score>224</Hsp_score>
      <Hsp_evalue>6.73023e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>369</Hsp_hit-from>
      <Hsp_hit-to>504</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>165</Hit_num>
  <Hit_id>pdb|5I25|A</Hit_id>
  <Hit_def>human recombinant coagulation FXI in complex with a peptide derived from human high molecular weight kininogen (HKP) [Homo sapiens] &gt;pdb|6I58|A Allosteric activation of human prekallikrein by apple domain disc rotation [Homo sapiens]</Hit_def>
  <Hit_accession>5I25_A</Hit_accession>
  <Hit_len>607</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.8929</Hsp_bit-score>
      <Hsp_score>224</Hsp_score>
      <Hsp_evalue>7.1371e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>370</Hsp_hit-from>
      <Hsp_hit-to>505</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   +CLPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>166</Hit_num>
  <Hit_id>pdb|1KLT|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF PMSF-TREATED HUMAN CHYMASE AT 1.9 ANGSTROMS RESOLUTION [Homo sapiens]</Hit_def>
  <Hit_accession>1KLT_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.8113</Hsp_bit-score>
      <Hsp_score>216</Hsp_score>
      <Hsp_evalue>7.35072e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-GRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E+ P S P+   L+  T      FCGG LI  N+V+TAAHC    S  V  G  +     +  QKL++ K F++ KYN+ T+++DI LLKL   AS +  V  +  PS  +    G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>167</Hit_num>
  <Hit_id>pdb|2ANY|A</Hit_id>
  <Hit_def>Chain A, plasma kallikrein, light chain [Homo sapiens] &gt;pdb|4OGX|A Crystal structure of Fab DX-2930 in complex with human plasma kallikrein at 2.4 Angstrom resolution [Homo sapiens] &gt;pdb|4OGY|A Crystal structure of Fab DX-2930 in complex with human plasma kallikrein at 2.1 Angstrom resolution [Homo sapiens] &gt;pdb|4OGY|B Crystal structure of Fab DX-2930 in complex with human plasma kallikrein at 2.1 Angstrom resolution [Homo sapiens]</Hit_def>
  <Hit_accession>2ANY_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.8113</Hsp_bit-score>
      <Hsp_score>216</Hsp_score>
      <Hsp_evalue>9.53481e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGDTSTIYTNCWVTGWGFSK</Hsp_hseq>
      <Hsp_midline>IV G E+  G WPWQVSLQ K     H CGGSLI   WV+TAAHC  G+   DV  + +G  +    ++     +I ++  +  Y     N+DI L+KL     +++    + LPS  D     T C  TGWG ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>168</Hit_num>
  <Hit_id>pdb|6AOD|C</Hit_id>
  <Hit_def>FXIa antibody complex [Homo sapiens]</Hit_def>
  <Hit_accession>6AOD_C</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.8113</Hsp_bit-score>
      <Hsp_score>216</Hsp_score>
      <Hsp_evalue>9.82103e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILQQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVQYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G   Q    E      + ++  + +Y       DI LLKL T   ++ +   + LPS  D     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>169</Hit_num>
  <Hit_id>pdb|5JB8|S</Hit_id>
  <Hit_def>Crystal structure of factor IXa variant K98T in complex with EGR-chloromethylketone [Homo sapiens] &gt;pdb|5JB9|S Crystal structure of factor IXa K98T variant in complex with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>5JB8_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.4261</Hsp_bit-score>
      <Hsp_score>215</Hsp_score>
      <Hsp_evalue>1.05555e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+   T N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>170</Hit_num>
  <Hit_id>pdb|2WPI|S</Hit_id>
  <Hit_def>factor IXa superactive double mutant [Homo sapiens]</Hit_def>
  <Hit_accession>2WPI_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.4261</Hsp_bit-score>
      <Hsp_score>215</Hsp_score>
      <Hsp_evalue>1.05555e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+   T N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>171</Hit_num>
  <Hit_id>pdb|4AFQ|A</Hit_id>
  <Hit_def>Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFQ|B Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFS|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFU|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFU|B Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFZ|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFZ|B Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AG1|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AG2|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AG2|B Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4KP0|A Crystal Structure of the human Chymase with TJK002 [Homo sapiens]</Hit_def>
  <Hit_accession>4AFQ_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.0409</Hsp_bit-score>
      <Hsp_score>214</Hsp_score>
      <Hsp_evalue>1.23718e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-GRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+   L+  T      FCGG LI  N+V+TAAHC    S  V  G  +     +  QKL++ K F++ KYN+ T+++DI LLKL   AS +  V  +  PS  +    G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>172</Hit_num>
  <Hit_id>pdb|6KD5|B</Hit_id>
  <Hit_def>Chain B, Transmembrane protease serine 13 [Homo sapiens]</Hit_def>
  <Hit_accession>6KD5_B</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.8113</Hsp_bit-score>
      <Hsp_score>216</Hsp_score>
      <Hsp_evalue>1.31947e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>52</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAG-EFDQGSSS--EKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGALASDSKWPWQVSLHFGT-THICGGTLIDAQWVLTAAHCFFVTREKVLEGWKVYAGTSNLHQLPEAASIAEIIINSNYTDEEDDYDIALMRLSKPLTLSAHIHPACLPMHGQTFSLNETCWITGFGKTR</Hsp_hseq>
      <Hsp_midline>IV G  A    WPWQVSL   T  H CGG+LI+  WV+TAAHC   T + V+ G +   G+S+  +  +   IA++  NS Y     + DI L++LS   + S  +   CLP     F+   TC  TG+G TR</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>173</Hit_num>
  <Hit_id>pdb|4CRC|A</Hit_id>
  <Hit_def>Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRE|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens]</Hit_def>
  <Hit_accession>4CRC_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.0409</Hsp_bit-score>
      <Hsp_score>214</Hsp_score>
      <Hsp_evalue>1.33568e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGERNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q   +E      + ++  + +Y       DI LLKL T  +++ +   + LPS  +     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>174</Hit_num>
  <Hit_id>pdb|1FI8|A</Hit_id>
  <Hit_def>Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd] [Rattus norvegicus] &gt;pdb|1FI8|B Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd] [Rattus norvegicus]</Hit_def>
  <Hit_accession>1FI8_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.0409</Hsp_bit-score>
      <Hsp_score>214</Hsp_score>
      <Hsp_evalue>1.37005e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ---DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKL-KIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSKIQVTLGAH--NIKEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNLPRRNVKVKPGDVCYVAGWG</Hsp_hseq>
      <Hsp_midline>I+ G EA P S P+   LQ   + +G   CGG LI E++V+TAAHC  +   V +          EK+Q++  + K+  +  YNS TI+NDI LLKL + A  S  V  + LP  +     G  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>175</Hit_num>
  <Hit_id>pdb|3N7O|A</Hit_id>
  <Hit_def>X-ray structure of human chymase in complex with small molecule inhibitor. [Homo sapiens]</Hit_def>
  <Hit_accession>3N7O_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.0409</Hsp_bit-score>
      <Hsp_score>214</Hsp_score>
      <Hsp_evalue>1.37583e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHC-AGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+   L+  T      FCGG LI  N+V+TAAHC    S  V  G  +     +  QKL++ K F++ KYN+ T+++DI LLKL   AS +  V  +  PS  +    G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>176</Hit_num>
  <Hit_id>pdb|1NN6|A</Hit_id>
  <Hit_def>Human Pro-Chymase [Homo sapiens]</Hit_def>
  <Hit_accession>1NN6_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.0409</Hsp_bit-score>
      <Hsp_score>214</Hsp_score>
      <Hsp_evalue>1.38467e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHC-AGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+   L+  T      FCGG LI  N+V+TAAHC    S  V  G  +     +  QKL++ K F++ KYN+ T+++DI LLKL   AS +  V  +  PS  +    G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>177</Hit_num>
  <Hit_id>pdb|1B0E|A</Hit_id>
  <Hit_def>Crystal Structure Of Porcine Pancreatic Elastase With Mdl 101,146 [Sus scrofa] &gt;pdb|1BMA|A Benzyl Methyl Aminimide Inhibitor Complexed To Porcine Pancreatic Elastase [Sus scrofa] &gt;pdb|1BTU|A Porcine Pancreatic Elastase Complexed With (3s, 4r)-1- Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic Acid [Sus scrofa] &gt;pdb|1E34|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para- Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid) Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute [Sus scrofa] &gt;pdb|1E35|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-para- Toluenesulphonyl -3-ethyl-4-(carboxylic Acid)pyrrolidin-2-one Soaked In Ph 9 Buffer For Two Minutes [Sus scrofa] &gt;pdb|1E36|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-para- Nitrobenzenesulphonyl -3-ethyl-4-(carboxylic Acid)pyrrolidin-2-one [Sus scrofa] &gt;pdb|1E37|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para- Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid) Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute [Sus scrofa] &gt;pdb|1E38|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para- Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid) Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes [Sus scrofa] &gt;pdb|1EAS|A Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3. Design, Synthesis, X-Ray Crystallographic Analysis, And Structure-Activity Relationships For A Series Of Orally Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl Ketones [Sus scrofa] &gt;pdb|1EAT|A Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5. Design, Synthesis, And X-Ray Crystallography Of A Series Of Orally Active 5- Amino-Pyrimidin-6-One-Containing Trifluoromethylketones [Sus scrofa] &gt;pdb|1EAU|A Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6. Design Of A Potent, Intratracheally Active, Pyridone-Based Trifluoromethyl Ketone [Sus scrofa] &gt;pdb|1ELA|A Analogous inhibitors of elastase do not always bind analogously [Sus scrofa] &gt;pdb|1ELB|A Analogous inhibitors of elastase do not always bind analogously [Sus scrofa] &gt;pdb|1ELC|A Analogous inhibitors of elastase do not always bind analogously [Sus scrofa] &gt;pdb|1ELD|E Structural analysis of the active site of porcine pancreatic elastase based on the x-ray crystal structures of complexes with trifluoroacetyl-dipeptide-anilide inhibitors [Sus scrofa] &gt;pdb|1ELE|E Structural Analysis Of The Active Site Of Porcine Pancreatic Elastase Based On The X-Ray Crystal Structures Of Complexes With Trifluoroacetyl-Dipeptide-Anilide Inhibitors [Sus scrofa] &gt;pdb|1ELF|A Nature Of The Inactivation Of Elastase By N-Peptidyl-O- Aroyl Hydroxylamine As A Function Of Ph [Sus scrofa] &gt;pdb|1ELG|A Nature Of The Inactivation Of Elastase By N-Peptidyl-O- Aroyl Hydroxylamine As A Function Of Ph [Sus scrofa] &gt;pdb|1ESA|A Direct Structure Observation Of An Acyl-Enzyme Intermediate In The Hydrolysis Of An Ester Substrate By Elastase [Sus scrofa] &gt;pdb|1ESB|A Direct Structure Observation Of An Acyl-Enzyme Intermediate In The Hydrolysis Of An Ester Substrate By Elastase [Sus scrofa] &gt;pdb|1EST|A The Atomic Structure Of Crystalline Porcine Pancreatic Elastase At 2.5 Angstroms Resolution. Comparisons With The Structure Of Alpha- Chymotrypsin [Sus scrofa] &gt;pdb|1FLE|E Crystal Structure Of Elafin Complexed With Porcine Pancreatic Elastase [Sus scrofa] &gt;pdb|1GVK|B Porcine pancreatic elastase acyl enzyme at 0.95 A resolution [Sus scrofa] &gt;pdb|1H9L|B PORCINE PANCREATIC ELASTASE COMPLEXED WITH ACETYL-VAL-GLU-PRO-ILE-COOH [Sus scrofa] &gt;pdb|1HAZ|B Snapshots of serine protease catalysis: (C) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 9 for 1 minute [Sus scrofa] &gt;pdb|1INC|A Crystal Structures Of The Complex Of Porcine Pancreatic Elastase With Two Valine-Derived Benzoxazinone Inhibitors [Sus scrofa domesticus] &gt;pdb|1JIM|A Stereospecific Reaction Of 3-Methoxy-4-Chloro-7- Aminoisocoumarin With Crystalline Porcine Pancreatic Elastase [Sus scrofa domesticus] &gt;pdb|1LVY|A Porcine Elastase [Sus scrofa] &gt;pdb|1NES|E Structure Of The Product Complex Of Acetyl-ala-pro-ala With Porcine Pancreatic Elastase At 1.65 Angstroms Resolution [Sus scrofa] &gt;pdb|1OKX|A Binding Structure of Elastase Inhibitor Scyptolin A [Sus scrofa] &gt;pdb|1OKX|B Binding Structure of Elastase Inhibitor Scyptolin A [Sus scrofa] &gt;pdb|1QGF|A PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3R, 4S)N-PARA-TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE [Sus scrofa] &gt;pdb|1QIX|B Porcine pancreatic elastase complexed with human beta-casomorphin-7 [Sus scrofa] &gt;pdb|1QR3|E Structure of porcine pancreatic elastase in complex with FR901277, a novel macrocyclic inhibitor of elastases at 1.6 angstrom resolution [Sus scrofa] &gt;pdb|2BB4|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Asp-Phe at pH 5.0 [Sus scrofa] &gt;pdb|2BD2|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 [Sus scrofa] &gt;pdb|2BD3|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ala-NH2 at pH 5.0 [Sus scrofa] &gt;pdb|2BD4|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ser at pH 5.0 [Sus scrofa] &gt;pdb|2BD5|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ser at pH 5 and immersed in pH 9 buffer for 30 seconds [Sus scrofa] &gt;pdb|2BD7|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak) [Sus scrofa] &gt;pdb|2BD8|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak) and immersed in pH 9 buffer for 30 seconds [Sus scrofa] &gt;pdb|2BD9|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak) and immersed in pH 9 buffer for 28 seconds (2nd pH jump) [Sus scrofa] &gt;pdb|2BDA|A Porcine pancreatic elastase complexed with N-acetyl-NPI and Ala-Ala at pH 5.0 [Sus scrofa] &gt;pdb|2BDB|A Porcine pancreatic elastase complexed with Asn-Pro-Ile and Ala-Ala at pH 5.0 [Sus scrofa] &gt;pdb|2BDC|A Porcine pancreatic elastase complexed with Asn-Pro-Ile at pH 5.0 [Sus scrofa] &gt;pdb|2EST|E Crystallographic study of the binding of a trifluoroacetyl dipeptide anilide inhibitor with elastase [Sus scrofa] &gt;pdb|2FO9|A Structure of porcine pancreatic elastase in 95% acetone [Sus scrofa] &gt;pdb|2FOA|A Structure of porcine pancreatic elastase in 40/50/10 % benzene [Sus scrofa] &gt;pdb|2FOB|A Structure of porcine pancreatic elastase in 40/50/10 cyclohexane [Sus scrofa] &gt;pdb|2FOC|A Structure of porcine pancreatic elastase in 55% dimethylformamide [Sus scrofa] &gt;pdb|2FOD|A Structure of porcine pancreatic elastase in 80% ethanol [Sus scrofa] &gt;pdb|2FOE|A Structure of porcine pancreatic elastase in 80% hexane [Sus scrofa] &gt;pdb|2FOF|A Structure of porcine pancreatic elastase in 80% isopropanol [Sus scrofa] &gt;pdb|2FOG|A Structure of porcine pancreatic elastase in 40% trifluoroethanol [Sus scrofa] &gt;pdb|2FOH|A Structure of porcine pancreatic elastase in 40% trifluoroethanol [Sus scrofa] &gt;pdb|2H1U|A Porcine pancreatic elastase complexed with MetPheLeuGlu at pH 5.0 [Sus scrofa] &gt;pdb|3E3T|A Structure of porcine pancreatic elastase with the magic triangle I3C [Sus scrofa] &gt;pdb|3EST|A Structure Of Native Porcine Pancreatic Elastase At 1.65 Angstroms Resolution [Sus scrofa] &gt;pdb|3MNB|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. First stage of radiation damage [Sus scrofa] &gt;pdb|3MNC|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Second stage of radiation damage [Sus scrofa] &gt;pdb|3MNS|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Third stage of radiation damage [Sus scrofa] &gt;pdb|3MNX|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Fourth stage of radiation damage [Sus scrofa] &gt;pdb|3MO3|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Fifth stage of radiation damage [Sus scrofa] &gt;pdb|3MO6|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Sixth stage of radiation damage [Sus scrofa] &gt;pdb|3MO9|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Seventh stage of radiation damage [Sus scrofa] &gt;pdb|3MOC|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Eighth stage of radiation damage [Sus scrofa] &gt;pdb|3MTY|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region A of the crystal. First step of radiation damage [Sus scrofa] &gt;pdb|3MU0|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region A of the crystal. Third step of radiation damage [Sus scrofa] &gt;pdb|3MU1|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region A of the crystal. Fifth step of radiation damage [Sus scrofa] &gt;pdb|3MU4|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region B of the crystal. First step of radiation damage [Sus scrofa] &gt;pdb|3MU5|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region B of the crystal. Third step of radiation damage [Sus scrofa] &gt;pdb|3MU8|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region B of the crystal. Fifth step of radiation damage [Sus scrofa] &gt;pdb|3ODD|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region B of the crystal. Second step of radiation damage [Sus scrofa] &gt;pdb|3ODF|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region A of the crystal. Second step of radiation damage [Sus scrofa] &gt;pdb|4EST|E CRYSTAL STRUCTURE OF THE COVALENT COMPLEX FORMED BY A PEPTIDYL ALPHA,ALPHA-DIFLUORO-BETA-KETO AMIDE WITH PORCINE PANCREATIC ELASTASE AT 1.78-ANGSTROMS RESOLUTION [Sus scrofa] &gt;pdb|4GVU|A Lyngbyastatin 7-Porcine Pancreatic Elastase Co-crystal Structure [Sus scrofa] &gt;pdb|5AVD|A The 0.86 angstrom structure of elastase crystallized in high-strength agarose hydrogel [Sus scrofa] &gt;pdb|5EST|E Crystallographic analysis of the inhibition of porcine pancreatic elastase by a peptidyl boronic acid: structure of a reaction intermediate [Sus scrofa] &gt;pdb|6EST|A Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla) With Porcine Pancreatic Elastase. X-Ray Studies At 1.8 Angstroms [Sus scrofa] &gt;pdb|7EST|E Interaction of the peptide CF3-LEU-ALA-NH-C6H4-CF3(TFLA) with porcine pancreatic elastase. X-ray studies at 1.8 Angstroms [Sus scrofa] &gt;pdb|8EST|E Reaction Of Porcine Pancreatic Elastase With 7-substituted 3-alkoxy-4-chloroisocoumarins: Design Of Potent Inhibitors Using The Crystal Structure Of The Complex Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin [Sus scrofa] &gt;pdb|9EST|A Structural Study Of Porcine Pancreatic Elastase Complexed With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A Nonreactivatable Doubly Covalent Enzyme-Inhibitor Complex [Sus scrofa]</Hit_def>
  <Hit_accession>1B0E_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.0409</Hsp_bit-score>
      <Hsp_score>214</Hsp_score>
      <Hsp_evalue>1.58944e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHC-GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNS--LTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGWGLTR</Hsp_hseq>
      <Hsp_midline>+V G EA   SWP Q+SLQ ++G    H CGG+LI +NWV+TAAHC     +  VV GE +   ++   Q + + K+  +  +N+  +    DI LL+L+ + + +  V    LP A    A  + C  TGWGLTR</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>178</Hit_num>
  <Hit_id>pdb|2F91|A</Hit_id>
  <Hit_def>1.2A resolution structure of a crayfish trypsin complexed with a peptide inhibitor, SGTI [Astacus leptodactylus] &gt;pdb|4BNR|A Extremely stable complex of crayfish trypsin with bovine trypsin inhibitor [Astacus leptodactylus] &gt;pdb|4BNR|B Extremely stable complex of crayfish trypsin with bovine trypsin inhibitor [Astacus leptodactylus]</Hit_def>
  <Hit_accession>2F91_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.0409</Hsp_bit-score>
      <Hsp_score>214</Hsp_score>
      <Hsp_evalue>1.70895e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKT---GFHFCGGSLINENWVVTAAHCGVTTSDV-------VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHC-VYGDDYENPSGLQIVAGELDMSVNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIALPEQG--HTATGDVIVTGWGTT</Hsp_hseq>
      <Hsp_midline>IV G +A  G +P+Q+S Q+      FHFCG S+ NEN+ +TA HC V   D        +VAGE D   +    Q + ++K+  +  ++   ++NDI+LLKLS + +F+  V+ + LP       A    + TGWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>179</Hit_num>
  <Hit_id>pdb|5TJX|A</Hit_id>
  <Hit_def>Structure of human plasma kallikrein [Homo sapiens] &gt;pdb|6O1S|E Structure of human plasma kallikrein protease domain with inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>5TJX_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.4261</Hsp_bit-score>
      <Hsp_score>215</Hsp_score>
      <Hsp_evalue>1.77329e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>151</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGDTSTIYTNCWVTGWGFSK</Hsp_hseq>
      <Hsp_midline>IV G E+  G WPWQVSLQ K     H CGGSLI   WV+TAAHC  G+   DV  + +G  +    ++     +I ++  +  Y     N+DI L+KL     +++    + LPS  D     T C  TGWG ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>180</Hit_num>
  <Hit_id>pdb|1C1M|A</Hit_id>
  <Hit_def>PORCINE ELASTASE UNDER XENON PRESSURE (8 BAR) [Sus scrofa] &gt;pdb|1EAI|A Complex Of Ascaris Chymotrpsin/elastase Inhibitor With Porcine Elastase [Sus scrofa] &gt;pdb|1EAI|B Complex Of Ascaris Chymotrpsin/elastase Inhibitor With Porcine Elastase [Sus scrofa] &gt;pdb|1FZZ|A The Crystal Structure Of The Complex Of Non-peptidic Inhibitor Ono- 6818 And Porcine Pancreatic Elastase. [Sus scrofa] &gt;pdb|1GWA|A Triiodide derivative of porcine pancreas elastase [Sus scrofa] &gt;pdb|1HV7|A Porcine Pancreatic Elastase Complexed With Gw311616a [Sus scrofa] &gt;pdb|1L0Z|A The Structure Of Porcine Pancreatic Elastase Complexed With Xenon And Bromide, Cryoprotected With Dry Paraffin Oil [Sus scrofa] &gt;pdb|1L1G|A The Structure of Porcine Pancreatic Elastase Complexed with Xenon and Bromide, Cryoprotected with Glycerol [Sus scrofa] &gt;pdb|1LKA|A Porcine Pancreatic Elastase/Ca-Complex [Sus scrofa] &gt;pdb|1LKB|A Porcine Pancreatic Elastase/Na-Complex [Sus scrofa] &gt;pdb|1MCV|A Crystal Structure Analysis of a Hybrid Squash Inhibitor in Complex with Porcine Pancreatic Elastase [Sus scrofa] &gt;pdb|1MMJ|N Porcine pancreatic elastase complexed with a potent peptidyl inhibitor, FR136706 [Sus scrofa] &gt;pdb|1QNJ|A THE STRUCTURE OF NATIVE PORCINE PANCREATIC ELASTASE AT ATOMIC RESOLUTION (1.1 A) [Sus scrofa] &gt;pdb|1UO6|A PORCINE PANCREATIC ELASTASE/Xe-COMPLEX [Sus scrofa] &gt;pdb|1UVO|A Structure Of The Complex Of Porcine Pancreatic Elastase In Complex With Cadmium Refined At 1.85 A Resolution (Crystal A) [Sus scrofa] &gt;pdb|1UVP|A Structure Of The Complex Of Porcine Pancreatic Elastase In Complex With Cadmium Refined At 1.85 A Resolution (Crystal B) [Sus scrofa] &gt;pdb|2A7C|A On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength [Sus scrofa] &gt;pdb|2A7J|A On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength [Sus scrofa] &gt;pdb|2BLO|A Elastase before a high dose x-ray &apos;burn&apos; [Sus scrofa] &gt;pdb|2BLQ|A Elastase After A High Dose X-Ray &apos;Burn&apos; [Sus scrofa] &gt;pdb|2CV3|A Crystal structure of porcine pancreatic elastase complexed with a macroclyclic peptide inhibitor [Sus scrofa] &gt;pdb|2D26|C Active site distortion is sufficient for proteinase inhibit second crystal structure of covalent serpin-proteinase complex [Sus scrofa] &gt;pdb|2DE8|A Crystal structure of porcine pancreatic elastase with a unique conformation induced by Tris [Sus scrofa] &gt;pdb|2DE9|A Crystal structure of porcine pancreatic elastase complexed with Tris after soaking a tris-free solution [Sus scrofa] &gt;pdb|2G4T|A anomalous substructure of porcine pancreatic elastase (Na) [Sus scrofa] &gt;pdb|2G4U|A Anomalous substructure of porcine pancreatic elastaase (Ca) [Sus scrofa] &gt;pdb|2IOT|A Clavulanic Acid bound to Elastase [Sus scrofa] &gt;pdb|2OQU|A High Pressure Cryocooling of Capillary Sample Cryoprotection and Diffraction Phasing at Long Wavelengths [Sus scrofa] &gt;pdb|2V0B|A SAD Structure solution porcine pancreatic elastase from a Selenate derivative [Sus scrofa] &gt;pdb|2V35|A Porcine Pancreatic Elastase in complex with inhibitor JM54 [Sus scrofa] &gt;pdb|3HGN|A Structure of porcine pancreatic elastase complexed with a potent peptidyl inhibitor FR130180 determined by neutron crystallography [Sus scrofa] &gt;pdb|3HGP|A Structure of porcine pancreatic elastase complexed with a potent peptidyl inhibitor FR130180 determined by high resolution crystallography [Sus scrofa] &gt;pdb|3UOU|A Crystal structure of the Kunitz-type protease inhibitor ShPI-1 Lys13Leu mutant in complex with pancreatic elastase [Sus scrofa] &gt;pdb|4YM9|A Crystal structure of Porcine Pancreatic Elastase (PPE) in complex with the novel inhibitor JM102 [Sus scrofa] &gt;pdb|6Q8S|A Elastase (PPE) under 2 kbar of argon [Sus scrofa] &gt;pdb|6QBU|A Crystal structure of Porcine Pancreatic Elastase (PPE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC188 [Sus scrofa] &gt;pdb|6QEN|A Crystal structure of Porcine Pancreatic Elastase (PPE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC240 [Sus scrofa] &gt;pdb|6QEO|A Crystal structure of Porcine Pancreatic Elastase (PPE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC269 [Sus scrofa] &gt;pdb|6TH7|A Structure of porcine pancreatic elastase in complex with tutuilamide [Sus scrofa] &gt;pdb|6TH7|B Structure of porcine pancreatic elastase in complex with tutuilamide [Sus scrofa]</Hit_def>
  <Hit_accession>1C1M_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.6557</Hsp_bit-score>
      <Hsp_score>213</Hsp_score>
      <Hsp_evalue>2.27749e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHC-GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNS--LTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNDGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGWGLTR</Hsp_hseq>
      <Hsp_midline>+V G EA   SWP Q+SLQ ++G    H CGG+LI +NWV+TAAHC     +  VV GE +   +    Q + + K+  +  +N+  +    DI LL+L+ + + +  V    LP A    A  + C  TGWGLTR</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>181</Hit_num>
  <Hit_id>pdb|3BG8|A</Hit_id>
  <Hit_def>Crystal structure of Factor XIa in complex with Clavatadine A [Homo sapiens]</Hit_def>
  <Hit_accession>3BG8_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.6557</Hsp_bit-score>
      <Hsp_score>213</Hsp_score>
      <Hsp_evalue>2.41627e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGERNVIYTDCWVTGWGYRK</Hsp_hseq>
      <Hsp_midline>IV G  +V G WPWQV+L     T  H CGGS+I   W++TAAHC  GV +  +  V +G  +Q    E      + ++  + +Y       DI LLKL T  +++ +   + LPS  +     T C  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>182</Hit_num>
  <Hit_id>pdb|2WPH|S</Hit_id>
  <Hit_def>factor IXa superactive triple mutant [Homo sapiens] &gt;pdb|2WPJ|S factor IXa superactive triple mutant, NaCl-soaked [Homo sapiens] &gt;pdb|2WPK|S factor IXa superactive triple mutant, ethylene glycol-soaked [Homo sapiens] &gt;pdb|2WPL|S factor IXa superactive triple mutant, EDTA-soaked [Homo sapiens]</Hit_def>
  <Hit_accession>2WPH_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.5001</Hsp_bit-score>
      <Hsp_score>210</Hsp_score>
      <Hsp_evalue>4.95499e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  +N+   T N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>183</Hit_num>
  <Hit_id>pdb|2WPM|S</Hit_id>
  <Hit_def>factor IXa superactive mutant, EGR-CMK inhibited [Homo sapiens]</Hit_def>
  <Hit_accession>2WPM_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.5001</Hsp_bit-score>
      <Hsp_score>210</Hsp_score>
      <Hsp_evalue>5.00771e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  +N+   T N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>184</Hit_num>
  <Hit_id>pdb|2RG3|A</Hit_id>
  <Hit_def>Covalent complex structure of elastase [Homo sapiens]</Hit_def>
  <Hit_accession>2RG3_A</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>5.1071e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IVGGRRARPHAWPFMVSLQLRGG-HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENG-YDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGL</Hsp_hseq>
      <Hsp_midline>IV G  A P +WP+ VSLQ + G HFCG +LI  N+V++AAHC    +   V    G  +        Q   + ++F+N  Y+ + + NDI +L+L+ +A+ +  V    LP+       G  C+  GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>185</Hit_num>
  <Hit_id>pdb|1H1B|A</Hit_id>
  <Hit_def>Crystal structure of human neutrophil elastase complexed with an inhibitor (GW475151) [Homo sapiens] &gt;pdb|1H1B|B Crystal structure of human neutrophil elastase complexed with an inhibitor (GW475151) [Homo sapiens] &gt;pdb|1PPG|E The refined 2.3 angstroms crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor [Homo sapiens] &gt;pdb|2Z7F|E Crystal structure of the complex of human neutrophil elastase with 1/2SLPI [Homo sapiens] &gt;pdb|3Q76|A Structure of human neutrophil elastase (uncomplexed) [Homo sapiens] &gt;pdb|3Q76|B Structure of human neutrophil elastase (uncomplexed) [Homo sapiens] &gt;pdb|3Q77|A Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|4NZL|A Chain A, Neutrophil elastase [Homo sapiens] &gt;pdb|4WVP|E Crystal structure of an activity-based probe HNE complex [Homo sapiens] &gt;pdb|5A09|A Chain A, NEUTROPHIL ELASTASE [Homo sapiens] &gt;pdb|5A0A|E Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A0B|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A0C|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A0C|B Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A8X|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A8Y|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A8Z|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5ABW|A Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases [Homo sapiens] &gt;pdb|6E69|A Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments [Homo sapiens] &gt;pdb|6E69|B Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments [Homo sapiens] &gt;pdb|6E69|C Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments [Homo sapiens] &gt;pdb|6E69|D Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments [Homo sapiens] &gt;pdb|6F5M|A Crystal structure of highly glycosylated human leukocyte elastase in complex with a thiazolidinedione inhibitor [Homo sapiens] &gt;pdb|6F5M|B Crystal structure of highly glycosylated human leukocyte elastase in complex with a thiazolidinedione inhibitor [Homo sapiens] &gt;pdb|6SMA|A Crystal structure of Human Neutrophil Elastase (HNE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC249 [Homo sapiens] &gt;pdb|6SMA|B Crystal structure of Human Neutrophil Elastase (HNE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC249 [Homo sapiens] &gt;pdb|6SMA|C Crystal structure of Human Neutrophil Elastase (HNE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC249 [Homo sapiens]</Hit_def>
  <Hit_accession>1H1B_A</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>5.1071e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IVGGRRARPHAWPFMVSLQLRGG-HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENG-YDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGL</Hsp_hseq>
      <Hsp_midline>IV G  A P +WP+ VSLQ + G HFCG +LI  N+V++AAHC    +   V    G  +        Q   + ++F+N  Y+ + + NDI +L+L+ +A+ +  V    LP+       G  C+  GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>186</Hit_num>
  <Hit_id>pdb|1PPF|E</Hit_id>
  <Hit_def>X-Ray Crystal Structure Of The Complex Of Human Leukocyte Elastase (Pmn Elastase) And The Third Domain Of The Turkey Ovomucoid Inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>1PPF_E</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>5.16168e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IVGGRRARPHAWPFMVSLQLRGG-HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENG-YDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGL</Hsp_hseq>
      <Hsp_midline>IV G  A P +WP+ VSLQ + G HFCG +LI  N+V++AAHC    +   V    G  +        Q   + ++F+N  Y+ + + NDI +L+L+ +A+ +  V    LP+       G  C+  GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>187</Hit_num>
  <Hit_id>pdb|3KCG|H</Hit_id>
  <Hit_def>Crystal structure of the antithrombin-factor IXa-pentasaccharide complex [Homo sapiens]</Hit_def>
  <Hit_accession>3KCG_H</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.5001</Hsp_bit-score>
      <Hsp_score>210</Hsp_score>
      <Hsp_evalue>5.16925e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+     N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>188</Hit_num>
  <Hit_id>pdb|6X5L|A</Hit_id>
  <Hit_def>Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>6X5L_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.5001</Hsp_bit-score>
      <Hsp_score>210</Hsp_score>
      <Hsp_evalue>5.1848e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+     N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>189</Hit_num>
  <Hit_id>pdb|4YZU|A</Hit_id>
  <Hit_def>Rapid development of two Factor IXa inhibitors from Hit to Lead [Homo sapiens] &gt;pdb|4Z0K|A Rapid development of two Factor IXa inhibitors from Hit to Lead [Homo sapiens] &gt;pdb|4ZAE|A Development of a novel class of potent and selective FIXa inhibitors [Homo sapiens] &gt;pdb|5EGM|A Development of a novel tricyclic class of potent and selective FIXa inhibitors [Homo sapiens] &gt;pdb|5TNO|A Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors [Homo sapiens] &gt;pdb|5TNT|A Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors [Homo sapiens] &gt;pdb|6X5P|A Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>4YZU_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.5001</Hsp_bit-score>
      <Hsp_score>210</Hsp_score>
      <Hsp_evalue>5.33599e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLT--INNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+     N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>190</Hit_num>
  <Hit_id>pdb|1RFN|A</Hit_id>
  <Hit_def>Human Coagulation Factor Ixa In Complex With P-Amino Benzamidine [Homo sapiens] &gt;pdb|3LC3|A Benzothiophene Inhibitors of Factor IXa [Homo sapiens] &gt;pdb|3LC3|C Benzothiophene Inhibitors of Factor IXa [Homo sapiens] &gt;pdb|3LC5|A Selective Benzothiophine Inhibitors of Factor IXa [Homo sapiens] &gt;pdb|6MV4|H CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR IXa [Homo sapiens] &gt;pdb|6X5J|A Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors [Homo sapiens] &gt;pdb|7AHV|H Chain H, Coagulation factor IX [Homo sapiens]</Hit_def>
  <Hit_accession>1RFN_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.5001</Hsp_bit-score>
      <Hsp_score>210</Hsp_score>
      <Hsp_evalue>5.45013e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSL--TINNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+     N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>191</Hit_num>
  <Hit_id>pdb|6RFK|S</Hit_id>
  <Hit_def>Crystal structure of EGRCK-inhibited Gla-domainless fIXa (K148Q, R150Q variant) [Homo sapiens]</Hit_def>
  <Hit_accession>6RFK_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.5001</Hsp_bit-score>
      <Hsp_score>210</Hsp_score>
      <Hsp_evalue>5.74625e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLT--INNDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGEDAKPGQFPWQVVLNGKVDA-FCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>+V GE+A PG +PWQV L  K    FCGGS++NE W+VTAAHC  T   + VVAGE +   +    QK  + ++  +  YN+     N+DI LL+L      +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>192</Hit_num>
  <Hit_id>pdb|6O1G|A</Hit_id>
  <Hit_def>Full length human plasma kallikrein with inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>6O1G_A</Hit_accession>
  <Hit_len>638</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.1965</Hsp_bit-score>
      <Hsp_score>217</Hsp_score>
      <Hsp_evalue>6.7167e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>391</Hsp_hit-from>
      <Hsp_hit-to>526</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSK</Hsp_hseq>
      <Hsp_midline>IV G  +  G WPWQVSLQ K     H CGGSLI   WV+TAAHC  G+   DV  + +G  +    ++     +I ++  +  Y     N+DI L+KL    ++++    +CLPS  D     T C  TGWG ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>193</Hit_num>
  <Hit_id>pdb|1HAX|B</Hit_id>
  <Hit_def>Snapshots of serine protease catalysis: (A) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 at pH 5 [Sus scrofa] &gt;pdb|1HAY|B Snapshots of serine protease catalysis: (B) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 10 for 10 seconds [Sus scrofa] &gt;pdb|1HB0|B Snapshots of serine protease catalysis: (D) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 10 for 2 minutes [Sus scrofa]</Hit_def>
  <Hit_accession>1HAX_B</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>7.68043e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG---FHFCGGSLINENWVVTAAHC-GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNS--LTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILRNNSPCYITGWGLTR</Hsp_hseq>
      <Hsp_midline>+V G EA   SWP Q+SLQ ++G    H CGG+LI +NWV+TAAHC     +  VV GE +   ++   Q + + K+  +  +N+  +    DI LL+L+ + + +  V    LP A       + C  TGWGLTR</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>194</Hit_num>
  <Hit_id>pdb|5F8T|A</Hit_id>
  <Hit_def>The crystal structure of human Plasma Kallikrein in complex with its peptide inhibitor pkalin-2 [Homo sapiens] &gt;pdb|5F8X|A The crystal structure of human plasma kallikrein in complex with its peptide inhibitor pkalin-3 [Homo sapiens] &gt;pdb|5F8Z|A The crystal structure of human Plasma Kallikrein in complex with its peptide inhibitor pkalin-1 [Homo sapiens]</Hit_def>
  <Hit_accession>5F8T_A</Hit_accession>
  <Hit_len>239</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>8.21168e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGDTSTIYTNCWVTGWGFSK</Hsp_hseq>
      <Hsp_midline>IV G  +  G WPWQVSLQ K     H CGGSLI   WV+TAAHC  G+   DV  + +G  +    ++     +I ++  +  Y     N+DI L+KL    ++++    + LPS  D     T C  TGWG ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>195</Hit_num>
  <Hit_id>pdb|2ANW|A</Hit_id>
  <Hit_def>Chain A, plasma kallikrein, light chain [Homo sapiens]</Hit_def>
  <Hit_accession>2ANW_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>9.06186e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGDTSTIYTNCWVTGWGFSK</Hsp_hseq>
      <Hsp_midline>IV G  +  G WPWQVSLQ K     H CGGSLI   WV+TAAHC  G+   DV  + +G  +    ++     +I ++  +  Y     N+DI L+KL    ++++    + LPS  D     T C  TGWG ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>196</Hit_num>
  <Hit_id>pdb|6I44|A</Hit_id>
  <Hit_def>Chain A, Plasma kallikrein [Homo sapiens]</Hit_def>
  <Hit_accession>6I44_A</Hit_accession>
  <Hit_len>627</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.4261</Hsp_bit-score>
      <Hsp_score>215</Hsp_score>
      <Hsp_evalue>1.04632e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>380</Hsp_hit-from>
      <Hsp_hit-to>514</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK--TGFHFCGGSLINENWVVTAAHC--GVTTSDV--VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGTQSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILQLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLQYTEFQKPICLPSKGDTSTIYTNCWVTGWGFS</Hsp_hseq>
      <Hsp_midline>IV G ++  G WPWQVSLQ K     H CGGSLI   WV+TAAHC  G+   DV  + +G       ++     +I ++  +  Y     N+DI L+KL     +++    +CLPS  D     T C  TGWG +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>197</Hit_num>
  <Hit_id>pdb|5ZFH|A</Hit_id>
  <Hit_def>Mouse Kallikrein 7 [Mus musculus] &gt;pdb|5ZFI|A Mouse kallikrein 7 in complex with 6-benzyl-1,4-diazepan-7-one derivative [Mus musculus] &gt;pdb|6AHS|A Mouse Kallikrein 7 in complex with imidazolinylindole derivative [Mus musculus]</Hit_def>
  <Hit_accession>5ZFH_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.7297</Hsp_bit-score>
      <Hsp_score>208</Hsp_score>
      <Hsp_evalue>1.04935e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKI-----QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIDGYKCKEGSHPWQVALLKGNQLH-CGGVLVDKYWVLTAAHCKM--------GQYQVQLGSDKIGDQSAQKIKATKSFRHPGYSTKTHVNDIMLVRLDEPVKMSSKVEAVQLPEHCE--PPGTSCTVSGWGTT</Hsp_hseq>
      <Hsp_midline>I++G +   GS PWQV+L      H CGG L+++ WV+TAAHC +        G++     S+KI     QK+K  K F++  Y++ T  NDI L++L      S  V AV LP   +    GT+C  +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>198</Hit_num>
  <Hit_id>pdb|3F6U|H</Hit_id>
  <Hit_def>Crystal structure of human Activated Protein C (APC) complexed with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>3F6U_H</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.7297</Hsp_bit-score>
      <Hsp_score>208</Hsp_score>
      <Hsp_evalue>1.12334e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA-GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSA----SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQAGQETLVTGWG</Hsp_hseq>
      <Hsp_midline>+++G+    G  PWQV L D      CG  LI+ +WV+TAAHC   +  ++V  GE+D     +    L I +VF +  Y+  T +NDI LL L+  A+ SQT+  +CLP +     +   AG   + TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>199</Hit_num>
  <Hit_id>pdb|1AZZ|A</Hit_id>
  <Hit_def>Fiddler Crab Collagenase Complexed To Ecotin [Leptuca pugilator] &gt;pdb|1AZZ|B Fiddler Crab Collagenase Complexed To Ecotin [Leptuca pugilator]</Hit_def>
  <Hit_accession>1AZZ_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>1.14868e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IVGGVEAVPNSWPHQAALFIDD-MYFCGGSLISPEWILTAAHCMDGAGFVDVVLGAHNIREDEATQV-TIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLPST--DVGVGTVVTPTGWGL</Hsp_hseq>
      <Hsp_midline>IV G EAVP SWP Q +L      +FCGGSLI+  W++TAAHC  G    DVV+     +   + ++  ++      +  YNS  I+NDI +++L    + +  ++ V LPS   D   GT    TGWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>200</Hit_num>
  <Hit_id>pdb|7CBK|B</Hit_id>
  <Hit_def>Structure of Human Neutrophil Elastase Ecotin complex [Homo sapiens] &gt;pdb|7CBK|D Structure of Human Neutrophil Elastase Ecotin complex [Homo sapiens]</Hit_def>
  <Hit_accession>7CBK_B</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>1.17266e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>158</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IVGGRRARPHAWPFMVSLQLRGG-HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENG-YDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGL</Hsp_hseq>
      <Hsp_midline>IV G  A P +WP+ VSLQ + G HFCG +LI  N+V++AAHC    +   V    G  +        Q   + ++F+N  Y+ + + NDI +L+L+ +A+ +  V    LP+       G  C+  GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>201</Hit_num>
  <Hit_id>pdb|1AUT|C</Hit_id>
  <Hit_def>Human activated protein C [Homo sapiens] &gt;pdb|6M3B|A hAPC-c25k23 Fab complex [Homo sapiens] &gt;pdb|6M3C|A hAPC-h1573 Fab complex [Homo sapiens] &gt;pdb|6M3C|C hAPC-h1573 Fab complex [Homo sapiens] &gt;pdb|6M3C|G hAPC-h1573 Fab complex [Homo sapiens]</Hit_def>
  <Hit_accession>1AUT_C</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.7297</Hsp_bit-score>
      <Hsp_score>208</Hsp_score>
      <Hsp_evalue>1.40432e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA-GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSA----SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQAGQETLVTGWG</Hsp_hseq>
      <Hsp_midline>+++G+    G  PWQV L D      CG  LI+ +WV+TAAHC   +  ++V  GE+D     +    L I +VF +  Y+  T +NDI LL L+  A+ SQT+  +CLP +     +   AG   + TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>202</Hit_num>
  <Hit_id>pdb|1PFX|C</Hit_id>
  <Hit_def>PORCINE FACTOR IXA [Sus scrofa] &gt;pdb|1X7A|C Porcine Factor IXa Complexed to 1-{3-[amino(imino)methyl]phenyl}-N-[4-(1H-benzimidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide [Sus scrofa]</Hit_def>
  <Hit_accession>1PFX_C</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>1.81965e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>52</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC---GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTIN---NDITLLKLSTAASFSQTVSAVCLPSA--SDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGENAKPGQFPWQVLLNGKID-AFCGGSIINEKWVVTAAHCIEPGVKIT--VVAGEYNTEETEPTEQRRNVIRAIPHHSYNA-TVNKYSHDIALLELDEPLTLNSYVTPICIADKEYTNIFLKFGSGYVSGWG</Hsp_hseq>
      <Hsp_midline>IV GE A PG +PWQV L  K    FCGGS+INE WVVTAAHC   GV  +  VVAGE++   +    Q+  + +   +  YN+ T+N   +DI LL+L    + +  V+ +C+     ++ F    +   +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>203</Hit_num>
  <Hit_id>pdb|2OQ5|A</Hit_id>
  <Hit_def>Crystal structure of DESC1, a new member of the type II transmembrane serine proteinases family [Homo sapiens]</Hit_def>
  <Hit_accession>2OQ5_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>1.91701e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>128</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVV-AGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGTEVEEGEWPWQASLQ-WDGSHRCGATLINATWLVSAAHCFTTYKNPARWTASFGVTIKPSKMKR-GLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPDASYEFQPGDVMFVTGFG</Hsp_hseq>
      <Hsp_midline>IV G E   G WPWQ SLQ   G H CG +LIN  W+V+AAHC  T  +       F       K+++  + ++  + KY   + + DI+L +LS+   ++  V  VCLP AS +F  G     TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>204</Hit_num>
  <Hit_id>pdb|1HNE|E</Hit_id>
  <Hit_def>Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-angstroms resolution [Homo sapiens]</Hit_def>
  <Hit_accession>1HNE_E</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.5741</Hsp_bit-score>
      <Hsp_score>205</Hsp_score>
      <Hsp_evalue>2.53959e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IVGGRRARPHAWPFMVSLQLRGG-HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFEDG-YDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGL</Hsp_hseq>
      <Hsp_midline>IV G  A P +WP+ VSLQ + G HFCG +LI  N+V++AAHC    +   V    G  +        Q   + ++F++  Y+ + + NDI +L+L+ +A+ +  V    LP+       G  C+  GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>205</Hit_num>
  <Hit_id>pdb|2ZGC|A</Hit_id>
  <Hit_def>Crystal Structure of Active Human Granzyme M [Homo sapiens] &gt;pdb|2ZGH|A Crystal Structure of active granzyme M bound to its product [Homo sapiens] &gt;pdb|2ZKS|A Structural insights into the proteolytic machinery of apoptosis-inducing Granzyme M [Homo sapiens]</Hit_def>
  <Hit_accession>2ZGC_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>2.64112e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>137</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKL-------KIAKVFKNSKYNSLT-INNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGREVIPHSRPYMASLQ-RNGSHLCGGVLVHPKWVLTAAHC--------LAQRMAQLRLVLGLHTLDSPGLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRCSMAGWGLT</Hsp_hseq>
      <Hsp_midline>I+ G E +P S P+  SLQ + G H CGG L++  WV+TAAHC        +A    Q      +  L        I    ++ +Y  +  + ND+ LL+L      S+T+  + LPS     AAGT C   GWGLT</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>206</Hit_num>
  <Hit_id>pdb|1ORF|A</Hit_id>
  <Hit_def>The Oligomeric Structure of Human Granzyme A Reveals the Molecular Determinants of Substrate Specificity [Homo sapiens]</Hit_def>
  <Hit_accession>1ORF_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.5741</Hsp_bit-score>
      <Hsp_score>205</Hsp_score>
      <Hsp_evalue>3.33465e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQV--SLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGNEVTPHSRPYMVLLSLDRKT---ICAGALIAKDWVLTAAHCNLNKRSQVILGAHSITREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPGTMCQVAGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+ V  SL  KT    C G+LI ++WV+TAAHC +     V+ G           Q + + K F    Y+  T   D+ LL+L+  A  ++ V+ + LP   DD   GT C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>207</Hit_num>
  <Hit_id>pdb|1OP8|A</Hit_id>
  <Hit_def>Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|B Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|C Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|D Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|E Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|F Crystal Structure of Human Granzyme A [Homo sapiens]</Hit_def>
  <Hit_accession>1OP8_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.1889</Hsp_bit-score>
      <Hsp_score>204</Hsp_score>
      <Hsp_evalue>3.66726e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQV--SLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGNEVTPHSRPYMVLLSLDRKT---ICAGALIAKDWVLTAAHCNLNKRSQVILGAHSITREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPGTMCQVAGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+ V  SL  KT    C G+LI ++WV+TAAHC +     V+ G           Q + + K F    Y+  T   D+ LL+L+  A  ++ V+ + LP   DD   GT C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>208</Hit_num>
  <Hit_id>pdb|1EUF|A</Hit_id>
  <Hit_def>BOVINE DUODENASE(NEW SERINE PROTEASE), CRYSTAL STRUCTURE [Bos taurus]</Hit_def>
  <Hit_accession>1EUF_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.8037</Hsp_bit-score>
      <Hsp_score>203</Hsp_score>
      <Hsp_evalue>5.04516e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>65</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTG--FHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHC-LGSSINVTLGAHNIMERERTQQVIPVRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPINLPRSLAEVKPGMMCSVAGWG</Hsp_hseq>
      <Hsp_midline>I+ G EA P S P+   L  KT    H CGG L+ E++V+TAAHC + +S  V  G  +        Q + + +   +  YN  T+ NDI LLKL+  A  +  VS + LP +  +   G  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>209</Hit_num>
  <Hit_id>pdb|1AU8|A</Hit_id>
  <Hit_def>Human Cathepsin G [Homo sapiens] &gt;pdb|1CGH|A Human cathepsin G [Homo sapiens] &gt;pdb|1T32|A A Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase with Therapeutic Efficacy in Animals Models of Inflammation [Homo sapiens] &gt;pdb|6VTM|A Chain A, Cathepsin G [Homo sapiens] &gt;pdb|6VTM|C Chain C, Cathepsin G [Homo sapiens] &gt;pdb|6VTM|D Chain D, Cathepsin G [Homo sapiens] &gt;pdb|6VTM|G Chain G, Cathepsin G [Homo sapiens]</Hit_def>
  <Hit_accession>1AU8_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.0333</Hsp_bit-score>
      <Hsp_score>201</Hsp_score>
      <Hsp_evalue>8.7335e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKT--GFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQ-QHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTLCTVAGWG</Hsp_hseq>
      <Hsp_midline>I+ G E+ P S P+   LQ ++  G   CGG L+ E++V+TAAHC  +  +V +     Q   + + Q +   +  ++ +YN  TI NDI LL+LS     ++ V+ V LP A +    GT C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>210</Hit_num>
  <Hit_id>pdb|1KYN|A</Hit_id>
  <Hit_def>Cathepsin-G [Homo sapiens] &gt;pdb|1KYN|B Cathepsin-G [Homo sapiens]</Hit_def>
  <Hit_accession>1KYN_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.4185</Hsp_bit-score>
      <Hsp_score>202</Hsp_score>
      <Hsp_evalue>9.64982e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKT--GFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQ-QHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTLCTVAGWG</Hsp_hseq>
      <Hsp_midline>I+ G E+ P S P+   LQ ++  G   CGG L+ E++V+TAAHC  +  +V +     Q   + + Q +   +  ++ +YN  TI NDI LL+LS     ++ V+ V LP A +    GT C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>211</Hit_num>
  <Hit_id>pdb|1B0F|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146 [Homo sapiens]</Hit_def>
  <Hit_accession>1B0F_A</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.6481</Hsp_bit-score>
      <Hsp_score>200</Hsp_score>
      <Hsp_evalue>1.08598e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IVGGRRARPHAWPFMVSLQLAGG-HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFEDG-YDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGL</Hsp_hseq>
      <Hsp_midline>IV G  A P +WP+ VSLQ   G HFCG +LI  N+V++AAHC    +   V    G  +        Q   + ++F++  Y+ + + NDI +L+L+ +A+ +  V    LP+       G  C+  GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>212</Hit_num>
  <Hit_id>pdb|1MZA|A</Hit_id>
  <Hit_def>crystal structure of human pro-granzyme K [Homo sapiens] &gt;pdb|1MZD|A crystal structure of human pro-granzyme K [Homo sapiens]</Hit_def>
  <Hit_accession>1MZA_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.0333</Hsp_bit-score>
      <Hsp_score>201</Hsp_score>
      <Hsp_evalue>1.19226e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVT----TSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGKEVSPHSRPFMASIQ-YGGHHVCGGVLIDPQWVLTAAHCQYRFTKGQSPTVVLGAHSLSKNEASKQTLEIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIRSKT-SLRSGTKCKVTGWGAT</Hsp_hseq>
      <Hsp_midline>I+ G+E  P S P+  S+Q   G H CGG LI+  WV+TAAHC        S  VV G      +    Q L+I K    S+  S   +NDI L+KL TAA  ++ V  + + S +    +GT C  TGWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>213</Hit_num>
  <Hit_id>pdb|2ZGJ|A</Hit_id>
  <Hit_def>Crystal Structure of D86N-GzmM Complexed with Its Optimal Synthesized Substrate [Homo sapiens]</Hit_def>
  <Hit_accession>2ZGJ_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.6481</Hsp_bit-score>
      <Hsp_score>200</Hsp_score>
      <Hsp_evalue>1.53503e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>137</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKL-------KIAKVFKNSKYNSLT-INNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGREVIPHSRPYMASLQ-RNGSHLCGGVLVHPKWVLTAAHC--------LAQRMAQLRLVLGLHTLDSPGLTFHIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRCSMAGWGLT</Hsp_hseq>
      <Hsp_midline>I+ G E +P S P+  SLQ + G H CGG L++  WV+TAAHC        +A    Q      +  L        I    ++ +Y  +  + N++ LL+L      S+T+  + LPS     AAGT C   GWGLT</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>214</Hit_num>
  <Hit_id>pdb|1BHX|B</Hit_id>
  <Hit_def>X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229-357 [Homo sapiens] &gt;pdb|1RIW|B Thrombin in complex with natural product inhibitor Oscillarin [Homo sapiens] &gt;pdb|2PKS|B Thrombin in complex with inhibitor [unidentified] &gt;pdb|3PO1|B Thrombin in complex with Benzothiazole Guanidine [Homo sapiens]</Hit_def>
  <Hit_accession>1BHX_B</Hit_accession>
  <Hit_len>147</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>79.7221</Hsp_bit-score>
      <Hsp_score>195</Hsp_score>
      <Hsp_evalue>1.67946e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>215</Hit_num>
  <Hit_id>pdb|1BBR|H</Hit_id>
  <Hit_def>Chain H, EPSILON-THROMBIN [Bos taurus] &gt;pdb|1UCY|H Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7- 19). Three Complexes, One With Epsilon-Thrombin And Two With Alpha-Thrombin [Bos taurus] &gt;pdb|1VIT|F Thrombin:hirudin 51-65 Complex [Bos taurus] &gt;pdb|1YCP|K The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y) Bound To Bovine Thrombin Explains Why The Mutation Of Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At Arginine-16 [Bos taurus]</Hit_def>
  <Hit_accession>1BBR_H</Hit_accession>
  <Hit_len>150</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>79.337</Hsp_bit-score>
      <Hsp_score>194</Hsp_score>
      <Hsp_evalue>2.1905e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLKIA-KVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRR</Hsp_hseq>
      <Hsp_midline>IV G++A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T  D++V  G+  +     K++K+ +  K++ + +YN    ++ DI LLKL      S  +  VCLP   +A+    AG     TGWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>216</Hit_num>
  <Hit_id>pdb|3RP2|A</Hit_id>
  <Hit_def>THE STRUCTURE OF RAT MAST CELL PROTEASE II AT 1.9-ANGSTROMS RESOLUTION [Rattus rattus] &gt;pdb|3RP2|B THE STRUCTURE OF RAT MAST CELL PROTEASE II AT 1.9-ANGSTROMS RESOLUTION [Rattus rattus]</Hit_def>
  <Hit_accession>3RP2_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.8777</Hsp_bit-score>
      <Hsp_score>198</Hsp_score>
      <Hsp_evalue>2.48862e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ---DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHCK-GREITVILGAHDVRKRESTQQKIKVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVVPLPSPSDFIHPGAMCWAAGWGKT</Hsp_hseq>
      <Hsp_midline>I+ G E++P S P+   L    +K     CGG LI+  +V+TAAHC       V+ G  D        QK+K+ K   +  YNS+   +DI LLKL      +  V+ V LPS SD    G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>217</Hit_num>
  <Hit_id>pdb|1FIW|A</Hit_id>
  <Hit_def>THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA [Ovis aries]</Hit_def>
  <Hit_accession>1FIW_A</Hit_accession>
  <Hit_len>290</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.0333</Hsp_bit-score>
      <Hsp_score>201</Hsp_score>
      <Hsp_evalue>3.00779e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>143</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>147</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ-----DKTGFHFCGGSLINENWVVTAAHC-----GVTTSDVVV-AGEFDQGSS---SEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGT-----TCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRLIFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPGCLP----QFRAGPPRVPQTCWVAGWGF</Hsp_hseq>
      <Hsp_midline>I+ G++A  G+WPW VSLQ     +   +H CGGSL+N  W++TAAHC      VT   ++  A E + G++      +Q+  + K+  + KY++ +  NDI L+K++   +    +   CLP     F AG      TC   GWG </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>218</Hit_num>
  <Hit_id>pdb|1EKB|B</Hit_id>
  <Hit_def>The Serine Protease Domain Of Enteropeptidase Bound To Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane [Bos taurus]</Hit_def>
  <Hit_accession>1EKB_B</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.8777</Hsp_bit-score>
      <Hsp_score>198</Hsp_score>
      <Hsp_evalue>3.24337e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSL--QDKTGFHFCGGSLINENWVVTAAHCGVTTS------DVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVGGSDSREGAWPWVVALYFDDQ---QVCGASLVSRDWLVSAAHCVYGRNMEPSKWKAVLGLHMASNLTSPQIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPEENQVFPPGRICSIAGWGALIY</Hsp_hseq>
      <Hsp_midline>IV G ++  G+WPW V+L   D+     CG SL++ +W+V+AAHC    +        V+        +S +I+   I ++  N  YN    NNDI ++ L    +++  +  +CLP  +  F  G  C   GWG   Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>219</Hit_num>
  <Hit_id>pdb|2ASU|B</Hit_id>
  <Hit_def>Crystal Structure of the beta-chain of HGFl/MSP [Homo sapiens]</Hit_def>
  <Hit_accession>2ASU_B</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>79.7221</Hsp_bit-score>
      <Hsp_score>195</Hsp_score>
      <Hsp_evalue>9.94353e-19</Hsp_evalue>
      <Hsp_query-from>9</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>6</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>PGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC------GVTTSDVVVAGEFDQGSSSEK-IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>PGNSPWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSCHMPLTGYEVWLGTLFQNPQHGEPSLQRVPVAKMVCGPS------GSQLVLLKLERSVTLNQRVALICLPPEWYVVPPGTKCEIAGWGETK</Hsp_hseq>
      <Hsp_midline>PG+ PW VSL+++ G HFCGGSL+ E W++TA  C       +T  +V +   F      E  +Q++ +AK+            + + LLKL  + + +Q V+ +CLP        GT C   GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>220</Hit_num>
  <Hit_id>pdb|4QT8|C</Hit_id>
  <Hit_def>Crystal Structure of RON Sema-PSI-IPT1 extracellular domains in complex with MSP beta-chain [Homo sapiens] &gt;pdb|4QT8|D Crystal Structure of RON Sema-PSI-IPT1 extracellular domains in complex with MSP beta-chain [Homo sapiens]</Hit_def>
  <Hit_accession>4QT8_C</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>79.7221</Hsp_bit-score>
      <Hsp_score>195</Hsp_score>
      <Hsp_evalue>1.39777e-18</Hsp_evalue>
      <Hsp_query-from>9</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>147</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>PGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC------GVTTSDVVVAGEFDQGSSSEK-IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>PGNSPWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSCHMPLTGYEVWLGTLFQNPQHGEPSLQRVPVAKMVCGPS------GSQLVLLKLERSVTLNQRVALICLPPEWYVVPPGTKCEIAGWGETK</Hsp_hseq>
      <Hsp_midline>PG+ PW VSL+++ G HFCGGSL+ E W++TA  C       +T  +V +   F      E  +Q++ +AK+            + + LLKL  + + +Q V+ +CLP        GT C   GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>221</Hit_num>
  <Hit_id>pdb|3R3G|B</Hit_id>
  <Hit_def>Structure of human thrombin with residues 145-150 of murine thrombin. [Homo sapiens]</Hit_def>
  <Hit_accession>3R3G_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.9518</Hsp_bit-score>
      <Hsp_score>193</Hsp_score>
      <Hsp_evalue>2.82244e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLR</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>222</Hit_num>
  <Hit_id>pdb|1VZQ|H</Hit_id>
  <Hit_def>Complex of thrombin with designed inhibitor 7165 [Homo sapiens]</Hit_def>
  <Hit_accession>1VZQ_H</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.5666</Hsp_bit-score>
      <Hsp_score>192</Hsp_score>
      <Hsp_evalue>3.18354e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  + +    I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>223</Hit_num>
  <Hit_id>pdb|1ID5|H</Hit_id>
  <Hit_def>Crystal Structure Of Bovine Thrombin Complex With Protease Inhibitor Ecotin [Bos taurus]</Hit_def>
  <Hit_accession>1ID5_H</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.5666</Hsp_bit-score>
      <Hsp_score>192</Hsp_score>
      <Hsp_evalue>3.51031e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLKIA-KVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRR</Hsp_hseq>
      <Hsp_midline>IV G++A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T  D++V  G+  +     K++K+ +  K++ + +YN    ++ DI LLKL      S  +  VCLP   +A+    AG     TGWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>224</Hit_num>
  <Hit_id>pdb|1A0H|B</Hit_id>
  <Hit_def>The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1: KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN INTERACTIONS AND Location Of The Linker Chain [Bos taurus] &gt;pdb|1A0H|E The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1: KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN INTERACTIONS AND Location Of The Linker Chain [Bos taurus] &gt;pdb|1AVG|H Thrombin Inhibitor From Triatoma Pallidipennis [Bos taurus] &gt;pdb|1BBR|K Chain K, EPSILON-THROMBIN [Bos taurus] &gt;pdb|1BBR|N Chain N, EPSILON-THROMBIN [Bos taurus] &gt;pdb|1ETR|H REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS [Bos taurus] &gt;pdb|1ETS|H REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS [Bos taurus] &gt;pdb|1ETT|H REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS [Bos taurus] &gt;pdb|1HRT|H The Structure Of A Complex Of Bovine Alpha-Thrombin And Recombinant Hirudin At 2.8 Angstroms Resolution [Bos taurus] &gt;pdb|1MKW|H The Co-Crystal Structure Of Unliganded Bovine Alpha- Thrombin And Prethrombin-2: Movement Of The Yppw Segment And Active Site Residues Upon Ligand Binding [Bos taurus] &gt;pdb|1MKX|H The Co-Crystal Structure Of Unliganded Bovine Alpha- Thrombin And Prethrombin-2: Movement Of The Yppw Segment And Active Site Residues Upon Ligand Binding [Bos taurus] &gt;pdb|1TBQ|H CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN [Bos taurus] &gt;pdb|1TBQ|K CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN [Bos taurus] &gt;pdb|1TBR|H CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN [Bos taurus] &gt;pdb|1TBR|K CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN [Bos taurus] &gt;pdb|1TOC|B STRUCTURE OF SERINE PROTEINASE [Bos taurus] &gt;pdb|1TOC|D STRUCTURE OF SERINE PROTEINASE [Bos taurus] &gt;pdb|1TOC|F STRUCTURE OF SERINE PROTEINASE [Bos taurus] &gt;pdb|1TOC|H STRUCTURE OF SERINE PROTEINASE [Bos taurus] &gt;pdb|1UCY|K Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7- 19). Three Complexes, One With Epsilon-Thrombin And Two With Alpha-Thrombin [Bos taurus] &gt;pdb|1UCY|N Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7- 19). Three Complexes, One With Epsilon-Thrombin And Two With Alpha-Thrombin [Bos taurus] &gt;pdb|1UVT|H Bovine Thrombin--Bm14.1248 Complex [Bos taurus] &gt;pdb|1UVU|H Bovine Thrombin--Bm12.1700 Complex [Bos taurus] &gt;pdb|1VIT|H Thrombin:hirudin 51-65 Complex [Bos taurus] &gt;pdb|1YCP|H The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y) Bound To Bovine Thrombin Explains Why The Mutation Of Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At Arginine-16 [Bos taurus] &gt;pdb|2A1D|B Staphylocoagulase bound to bovine thrombin [Bos taurus] &gt;pdb|2A1D|F Staphylocoagulase bound to bovine thrombin [Bos taurus] &gt;pdb|2ODY|B Chain B, Prothrombin (EC 3.4.21.5) [Bos taurus] &gt;pdb|2ODY|D Chain D, Prothrombin (EC 3.4.21.5) [Bos taurus] &gt;pdb|3PMA|B 2.2 Angstrom crystal structure of the complex between Bovine Thrombin and Sucrose Octasulfate [Bos taurus] &gt;pdb|3PMA|D 2.2 Angstrom crystal structure of the complex between Bovine Thrombin and Sucrose Octasulfate [Bos taurus] &gt;pdb|3PMB|B 2.9 Angstrom crystal structure of bovine thrombin in tetragonal spacegroup [Bos taurus] &gt;pdb|3PMB|D 2.9 Angstrom crystal structure of bovine thrombin in tetragonal spacegroup [Bos taurus] &gt;pdb|7A0D|HHH Chain HHH, Prothrombin [Bos taurus] &gt;pdb|7A0E|HHH Chain HHH, Prothrombin [Bos taurus] &gt;pdb|7A0F|HHH Chain HHH, Prothrombin [Bos taurus]</Hit_def>
  <Hit_accession>1A0H_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.5666</Hsp_bit-score>
      <Hsp_score>192</Hsp_score>
      <Hsp_evalue>3.5129e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLKIA-KVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRR</Hsp_hseq>
      <Hsp_midline>IV G++A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T  D++V  G+  +     K++K+ +  K++ + +YN    ++ DI LLKL      S  +  VCLP   +A+    AG     TGWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>225</Hit_num>
  <Hit_id>pdb|3GIC|B</Hit_id>
  <Hit_def>Structure of thrombin mutant delta(146-149e) in the free form [Homo sapiens]</Hit_def>
  <Hit_accession>3GIC_B</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>3.9648e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>226</Hit_num>
  <Hit_id>pdb|6FJT|H</Hit_id>
  <Hit_def>4-chloro-benzamidine in complex with thrombin [Homo sapiens]</Hit_def>
  <Hit_accession>6FJT_H</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>4.19516e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>227</Hit_num>
  <Hit_id>pdb|2BVR|H</Hit_id>
  <Hit_def>Human thrombin complexed with fragment-based small molecules occupying the S1 pocket [Homo sapiens]</Hit_def>
  <Hit_accession>2BVR_H</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>4.2126e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>228</Hit_num>
  <Hit_id>pdb|1IAU|A</Hit_id>
  <Hit_def>Human Granzyme B In Complex With Ac-Iepd-Cho [Homo sapiens]</Hit_def>
  <Hit_accession>1IAU_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>4.33606e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWGSSINVTL-GAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQT</Hsp_hseq>
      <Hsp_midline>I+ G EA P S P+   L   D+     CGG LI +++V+TAAHC  ++ +V + G  +        Q + + +   +  YN    +NDI LL+L   A  ++ V  + LPS       G TC   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>229</Hit_num>
  <Hit_id>pdb|2PGB|B</Hit_id>
  <Hit_def>Inhibitor-free human thrombin mutant C191A-C220A [Homo sapiens] &gt;pdb|2PGQ|B Human thrombin mutant C191A-C220A in complex with the inhibitor PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>2PGB_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>4.41772e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>230</Hit_num>
  <Hit_id>pdb|3EE0|B</Hit_id>
  <Hit_def>Crystal Structure of the W215A/E217A Mutant of Human Thrombin (space group P2(1)2(1)2(1)) [Homo sapiens] &gt;pdb|3HKJ|B Crystal structure of human thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 [Homo sapiens] &gt;pdb|3HKJ|E Crystal structure of human thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 [Homo sapiens]</Hit_def>
  <Hit_accession>3EE0_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>4.65387e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>231</Hit_num>
  <Hit_id>pdb|1TQ0|B</Hit_id>
  <Hit_def>Crystal structure of the potent anticoagulant thrombin mutant W215A/E217A in free form [Homo sapiens] &gt;pdb|1TQ0|D Crystal structure of the potent anticoagulant thrombin mutant W215A/E217A in free form [Homo sapiens] &gt;pdb|1TQ7|B Crystal structure of the anticoagulant thrombin mutant W215A/E217A bound to PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>1TQ0_B</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>4.86779e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>232</Hit_num>
  <Hit_id>pdb|1FQ3|A</Hit_id>
  <Hit_def>Crystal Structure Of Human Granzyme B [Homo sapiens] &gt;pdb|1FQ3|B Crystal Structure Of Human Granzyme B [Homo sapiens]</Hit_def>
  <Hit_accession>1FQ3_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>4.91977e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHCWGSSINVTL-GAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQT</Hsp_hseq>
      <Hsp_midline>I+ G EA P S P+   L   D+     CGG LI +++V+TAAHC  ++ +V + G  +        Q + + +   +  YN    +NDI LL+L   A  ++ V  + LPS       G TC   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>233</Hit_num>
  <Hit_id>pdb|1H8I|H</Hit_id>
  <Hit_def>X-ray crystal structure of human alpha-thrombin with a tripeptide phosphonate inhibitor. [Homo sapiens] &gt;pdb|6ROT|H Thrombin in complex with MI2105 [Homo sapiens]</Hit_def>
  <Hit_accession>1H8I_H</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>4.94654e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>234</Hit_num>
  <Hit_id>pdb|1H8D|H</Hit_id>
  <Hit_def>X-ray structure of the human alpha-thrombin complex with a tripeptide phosphonate inhibitor. [Homo sapiens]</Hit_def>
  <Hit_accession>1H8D_H</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>5.1287e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>235</Hit_num>
  <Hit_id>pdb|6P9U|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin mutant W215A [Homo sapiens] &gt;pdb|6P9U|D Crystal structure of human thrombin mutant W215A [Homo sapiens] &gt;pdb|6P9U|F Crystal structure of human thrombin mutant W215A [Homo sapiens] &gt;pdb|6P9U|H Crystal structure of human thrombin mutant W215A [Homo sapiens]</Hit_def>
  <Hit_accession>6P9U_B</Hit_accession>
  <Hit_len>273</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>5.21334e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>236</Hit_num>
  <Hit_id>pdb|1Z8J|B</Hit_id>
  <Hit_def>Crystal structure of the thrombin mutant G193P bound to PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>1Z8J_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>5.27334e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>237</Hit_num>
  <Hit_id>pdb|1D3D|B</Hit_id>
  <Hit_def>Crystal Structure Of Human Alpha Thrombin In Complex With Benzothiophene Inhibitor 4 [Homo sapiens] &gt;pdb|1EB1|H Complex structure of human thrombin with N-methyl-arginine inhibitor [Homo sapiens] &gt;pdb|1GHV|H A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GHW|H A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GHX|H A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GHY|H A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1QUR|H Human Alpha-Thrombin In Complex With Bivalent, Benzamidine-Based Synthetic Inhibitor [Homo sapiens] &gt;pdb|1YPE|H Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1YPG|H Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1YPJ|H Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1YPK|H Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1YPL|H X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue RA-1008 [Homo sapiens] &gt;pdb|1YPM|H X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue RA-1014 [Homo sapiens] &gt;pdb|2ANM|H Ternary complex of an orally active thrombin inhibitor with human thrombin and a c-terminal hirudin derived exo-sit inhibitor [Homo sapiens] &gt;pdb|2CF8|H Complex of recombinant human thrombin with an inhibitor [Homo sapiens] &gt;pdb|2CF9|H Complex of recombinant human thrombin with an inhibitor [Homo sapiens] &gt;pdb|2CN0|H Complex of Recombinant Human Thrombin with a Designed Inhibitor [Homo sapiens] &gt;pdb|2V3H|H Thrombin with 3-cycle no F [Homo sapiens] &gt;pdb|2V3O|H Thrombin with 3-cycle with F [Homo sapiens] &gt;pdb|3BIU|H Human thrombin-in complex with UB-THR10 [Homo sapiens] &gt;pdb|3BIV|H Human thrombin-in complex with UB-THR11 [Homo sapiens] &gt;pdb|4AX9|H Human thrombin complexed with Napsagatran, RO0466240 [Homo sapiens] &gt;pdb|4AYV|B Human thrombin - inhibitor complex [Homo sapiens] &gt;pdb|4AYY|B Human thrombin - inhibitor complex [Homo sapiens] &gt;pdb|4AZ2|B Human thrombin - inhibitor complex [Homo sapiens] &gt;pdb|4LOY|H Crystal Structure Analysis of thrombin in complex with compound D57, 5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2- oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1- yl)-3-oxopropyl]amide (SAR107375) [Homo sapiens] &gt;pdb|6GWE|A Crystal structure of Thrombin bound to P2 macrocycle [Homo sapiens]</Hit_def>
  <Hit_accession>1D3D_B</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>5.3464e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>238</Hit_num>
  <Hit_id>pdb|1DM4|B</Hit_id>
  <Hit_def>SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16) [Homo sapiens] &gt;pdb|1JMO|H Crystal Structure of the Heparin Cofactor II-S195A Thrombin Complex [Homo sapiens]</Hit_def>
  <Hit_accession>1DM4_B</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>5.57406e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>143</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>239</Hit_num>
  <Hit_id>pdb|4RKJ|B</Hit_id>
  <Hit_def>Crystal structure of thrombin mutant S195T (free form) [Homo sapiens] &gt;pdb|4RKO|B Crystal structure of thrombin mutant S195T bound with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>4RKJ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>5.6133e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>240</Hit_num>
  <Hit_id>pdb|1Z8I|B</Hit_id>
  <Hit_def>Crystal structure of the thrombin mutant G193A bound to PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>1Z8I_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>5.6133e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>241</Hit_num>
  <Hit_id>pdb|3JZ1|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin mutant N143P in E:Na+ form [Homo sapiens] &gt;pdb|3JZ2|B Crystal structure of human thrombin mutant N143P in E* form [Homo sapiens] &gt;pdb|3QGN|B The allosteric E*-E equilibrium is a key property of the trypsin fold [Homo sapiens]</Hit_def>
  <Hit_accession>3JZ1_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>5.73141e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>242</Hit_num>
  <Hit_id>pdb|1JOU|B</Hit_id>
  <Hit_def>Crystal Structure of Native S195A Thrombin with an Unoccupied Active Site [Homo sapiens] &gt;pdb|1JOU|D Crystal Structure of Native S195A Thrombin with an Unoccupied Active Site [Homo sapiens] &gt;pdb|1JOU|F Crystal Structure of Native S195A Thrombin with an Unoccupied Active Site [Homo sapiens] &gt;pdb|1TB6|H 2.5A Crystal Structure of the Antithrombin-Thrombin-Heparin Ternary Complex [Homo sapiens] &gt;pdb|2B5T|B 2.1 Angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic SR123781 and two S195A thrombin molecules [Homo sapiens] &gt;pdb|2B5T|D 2.1 Angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic SR123781 and two S195A thrombin molecules [Homo sapiens] &gt;pdb|3B9F|H 1.6 A structure of the PCI-thrombin-heparin complex [Homo sapiens] &gt;pdb|3GIS|B Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin [Homo sapiens] &gt;pdb|3GIS|D Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin [Homo sapiens] &gt;pdb|3GIS|F Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin [Homo sapiens] &gt;pdb|3LU9|B Crystal structure of human thrombin mutant S195A in complex with the extracellular fragment of human PAR1 [Homo sapiens] &gt;pdb|3LU9|E Crystal structure of human thrombin mutant S195A in complex with the extracellular fragment of human PAR1 [Homo sapiens] &gt;pdb|4DT7|B Crystal structure of thrombin bound to the activation domain QEDQVDPRLIDGKMTRRGDS of protein C [Homo sapiens] &gt;pdb|4DT7|D Crystal structure of thrombin bound to the activation domain QEDQVDPRLIDGKMTRRGDS of protein C [Homo sapiens] &gt;pdb|4DY7|B Crystal structures of protease nexin-1 in complex with S195A thrombin [Homo sapiens] &gt;pdb|4DY7|E Crystal structures of protease nexin-1 in complex with S195A thrombin [Homo sapiens] &gt;pdb|4HFP|B Structure of thrombin mutant S195a bound to the active site inhibitor argatroban [Homo sapiens] &gt;pdb|4HFP|D Structure of thrombin mutant S195a bound to the active site inhibitor argatroban [Homo sapiens] &gt;pdb|6PX5|B CRYSTAL STRUCTURE OF HUMAN MEIZOTHROMBIN DESF1 MUTANT S195A bound with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>1JOU_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>5.852e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>243</Hit_num>
  <Hit_id>pdb|2OD3|B</Hit_id>
  <Hit_def>Human thrombin chimera with human residues 184a, 186, 186a, 186b, 186c and 222 replaced by murine thrombin equivalents. [Homo sapiens]</Hit_def>
  <Hit_accession>2OD3_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>5.91324e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>244</Hit_num>
  <Hit_id>pdb|1GJ4|H</Hit_id>
  <Hit_def>SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN [Homo sapiens] &gt;pdb|1GJ5|H SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN [Homo sapiens] &gt;pdb|1SB1|H Novel Non-Covalent Thrombin Inhibitors Incorporating P1 4,5,6,7-Tetrahydrobenzothiazole Arginine Side Chain Mimetics [Homo sapiens] &gt;pdb|2PW8|H Crystal structure of sulfo-hirudin complexed to thrombin [Homo sapiens] &gt;pdb|3DD2|H Crystal structure of an RNA aptamer bound to human thrombin [Homo sapiens] &gt;pdb|4UDW|H Thrombin in complex with 1-(2R)-2-amino-3-phenyl-propanoyl-N-(2, 5dichlorophenyl)methylpyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|4UE7|H Thrombin in complex with 1-amidinopiperidine [Homo sapiens] &gt;pdb|4UEH|H Thrombin in complex with benzamidine [Homo sapiens] &gt;pdb|4UFD|H Thrombin in complex with 4-(((1-((2S)-1-((2R)-2-(benzylsulfonylamino)- 3-phenyl-propanoyl)pyrrolidin-2-yl)-1-oxo-ethyl)amino)methyl) benzamidine [Homo sapiens] &gt;pdb|4UFE|H Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-butyl)-3-phenyl-propanamide [Homo sapiens] &gt;pdb|4UFF|H Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-ethyl)-N-methyl-3-phenyl- propanamide [Homo sapiens] &gt;pdb|4UFG|H Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-((1S)-2-((4- carbamimidoylphenyl)methylamino)-1-methyl-2-oxo-ethyl)-N-methyl-3- phenyl-propanamide ethane [Homo sapiens] &gt;pdb|5A2M|H Thrombin Inhibitor [Homo sapiens] &gt;pdb|5AF9|H Thrombin in complex with 4-Methoxy-N-(2-pyridinyl)benzamide [Homo sapiens] &gt;pdb|5AFY|H Thrombin in complex with 3-chloro-benzamide [Homo sapiens] &gt;pdb|5AFZ|H Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-propyl)-3-phenyl-propanamide [Homo sapiens] &gt;pdb|5AHG|H Thrombin in complex with ((4-chlorophenyl)sulfamoyl))diemethylamine [Homo sapiens] &gt;pdb|5DO4|H Thrombin-RNA aptamer complex [Homo sapiens] &gt;pdb|6GWE|H Crystal structure of Thrombin bound to P2 macrocycle [Homo sapiens] &gt;pdb|6ZUG|H Crystal Structure of Thrombin in complex with compound10 [Homo sapiens]</Hit_def>
  <Hit_accession>1GJ4_H</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>5.95452e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>245</Hit_num>
  <Hit_id>pdb|1WBG|B</Hit_id>
  <Hit_def>Active site thrombin inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>1WBG_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>5.97513e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>246</Hit_num>
  <Hit_id>pdb|1A2C|H</Hit_id>
  <Hit_def>Structure of thrombin inhibited by AERUGINOSIN298-A from a BLUE-GREEN ALGA [Homo sapiens] &gt;pdb|1A3B|H Complex Of Human Alpha-Thrombin With The Bifunctional Boronate Inhibitor Borolog1 [Homo sapiens] &gt;pdb|1A3E|H Complex Of Human Alpha-Thrombin With The Bifunctional Boronate Inhibitor Borolog2 [Homo sapiens] &gt;pdb|1A46|H Thrombin Complexed With Hirugen And A Beta-Strand Mimetic Inhibitor [Homo sapiens] &gt;pdb|1A4W|H Crystal Structures Of Thrombin With Thiazole-Containing Inhibitors: Probes Of The S1&apos; Binding Site [Homo sapiens] &gt;pdb|1A5G|H Human Thrombin Complexed With Novel Synthetic Peptide Mimetic Inhibitor And Hirugen [Homo sapiens] &gt;pdb|1A61|H Thrombin Complexed With A Beta-Mimetic Thiazole-Containing Inhibitor [Homo sapiens] &gt;pdb|1ABI|H Structure Of The Hirulog 3-Thrombin Complex And Nature Of The S&apos; Subsites Of Substrates And Inhibitors [Homo sapiens] &gt;pdb|1ABJ|H Structure Of The Hirulog 3-Thrombin Complex And Nature Of The S&apos; Subsites Of Substrates And Inhibitors [Homo sapiens] &gt;pdb|1AD8|H Complex Of Thrombin With And Inhibitor Containing A Novel P1 Moiety [Homo sapiens] &gt;pdb|1AE8|H Human Alpha-Thrombin Inhibition By Eoc-D-Phe-Pro-Azalys-Onp [Homo sapiens] &gt;pdb|1AFE|H Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp [Homo sapiens] &gt;pdb|1AHT|H Crystal Structure Of Human Alpha-Thrombin Complexed With Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms Resolution [Homo sapiens] &gt;pdb|1AI8|H Human Alpha-Thrombin Ternary Complex With The Exosite Inhibitor Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Borompg [Homo sapiens] &gt;pdb|1AIX|H Human Alpha-Thrombin Ternary Complex With Exosite Inhibitor Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Boroval [Homo sapiens] &gt;pdb|1AWF|H NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT [Homo sapiens] &gt;pdb|1AWH|B NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT [Homo sapiens] &gt;pdb|1AWH|D NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT [Homo sapiens] &gt;pdb|1AY6|H Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based Macrocyclic Tripeptide Motif [Homo sapiens] &gt;pdb|1B5G|H Human Thrombin Complexed With Novel Synthetic Peptide Mimetic Inhibitor And Hirugen [Homo sapiens] &gt;pdb|1BA8|B Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes [Homo sapiens] &gt;pdb|1BB0|B Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes [Homo sapiens] &gt;pdb|1BCU|H ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN [Homo sapiens] &gt;pdb|1BMM|H Human Alpha-Thrombin Complexed With [s-(R,R)]-4-[(Aminoiminomethyl) Amino]-N-[[1-[3-Hydroxy-2-[(2-Naphthalenylsulfonyl)amino]-1- Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide (Bms-186282) [Homo sapiens] &gt;pdb|1BMN|H Human Alpha-Thrombin Complexed With [s-(R,R)]-1-(Aminoiminomethyl)- N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-Pyrrolidinyl]methyl]-3- Piperidenecarboxamide (Bms-189090) [Homo sapiens] &gt;pdb|1C1U|H RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Homo sapiens] &gt;pdb|1C1V|H RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Homo sapiens] &gt;pdb|1C1W|H RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Homo sapiens] &gt;pdb|1C4U|2 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. [Homo sapiens] &gt;pdb|1C4V|2 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. [Homo sapiens] &gt;pdb|1C4Y|2 SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS [Homo sapiens] &gt;pdb|1C5L|H STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5N|H STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5O|H Chain H, Thrombin heavy chain [Homo sapiens] &gt;pdb|1CA8|B Thrombin inhibitors with rigid tripeptidyl aldehydes [Homo sapiens] &gt;pdb|1D3P|B Crystal Structure Of Human Aplha-Thrombin In Complex With Benzo[b]thiophene Inhibitor 3 [Homo sapiens] &gt;pdb|1D3Q|B Crystal Structure Of Human Alpha Thrombin In Complex With Benzo[b]thiophene Inhibitor 2 [Homo sapiens] &gt;pdb|1D3T|B Crystal Structure Of Human Alpha Thrombin In Complex With Benzo[b]thiophene Inhibitor 1 [Homo sapiens] &gt;pdb|1D4P|B Chain B, ALPHA-THROMBIN [Homo sapiens] &gt;pdb|1DE7|H Interaction Of Factor Xiii Activation Peptide With Alpha-Thrombin: Crystal Structure Of The Enzyme-Substrate Complex [Homo sapiens] &gt;pdb|1DE7|K Interaction Of Factor Xiii Activation Peptide With Alpha-Thrombin: Crystal Structure Of The Enzyme-Substrate Complex [Homo sapiens] &gt;pdb|1DIT|H Complex Of A Divalent Inhibitor With Thrombin [Homo sapiens] &gt;pdb|1DWB|H Crystallographic Analysis At 3.0-angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-directed Inhibitors [Homo sapiens] &gt;pdb|1DWC|H Crystallographic Analysis At 3.0-Angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-Directed Inhibitors [Homo sapiens] &gt;pdb|1DWD|H Crystallographic Analysis At 3.0-Angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-Directed Inhibitors [Homo sapiens] &gt;pdb|1DWE|H Crystallographic analysis at 3.0-Angstroms resolution of the binding to human thrombin of four active site-directed inhibitors [Homo sapiens] &gt;pdb|1FPC|H Active Site Mimetic Inhibition Of Thrombin [Homo sapiens] &gt;pdb|1FPH|H The Interaction Of Thrombin With Fibrinogen: A Structural Basis For Its Specificity [Homo sapiens] &gt;pdb|1G30|B THROMBIN INHIBITOR COMPLEX [Homo sapiens] &gt;pdb|1G32|B Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1HAH|H THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN [Homo sapiens] &gt;pdb|1HAI|H THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN [Homo sapiens] &gt;pdb|1HAO|H Complex Of Human Alpha-thrombin With A 15mer Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of Dna) [Homo sapiens] &gt;pdb|1HAP|H Complex Of Human Alpha-Thrombin With A 15mer Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of Dna) [Homo sapiens] &gt;pdb|1HBT|H Human alpha-thrombin complexed with a peptidyl pyridinium methyl ketone containing bivalent inhibitor [Homo sapiens] &gt;pdb|1HDT|H Structure Of A Retro-Binding Peptide Inhibitor Complexed With Human Alpha-Thrombin [Homo sapiens] &gt;pdb|1HGT|H STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN [Homo sapiens] &gt;pdb|1HLT|H THE STRUCTURE OF A NONADECAPEPTIDE OF THE FIFTH EGF DOMAIN OF THROMBOMODULIN COMPLEXED WITH THROMBIN [Homo sapiens] &gt;pdb|1HLT|K THE STRUCTURE OF A NONADECAPEPTIDE OF THE FIFTH EGF DOMAIN OF THROMBOMODULIN COMPLEXED WITH THROMBIN [Homo sapiens] &gt;pdb|1HUT|H The Structure Of Alpha-Thrombin Inhibited By A 15-Mer Single-Stranded Dna Aptamer [Homo sapiens] &gt;pdb|1HXE|H Serine Protease [Homo sapiens] &gt;pdb|1HXF|H Human Thrombin Complex With Hirudin Variant [Homo sapiens] &gt;pdb|1IHS|H Crystal Structure Of The Complex Of Human Alpha-thrombin And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 And Hirutonin-6 [Homo sapiens] &gt;pdb|1IHT|H Crystal Structure Of The Complex Of Human Alpha-Thrombin And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 And Hirutonin-6 [Homo sapiens] &gt;pdb|1K21|H Human Thrombin-Inhibitor Complex [Homo sapiens] &gt;pdb|1K22|H Human Thrombin-inhibitor Complex [Homo sapiens] &gt;pdb|1KTS|B Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1KTT|B Thrombin inhibitor complex [Homo sapiens] &gt;pdb|1LHC|H Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boroarg-Oh [Homo sapiens] &gt;pdb|1LHD|H Human Alpha-thrombin Complexed With Ac-(d)phe-pro-borolys-oh [Homo sapiens] &gt;pdb|1LHE|H Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N- Butyl-Amidino-Glycine-Oh [Homo sapiens] &gt;pdb|1LHF|H Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro- Homolys-Oh [Homo sapiens] &gt;pdb|1LHG|H Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro- Boroornithine-Oh [Homo sapiens] &gt;pdb|1MU6|B Chain B, THROMBIN [Homo sapiens] &gt;pdb|1MU8|B Chain B, THROMBIN [Homo sapiens] &gt;pdb|1MUE|B Thrombin-Hirugen-L405,426 [Homo sapiens] &gt;pdb|1NO9|H Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies. [Homo sapiens] &gt;pdb|1NRN|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NRO|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NRP|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NRQ|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NRR|H Crystallographic structures of Thrombin complexed with Thrombin receptor peptides: Existence of expected and novel binding modes [Homo sapiens] &gt;pdb|1NRS|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NU7|B Staphylocoagulase-Thrombin Complex [Homo sapiens] &gt;pdb|1NU7|F Staphylocoagulase-Thrombin Complex [Homo sapiens] &gt;pdb|1NY2|2 Human alpha thrombin inhibited by RPPGF and hirugen [Homo sapiens] &gt;pdb|1NZQ|H D-Phe-Pro-Arg-Type Thrombin Inhibitor [Homo sapiens] &gt;pdb|1O0D|H Human Thrombin complexed with a d-Phe-Pro-Arg-type Inhibitor and a C-terminal Hirudin derived exo-site inhibitor [Homo sapiens] &gt;pdb|1O2G|H Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Homo sapiens] &gt;pdb|1O5G|H Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1OOK|B Crystal Structure of the Complex of Platelet Receptor GPIb-alpha and Human alpha-Thrombin [Homo sapiens] &gt;pdb|1OYT|H Complex Of Recombinant Human Thrombin With A Designed Fluorinated Inhibitor [Homo sapiens] &gt;pdb|1P8V|C Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a [Homo sapiens] &gt;pdb|1PPB|H The Refined 1.9 Angstroms Crystal Structure Of Human Alpha-Thrombin: Interaction With D-Phe-Pro-Arg Chloromethylketone And Significance Of The Tyr-Pro-Pro-Trp Insertion Segment [Homo sapiens] &gt;pdb|1QBV|H Crystal Structure Of Thrombin Complexed With An Guanidine-mimetic Inhibitor [Homo sapiens] &gt;pdb|1QHR|B NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS [Homo sapiens] &gt;pdb|1QJ1|B Novel Covalent Active Site Thrombin Inhibitors [Homo sapiens] &gt;pdb|1QJ6|B Novel Covalent Active Site Thrombin Inhibitors [Homo sapiens] &gt;pdb|1QJ7|B Novel Covalent Active Site Thrombin Inhibitors [Homo sapiens] &gt;pdb|1SR5|C ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE [Homo sapiens] &gt;pdb|1T4U|H Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin [Homo sapiens] &gt;pdb|1T4V|H Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin [Homo sapiens] &gt;pdb|1TBZ|H Human Thrombin With Active Site N-Methyl-D Phenylalanyl-N-[5- (Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl] Butyl]-L- Prolinamide Trifluroacetate And Exosite-Hirugen [Homo sapiens] &gt;pdb|1THR|H Structures Of Thrombin Complexes With A Designed And A Natural Exosite Inhibitor [Homo sapiens] &gt;pdb|1THS|H Structures Of Thrombin Complexes With A Designed And A Natural Exosite Inhibitor [Homo sapiens] &gt;pdb|1TMB|H Molecular Basis For The Inhibition Of Human Alpha-thrombin By The Macrocyclic Peptide Cyclotheonamide A [Homo sapiens] &gt;pdb|1TMT|H CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS [Homo sapiens] &gt;pdb|1TMU|H Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms [Homo sapiens] &gt;pdb|1TOM|H Alpha-Thrombin Complexed With Hirugen [Homo sapiens] &gt;pdb|1UMA|H Alpha-Thrombin (Hirugen) Complexed With Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine [Homo sapiens] &gt;pdb|1UVS|H BOVINE THROMBIN--BM51.1011 COMPLEX [Homo sapiens] &gt;pdb|1W7G|H Alpha-thrombin complex with sulfated hirudin (residues 54-65) and L- Arginine template inhibitor CS107 [Homo sapiens] &gt;pdb|1WAY|B Active site thrombin inhibitors [Homo sapiens] &gt;pdb|1XMN|B Crystal structure of thrombin bound to heparin [Homo sapiens] &gt;pdb|1XMN|D Crystal structure of thrombin bound to heparin [Homo sapiens] &gt;pdb|1XMN|F Crystal structure of thrombin bound to heparin [Homo sapiens] &gt;pdb|1XMN|H Crystal structure of thrombin bound to heparin [Homo sapiens] &gt;pdb|2A2X|H Orally Active Thrombin Inhibitors in Complex with Thrombin Inh12 [Homo sapiens] &gt;pdb|2A45|B Crystal structure of the complex between thrombin and the central &apos;E&apos; region of fibrin [Homo sapiens] &gt;pdb|2A45|E Crystal structure of the complex between thrombin and the central &apos;E&apos; region of fibrin [Homo sapiens] &gt;pdb|2AFQ|B 1.9 angstrom crystal structure of wild-type human thrombin in the sodium free state [Homo sapiens] &gt;pdb|2AFQ|D 1.9 angstrom crystal structure of wild-type human thrombin in the sodium free state [Homo sapiens] &gt;pdb|2ANK|H orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide [Homo sapiens] &gt;pdb|2BVS|H Human thrombin complexed with fragment-based small molecules occupying the S1 pocket [Homo sapiens] &gt;pdb|2BVX|H Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker [Homo sapiens] &gt;pdb|2BXT|H Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker [Homo sapiens] &gt;pdb|2BXU|H Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker [Homo sapiens] &gt;pdb|2C8W|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C8X|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C8Y|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C8Z|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C90|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C93|B thrombin inhibitors [Homo sapiens] &gt;pdb|2FEQ|H orally active thrombin inhibitors [Homo sapiens] &gt;pdb|2FES|H Orally active thrombin inhibitors [Homo sapiens] &gt;pdb|2GDE|H Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|2H9T|H Crystal structure of human alpha-thrombin in complex with suramin [Homo sapiens] &gt;pdb|2HGT|H STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN [Homo sapiens] &gt;pdb|2HPP|H Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin [Homo sapiens] &gt;pdb|2HPQ|H Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin [Homo sapiens] &gt;pdb|2JH0|D Human Thrombin Hirugen Inhibitor complex [Homo sapiens] &gt;pdb|2JH5|D Human Thrombin Hirugen Inhibitor complex [Homo sapiens] &gt;pdb|2JH6|D Human Thrombin Hirugen Inhibitor complex [Homo sapiens] &gt;pdb|2R2M|B 2-(2-Chloro-6-Fluorophenyl)Acetamides as Potent Thrombin Inhibitors [Homo sapiens] &gt;pdb|2UUF|B Thrombin-hirugen binary complex at 1.26A resolution [Homo sapiens] &gt;pdb|2UUJ|B Thrombin-hirugen-gw473178 ternary complex at 1.32A resolution [Homo sapiens] &gt;pdb|2UUK|B Thrombin-hirugen-gw420128 ternary complex at 1.39A resolution [Homo sapiens] &gt;pdb|2ZC9|H Thrombin in complex with Inhibitor [Homo sapiens] &gt;pdb|2ZDA|H Exploring Thrombin S1 pocket [Homo sapiens] &gt;pdb|2ZDV|H Exploring Thrombin S1 pocket [Homo sapiens] &gt;pdb|2ZF0|H Exploring Thrombin S1 Pocket [Homo sapiens] &gt;pdb|2ZFF|H Exploring Thrombin S1-pocket [Homo sapiens] &gt;pdb|2ZFP|H Thrombin Inibition [Homo sapiens] &gt;pdb|2ZFQ|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZFR|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZG0|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZGB|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZGX|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZHE|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZHF|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZHQ|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZHW|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZI2|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZIQ|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZNK|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZO3|H Bisphenylic Thrombin Inhibitors [Homo sapiens] &gt;pdb|3B23|B Crystal structure of thrombin-variegin complex: Insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors [Homo sapiens] &gt;pdb|3BF6|H Thrombin:suramin complex [Homo sapiens] &gt;pdb|3C27|B Cyanofluorophenylacetamides as Orally Efficacious Thrombin Inhibitors [Homo sapiens] &gt;pdb|3D49|H Thrombin Inhibition [Homo sapiens] &gt;pdb|3DA9|B Crystal structure of thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|3DHK|H Bisphenylic Thrombin Inhibitors [Homo sapiens] &gt;pdb|3DT0|H Understanding Thrombin Inhibition [Homo sapiens] &gt;pdb|3DUX|H Understanding Thrombin Inhibition [Homo sapiens] &gt;pdb|3E6P|H Crystal structure of human meizothrombin desF1 [Homo sapiens] &gt;pdb|3EGK|H KNOBLE Inhibitor [Homo sapiens] &gt;pdb|3EQ0|H Thrombin Inhibitor [Homo sapiens] &gt;pdb|3F68|H Thrombin Inhibition [Homo sapiens] &gt;pdb|3HAT|H Active Site Mimetic Inhibition Of Thrombin [Homo sapiens] &gt;pdb|3HTC|H The Structure Of A Complex Of Recombinant Hirudin And Human Alpha-Thrombin [Homo sapiens] &gt;pdb|3LDX|H Discovery and Clinical Evaluation of RWJ-671818, a Thrombin Inhibitor with an Oxyguanidine P1 Motif [Homo sapiens] &gt;pdb|3P17|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3P6Z|B Structural basis of thrombin mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P6Z|H Structural basis of thrombin mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P70|B Structural basis of thrombin-mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P70|D Structural basis of thrombin-mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P70|F Structural basis of thrombin-mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P70|H Structural basis of thrombin-mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3PMH|B Mechanism of Sulfotyrosine-Mediated Glycoprotein Ib Interaction with Two Distinct alpha-Thrombin Sites [Homo sapiens] &gt;pdb|3QLP|H X-ray structure of the complex between human alpha thrombin and a modified thrombin binding aptamer (mTBA) [Homo sapiens] &gt;pdb|3QTO|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3QTV|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3QWC|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3QX5|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3RLW|H Human Thrombin in complex with MI328 [Homo sapiens] &gt;pdb|3RLY|H Human Thrombin in complex with MI329 [Homo sapiens] &gt;pdb|3RM0|H Human Thrombin in complex with MI354 [Homo sapiens] &gt;pdb|3RM2|H Human Thrombin in complex with MI003 [Homo sapiens] &gt;pdb|3RML|H Human Thrombin in complex with MI331 [Homo sapiens] &gt;pdb|3RMM|H Human Thrombin in complex with MI332 [Homo sapiens] &gt;pdb|3RMN|H Human Thrombin in complex with MI341 [Homo sapiens] &gt;pdb|3RMO|H Human Thrombin in complex with MI004 [Homo sapiens] &gt;pdb|3SHA|H Human Thrombin In Complex With UBTHR97 [Homo sapiens] &gt;pdb|3SHC|H Human Thrombin In Complex With UBTHR101 [Homo sapiens] &gt;pdb|3SI3|H Human Thrombin In Complex With UBTHR103 [Homo sapiens] &gt;pdb|3SI4|H Human Thrombin In Complex With UBTHR104 [Homo sapiens] &gt;pdb|3SV2|H Human Thrombin In Complex With UBTHR105 [Homo sapiens] &gt;pdb|3T5F|H Human Thrombin In Complex With MI340 [Homo sapiens] &gt;pdb|3TU7|H Human alpha-thrombin complexed with N-(methylsulfonyl)-D-phenylalanyl-N-((1-carbamimidoyl-4-piperidinyl)methyl)-l-prolinamide (BMS-189664) [Homo sapiens] &gt;pdb|3U69|H Unliganded wild-type human thrombin [Homo sapiens] &gt;pdb|3U8O|H Human thrombin complexed with D-Phe-Pro-D-Arg-D-Thr [Homo sapiens] &gt;pdb|3U8R|H Human thrombin complexed with D-Phe-Pro-D-Arg-Ile [Homo sapiens] &gt;pdb|3U8T|H Human thrombin complexed with D-Phe-Pro-D-Arg-Cys [Homo sapiens] &gt;pdb|3U98|H Human Thrombin In Complex With MI001 [Homo sapiens] &gt;pdb|3U9A|H Human Thrombin In Complex With MI330 [Homo sapiens] &gt;pdb|3UTU|H High affinity inhibitor of human thrombin [Homo sapiens] &gt;pdb|3UWJ|H Human Thrombin In Complex With MI353 [Homo sapiens] &gt;pdb|3VXE|H Human alpha-thrombin-Bivalirudin complex at PD5.0 [Homo sapiens] &gt;pdb|3VXF|H X/N Joint refinement of Human alpha-thrombin-Bivalirudin complex PD5 [Homo sapiens] &gt;pdb|4BAH|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAK|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAM|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAN|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAO|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAQ|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BOH|A Madanins (MEROPS I53) are cleaved by thrombin and factor Xa [Homo sapiens] &gt;pdb|4BOH|H Madanins (MEROPS I53) are cleaved by thrombin and factor Xa [Homo sapiens] &gt;pdb|4CH2|B Low-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH2|D Low-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH8|B High-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH8|D High-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH8|F High-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH8|H High-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4DIH|H X-ray structure of the complex between human alpha thrombin and thrombin binding aptamer in the presence of sodium ions [Homo sapiens] &gt;pdb|4DII|H X-ray structure of the complex between human alpha thrombin and thrombin binding aptamer in the presence of potassium ions [Homo sapiens] &gt;pdb|4E05|H Anophelin from the malaria vector inhibits thrombin through a novel reverse-binding mechanism [Homo sapiens] &gt;pdb|4E06|H Anophelin from the malaria vector inhibits thrombin through a novel reverse-binding mechanism [Homo sapiens] &gt;pdb|4E7R|G Thrombin in complex with 3-amidinophenylalanine inhibitor [Homo sapiens] &gt;pdb|4E7R|H Thrombin in complex with 3-amidinophenylalanine inhibitor [Homo sapiens] &gt;pdb|4HTC|H THE REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX [Homo sapiens] &gt;pdb|4I7Y|H Crystal Structure of Human Alpha Thrombin in Complex with a 27-mer Aptamer Bound to Exosite II [Homo sapiens] &gt;pdb|4LXB|H Crystal Structure Analysis of thrombin in complex with compound D58 [Homo sapiens] &gt;pdb|4LZ1|H X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 12 nucleobase [Homo sapiens] &gt;pdb|4LZ4|B X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 3 nucleobase [Homo sapiens] &gt;pdb|4LZ4|D X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 3 nucleobase [Homo sapiens] &gt;pdb|4THN|H The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv Complex Reveals A Novel Specificity Site Recognition Mode. [Homo sapiens] &gt;pdb|4UD9|H Thrombin in complex with 5-chlorothiophene-2-carboxamide [Homo sapiens] &gt;pdb|4YES|B Thrombin in complex with (S)-(4-chloro-2-((1-(5-methyl-1H-pyrrole-2-carbonyl)pyrrolidine-2-carboxamido)methyl)phenyl)methanaminium [Homo sapiens] &gt;pdb|5CMX|H X-ray structure of the complex between human alpha thrombin and a duplex/quadruplex 31-mer DNA aptamer [Homo sapiens] &gt;pdb|5E8E|H Crystal structure of thrombin bound to an exosite 1-specific IgA Fab [Homo sapiens] &gt;pdb|5EW1|H Human thrombin sandwiched between two DNA aptamers: HD22 and HD1-deltaT3 [Homo sapiens] &gt;pdb|5EW2|H Human thrombin sandwiched between two DNA aptamers: HD22 and HD1-deltaT12 [Homo sapiens] &gt;pdb|5GDS|H Hirunorms Are True Hirudin Mimetics. The Crystal Structure Of Human Alpha-Thrombin:hirunorm V Complex [Homo sapiens] &gt;pdb|5GIM|B Crystal structure of thrombin-avathrin complex [Homo sapiens] &gt;pdb|5JFD|H Thrombin in complex with (S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-D-arginyl)pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5JZY|H Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5L6N|H Disulfated madanin-thrombin complex [Homo sapiens] &gt;pdb|5LCE|H Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(5-chloro-2-(hydroxymethyl)benzy l)pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5LPD|H Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(2-(aminomethyl)-5-chlorobenzyl) pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5NHU|A HUMAN ALPHA THROMBIN COMPLEXED WITH ANOPHELES GAMBIAE cE5 ANTICOAGULANT [Homo sapiens] &gt;pdb|5NHU|C HUMAN ALPHA THROMBIN COMPLEXED WITH ANOPHELES GAMBIAE cE5 ANTICOAGULANT [Homo sapiens] &gt;pdb|5NHU|H HUMAN ALPHA THROMBIN COMPLEXED WITH ANOPHELES GAMBIAE cE5 ANTICOAGULANT [Homo sapiens] &gt;pdb|6CYM|A Reversible Covalent Direct Thrombin Inhibitors [Homo sapiens] &gt;pdb|6CYM|C Reversible Covalent Direct Thrombin Inhibitors [Homo sapiens] &gt;pdb|6EO6|H X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(2-(1H-indol-3-yl)acetamide-N-yl)-1-propen-1-yl)-2&apos;-deoxyuridine residue [Homo sapiens] &gt;pdb|6EO7|H X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(acetamide-N-yl)-1-propen-1-yl)-2&apos;-deoxyuridine residue [Homo sapiens] &gt;pdb|6EO8|H Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor [Homo sapiens] &gt;pdb|6EO9|H Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor [Homo sapiens] &gt;pdb|6EVV|H X-ray structure of the complex between human alpha thrombin and NU172, a duplex/quadruplex 26-mer DNA aptamer, in the presence of potassium ions. [Homo sapiens] &gt;pdb|6GBW|H Thrombin in complex with MI2100 ((S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-L-arginyl)pyrrolidine-2-carboxamide) [Homo sapiens] &gt;pdb|6GN7|H X-ray structure of the complex between human alpha thrombin and NU172, a duplex/quadruplex 26-mer DNA aptamer, in the presence of sodium ions. [Homo sapiens] &gt;pdb|6HSX|H Thrombin in Complex with a D-Phe-Pro-diaminopyridine derivative [Homo sapiens] &gt;pdb|6I51|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6T3M|H Thrombin in Complex with a D-Phe-Pro-p-phenol derivative [Homo sapiens] &gt;pdb|6T3Q|H Thrombin in Complex with a D-Phe-Pro-2-aminopyridine derivative [Homo sapiens] &gt;pdb|6T4A|H Thrombin in Complex with a D-Phe-Pro-p-aminopyridine derivative [Homo sapiens] &gt;pdb|6T52|H Thrombin in Complex with a D-Phe-Pro-imidazole derivative [Homo sapiens] &gt;pdb|6T53|H Thrombin in Complex with a D-Phe-Pro-p-benzylamine derivative [Homo sapiens] &gt;pdb|6T54|H Thrombin in Complex with a D-Phe-Pro-2-bromothiophene Derivative [Homo sapiens] &gt;pdb|6T55|H Thrombin in Complex with Methylbenzylamine [Homo sapiens] &gt;pdb|6T56|H Thrombin in Complex with Benzylamine [Homo sapiens] &gt;pdb|6T57|H Thrombin in Complex with a D-Phe-Pro-N-amidinopiperidine Derivative [Homo sapiens] &gt;pdb|6T7H|A Chain A, Prothrombin [Homo sapiens] &gt;pdb|6T7H|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6T89|H Thrombin in complex with (S)-N-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2&apos;,4&apos;-dimethoxy-[1,1&apos;-biphenyl])-3-sulfonamido)propanoyl)piperazine-1-carboxamide (MI-498) [Homo sapiens] &gt;pdb|6T8A|H Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((S)-1-((R)-3-cyclohexyl 2-((phenylmethyl)sulfonamido)propanoyl)pyrrolidine-2-carboxamido)methyl)phosphonate (MI-492) [Homo sapiens] &gt;pdb|6TDT|H Thrombin in Complex with a D-DiPhe-Pro-p-pyridine derivative [Homo sapiens] &gt;pdb|6TKG|H Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 12keV [Homo sapiens] &gt;pdb|6TKH|H Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 7keV [Homo sapiens] &gt;pdb|6TKI|H Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 12.7keV [Homo sapiens] &gt;pdb|6TKJ|H Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 7keV [Homo sapiens] &gt;pdb|6TKL|H Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin [Homo sapiens] &gt;pdb|6Y02|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6Y9H|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YB6|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YHG|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YHJ|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YMP|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YN3|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YQV|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YSJ|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YSX|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6Z8V|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6Z8W|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6Z8X|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6ZGO|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6ZUH|H Crystal Structure of Thrombin in complex with compound17 [Homo sapiens] &gt;pdb|6ZUN|H Crystal Structure of Thrombin in complex with compound20a [Homo sapiens] &gt;pdb|6ZUU|H Crystal structure of Thrombin in complex with compound30 [Homo sapiens] &gt;pdb|6ZUW|H Crystal Structure of Thrombin in complex with compound40 [Homo sapiens] &gt;pdb|6ZUX|H Crystal Structure of Thrombin in complex with compound42a [Homo sapiens] &gt;pdb|6ZV7|H Crystal Structure of Thrombin in complex with compound42b [Homo sapiens] &gt;pdb|6ZV8|H Crystal Structure of Thrombin in complex with compound51 [Homo sapiens] &gt;pdb|7KME|H CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2711. [Homo sapiens] &gt;pdb|7NTU|B Chain B, Prothrombin [Homo sapiens] &gt;pdb|7NTU|D Chain D, Prothrombin [Homo sapiens] &gt;pdb|8KME|2 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770. [Homo sapiens]</Hit_def>
  <Hit_accession>1A2C_H</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>5.97513e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>247</Hit_num>
  <Hit_id>pdb|1TWX|B</Hit_id>
  <Hit_def>Crystal structure of the thrombin mutant D221A/D222K [Homo sapiens]</Hit_def>
  <Hit_accession>1TWX_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.03766e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>248</Hit_num>
  <Hit_id>pdb|1D6W|A</Hit_id>
  <Hit_def>Structure Of Thrombin Complexed With Selective Non-electrophilic Inhibitors Having Cyclohexyl Moieties At P1 [Homo sapiens] &gt;pdb|1G37|A CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE [Homo sapiens]</Hit_def>
  <Hit_accession>1D6W_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>6.04832e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>172</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>249</Hit_num>
  <Hit_id>pdb|5JDU|B</Hit_id>
  <Hit_def>Crystal structure for human thrombin mutant D189A [Homo sapiens] &gt;pdb|5JDU|D Crystal structure for human thrombin mutant D189A [Homo sapiens]</Hit_def>
  <Hit_accession>5JDU_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.10084e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>250</Hit_num>
  <Hit_id>pdb|6PXQ|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin mutant D194A [Homo sapiens]</Hit_def>
  <Hit_accession>6PXQ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.10084e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>251</Hit_num>
  <Hit_id>pdb|1THP|B</Hit_id>
  <Hit_def>STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE [Homo sapiens] &gt;pdb|3S7H|B Structure of thrombin mutant Y225P in the E* form [Homo sapiens] &gt;pdb|3S7K|B Structure of thrombin mutant Y225P in the E form [Homo sapiens] &gt;pdb|3S7K|D Structure of thrombin mutant Y225P in the E form [Homo sapiens]</Hit_def>
  <Hit_accession>1THP_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.16468e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>252</Hit_num>
  <Hit_id>pdb|5MJT|H</Hit_id>
  <Hit_def>Thrombin Mutant A190S in complex with (S) -1 - ((R) -2-amino-3,3-diphenylpropanoyl) -N- (3-chlorobenzyl) pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5MLS|H Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(3-chlorobenzyl)pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5MM6|H Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide [Homo sapiens]</Hit_def>
  <Hit_accession>5MJT_H</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.16468e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>253</Hit_num>
  <Hit_id>pdb|2BDY|A</Hit_id>
  <Hit_def>thrombin in complex with inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>2BDY_A</Hit_accession>
  <Hit_len>289</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>6.18782e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>172</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>254</Hit_num>
  <Hit_id>pdb|1BTH|H</Hit_id>
  <Hit_def>STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR &gt;pdb|1BTH|K STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR</Hit_def>
  <Hit_accession>1BTH_H</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.22919e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>255</Hit_num>
  <Hit_id>pdb|1RD3|B</Hit_id>
  <Hit_def>2.5A Structure of Anticoagulant Thrombin Variant E217K [Homo sapiens] &gt;pdb|1RD3|D 2.5A Structure of Anticoagulant Thrombin Variant E217K [Homo sapiens]</Hit_def>
  <Hit_accession>1RD3_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.29438e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>256</Hit_num>
  <Hit_id>pdb|3SQE|E</Hit_id>
  <Hit_def>Crystal structure of prethrombin-2 mutant S195A in the alternative form [Homo sapiens] &gt;pdb|3SQH|E Crystal structure of prethrombin-2 mutant S195A in the the open form [Homo sapiens] &gt;pdb|4RN6|A Structure of prethrombin-2 mutant s195a bound to the active site inhibitor argatroban [Homo sapiens] &gt;pdb|4RN6|B Structure of prethrombin-2 mutant s195a bound to the active site inhibitor argatroban [Homo sapiens]</Hit_def>
  <Hit_accession>3SQE_E</Hit_accession>
  <Hit_len>290</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>6.38818e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>32</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>257</Hit_num>
  <Hit_id>pdb|1B7X|B</Hit_id>
  <Hit_def>Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D- Phe-Pro-Arg-Chloromethylketone [Homo sapiens]</Hit_def>
  <Hit_accession>1B7X_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.4268e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>258</Hit_num>
  <Hit_id>pdb|2THF|B</Hit_id>
  <Hit_def>Structure Of Human Alpha-thrombin Y225f Mutant Bound To D-phe-pro-arg- Chloromethylketone [Homo sapiens]</Hit_def>
  <Hit_accession>2THF_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>6.49405e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>259</Hit_num>
  <Hit_id>pdb|1D9I|A</Hit_id>
  <Hit_def>Structure Of Thrombin Complexed With Selective Non-electophilic Inhibitors Having Cyclohexyl Moieties At P1 [Homo sapiens]</Hit_def>
  <Hit_accession>1D9I_A</Hit_accession>
  <Hit_len>288</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>6.50812e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>172</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>260</Hit_num>
  <Hit_id>pdb|1EOJ|A</Hit_id>
  <Hit_def>Design of P1&apos; and P3&apos; residues of trivalent thrombin inhibitors and their crystal structures [Homo sapiens] &gt;pdb|1EOL|A Design of P1&apos; and P3&apos; residues of trivalent thrombin inhibitors and their crystal structures [Homo sapiens]</Hit_def>
  <Hit_accession>1EOJ_A</Hit_accession>
  <Hit_len>289</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>6.51486e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>174</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>261</Hit_num>
  <Hit_id>pdb|1NM6|A</Hit_id>
  <Hit_def>thrombin in complex with selective macrocyclic inhibitor at 1.8A [Homo sapiens] &gt;pdb|1NT1|A thrombin in complex with selective macrocyclic inhibitor [Homo sapiens] &gt;pdb|1SL3|A crystal structue of Thrombin in complex with a potent P1 heterocycle-Aryl based inhibitor [Homo sapiens] &gt;pdb|1TA2|A Crystal structure of thrombin in complex with compound 1 [Homo sapiens] &gt;pdb|1TA6|A Crystal structure of thrombin in complex with compound 14b [Homo sapiens] &gt;pdb|1Z71|A thrombin and P2 pyridine N-oxide inhibitor complex structure [Homo sapiens] &gt;pdb|1ZGI|A thrombin in complex with an oxazolopyridine inhibitor 21 [Homo sapiens] &gt;pdb|1ZGV|A Thrombin in complex with an oxazolopyridine inhibitor 2 [Homo sapiens] &gt;pdb|1ZRB|A Thrombin in complex with an azafluorenyl inhibitor 23b [Homo sapiens] &gt;pdb|3C1K|A Crystal structure of thrombin in complex with inhibitor 15 [Homo sapiens]</Hit_def>
  <Hit_accession>1NM6_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>6.56823e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>171</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>262</Hit_num>
  <Hit_id>pdb|1MKW|K</Hit_id>
  <Hit_def>The Co-Crystal Structure Of Unliganded Bovine Alpha- Thrombin And Prethrombin-2: Movement Of The Yppw Segment And Active Site Residues Upon Ligand Binding [Bos taurus] &gt;pdb|1MKX|K The Co-Crystal Structure Of Unliganded Bovine Alpha- Thrombin And Prethrombin-2: Movement Of The Yppw Segment And Active Site Residues Upon Ligand Binding [Bos taurus]</Hit_def>
  <Hit_accession>1MKW_K</Hit_accession>
  <Hit_len>308</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.5666</Hsp_bit-score>
      <Hsp_score>192</Hsp_score>
      <Hsp_evalue>6.75265e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>50</Hsp_hit-from>
      <Hsp_hit-to>194</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLKIA-KVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRR</Hsp_hseq>
      <Hsp_midline>IV G++A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T  D++V  G+  +     K++K+ +  K++ + +YN    ++ DI LLKL      S  +  VCLP   +A+    AG     TGWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>263</Hit_num>
  <Hit_id>pdb|1FY3|A</Hit_id>
  <Hit_def>[G175Q]HBP, A mutant of human heparin binding protein (CAP37) [Homo sapiens]</Hit_def>
  <Hit_accession>1FY3_A</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>6.95026e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>137</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC------GVTTSDVVVAGEFD-QGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGRKARPRQFPFLASIQNQ-GRHFCGGALIHARFVMTAASCFQSQNPGVST---VVLGAYDLRRRERQSRQTFSISSMSENG-YDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQR</Hsp_hseq>
      <Hsp_midline>IV G +A P  +P+  S+Q++ G HFCGG+LI+  +V+TAA C      GV+T   VV G +D +    +  Q   I+ + +N  Y+     ND+ LL+L   A+ + +V+ + LP  +    AGT C   GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>264</Hit_num>
  <Hit_id>pdb|1NU9|A</Hit_id>
  <Hit_def>Staphylocoagulase-Prethrombin-2 complex [Homo sapiens] &gt;pdb|1NU9|D Staphylocoagulase-Prethrombin-2 complex [Homo sapiens]</Hit_def>
  <Hit_accession>1NU9_A</Hit_accession>
  <Hit_len>291</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>7.01441e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>174</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>265</Hit_num>
  <Hit_id>pdb|2RDL|A</Hit_id>
  <Hit_def>Hamster Chymase 2 [Mesocricetus auratus] &gt;pdb|2RDL|B Hamster Chymase 2 [Mesocricetus auratus]</Hit_def>
  <Hit_accession>2RDL_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>7.37085e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>65</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ---DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCA-GRSITVLLGAHNKKVKEDTWQKLEVEKQFPHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPISAKSNSIPPGRVCRAVGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G E  P + P+   L+    +     C G LI  N+V+TAAHC    S  V+ G  ++    +  QKL++ K F + KY+   + NDI LLKL   A+ +  V  + + + S+    G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>266</Hit_num>
  <Hit_id>pdb|1JWT|A</Hit_id>
  <Hit_def>Crystal Structure Of Thrombin In Complex With A Novel Bicyclic Lactam Inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>1JWT_A</Hit_accession>
  <Hit_len>305</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>7.88164e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>37</Hsp_hit-from>
      <Hsp_hit-to>178</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>267</Hit_num>
  <Hit_id>pdb|1A7S|A</Hit_id>
  <Hit_def>Atomic Resolution Structure Of Hbp [Homo sapiens] &gt;pdb|1AE5|A Human Heparin Binding Protein [Homo sapiens]</Hit_def>
  <Hit_accession>1A7S_A</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>7.96932e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>137</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC------GVTTSDVVVAGEFD-QGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGRKARPRQFPFLASIQNQ-GRHFCGGALIHARFVMTAASCFQSQNPGVST---VVLGAYDLRRRERQSRQTFSISSMSENG-YDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQR</Hsp_hseq>
      <Hsp_midline>IV G +A P  +P+  S+Q++ G HFCGG+LI+  +V+TAA C      GV+T   VV G +D +    +  Q   I+ + +N  Y+     ND+ LL+L   A+ + +V+ + LP  +    AGT C   GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>268</Hit_num>
  <Hit_id>pdb|1FIZ|A</Hit_id>
  <Hit_def>THREE DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM BOAR SPERMATOZOA [Sus scrofa]</Hit_def>
  <Hit_accession>1FIZ_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>8.35451e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ-----DKTGFHFCGGSLINENWVVTAAHC-----GVTTSDVVV-AGEFDQGSS---SEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS-ASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRLIFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPGCLPQFKAGPPRAPQTCWVTGWGYLK</Hsp_hseq>
      <Hsp_midline>+V G  A PG+WPW VSLQ     +   +H CGG L+N +WV+TAAHC      VT   ++  A E   GS+      +Q+  + ++  + KY S    NDI L+K++        +   CLP   +    A  TC  TGWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>269</Hit_num>
  <Hit_id>pdb|1DOJ|A</Hit_id>
  <Hit_def>Crystal structure of human alpha-thrombin*RWJ-51438 complex at 1.7 A [Homo sapiens] &gt;pdb|1HAG|E THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN [Homo sapiens] &gt;pdb|1XM1|A Nonbasic Thrombin Inhibitor Complex [Homo sapiens]</Hit_def>
  <Hit_accession>1DOJ_A</Hit_accession>
  <Hit_len>295</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>8.37528e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>37</Hsp_hit-from>
      <Hsp_hit-to>178</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>270</Hit_num>
  <Hit_id>pdb|3K65|B</Hit_id>
  <Hit_def>Crystal Structure of Prethombin-2/Fragment-2 Complex [Homo sapiens]</Hit_def>
  <Hit_accession>3K65_B</Hit_accession>
  <Hit_len>308</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>8.71984e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>50</Hsp_hit-from>
      <Hsp_hit-to>191</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>271</Hit_num>
  <Hit_id>pdb|4H6S|B</Hit_id>
  <Hit_def>Crystal structure of thrombin mutant E14eA/D14lA/E18A/S195A [Homo sapiens]</Hit_def>
  <Hit_accession>4H6S_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>1.1998e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVAGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>272</Hit_num>
  <Hit_id>pdb|1MH0|A</Hit_id>
  <Hit_def>Crystal structure of the anticoagulant slow form of thrombin [Homo sapiens] &gt;pdb|1MH0|B Crystal structure of the anticoagulant slow form of thrombin [Homo sapiens]</Hit_def>
  <Hit_accession>1MH0_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.411</Hsp_bit-score>
      <Hsp_score>189</Hsp_score>
      <Hsp_evalue>1.20619e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>172</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>273</Hit_num>
  <Hit_id>pdb|2A0Q|B</Hit_id>
  <Hit_def>Structure of thrombin in 400 mM potassium chloride [Homo sapiens] &gt;pdb|2A0Q|D Structure of thrombin in 400 mM potassium chloride [Homo sapiens]</Hit_def>
  <Hit_accession>2A0Q_B</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>1.22982e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>274</Hit_num>
  <Hit_id>pdb|1SFQ|B</Hit_id>
  <Hit_def>Fast form of thrombin mutant R(77a)A bound to PPACK [Homo sapiens] &gt;pdb|1SFQ|E Fast form of thrombin mutant R(77a)A bound to PPACK [Homo sapiens] &gt;pdb|1SG8|B Crystal structure of the procoagulant fast form of thrombin [Homo sapiens] &gt;pdb|1SG8|E Crystal structure of the procoagulant fast form of thrombin [Homo sapiens] &gt;pdb|1SGI|B Crystal structure of the anticoagulant slow form of thrombin [Homo sapiens] &gt;pdb|1SGI|E Crystal structure of the anticoagulant slow form of thrombin [Homo sapiens] &gt;pdb|1SHH|B Slow form of Thrombin Bound with PPACK [Homo sapiens] &gt;pdb|1SHH|E Slow form of Thrombin Bound with PPACK [Homo sapiens] &gt;pdb|2HWL|B Crystal structure of thrombin in complex with fibrinogen gamma&apos; peptide [Homo sapiens] &gt;pdb|2HWL|D Crystal structure of thrombin in complex with fibrinogen gamma&apos; peptide [Homo sapiens] &gt;pdb|3BV9|B Structure of Thrombin Bound to the Inhibitor FM19 [Homo sapiens]</Hit_def>
  <Hit_accession>1SFQ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>1.30388e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>275</Hit_num>
  <Hit_id>pdb|1VR1|H</Hit_id>
  <Hit_def>Specifity for Plasminogen Activator Inhibitor-1 [Homo sapiens]</Hit_def>
  <Hit_accession>1VR1_H</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>1.48607e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>51</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>146</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSL----QDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L    +   G  F CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>276</Hit_num>
  <Hit_id>pdb|4H6T|A</Hit_id>
  <Hit_def>Crystal structure of prethrombin-2 mutant E14eA/D14lA/E18A/S195A [Homo sapiens]</Hit_def>
  <Hit_accession>4H6T_A</Hit_accession>
  <Hit_len>306</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.411</Hsp_bit-score>
      <Hsp_score>189</Hsp_score>
      <Hsp_evalue>1.64531e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>48</Hsp_hit-from>
      <Hsp_hit-to>189</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVAGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>277</Hit_num>
  <Hit_id>pdb|7JQK|E</Hit_id>
  <Hit_def>Chain E, Kallikrein-4 [Homo sapiens] &gt;pdb|7JQN|E Chain E, Kallikrein-4 [Homo sapiens]</Hit_def>
  <Hit_accession>7JQK_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.8702</Hsp_bit-score>
      <Hsp_score>185</Hsp_score>
      <Hsp_evalue>2.4012e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>128</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IINGEDCSPHSQPWQAALVMENEL-FCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISI--ASQCPTAGNSCLVSGWGL</Hsp_hseq>
      <Hsp_midline>I+NGE+  P S PWQ +L  +    FC G L++  WV++AAHC   +  + +     +       Q ++ +   ++ +YN   + ND+ L+KL  + S S T+ ++ +  AS    AG +C+ +GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>278</Hit_num>
  <Hit_id>pdb|7JQO|E</Hit_id>
  <Hit_def>Chain E, Kallikrein-4 [Homo sapiens]</Hit_def>
  <Hit_accession>7JQO_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.8702</Hsp_bit-score>
      <Hsp_score>185</Hsp_score>
      <Hsp_evalue>2.42658e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>128</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IINGEDCSPHSQPWQAALVMENEL-FCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISI--ASQCPTAGNSCLVSGWGL</Hsp_hseq>
      <Hsp_midline>I+NGE+  P S PWQ +L  +    FC G L++  WV++AAHC   +  + +     +       Q ++ +   ++ +YN   + ND+ L+KL  + S S T+ ++ +  AS    AG +C+ +GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>279</Hit_num>
  <Hit_id>pdb|3EDX|B</Hit_id>
  <Hit_def>Crystal structure of the W215A/E217A mutant of murine thrombin [Mus musculus] &gt;pdb|3EDX|D Crystal structure of the W215A/E217A mutant of murine thrombin [Mus musculus] &gt;pdb|3EDX|F Crystal structure of the W215A/E217A mutant of murine thrombin [Mus musculus] &gt;pdb|3HK3|B Crystal structure of murine thrombin mutant W215A/E217A (one molecule in the asymmetric unit) [Mus musculus] &gt;pdb|3HK6|B Crystal structure of murine thrombin mutant W215A/E217A (two molecules in the asymmetric unit) [Mus musculus] &gt;pdb|3HK6|D Crystal structure of murine thrombin mutant W215A/E217A (two molecules in the asymmetric unit) [Mus musculus] &gt;pdb|3HKI|B Crystal structure of murine thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 [Mus musculus] &gt;pdb|3HKI|E Crystal structure of murine thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 [Mus musculus]</Hit_def>
  <Hit_accession>3EDX_B</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>2.50207e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVTGWGNLR</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      ++K+  + K++ + +YN    ++ DI LLKL     FS  +  VCLP   + +    AG     TGWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>280</Hit_num>
  <Hit_id>pdb|6NVB|A</Hit_id>
  <Hit_def>Crystal structure of the inhibitor-free form of the serine protease kallikrein-4 [Homo sapiens] &gt;pdb|6NVB|B Crystal structure of the inhibitor-free form of the serine protease kallikrein-4 [Homo sapiens] &gt;pdb|6NVB|C Crystal structure of the inhibitor-free form of the serine protease kallikrein-4 [Homo sapiens] &gt;pdb|6NVB|D Crystal structure of the inhibitor-free form of the serine protease kallikrein-4 [Homo sapiens]</Hit_def>
  <Hit_accession>6NVB_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.8702</Hsp_bit-score>
      <Hsp_score>185</Hsp_score>
      <Hsp_evalue>2.54577e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>128</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IINGEDCSPHSQPWQAALVMENEL-FCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISI--ASQCPTAGNSCLVSGWGL</Hsp_hseq>
      <Hsp_midline>I+NGE+  P S PWQ +L  +    FC G L++  WV++AAHC   +  + +     +       Q ++ +   ++ +YN   + ND+ L+KL  + S S T+ ++ +  AS    AG +C+ +GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>281</Hit_num>
  <Hit_id>pdb|2PUX|B</Hit_id>
  <Hit_def>Crystal structure of murine thrombin in complex with the extracellular fragment of murine PAR3 [Mus musculus] &gt;pdb|2PV9|B Crystal structure of murine thrombin in complex with the extracellular fragment of murine PAR4 [Mus musculus]</Hit_def>
  <Hit_accession>2PUX_B</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>2.60825e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVTGWGNLR</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      ++K+  + K++ + +YN    ++ DI LLKL     FS  +  VCLP   + +    AG     TGWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>282</Hit_num>
  <Hit_id>pdb|2OCV|B</Hit_id>
  <Hit_def>Structural basis of Na+ activation mimicry in murine thrombin [Mus musculus]</Hit_def>
  <Hit_accession>2OCV_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>2.6987e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>145</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVTGWGNLR</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      ++K+  + K++ + +YN    ++ DI LLKL     FS  +  VCLP   + +    AG     TGWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>283</Hit_num>
  <Hit_id>pdb|1DX5|M</Hit_id>
  <Hit_def>Crystal structure of the thrombin-thrombomodulin complex [Homo sapiens] &gt;pdb|1DX5|N Crystal structure of the thrombin-thrombomodulin complex [Homo sapiens] &gt;pdb|1DX5|O Crystal structure of the thrombin-thrombomodulin complex [Homo sapiens] &gt;pdb|1DX5|P Crystal structure of the thrombin-thrombomodulin complex [Homo sapiens] &gt;pdb|1E0F|D Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor [Homo sapiens] &gt;pdb|1E0F|E Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor [Homo sapiens] &gt;pdb|1E0F|F Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>1DX5_M</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>2.75534e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC            +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>284</Hit_num>
  <Hit_id>pdb|6PXJ|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin mutant I16T [Homo sapiens] &gt;pdb|6PXJ|H Crystal structure of human thrombin mutant I16T [Homo sapiens]</Hit_def>
  <Hit_accession>6PXJ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>2.81317e-17</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>VNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>V G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>285</Hit_num>
  <Hit_id>pdb|2BDG|A</Hit_id>
  <Hit_def>Human Kallikrein 4 complex with nickel and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDG|B Human Kallikrein 4 complex with nickel and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDH|A Human Kallikrein 4 complex with zinc and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDH|B Human Kallikrein 4 complex with zinc and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDH|C Human Kallikrein 4 complex with zinc and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDH|D Human Kallikrein 4 complex with zinc and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|A Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|B Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|C Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|D Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|E Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|F Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|G Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|H Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|I Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|J Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|K Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|L Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|M Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|N Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|O Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|P Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|4K1E|A Atomic resolution crystal structures of Kallikrein-Related Peptidase 4 complexed with a modified SFTI inhibitor FCQR [Homo sapiens] &gt;pdb|4K8Y|A Atomic resolution crystal structures of Kallikrein-Related Peptidase 4 complexed with Sunflower Trypsin Inhibitor (SFTI-1) [Homo sapiens] &gt;pdb|4KEL|A Atomic resolution crystal structure of Kallikrein-Related Peptidase 4 complexed with a modified SFTI inhibitor FCQR(N) [Homo sapiens] &gt;pdb|4KGA|A Crystal structure of kallikrein-related peptidase 4 [Homo sapiens] &gt;pdb|4KGA|B Crystal structure of kallikrein-related peptidase 4 [Homo sapiens] &gt;pdb|6O21|A Crystal Structure of Human KLK4 in Complex With Cleaved SFTI-FCQR(Asn14)[1,14] Inhibitor [Homo sapiens] &gt;pdb|7JOD|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOE|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|A Chain A, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|C Chain C, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|G Chain G, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|I Chain I, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|K Chain K, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|M Chain M, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOW|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JQV|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens]</Hit_def>
  <Hit_accession>2BDG_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.485</Hsp_bit-score>
      <Hsp_score>184</Hsp_score>
      <Hsp_evalue>2.84109e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>128</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IINGEDCSPHSQPWQAALVMENEL-FCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISI--ASQCPTAGNSCLVSGWGL</Hsp_hseq>
      <Hsp_midline>I+NGE+  P S PWQ +L  +    FC G L++  WV++AAHC   +  + +     +       Q ++ +   ++ +YN   + ND+ L+KL  + S S T+ ++ +  AS    AG +C+ +GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>286</Hit_num>
  <Hit_id>pdb|1DST|A</Hit_id>
  <Hit_def>Mutant Of Factor D With Enhanced Catalytic Activity [Homo sapiens]</Hit_def>
  <Hit_accession>1DST_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.485</Hsp_bit-score>
      <Hsp_score>184</Hsp_score>
      <Hsp_evalue>2.89241e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-LNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRL--YDVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++    + +   +  Y   TI++D+ LL+LS  A+    V  +       D A GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>287</Hit_num>
  <Hit_id>pdb|2GP9|B</Hit_id>
  <Hit_def>Crystal structure of the slow form of thrombin in a self-inhibited conformation [Homo sapiens] &gt;pdb|3BEF|B Crystal structure of thrombin bound to the extracellular fragment of PAR1 [Homo sapiens] &gt;pdb|3BEF|E Crystal structure of thrombin bound to the extracellular fragment of PAR1 [Homo sapiens] &gt;pdb|3BEI|B Crystal structure of the slow form of thrombin in a self_inhibited conformation [Homo sapiens] &gt;pdb|3QDZ|B Crystal structure of the human thrombin mutant D102N in complex with the extracellular fragment of human PAR4. [Homo sapiens] &gt;pdb|3QDZ|D Crystal structure of the human thrombin mutant D102N in complex with the extracellular fragment of human PAR4. [Homo sapiens] &gt;pdb|4MLF|B Crystal structure for the complex of thrombin mutant D102N and hirudin [Homo sapiens]</Hit_def>
  <Hit_accession>2GP9_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.8702</Hsp_bit-score>
      <Hsp_score>185</Hsp_score>
      <Hsp_evalue>3.49857e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>49</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ +I L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>288</Hit_num>
  <Hit_id>pdb|6KBR|A</Hit_id>
  <Hit_def>Crystal structure of Human KLK4 and SPINK2 derived KLK4 inhibitor complex [Homo sapiens]</Hit_def>
  <Hit_accession>6KBR_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.0998</Hsp_bit-score>
      <Hsp_score>183</Hsp_score>
      <Hsp_evalue>6.49752e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>155</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>128</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IINGEDCSPHSQPWQAALVMENEL-FCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISI--ASQCPTAGNSCLVSGWGL</Hsp_hseq>
      <Hsp_midline>I+NGE+  P S PWQ +L  +    FC G L++  WV++AAHC   +  + +     +       Q ++ +   ++ +YN   + ND+ L+KL  + S S T+ ++ +  AS    AG +C+ +GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>289</Hit_num>
  <Hit_id>pdb|2XW9|A</Hit_id>
  <Hit_def>Crystal Structure of Complement Factor D mutant S183A [Homo sapiens] &gt;pdb|2XWB|I Crystal Structure of Complement C3b in complex with Factors B and D [Homo sapiens] &gt;pdb|2XWB|J Crystal Structure of Complement C3b in complex with Factors B and D [Homo sapiens]</Hit_def>
  <Hit_accession>2XW9_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>2.18608e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-LNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPD--TIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++  +  A    +S+ +  TI++D+ LL+LS  A+    V  +       D A GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>290</Hit_num>
  <Hit_id>pdb|3ELA|H</Hit_id>
  <Hit_def>Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor [Homo sapiens]</Hit_def>
  <Hit_accession>3ELA_H</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.559</Hsp_bit-score>
      <Hsp_score>179</Hsp_score>
      <Hsp_evalue>2.32865e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGKDCPKGECPWQVLLL-VNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWG</Hsp_hseq>
      <Hsp_midline>IV G++   G  PWQV L    G   CGG+LIN  WVV+AAHC     +    + V GE D        Q  ++A+V   S Y   T N+DI LL+L      +  V  +CLP    +    A     + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>291</Hit_num>
  <Hit_id>pdb|1BIO|A</Hit_id>
  <Hit_def>Human Complement Factor D In Complex With Isatoic Anhydride Inhibitor [Homo sapiens] &gt;pdb|1DFP|A Factor D Inhibited By Diisopropyl Fluorophosphate [Homo sapiens] &gt;pdb|1DFP|B Factor D Inhibited By Diisopropyl Fluorophosphate [Homo sapiens] &gt;pdb|1DIC|A Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D [Homo sapiens] &gt;pdb|1DSU|A Human Factor D, Complement Activating Enzyme [Homo sapiens] &gt;pdb|1DSU|B Human Factor D, Complement Activating Enzyme [Homo sapiens] &gt;pdb|1HFD|A Human Complement Factor D In A P21 Crystal Form [Homo sapiens] &gt;pdb|4D9R|A Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D [Homo sapiens] &gt;pdb|4D9R|B Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D [Homo sapiens] &gt;pdb|5TCA|A Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|B Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|C Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|D Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|E Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|F Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|G Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCC|A Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|B Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|C Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|D Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|E Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|F Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|G Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|6VMJ|W Chain W, Complement factor D [Homo sapiens] &gt;pdb|6VMJ|X Chain X, Complement factor D [Homo sapiens] &gt;pdb|6VMJ|Y Chain Y, Complement factor D [Homo sapiens] &gt;pdb|6VMJ|Z Chain Z, Complement factor D [Homo sapiens] &gt;pdb|6VMK|C Chain C, Complement factor D [Homo sapiens] &gt;pdb|6VMK|F Chain F, Complement factor D [Homo sapiens] &gt;pdb|6VMK|I Chain I, Complement factor D [Homo sapiens] &gt;pdb|6VMK|N Chain N, Complement factor D [Homo sapiens] &gt;pdb|6VMK|Q Chain Q, Complement factor D [Homo sapiens] &gt;pdb|6VMK|T Chain T, Complement factor D [Homo sapiens] &gt;pdb|6VMK|W Chain W, Complement factor D [Homo sapiens] &gt;pdb|6VMK|X Chain X, Complement factor D [Homo sapiens] &gt;pdb|6VMK|a Chain a, Complement factor D [Homo sapiens] &gt;pdb|6VMK|d Chain d, Complement factor D [Homo sapiens] &gt;pdb|6VMK|g Chain g, Complement factor D [Homo sapiens] &gt;pdb|6VMK|j Chain j, Complement factor D [Homo sapiens] &gt;pdb|6VMK|m Chain m, Complement factor D [Homo sapiens] &gt;pdb|6VMK|p Chain p, Complement factor D [Homo sapiens] &gt;pdb|6VMK|s Chain s, Complement factor D [Homo sapiens] &gt;pdb|6VMK|v Chain v, Complement factor D [Homo sapiens]</Hit_def>
  <Hit_accession>1BIO_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>2.37695e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-LNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPD--TIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++  +  A    +S+ +  TI++D+ LL+LS  A+    V  +       D A GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>292</Hit_num>
  <Hit_id>pdb|2XWA|A</Hit_id>
  <Hit_def>Crystal Structure of Complement Factor D Mutant R202A [Homo sapiens] &gt;pdb|2XWA|B Crystal Structure of Complement Factor D Mutant R202A [Homo sapiens] &gt;pdb|4CBN|A Crystal structure of Complement Factor D mutant R202A after conventional refinement [Homo sapiens] &gt;pdb|4CBN|B Crystal structure of Complement Factor D mutant R202A after conventional refinement [Homo sapiens] &gt;pdb|4CBO|A Crystal structure of Complement Factor D mutant R202A after ensemble refinement [Homo sapiens] &gt;pdb|4CBO|B Crystal structure of Complement Factor D mutant R202A after ensemble refinement [Homo sapiens]</Hit_def>
  <Hit_accession>2XWA_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>2.40195e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-LNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPD--TIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++  +  A    +S+ +  TI++D+ LL+LS  A+    V  +       D A GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>293</Hit_num>
  <Hit_id>pdb|5NB7|A</Hit_id>
  <Hit_def>Complement factor D [Homo sapiens] &gt;pdb|5NBA|A Complement factor D in complex with the inhibitor (2S,4R)-4-Fluoro-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1H-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens]</Hit_def>
  <Hit_accession>5NB7_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>2.52791e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-LNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPD--TIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++  +  A    +S+ +  TI++D+ LL+LS  A+    V  +       D A GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>294</Hit_num>
  <Hit_id>pdb|1FDP|A</Hit_id>
  <Hit_def>Proenzyme Of Human Complement Factor D, Recombinant Profactor D [Homo sapiens] &gt;pdb|1FDP|B Proenzyme Of Human Complement Factor D, Recombinant Profactor D [Homo sapiens] &gt;pdb|1FDP|C Proenzyme Of Human Complement Factor D, Recombinant Profactor D [Homo sapiens] &gt;pdb|1FDP|D Proenzyme Of Human Complement Factor D, Recombinant Profactor D [Homo sapiens]</Hit_def>
  <Hit_accession>1FDP_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>2.58311e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>8</Hsp_hit-from>
      <Hsp_hit-to>140</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-LNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPD--TIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++  +  A    +S+ +  TI++D+ LL+LS  A+    V  +       D A GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>295</Hit_num>
  <Hit_id>pdb|5FBE|A</Hit_id>
  <Hit_def>Complement Factor D In Complex With Compound2 [Homo sapiens] &gt;pdb|5FBI|A COMPLEMENT FACTOR D IN COMPLEX WITH COMPOUND 3b [Homo sapiens] &gt;pdb|5FCK|A Complement Factor D In Complex With Compound 5 [Homo sapiens] &gt;pdb|5MT0|A COMPLEMENT FACTOR D IN COMPLEX WITH A REVERSIBLE INDOLE CARBOXYLIC ACID BASED INHIBITOR [Homo sapiens] &gt;pdb|5MT4|A Complement Factor D In Complex With A Reversible Benzoic Acid Based Inhibitor [Homo sapiens] &gt;pdb|5NAR|A Complement factor D in complex with the inhibitor (S)-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1H-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens] &gt;pdb|5NAT|A Complement factor D in complex with the inhibitor (S)-Pyrrolidine-1,2-dicarboxylic acid 1-[(1-methyl-1H-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens] &gt;pdb|5NAW|A Complement factor D in complex with the inhibitor (1R,3S,5R)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic acid 2-[(1-carbamoyl-1H-indol-3-yl)-amide] 3-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens] &gt;pdb|5NB6|A Complement factor D in complex with the inhibitor (2S,4S)-4-Amino-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1H-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens] &gt;pdb|6FTY|A COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 5 [Homo sapiens] &gt;pdb|6FTZ|A COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 6 [Homo sapiens] &gt;pdb|6FUG|A Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|B Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|C Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|D Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|E Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|F Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUH|A Complement factor D in complex with the inhibitor (4-((3-(aminomethyl)phenyl)amino)quinazolin-2-yl)-L-valine [Homo sapiens] &gt;pdb|6FUI|A Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUJ|A Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|B Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|C Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|D Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|E Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|F Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUT|A Complement factor D in complex with the inhibitor (S)-3&apos;-(aminomethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-[1,1&apos;-biphenyl]-3-carboxamide [Homo sapiens]</Hit_def>
  <Hit_accession>5FBE_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>2.65936e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-LNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPD--TIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++  +  A    +S+ +  TI++D+ LL+LS  A+    V  +       D A GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>296</Hit_num>
  <Hit_id>pdb|1FY1|A</Hit_id>
  <Hit_def>[r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein (Cap37) [Homo sapiens]</Hit_def>
  <Hit_accession>1FY1_A</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>2.68411e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>137</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC------GVTTSDVVVAGEFD-QGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGRKARPRQFPFLASIQNQ-GSHECGGALIHARFVMTAASCFQSQNPGVST---VVLGAYDLRRRERQSRQTFSISSMSENG-YDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQR</Hsp_hseq>
      <Hsp_midline>IV G +A P  +P+  S+Q++ G H CGG+LI+  +V+TAA C      GV+T   VV G +D +    +  Q   I+ + +N  Y+     ND+ LL+L   A+ + +V+ + LP  +    AGT C   GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>297</Hit_num>
  <Hit_id>pdb|5TO3|B</Hit_id>
  <Hit_def>Crystal structure of thrombin mutant W215A/E217A fused to EGF456 of thrombomodulin via a 31-residue linker and bound to PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>5TO3_B</Hit_accession>
  <Hit_len>409</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>74.7146</Hsp_bit-score>
      <Hsp_score>182</Hsp_score>
      <Hsp_evalue>2.76675e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVV-AGEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>298</Hit_num>
  <Hit_id>pdb|6QMR|A</Hit_id>
  <Hit_def>Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|B Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|C Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|D Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|E Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|F Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMT|A Complement factor D in complex with the inhibitor 2-(2-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-carboxamido)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMT|B Complement factor D in complex with the inhibitor 2-(2-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-carboxamido)phenyl)acetic acid [Homo sapiens]</Hit_def>
  <Hit_accession>6QMR_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>3.71202e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>157</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-LNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPD--TIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++  +  A    +S+ +  TI++D+ LL+LS  A+    V  +       D A GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>299</Hit_num>
  <Hit_id>pdb|1FXY|A</Hit_id>
  <Hit_def>COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE [Homo sapiens]</Hit_def>
  <Hit_accession>1FXY_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.4034</Hsp_bit-score>
      <Hsp_score>176</Hsp_score>
      <Hsp_evalue>4.40537e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYNCKDGEVPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAPP--ATGTKCLISGWGNT</Hsp_hseq>
      <Hsp_midline>IV G     G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+   LP+A    A GT C+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>300</Hit_num>
  <Hit_id>pdb|3NXP|A</Hit_id>
  <Hit_def>Crystal structure of human prethrombin-1 [Homo sapiens]</Hit_def>
  <Hit_accession>3NXP_A</Hit_accession>
  <Hit_len>424</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.9442</Hsp_bit-score>
      <Hsp_score>180</Hsp_score>
      <Hsp_evalue>4.62285e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>166</Hsp_hit-from>
      <Hsp_hit-to>307</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVV-AGEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>301</Hit_num>
  <Hit_id>pdb|4GAW|A</Hit_id>
  <Hit_def>Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|B Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|C Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|D Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|E Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|F Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|G Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|H Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|I Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|J Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|K Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|L Crystal structure of active human granzyme H [Homo sapiens]</Hit_def>
  <Hit_accession>4GAW_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>5.97351e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSSINVTL-GAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWG</Hsp_hseq>
      <Hsp_midline>I+ G EA P S P+   +Q   +     CGG L+ +++V+TAAHC  ++ +V + G  +        Q + + +   +  YN    +NDI LL+L   A ++  V  + LPS+      G  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>302</Hit_num>
  <Hit_id>pdb|4HZH|A</Hit_id>
  <Hit_def>Structure of recombinant Gla-domainless prothrombin mutant S525A [Homo sapiens] &gt;pdb|4HZH|B Structure of recombinant Gla-domainless prothrombin mutant S525A [Homo sapiens]</Hit_def>
  <Hit_accession>4HZH_A</Hit_accession>
  <Hit_len>533</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.9442</Hsp_bit-score>
      <Hsp_score>180</Hsp_score>
      <Hsp_evalue>6.36531e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>275</Hsp_hit-from>
      <Hsp_hit-to>416</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVV-AGEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>303</Hit_num>
  <Hit_id>pdb|4DGJ|A</Hit_id>
  <Hit_def>Structure of a human enteropeptidase light chain variant [Homo sapiens] &gt;pdb|4DGJ|B Structure of a human enteropeptidase light chain variant [Homo sapiens] &gt;pdb|4DGJ|C Structure of a human enteropeptidase light chain variant [Homo sapiens] &gt;pdb|4DGJ|D Structure of a human enteropeptidase light chain variant [Homo sapiens] &gt;pdb|6ZOV|A ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6 [Homo sapiens] &gt;pdb|6ZOV|B ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6 [Homo sapiens] &gt;pdb|6ZOV|C ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6 [Homo sapiens] &gt;pdb|6ZOV|D ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6 [Homo sapiens]</Hit_def>
  <Hit_accession>4DGJ_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>6.53436e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>137</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTS------DVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IVGGSDAKEGAWPWVVGLYYDDRL-LCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILGLHMKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQVFPPGRNCSIAGWGTVVY</Hsp_hseq>
      <Hsp_midline>IV G +A  G+WPW V L        CG SL++ +W+V+AAHC    +        ++        +S +     I ++  N  YN    +NDI ++ L    +++  +  + LP  +  F  G  C   GWG   Y</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>304</Hit_num>
  <Hit_id>pdb|2R0L|A</Hit_id>
  <Hit_def>Short Form HGFA with Inhibitory Fab75 [Homo sapiens]</Hit_def>
  <Hit_accession>2R0L_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.4034</Hsp_bit-score>
      <Hsp_score>176</Hsp_score>
      <Hsp_evalue>7.0261e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI-NNDITLLKL----STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGSSSLPGSHPWLAAIY--IGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWG</Hsp_hseq>
      <Hsp_midline>I+ G  ++PGS PW  ++    G  FC GSL++  WVV+AAHC        S  VV G+     +++  Q   I K    + Y+     ++D+ L++L       A+ SQ V  +CLP     F AG  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>305</Hit_num>
  <Hit_id>pdb|1YBW|A</Hit_id>
  <Hit_def>Protease domain of HGFA with no inhibitor [Homo sapiens] &gt;pdb|1YBW|B Protease domain of HGFA with no inhibitor [Homo sapiens] &gt;pdb|1YC0|A short form HGFA with first Kunitz domain from HAI-1 [Homo sapiens] &gt;pdb|2R0K|A Protease domain of HGFA with inhibitor Fab58 [Homo sapiens]</Hit_def>
  <Hit_accession>1YBW_A</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.7886</Hsp_bit-score>
      <Hsp_score>177</Hsp_score>
      <Hsp_evalue>7.46143e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>36</Hsp_hit-from>
      <Hsp_hit-to>169</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI-NNDITLLKLS----TAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGSSSLPGSHPWLAAIY--IGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWG</Hsp_hseq>
      <Hsp_midline>I+ G  ++PGS PW  ++    G  FC GSL++  WVV+AAHC        S  VV G+     +++  Q   I K    + Y+     ++D+ L++L       A+ SQ V  +CLP     F AG  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>306</Hit_num>
  <Hit_id>pdb|2WUB|A</Hit_id>
  <Hit_def>Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp [Homo sapiens] &gt;pdb|2WUB|C Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp [Homo sapiens] &gt;pdb|2WUC|A Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp and Ac-KQLR-chloromethylketone [Homo sapiens] &gt;pdb|3K2U|A Crystal structure of HGFA in complex with the allosteric inhibitory antibody Fab40 [Homo sapiens]</Hit_def>
  <Hit_accession>2WUB_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.4034</Hsp_bit-score>
      <Hsp_score>176</Hsp_score>
      <Hsp_evalue>7.86648e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI-NNDITLLKL----STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGSSSLPGSHPWLAAIY--IGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWG</Hsp_hseq>
      <Hsp_midline>I+ G  ++PGS PW  ++    G  FC GSL++  WVV+AAHC        S  VV G+     +++  Q   I K    + Y+     ++D+ L++L       A+ SQ V  +CLP     F AG  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>307</Hit_num>
  <Hit_id>pdb|5EDK|A</Hit_id>
  <Hit_def>Crystal structure of prothrombin deletion mutant residues 146-167 (Form II). [Homo sapiens]</Hit_def>
  <Hit_accession>5EDK_A</Hit_accession>
  <Hit_len>560</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.559</Hsp_bit-score>
      <Hsp_score>179</Hsp_score>
      <Hsp_evalue>8.2621e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>299</Hsp_hit-from>
      <Hsp_hit-to>440</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVV-AGEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>308</Hit_num>
  <Hit_id>pdb|6R2W|H</Hit_id>
  <Hit_def>Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor [Homo sapiens]</Hit_def>
  <Hit_accession>6R2W_H</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>8.8479e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGKVCPKGECPWQVLLL-VNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWG</Hsp_hseq>
      <Hsp_midline>IV G+    G  PWQV L    G   CGG+LIN  WVV+AAHC     +    + V GE D        Q  ++A+V   S Y   T N+DI LL+L      +  V  +CLP    +    A     + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>309</Hit_num>
  <Hit_id>pdb|4Z6A|H</Hit_id>
  <Hit_def>Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor [Homo sapiens]</Hit_def>
  <Hit_accession>4Z6A_H</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>9.22228e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGKVCPKGECPWQVLLL-VNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWG</Hsp_hseq>
      <Hsp_midline>IV G+    G  PWQV L    G   CGG+LIN  WVV+AAHC     +    + V GE D        Q  ++A+V   S Y   T N+DI LL+L      +  V  +CLP    +    A     + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>310</Hit_num>
  <Hit_id>pdb|1CVW|H</Hit_id>
  <Hit_def>Crystal structure of active site-inhibited human coagulation factor VIIA (DES-GLA) [Homo sapiens] &gt;pdb|1DAN|H Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor [Homo sapiens] &gt;pdb|1DVA|H Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA [Homo sapiens] &gt;pdb|1DVA|I Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA [Homo sapiens] &gt;pdb|1FAK|H Human Tissue Factor Complexed With Coagulation Factor Viia Inhibited With A Bpti-Mutant [Homo sapiens] &gt;pdb|1J9C|H Crystal Structure of tissue factor-factor VIIa complex [Homo sapiens] &gt;pdb|1JBU|H Coagulation Factor VII Zymogen (EGF2/Protease) in Complex with Inhibitory Exosite Peptide A-183 [Homo sapiens] &gt;pdb|1KLI|H Cofactor-and substrate-assisted activation of factor VIIa [Homo sapiens] &gt;pdb|1KLJ|H Crystal structure of uninhibited factor VIIa [Homo sapiens] &gt;pdb|1O5D|H Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1QFK|H Structure Of Human Factor Viia And Its Implications For The Triggering Of Blood Coagulation [Homo sapiens] &gt;pdb|1W0Y|H tf7a_3771 complex [Homo sapiens] &gt;pdb|1W2K|H tf7a_4380 complex [Homo sapiens] &gt;pdb|1W7X|H Factor7 - 413 complex [Homo sapiens] &gt;pdb|1W8B|H Factor7 - 413 complex [Homo sapiens] &gt;pdb|1WQV|H Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine [Homo sapiens] &gt;pdb|1WSS|H Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged groups in P2 and P4 [Homo sapiens] &gt;pdb|1WTG|H Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine [Homo sapiens] &gt;pdb|1WUN|H Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine [Homo sapiens] &gt;pdb|1WV7|H Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine [Homo sapiens] &gt;pdb|1YGC|H Short Factor VIIa with a small molecule inhibitor [Homo sapiens] &gt;pdb|1Z6J|H Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor [Homo sapiens] &gt;pdb|2A2Q|H Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+ [Homo sapiens] &gt;pdb|2AEI|H Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid [Homo sapiens] &gt;pdb|2AER|H Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. [Homo sapiens] &gt;pdb|2B7D|H Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy in a Baboon Thrombosis Model [Homo sapiens] &gt;pdb|2B8O|H Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex [Homo sapiens] &gt;pdb|2BZ6|H Orally available Factor7a inhibitor [Homo sapiens] &gt;pdb|2C4F|H crystal structure of factor VII.stf complexed with pd0297121 [Homo sapiens] &gt;pdb|2EC9|H Crystal structure analysis of human Factor VIIa, Souluble tissue factor complexed with BCX-3607 [Homo sapiens] &gt;pdb|2F9B|H Discovery of Novel Heterocyclic Factor VIIa Inhibitors [Homo sapiens] &gt;pdb|2FIR|H Crystal structure of DFPR-VIIa/sTF [Homo sapiens] &gt;pdb|2FLB|H Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor [Homo sapiens] &gt;pdb|2FLR|H Novel 5-Azaindole Factor VIIa Inhibitors [Homo sapiens] &gt;pdb|2PUQ|H Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor [Homo sapiens] &gt;pdb|2ZP0|H Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine [Homo sapiens] &gt;pdb|2ZWL|H Human factor viia-tissue factor complexed with highly selective peptide inhibitor [Homo sapiens] &gt;pdb|2ZZU|H Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine [Homo sapiens] &gt;pdb|3TH2|H Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ [Homo sapiens] &gt;pdb|3TH3|H Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ [Homo sapiens] &gt;pdb|3TH4|H Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ [Homo sapiens] &gt;pdb|4IBL|H Chain H, Coagulation factor VII [Homo sapiens] &gt;pdb|4ISH|H Structure of FACTOR VIIA in complex with the inhibitor BMS-593214 also known as 2&apos;-[(6R,6AR,11BR)-2-CARBAMIMIDOYL-6,6A,7,11B-TETRAHYDRO-5H-INDENO[2,1-C]QUINOLIN-6-YL]-5&apos;-HYDROXY-4&apos;-METHOXYBIPHENYL-4-CARBOXYLIC ACID [Homo sapiens] &gt;pdb|4ISI|H Structure of FACTOR VIIA in complex with the inhibitor (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(CYCLOBUTYLAMINO)-8,8-DIETHYL-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE [Homo sapiens] &gt;pdb|4JYU|H Structure of factor VIIA in complex with the inhibitor (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(PHENYLSULFONYL)ETHANAMIDE [Homo sapiens] &gt;pdb|4JYV|H Structure of factor VIIA in complex with the inhibitor (2R)-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2-(ISOQUINOLIN-6-YLAMINO)-N-[(3-SULFAMOYLPHENYL)SULFONYL]ETHANAMIDE [Homo sapiens] &gt;pdb|4JZD|H Structure of factor VIIA in complex with the inhibitor 2-{2-[(4-carbamimidoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid [Homo sapiens] &gt;pdb|4JZE|H Structure of factor VIIA in complex with the inhibitor 2-{2-[(1-aminoisoquinolin-6-yl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid [Homo sapiens] &gt;pdb|4JZF|H Structure of factor VIIA in complex with the inhibitor 2-{2-[(3-carbamoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid [Homo sapiens] &gt;pdb|4NA9|H Factor VIIa in complex with the inhibitor 3&apos;-amino-5&apos;-[(2s,4r)-6-carbamimidoyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]biphenyl-2-carboxylic acid [Homo sapiens] &gt;pdb|4NG9|H Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-(3-sulfamoylbenzyl)ethanamide [Homo sapiens] &gt;pdb|4NGA|H Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-N-[2-(propan-2-ylsulfonyl)benzyl]ethanamide [Homo sapiens] &gt;pdb|4X8S|H Factor Viia In Complex With The Inhibitor 4-bromo-2-methoxyphenol [Homo sapiens] &gt;pdb|4X8T|H FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 7-chloro-3,4-dihydroisoquinolin-1(2H)-one [Homo sapiens] &gt;pdb|4X8U|H Factor Viia In Complex With The Inhibitor 5-chloro-1h-indole-2- Carboxylic Acid [Homo sapiens] &gt;pdb|4X8V|H FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (methyl {3-[(2R)-1-{(2R)-2-(3,4-dimethoxyphenyl)-2-[(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]acetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}carbamate) [Homo sapiens] &gt;pdb|4YT6|H Factor VIIa in complex with the inhibitor 4-{[(R)-[5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl](4-phenyl-1H-imidazol-2-yl)methyl]amino}benzenecarboximidamide [Homo sapiens] &gt;pdb|4YT7|H Factor VIIa in complex with the inhibitor 2-(2-{(R)-[(4-carbamimidoylphenyl)amino][5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl]methyl}-1H-imidazol-4-yl)benzamide [Homo sapiens] &gt;pdb|4ZXX|H FACTOR VIIA IN COMPLEX WITH THE INHIBITOR N-{3-[(2R)-1-{(2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-phenylacetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}acetamide [Homo sapiens] &gt;pdb|4ZXY|H FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5I46|H Factor VIIA in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-8-fluoro-7-hydroxy-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5L2Y|H Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,20-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6,8,10(21),16,19-hexaen-7-yl] cyclobutane-1-carboxylic acid [Homo sapiens] &gt;pdb|5L2Z|H Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-7-yl]cyclohexane-1-carboxylic acid [Homo sapiens] &gt;pdb|5L30|H Factor VIIa in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-[1-(1H-tetrazol-5-yl)cyclopropyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5PA8|C Crystal Structure of Factor VIIa in complex with cyclohexanamine [Homo sapiens] &gt;pdb|5PA9|C Crystal Structure of Factor VIIa in complex with phenylmethanamine;hydrochloride [Homo sapiens] &gt;pdb|5PAA|C Crystal Structure of Factor VIIa in complex with cyclohexylmethanamine [Homo sapiens] &gt;pdb|5PAC|B human factor VIIa in complex with 5-hydroxy-N-(4-oxo-3H-quinazolin-6-yl)-1-[3-[(phenylcarbamoylamino)methyl]phenyl]pyrazole-4-carboxamide at 1.50A [Homo sapiens] &gt;pdb|5PAE|B Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]propanamide [Homo sapiens] &gt;pdb|5PAF|B Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-[3-[(2-amino-2-oxoethyl)-methylsulfonylamino]-5-chlorophenyl]acetamide;2,2,2-trifluoroacetic acid [Homo sapiens] &gt;pdb|5PAG|B Crystal Structure of Factor VIIa in complex with (2R)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-methylbutanamide;hydrobromide [Homo sapiens] &gt;pdb|5PAI|B human factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-1-[3-[[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]methyl]phenyl]-5-hydroxypyrazole-4-carboxamide at 1.73A [Homo sapiens] &gt;pdb|5PAJ|B Crystal Structure of Factor VIIa in complex with 1-(1-aminoisoquinolin-6-yl)-3-benzylurea [Homo sapiens] &gt;pdb|5PAK|C Crystal Structure of Factor VIIa in complex with N-[[4-(aminomethyl)-2-(2-amino-2-oxoethoxy)phenyl]methyl]-2-(4-hydroxyphenyl)-2-methoxyacetamide;hydrochloride [Homo sapiens] &gt;pdb|5PAM|B Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(5-ethoxy-2-fluorophenyl)-1-(2-phenylpyrrolidin-1-yl)ethanone [Homo sapiens] &gt;pdb|5PAN|B Crystal Structure of Factor VIIa in complex with 5-hydroxy-N-(3-oxo-1,2-dihydroisoindol-5-yl)-1-[3-[(phenylcarbamoylamino)methyl]phenyl]pyrazole-4-carboxamide [Homo sapiens] &gt;pdb|5PAO|C Crystal Structure of Factor VIIa in complex with (2S)-2,3-dihydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]propanamide;hydrobromide [Homo sapiens] &gt;pdb|5PAQ|B Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(3-ethoxy-4-propan-2-yloxyphenyl)-1-(2-phenylpyrrolidin-1-yl)ethanone [Homo sapiens] &gt;pdb|5PAR|C Crystal Structure of Factor VIIa in complex with 1H-benzimidazol-2-amine [Homo sapiens] &gt;pdb|5PAS|C Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylpropanamide [Homo sapiens] &gt;pdb|5PAT|B Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-(3-chlorophenyl)acetamide [Homo sapiens] &gt;pdb|5PAU|C Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-[3-[(2-amino-2-oxoethyl)-methylsulfonylamino]phenyl]acetamide;2,2,2-trifluoroacetic acid [Homo sapiens] &gt;pdb|5PAV|C Crystal Structure of Factor VIIa in complex with N-(6-aminopyridin-3-yl)-5-hydroxy-1-phenylpyrazole-4-carboxamide [Homo sapiens] &gt;pdb|5PAW|B Crystal Structure of Factor VIIa in complex with isoquinoline-1,6-diamine [Homo sapiens] &gt;pdb|5PAX|C Crystal Structure of Factor VIIa in complex with 1-(2,6-difluorophenyl)-3-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]urea [Homo sapiens] &gt;pdb|5PAY|C Crystal Structure of Factor VIIa in complex with 1-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea [Homo sapiens] &gt;pdb|5PB0|B Crystal Structure of Factor VIIa in complex with 2-(4-ethoxy-3-methoxyphenyl)-2-(isoquinolin-6-ylamino)acetic acid [Homo sapiens] &gt;pdb|5PB2|C Crystal Structure of Factor VIIa in complex with 2-phenyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-3-ol [Homo sapiens] &gt;pdb|5PB3|C Crystal Structure of Factor VIIa in complex with 1-[[3-[4-(5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-5-hydroxypyrazol-1-yl]phenyl]methyl]-3-phenylurea [Homo sapiens] &gt;pdb|5PB4|C human factor VIIa in complex with 1-[[3-[5-hydroxy-3-methyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 2.43A [Homo sapiens] &gt;pdb|5PB5|B human factor VIIa in complex with 1-[[3-[5-hydroxy-4-(7H-pyrrolo[2,3-d]pyrimidin-6-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 1.84A [Homo sapiens] &gt;pdb|5PB6|C Crystal Structure of Factor VIIa in complex with N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]pentanamide [Homo sapiens] &gt;pdb|5TQE|H Factor VIIa in complex with the inhibitor (5R)-5-[(1-aminoisoquinolin-6-yl)amino]-19-(cyclopropylsulfonyl)-3-methyl-13-oxa-3,15-diazatricyclo[14.3.1.1~6,10~]henicosa-1(20),6(21),7,9,16,18-hexaene-4,14-dione [Homo sapiens] &gt;pdb|5TQF|H Factor VIIa in complex with the inhibitor (11R)-11-[(1-aminoisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-13-methyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5TQG|H Factor VIIa in complex with the inhibitor (5R,11R)-11-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-7-(2,2-difluoroethoxy)-5,13-dimethyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5U6J|H Factor VIIa in complex with the inhibitor 3-{[(2R)-17-ethyl-4-methyl-3,12-dioxo-7-[(propan-2-yl)sulfonyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-2-yl]amino}benzamide [Homo sapiens]</Hit_def>
  <Hit_accession>1CVW_H</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>9.22854e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGKVCPKGECPWQVLLL-VNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWG</Hsp_hseq>
      <Hsp_midline>IV G+    G  PWQV L    G   CGG+LIN  WVV+AAHC     +    + V GE D        Q  ++A+V   S Y   T N+DI LL+L      +  V  +CLP    +    A     + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>311</Hit_num>
  <Hit_id>pdb|4YLQ|H</Hit_id>
  <Hit_def>Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor [Homo sapiens]</Hit_def>
  <Hit_accession>4YLQ_H</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>9.61246e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGKVCPKGECPWQVLLL-VNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWG</Hsp_hseq>
      <Hsp_midline>IV G+    G  PWQV L    G   CGG+LIN  WVV+AAHC     +    + V GE D        Q  ++A+V   S Y   T N+DI LL+L      +  V  +CLP    +    A     + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>312</Hit_num>
  <Hit_id>pdb|4ZMA|H</Hit_id>
  <Hit_def>Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor [Homo sapiens]</Hit_def>
  <Hit_accession>4ZMA_H</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>9.71256e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGKVCPKGECPWQVLLL-VNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWG</Hsp_hseq>
      <Hsp_midline>IV G+    G  PWQV L    G   CGG+LIN  WVV+AAHC     +    + V GE D        Q  ++A+V   S Y   T N+DI LL+L      +  V  +CLP    +    A     + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>313</Hit_num>
  <Hit_id>pdb|5PAB|H</Hit_id>
  <Hit_def>Crystal Structure of Factor VIIa in complex with 1-[[3-[2-hydroxy-3-(1H-pyrrolo[3,2-c]pyridin-2-yl)phenyl]phenyl]methyl]-3-phenylurea [Homo sapiens] &gt;pdb|5PB1|D Crystal Structure of Factor VIIa in complex with benzenecarboximidamide [Homo sapiens]</Hit_def>
  <Hit_accession>5PAB_H</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>9.92125e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGKVCPKGECPWQVLLL-VNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWG</Hsp_hseq>
      <Hsp_midline>IV G+    G  PWQV L    G   CGG+LIN  WVV+AAHC     +    + V GE D        Q  ++A+V   S Y   T N+DI LL+L      +  V  +CLP    +    A     + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>314</Hit_num>
  <Hit_id>pdb|6BJR|A</Hit_id>
  <Hit_def>Crystal structure of prothrombin mutant S101C/A470C [Homo sapiens] &gt;pdb|6C2W|A Crystal structure of human prothrombin mutant S101C/A470C [Homo sapiens] &gt;pdb|6C2W|B Crystal structure of human prothrombin mutant S101C/A470C [Homo sapiens]</Hit_def>
  <Hit_accession>6BJR_A</Hit_accession>
  <Hit_len>582</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>1.00893e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>321</Hsp_hit-from>
      <Hsp_hit-to>462</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVV-AGEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>315</Hit_num>
  <Hit_id>pdb|5EDM|A</Hit_id>
  <Hit_def>Crystal structure of prothrombin deletion mutant residues 154-167 (Form I) [Homo sapiens]</Hit_def>
  <Hit_accession>5EDM_A</Hit_accession>
  <Hit_len>568</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>1.01498e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>307</Hsp_hit-from>
      <Hsp_hit-to>448</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVV-AGEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>316</Hit_num>
  <Hit_id>pdb|4D9Q|A</Hit_id>
  <Hit_def>Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D [Macaca mulatta] &gt;pdb|4D9Q|B Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D [Macaca mulatta]</Hit_def>
  <Hit_accession>4D9Q_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>71.633</Hsp_bit-score>
      <Hsp_score>174</Hsp_score>
      <Hsp_evalue>1.03745e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGREAEAHARPYMASVQ-VNGEHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSRPD--TIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVEPGTLCDVAGWGIVSH</Hsp_hseq>
      <Hsp_midline>I+ G EA   + P+  S+Q   G H CGG L+ E WV++AAHC    +D     ++ A    Q   S+++  +  A    +S+ +  TI++D+ LL+LS  A+    V  +       D   GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>317</Hit_num>
  <Hit_id>pdb|4NZQ|A</Hit_id>
  <Hit_def>Crystal structure of Ca2+-free prothrombin deletion mutant residues 146-167 [Homo sapiens] &gt;pdb|4O03|A Crystal structure of Ca2+ bound prothrombin deletion mutant residues 146-167 [Homo sapiens]</Hit_def>
  <Hit_accession>4NZQ_A</Hit_accession>
  <Hit_len>557</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>1.10401e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>299</Hsp_hit-from>
      <Hsp_hit-to>440</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>50</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVV-AGEFDQGSSSEKIQKLK-IAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>318</Hit_num>
  <Hit_id>pdb|3FZZ|A</Hit_id>
  <Hit_def>Structure of GrC [Mus musculus] &gt;pdb|3FZZ|B Structure of GrC [Mus musculus]</Hit_def>
  <Hit_accession>3FZZ_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>71.2478</Hsp_bit-score>
      <Hsp_score>173</Hsp_score>
      <Hsp_evalue>1.17094e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ-DKTGFH--FCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHCK-GRSMTVTLGAHNIKAKEETQQIIPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDECYVAGWG</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+    +  K G    FCGG L+ + +V+TAAHC    S  V  G  +  +  E  Q + +AK   +  YN    +NDI LLKL   A  ++ V  + LP  +     G  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>319</Hit_num>
  <Hit_id>pdb|3G01|A</Hit_id>
  <Hit_def>Structure of GrC mutant E192R/E193G [Mus musculus] &gt;pdb|3G01|B Structure of GrC mutant E192R/E193G [Mus musculus]</Hit_def>
  <Hit_accession>3G01_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>71.2478</Hsp_bit-score>
      <Hsp_score>173</Hsp_score>
      <Hsp_evalue>1.23368e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ-DKTGFH--FCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHCK-GRSMTVTLGAHNIKAKEETQQIIPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDECYVAGWG</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+    +  K G    FCGG L+ + +V+TAAHC    S  V  G  +  +  E  Q + +AK   +  YN    +NDI LLKL   A  ++ V  + LP  +     G  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>320</Hit_num>
  <Hit_id>pdb|3GOV|B</Hit_id>
  <Hit_def>Crystal structure of the catalytic region of human MASP-1 [Homo sapiens] &gt;pdb|4DJZ|B Catalytic fragment of masp-1 in complex with its specific inhibitor developed by directed evolution on sgci scaffold [Homo sapiens] &gt;pdb|4DJZ|D Catalytic fragment of masp-1 in complex with its specific inhibitor developed by directed evolution on sgci scaffold [Homo sapiens]</Hit_def>
  <Hit_accession>3GOV_B</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>71.2478</Hsp_bit-score>
      <Hsp_score>173</Hsp_score>
      <Hsp_evalue>1.75972e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>144</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----------GVTTSDVVVAGEFD-------QGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFVMPICLPEGPQ--QEGAMVIVSGWG</Hsp_hseq>
      <Hsp_midline>I NG  A  G+ PW   L    G  FCGGSL+  +W+VTAAHC           +  SD++   +F        +  S E  Q L +     + +Y+  T  ND+ L++L  +   +  V  +CLP        G   + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>321</Hit_num>
  <Hit_id>pdb|4Q7X|A</Hit_id>
  <Hit_def>Neutrophil serine protease 4 (PRSS57) apo form 1 [Homo sapiens] &gt;pdb|4Q7X|B Neutrophil serine protease 4 (PRSS57) apo form 1 [Homo sapiens] &gt;pdb|4Q7Y|A Neutrophil serine protease 4 (PRSS57) apo form 2 [Homo sapiens] &gt;pdb|4Q7Z|A Neutrophil serine protease 4 (PRSS57) with phe-phe-arg-chloromethylketone (FFR-cmk) [Homo sapiens] &gt;pdb|4Q80|A Neutrophil serine protease 4 (PRSS57) with val-leu-lys-chloromethylketone (VLK-cmk) [Homo sapiens] &gt;pdb|4Q80|B Neutrophil serine protease 4 (PRSS57) with val-leu-lys-chloromethylketone (VLK-cmk) [Homo sapiens]</Hit_def>
  <Hit_accession>4Q7X_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.8626</Hsp_bit-score>
      <Hsp_score>172</Hsp_score>
      <Hsp_evalue>2.41977e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC---GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLP-SASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IIGGHEVTPHSRPYMASVR-FGGQHHCGGFLLRARWVVSAAHCFSHRDLRTGLVVLGAHVLSTAEPTQQVFGIDALTTHPDYHPMTHANDICLLRLNGSAVLGPAVGLLRLPGRRARPPTAGTRCRVAGWGF</Hsp_hseq>
      <Hsp_midline>I+ G E  P S P+  S++   G H CGG L+   WVV+AAHC       + +VV G     ++    Q   I  +  +  Y+ +T  NDI LL+L+ +A     V  + LP   +    AGT C   GWG </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>322</Hit_num>
  <Hit_id>pdb|1EQ9|A</Hit_id>
  <Hit_def>Crystal Structure Of Fire Ant Chymotrypsin Complexed To Pmsf [Solenopsis invicta] &gt;pdb|1EQ9|B Crystal Structure Of Fire Ant Chymotrypsin Complexed To Pmsf [Solenopsis invicta]</Hit_def>
  <Hit_accession>1EQ9_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>2.53396e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTT-SDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGKDAPVGKYPYQVSLR-LSGSHRCGASILDNNNVLTAAHCVDGLSNLNRLKVHVGTNYLSESGDVYDVEDAVVNKN--YDDFLLRNDVALVHLTNPIKFNDLVQPIKLSTNDEDLES-NPCTLTGWGSTR</Hsp_hseq>
      <Hsp_midline>IV G++A  G +P+QVSL+  +G H CG S+++ N V+TAAHC  G++  + + V    +  S S  +  ++ A V KN  Y+   + ND+ L+ L+    F+  V  + L +  +D  +   C  TGWG TR</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>323</Hit_num>
  <Hit_id>pdb|4NFE|A</Hit_id>
  <Hit_def>Human kallikrein-related peptidase 2 in complex with benzamidine [Homo sapiens] &gt;pdb|4NFF|A Human kallikrein-related peptidase 2 in complex with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>4NFE_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>2.73616e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>138</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI-----------NNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGWECEKHSQPWQVAVYSH-GWAHCGGVLVHPQWVLTAAHCLKKNSQVWL-GRHNLFEPEDTGQRVPVSHSFPHPLYNMSLLKHQSLRPDEDSSHDLMLLRLSEPAKITDVVKVLGLP--TQEPALGTTCYASGWG</Hsp_hseq>
      <Hsp_midline>IV G E    S PWQV++    G+  CGG L++  WV+TAAHC    S V + G  +     +  Q++ ++  F +  YN   +           ++D+ LL+LS  A  +  V  + LP  + + A GTTC  +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>324</Hit_num>
  <Hit_id>pdb|2ZCH|P</Hit_id>
  <Hit_def>Crystal structure of human prostate specific antigen complexed with an activating antibody [Homo sapiens] &gt;pdb|2ZCK|P Crystal structure of a ternary complex between PSA, a substrat-acyl intermediate and an activating antibody [Homo sapiens] &gt;pdb|2ZCL|P Crystal structure of human prostate specific antigen complexed with an activating antibody [Homo sapiens] &gt;pdb|3QUM|P Crystal structure of human prostate specific antigen (PSA) in Fab sandwich with a high affinity and a PCa selective antibody [Homo sapiens] &gt;pdb|3QUM|Q Crystal structure of human prostate specific antigen (PSA) in Fab sandwich with a high affinity and a PCa selective antibody [Homo sapiens]</Hit_def>
  <Hit_accession>2ZCH_P</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>2.85223e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>138</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN-----------DITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGWECEKHSQPWQVLVASR-GRAVCGGVLVHPQWVLTAAHC-IRNKSVILLGRHSLFHPEDTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVMDLP--TQEPALGTTCYASGWG</Hsp_hseq>
      <Hsp_midline>IV G E    S PWQV +  + G   CGG L++  WV+TAAHC +    V++ G        +  Q  +++  F +  Y+   + N           D+ LL+LS  A  +  V  + LP  + + A GTTC  +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>325</Hit_num>
  <Hit_id>pdb|5VOE|H</Hit_id>
  <Hit_def>DesGla-XaS195A Bound to Aptamer 11F7t [Homo sapiens] &gt;pdb|5VOF|H DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban [Homo sapiens]</Hit_def>
  <Hit_accession>5VOE_H</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>2.875e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>326</Hit_num>
  <Hit_id>pdb|2GD4|B</Hit_id>
  <Hit_def>Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex [Homo sapiens] &gt;pdb|2GD4|H Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex [Homo sapiens]</Hit_def>
  <Hit_accession>2GD4_B</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>2.97614e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>327</Hit_num>
  <Hit_id>pdb|1G2L|A</Hit_id>
  <Hit_def>Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|1G2M|A Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|1IOE|A Human coagulation factor Xa in complex with M55532 [Homo sapiens] &gt;pdb|1IQE|A Human coagulation factor Xa in complex with M55590 [Homo sapiens] &gt;pdb|1IQF|A Human coagulation factor Xa in complex with M55165 [Homo sapiens] &gt;pdb|1IQG|A Human coagulation factor Xa in complex with M55159 [Homo sapiens] &gt;pdb|1IQH|A Human coagulation factor Xa in complex with M55143 [Homo sapiens] &gt;pdb|1IQI|A Human coagulation factor Xa in complex with M55125 [Homo sapiens] &gt;pdb|1IQJ|A Human coagulation factor Xa in complex with M55124 [Homo sapiens] &gt;pdb|1IQK|A Human coagulation factor Xa in complex with M55113 [Homo sapiens] &gt;pdb|1IQL|A Human coagulation factor Xa in complex with M54476 [Homo sapiens] &gt;pdb|1IQM|A Human coagulation factor Xa in complex with M54471 [Homo sapiens] &gt;pdb|1IQN|A Human coagulation factor Xa in complex with M55192 [Homo sapiens] &gt;pdb|1XKA|C Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3&apos;- Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid [Homo sapiens] &gt;pdb|1XKB|C Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3&apos;- Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid [Homo sapiens] &gt;pdb|1XKB|D Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3&apos;- Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid [Homo sapiens] &gt;pdb|2P3F|H Crystal structure of the factor Xa/NAP5 complex [Homo sapiens]</Hit_def>
  <Hit_accession>1G2L_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>3.01685e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>328</Hit_num>
  <Hit_id>pdb|1HCG|A</Hit_id>
  <Hit_def>Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms Resolution [Homo sapiens] &gt;pdb|2XBW|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XBX|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XBY|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XC0|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XC4|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XC5|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|3KL6|A Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally active factor Xa inhibitor [Homo sapiens] &gt;pdb|7AHU|C Chain C, Coagulation factor X [Homo sapiens] &gt;pdb|7AHU|E Chain E, Coagulation factor X [Homo sapiens]</Hit_def>
  <Hit_accession>1HCG_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>3.07018e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>329</Hit_num>
  <Hit_id>pdb|3TJU|A</Hit_id>
  <Hit_def>Crystal structure of human granzyme H with an inhibitor [Homo sapiens] &gt;pdb|3TJV|A Crystal structure of human granzyme H with a peptidyl substrate [Homo sapiens] &gt;pdb|3TK9|A Crystal structure of human granzyme H [Homo sapiens]</Hit_def>
  <Hit_accession>3TJU_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>3.10938e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ--DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSSINVTL-GAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWG</Hsp_hseq>
      <Hsp_midline>I+ G EA P S P+   +Q   +     CGG L+ +++V+TAAHC  ++ +V + G  +        Q + + +   +  YN    +N+I LL+L   A ++  V  + LPS+      G  C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>330</Hit_num>
  <Hit_id>pdb|1MQ5|A</Hit_id>
  <Hit_def>Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa [Homo sapiens] &gt;pdb|1MQ6|A Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa [Homo sapiens] &gt;pdb|1V3X|A Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine [Homo sapiens] &gt;pdb|1WU1|A Factor Xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine [Homo sapiens] &gt;pdb|2D1J|A Factor Xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide [Homo sapiens] &gt;pdb|2EI6|A FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-cis-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine [Homo sapiens] &gt;pdb|2EI7|A FACTOR XA IN COMPLEX WITH THE INHIBITOR trans-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine [Homo sapiens] &gt;pdb|2EI8|A FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-chloroindol-2-yl)carbonyl]-4-(N,N-dimethylcarbamoyl)-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine [Homo sapiens] &gt;pdb|2H9E|H Crystal Structure of FXa/selectide/NAPC2 ternary complex [Homo sapiens] &gt;pdb|2P3T|B Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide [Homo sapiens] &gt;pdb|2P3U|B Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1H-imidazol-2-yl)methyl]thiophene-2-carboxamide {Pfizer 320663} [Homo sapiens] &gt;pdb|3IIT|A Factor XA in complex with a cis-1,2-diaminocyclohexane derivative [Homo sapiens] &gt;pdb|3Q3K|A Factor Xa in complex with a phenylenediamine derivative [Homo sapiens] &gt;pdb|3TK5|A Factor Xa in complex with D102-4380 [Homo sapiens] &gt;pdb|3TK6|A factor Xa in complex with D46-5241 [Homo sapiens]</Hit_def>
  <Hit_accession>1MQ5_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>3.1901e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>331</Hit_num>
  <Hit_id>pdb|2BOK|A</Hit_id>
  <Hit_def>Factor Xa - cation [Homo sapiens] &gt;pdb|2JKH|A Factor Xa - cation inhibitor complex [Homo sapiens] &gt;pdb|2VVC|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VVC|B Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VVU|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VVV|A Aminopyrrolidine-related triazole Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWL|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWM|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWM|B Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWN|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWO|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2XBV|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>2BOK_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>3.40557e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>332</Hit_num>
  <Hit_id>pdb|1FJS|A</Hit_id>
  <Hit_def>Crystal Structure Of The Inhibitor Zk-807834 (ci-1031) Complexed With Factor Xa [Homo sapiens] &gt;pdb|1Z6E|A Factor XA in complex with the inhibitor 1-(3&apos;-amino-1,2-benzisoxazol-5&apos;-yl)-n-(4-(2&apos;-((dimethylamino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (razaxaban; DPC906; BMS-561389) [Homo sapiens] &gt;pdb|2BMG|B Crystal structure of factor Xa in complex with 50 [Homo sapiens] &gt;pdb|2FZZ|A Factor Xa in complex with the inhibitor 1-(3-amino-1,2-benzisoxazol-5-yl)-6-(2&apos;-(((3r)-3-hydroxy-1-pyrrolidinyl)methyl)-4-biphenylyl)-3-(trifluoromethyl)-1,4,5,6-tetrahydro-7h-pyrazolo[3,4-c]pyridin-7-one [Homo sapiens] &gt;pdb|2G00|A Factor Xa in complex with the inhibitor 3-(6-(2&apos;-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-1-yl)benzamide [Homo sapiens] &gt;pdb|2P16|A Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE [Homo sapiens] &gt;pdb|2P93|A Factor xa in complex with the inhibitor 5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide [Homo sapiens] &gt;pdb|2P94|A Factor xa in complex with the inhibitor 3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclohexyl)-1H-indole-6-carboxamide [Homo sapiens] &gt;pdb|2P95|A Factor xa in complex with the inhibitor 5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) cyclopentyl)thiophene-2-carboxamide [Homo sapiens] &gt;pdb|2PHB|A An Orally Efficacious Factor Xa Inhibitor [Homo sapiens] &gt;pdb|2PR3|A Factor XA inhibitor [Homo sapiens] &gt;pdb|2Q1J|A The discovery of glycine and related amino acid-based factor xa inhibitors [Homo sapiens] &gt;pdb|2RA0|A X-ray Structure of FXa in complex with 7-fluoroindazole [Homo sapiens] &gt;pdb|2W26|A Chain A, ACTIVATED FACTOR XA HEAVY CHAIN [Homo sapiens] &gt;pdb|2W3I|A Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2 [Homo sapiens] &gt;pdb|2W3K|A Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1 [Homo sapiens] &gt;pdb|3CEN|A Factor XA in complex with the inhibitor N-(2-(((5-chloro-2-pyridinyl) amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide [Homo sapiens] &gt;pdb|3CS7|A FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one [Homo sapiens] &gt;pdb|3FFG|A Factor XA in complex with the inhibitor (R)-6-(2&apos;-((3- HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN- 7(4H)-ONE [Homo sapiens] &gt;pdb|3KQB|A Factor xa in complex with the inhibitor n-(3-fluoro-2&apos;- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-1h- pyrazole-5-carboxamide [Homo sapiens] &gt;pdb|3KQC|A Factor xa in complex with the inhibitor 6-(2&apos;- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6- dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one [Homo sapiens] &gt;pdb|3KQD|A Factor xa in complex with the inhibitor 1-(3-(5-oxo-4,5- dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2&apos;-(pyrrolidin-1- ylmethyl)biphenyl-4-yl)-3-(trifluoromethyl)-5,6-dihydro- 1h-pyrazolo[3,4-c]pyridin-7(4h)-one [Homo sapiens] &gt;pdb|3KQE|A Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2&apos;- (pyrrolidin-1-ylmethyl)biphenyl-4-yl)-5,6-dihydro-1h- pyrazolo[3,4-c]pyridin-7(4h)-one [Homo sapiens] &gt;pdb|3LIW|A Factor XA in complex with (R)-2-(1-ADAMANTYLCARBAMOYLAMINO)-3-(3-CARBAMIDOYL-PHENYL)-N-PHENETHYL-PROPIONIC ACID AMIDE [Homo sapiens] &gt;pdb|3M36|A Factor XA in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2&apos;-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423) [Homo sapiens] &gt;pdb|3M37|A Factor XA in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2&apos;-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC602) [Homo sapiens] &gt;pdb|5K0H|A Human factor Xa in complex with synthetic inhibitor benzylsulfonyl-dSer(Benzyl)-Gly-4-amidinobenzylamide [Homo sapiens]</Hit_def>
  <Hit_accession>1FJS_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>3.58834e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>333</Hit_num>
  <Hit_id>pdb|5FCR|A</Hit_id>
  <Hit_def>Mouse Complement Factor D [Mus musculus] &gt;pdb|5FCR|B Mouse Complement Factor D [Mus musculus] &gt;pdb|5FCR|C Mouse Complement Factor D [Mus musculus] &gt;pdb|5FCR|D Mouse Complement Factor D [Mus musculus]</Hit_def>
  <Hit_accession>5FCR_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>3.62583e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>65</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSD--VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>ILGGQEAAAHARPYMASVQ-VNGTHVCGGTLLDEQWVLSAAHCMDGVTDDDSVQVLLGAHSLSAPEPYKRWYDVQSVVPHPGSRPDSLEDDLILFKLSQNASLGPHVRPLPLQYEDKEVEPGTLCDVAGWGVVTH</Hsp_hseq>
      <Hsp_midline>I+ G+EA   + P+  S+Q   G H CGG+L++E WV++AAHC  GVT  D   V+ G     +     +   +  V  +      ++ +D+ L KLS  AS    V  + L     +   GT C   GWG+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>334</Hit_num>
  <Hit_id>pdb|1EZQ|A</Hit_id>
  <Hit_def>Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr128515 [Homo sapiens] &gt;pdb|1F0R|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr208815 [Homo sapiens] &gt;pdb|1F0S|A Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707 [Homo sapiens] &gt;pdb|1KSN|A Crystal Structure of Human Coagulation Factor XA Complexed with FXV673 [Homo sapiens] &gt;pdb|1LPG|B Crystal Structure Of Fxa In Complex With 79. [Homo sapiens] &gt;pdb|1LPK|B Crystal Structure Of Fxa In Complex With 125. [Homo sapiens] &gt;pdb|1LPZ|B Crystal Structure Of Fxa In Complex With 41. [Homo sapiens] &gt;pdb|1LQD|B Crystal Structure Of Fxa In Complex With 45. [Homo sapiens] &gt;pdb|1NFU|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr132747 [Homo sapiens] &gt;pdb|1NFW|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr209685 [Homo sapiens] &gt;pdb|1NFX|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr208944 [Homo sapiens] &gt;pdb|1NFY|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr200095 [Homo sapiens] &gt;pdb|1P0S|H Crystal Structure of Blood Coagulation Factor Xa in Complex with Ecotin M84R [Homo sapiens] &gt;pdb|2BOH|B Crystal structure of factor Xa in complex with compound &apos;1&apos; [Homo sapiens] &gt;pdb|2CJI|A Crystal structure of a Human Factor Xa inhibitor complex [Homo sapiens] &gt;pdb|2J2U|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J34|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J38|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J4I|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J94|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J95|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2UWL|A Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa [Homo sapiens] &gt;pdb|2UWO|A Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa [Homo sapiens] &gt;pdb|2UWP|A Factor Xa inhibitor complex [Homo sapiens] &gt;pdb|2VH0|A Structure and property based design of factor Xa inhibitors:biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs [Homo sapiens] &gt;pdb|2VH6|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs [Homo sapiens] &gt;pdb|2WYG|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs [Homo sapiens] &gt;pdb|2WYJ|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs [Homo sapiens] &gt;pdb|2Y7X|A The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs [Homo sapiens] &gt;pdb|2Y7Z|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs [Homo sapiens] &gt;pdb|2Y80|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs [Homo sapiens] &gt;pdb|2Y81|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs [Homo sapiens] &gt;pdb|2Y82|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs [Homo sapiens] &gt;pdb|4A7I|B Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor [Homo sapiens] &gt;pdb|4BTI|B factor Xa in complex with the dual thrombin-FXa inhibitor 58. [Homo sapiens] &gt;pdb|4BTI|F factor Xa in complex with the dual thrombin-FXa inhibitor 58. [Homo sapiens] &gt;pdb|4BTT|B factor Xa in complex with the dual thrombin-FXa inhibitor 31. [Homo sapiens] &gt;pdb|4BTT|F factor Xa in complex with the dual thrombin-FXa inhibitor 31. [Homo sapiens] &gt;pdb|4BTU|B Factor Xa in complex with the dual thrombin-FXa inhibitor 57. [Homo sapiens] &gt;pdb|4BTU|F Factor Xa in complex with the dual thrombin-FXa inhibitor 57. [Homo sapiens] &gt;pdb|4Y6D|A Factor Xa complex with GTC000101 [Homo sapiens] &gt;pdb|4Y71|A Factor Xa complex with GTC000398 [Homo sapiens] &gt;pdb|4Y76|A Factor Xa complex with GTC000401 [Homo sapiens] &gt;pdb|4Y79|A Factor Xa complex with GTC000406 [Homo sapiens] &gt;pdb|4Y7A|A Factor Xa complex with GTC000422 [Homo sapiens] &gt;pdb|4Y7B|A Factor Xa complex with GTC000441 [Homo sapiens] &gt;pdb|4ZH8|A Factor Xa complex with GTC000006 [Homo sapiens] &gt;pdb|4ZHA|A Factor Xa complex with GTC000102 [Homo sapiens]</Hit_def>
  <Hit_accession>1EZQ_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>3.68228e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>335</Hit_num>
  <Hit_id>pdb|3ENS|B</Hit_id>
  <Hit_def>Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate [Homo sapiens] &gt;pdb|3ENS|D Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate [Homo sapiens] &gt;pdb|3HPT|B Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine [Homo sapiens] &gt;pdb|3HPT|D Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine [Homo sapiens] &gt;pdb|3K9X|B X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE [Homo sapiens] &gt;pdb|3K9X|D X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE [Homo sapiens] &gt;pdb|3SW2|B X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-5,6-dihydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2H,4H,8H)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide [Homo sapiens]</Hit_def>
  <Hit_accession>3ENS_B</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>3.74696e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>336</Hit_num>
  <Hit_id>pdb|1C5M|D</Hit_id>
  <Hit_def>STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens]</Hit_def>
  <Hit_accession>1C5M_D</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>3.80332e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>337</Hit_num>
  <Hit_id>pdb|2Y5F|A</Hit_id>
  <Hit_def>FACTOR XA - CATION INHIBITOR COMPLEX [Homo sapiens] &gt;pdb|2Y5G|A FACTOR XA - CATION INHIBITOR COMPLEX [Homo sapiens] &gt;pdb|2Y5H|A FACTOR XA - CATION INHIBITOR COMPLEX [Homo sapiens]</Hit_def>
  <Hit_accession>2Y5F_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>3.81921e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>338</Hit_num>
  <Hit_id>pdb|2BQ6|B</Hit_id>
  <Hit_def>Crystal structure of factor Xa in complex with 21 [Homo sapiens] &gt;pdb|2BQ7|B Crystal structure of factor Xa in complex with 43 [Homo sapiens] &gt;pdb|2BQW|B CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45 [Homo sapiens]</Hit_def>
  <Hit_accession>2BQ6_B</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>4.13362e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>148</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEF--DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V  G+   +Q    E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>339</Hit_num>
  <Hit_id>pdb|1KIG|H</Hit_id>
  <Hit_def>BOVINE FACTOR XA [Bos taurus]</Hit_def>
  <Hit_accession>1KIG_H</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>69.707</Hsp_bit-score>
      <Hsp_score>169</Hsp_score>
      <Hsp_evalue>5.83692e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKL--KIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGT-----TCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGRDCAEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHC-LHQAKRFTVRVGDRNTEQEEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLP--EKDWAEATLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G +   G  PWQ  L ++    FCGG+++NE +V+TAAHC +  +        D+ +  E+  ++  ++    K+S++   T + DI +L+L T   F + V+  CLP    D+A  T     T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>340</Hit_num>
  <Hit_id>pdb|1M9U|A</Hit_id>
  <Hit_def>Chain A, Earthworm Fibrinolytic Enzyme [Eisenia fetida] &gt;pdb|1M9U|B Chain B, Earthworm Fibrinolytic Enzyme [Eisenia fetida] &gt;pdb|1M9U|C Chain C, Earthworm Fibrinolytic Enzyme [Eisenia fetida]</Hit_def>
  <Hit_accession>1M9U_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>69.707</Hsp_bit-score>
      <Hsp_score>169</Hsp_score>
      <Hsp_evalue>5.89768e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>135</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF--HFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFDQG-SSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNIRVIAGLWQQSDTSGTQTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLPANNNNDYAGTTCVISGWGRT</Hsp_hseq>
      <Hsp_midline>++ G  A PG +PWQ+S Q ++G   H CG SL++    ++A+HC  GV  +++ V+AG + Q  +S  +   +    + +N    + + +NDI +L L+T+ S    + A  LP+ +++  AGTTCV +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>341</Hit_num>
  <Hit_id>pdb|2OLG|A</Hit_id>
  <Hit_def>Crystal structure of the serine protease domain of prophenoloxidase activating factor-I in a zymogen form [Holotrichia diomphalia]</Hit_def>
  <Hit_accession>2OLG_A</Hit_accession>
  <Hit_len>278</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>69.707</Hsp_bit-score>
      <Hsp_score>169</Hsp_score>
      <Hsp_evalue>7.84219e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>175</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>24</Hsp_gaps>
      <Hsp_align-len>153</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF----CGGSLINENWVVTAAHCG-------VTTSDVVVAGEFDQGSSSE-----------KIQKLKIAKVFKNSKY--NSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>ILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGRVLRVVGALNKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYHDIALIRLNRQVEFTNYIRPVCLPQPNEEVQVGQRLTVVGWGRT</Hsp_hseq>
      <Hsp_midline>I+NG++ VP  +PW   +  K   +F    CGGSLIN  ++VTAAHC        V   + V  GE++  +  +           K   L I +  ++  Y   S    +DI L++L+    F+  +  VCLP  +++   G      GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>342</Hit_num>
  <Hit_id>pdb|1FAX|A</Hit_id>
  <Hit_def>COAGULATION FACTOR XA INHIBITOR COMPLEX [Homo sapiens]</Hit_def>
  <Hit_accession>1FAX_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>69.707</Hsp_bit-score>
      <Hsp_score>169</Hsp_score>
      <Hsp_evalue>7.89427e-15</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-------GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS---ASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTAAE----EGGEAVHEVEV--VIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT</Hsp_hseq>
      <Hsp_midline>IV G+E   G  PWQ  L ++    FCGG++++E +++TAAHC        V   D   A E       E + ++++  V K++++   T + DI +L+L T  +F   V+  CLP    A        T + +G+G T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>343</Hit_num>
  <Hit_id>pdb|1NPM|A</Hit_id>
  <Hit_def>Neuropsin, A Serine Protease Expressed In The Limbic System Of Mouse Brain [Mus musculus] &gt;pdb|1NPM|B Neuropsin, A Serine Protease Expressed In The Limbic System Of Mouse Brain [Mus musculus]</Hit_def>
  <Hit_accession>1NPM_A</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>68.5514</Hsp_bit-score>
      <Hsp_score>166</Hsp_score>
      <Hsp_evalue>1.08126e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN---DITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>ILEGRECIPHSQPWQAALFQGERL-ICGGVLVGDRWVLTAAHCKKQKYSVRL-GDHSLQSRDQPEQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQL--ANLCPKVGQKCIISGWG</Hsp_hseq>
      <Hsp_midline>I+ G E +P S PWQ +L        CGG L+ + WV+TAAHC      V + G+    S  +  Q++++A+  ++  YN+    +   DI L++L  +A+    V  V L  A+     G  C+ +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>344</Hit_num>
  <Hit_id>pdb|4IGD|A</Hit_id>
  <Hit_def>Crystal structure of the zymogen catalytic region of Human MASP-1 [Homo sapiens]</Hit_def>
  <Hit_accession>4IGD_A</Hit_accession>
  <Hit_len>406</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>69.707</Hsp_bit-score>
      <Hsp_score>169</Hsp_score>
      <Hsp_evalue>1.86026e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>156</Hsp_hit-from>
      <Hsp_hit-to>297</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>144</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----------GVTTSDVVVAGEFD-------QGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFVMPICLPEGPQQ--EGAMVIVSGWG</Hsp_hseq>
      <Hsp_midline>I NG  A  G+ PW   L    G  FCGGSL+  +W+VTAAHC           +  SD++   +F        +  S E  Q L +     + +Y+  T  ND+ L++L  +   +  V  +CLP        G   + +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>345</Hit_num>
  <Hit_id>pdb|4BXS|A</Hit_id>
  <Hit_def>Crystal Structure of the Prothrombinase Complex from the Venom of Pseudonaja Textilis [Pseudonaja textilis] &gt;pdb|4BXW|A Crystal Structure of the Prothrombinase Complex from the Venom of Pseudonaja Textilis [Pseudonaja textilis] &gt;pdb|4BXW|B Crystal Structure of the Prothrombinase Complex from the Venom of Pseudonaja Textilis [Pseudonaja textilis]</Hit_def>
  <Hit_accession>4BXS_A</Hit_accession>
  <Hit_len>423</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>69.707</Hsp_bit-score>
      <Hsp_score>169</Hsp_score>
      <Hsp_evalue>1.88931e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>116</Hsp_query-to>
      <Hsp_hit-from>170</Hsp_hit-from>
      <Hsp_hit-to>292</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>125</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-VVAGEFDQGSSSE----KIQKLKIAKVF----KNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFA</Hsp_qseq>
      <Hsp_hseq>IVNGMDCKLGECPWQAALVDEKEGVFCGGTILSPIYVLTAAHCINETETISVVVGEIDKSRIETGPLLSVDKIYVHKKFVPPQKAYKFDLAAYDYDIAIIQMKTPIQFSENVVPACLPTA--DFA</Hsp_hseq>
      <Hsp_midline>IVNG +   G  PWQ +L D+    FCGG++++  +V+TAAHC   T  + VV GE D+          + K+ + K F    K  K++    + DI ++++ T   FS+ V   CLP+A  DFA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>346</Hit_num>
  <Hit_id>pdb|6B74|B</Hit_id>
  <Hit_def>Structures of the two-chain human plasma Factor XIIa co-crystallized with potent inhibitors [Homo sapiens] &gt;pdb|6B77|B Structures of the two-chain human plasma factor XIIa co-crystallized with potent inhibitors [Homo sapiens] &gt;pdb|6L63|A Human Coagulation Factor XIIa (FXIIa) bound with the macrocyclic peptide F3 containing two (1S,2S)-2-ACHC residues [Homo sapiens] &gt;pdb|6L63|C Human Coagulation Factor XIIa (FXIIa) bound with the macrocyclic peptide F3 containing two (1S,2S)-2-ACHC residues [Homo sapiens]</Hit_def>
  <Hit_accession>6B74_B</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>3.00009e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLS-----TAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGLVALRGAHPYIAAL--YWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWG</Hsp_hseq>
      <Hsp_midline>+V G  A+ G+ P+  +L    G  FC GSLI   WV+TAAHC           VV G+  +  S E  Q L +     +  ++ ++  +D+ LL+L      + A  S  V  VCLPS +   +  T C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>347</Hit_num>
  <Hit_id>pdb|1A5I|A</Hit_id>
  <Hit_def>Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva Plasminogen Activator In Complex With Egr-Cmk (Glu-Gly-Arg Chloromethyl Ketone) [Desmodus rotundus]</Hit_def>
  <Hit_accession>1A5I_A</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>68.1662</Hsp_bit-score>
      <Hsp_score>165</Hsp_score>
      <Hsp_evalue>3.23371e-14</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>153</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>SWPWQVSL----QDKTGFHF-CGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>SHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHCFQESYLPDQLKVVLGRTYRVKPGEEEQTFKVKKYIVHKEFDDDTYNNDIALLQLKSDSPQCAQESDSVRAICLPEANLQLPDWTECELSGYG</Hsp_hseq>
      <Hsp_midline>S PWQ ++    +  +G  F CGG LI+  WV+TAAHC     +     VV G   +    E+ Q  K+ K   + +++  T NNDI LL+L +     A  S +V A+CLP A+      T C  +G+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>348</Hit_num>
  <Hit_id>pdb|6X0S|A</Hit_id>
  <Hit_def>Chain A, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0S|B Chain B, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0S|C Chain C, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0T|A Chain A, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0T|B Chain B, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0T|C Chain C, Coagulation factor XII [Homo sapiens]</Hit_def>
  <Hit_accession>6X0S_A</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>3.26876e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>17</Hsp_hit-from>
      <Hsp_hit-to>150</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC---GVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLS-----TAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGLVALRGAHPYIAAL--YWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWG</Hsp_hseq>
      <Hsp_midline>+V G  A+ G+ P+  +L    G  FC GSLI   WV+TAAHC        D+ VV G+  +  S E  Q L +     +  ++ ++  +D+ LL+L      + A  S  V  VCLPS +   +  T C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>349</Hit_num>
  <Hit_id>pdb|6QF7|B</Hit_id>
  <Hit_def>Crystal structures of the recombinant beta-Factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics [Homo sapiens] &gt;pdb|6QF7|D Crystal structures of the recombinant beta-Factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics [Homo sapiens]</Hit_def>
  <Hit_accession>6QF7_B</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>3.39947e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLS-----TAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGLVALRGAHPYIAAL--YWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWG</Hsp_hseq>
      <Hsp_midline>+V G  A+ G+ P+  +L    G  FC GSLI   WV+TAAHC           VV G+  +  S E  Q L +     +  ++ ++  +D+ LL+L      + A  S  V  VCLPS +   +  T C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>350</Hit_num>
  <Hit_id>pdb|6GT6|B</Hit_id>
  <Hit_def>Crystal structure of recombinant coagulation factor beta-XIIa [Homo sapiens]</Hit_def>
  <Hit_accession>6GT6_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>3.65062e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLS-----TAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGLVALRGAHPYIAAL--YWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWG</Hsp_hseq>
      <Hsp_midline>+V G  A+ G+ P+  +L    G  FC GSLI   WV+TAAHC           VV G+  +  S E  Q L +     +  ++ ++  +D+ LL+L      + A  S  V  VCLPS +   +  T C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>351</Hit_num>
  <Hit_id>pdb|1TON|A</Hit_id>
  <Hit_def>RAT SUBMAXILLARY GLAND SERINE PROTEASE, TONIN. STRUCTURE SOLUTION AND REFINEMENT AT 1.8 ANGSTROMS RESOLUTION [Rattus rattus]</Hit_def>
  <Hit_accession>1TON_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.0106</Hsp_bit-score>
      <Hsp_score>162</Hsp_score>
      <Hsp_evalue>4.85306e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI-----------NNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGYKCEKNSQPWQVAVINE---YLCGGVLIDPSWVITAAHC-YSNNYQVLLGRNNLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITGGVKVIDLPTK--EPKVGSTCLASGWGST</Hsp_hseq>
      <Hsp_midline>IV G +    S PWQV++ ++   + CGG LI+ +WV+TAAHC  + +  V+ G  +        Q+  + + F++  Y  L +           +ND+ LL LS  A  +  V  + LP+   +   G+TC+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>352</Hit_num>
  <Hit_id>pdb|1SGF|G</Hit_id>
  <Hit_def>Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (serine Proteinases) [Mus musculus] &gt;pdb|1SGF|Z Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (serine Proteinases) [Mus musculus]</Hit_def>
  <Hit_accession>1SGF_G</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.0106</Hsp_bit-score>
      <Hsp_score>162</Hsp_score>
      <Hsp_evalue>6.3733e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>137</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGE---FDQGSSSEKI-------QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGFKCEKNSQPWHVAVYRYTQY-LCGGVLLDPNWVLTAAHCYDDNYKVWLGKNNLFKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTVKPITLP--TEEPKLGSTCLASGWG</Hsp_hseq>
      <Hsp_midline>IV G +    S PW V++   T +  CGG L++ NWV+TAAHC      V +       D+ S+  +            ++ + K+ ++     +ND+ LL+LS  A  + TV  + LP  +++   G+TC+ +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>353</Hit_num>
  <Hit_id>pdb|3IG6|B</Hit_id>
  <Hit_def>Low molecular weigth human Urokinase type Plasminogen activator 2-[6-(3&apos;-Aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic acid complex [Homo sapiens] &gt;pdb|3IG6|D Low molecular weigth human Urokinase type Plasminogen activator 2-[6-(3&apos;-Aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic acid complex [Homo sapiens]</Hit_def>
  <Hit_accession>3IG6_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.0106</Hsp_bit-score>
      <Hsp_score>162</Hsp_score>
      <Hsp_evalue>7.18618e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>354</Hit_num>
  <Hit_id>pdb|6NMB|A</Hit_id>
  <Hit_def>Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator [Homo sapiens] &gt;pdb|6NMB|B Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator [Homo sapiens] &gt;pdb|6NMB|C Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator [Homo sapiens] &gt;pdb|6NMB|D Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator [Homo sapiens]</Hit_def>
  <Hit_accession>6NMB_A</Hit_accession>
  <Hit_len>281</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.3958</Hsp_bit-score>
      <Hsp_score>163</Hsp_score>
      <Hsp_evalue>7.38863e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>29</Hsp_hit-from>
      <Hsp_hit-to>169</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>355</Hit_num>
  <Hit_id>pdb|1AO5|A</Hit_id>
  <Hit_def>Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme) [Mus musculus] &gt;pdb|1AO5|B Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme) [Mus musculus]</Hit_def>
  <Hit_accession>1AO5_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.2402</Hsp_bit-score>
      <Hsp_score>160</Hsp_score>
      <Hsp_evalue>1.04584e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>138</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYN-SLTI----------NNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGFNCEKNSQPWQVAVYYQKE-HICGGVLLDRNWVLTAAHCYVDQYEVWL-GKNKLFQEEPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKPIALPTKEP--KPGSKCLASGWG</Hsp_hseq>
      <Hsp_midline>+V G      S PWQV++  +   H CGG L++ NWV+TAAHC V   +V + G+          Q   ++K F +  +N SL +          ++D+ LL+LS  A  +  V  + LP+       G+ C+ +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>356</Hit_num>
  <Hit_id>pdb|6V64|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin bound to ppack with tryptophans replaced by 5-F-tryptophan [Homo sapiens]</Hit_def>
  <Hit_accession>6V64_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>1.0604e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYNSL-TINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPXQVMLFRKSPQELLCGASLISDRXVLTAAHCLLYPPXDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNXRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGXG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  P QV L  K+     CG SLI++  V+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TG G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>357</Hit_num>
  <Hit_id>pdb|6V5T|E</Hit_id>
  <Hit_def>Crystal structure of human prethrombin-2 with tryptophans replaced by 5-F-tryptophan [Homo sapiens]</Hit_def>
  <Hit_accession>6V5T_E</Hit_accession>
  <Hit_len>290</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.0106</Hsp_bit-score>
      <Hsp_score>162</Hsp_score>
      <Hsp_evalue>1.09477e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>32</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>142</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC--------GVTTSDVVVA-GEFDQGSSSEKIQKLK-IAKVFKNSKYNSL-TINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPXQVMLFRKSPQELLCGASLISDRXVLTAAHCLLYPPXDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNXRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGXG</Hsp_hseq>
      <Hsp_midline>IV G +A  G  P QV L  K+     CG SLI++  V+TAAHC          T +D++V  G+  +      I+K+  + K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TG G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>358</Hit_num>
  <Hit_id>pdb|1OWE|A</Hit_id>
  <Hit_def>Substituted 2-Naphthamidine inhibitors of urokinase [Homo sapiens] &gt;pdb|1OWH|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1SQA|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1SQO|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens]</Hit_def>
  <Hit_accession>1OWE_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>1.59323e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSL++  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>359</Hit_num>
  <Hit_id>pdb|1C5W|B</Hit_id>
  <Hit_def>STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5X|B STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5Y|B STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5Z|B Chain B, PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR) [Homo sapiens] &gt;pdb|1GJ7|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJ8|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJ9|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJA|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJB|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJC|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJD|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1O3P|B Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>1C5W_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>1.61433e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSL++  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>360</Hit_num>
  <Hit_id>pdb|1OWD|A</Hit_id>
  <Hit_def>Substituted 2-Naphthamidine inhibitors of urokinase [Homo sapiens] &gt;pdb|1OWI|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1OWJ|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1OWK|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1SQT|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1U6Q|A Substituted 2-Naphthamadine inhibitors of Urokinase [Homo sapiens]</Hit_def>
  <Hit_accession>1OWD_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>1.66003e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSL++  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>361</Hit_num>
  <Hit_id>pdb|5UBM|A</Hit_id>
  <Hit_def>Crystal structure of human C1s in complex with inhibitor gigastasin [Homo sapiens]</Hit_def>
  <Hit_accession>5UBM_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>1.68172e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>137</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI-------NNDITLLKLSTAASFSQTVSAVCLPSASDDF--AAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGSDADIKNFPWQVFFDNP----WAGGALINEYWVLTAAHVVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLEVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRT</Hsp_hseq>
      <Hsp_midline>I+ G +A   ++PWQV   +     + GG+LINE WV+TAAH   G     + V     Q S   K + L    VF +  +  L +       +NDI L++L        TVS +CLP  S D+    G   + +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>362</Hit_num>
  <Hit_id>pdb|1GI7|B</Hit_id>
  <Hit_def>A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GI8|B A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GI9|B A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens]</Hit_def>
  <Hit_accession>1GI7_B</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>1.69448e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSL++  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>363</Hit_num>
  <Hit_id>pdb|1LMW|B</Hit_id>
  <Hit_def>LMW U-PA Structure complexed with EGRCMK (GLU-GLY-ARG Chloromethyl Ketone) [Homo sapiens] &gt;pdb|1LMW|D LMW U-PA Structure complexed with EGRCMK (GLU-GLY-ARG Chloromethyl Ketone) [Homo sapiens]</Hit_def>
  <Hit_accession>1LMW_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>1.73422e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSL++  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>364</Hit_num>
  <Hit_id>pdb|1O5A|B</Hit_id>
  <Hit_def>Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1O5B|B Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1O5C|B Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens]</Hit_def>
  <Hit_accession>1O5A_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>1.82527e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSL++  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>365</Hit_num>
  <Hit_id>pdb|1GVZ|A</Hit_id>
  <Hit_def>Prostate Specific Antigen (PSA) from stallion seminal plasma [Equus caballus]</Hit_def>
  <Hit_accession>1GVZ_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.4698</Hsp_bit-score>
      <Hsp_score>158</Hsp_score>
      <Hsp_evalue>2.00192e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>135</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYN-SL----------TINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IIGGWECEKHSKPWQVAVYHQGHFQ-CGGVLVHPQWVLTAAHC-MSDDYQIWLGRHNLSKDEDTAQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITDAVKILDLPTQEPKL--GSTCYTSGWGL</Hsp_hseq>
      <Hsp_midline>I+ G E    S PWQV++  +  F  CGG L++  WV+TAAHC ++    +  G  +     +  Q  +++  F + +++ SL           I++D+ LL+L+  A  +  V  + LP+       G+TC T+GWGL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>366</Hit_num>
  <Hit_id>pdb|2VNT|A</Hit_id>
  <Hit_def>Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|B Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|C Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|D Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|E Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|F Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens]</Hit_def>
  <Hit_accession>2VNT_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>2.09783e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>164</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSL++  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  +CLPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>367</Hit_num>
  <Hit_id>pdb|5MS3|A</Hit_id>
  <Hit_def>Kallikrein-related peptidase 8 calcium complex [Homo sapiens] &gt;pdb|5MS4|A Kallikrein-related peptidase 8 leupeptin inhibitor complex [Homo sapiens] &gt;pdb|5MS4|B Kallikrein-related peptidase 8 leupeptin inhibitor complex [Homo sapiens] &gt;pdb|5MS4|C Kallikrein-related peptidase 8 leupeptin inhibitor complex [Homo sapiens] &gt;pdb|5MS4|D Kallikrein-related peptidase 8 leupeptin inhibitor complex [Homo sapiens]</Hit_def>
  <Hit_accession>5MS3_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.0846</Hsp_bit-score>
      <Hsp_score>157</Hsp_score>
      <Hsp_evalue>2.2309e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI---NNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VLGGHECQPHSQPWQAALFQGQQL-LCGGVLVGGNWVLTAAHCKKPKYTVRLGDHSLQNKDGPE-QEIPVVQSIPHPCYNSSDVEDHNHDLMLLQLRDQASLGSKVKPISL--ADHCTQPGQKCTVSGWG</Hsp_hseq>
      <Hsp_midline>++ G E  P S PWQ +L        CGG L+  NWV+TAAHC      V +     Q     + Q++ + +   +  YNS  +   N+D+ LL+L   AS    V  + L  A      G  C  +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>368</Hit_num>
  <Hit_id>pdb|6QFH|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK144. [Homo sapiens] &gt;pdb|6QFH|B Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK144. [Homo sapiens]</Hit_def>
  <Hit_accession>6QFH_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.0846</Hsp_bit-score>
      <Hsp_score>157</Hsp_score>
      <Hsp_evalue>2.7619e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>LVHGGPCDKTSHPYQAALY-TSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL-GKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQTTSCHILGWGKT</Hsp_hseq>
      <Hsp_midline>+V+G      S P+Q +L   +G   CGG LI+  WV+TAAHC      V + G+ + G      ++  + +   +  Y++ + + DI LL+L+  A  S+ +    LP   D  A  T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>369</Hit_num>
  <Hit_id>pdb|3VFE|A</Hit_id>
  <Hit_def>Virtual Screening and X-Ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group [Homo sapiens] &gt;pdb|4D8N|A Human Kallikrein 6 Inhibitors with a para-Amidobenzylanmine P1 Group Carry a High Binding Efficiency [Homo sapiens] &gt;pdb|5NX1|A Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy [Homo sapiens] &gt;pdb|5NX3|A Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy [Homo sapiens] &gt;pdb|6QH9|A Crystal Structure of Human Kallikrein 6 in complex with GSK3239861A [Homo sapiens] &gt;pdb|6QH9|B Crystal Structure of Human Kallikrein 6 in complex with GSK3239861A [Homo sapiens] &gt;pdb|6QHA|A Crystal Structure of Human Kallikrein 6 in complex with GSK3205388B [Homo sapiens] &gt;pdb|6QHA|B Crystal Structure of Human Kallikrein 6 in complex with GSK3205388B [Homo sapiens] &gt;pdb|6QHB|A Crystal Structure of Human Kallikrein 6 in complex with GSK578724A [Homo sapiens] &gt;pdb|6QHB|B Crystal Structure of Human Kallikrein 6 in complex with GSK578724A [Homo sapiens] &gt;pdb|6QHC|A Crystal Structure of Human Kallikrein 6 in complex with GSK358180B [Homo sapiens] &gt;pdb|6QHC|B Crystal Structure of Human Kallikrein 6 in complex with GSK358180B [Homo sapiens]</Hit_def>
  <Hit_accession>3VFE_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.6994</Hsp_bit-score>
      <Hsp_score>156</Hsp_score>
      <Hsp_evalue>3.07086e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>LVHGGPCDKTSHPYQAALY-TSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL-GKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQTTSCHILGWGKT</Hsp_hseq>
      <Hsp_midline>+V+G      S P+Q +L   +G   CGG LI+  WV+TAAHC      V + G+ + G      ++  + +   +  Y++ + + DI LL+L+  A  S+ +    LP   D  A  T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>370</Hit_num>
  <Hit_id>pdb|6QFG|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK144 [Homo sapiens] &gt;pdb|6QFG|B Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK144 [Homo sapiens] &gt;pdb|6SKC|A Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3448330A [Homo sapiens] &gt;pdb|6SKC|B Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3448330A [Homo sapiens] &gt;pdb|6SKD|A Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3397892A [Homo sapiens] &gt;pdb|6SKD|B Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3397892A [Homo sapiens]</Hit_def>
  <Hit_accession>6QFG_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.6994</Hsp_bit-score>
      <Hsp_score>156</Hsp_score>
      <Hsp_evalue>3.1028e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>LVHGGPCDKTSHPYQAALY-TSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL-GKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQTTSCHILGWGKT</Hsp_hseq>
      <Hsp_midline>+V+G      S P+Q +L   +G   CGG LI+  WV+TAAHC      V + G+ + G      ++  + +   +  Y++ + + DI LL+L+  A  S+ +    LP   D  A  T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>371</Hit_num>
  <Hit_id>pdb|6QFF|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 6 in complex with GSK144 [Homo sapiens] &gt;pdb|6QFF|B Crystal Structure of Human Kallikrein 6 in complex with GSK144 [Homo sapiens]</Hit_def>
  <Hit_accession>6QFF_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.6994</Hsp_bit-score>
      <Hsp_score>156</Hsp_score>
      <Hsp_evalue>3.19273e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>LVHGGPCDKTSHPYQAALY-TSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL-GKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQTTSCHILGWGKT</Hsp_hseq>
      <Hsp_midline>+V+G      S P+Q +L   +G   CGG LI+  WV+TAAHC      V + G+ + G      ++  + +   +  Y++ + + DI LL+L+  A  S+ +    LP   D  A  T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>372</Hit_num>
  <Hit_id>pdb|1ELV|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COMPLEMENT C1S PROTEASE [Homo sapiens]</Hit_def>
  <Hit_accession>1ELV_A</Hit_accession>
  <Hit_len>333</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.4698</Hsp_bit-score>
      <Hsp_score>158</Hsp_score>
      <Hsp_evalue>4.32975e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>83</Hsp_hit-from>
      <Hsp_hit-to>219</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI-------NNDITLLKLSTAASFSQTVSAVCLPSASDDF--AAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IIGGSDADIKNFPWQVFFDNP----WAGGALINEYWVLTAAHVVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRTE</Hsp_hseq>
      <Hsp_midline>I+ G +A   ++PWQV   +     + GG+LINE WV+TAAH   G     + V     Q S   K + L    VF +  +  L +       +NDI L++L        TVS +CLP  S D+    G   + +GWG T </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>373</Hit_num>
  <Hit_id>pdb|6SKB|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK3496783A [Homo sapiens] &gt;pdb|6SKB|B Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK3496783A [Homo sapiens] &gt;pdb|6SKB|C Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK3496783A [Homo sapiens]</Hit_def>
  <Hit_accession>6SKB_A</Hit_accession>
  <Hit_len>289</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.0846</Hsp_bit-score>
      <Hsp_score>157</Hsp_score>
      <Hsp_evalue>5.0263e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>67</Hsp_hit-from>
      <Hsp_hit-to>191</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>LVHGGPCDKTSHPYQAALY-TSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL-GKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQTTSCHILGWGKT</Hsp_hseq>
      <Hsp_midline>+V+G      S P+Q +L   +G   CGG LI+  WV+TAAHC      V + G+ + G      ++  + +   +  Y++ + + DI LL+L+  A  S+ +    LP   D  A  T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>374</Hit_num>
  <Hit_id>pdb|2B9L|A</Hit_id>
  <Hit_def>Crystal structure of prophenoloxidase activating factor-II from the beetle Holotrichia diomphalia [Holotrichia diomphalia]</Hit_def>
  <Hit_accession>2B9L_A</Hit_accession>
  <Hit_len>394</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.0846</Hsp_bit-score>
      <Hsp_score>157</Hsp_score>
      <Hsp_evalue>7.59703e-13</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>270</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>EAVPGSWPWQVSLQDKTGFH-------FCGGSLINENWVVTAAHC-GVTTSDV----VVAGEFDQGSSSEKI--QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>EAEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTGAHCVNSYQSNLDAIKIRAGEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTICLPQQSQIFDS-TECFASGWG</Hsp_hseq>
      <Hsp_midline>EA  G +PW V++               CGGSLI  + V+T AHC     S++    + AGE+D  +  E++  Q+ KI +V  +S +N  T+ ND+ LL L      +  +  +CLP  S  F + T C  +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>375</Hit_num>
  <Hit_id>pdb|4X0W|U</Hit_id>
  <Hit_def>The crystal structure of mupain-1-17 in complex with murinised human uPA [Homo sapiens] &gt;pdb|4X1N|U The crystal structure of mupain-1-16 in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4X1P|U The crystal structure of mupain-1-17 in complex with murinised human uPA at pH4.6 [Homo sapiens] &gt;pdb|4X1Q|U The crystal structure of mupain-1 in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4X1R|U The crystal structure of mupain-1-12 in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4X1S|U The crystal structure of mupain-1-16-D9A in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4ZHL|U The crystal structure of mupain-1-IG in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4ZHM|U The crystal structure of mupain-1--16-IG in complex with murinised human uPA at pH7.4 [Homo sapiens]</Hit_def>
  <Hit_accession>4X0W_U</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>8.73327e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAYHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>376</Hit_num>
  <Hit_id>pdb|6JYP|U</Hit_id>
  <Hit_def>Crystal structure of uPA_H99Y in complex with 3-azanyl-5-(azepan-1-yl)-N-[bis(azanyl)methylidene]-6-chloranyl-pyrazine-2-carboxamide [Homo sapiens] &gt;pdb|6JYQ|U Crystal structure of uPA_H99Y in complex with 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(furan-2-yl)pyrazine-2-carboxamide [Homo sapiens]</Hit_def>
  <Hit_accession>6JYP_U</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>8.73444e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAYHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>377</Hit_num>
  <Hit_id>pdb|6L04|U</Hit_id>
  <Hit_def>Crystal structure of uPA_H99Y in complex with 31F [Homo sapiens] &gt;pdb|6L05|U Crystal structure of uPA_H99Y in complex with 50F [Homo sapiens]</Hit_def>
  <Hit_accession>6L04_U</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>9.00708e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAYHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>378</Hit_num>
  <Hit_id>pdb|4XE4|A</Hit_id>
  <Hit_def>Coagulation Factor XII protease domain crystal structure [Homo sapiens]</Hit_def>
  <Hit_accession>4XE4_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>1.14489e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>134</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLS-----TAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGLVALRGAHPYIAAL--YWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVSLPSGAARPSETTLCQVAGWG</Hsp_hseq>
      <Hsp_midline>+V G  A+ G+ P+  +L    G  FC GSLI   WV+TAAHC           VV G+  +  S E  Q L +     +  ++ ++  +D+ LL+L      + A  S  V  V LPS +   +  T C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>379</Hit_num>
  <Hit_id>pdb|4XSK|U</Hit_id>
  <Hit_def>Structure of PAItrap, an uPA mutant [Homo sapiens]</Hit_def>
  <Hit_accession>4XSK_U</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>1.28801e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGF----HFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRRGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +       + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>380</Hit_num>
  <Hit_id>pdb|4XDE|A</Hit_id>
  <Hit_def>Coagulation Factor XII protease domain crystal structure [Homo sapiens]</Hit_def>
  <Hit_accession>4XDE_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>1.30392e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLS-----TAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGLVALRGAHPYIAAL--YWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVSLPSGAARPSETTLCQVAGWG</Hsp_hseq>
      <Hsp_midline>+V G  A+ G+ P+  +L    G  FC GSLI   WV+TAAHC           VV G+  +  S E  Q L +     +  ++ ++  +D+ LL+L      + A  S  V  V LPS +   +  T C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>381</Hit_num>
  <Hit_id>pdb|4GLY|A</Hit_id>
  <Hit_def>Human urokinase-type plasminogen activator uPA in complex with the two-disulfide bridge peptide UK504 [Homo sapiens] &gt;pdb|4JK5|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4JK6|A Human urokinase-type Plasminogen Activator (uPA) in complex with a bicyclic peptide inhibitor (UK18-D-Aba) [Homo sapiens] &gt;pdb|4MNV|A Crystal structure of bicyclic peptide UK729 bound as an acyl-enzyme intermediate to urokinase-type plasminogen activator (uPA) [Homo sapiens] &gt;pdb|4MNW|A Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK749 [Homo sapiens] &gt;pdb|4MNX|A Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK811 [Homo sapiens] &gt;pdb|4MNY|A Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK903 [Homo sapiens] &gt;pdb|4MNY|B Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK903 [Homo sapiens] &gt;pdb|4OS1|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS2|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS4|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS5|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS6|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS7|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|5Z1C|U The crystal structure of uPA in complex with 4-Iodobenzylamine at pH7.4 [Homo sapiens] &gt;pdb|6AG7|U The crystal structure of uPA in complex with HMA-55F [Homo sapiens] &gt;pdb|7DZD|U Chain U, Urokinase-type plasminogen activator [Homo sapiens]</Hit_def>
  <Hit_accession>4GLY_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>1.56434e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>382</Hit_num>
  <Hit_id>pdb|4DVA|U</Hit_id>
  <Hit_def>The crystal structure of human urokinase-type plasminogen activator catalytic domain [Homo sapiens] &gt;pdb|4DW2|U The crystal structure of uPA in complex with the Fab fragment of mAb-112 [Homo sapiens] &gt;pdb|4FU7|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FU8|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FU9|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUB|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUC|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUD|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUE|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUF|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUG|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUH|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUI|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUJ|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|5HGG|A Crystal structure of uPA in complex with a camelid-derived antibody fragment [Homo sapiens] &gt;pdb|5HGG|B Crystal structure of uPA in complex with a camelid-derived antibody fragment [Homo sapiens] &gt;pdb|5XG4|U Crystal structure of uPA in complex with quercetin [Homo sapiens] &gt;pdb|5YC6|U The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH4.6 [Homo sapiens] &gt;pdb|5YC7|U The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH7.4 [Homo sapiens]</Hit_def>
  <Hit_accession>4DVA_U</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>1.62907e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>383</Hit_num>
  <Hit_id>pdb|2NWN|A</Hit_id>
  <Hit_def>New Pharmacophore for Serine Protease Inhibition Revealed by Crystal Structure of Human Urokinase-type Plasminogen Activator Complexed with a Cyclic Peptidyl Inhibitor, upain-1 [Homo sapiens] &gt;pdb|2O8T|A Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q) in complex with Inhibitors [Homo sapiens] &gt;pdb|3KGP|A Crystal Structures of Urokinase-type Plasminogen Activator in Complex with 4-(Aminomethyl) Benzoic Acid and 4-(Aminomethyl-phenyl)-methanol [Homo sapiens] &gt;pdb|3KHV|A Crystal Structures of Urokinase-type Plasminogen Activator in Complex with 4-(Aminomethyl) Benzoic Acid and 4-(Aminomethyl-phenyl)-methanol [Homo sapiens] &gt;pdb|3KID|U The Crystal Structures of 2-Aminobenzothiazole-based Inhibitors in Complexes with Urokinase-type Plasminogen Activator [Homo sapiens] &gt;pdb|3M61|U Crystal structure of complex of urokinase and a upain-1 variant(W3A) in pH4.6 condition [Homo sapiens] &gt;pdb|3OX7|U The crystal structure of uPA complex with peptide inhibitor MH027 at pH4.6 [Homo sapiens] &gt;pdb|3OY5|U The crystal structure of uPA complex with peptide inhibitor MH027 at pH7.4 [Homo sapiens] &gt;pdb|3OY6|U The crystal structure of uPA complex with peptide inhibitor MH036 at pH4.6 [Homo sapiens] &gt;pdb|3QN7|A Potent and selective bicyclic peptide inhibitor (UK18) of human urokinase-type plasminogen activator(uPA) [Homo sapiens] &gt;pdb|5WXF|U Crystal structure of uPA in complex with upain-2-2 [Homo sapiens] &gt;pdb|5WXO|U Crystal structure of uPA in complex with upain-2-2-W3A [Homo sapiens] &gt;pdb|5WXP|U Crystal structure of uPA in complex with upain-2-3-W3A [Homo sapiens] &gt;pdb|5WXQ|U Crystal structure of uPA in complex with upain-2-4 [Homo sapiens] &gt;pdb|5WXR|U Crystal structure of uPA in complex with upain-2-4-W3A [Homo sapiens] &gt;pdb|5WXS|U Crystal structure of uPA in complex with S2444 [Homo sapiens] &gt;pdb|5ZA7|U uPA-HMA [Homo sapiens] &gt;pdb|5ZA8|U uPA-BB2-27F [Homo sapiens] &gt;pdb|5ZA9|U uPA-BB2-50F [Homo sapiens] &gt;pdb|5ZAE|U uPA-6F-HMA [Homo sapiens] &gt;pdb|5ZAF|U uPA-BB2-28F [Homo sapiens] &gt;pdb|5ZAG|U uPA-BB2-94F [Homo sapiens] &gt;pdb|5ZAH|U uPA-BB2-30F [Homo sapiens] &gt;pdb|5ZAJ|U uPA-31F [Homo sapiens] &gt;pdb|5ZC5|U uPA-NU-09F [Homo sapiens] &gt;pdb|6AG2|U uPA-HMA [Homo sapiens] &gt;pdb|6AG3|U Crystal structure of uPA in complex with 3,5-bis(azanyl)-N-carbamimidoyl-6-(2,4-dimethoxypyrimidin-5-yl)pyrazine-2-carboxamide [Homo sapiens] &gt;pdb|6AG9|U Crystal structure of uPA in complex with 3,5-bis(azanyl)-6-(1-benzofuran-2-yl)-N-carbamimidoyl-pyrazine-2- carboxamide [Homo sapiens] &gt;pdb|6XVD|U Crystal structure of complex of urokinase and a upain-1 variant(W3F) in pH7.4 condition [Homo sapiens]</Hit_def>
  <Hit_accession>2NWN_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>1.65489e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>384</Hit_num>
  <Hit_id>pdb|1L2E|A</Hit_id>
  <Hit_def>Human Kallikrein 6 (hK6) Active Form with benzamidine inhibitor [Homo sapiens] &gt;pdb|1LO6|A Human Kallikrein 6 (hK6) active form with benzamidine inhibitor at 1.56 A resolution [Homo sapiens]</Hit_def>
  <Hit_accession>1L2E_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>1.7061e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>LVHGGPCDKTSHPYQAALY-TSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL-GKHNLRQRESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSANTTSCHILGWGKT</Hsp_hseq>
      <Hsp_midline>+V+G      S P+Q +L   +G   CGG LI+  WV+TAAHC      V + G+ +        ++  + +   +  Y++ + + DI LL+L+  A  S+ +    LP   D  A  T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>385</Hit_num>
  <Hit_id>pdb|2O8U|A</Hit_id>
  <Hit_def>Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in complex with Inhibitors [Homo sapiens] &gt;pdb|2O8W|A Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in complex with Inhibitors [Homo sapiens] &gt;pdb|3PB1|E Crystal Structure of a Michaelis Complex between Plasminogen Activator Inhibitor-1 and Urokinase-type Plasminogen Activator [Homo sapiens] &gt;pdb|5WXT|U Crystal structure of uPA-S195A in complex with S2444 [Homo sapiens]</Hit_def>
  <Hit_accession>2O8U_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>1.7062e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>386</Hit_num>
  <Hit_id>pdb|4H42|U</Hit_id>
  <Hit_def>Synthesis of a Weak Basic uPA Inhibitor and Crystal Structure of Complex with uPA [Homo sapiens]</Hit_def>
  <Hit_accession>4H42_U</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>1.71279e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>387</Hit_num>
  <Hit_id>pdb|3MWI|U</Hit_id>
  <Hit_def>The complex crystal Structure of Urokianse and 5-nitro-1H-indole-2-amidine [Homo sapiens]</Hit_def>
  <Hit_accession>3MWI_U</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>1.7144e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>388</Hit_num>
  <Hit_id>pdb|4ZKS|U</Hit_id>
  <Hit_def>The crystal structure of upain-1-W3A in complex with inactive uPA (uPA-S195A) at pH7.4 [Homo sapiens]</Hit_def>
  <Hit_accession>4ZKS_U</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>1.73125e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>389</Hit_num>
  <Hit_id>pdb|4ZKN|U</Hit_id>
  <Hit_def>The crystal structure of upain-1-W3A in complex with uPA at pH5.5 [Homo sapiens] &gt;pdb|4ZKO|U The crystal structure of upain-1-W3A in complex with uPA at pH7.4 [Homo sapiens] &gt;pdb|4ZKR|U The crystal structure of upain-1-W3A in complex with uPA at pH9.0 [Homo sapiens]</Hit_def>
  <Hit_accession>4ZKN_U</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>1.749e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>390</Hit_num>
  <Hit_id>pdb|1W0Z|U</Hit_id>
  <Hit_def>Urokinase type plasminogen activator [Homo sapiens] &gt;pdb|1W10|U Urokinase type plasminogen activator [Homo sapiens] &gt;pdb|1W11|U UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1W12|U UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1W13|U UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1W14|U UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|3MHW|U The complex crystal Structure of Urokianse and 2-Aminobenzothiazole [Homo sapiens]</Hit_def>
  <Hit_accession>1W0Z_U</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>2.14489e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>391</Hit_num>
  <Hit_id>pdb|1SC8|U</Hit_id>
  <Hit_def>Urokinase Plasminogen Activator B-Chain-J435 Complex [Homo sapiens] &gt;pdb|1VJ9|U Urokinase Plasminogen Activator B-Chain-JT464 Complex [Homo sapiens] &gt;pdb|1VJA|U Urokinase Plasminogen Activator B-Chain-JT463 Complex [Homo sapiens]</Hit_def>
  <Hit_accession>1SC8_U</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>2.1715e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>156</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>392</Hit_num>
  <Hit_id>pdb|1EJN|A</Hit_id>
  <Hit_def>Urokinase Plasminogen Activator B-chain Inhibitor Complex [Homo sapiens] &gt;pdb|1F5K|U Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1F5L|A Urokinase Plasminogen Activator B-Chain-Amiloride Complex [Homo sapiens] &gt;pdb|1F92|A Urokinase Plasminogen Activator B Chain-Uki-1d Complex [Homo sapiens] &gt;pdb|2R2W|U Urokinase plasminogen activator B-chain-GPPE complex [Homo sapiens] &gt;pdb|2VIN|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIO|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIP|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIQ|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIV|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIW|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens]</Hit_def>
  <Hit_accession>1EJN_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>2.41139e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSLI+  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>393</Hit_num>
  <Hit_id>pdb|4LK4|A</Hit_id>
  <Hit_def>Structure of Vibrio cholerae VesB protease [Vibrio cholerae 569B]</Hit_def>
  <Hit_accession>4LK4_A</Hit_accession>
  <Hit_len>357</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>2.43425e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>143</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSL----QDKTGFHFCGGSLINENWVVTAAHCGVTTS----DVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCL--PSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IINGSNANSAEWPSIVALVKRGADAYQGQFCGGSFLGGRYVLTAAHCFDSRSAASVDVII-GAYDLNNSSQG-ERIAAQKIYRHLSYSPSNLLNDIAIVELAQTSS----LPAITLAGPATRTSLPALTPLTVAGWGIT</Hsp_hseq>
      <Hsp_midline>I+NG  A    WP  V+L     D     FCGGS +   +V+TAAHC  + S    DV++ G +D  +SS+  +++   K++++  Y+   + NDI +++L+  +S    + A+ L  P+      A T     GWG+T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>394</Hit_num>
  <Hit_id>pdb|1PPZ|A</Hit_id>
  <Hit_def>Trypsin complexes at atomic and ultra-high resolution [Fusarium oxysporum] &gt;pdb|1PQA|A Trypsin with PMSF at atomic resolution [Fusarium oxysporum]</Hit_def>
  <Hit_accession>1PPZ_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.3882</Hsp_bit-score>
      <Hsp_score>150</Hsp_score>
      <Hsp_evalue>2.80199e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGTSASAGDFPFIVSIS-RNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR-TSGGITSSLSSVRVHPSYSGN----NNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGAT</Hsp_hseq>
      <Hsp_midline>IV G  A  G +P+ VS+  + G  +CGGSL+N N V+TAAHC  G   S   + AG   + +S      L   +V  +   N    NND+ +LKLST+      +    L ++  D  AG++    GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>395</Hit_num>
  <Hit_id>pdb|1SGF|A</Hit_id>
  <Hit_def>Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (serine Proteinases) [Mus musculus] &gt;pdb|1SGF|X Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (serine Proteinases) [Mus musculus]</Hit_def>
  <Hit_accession>1SGF_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.3882</Hsp_bit-score>
      <Hsp_score>150</Hsp_score>
      <Hsp_evalue>2.86119e-12</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>139</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>SWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA-GEFDQGSSSEKIQKLKIAKVFKNSKYNSLTIN-----------NDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>SQPWHVAVYRFNKYQ-CGGVLLDRNWVLTAAHCYNDKYQVWLGKNNFLEDEPSD--QHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLP--TEEPKLGSTCLASGWGST</Hsp_hseq>
      <Hsp_midline>S PW V++     +  CGG L++ NWV+TAAHC      V +    F +   S+  Q   ++K   +  +N   +N           ND+ LL+LS  A  +  V  + LP  +++   G+TC+ +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>396</Hit_num>
  <Hit_id>pdb|1A5H|A</Hit_id>
  <Hit_def>CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE [Homo sapiens] &gt;pdb|1A5H|B CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE [Homo sapiens] &gt;pdb|1RTF|B COMPLEX OF BENZAMIDINE WITH THE CATALYTIC DOMAIN OF HUMAN TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR [(TC)-T-PA] [Homo sapiens]</Hit_def>
  <Hit_accession>1A5H_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.3882</Hsp_bit-score>
      <Hsp_score>150</Hsp_score>
      <Hsp_evalue>2.92871e-12</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>140</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>SWPWQVSL----QDKTGFHF-CGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKL----STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>SHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYG</Hsp_hseq>
      <Hsp_midline>S PWQ ++    +   G  F CGG LI+  W+++AAHC           V+ G   +    E+ QK ++ K   + +++  T +NDI LL+L    S  A  S  V  VCLP A       T C  +G+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>397</Hit_num>
  <Hit_id>pdb|1GDU|A</Hit_id>
  <Hit_def>FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1PQ5|A Trypsin at pH 5, 0.85 A [Fusarium oxysporum] &gt;pdb|1PQ7|A Trypsin at 0.8 A, pH5 / borax [Fusarium oxysporum] &gt;pdb|1PQ8|A Trypsin at pH 4 at atomic resolution [Fusarium oxysporum] &gt;pdb|1TRY|A STRUCTURE OF INHIBITED TRYPSIN FROM FUSARIUM OXYSPORUM AT 1.55 ANGSTROMS [Fusarium oxysporum] &gt;pdb|2G51|A anomalous substructure of trypsin (p1) [Fusarium oxysporum] &gt;pdb|2G52|A Anomalous substructure of trypsin (P21) [Fusarium oxysporum] &gt;pdb|2VU8|E Crystal structure of an insect inhibitor with a fungal trypsin [Fusarium oxysporum]</Hit_def>
  <Hit_accession>1GDU_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>2.98052e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGTSASAGDFPFIVSIS-RNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR-TSGGITSSLSSVRVHPSYSGN----NNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGAT</Hsp_hseq>
      <Hsp_midline>IV G  A  G +P+ VS+  + G  +CGGSL+N N V+TAAHC  G   S   + AG   + +S      L   +V  +   N    NND+ +LKLST+      +    L ++  D  AG++    GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>398</Hit_num>
  <Hit_id>pdb|1GVL|A</Hit_id>
  <Hit_def>Human prokallikrein 6 (hK6)/ prozyme/ proprotease M/ proneurosin [Homo sapiens]</Hit_def>
  <Hit_accession>1GVL_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>3.03818e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>LVHGGPCDKTSHPYQAALY-TSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL-GKHNLRQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQTTSCHILGWGKT</Hsp_hseq>
      <Hsp_midline>+V+G      S P+Q +L   +G   CGG LI+  WV+TAAHC      V + G+ +        ++  + +   +  Y++ + + DI LL+L+  A  S+ +    LP   D  A  T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>399</Hit_num>
  <Hit_id>pdb|1BDA|A</Hit_id>
  <Hit_def>Catalytic Domain Of Human Single Chain Tissue Plasminogen Activator In Complex With Dansyl-Egr-Cmk (Dansyl-Glu-Gly-Arg Chloromethyl Ketone) [Homo sapiens] &gt;pdb|1BDA|B Catalytic Domain Of Human Single Chain Tissue Plasminogen Activator In Complex With Dansyl-Egr-Cmk (Dansyl-Glu-Gly-Arg Chloromethyl Ketone) [Homo sapiens]</Hit_def>
  <Hit_accession>1BDA_A</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.3882</Hsp_bit-score>
      <Hsp_score>150</Hsp_score>
      <Hsp_evalue>3.30144e-12</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>153</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>SWPWQVSL----QDKTGFHF-CGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKL----STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>SHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYG</Hsp_hseq>
      <Hsp_midline>S PWQ ++    +   G  F CGG LI+  W+++AAHC           V+ G   +    E+ QK ++ K   + +++  T +NDI LL+L    S  A  S  V  VCLP A       T C  +G+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>400</Hit_num>
  <Hit_id>pdb|1FV9|A</Hit_id>
  <Hit_def>Crystal structure of human microurokinase in complex with 2-amino-5-hydroxy-benzimidazole [Homo sapiens]</Hit_def>
  <Hit_accession>1FV9_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>3.99993e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>141</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK----TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLST----AASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG</Hsp_hseq>
      <Hsp_midline>I+ GE     + PW  ++  +    +  + CGGSL++  WV++A HC +        +V  G     S+++   K ++  +  +  Y  ++L  +NDI LLK+ +     A  S+T+  + LPS  +D   GT+C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>401</Hit_num>
  <Hit_id>pdb|2PSX|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 5 in complex with Leupeptin [Homo sapiens] &gt;pdb|2PSY|A Crystal Structure of Human Kallikrein 5 in complex with Leupeptin and Zinc [Homo sapiens] &gt;pdb|6QFE|A Crystal Structure of Human Kallikrein 5 in complex with GSK144 [Homo sapiens] &gt;pdb|6QFE|B Crystal Structure of Human Kallikrein 5 in complex with GSK144 [Homo sapiens]</Hit_def>
  <Hit_accession>2PSX_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>61.6178</Hsp_bit-score>
      <Hsp_score>148</Hsp_score>
      <Hsp_evalue>4.42073e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKL-KIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKVFRVRL-GHYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINV--SSHCPSAGTKCLVSGWGTTK</Hsp_hseq>
      <Hsp_midline>I+NG +    + PWQ +L  +    +CG  L++  W++TAAHC      V + G +      E  Q++ +  K   +  Y+    +ND+ L+KL+     ++ V  + +  +S   +AGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>402</Hit_num>
  <Hit_id>pdb|6BQM|A</Hit_id>
  <Hit_def>Secreted serine protease VesC from Vibrio cholerae [Vibrio cholerae O395]</Hit_def>
  <Hit_accession>6BQM_A</Hit_accession>
  <Hit_len>506</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.3882</Hsp_bit-score>
      <Hsp_score>150</Hsp_score>
      <Hsp_evalue>5.85071e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>106</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFH-FCGGSLINENWVVTAAHCGVTTSDV----VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKL</Hsp_qseq>
      <Hsp_hseq>IIGGEQATAGEWPYMVALTARNSSHVFCGGSYLGGRYVLTAAHC-VDKEDPAKGDVLLGAFDM-NDVNTAERIHVRQIYVHNSYITASMGNDIAVLEL</Hsp_hseq>
      <Hsp_midline>I+ GE+A  G WP+ V+L  +   H FCGGS +   +V+TAAHC V   D     V+ G FD  +     +++ + +++ ++ Y + ++ NDI +L+L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>403</Hit_num>
  <Hit_id>pdb|3F1S|B</Hit_id>
  <Hit_def>Crystal structure of Protein Z complexed with protein Z-dependent inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>3F1S_B</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>6.25253e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>116</Hsp_query-to>
      <Hsp_hit-from>51</Hsp_hit-from>
      <Hsp_hit-to>164</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPG--SWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFA</Hsp_qseq>
      <Hsp_hseq>VLTSEKRAPDLQDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSLLHRNITVKTYFNR--TSQDPLMIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEK--DFA</Hsp_hseq>
      <Hsp_midline>++  E+  P     PWQV L +  G  FCGG +I EN+V+T A C +   ++ V   F++  +S+    +KI  V  + +Y++    ND++LL+L            VC P    DFA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>404</Hit_num>
  <Hit_id>pdb|4J1Y|A</Hit_id>
  <Hit_def>The X-ray crystal structure of human complement protease C1s zymogen [Homo sapiens] &gt;pdb|4J1Y|B The X-ray crystal structure of human complement protease C1s zymogen [Homo sapiens]</Hit_def>
  <Hit_accession>4J1Y_A</Hit_accession>
  <Hit_len>397</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.3882</Hsp_bit-score>
      <Hsp_score>150</Hsp_score>
      <Hsp_evalue>6.42358e-12</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>148</Hsp_hit-from>
      <Hsp_hit-to>282</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>65</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>VNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI-------NNDITLLKLSTAASFSQTVSAVCLPSASDDF--AAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IGGSDADIKNFPWQVFFDNP----WAGGALINEYWVLTAAHVVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLEVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRT</Hsp_hseq>
      <Hsp_midline>+ G +A   ++PWQV   +     + GG+LINE WV+TAAH   G     + V     Q S   K + L    VF +  +  L +       +NDI L++L        TVS +CLP  S D+    G   + +GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>405</Hit_num>
  <Hit_id>pdb|5LHN|A</Hit_id>
  <Hit_def>The catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody Nb7 [Mus musculus] &gt;pdb|5LHP|A The p-aminobenzamidine active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody Nb7 [Mus musculus] &gt;pdb|5LHQ|A The EGR-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody Nb7 [Mus musculus] &gt;pdb|5LHR|A The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody Nb22 [Mus musculus] &gt;pdb|5LHS|A The ligand free catalytic domain of murine urokinase-type plasminogen activator [Mus musculus] &gt;pdb|5LHS|B The ligand free catalytic domain of murine urokinase-type plasminogen activator [Mus musculus] &gt;pdb|5LHS|C The ligand free catalytic domain of murine urokinase-type plasminogen activator [Mus musculus] &gt;pdb|5LHS|D The ligand free catalytic domain of murine urokinase-type plasminogen activator [Mus musculus] &gt;pdb|6A8G|A The crystal structure of muPAin-1-IG in complex with muPA-SPD at pH8.5 [Mus musculus] &gt;pdb|6A8G|B The crystal structure of muPAin-1-IG in complex with muPA-SPD at pH8.5 [Mus musculus] &gt;pdb|6A8N|A The crystal structure of muPAin-1-IG-2 in complex with muPA-SPD at pH8.5 [Mus musculus] &gt;pdb|6A8N|B The crystal structure of muPAin-1-IG-2 in complex with muPA-SPD at pH8.5 [Mus musculus]</Hit_def>
  <Hit_accession>5LHN_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>61.2326</Hsp_bit-score>
      <Hsp_score>147</Hsp_score>
      <Hsp_evalue>7.65999e-12</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>142</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDK------TGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKY--NSLTINNDITLLKLSTA----ASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGEFTEVENQPWFAAIYQKNKGGSPPSFK-CGGSLISPCWVASAAHCFIQLPKKENYVVYLGQSKESSYNPGEMKFEVEQLILHEYYREDSLAYHNDIALLKIRTSTGQCAQPSRSIQTIALPPRFTDAPFGSDCEITGFG</Hsp_hseq>
      <Hsp_midline>IV GE     + PW  ++  K        F  CGGSLI+  WV +AAHC +        VV  G+  + S +    K ++ ++  +  Y  +SL  +NDI LLK+ T+    A  S+++  + LP    D   G+ C  TG+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>406</Hit_num>
  <Hit_id>pdb|3H5C|B</Hit_id>
  <Hit_def>X-Ray Structure of Protein Z-Protein Z Inhibitor Complex [Homo sapiens]</Hit_def>
  <Hit_accession>3H5C_B</Hit_accession>
  <Hit_len>317</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>7.91816e-12</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>116</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>104</Hsp_align-len>
      <Hsp_qseq>PWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFA</Hsp_qseq>
      <Hsp_hseq>PWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSLLHRNITVKTYFNR--TSQDPLMIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEK--DFA</Hsp_hseq>
      <Hsp_midline>PWQV L +  G  FCGG +I EN+V+T A C +   ++ V   F++  +S+    +KI  V  + +Y++    ND++LL+L            VC P    DFA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>407</Hit_num>
  <Hit_id>pdb|5LPE|A</Hit_id>
  <Hit_def>Kallikrein-related peptidase 10 complex with Zn2+ [Homo sapiens] &gt;pdb|5LPE|B Kallikrein-related peptidase 10 complex with Zn2+ [Homo sapiens] &gt;pdb|5LPF|A Kallikrein-related peptidase 10 [Homo sapiens] &gt;pdb|5LPF|B Kallikrein-related peptidase 10 [Homo sapiens]</Hit_def>
  <Hit_accession>5LPE_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.8474</Hsp_bit-score>
      <Hsp_score>146</Hsp_score>
      <Hsp_evalue>1.10324e-11</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>135</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>GEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI------NNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>GSPCARGSQPWQVSLFNGLSFH-CAGVLVDQSWVLTAAHCGNKPLWARVGDDHLLLLQGEQLRRTTRSVVHPKYHQGSGPILPRRTDEHDLMLLKLARPVVLGPRVRALQLPYRCAQ--PGDQCQVAGWGTT</Hsp_hseq>
      <Hsp_midline>G     GS PWQVSL +   FH C G L++++WV+TAAHCG       V  +       E++++   + V       S  I       +D+ LLKL+        V A+ LP        G  C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>408</Hit_num>
  <Hit_id>pdb|1FN8|A</Hit_id>
  <Hit_def>FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1FY4|A FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1FY5|A Fusarium oxysporum trypsin at atomic resolution [Fusarium oxysporum] &gt;pdb|1GDN|A FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1GDQ|A FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1XVM|A Trypsin from Fusarium oxysporum- room temperature to atomic resolution [Fusarium oxysporum] &gt;pdb|1XVO|A Trypsin from Fusarium oxysporum at pH 6 [Fusarium oxysporum]</Hit_def>
  <Hit_accession>1FN8_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.4622</Hsp_bit-score>
      <Hsp_score>145</Hsp_score>
      <Hsp_evalue>1.43554e-11</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>65</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>VNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>VGGTSASAGDFPFIVSIS-RNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR-TSGGITSSLSSVRVHPSYSGN----NNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGAT</Hsp_hseq>
      <Hsp_midline>V G  A  G +P+ VS+  + G  +CGGSL+N N V+TAAHC  G   S   + AG   + +S      L   +V  +   N    NND+ +LKLST+      +    L ++  D  AG++    GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>409</Hit_num>
  <Hit_id>pdb|1SPJ|A</Hit_id>
  <Hit_def>Structure Of Mature Human Tissue Kallikrein (Human Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With Vacant Active Site [Homo sapiens]</Hit_def>
  <Hit_accession>1SPJ_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.4622</Hsp_bit-score>
      <Hsp_score>145</Hsp_score>
      <Hsp_evalue>1.69069e-11</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>135</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN-----------DITLLKLSTAA-SFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGWECEQHSQPWQAALYHFSTFQ-CGGILVHRQWVLTAAHC-ISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPE--VGSTCLASGWG</Hsp_hseq>
      <Hsp_midline>IV G E    S PWQ +L   + F  CGG L++  WV+TAAHC ++ +  +  G  +        Q + +++ F +  +N   + N           D+ LL+L+  A + +  V  V LP+   +   G+TC+ +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>410</Hit_num>
  <Hit_id>pdb|5O32|I</Hit_id>
  <Hit_def>The structure of complement complex [Homo sapiens] &gt;pdb|5O32|J The structure of complement complex [Homo sapiens]</Hit_def>
  <Hit_accession>5O32_I</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>59.6918</Hsp_bit-score>
      <Hsp_score>143</Hsp_score>
      <Hsp_evalue>2.68201e-11</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>137</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC---GVTTSDVVVAGEFDQ-GSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAAS-----FSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>IVGGKRAQLGDLPWQVAIKDASGIT-CGGIYIGGCWILTAAHCLRASKTHRYQIWTTVVDWIHPDLKRIVIEYVDRIIFHENYNAGTYQNDIALIEMKKDGNKKDCELPRSIPA-CVPWSPYLFQPNDTCIVSGWGREK</Hsp_hseq>
      <Hsp_midline>IV G+ A  G  PWQV+++D +G   CGG  I   W++TAAHC     T    +     D      ++I    + ++  +  YN+ T  NDI L+++    +       +++ A C+P +   F    TC+ +GWG  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>411</Hit_num>
  <Hit_id>pdb|1HYL|A</Hit_id>
  <Hit_def>The 1.8 A Structure Of Collagenase From Hypoderma Lineatum [Hypoderma lineatum] &gt;pdb|1HYL|B The 1.8 A Structure Of Collagenase From Hypoderma Lineatum [Hypoderma lineatum] &gt;pdb|2HLC|A Hl Collagenase Structure At 1.7a Resolution [Hypoderma lineatum] &gt;pdb|2HLC|B Hl Collagenase Structure At 1.7a Resolution [Hypoderma lineatum]</Hit_def>
  <Hit_accession>1HYL_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>59.6918</Hsp_bit-score>
      <Hsp_score>143</Hsp_score>
      <Hsp_evalue>2.71183e-11</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>113</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>113</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>117</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQ----VSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASD</Hsp_qseq>
      <Hsp_hseq>IINGYEAYTGLFPYQAGLDITLQDQRRV-WCGGSLIDNKWILTAAHCVHDAVSVVVY--LGSAVQYEGEAVVNSERIISHSMFNPDTYLNDVALIKIP-HVEYTDNIQPIRLPSGEE</Hsp_hseq>
      <Hsp_midline>I+NG EA  G +P+Q    ++LQD+    +CGGSLI+  W++TAAHC      VVV          E    +   ++  +S +N  T  ND+ L+K+     ++  +  + LPS  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>412</Hit_num>
  <Hit_id>pdb|5BRR|E</Hit_id>
  <Hit_def>Michaelis complex of tPA-S195A:PAI-1 [Homo sapiens]</Hit_def>
  <Hit_accession>5BRR_E</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.9214</Hsp_bit-score>
      <Hsp_score>141</Hsp_score>
      <Hsp_evalue>6.76469e-11</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>140</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>SWPWQVSL----QDKTGFHF-CGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKL----STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>SHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVALPPADLQLPDWTECELSGYG</Hsp_hseq>
      <Hsp_midline>S PWQ ++    +   G  F CGG LI+  W+++AAHC           V+ G   +    E+ QK ++ K   + +++  T +NDI LL+L    S  A  S  V  V LP A       T C  +G+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>413</Hit_num>
  <Hit_id>pdb|4FXG|H</Hit_id>
  <Hit_def>Complement C4 in complex with MASP-2 [Homo sapiens] &gt;pdb|4FXG|J Complement C4 in complex with MASP-2 [Homo sapiens] &gt;pdb|5JPM|H Structure of the complex of human complement C4 with MASP-2 rebuilt using iMDFF [Homo sapiens] &gt;pdb|5JPM|J Structure of the complex of human complement C4 with MASP-2 rebuilt using iMDFF [Homo sapiens]</Hit_def>
  <Hit_accession>4FXG_H</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.5362</Hsp_bit-score>
      <Hsp_score>140</Hsp_score>
      <Hsp_evalue>7.64352e-11</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS----SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTT--GWGLTR</Hsp_qseq>
      <Hsp_hseq>IYGGQKAKPGDFPWQVLILGGT---TAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ</Hsp_hseq>
      <Hsp_midline>I  G++A PG +PWQV +   T      G+L+ +NWV+TAAH          A +   G+    S    Q    A        +    +NDI L+KL+     +  ++ +CLP    +    T  + T  GWGLT+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>414</Hit_num>
  <Hit_id>pdb|5ZLZ|E</Hit_id>
  <Hit_def>Structure of tPA and PAI-1 [Homo sapiens]</Hit_def>
  <Hit_accession>5ZLZ_E</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.5362</Hsp_bit-score>
      <Hsp_score>140</Hsp_score>
      <Hsp_evalue>7.65408e-11</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>140</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>SWPWQVSL----QDKTGFHF-CGGSLINENWVVTAAHCGVTTSD----VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKL----STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>SHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVALPPADLQLPDWTECELSGYG</Hsp_hseq>
      <Hsp_midline>S PWQ ++    +   G  F CGG LI+  W+++AAHC           V+ G   +    E+ QK ++ K   + +++  T +NDI LL+L    S  A  S  V  V LP A       T C  +G+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>415</Hit_num>
  <Hit_id>pdb|3TVJ|B</Hit_id>
  <Hit_def>Catalytic fragment of MASP-2 in complex with its specific inhibitor developed by directed evolution on SGCI scaffold [Homo sapiens]</Hit_def>
  <Hit_accession>3TVJ_B</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.5362</Hsp_bit-score>
      <Hsp_score>140</Hsp_score>
      <Hsp_evalue>8.04052e-11</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS----SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTT--GWGLTR</Hsp_qseq>
      <Hsp_hseq>IYGGQKAKPGDFPWQVLILGGT---TAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ</Hsp_hseq>
      <Hsp_midline>I  G++A PG +PWQV +   T      G+L+ +NWV+TAAH          A +   G+    S    Q    A        +    +NDI L+KL+     +  ++ +CLP    +    T  + T  GWGLT+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>416</Hit_num>
  <Hit_id>pdb|3S9A|A</Hit_id>
  <Hit_def>Russell&apos;s viper venom serine proteinase, RVV-V (closed-form) [Daboia siamensis] &gt;pdb|3S9B|A Russell&apos;s viper venom serine proteinase, RVV-V (open-form) [Daboia siamensis] &gt;pdb|3S9C|A Russell&apos;s viper venom serine proteinase, RVV-V in complex with the fragment (residues 1533-1546) of human factor V [Daboia siamensis] &gt;pdb|3SBK|A Russell&apos;s viper venom serine proteinase, RVV-V (PPACK-bound form) [Daboia siamensis]</Hit_def>
  <Hit_accession>3S9A_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.7658</Hsp_bit-score>
      <Hsp_score>138</Hsp_score>
      <Hsp_evalue>1.52576e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQ-DKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVF-KNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRNIRIKLGMHSKNIRNEDEQIRVPRGKYFCLNTKFPN-GLDKDIMLIRLRRPVTYSTHIAPVSLPSRSR--GVGSRCRIMGWG</Hsp_hseq>
      <Hsp_midline>+V G+E      P+ V+L    +    C G+LIN  WV+TAAHC      + +        + ++  ++   K F  N+K+ +  ++ DI L++L    ++S  ++ V LPS S     G+ C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>417</Hit_num>
  <Hit_id>pdb|4GSO|A</Hit_id>
  <Hit_def>structure of Jararacussin-I [Bothrops jararacussu]</Hit_def>
  <Hit_accession>4GSO_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.3806</Hsp_bit-score>
      <Hsp_score>137</Hsp_score>
      <Hsp_evalue>1.89291e-10</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>103</Hsp_align-len>
      <Hsp_qseq>HFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>YFCGLTLINQEWVVTAAHCDSTNFQMQLGVHSKKVLNEDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLPSNPP--SVGSVCRIMGWG</Hsp_hseq>
      <Hsp_midline>+FCG +LIN+ WVVTAAHC  T   + +     +  + ++  +    K    +K  S  ++ DI L+KL    S S+ ++ + LPS     + G+ C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>418</Hit_num>
  <Hit_id>pdb|1Q3X|A</Hit_id>
  <Hit_def>Crystal structure of the catalytic region of human MASP-2 [Homo sapiens] &gt;pdb|1Q3X|B Crystal structure of the catalytic region of human MASP-2 [Homo sapiens]</Hit_def>
  <Hit_accession>1Q3X_A</Hit_accession>
  <Hit_len>328</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.7658</Hsp_bit-score>
      <Hsp_score>138</Hsp_score>
      <Hsp_evalue>2.12018e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>87</Hsp_hit-from>
      <Hsp_hit-to>219</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS----SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTT--GWGLTR</Hsp_qseq>
      <Hsp_hseq>IYGGQKAKPGDFPWQVLILGGT---TAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ</Hsp_hseq>
      <Hsp_midline>I  G++A PG +PWQV +   T      G+L+ +NWV+TAAH          A +   G+    S    Q    A        +    +NDI L+KL+     +  ++ +CLP    +    T  + T  GWGLT+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>419</Hit_num>
  <Hit_id>pdb|1ZJK|A</Hit_id>
  <Hit_def>Crystal structure of the zymogen catalytic region of human MASP-2 [Homo sapiens]</Hit_def>
  <Hit_accession>1ZJK_A</Hit_accession>
  <Hit_len>403</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.7658</Hsp_bit-score>
      <Hsp_score>138</Hsp_score>
      <Hsp_evalue>2.57538e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>162</Hsp_hit-from>
      <Hsp_hit-to>294</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGS----SSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTT--GWGLTR</Hsp_qseq>
      <Hsp_hseq>IYGGQKAKPGDFPWQVLILGGT---TAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ</Hsp_hseq>
      <Hsp_midline>I  G++A PG +PWQV +   T      G+L+ +NWV+TAAH          A +   G+    S    Q    A        +    +NDI L+KL+     +  ++ +CLP    +    T  + T  GWGLT+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>420</Hit_num>
  <Hit_id>pdb|2XXL|A</Hit_id>
  <Hit_def>Crystal structure of drosophila Grass clip serine protease of Toll pathway [Drosophila melanogaster] &gt;pdb|2XXL|B Crystal structure of drosophila Grass clip serine protease of Toll pathway [Drosophila melanogaster]</Hit_def>
  <Hit_accession>2XXL_A</Hit_accession>
  <Hit_len>408</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.3806</Hsp_bit-score>
      <Hsp_score>137</Hsp_score>
      <Hsp_evalue>3.25998e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>119</Hsp_hit-from>
      <Hsp_hit-to>268</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>151</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSL---QDKTGFHFCGGSLINENWVVTAAHC---------GVTTSDVVVAGEFD---QGSSSE---KIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAG----TTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>VSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCVHGLQNDLYEIRLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIMHDIALLKLNRSVPFQKHIKPICLP-ITDELKEKAEQISTYFVTGWGTT</Hsp_hseq>
      <Hsp_midline>+ NG E    S PW   L   Q       CGG++I+E +++TAAHC          +   +  ++ E D   QG   +    +  + I K   + KY++  I +DI LLKL+ +  F + +  +CLP  +D+        +T   TGWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>421</Hit_num>
  <Hit_id>pdb|2XRC|A</Hit_id>
  <Hit_def>Human complement factor I [Homo sapiens] &gt;pdb|2XRC|B Human complement factor I [Homo sapiens] &gt;pdb|2XRC|C Human complement factor I [Homo sapiens] &gt;pdb|2XRC|D Human complement factor I [Homo sapiens]</Hit_def>
  <Hit_accession>2XRC_A</Hit_accession>
  <Hit_len>565</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.9954</Hsp_bit-score>
      <Hsp_score>136</Hsp_score>
      <Hsp_evalue>5.50898e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>322</Hsp_hit-from>
      <Hsp_hit-to>455</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC---GVTTSDVVVAGEFDQ-GSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAAS-----FSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IVGGKRAQLGDLPWQVAIKDASGIT-CGGIYIGGCWILTAAHCLRASKTHRYQIWTTVVDWIHPDLKRIVIEYVDRIIFHENYNAGTYQNDIALIEMKKDGNKKDCELPRSIPA-CVPWSPYLFQPNDTCIVSGWG</Hsp_hseq>
      <Hsp_midline>IV G+ A  G  PWQV+++D +G   CGG  I   W++TAAHC     T    +     D      ++I    + ++  +  YN+ T  NDI L+++    +       +++ A C+P +   F    TC+ +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>422</Hit_num>
  <Hit_id>pdb|1OP2|A</Hit_id>
  <Hit_def>Crystal Structure of AaV-SP-II, a Glycosylated Snake Venom Serine Proteinase from Agkistrodon acutus [Deinagkistrodon acutus]</Hit_def>
  <Hit_accession>1OP2_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.69143e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>127</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VIGGNECDINEHRFLVAFFNTTGF-FCGGTLINPEWVVTAAHCDSTNFQMQLGVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPL--SLPSSPPSVGSVCRIMGWG</Hsp_hseq>
      <Hsp_midline>++ G E       + V+  + TGF FCGG+LIN  WVVTAAHC  T   + +     +  + ++  +    K    +K N+  ++ DI L+KL    S S+ ++ +     S   + G+ C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>423</Hit_num>
  <Hit_id>pdb|1EPT|A</Hit_id>
  <Hit_def>REFINED 1.8 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF PORCINE EPSILON-TRYPSIN [Sus scrofa]</Hit_def>
  <Hit_accession>1EPT_A</Hit_accession>
  <Hit_len>43</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.373</Hsp_bit-score>
      <Hsp_score>124</Hsp_score>
      <Hsp_evalue>5.79172e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>43</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>41</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>29</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>43</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC</Hsp_qseq>
      <Hsp_hseq>IVGGYTCAANSIPYQVSL--NSGSHFCGGSLINSQWVVSAAHC</Hsp_hseq>
      <Hsp_midline>IV G      S P+QVSL   +G HFCGGSLIN  WVV+AAHC</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>424</Hit_num>
  <Hit_id>pdb|1SHY|A</Hit_id>
  <Hit_def>The Crystal Structure of HGF beta-chain in Complex with the Sema Domain of the Met Receptor. [Homo sapiens]</Hit_def>
  <Hit_accession>1SHY_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>6.82676e-10</Hsp_evalue>
      <Hsp_query-from>14</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>122</Hsp_align-len>
      <Hsp_qseq>WQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV----VVAGEFD-QGSSSEKI-QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>WMVSLRYRNK-HICGGSLIKESWVLTARQC-FPSRDLKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPE------GSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWGYT</Hsp_hseq>
      <Hsp_midline>W VSL+ +   H CGGSLI E+WV+TA  C   + D+       G  D  G   EK  Q L ++++    +       +D+ L+KL+  A     VS + LP+        T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>425</Hit_num>
  <Hit_id>pdb|1OP0|A</Hit_id>
  <Hit_def>Crystal Structure of AaV-SP-I, a Glycosylated Snake Venom Serine Proteinase from Agkistrodon acutus [Deinagkistrodon acutus]</Hit_def>
  <Hit_accession>1OP0_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>6.89608e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>127</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VIGGNECDINEHRFLVAFFNTTGF-FCGGTLINPEWVVTAAHCDSTDFQMQLGVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPL--SLPSSPPSVGSVCRIMGWG</Hsp_hseq>
      <Hsp_midline>++ G E       + V+  + TGF FCGG+LIN  WVVTAAHC  T   + +     +  + ++  +    K    +K N+  ++ DI L+KL    S S+ ++ +     S   + G+ C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>426</Hit_num>
  <Hit_id>pdb|1SI5|H</Hit_id>
  <Hit_def>Protease-like domain from 2-chain hepatocyte growth factor [Homo sapiens]</Hit_def>
  <Hit_accession>1SI5_H</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>7.15449e-10</Hsp_evalue>
      <Hsp_query-from>14</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>122</Hsp_align-len>
      <Hsp_qseq>WQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV----VVAGEFD-QGSSSEKI-QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>WMVSLRYRNK-HICGGSLIKESWVLTARQC-FPSRDLKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPE------GSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWGYT</Hsp_hseq>
      <Hsp_midline>W VSL+ +   H CGGSLI E+WV+TA  C   + D+       G  D  G   EK  Q L ++++    +       +D+ L+KL+  A     VS + LP+        T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>427</Hit_num>
  <Hit_id>pdb|4O3T|A</Hit_id>
  <Hit_def>Zymogen HGF-beta/MET with Zymogen Activator Peptide ZAP.14 [Homo sapiens] &gt;pdb|4O3U|A Zymogen HGF-beta/MET with Zymogen Activator Peptide ZAP2.3 [Homo sapiens]</Hit_def>
  <Hit_accession>4O3T_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>7.52401e-10</Hsp_evalue>
      <Hsp_query-from>14</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>122</Hsp_align-len>
      <Hsp_qseq>WQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV----VVAGEFD-QGSSSEKI-QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>WMVSLRYRNK-HICGGSLIKESWVLTARQC-FPSRDLKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPE------GSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWGYT</Hsp_hseq>
      <Hsp_midline>W VSL+ +   H CGGSLI E+WV+TA  C   + D+       G  D  G   EK  Q L ++++    +       +D+ L+KL+  A     VS + LP+        T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>428</Hit_num>
  <Hit_id>pdb|4K3J|A</Hit_id>
  <Hit_def>Crystal structure of Onartuzumab Fab in complex with MET and HGF-beta [Homo sapiens]</Hit_def>
  <Hit_accession>4K3J_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>8.12202e-10</Hsp_evalue>
      <Hsp_query-from>14</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>122</Hsp_align-len>
      <Hsp_qseq>WQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV----VVAGEFD-QGSSSEKI-QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>WMVSLRYRNK-HICGGSLIKESWVLTARQC-FPSRDLKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPE------GSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWGYT</Hsp_hseq>
      <Hsp_midline>W VSL+ +   H CGGSLI E+WV+TA  C   + D+       G  D  G   EK  Q L ++++    +       +D+ L+KL+  A     VS + LP+        T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>429</Hit_num>
  <Hit_id>pdb|6LZ9|B</Hit_id>
  <Hit_def>t8E4 antibody Fab complexed with the active form of HGF [Homo sapiens]</Hit_def>
  <Hit_accession>6LZ9_B</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.4546</Hsp_bit-score>
      <Hsp_score>132</Hsp_score>
      <Hsp_evalue>1.11902e-09</Hsp_evalue>
      <Hsp_query-from>14</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>22</Hsp_gaps>
      <Hsp_align-len>126</Hsp_align-len>
      <Hsp_qseq>WQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVV----------VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>WMVSLRYRNK-HICGGSLIKESWVLTARQC-FPSRDLKDYEAWLGIHDVHGRGDEKSK----QVLQVSQLVYGPE------GSDLVLMKLARPAVLDDFVSTIDLPNYGCTIPEKTSCSVYGWGYT</Hsp_hseq>
      <Hsp_midline>W VSL+ +   H CGGSLI E+WV+TA  C   + D+           V G  D+ S     Q L+++++    +       +D+ L+KL+  A     VS + LP+        T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>430</Hit_num>
  <Hit_id>pdb|3S69|A</Hit_id>
  <Hit_def>Crystal structure of saxthrombin [Gloydius saxatilis]</Hit_def>
  <Hit_accession>3S69_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>54.6842</Hsp_bit-score>
      <Hsp_score>130</Hsp_score>
      <Hsp_evalue>1.78e-09</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>127</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>VIGGDECNINEHRSLVAFFNSTGF-FCSGTLINEEWVLTAAHCDNTNFQMKLGVHSKKVLNEDEQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHI--VPLSLPSSPPSVGSVCHIMGWG</Hsp_hseq>
      <Hsp_midline>++ G+E         V+  + TGF FC G+LINE WV+TAAHC  T   + +     +  + ++  +    K    +K N   ++ DI L+KL +  S S+ +  V L   S   + G+ C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>431</Hit_num>
  <Hit_id>pdb|2AIP|A</Hit_id>
  <Hit_def>Crystal structure of native protein C activator from the venom of copperhead snake Agkistrodon contortrix contortrix [Agkistrodon contortrix contortrix] &gt;pdb|2AIQ|A Crystal structure of benzamidine-inhibited protein C activator from the venom of copperhead snake Agkistrodon contortrix contortrix [Agkistrodon contortrix contortrix]</Hit_def>
  <Hit_accession>2AIP_A</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>54.6842</Hsp_bit-score>
      <Hsp_score>130</Hsp_score>
      <Hsp_evalue>2.04349e-09</Hsp_evalue>
      <Hsp_query-from>26</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>102</Hsp_align-len>
      <Hsp_qseq>FCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>LCGGTLINQEWVLTARHCDRGNMRIYLGMHNLKVLNKDALRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLP--SNPPSVGSVCRIMGWG</Hsp_hseq>
      <Hsp_midline> CGG+LIN+ WV+TA HC      + +     +  + + +++    K F  +  N    + DI L++L+     S  ++ + LP  S+  + G+ C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>432</Hit_num>
  <Hit_id>pdb|1EPT|B</Hit_id>
  <Hit_def>REFINED 1.8 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF PORCINE EPSILON-TRYPSIN [Sus scrofa]</Hit_def>
  <Hit_accession>1EPT_B</Hit_accession>
  <Hit_len>82</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.6026</Hsp_bit-score>
      <Hsp_score>122</Hsp_score>
      <Hsp_evalue>2.18738e-09</Hsp_evalue>
      <Hsp_query-from>66</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>82</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>41</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>65</Hsp_align-len>
      <Hsp_qseq>QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>QFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC--AAAGTECLISGWGNTK</Hsp_hseq>
      <Hsp_midline>Q +  AK+  +  +N  T++NDI L+KLS+ A+ +  V+ V LP +    AAGT C+ +GWG T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>433</Hit_num>
  <Hit_id>pdb|1BQY|A</Hit_id>
  <Hit_def>Plasminogen activator (TSV-PA) from snake venom [Trimeresurus stejnegeri] &gt;pdb|1BQY|B Plasminogen activator (TSV-PA) from snake venom [Trimeresurus stejnegeri]</Hit_def>
  <Hit_accession>1BQY_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>4.49094e-09</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>114</Hsp_align-len>
      <Hsp_qseq>VSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>VVLFNSNGF-LCGGTLINQDWVVTAAHCDSNNFQLLFGVHSKKILNEDEQTRDPKEKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHIAPL--SLPSSPPSVGSVCRIMGWGKT</Hsp_hseq>
      <Hsp_midline>V L +  GF  CGG+LIN++WVVTAAHC      ++      +  + ++  +    K F  ++     ++ DI L+KL ++ S S+ ++ +     S   + G+ C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>434</Hit_num>
  <Hit_id>pdb|3I77|A</Hit_id>
  <Hit_def>35/99/170-loops of FXa in SGT [Streptomyces griseus]</Hit_def>
  <Hit_accession>3I77_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>6.13874e-09</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVDLQSSSAV--KVRSTKVLQAPGFTKETYGKDWALIKL------AQPINQPTLKIATTTAYNQGTFTVAGWGANR</Hsp_hseq>
      <Hsp_midline>+V G  A  G +P+ V L ++    FCGG+L  ++ V+TAAHC    G  TS     G  D  SSS    K++  KV +   +   T   D  L+KL      +Q ++   L  A+       T    GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>435</Hit_num>
  <Hit_id>pdb|3I78|A</Hit_id>
  <Hit_def>35/99/170/186/220-loops of FXa in SGT [Streptomyces griseus]</Hit_def>
  <Hit_accession>3I78_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>6.15485e-09</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>12</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVDLQSSSAV--KVRSTKVLQAPGFTKETYGKDWALIKL------AQPINQPTLKIATTTAYNQGTFTVAGWGANR</Hsp_hseq>
      <Hsp_midline>+V G  A  G +P+ V L ++    FCGG+L  ++ V+TAAHC    G  TS     G  D  SSS    K++  KV +   +   T   D  L+KL      +Q ++   L  A+       T    GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>436</Hit_num>
  <Hit_id>pdb|3H7T|A</Hit_id>
  <Hit_def>Crystal structure of scabies mite inactivated protease paralogue S-D1 (SMIPP-S-D1) [Sarcoptes scabiei] &gt;pdb|3H7T|B Crystal structure of scabies mite inactivated protease paralogue S-D1 (SMIPP-S-D1) [Sarcoptes scabiei]</Hit_def>
  <Hit_accession>3H7T_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.373</Hsp_bit-score>
      <Hsp_score>124</Hsp_score>
      <Hsp_evalue>1.30875e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>131</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVS-LQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVAGEFDQGSSSEKIQKLKI-AKVFKNSKYNSLTINNDITLLKLSTAASF-SQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY</Hsp_qseq>
      <Hsp_hseq>IIGGKKSDITKEPWAVGVLVDEK--PFCGGSILTANFVITAAQCVDGTKPSDISIH----YGSSYRTTKGTSVMAKKIYIVRYHPLTMQNNYAVIETEMPIKLDDKTTKKIELPSLLYDPEPDTSVLVSGWGSTNF</Hsp_hseq>
      <Hsp_midline>I+ G+++     PW V  L D+    FCGGS++  N+V+TAA C  G   SD+ +      GSS    +   + AK     +Y+ LT+ N+  +++         +T   + LPS   D    T+ + +GWG T +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>437</Hit_num>
  <Hit_id>pdb|7MO7|A</Hit_id>
  <Hit_def>Chain A, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MO7|D Chain D, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MO8|A Chain A, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MO9|A Chain A, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MO9|D Chain D, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MOA|A Chain A, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MOA|D Chain D, Hepatocyte growth factor [Homo sapiens]</Hit_def>
  <Hit_accession>7MO7_A</Hit_accession>
  <Hit_len>728</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.373</Hsp_bit-score>
      <Hsp_score>124</Hsp_score>
      <Hsp_evalue>1.80878e-08</Hsp_evalue>
      <Hsp_query-from>14</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>507</Hsp_hit-from>
      <Hsp_hit-to>620</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>122</Hsp_align-len>
      <Hsp_qseq>WQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV----VVAGEFD-QGSSSEKI-QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>WMVSLRYRNK-HICGGSLIKESWVLTARQC-FPSRDLKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPE------GSDLVLMKLARPAVLDDFVSTIDLPNYGCTIPEKTSCSVYGWGYT</Hsp_hseq>
      <Hsp_midline>W VSL+ +   H CGGSLI E+WV+TA  C   + D+       G  D  G   EK  Q L ++++    +       +D+ L+KL+  A     VS + LP+        T+C   GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>438</Hit_num>
  <Hit_id>pdb|4E7N|A</Hit_id>
  <Hit_def>Crystal Structure of AhV_TL-I, a Glycosylated Snake-venom Thrombin-like Enzyme from Agkistrodon halys [Gloydius halys]</Hit_def>
  <Hit_accession>4E7N_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.6026</Hsp_bit-score>
      <Hsp_score>122</Hsp_score>
      <Hsp_evalue>2.60412e-08</Hsp_evalue>
      <Hsp_query-from>26</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>27</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>102</Hsp_align-len>
      <Hsp_qseq>FCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>FCGGTLINQEWVLTAAHCDRKNFRIKLGMHSKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHIAPF--SLPSSPPSVGSVCRIMGWG</Hsp_hseq>
      <Hsp_midline>FCGG+LIN+ WV+TAAHC      + +     +  + ++  ++   K F  S  N    + DI L++L +    S+ ++       S   + G+ C   GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>439</Hit_num>
  <Hit_id>pdb|4IW4|E</Hit_id>
  <Hit_def>Crystal structure of the serine protease domain of MASP-3 in complex with ecotin [Homo sapiens] &gt;pdb|4IW4|F Crystal structure of the serine protease domain of MASP-3 in complex with ecotin [Homo sapiens]</Hit_def>
  <Hit_accession>4IW4_E</Hit_accession>
  <Hit_len>279</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.2174</Hsp_bit-score>
      <Hsp_score>121</Hsp_score>
      <Hsp_evalue>3.98787e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>147</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>20</Hsp_gaps>
      <Hsp_align-len>148</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQ--VSLQDKTGFH----FCGGSLINENWVVTAAHC-----------GVTTSDVVV-AGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTC-VTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGRNAEPGLFPWQALIVVEDTSRVPNDKWFGSGALLSASWILTAAHVLRSQRRDTTVIPVSKEHVTVYLGLHDVRDKSGAVNS-SAARVVLHPDFNIQNYNHDIALVQLQEPVPLGPHVMPVCLPRLEPEGPAPHMLGLVAGWGIS</Hsp_hseq>
      <Hsp_midline>I+ G  A PG +PWQ  + ++D +       F  G+L++ +W++TAAH             V+   V V  G  D    S  +     A+V  +  +N    N+DI L++L         V  VCLP    +  A     +  GWG++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>440</Hit_num>
  <Hit_id>pdb|4M7G|A</Hit_id>
  <Hit_def>Streptomyces Erythraeus Trypsin [Saccharopolyspora erythraea]</Hit_def>
  <Hit_accession>4M7G_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.8322</Hsp_bit-score>
      <Hsp_score>120</Hsp_score>
      <Hsp_evalue>4.46752e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>127</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASD-DFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGEDANVQDHPFTVALVTPDGQQFCGGTLAAPNKVVTAAHCTVGSQPADINVVSGRTVMSSNEGTVS--KVTNVWVHPEYQDAAKGFDVSVLTLEAPVKE----APIELAKADDAGYAPDTAATILGWGNT</Hsp_hseq>
      <Hsp_midline>IV GE+A     P+ V+L    G  FCGG+L   N VVTAAHC  G   +D+ VV+G     S+   +   K+  V+ + +Y       D+++L L          + + L  A D  +A  T     GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>441</Hit_num>
  <Hit_id>pdb|5DK1|A</Hit_id>
  <Hit_def>S. erythraea trypsin mixed catalytic intermediate [Saccharopolyspora erythraea]</Hit_def>
  <Hit_accession>5DK1_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.8322</Hsp_bit-score>
      <Hsp_score>120</Hsp_score>
      <Hsp_evalue>4.98443e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>127</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASD-DFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGEDANVQDHPFTVALVTPDGQQFCGGTLAAPNKVVTAAHCTVGSQPADINVVSGRTVMSSNEGTVS--KVTNVWVHPEYQDAAKGFDVSVLTLEAPVKE----APIELAKADDAGYAPDTAATILGWGNT</Hsp_hseq>
      <Hsp_midline>IV GE+A     P+ V+L    G  FCGG+L   N VVTAAHC  G   +D+ VV+G     S+   +   K+  V+ + +Y       D+++L L          + + L  A D  +A  T     GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>442</Hit_num>
  <Hit_id>pdb|5DJ7|A</Hit_id>
  <Hit_def>S. erythraea trypsin acyl-enzyme [Saccharopolyspora erythraea] &gt;pdb|5DKM|A S. erythraea trypsin Michaelis-Menten complex [Saccharopolyspora erythraea] &gt;pdb|5KWM|A S. erythraea trypsin long construct apoenzyme [Saccharopolyspora erythraea]</Hit_def>
  <Hit_accession>5DJ7_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.8322</Hsp_bit-score>
      <Hsp_score>120</Hsp_score>
      <Hsp_evalue>5.03445e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>127</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>133</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASD-DFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IVGGEDANVQDHPFTVALVTPDGQQFCGGTLAAPNKVVTAAHCTVGSQPADINVVSGRTVMSSNEGTVS--KVTNVWVHPEYQDAAKGFDVSVLTLEAPVKE----APIELAKADDAGYAPDTAATILGWGNT</Hsp_hseq>
      <Hsp_midline>IV GE+A     P+ V+L    G  FCGG+L   N VVTAAHC  G   +D+ VV+G     S+   +   K+  V+ + +Y       D+++L L          + + L  A D  +A  T     GWG T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>443</Hit_num>
  <Hit_id>pdb|4X0L|C</Hit_id>
  <Hit_def>Human haptoglobin-haemoglobin complex [Homo sapiens] &gt;pdb|5HU6|C Structure of the T. brucei haptoglobin-haemoglobin receptor bound to human haptolgobin-haemoglobin [Homo sapiens]</Hit_def>
  <Hit_accession>4X0L_C</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>7.54897e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>138</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-------GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFA-AGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>ILGGHLDAKGSFPWQAKMVSHHNL-TTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVG----KKQLVEIEKVVLHPNYSQV----DIGLIKLKQKVSVNERVMPICLPSK--DYAEVGRVGYVSGWG</Hsp_hseq>
      <Hsp_midline>I+ G     GS+PWQ  +         G +LINE W++T A           T  D+        G    K Q ++I KV  +  Y+ +    DI L+KL    S ++ V  +CLPS   D+A  G     +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>444</Hit_num>
  <Hit_id>pdb|4KKD|A</Hit_id>
  <Hit_def>The X-ray crystal structure of Mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the 3MC syndrome [Homo sapiens] &gt;pdb|4KKD|B The X-ray crystal structure of Mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the 3MC syndrome [Homo sapiens]</Hit_def>
  <Hit_accession>4KKD_A</Hit_accession>
  <Hit_len>433</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>8.8187e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>301</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>20</Hsp_gaps>
      <Hsp_align-len>148</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQ--VSLQDKTGFH----FCGGSLINENWVVTAAHC-----------GVTTSDVVV-AGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTC-VTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGRNAEPGLFPWQALIVVEDTSRVPNDKWFGSGALLSASWILTAAHVLRSQRRDTTVIPVSKEHVTVYLGLHDVRDKSGAVNS-SAARVVLHPDFNIQNYNHDIALVQLQEPVPLGPHVMPVCLPRLEPEGPAPHMLGLVAGWGIS</Hsp_hseq>
      <Hsp_midline>I+ G  A PG +PWQ  + ++D +       F  G+L++ +W++TAAH             V+   V V  G  D    S  +     A+V  +  +N    N+DI L++L         V  VCLP    +  A     +  GWG++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>445</Hit_num>
  <Hit_id>pdb|4WJG|2</Hit_id>
  <Hit_def>Chain 2, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|C Chain C, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|H Chain H, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|M Chain M, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|R Chain R, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|W Chain W, Haptoglobin [Homo sapiens]</Hit_def>
  <Hit_accession>4WJG_2</Hit_accession>
  <Hit_len>315</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>9.30658e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>71</Hsp_hit-from>
      <Hsp_hit-to>194</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-------GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFA-AGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>ILGGHLDAKGSFPWQAKMVSHHNL-TTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVG----KKQLVEIEKVVLHPNYSQV----DIGLIKLKQKVSVNERVMPICLPSK--DYAEVGRVGYVSGWG</Hsp_hseq>
      <Hsp_midline>I+ G     GS+PWQ  +         G +LINE W++T A           T  D+        G    K Q ++I KV  +  Y+ +    DI L+KL    S ++ V  +CLPS   D+A  G     +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>446</Hit_num>
  <Hit_id>pdb|2QY0|B</Hit_id>
  <Hit_def>Active dimeric structure of the catalytic domain of C1r reveals enzyme-product like contacts [Homo sapiens] &gt;pdb|2QY0|D Active dimeric structure of the catalytic domain of C1r reveals enzyme-product like contacts [Homo sapiens]</Hit_def>
  <Hit_accession>2QY0_B</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.0618</Hsp_bit-score>
      <Hsp_score>118</Hsp_score>
      <Hsp_evalue>9.69263e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>129</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFH-FCGGSLINENWVVTAAHCGVTTSDVVVAGE----FDQGSSSEKIQKL---KIAKVFKNSKYN---SLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLT</Hsp_qseq>
      <Hsp_hseq>IIGGQKAKMGNFPWQVF----TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVM</Hsp_hseq>
      <Hsp_midline>I+ G++A  G++PWQV     T  H   GG+L+ + W++TAAH          +      F   ++ E++ KL    I +V  +  Y    S     DI LL+L  + +    +  +CLP     +  G     +G+G+ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>447</Hit_num>
  <Hit_id>pdb|6TB2|C</Hit_id>
  <Hit_def>Structure of human haptoglobin-hemoglobin bound to S. aureus IsdH [Homo sapiens]</Hit_def>
  <Hit_accession>6TB2_C</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.0618</Hsp_bit-score>
      <Hsp_score>118</Hsp_score>
      <Hsp_evalue>9.84106e-08</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC-------GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFA-AGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>ILGGHLDAKGSFPWQAKMVSHHSL-TTGATLINEQWLLTTAKNLFLSHSESATAKDIAPTLTLYVG----KKQLVEIEKVVLHPSYSQV----DIGLIKLKQKVSVNERVMPICLP--SKDYAEVGRVGYVSGWG</Hsp_hseq>
      <Hsp_midline>I+ G     GS+PWQ  +         G +LINE W++T A           T  D+        G    K Q ++I KV  +  Y+ +    DI L+KL    S ++ V  +CLP  S D+A  G     +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>448</Hit_num>
  <Hit_id>pdb|1MD7|A</Hit_id>
  <Hit_def>Monomeric structure of the zymogen of complement protease C1r [Homo sapiens]</Hit_def>
  <Hit_accession>1MD7_A</Hit_accession>
  <Hit_len>328</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>1.5073e-07</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>90</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFH-FCGGSLINENWVVTAAHCGVTTSDVVVAGE----FDQGSSSEKIQKL---KIAKVFKNSKYN---SLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IIGGQKAKMGNFPWQVF----TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGV</Hsp_hseq>
      <Hsp_midline>I+ G++A  G++PWQV     T  H   GG+L+ + W++TAAH          +      F   ++ E++ KL    I +V  +  Y    S     DI LL+L  + +    +  +CLP     +  G     +G+G+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>449</Hit_num>
  <Hit_id>pdb|1MD8|A</Hit_id>
  <Hit_def>Monomeric structure of the active catalytic domain of complement protease C1r [Homo sapiens]</Hit_def>
  <Hit_accession>1MD8_A</Hit_accession>
  <Hit_len>329</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>1.50902e-07</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>90</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFH-FCGGSLINENWVVTAAHCGVTTSDVVVAGE----FDQGSSSEKIQKL---KIAKVFKNSKYN---SLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IIGGQKAKMGNFPWQVF----TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGV</Hsp_hseq>
      <Hsp_midline>I+ G++A  G++PWQV     T  H   GG+L+ + W++TAAH          +      F   ++ E++ KL    I +V  +  Y    S     DI LL+L  + +    +  +CLP     +  G     +G+G+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>450</Hit_num>
  <Hit_id>pdb|1HIA|A</Hit_id>
  <Hit_def>Kallikrein Complexed With Hirustasin [Sus scrofa] &gt;pdb|1HIA|X Kallikrein Complexed With Hirustasin [Sus scrofa] &gt;pdb|2KAI|A Refined 2.5 Angstroms X-Ray Crystal Structure Of The Complex Formed By Porcine Kallikrein A And The Bovine Pancreatic Trypsin Inhibitor. Crystallization, Patterson Search, Structure Determination, Refinement, Structure And Comparison With Its Components And With The Bovine Trypsin- Pancreatic Trypsin Inhibitor Complex [Sus scrofa] &gt;pdb|2PKA|A Refined 2 Angstroms X-Ray Crystal Structure Of Porcine Pancreatic Kallikrein A, A Specific Trypsin-Like Serine Proteinase. Crystallization, Structure Determination, Crystallographic Refinement, Structure And Its Comparison With Bovine Trypsin [Sus scrofa] &gt;pdb|2PKA|X Refined 2 Angstroms X-Ray Crystal Structure Of Porcine Pancreatic Kallikrein A, A Specific Trypsin-Like Serine Proteinase. Crystallization, Structure Determination, Crystallographic Refinement, Structure And Its Comparison With Bovine Trypsin [Sus scrofa]</Hit_def>
  <Hit_accession>1HIA_A</Hit_accession>
  <Hit_len>80</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>2.42727e-07</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>80</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>78</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>39</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>80</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYN</Hsp_qseq>
      <Hsp_hseq>IIGGRECEKNSHPWQVAIYHYSSFQ-CGGVLVNPKWVLTAAHCKNDNYEVWL-GRHNLFENENTAQFFGVTADFPHPGFN</Hsp_hseq>
      <Hsp_midline>I+ G E    S PWQV++   + F  CGG L+N  WV+TAAHC     +V + G  +   +    Q   +   F +  +N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>451</Hit_num>
  <Hit_id>pdb|2ODP|A</Hit_id>
  <Hit_def>Complement component C2a, the catalytic fragment of C3- and C5-convertase of human complement [Homo sapiens] &gt;pdb|2ODQ|A Complement component C2a, the catalytic fragment of C3- and C5-convertase of human complement [Homo sapiens]</Hit_def>
  <Hit_accession>2ODP_A</Hit_accession>
  <Hit_len>509</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>4.91134e-07</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>236</Hsp_hit-from>
      <Hsp_hit-to>357</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>123</Hsp_align-len>
      <Hsp_qseq>PWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIA---KVFKNSKYNSLTI-NNDITLLKLSTAASFSQTVSAVCLPSASDDFAA-----GTTC</Hsp_qseq>
      <Hsp_hseq>PWHVTIKPKSQ-ETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTC</Hsp_hseq>
      <Hsp_midline>PW V+++ K+    C G+LI++ WV+TAAHC    +D     V V     Q      I+K  I+    VF       L    +DI LLKL+     S     +CLP   +   A     G+TC</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>452</Hit_num>
  <Hit_id>pdb|2I6Q|A</Hit_id>
  <Hit_def>Complement component C2a [Homo sapiens] &gt;pdb|2I6S|A Complement component C2a [Homo sapiens]</Hit_def>
  <Hit_accession>2I6Q_A</Hit_accession>
  <Hit_len>517</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>5.11715e-07</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>121</Hsp_query-to>
      <Hsp_hit-from>244</Hsp_hit-from>
      <Hsp_hit-to>365</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>123</Hsp_align-len>
      <Hsp_qseq>PWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD-----VVVAGEFDQGSSSEKIQKLKIA---KVFKNSKYNSLTI-NNDITLLKLSTAASFSQTVSAVCLPSASDDFAA-----GTTC</Hsp_qseq>
      <Hsp_hseq>PWHVTIKPKSQ-ETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTC</Hsp_hseq>
      <Hsp_midline>PW V+++ K+    C G+LI++ WV+TAAHC    +D     V V     Q      I+K  I+    VF       L    +DI LLKL+     S     +CLP   +   A     G+TC</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>453</Hit_num>
  <Hit_id>pdb|2HNT|C</Hit_id>
  <Hit_def>Crystallographic Structure Of Human Gamma-Thrombin [Homo sapiens]</Hit_def>
  <Hit_accession>2HNT_C</Hit_accession>
  <Hit_len>70</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>7.81035e-07</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>43</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>44</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>23</Hsp_identity>
      <Hsp_positive>28</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>44</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC</Hsp_qseq>
      <Hsp_hseq>IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHC</Hsp_hseq>
      <Hsp_midline>IV G +A  G  PWQV L  K+     CG SLI++ WV+TAAHC</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>454</Hit_num>
  <Hit_id>pdb|1GPZ|A</Hit_id>
  <Hit_def>THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R [Homo sapiens] &gt;pdb|1GPZ|B THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R [Homo sapiens]</Hit_def>
  <Hit_accession>1GPZ_A</Hit_accession>
  <Hit_len>399</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.595</Hsp_bit-score>
      <Hsp_score>109</Hsp_score>
      <Hsp_evalue>2.2603e-06</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>158</Hsp_hit-from>
      <Hsp_hit-to>292</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFH-FCGGSLINENWVVTAAHCGVTTSDVVVAGE----FDQGSSSEKIQKL---KIAKVFKNSKY---NSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>IIGGQKAKMGNFPWQVF----TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGV</Hsp_hseq>
      <Hsp_midline>I+ G++A  G++PWQV     T  H   GG+L+ + W++TAAH          +      F   ++ E++ KL    I +V  +  Y    S     DI LL+L  + +    +  +CLP     +  G     +G+G+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>455</Hit_num>
  <Hit_id>pdb|2HNT|E</Hit_id>
  <Hit_def>Crystallographic Structure Of Human Gamma-Thrombin [Homo sapiens]</Hit_def>
  <Hit_accession>2HNT_E</Hit_accession>
  <Hit_len>81</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.8986</Hsp_bit-score>
      <Hsp_score>102</Hsp_score>
      <Hsp_evalue>2.27294e-06</Hsp_evalue>
      <Hsp_query-from>63</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>69</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>25</Hsp_identity>
      <Hsp_positive>37</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>EKIQKLKIAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLP---SASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>EKISMLE--KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG</Hsp_hseq>
      <Hsp_midline>EKI  L+  K++ + +YN    ++ DI L+KL    +FS  +  VCLP   +A+    AG     TGWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>456</Hit_num>
  <Hit_id>pdb|3BEU|A</Hit_id>
  <Hit_def>Na+-Dependent Allostery Mediates Coagulation Factor Protease Active Site Selectivity [Streptomyces griseus] &gt;pdb|3BEU|B Na+-Dependent Allostery Mediates Coagulation Factor Protease Active Site Selectivity [Streptomyces griseus]</Hit_def>
  <Hit_accession>3BEU_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>3.31158e-06</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>121</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTRAAQGEFPFMVRLS-----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVDLQSSSAV--KVRSTKVLQAPGFTKETYGKDWALIKL------AQPINQPTLKIATTTAYNQGTFTVAGWGANR</Hsp_hseq>
      <Hsp_midline>+V G  A  G +P+ V L        CGG+L  ++ V+TAAHC    G  TS     G  D  SSS    K++  KV +   +   T   D  L+KL      +Q ++   L  A+       T    GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>457</Hit_num>
  <Hit_id>pdb|4F4O|C</Hit_id>
  <Hit_def>Structure of the Haptoglobin-Haemoglobin Complex [Sus scrofa] &gt;pdb|4F4O|F Structure of the Haptoglobin-Haemoglobin Complex [Sus scrofa] &gt;pdb|4F4O|I Structure of the Haptoglobin-Haemoglobin Complex [Sus scrofa] &gt;pdb|4F4O|L Structure of the Haptoglobin-Haemoglobin Complex [Sus scrofa]</Hit_def>
  <Hit_accession>4F4O_C</Hit_accession>
  <Hit_len>347</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>6.19387e-06</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>103</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAA------HCGVTTS-DVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>IMGGSLDAKGSFPWQAKMISHHNL-TSGATLINEQWLLTTAKNLRLGHKNDTKAKDIAPTLRLYVG----KKQEVEIEKVIFHPDNSTV----DIGLIKLKQKVPVNERVMPICLPS-KDYVNVGLVGYVSGWG</Hsp_hseq>
      <Hsp_midline>I+ G     GS+PWQ  +         G +LINE W++T A      H   T + D+        G    K Q+++I KV  +   +++    DI L+KL      ++ V  +CLPS  D    G     +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>458</Hit_num>
  <Hit_id>pdb|6QSW|AAA</Hit_id>
  <Hit_def>Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6QSW|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6QSW|CCC Chain CCC, Complement factor B [Homo sapiens] &gt;pdb|6QSX|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6QSX|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6RAV|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6RAV|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6T8U|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6T8U|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6T8U|CCC Chain CCC, Complement factor B [Homo sapiens] &gt;pdb|6T8V|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6T8V|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6T8W|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6T8W|BBB Chain BBB, Complement factor B [Homo sapiens]</Hit_def>
  <Hit_accession>6QSW_AAA</Hit_accession>
  <Hit_len>291</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>6.44051e-06</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>109</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYN---------SLTINNDITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGEK---RDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D   + +   G      + L+I  V  +  YN             + D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>459</Hit_num>
  <Hit_id>pdb|1DLE|A</Hit_id>
  <Hit_def>FACTOR B SERINE PROTEASE DOMAIN [Homo sapiens] &gt;pdb|1DLE|B FACTOR B SERINE PROTEASE DOMAIN [Homo sapiens]</Hit_def>
  <Hit_accession>1DLE_A</Hit_accession>
  <Hit_len>298</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>6.75881e-06</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>28</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>28</Hsp_gaps>
      <Hsp_align-len>115</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSD------VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYN---------SLTINNDITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGE---------KRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D      V V GE          + L+I  V  +  YN             + D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>460</Hit_num>
  <Hit_id>pdb|1OS8|A</Hit_id>
  <Hit_def>Recombinant Streptomyces Griseus Trypsin [Streptomyces griseus]</Hit_def>
  <Hit_accession>1OS8_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.8986</Hsp_bit-score>
      <Hsp_score>102</Hsp_score>
      <Hsp_evalue>1.24595e-05</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTRAAQGEFPFMVRLS-----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVDLQSSSAV--KVRSTKVLQAPGYNG--TGKDWALIKL------AQPINQPTLKIATTTAYNQGTFTVAGWGANR</Hsp_hseq>
      <Hsp_midline>+V G  A  G +P+ V L        CGG+L  ++ V+TAAHC    G  TS     G  D  SSS    K++  KV +   YN      D  L+KL      +Q ++   L  A+       T    GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>461</Hit_num>
  <Hit_id>pdb|2FMJ|A</Hit_id>
  <Hit_def>220-loop mutant of streptomyces griseus trypsin [Streptomyces griseus]</Hit_def>
  <Hit_accession>2FMJ_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.8986</Hsp_bit-score>
      <Hsp_score>102</Hsp_score>
      <Hsp_evalue>1.26516e-05</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTRAAQGEFPFMVRLS-----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVDLQSSSAV--KVRSTKVLQAPGYNG--TGKDWALIKL------AQPINQPTLKIATTTAYNQGTFTVAGWGANR</Hsp_hseq>
      <Hsp_midline>+V G  A  G +P+ V L        CGG+L  ++ V+TAAHC    G  TS     G  D  SSS    K++  KV +   YN      D  L+KL      +Q ++   L  A+       T    GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>462</Hit_num>
  <Hit_id>pdb|1OSS|A</Hit_id>
  <Hit_def>T190p Streptomyces Griseus Trypsin In Complex With Benzamidine [Streptomyces griseus]</Hit_def>
  <Hit_accession>1OSS_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.8986</Hsp_bit-score>
      <Hsp_score>102</Hsp_score>
      <Hsp_evalue>1.34786e-05</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTRAAQGEFPFMVRLS-----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVDLQSSSAV--KVRSTKVLQAPGYNG--TGKDWALIKL------AQPINQPTLKIATTTAYNQGTFTVAGWGANR</Hsp_hseq>
      <Hsp_midline>+V G  A  G +P+ V L        CGG+L  ++ V+TAAHC    G  TS     G  D  SSS    K++  KV +   YN      D  L+KL      +Q ++   L  A+       T    GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>463</Hit_num>
  <Hit_id>pdb|6RUR|J</Hit_id>
  <Hit_def>Structure of the SCIN stabilized C3bBb convertase bound to properdin [Homo sapiens] &gt;pdb|6RUR|L Structure of the SCIN stabilized C3bBb convertase bound to properdin [Homo sapiens] &gt;pdb|6RUV|J Structure of the SCIN stabilized C3bBb convertase bound to Properdin and a the non-inhibitory nanobody hFPNb1 [Homo sapiens] &gt;pdb|6RUV|L Structure of the SCIN stabilized C3bBb convertase bound to Properdin and a the non-inhibitory nanobody hFPNb1 [Homo sapiens]</Hit_def>
  <Hit_accession>6RUR_J</Hit_accession>
  <Hit_len>505</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>2.88507e-05</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>235</Hsp_hit-from>
      <Hsp_hit-to>339</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>34</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSD------VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN------------DITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGE---------KRDLEIEVVLFHPNYN---INGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D      V V GE          + L+I  V  +  YN   IN             D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>464</Hit_num>
  <Hit_id>pdb|1RRK|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of the Bb segment of Factor B [Homo sapiens] &gt;pdb|1RS0|A Crystal Structure Analysis of the Bb segment of Factor B complexed with Di-isopropyl-phosphate (DIP) [Homo sapiens] &gt;pdb|1RTK|A Crystal Structure Analysis of the Bb segment of Factor B complexed with 4-guanidinobenzoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>1RRK_A</Hit_accession>
  <Hit_len>497</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>2.90557e-05</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>227</Hsp_hit-from>
      <Hsp_hit-to>331</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>34</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSD------VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN------------DITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGE---------KRDLEIEVVLFHPNYN---INGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D      V V GE          + L+I  V  +  YN   IN             D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>465</Hit_num>
  <Hit_id>pdb|2WIN|I</Hit_id>
  <Hit_def>C3 convertase (C3bBb) stabilized by SCIN [Homo sapiens] &gt;pdb|2WIN|J C3 convertase (C3bBb) stabilized by SCIN [Homo sapiens] &gt;pdb|2WIN|K C3 convertase (C3bBb) stabilized by SCIN [Homo sapiens] &gt;pdb|2WIN|L C3 convertase (C3bBb) stabilized by SCIN [Homo sapiens]</Hit_def>
  <Hit_accession>2WIN_I</Hit_accession>
  <Hit_len>507</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>2.91476e-05</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>235</Hsp_hit-from>
      <Hsp_hit-to>339</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>34</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSD------VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN------------DITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGE---------KRDLEIEVVLFHPNYN---INGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D      V V GE          + L+I  V  +  YN   IN             D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>466</Hit_num>
  <Hit_id>pdb|7JTN|A</Hit_id>
  <Hit_def>Chain A, Complement factor B [Homo sapiens] &gt;pdb|7JTN|C Chain C, Complement factor B [Homo sapiens] &gt;pdb|7JTQ|A Chain A, Complement factor B [Homo sapiens] &gt;pdb|7JTQ|C Chain C, Complement factor B [Homo sapiens]</Hit_def>
  <Hit_accession>7JTN_A</Hit_accession>
  <Hit_len>764</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>7.94496e-05</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>494</Hsp_hit-from>
      <Hsp_hit-to>598</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>34</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSD------VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN------------DITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGE---------KRDLEIEVVLFHPNYN---INGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D      V V GE          + L+I  V  +  YN   IN             D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>467</Hit_num>
  <Hit_id>pdb|2XWB|F</Hit_id>
  <Hit_def>Crystal Structure of Complement C3b in complex with Factors B and D [Homo sapiens] &gt;pdb|2XWB|H Crystal Structure of Complement C3b in complex with Factors B and D [Homo sapiens]</Hit_def>
  <Hit_accession>2XWB_F</Hit_accession>
  <Hit_len>732</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>8.14222e-05</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>460</Hsp_hit-from>
      <Hsp_hit-to>564</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>34</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSD------VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN------------DITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGE---------KRDLEIEVVLFHPNYN---INGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D      V V GE          + L+I  V  +  YN   IN             D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>468</Hit_num>
  <Hit_id>pdb|2XWJ|I</Hit_id>
  <Hit_def>Crystal Structure of Complement C3b in Complex with Factor B [Homo sapiens] &gt;pdb|2XWJ|J Crystal Structure of Complement C3b in Complex with Factor B [Homo sapiens] &gt;pdb|2XWJ|K Crystal Structure of Complement C3b in Complex with Factor B [Homo sapiens] &gt;pdb|2XWJ|L Crystal Structure of Complement C3b in Complex with Factor B [Homo sapiens] &gt;pdb|3HRZ|D Cobra Venom Factor (CVF) in complex with human factor B [Homo sapiens] &gt;pdb|3HS0|D Cobra Venom Factor (CVF) in complex with human factor B [Homo sapiens] &gt;pdb|3HS0|I Cobra Venom Factor (CVF) in complex with human factor B [Homo sapiens]</Hit_def>
  <Hit_accession>2XWJ_I</Hit_accession>
  <Hit_len>741</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>8.15238e-05</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>469</Hsp_hit-from>
      <Hsp_hit-to>573</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>34</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSD------VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN------------DITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGE---------KRDLEIEVVLFHPNYN---INGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D      V V GE          + L+I  V  +  YN   IN             D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>469</Hit_num>
  <Hit_id>pdb|1SGT|A</Hit_id>
  <Hit_def>REFINED CRYSTAL STRUCTURE OF STREPTOMYCES GRISEUS TRYPSIN AT 1.7 ANGSTROMS RESOLUTION [Streptomyces griseus]</Hit_def>
  <Hit_accession>1SGT_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>8.41451e-05</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>130</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>19</Hsp_gaps>
      <Hsp_align-len>134</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC----GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTR</Hsp_qseq>
      <Hsp_hseq>VVGGTRAAQGEFPFMVRLS-----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVDLQSGAAV--KVRSTKVLQAPGYNG--TGKDWALIKL------AQPINQPTLKIATTTAYNQGTFTVAGWGANR</Hsp_hseq>
      <Hsp_midline>+V G  A  G +P+ V L        CGG+L  ++ V+TAAHC    G  TS     G  D  S +    K++  KV +   YN      D  L+KL      +Q ++   L  A+       T    GWG  R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>470</Hit_num>
  <Hit_id>pdb|2OK5|A</Hit_id>
  <Hit_def>Human Complement factor B [Homo sapiens]</Hit_def>
  <Hit_accession>2OK5_A</Hit_accession>
  <Hit_len>752</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>9.61261e-05</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>109</Hsp_query-to>
      <Hsp_hit-from>479</Hsp_hit-from>
      <Hsp_hit-to>583</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>34</Hsp_gaps>
      <Hsp_align-len>118</Hsp_align-len>
      <Hsp_qseq>PWQVSL---QDKTGFHFCGGSLINENWVVTAAHCGVTTSD------VVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINN------------DITLLKLSTAASFSQTVSAVCLP</Hsp_qseq>
      <Hsp_hseq>PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-FTVDDKEHSIKVSVGGE---------KRDLEIEVVLFHPNYN---INGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP</Hsp_hseq>
      <Hsp_midline>PWQ  +   +   G   C G++++E +V+TAAHC  T  D      V V GE          + L+I  V  +  YN   IN             D+ L+KL     + QT+  +CLP</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>471</Hit_num>
  <Hit_id>pdb|5XRF|A</Hit_id>
  <Hit_def>Crystal structure of Da-36, a thrombin-like enzyme from Deinagkistrodon acutus [Deinagkistrodon acutus]</Hit_def>
  <Hit_accession>5XRF_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.2022</Hsp_bit-score>
      <Hsp_score>95</Hsp_score>
      <Hsp_evalue>0.000108168</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>128</Hsp_query-to>
      <Hsp_hit-from>34</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>25</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>102</Hsp_align-len>
      <Hsp_qseq>CGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGL</Hsp_qseq>
      <Hsp_hseq>CAGTLIHEEWVLAAAHCYKRGLNIYLGMHNQSIQFDDEQRRYAIEEHYYRCDEKLTKWEKDVVLLKLNKPVSNSTHIAPL--SLPSSPPSIGSVCRVMGWGI</Hsp_hseq>
      <Hsp_midline>C G+LI+E WV+ AAHC     ++ +          ++ ++  I + +            D+ LLKL+   S S  ++ +     S   + G+ C   GWG+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>472</Hit_num>
  <Hit_id>pdb|3H7O|A</Hit_id>
  <Hit_def>Crystal structure of scabies mite inactivated protease paralogue S-I1 (SMIPP-S-I1) [Sarcoptes scabiei] &gt;pdb|3H7O|B Crystal structure of scabies mite inactivated protease paralogue S-I1 (SMIPP-S-I1) [Sarcoptes scabiei]</Hit_def>
  <Hit_accession>3H7O_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.0466</Hsp_bit-score>
      <Hsp_score>92</Hsp_score>
      <Hsp_evalue>0.000340458</Hsp_evalue>
      <Hsp_query-from>13</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>125</Hsp_align-len>
      <Hsp_qseq>PWQVSLQDKTGFH--FCGGSLINENWVVTAAHCGVTTSDVVVAGEF-------DQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVC-LPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>PWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPETIVIQYESTNLWEDPGKSDPYVSHVYL------SFYRQETMENDIAILELSRPLKLDGLKSKPAKLPDIEFRPKTGSDVLVSGYG</Hsp_hseq>
      <Hsp_midline>PW V+++   G     CGG+++++ +V+TAAHC        +  ++       D G S   +  + +      S Y   T+ NDI +L+LS         S    LP        G+  + +G+G</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>473</Hit_num>
  <Hit_id>pdb|1OXG|B</Hit_id>
  <Hit_def>Crystal structure of a complex formed between organic solvent treated bovine alpha-chymotrypsin and its autocatalytically produced highly potent 14-residue peptide at 2.2 resolution [Bos taurus]</Hit_def>
  <Hit_accession>1OXG_B</Hit_accession>
  <Hit_len>14</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.2686</Hsp_bit-score>
      <Hsp_score>77</Hsp_score>
      <Hsp_evalue>0.00317514</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>14</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>14</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>14</Hsp_identity>
      <Hsp_positive>14</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>14</Hsp_align-len>
      <Hsp_qseq>IVNGEEAVPGSWPW</Hsp_qseq>
      <Hsp_hseq>IVNGEEAVPGSWPW</Hsp_hseq>
      <Hsp_midline>IVNGEEAVPGSWPW</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>474</Hit_num>
  <Hit_id>pdb|1HIA|B</Hit_id>
  <Hit_def>Kallikrein Complexed With Hirustasin [Sus scrofa] &gt;pdb|1HIA|Y Kallikrein Complexed With Hirustasin [Sus scrofa] &gt;pdb|2KAI|B Refined 2.5 Angstroms X-Ray Crystal Structure Of The Complex Formed By Porcine Kallikrein A And The Bovine Pancreatic Trypsin Inhibitor. Crystallization, Patterson Search, Structure Determination, Refinement, Structure And Comparison With Its Components And With The Bovine Trypsin- Pancreatic Trypsin Inhibitor Complex [Sus scrofa] &gt;pdb|2PKA|B Refined 2 Angstroms X-Ray Crystal Structure Of Porcine Pancreatic Kallikrein A, A Specific Trypsin-Like Serine Proteinase. Crystallization, Structure Determination, Crystallographic Refinement, Structure And Its Comparison With Bovine Trypsin [Sus scrofa] &gt;pdb|2PKA|Y Refined 2 Angstroms X-Ray Crystal Structure Of Porcine Pancreatic Kallikrein A, A Specific Trypsin-Like Serine Proteinase. Crystallization, Structure Determination, Crystallographic Refinement, Structure And Its Comparison With Bovine Trypsin [Sus scrofa]</Hit_def>
  <Hit_accession>1HIA_B</Hit_accession>
  <Hit_len>152</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.5722</Hsp_bit-score>
      <Hsp_score>70</Hsp_score>
      <Hsp_evalue>0.184965</Hsp_evalue>
      <Hsp_query-from>85</Hsp_query-from>
      <Hsp_query-to>127</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>47</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>14</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>43</Hsp_align-len>
      <Hsp_qseq>NNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWG</Hsp_qseq>
      <Hsp_hseq>SHDLMLLRLQSPAKITDAVKVLELPTQEPEL--GSTCEASGWG</Hsp_hseq>
      <Hsp_midline>++D+ LL+L + A  +  V  + LP+   +   G+TC  +GWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>475</Hit_num>
  <Hit_id>pdb|4NSY|A</Hit_id>
  <Hit_def>Wild-type lysobacter enzymogenes lysc endoproteinase covalently inhibited by TLCK [Lysobacter enzymogenes] &gt;pdb|4NSY|B Wild-type lysobacter enzymogenes lysc endoproteinase covalently inhibited by TLCK [Lysobacter enzymogenes]</Hit_def>
  <Hit_accession>4NSY_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.5722</Hsp_bit-score>
      <Hsp_score>70</Hsp_score>
      <Hsp_evalue>0.278157</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>98</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>VSLQDKTGFHFCGGSLINEN------WVVTAAHCGVTT----SDVVVAGEFDQ------GSSSEKIQ-KLKIAKVFKNSKYNSLTINNDITLLKLSTAAS</Hsp_qseq>
      <Hsp_hseq>VAAYSKQGTMWCTGSLVNNSANDKKMYFLTANHCGMTTAAIASSMVVYWNYQNSTCRAPGSSSSGANGDGSLAQSQTGAVVRATNAASDFTLLELNTAAN</Hsp_hseq>
      <Hsp_midline>V+   K G  +C GSL+N +      + +TA HCG+TT    S +VV   +        GSSS        +A+    +   +    +D TLL+L+TAA+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>476</Hit_num>
  <Hit_id>pdb|4NSV|A</Hit_id>
  <Hit_def>Lysobacter enzymogenes lysc endoproteinase K30R mutant covalently inhibited by TLCK [Lysobacter enzymogenes] &gt;pdb|4NSV|B Lysobacter enzymogenes lysc endoproteinase K30R mutant covalently inhibited by TLCK [Lysobacter enzymogenes]</Hit_def>
  <Hit_accession>4NSV_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>30.8018</Hsp_bit-score>
      <Hsp_score>68</Hsp_score>
      <Hsp_evalue>0.487508</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>98</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>124</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>VSLQDKTGFHFCGGSLINEN------WVVTAAHCGVTT----SDVVVAGEFDQ------GSSSEKIQ-KLKIAKVFKNSKYNSLTINNDITLLKLSTAAS</Hsp_qseq>
      <Hsp_hseq>VAAYSRQGTMWCTGSLVNNSANDKKMYFLTANHCGMTTAAIASSMVVYWNYQNSTCRAPGSSSSGANGDGSLAQSQTGAVVRATNAASDFTLLELNTAAN</Hsp_hseq>
      <Hsp_midline>V+   + G  +C GSL+N +      + +TA HCG+TT    S +VV   +        GSSS        +A+    +   +    +D TLL+L+TAA+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>477</Hit_num>
  <Hit_id>pdb|6FVQ|A</Hit_id>
  <Hit_def>The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - R86A [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVQ|B The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - R86A [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVQ|C The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - R86A [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVQ|D The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - R86A [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVQ|E The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - R86A [endosymbiont of Tevnia jerichonana (vent Tica)]</Hit_def>
  <Hit_accession>6FVQ_A</Hit_accession>
  <Hit_len>320</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>27.335</Hsp_bit-score>
      <Hsp_score>59</Hsp_score>
      <Hsp_evalue>7.79794</Hsp_evalue>
      <Hsp_query-from>17</Hsp_query-from>
      <Hsp_query-to>72</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>193</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>15</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>56</Hsp_align-len>
      <Hsp_qseq>SLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAK</Hsp_qseq>
      <Hsp_hseq>RFQEMQGFSGLGDQLGEEEWIVTEVNTHLTTHN-----EFTKGDASRFVLEFHAER</Hsp_hseq>
      <Hsp_midline>  Q+  GF   G  L  E W+VT  +  +TT +     EF +G +S  + +    +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>478</Hit_num>
  <Hit_id>pdb|6FL9|A</Hit_id>
  <Hit_def>The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Wild type 2.3 Angstrom resolution [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FL9|B The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Wild type 2.3 Angstrom resolution [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FL9|C The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Wild type 2.3 Angstrom resolution [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FL9|D The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Wild type 2.3 Angstrom resolution [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FL9|E The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Wild type 2.3 Angstrom resolution [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FLI|A The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Co-crystallization with 4-bromo cinnamic acid [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FLI|B The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Co-crystallization with 4-bromo cinnamic acid [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FLI|C The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Co-crystallization with 4-bromo cinnamic acid [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FLI|D The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Co-crystallization with 4-bromo cinnamic acid [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FLI|E The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - Co-crystallization with 4-bromo cinnamic acid [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVR|A The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Cesium ions (Cs+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVR|B The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Cesium ions (Cs+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVR|C The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Cesium ions (Cs+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVR|D The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Cesium ions (Cs+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVR|E The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Cesium ions (Cs+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVS|A The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Barium ions (Ba2+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVS|B The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Barium ions (Ba2+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVS|C The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Barium ions (Ba2+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVS|D The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Barium ions (Ba2+) [endosymbiont of Tevnia jerichonana (vent Tica)] &gt;pdb|6FVS|E The active form of a pentameric ion channel (sTeLIC) gated by alkaline pH - sTeLIC in complex with Barium ions (Ba2+) [endosymbiont of Tevnia jerichonana (vent Tica)]</Hit_def>
  <Hit_accession>6FL9_A</Hit_accession>
  <Hit_len>320</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>27.335</Hsp_bit-score>
      <Hsp_score>59</Hsp_score>
      <Hsp_evalue>8.02144</Hsp_evalue>
      <Hsp_query-from>17</Hsp_query-from>
      <Hsp_query-to>72</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>193</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>15</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>56</Hsp_align-len>
      <Hsp_qseq>SLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKLKIAK</Hsp_qseq>
      <Hsp_hseq>RFQEMQGFSGLGDQLGEEEWIVTEVNTHLTTHN-----EFTKGDASRFVLEFHAER</Hsp_hseq>
      <Hsp_midline>  Q+  GF   G  L  E W+VT  +  +TT +     EF +G +S  + +    +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
</Iteration_hits>
  <Iteration_stat>
    <Statistics>
      <Statistics_db-num>130881</Statistics_db-num>
      <Statistics_db-len>34844698</Statistics_db-len>
      <Statistics_hsp-len>93</Statistics_hsp-len>
      <Statistics_eff-space>861565070</Statistics_eff-space>
      <Statistics_kappa>0.041</Statistics_kappa>
      <Statistics_lambda>0.267</Statistics_lambda>
      <Statistics_entropy>0.14</Statistics_entropy>
    </Statistics>
  </Iteration_stat>
</Iteration>
<Iteration>
  <Iteration_iter-num>3</Iteration_iter-num>
  <Iteration_query-ID>Query_3</Iteration_query-ID>
  <Iteration_query-def>1AFQ_3|Chain C|BOVINE GAMMA-CHYMOTRYPSIN|Bos taurus (9913)</Iteration_query-def>
  <Iteration_query-len>96</Iteration_query-len>
<Iteration_hits>
<Hit>
  <Hit_num>1</Hit_num>
  <Hit_id>pdb|1AFQ|C</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR [Bos taurus] &gt;pdb|3RU4|E Crystal structure of the Bowman-Birk serine protease inhibitor BTCI in complex with trypsin and chymotrypsin [Bos taurus]</Hit_def>
  <Hit_accession>1AFQ_C</Hit_accession>
  <Hit_len>96</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>193.741</Hsp_bit-score>
      <Hsp_score>491</Hsp_score>
      <Hsp_evalue>1.06564e-65</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>96</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>96</Hsp_identity>
      <Hsp_positive>96</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_hseq>
      <Hsp_midline>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>2</Hit_num>
  <Hit_id>pdb|1AB9|C</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1CA0|C Bovine Chymotrypsin Complexed To Appi [Bos taurus] &gt;pdb|1CA0|H Bovine Chymotrypsin Complexed To Appi [Bos taurus] &gt;pdb|1CBW|C BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI [Bos taurus] &gt;pdb|1CBW|H BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI [Bos taurus] &gt;pdb|1CHO|G CRYSTAL AND MOLECULAR STRUCTURES OF THE COMPLEX OF ALPHA-*CHYMOTRYPSIN WITH ITS INHIBITOR TURKEY OVOMUCOID THIRD DOMAIN AT 1.8 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|1GCT|C Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of Gamma- Chymotrypsin? [Bos taurus] &gt;pdb|1GG6|C Crystal Structure Of Gamma Chymotrypsin With N-acetyl-phenylalanine Trifluoromethyl Ketone Bound At The Active Site [Bos taurus] &gt;pdb|1GGD|C CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-LEUCIL-PHENYLALANINE ALDEHYDE BOUND AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GHA|G A Second Active Site In Chymotrypsin? The X-Ray Crystal Structure Of N-Acetyl-D-Tryptophan Bound To Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GHB|G A Second Active Site In Chymotrypsin? The X-Ray Crystal Structure Of N-Acetyl-D-Tryptophan Bound To Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GMC|G The X-Ray Crystal Structure Of The Tetrahedral Intermediate Of Gamma- Chymotrypsin In Hexane [Bos taurus] &gt;pdb|1GMD|G X-ray crystal structure of gamma-chymotrypsin in hexane [Bos taurus] &gt;pdb|1GMH|G REFINED CRYSTAL STRUCTURE OF &quot;AGED&quot; AND &quot;NON-AGED&quot; ORGANOPHOSPHORYL CONJUGATES OF GAMMA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1HJA|C LYS 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH ALPHA-CHYMOTRYPSIN [Bos taurus] &gt;pdb|1MTN|C BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION [Bos taurus] &gt;pdb|1MTN|G BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION [Bos taurus] &gt;pdb|1N8O|C Crystal structure of a complex between bovine chymotrypsin and ecotin [Bos taurus] &gt;pdb|1VGC|C Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|1YPH|E High resolution structure of bovine alpha-chymotrypsin [Bos taurus] &gt;pdb|1YPH|F High resolution structure of bovine alpha-chymotrypsin [Bos taurus] &gt;pdb|2CHA|C The Structure Of Crystalline Alpha-Chymotrypsin, v.The Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2 Angstroms Resolution [Bos taurus] &gt;pdb|2CHA|G The Structure Of Crystalline Alpha-Chymotrypsin, v.The Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2 Angstroms Resolution [Bos taurus] &gt;pdb|2GCH|G Refined Crystal Structure Of Gamma-chymotrypsin At 1.9 Angstroms Resolution [Bos taurus] &gt;pdb|2GCT|C Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph 10.5 Suggests That Gamma-Chymotrypsin Is A Covalent Acyl-Enzyme Adduct At Low Ph [Bos taurus] &gt;pdb|2GMT|C Three-Dimensional Structure Of Chymotrypsin Inactivated With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl Ketone: Implications For The Mechanism Of Inactivation Of Serine Proteases By Chloroketones [Bos taurus] &gt;pdb|2P8O|C Crystal Structure of a Benzohydroxamic Acid/Vanadate complex bound to chymotrypsin A [Bos taurus] &gt;pdb|2VGC|C Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|3BG4|C The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor [Bos taurus] &gt;pdb|3GCH|C Chemistry Of Caged Enzymes. Binding Of Photoreversible Cinnamates To Chymotrypsin [Bos taurus] &gt;pdb|3GCT|G Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH 10.5 Suggests That Gamma-Chymotrypsin Is A Covalent Acyl-Enzyme Adduct At Low pH [Bos taurus] &gt;pdb|3VGC|C Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid Acid Inhibitor Complex [Bos taurus] &gt;pdb|4CHA|C Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms Resolution [Bos taurus] &gt;pdb|4CHA|G Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms Resolution [Bos taurus] &gt;pdb|4GCH|G Structure And Activity Of Two Photoreversible Cinnamates Bound To Chymotrypsin [Bos taurus] &gt;pdb|4VGC|C Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid Inhibitor Complex [Bos taurus] &gt;pdb|5CHA|C The Refinement And The Structure Of The Dimer Of Alpha- Chymotrypsin At 1.67-Angstroms Resolution [Bos taurus] &gt;pdb|5CHA|G The Refinement And The Structure Of The Dimer Of Alpha- Chymotrypsin At 1.67-Angstroms Resolution [Bos taurus] &gt;pdb|5GCH|G Chemistry Of Caged Enzymes II. Photoactivation Of Inhibited Chymotrypsin [Bos taurus] &gt;pdb|6CHA|C STRUCTURE OF A TETRAHEDRAL TRANSITION STATE COMPLEX OF ALPHA-*CHYMOTRYPSIN AT 1.8-*ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|6CHA|G STRUCTURE OF A TETRAHEDRAL TRANSITION STATE COMPLEX OF ALPHA-*CHYMOTRYPSIN AT 1.8-*ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|6DI8|C Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|F Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|I Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6DI8|L Crystal structure of bovine alpha-chymotrypsin in space group P65 [Bos taurus] &gt;pdb|6GCH|G Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor Complexes. Comparison Of Slowly And Rapidly Equilibrating Inhibitors [Bos taurus] &gt;pdb|7GCH|G Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor Complexes. Comparison Of Slowly And Rapidly Equilibrating Inhibitors [Bos taurus] &gt;pdb|7JRX|C Chain C, Chymotrypsin A chain C [Bos taurus] &gt;pdb|7JRX|c Chain c, Chymotrypsin A chain C [Bos taurus] &gt;pdb|8GCH|G Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With Its Own Autolysis Products [Bos taurus]</Hit_def>
  <Hit_accession>1AB9_C</Hit_accession>
  <Hit_len>97</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>193.741</Hsp_bit-score>
      <Hsp_score>491</Hsp_score>
      <Hsp_evalue>1.13634e-65</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>97</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>96</Hsp_identity>
      <Hsp_positive>96</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_hseq>
      <Hsp_midline>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>3</Hit_num>
  <Hit_id>pdb|1DLK|B</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR [Bos taurus] &gt;pdb|1DLK|D CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR [Bos taurus]</Hit_def>
  <Hit_accession>1DLK_B</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>196.438</Hsp_bit-score>
      <Hsp_score>498</Hsp_score>
      <Hsp_evalue>6.7777e-65</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>96</Hsp_identity>
      <Hsp_positive>96</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_hseq>
      <Hsp_midline>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>4</Hit_num>
  <Hit_id>pdb|1ACB|E</Hit_id>
  <Hit_def>CRYSTAL AND MOLECULAR STRUCTURE OF THE BOVINE ALPHA-CHYMOTRYPSIN-EGLIN C COMPLEX AT 2.0 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|1CGI|E Three-Dimensional Structure Of The Complexes Between Bovine ChymotrypsinogenA And Two Recombinant Variants Of Human Pancreatic Secretory Trypsin Inhibitor (Kazal-Type) [Bos taurus] &gt;pdb|1CGJ|E Three-Dimensional Structure Of The Complexes Between Bovine ChymotrypsinogenA And Two Recombinant Variants Of Human Pancreatic Secretory Trypsin Inhibitor (Kazal-Type) [Bos taurus] &gt;pdb|1CHG|A Chymotrypsinogen,2.5 Angstroms Crystal Structure, Comparison With Alpha-Chymotrypsin,And Implications For Zymogen Activation [Bos taurus] &gt;pdb|1EX3|A Crystal Structure Of Bovine Chymotrypsinogen A (tetragonal) [Bos taurus] &gt;pdb|1GCD|A Refined Crystal Structure Of &quot;aged&quot; And &quot;non-Aged&quot; Organophosphoryl Conjugates Of Gamma-Chymotrypsin [Bos taurus] &gt;pdb|1GL0|E structure of the complex between bovine alpha-chymotrypsin and PMP-D2v, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|A structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|B structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1GL1|C structure of the complex between bovine alpha-chymotrypsin and PMP-C, an inhibitor from the insect Locusta migratoria [Bos taurus] &gt;pdb|1K2I|1 Crystal Structure of Gamma-Chymotrypsin in Complex with 7-Hydroxycoumarin [Bos taurus] &gt;pdb|1OXG|A Crystal structure of a complex formed between organic solvent treated bovine alpha-chymotrypsin and its autocatalytically produced highly potent 14-residue peptide at 2.2 resolution [Bos taurus] &gt;pdb|1P2M|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2M|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2N|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2N|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2O|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2O|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2Q|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2Q|C Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1T7C|A Crystal Structure Of The P1 Glu Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T7C|C Crystal Structure Of The P1 Glu Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8L|A Crystal Structure Of The P1 Met Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8L|C Crystal Structure Of The P1 Met Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8M|A Crystal Structure Of The P1 His Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8M|C Crystal Structure Of The P1 His Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8N|A Crystal Structure Of The P1 Thr Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8N|C Crystal Structure Of The P1 Thr Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8O|A Crystal Structure Of The P1 Trp Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|1T8O|C Crystal Structure Of The P1 Trp Bpti Mutant- Bovine Chymotrypsin Complex [Bos taurus] &gt;pdb|2CGA|A Bovine Chymotrypsinogen A. X-Ray Crystal Structure Analysis And Refinement Of A New Crystal Form At 1.8 Angstroms Resolution [Bos taurus] &gt;pdb|2CGA|B Bovine Chymotrypsinogen A. X-Ray Crystal Structure Analysis And Refinement Of A New Crystal Form At 1.8 Angstroms Resolution [Bos taurus] &gt;pdb|2Y6T|A Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|B Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|C Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|2Y6T|D Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis [Bos taurus] &gt;pdb|3T62|A Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|3T62|B Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|3T62|C Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean Sea anemone Stichodactyla helianthus in complex with bovine chymotrypsin [Bos taurus] &gt;pdb|4Q2K|A Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|B Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|C Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|4Q2K|D Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b [Bos taurus] &gt;pdb|5J4Q|A alpha-chymotrypsin from bovine pancreas in complex with Bowman-Birk inhibitor from soybean [Bos taurus] &gt;pdb|5J4S|A alpha-chymotrypsin from bovine pancreas in complex with a modified Bowman-Birk inhibitor from soybean [Bos taurus] &gt;pdb|7KTY|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KTZ|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU0|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU1|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU2|A Chain A, Chymotrypsinogen A [Bos taurus] &gt;pdb|7KU3|A Chain A, Chymotrypsinogen A [Bos taurus]</Hit_def>
  <Hit_accession>1ACB_E</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>196.052</Hsp_bit-score>
      <Hsp_score>497</Hsp_score>
      <Hsp_evalue>1.38205e-64</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>150</Hsp_hit-from>
      <Hsp_hit-to>245</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>96</Hsp_identity>
      <Hsp_positive>96</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_hseq>
      <Hsp_midline>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>5</Hit_num>
  <Hit_id>pdb|2JET|C</Hit_id>
  <Hit_def>Crystal structure of a trypsin-like mutant (S189D, A226G) chymotrypsin. [Rattus norvegicus]</Hit_def>
  <Hit_accession>2JET_C</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>150.984</Hsp_bit-score>
      <Hsp_score>380</Hsp_score>
      <Hsp_evalue>9.37224e-49</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>99</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>70</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>KTPEKLQQAALPIVSEADCKKSWGSKITDVMTCAGASGVDSCMGDSGGPLVCQKDGVWTLAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQILEAN</Hsp_hseq>
      <Hsp_midline> TP++LQQA+LP++S  +CKK WG+KI D M CAGASGV SCMGDSGGPLVC+K+G WTL GIVSWGS  CSTSTPGVY+RVTAL+ WVQQ L AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>6</Hit_num>
  <Hit_id>pdb|1KDQ|B</Hit_id>
  <Hit_def>Crystal Structure Analysis of the Mutant S189D Rat Chymotrypsin [Rattus norvegicus]</Hit_def>
  <Hit_accession>1KDQ_B</Hit_accession>
  <Hit_len>99</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>149.058</Hsp_bit-score>
      <Hsp_score>375</Hsp_score>
      <Hsp_evalue>4.75365e-48</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>99</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>69</Hsp_identity>
      <Hsp_positive>80</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>KTPEKLQQAALPIVSEADCKKSWGSKITDVMTCAGASGVDSCMGDSGGPLVCQKDGVWTLAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQILEAN</Hsp_hseq>
      <Hsp_midline> TP++LQQA+LP++S  +CKK WG+KI D M CAGASGV SCMGDSGGPLVC+K+G WTL GIVSWGS  CSTSTP VY+RVTAL+ WVQQ L AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>7</Hit_num>
  <Hit_id>pdb|4CRC|A</Hit_id>
  <Hit_def>Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRE|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens]</Hit_def>
  <Hit_accession>4CRC_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>7.95437e-24</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>8</Hit_num>
  <Hit_id>pdb|1ZLR|A</Hit_id>
  <Hit_def>Factor XI catalytic domain complexed with 2-guanidino-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl nicotinate [Homo sapiens]</Hit_def>
  <Hit_accession>1ZLR_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>8.05583e-24</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>9</Hit_num>
  <Hit_id>pdb|3SOR|A</Hit_id>
  <Hit_def>Factor XIa in complex with a clorophenyl-tetrazole inhibitor [Homo sapiens] &gt;pdb|3SOS|A Benzothiazinone inhibitor in complex with FXIa [Homo sapiens] &gt;pdb|4X6P|A FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE INHIBITOR (2E)-N-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-1H-imidazol-2-yl]-2-phenylethyl}-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enamide [Homo sapiens] &gt;pdb|4X6P|B FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE INHIBITOR (2E)-N-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-1H-imidazol-2-yl]-2-phenylethyl}-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enamide [Homo sapiens] &gt;pdb|5EXN|A FACTOR XIA (C500S [C122S]) IN COMPLEX WITH THE INHIBITOR methyl ~{N}-[4-[2-[(1~{S})-1-[[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate [Homo sapiens] &gt;pdb|6HHC|A Allosteric Inhibition as a new mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated form of Coagulation Factor XI [Homo sapiens] &gt;pdb|6R8X|A COAGULATION FACTOR XI CATALYTIC DOMAIN IN COMPLEX WITH FAB-PORTION OF MAA868 [Homo sapiens] &gt;pdb|6TS5|A Coagulation factor XI protease domain in complex with active site inhibitor [Homo sapiens] &gt;pdb|6TS6|A Coagulation factor XI protease domain in complex with active site inhibitor [Homo sapiens] &gt;pdb|6TS7|A Coagulation factor XI protease domain in complex with active site inhibitor [Homo sapiens] &gt;pdb|6USY|A COAGULATION FACTOR XI CATALYTIC DOMAIN (C123S) IN COMPLEX WITH NVP-XIV936 [Homo sapiens] &gt;pdb|6VLU|A Factor XIa in complex with compound 7 [Homo sapiens] &gt;pdb|6VLV|A Factor XIa in complex with compound 11 [Homo sapiens]</Hit_def>
  <Hit_accession>3SOR_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>8.12587e-24</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>10</Hit_num>
  <Hit_id>pdb|1ZPZ|A</Hit_id>
  <Hit_def>Factor XI catalytic domain complexed with N-((R)-1-(4-bromophenyl)ethyl)urea-Asn-Val-Arg-alpha-ketothiazole [Homo sapiens] &gt;pdb|1ZRK|A Factor XI complexed with 3-hydroxypropyl 3-(7-amidinonaphthalene-1-carboxamido)benzenesulfonate [Homo sapiens] &gt;pdb|1ZSL|A Factor XI complexed with a pyrimidinone inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>1ZPZ_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>8.30107e-24</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>11</Hit_num>
  <Hit_id>pdb|3BG8|A</Hit_id>
  <Hit_def>Crystal structure of Factor XIa in complex with Clavatadine A [Homo sapiens]</Hit_def>
  <Hit_accession>3BG8_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>8.39008e-24</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>12</Hit_num>
  <Hit_id>pdb|1ZJD|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with Kunitz Protease Inhibitor Domain of Protease Nexin II [Homo sapiens]</Hit_def>
  <Hit_accession>1ZJD_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>8.58834e-24</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>13</Hit_num>
  <Hit_id>pdb|1ZHR|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with Benzamidine (S434A-T475A-C482S-K437A Mutant) [Homo sapiens] &gt;pdb|1ZMJ|A Crystal Structure of the Catalytic Domain of Factor XI in complex with 4-(guanidinomethyl)-phenylboronic acid [Homo sapiens] &gt;pdb|1ZML|A Crystal Structure of the Catalytic Domain of Factor XI in complex with (R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)phenethyl)guanidine [Homo sapiens] &gt;pdb|1ZMN|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with (R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)phenyl)guanidine [Homo sapiens] &gt;pdb|1ZOM|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in complex with a peptidomimetic Inhibitor [Homo sapiens] &gt;pdb|1ZPB|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 4-Methyl-pentanoic acid {1-[4-guanidino-1-(thiazole-2-carbonyl)-butylcarbamoyl]-2-methyl-propyl}-amide [Homo sapiens] &gt;pdb|1ZPC|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 2-[2-(3-Chloro-phenyl)-2-hydroxy-acetylamino]-N-[4-guanidino-1-(thiazole-2-carbonyl)-butyl]-3-methyl-butyramide [Homo sapiens] &gt;pdb|1ZSJ|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in complex with N-(7-Carbamimidoyl-naphthalen-1-yl)-3-hydroxy-2-methyl-benzamide [Homo sapiens] &gt;pdb|1ZSK|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester [Homo sapiens] &gt;pdb|1ZTJ|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 2-(5-Benzylamino-2-methylsulfanyl-6-oxo-6H-pyrimidin-1-yl)-N-[4-guanidino-1-(thiazole-2-carbonyl)-butyl]-acetamide [Homo sapiens] &gt;pdb|1ZTK|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with 2-(5-Amino-6-oxo-2-m-tolyl-6H-pyrimidin-1-yl)-N-[4-guanidino-1-(thiazole-2-carbonyl)-butyl]-acetamide [Homo sapiens] &gt;pdb|1ZTL|A Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with N-[4-Guanidino-1-(thiazole-2-carbonyl)-butyl]-2-{6-oxo-5-[(quinolin-8-ylmethyl)-amino]-2-m-tolyl-6H-pyrimidin-1-yl}-acetamide [Homo sapiens] &gt;pdb|2FDA|A Crystal Structure of the Catalytic Domain of Human Coagulation Factor XIa in Complex with alpha-Ketothiazole Arginine Derived Ligand [Homo sapiens] &gt;pdb|4CR5|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CR9|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRA|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRB|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRD|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRF|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4CRG|A Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design [Homo sapiens] &gt;pdb|4D76|A Human FXIa in complex with small molecule inhibitors. [Homo sapiens] &gt;pdb|4D7F|A Human FXIa in complex with small molecule inhibitors. [Homo sapiens] &gt;pdb|4D7G|A Human FXIa in complex with small molecule inhibitors. [Homo sapiens]</Hit_def>
  <Hit_accession>1ZHR_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>8.75576e-24</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>14</Hit_num>
  <Hit_id>pdb|1XXD|A</Hit_id>
  <Hit_def>Crystal Structure of the FXIa Catalytic Domain in Complex with mutated Ecotin [Homo sapiens] &gt;pdb|1XXD|B Crystal Structure of the FXIa Catalytic Domain in Complex with mutated Ecotin [Homo sapiens] &gt;pdb|1XXF|A Crystal Structure of the FXIa Catalytic Domain in Complex with Ecotin Mutant (EcotinP) [Homo sapiens] &gt;pdb|1XXF|B Crystal Structure of the FXIa Catalytic Domain in Complex with Ecotin Mutant (EcotinP) [Homo sapiens]</Hit_def>
  <Hit_accession>1XXD_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>1.02747e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>15</Hit_num>
  <Hit_id>pdb|1XX9|A</Hit_id>
  <Hit_def>Crystal Structure of the FXIa Catalytic Domain in Complex with EcotinM84R [Homo sapiens] &gt;pdb|1XX9|B Crystal Structure of the FXIa Catalytic Domain in Complex with EcotinM84R [Homo sapiens]</Hit_def>
  <Hit_accession>1XX9_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>1.03848e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>16</Hit_num>
  <Hit_id>pdb|4TY6|A</Hit_id>
  <Hit_def>Factor XIa in complex with the inhibitor 4-{2-[(1S)-1-({[trans-4-(aminomethyl)cyclohexyl]carbonyl}amino)-2-phenylethyl]-1H-imidazol-4-yl}benzamide [Homo sapiens] &gt;pdb|4TY7|A Factor XIa in complex with the inhibitor (2S)-6-amino-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl}-2-ethylhexanamide [Homo sapiens] &gt;pdb|4WXI|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR trans-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)pyridin-2-yl]-2-phenylethyl}-4-(aminomethyl)cyclohexanecarboxamide [Homo sapiens] &gt;pdb|4X6M|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl}-3-[2-(aminomethyl)-5-chlorobenzyl]urea [Homo sapiens] &gt;pdb|4X6N|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl}-3-[5-chloro-2-(1H-tetrazol-1-yl)benzyl]urea [Homo sapiens] &gt;pdb|4X6O|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl (4-{4-chloro-2-[(1S)-1-({3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]propanoyl}amino)-2-phenylethyl]-1H-imidazol-5-yl}phenyl)carbamate [Homo sapiens] &gt;pdb|4Y8X|A Factor XIa in complex with the inhibitor methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-phenylethyl]-1H-imidazol-5-yl}phenyl)carbamate [Homo sapiens] &gt;pdb|4Y8Y|A Factor XIa in complex with the inhibitor methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-3-(morpholin-4-yl)-3-oxopropyl]-1H-imidazol-5-yl}phenyl)carbamate [Homo sapiens] &gt;pdb|4Y8Z|A Factor XIa in complex with the inhibitor (2E)-N-[(1S)-1-[5-chloro-4-(4-hydroxy-2-oxo-1,2-dihydroquinolin-6-yl)-1H-imidazol-2-yl]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enamide [Homo sapiens] &gt;pdb|5E2O|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[(N-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}-L-phenylalanyl)amino]benzoic acid [Homo sapiens] &gt;pdb|5E2P|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR N-[(1S)-1-benzyl-2-[2-[5-chloro-2-(tetrazol-1-yl)phenyl]ethylamino]-2-oxo-ethyl]-4-hydroxy-2-oxo-1H-quinoline-6-carboxamide [Homo sapiens] &gt;pdb|5EXL|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-(aminomethyl)-~{N}-[(1~{S})-1-[4-(3-oxidanyl-1~{H}-indazol-5-yl)pyridin-2-yl]-2-phenyl-ethyl]cyclohexane-1-carboxamide [Homo sapiens] &gt;pdb|5EXM|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl ~{N}-[4-[2-[(1~{S})-1-[[4-(aminomethyl)cyclohexyl]carbonylamino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate [Homo sapiens] &gt;pdb|5Q0D|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-oxo-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecin-14-yl]carbamate [Homo sapiens] &gt;pdb|5Q0E|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(4S,8S)-8-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-4-methyl-2-oxo-1,3,4,5,6,7,8,10-octahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5Q0F|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(4R,5E,8S)-8-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-4-methyl-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5Q0G|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-3-ethyl-2-oxo-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecin-14-yl]carbamate [Homo sapiens] &gt;pdb|5Q0H|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(4R,5E,8S)-11-chloro-8-[(2,6-difluoro-4-methylbenzene-1-carbonyl)amino]-4-methyl-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QCK|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(2~{S},3~{R})-1-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3-phenyl-pyrrolidin-2-yl]carbonylamino]benzoic acid [Homo sapiens] &gt;pdb|5QCL|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid [Homo sapiens] &gt;pdb|5QCM|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl ~{N}-[4-[[(1~{S})-2-[(~{E})-3-[3-chloranyl-2-fluoranyl-6-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]phenyl]carbamate [Homo sapiens] &gt;pdb|5QCN|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-5-[(3~{S})-3-ethoxycarbonylpiperidin-1-yl]carbonyl-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid [Homo sapiens] &gt;pdb|5QQO|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(5E,8S)-8-[(6R)-6-(3-chlorophenyl)-2-oxo-1,3-oxazinan-3-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QQP|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(5E,8S)-8-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QTT|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-{[5-amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QTU|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate [Homo sapiens] &gt;pdb|5QTV|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-(trifluoromethyl)-2,3,4,5,6,7-hexahydro-1H-8,11-epimino-1,9-benzodiazacyclotridecin-14-yl]carbamate [Homo sapiens] &gt;pdb|5QTW|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-14-[(methoxycarbonyl)amino]-2,3,4,5,6,7-hexahydro-1H-8,11-epimino-1,9-benzodiazacyclotridecine-2-carboxylate [Homo sapiens] &gt;pdb|5QTX|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR ethyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-14-[(methoxycarbonyl)amino]-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecine-2-carboxylate [Homo sapiens] &gt;pdb|5QTY|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR ethyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-15-[(methoxycarbonyl)amino]-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecine-2-carboxylate [Homo sapiens] &gt;pdb|5TKS|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR ((15S)-18-CHLORO- 15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2- PROPENOYL)AMINO)-17,19-DIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,16(19)-PENTAEN-5-YL)CARBAMATE [Homo sapiens] &gt;pdb|5TKT|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((12E,15S)-15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2-PROPENOYL)AMINO)-9-OXO-8,17,19-TRIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,12,16(19)-HEXAEN-5-YL)CARBAMATE [Homo sapiens] &gt;pdb|5TKU|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((15S)-15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2-PROPENOYL)AMINO)-9-OXO-8,17,19-TRIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,16(19)-PENTAEN-5-YL)CARBAMATE [Homo sapiens] &gt;pdb|5WB6|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(11S)-11-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-6-fluoro-2-oxo-1,3,4,10,11,13-hexahydro-2H-5,9:15,12-di(azeno)-1,13-benzodiazacycloheptadecin-18-yl]carbamate [Homo sapiens] &gt;pdb|6C0S|A Factor XIA in complex with the inhibitor methyl (4-{6-[(1S)-2-[(3R)-1-acetylpiperidin-3-yl]-1-({(2E)-3-[5-chloro-2- (1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)ethyl]-3-chloropyridazin-4-yl}phenyl) carbamate [Homo sapiens] &gt;pdb|6TWC|A Crystal Structure of the Catalytic Domain of the Coagulation Factor XIa in Complex with Double Bridged Peptide F21 [Homo sapiens] &gt;pdb|6W50|A FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((10R,14S)- 14-(4-(3-CHLORO-2,6-DIFLUOROPHENYL)-6-OXO-3,6-DIHYDRO- 1(2H)-PYRIDINYL)-10-METHYL-9-OXO-8,16- DIAZATRICYCLO[13.3.1.0~2,7~]NONADECA-1(19),2,4,6,15,17- HEXAEN-5-YL)CARBAMATE [Homo sapiens]</Hit_def>
  <Hit_accession>4TY6_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>1.1034e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>17</Hit_num>
  <Hit_id>pdb|1ZHM|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of the Coagulation Factor XIa in Complex with Benzamidine (S434A-T475A-K437 Mutant) [Homo sapiens]</Hit_def>
  <Hit_accession>1ZHM_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>1.15534e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>18</Hit_num>
  <Hit_id>pdb|1ZHP|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with Benzamidine (S434A-T475A-K505 Mutant) [Homo sapiens]</Hit_def>
  <Hit_accession>1ZHP_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>1.15534e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>19</Hit_num>
  <Hit_id>pdb|6TWB|A</Hit_id>
  <Hit_def>Crystal Structure of the Catalytic Domain of Coagulation Factor XIa in Complex with Double Bridged Peptide F19 [Homo sapiens] &gt;pdb|6TWB|H Crystal Structure of the Catalytic Domain of Coagulation Factor XIa in Complex with Double Bridged Peptide F19 [Homo sapiens]</Hit_def>
  <Hit_accession>6TWB_A</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>1.15868e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>163</Hsp_hit-from>
      <Hsp_hit-to>255</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>20</Hit_num>
  <Hit_id>pdb|4NA7|A</Hit_id>
  <Hit_def>Factor XIA in complex with the inhibitor 3&apos;-[(2S,4R)-6-carbamimidoyl-4-methyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]-4-carbamoyl-5&apos;-[(3-methylbutanoyl)amino]biphenyl-2-carboxylic acid [Homo sapiens] &gt;pdb|4NA8|A Factor XIa in complex with the inhibitor 5-aminocarbonyl-2-[3-[(2s,4r)-6-carbamimidoyl-4-methyl-4-phenyl-2,3-dihydro-1h-quinolin-2-yl]phenyl]benzoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>4NA7_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.2781</Hsp_bit-score>
      <Hsp_score>225</Hsp_score>
      <Hsp_evalue>1.16373e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>21</Hit_num>
  <Hit_id>pdb|6TS4|A</Hit_id>
  <Hit_def>Coagulation factor XI protease domain in complex with active site inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>6TS4_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.5077</Hsp_bit-score>
      <Hsp_score>223</Hsp_score>
      <Hsp_evalue>2.03278e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDAGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GD+GGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>22</Hit_num>
  <Hit_id>pdb|6AOD|C</Hit_id>
  <Hit_def>FXIa antibody complex [Homo sapiens]</Hit_def>
  <Hit_accession>6AOD_C</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.5077</Hsp_bit-score>
      <Hsp_score>223</Hsp_score>
      <Hsp_evalue>2.34282e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDAGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GD+GGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>23</Hit_num>
  <Hit_id>pdb|2ANY|A</Hit_id>
  <Hit_def>Chain A, plasma kallikrein, light chain [Homo sapiens] &gt;pdb|4OGX|A Crystal structure of Fab DX-2930 in complex with human plasma kallikrein at 2.4 Angstrom resolution [Homo sapiens] &gt;pdb|4OGY|A Crystal structure of Fab DX-2930 in complex with human plasma kallikrein at 2.1 Angstrom resolution [Homo sapiens] &gt;pdb|4OGY|B Crystal structure of Fab DX-2930 in complex with human plasma kallikrein at 2.1 Angstrom resolution [Homo sapiens]</Hit_def>
  <Hit_accession>2ANY_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>2.89889e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI</Hsp_hseq>
      <Hsp_midline>LQ+ ++PL++N  C K+Y   KI   M+CAG    G  +C GDSGGPLVCK NG W LVGI SWG        PGVY +V   ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>24</Hit_num>
  <Hit_id>pdb|1EKB|B</Hit_id>
  <Hit_def>The Serine Protease Domain Of Enteropeptidase Bound To Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane [Bos taurus]</Hit_def>
  <Hit_accession>1EKB_B</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>3.20209e-23</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>234</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>TPDRLQQASLPLLSNTNCKKYWGT-KIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>TADVLQEADVPLLSNEKCQQQMPEYNITENMVCAGYEAGGVDSCQGDSGGPLMCQENNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWIQSFL</Hsp_hseq>
      <Hsp_midline>T D LQ+A +PLLSN  C++      I + M+CAG  A GV SC GDSGGPL+C++N  W L G+ S+G      + PGVYARV     W+Q  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>25</Hit_num>
  <Hit_id>pdb|2ANW|A</Hit_id>
  <Hit_def>Chain A, plasma kallikrein, light chain [Homo sapiens]</Hit_def>
  <Hit_accession>2ANW_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>3.22455e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI</Hsp_hseq>
      <Hsp_midline>LQ+ ++PL++N  C K+Y   KI   M+CAG    G  +C GDSGGPLVCK NG W LVGI SWG        PGVY +V   ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>26</Hit_num>
  <Hit_id>pdb|5F8T|A</Hit_id>
  <Hit_def>The crystal structure of human Plasma Kallikrein in complex with its peptide inhibitor pkalin-2 [Homo sapiens] &gt;pdb|5F8X|A The crystal structure of human plasma kallikrein in complex with its peptide inhibitor pkalin-3 [Homo sapiens] &gt;pdb|5F8Z|A The crystal structure of human Plasma Kallikrein in complex with its peptide inhibitor pkalin-1 [Homo sapiens]</Hit_def>
  <Hit_accession>5F8T_A</Hit_accession>
  <Hit_len>239</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>3.27562e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI</Hsp_hseq>
      <Hsp_midline>LQ+ ++PL++N  C K+Y   KI   M+CAG    G  +C GDSGGPLVCK NG W LVGI SWG        PGVY +V   ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>27</Hit_num>
  <Hit_id>pdb|4DGJ|A</Hit_id>
  <Hit_def>Structure of a human enteropeptidase light chain variant [Homo sapiens] &gt;pdb|4DGJ|B Structure of a human enteropeptidase light chain variant [Homo sapiens] &gt;pdb|4DGJ|C Structure of a human enteropeptidase light chain variant [Homo sapiens] &gt;pdb|4DGJ|D Structure of a human enteropeptidase light chain variant [Homo sapiens] &gt;pdb|6ZOV|A ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6 [Homo sapiens] &gt;pdb|6ZOV|B ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6 [Homo sapiens] &gt;pdb|6ZOV|C ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6 [Homo sapiens] &gt;pdb|6ZOV|D ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6 [Homo sapiens]</Hit_def>
  <Hit_accession>4DGJ_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.7373</Hsp_bit-score>
      <Hsp_score>221</Hsp_score>
      <Hsp_evalue>3.48721e-23</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>234</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>TPDRLQQASLPLLSNTNCKKYWGT-KIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>TADILQEADVPLLSNERCQQQMPEYNITENMICAGYEEGGIDSCQGDSGGPLMCQENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQSFL</Hsp_hseq>
      <Hsp_midline>T D LQ+A +PLLSN  C++      I + MICAG    G+ SC GDSGGPL+C++N  W L G+ S+G      + PGVYARV+    W+Q  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>28</Hit_num>
  <Hit_id>pdb|5TJX|A</Hit_id>
  <Hit_def>Structure of human plasma kallikrein [Homo sapiens] &gt;pdb|6O1S|E Structure of human plasma kallikrein protease domain with inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>5TJX_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.1225</Hsp_bit-score>
      <Hsp_score>222</Hsp_score>
      <Hsp_evalue>3.81878e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>160</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI</Hsp_hseq>
      <Hsp_midline>LQ+ ++PL++N  C K+Y   KI   M+CAG    G  +C GDSGGPLVCK NG W LVGI SWG        PGVY +V   ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>29</Hit_num>
  <Hit_id>pdb|6T7P|A</Hit_id>
  <Hit_def>human plasmakallikrein protease domain in complex with active site directed inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>6T7P_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.7373</Hsp_bit-score>
      <Hsp_score>221</Hsp_score>
      <Hsp_evalue>4.10798e-23</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI</Hsp_hseq>
      <Hsp_midline>LQ+ ++PL++N  C K+Y   KI   M+CAG    G  +C GDSGGPLVCK NG W LVGI SWG        PGVY +V   ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>30</Hit_num>
  <Hit_id>pdb|5GVT|A</Hit_id>
  <Hit_def>Crystal structures of the serine protease domain of murine plasma kallikrein [Mus musculus] &gt;pdb|5GVT|B Crystal structures of the serine protease domain of murine plasma kallikrein [Mus musculus]</Hit_def>
  <Hit_accession>5GVT_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.3521</Hsp_bit-score>
      <Hsp_score>220</Hsp_score>
      <Hsp_evalue>6.06701e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>ETQNILQKATIPLVPNEECQKKYRDYVINKQMICAGYKEGGTDACKGDSGGPLVCKHSGRWQLVGITSWGEGCARKDQPGVYTKVSEYMDWI</Hsp_hseq>
      <Hsp_midline> T + LQ+A++PL+ N  C KKY    I   MICAG    G  +C GDSGGPLVCK +G W LVGI SWG        PGVY +V+  ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>31</Hit_num>
  <Hit_id>pdb|6A8O|A</Hit_id>
  <Hit_def>Crystal structures of the serine protease domain of murine plasma kallikrein with peptide inhibitor mupain-1-16 [Mus musculus] &gt;pdb|6A8O|B Crystal structures of the serine protease domain of murine plasma kallikrein with peptide inhibitor mupain-1-16 [Mus musculus]</Hit_def>
  <Hit_accession>6A8O_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.3521</Hsp_bit-score>
      <Hsp_score>220</Hsp_score>
      <Hsp_evalue>6.17288e-23</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>ETQNILQKATIPLVPNEECQKKYRDYVINKQMICAGYKEGGTDACKGDSGGPLVCKHSGRWQLVGITSWGEGCARKDQPGVYTKVSEYMDWI</Hsp_hseq>
      <Hsp_midline> T + LQ+A++PL+ N  C KKY    I   MICAG    G  +C GDSGGPLVCK +G W LVGI SWG        PGVY +V+  ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>32</Hit_num>
  <Hit_id>pdb|6O1G|A</Hit_id>
  <Hit_def>Full length human plasma kallikrein with inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>6O1G_A</Hit_accession>
  <Hit_len>638</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.8929</Hsp_bit-score>
      <Hsp_score>224</Hsp_score>
      <Hsp_evalue>2.12647e-22</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>535</Hsp_hit-from>
      <Hsp_hit-to>621</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI</Hsp_hseq>
      <Hsp_midline>LQ+ ++PL++N  C K+Y   KI   M+CAG    G  +C GDSGGPLVCK NG W LVGI SWG        PGVY +V   ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>33</Hit_num>
  <Hit_id>pdb|2F91|A</Hit_id>
  <Hit_def>1.2A resolution structure of a crayfish trypsin complexed with a peptide inhibitor, SGTI [Astacus leptodactylus] &gt;pdb|4BNR|A Extremely stable complex of crayfish trypsin with bovine trypsin inhibitor [Astacus leptodactylus] &gt;pdb|4BNR|B Extremely stable complex of crayfish trypsin with bovine trypsin inhibitor [Astacus leptodactylus]</Hit_def>
  <Hit_accession>2F91_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.4261</Hsp_bit-score>
      <Hsp_score>215</Hsp_score>
      <Hsp_evalue>3.61157e-22</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>141</Hsp_hit-from>
      <Hsp_hit-to>233</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGT-KIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>NTPDVLQKVTVPLVSDEDCRADYGADEILDSMICAGVPEGGKDSCQGDSGGPLAASDTGSTYLAGIVSWGYGCARPGYPGVYTEVSYHVDWIK</Hsp_hseq>
      <Hsp_midline>NTPD LQ+ ++PL+S+ +C+  +G  +I D+MICAG    G  SC GDSGGPL     G+  L GIVSWG        PGVY  V+  V+W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>34</Hit_num>
  <Hit_id>pdb|6I44|A</Hit_id>
  <Hit_def>Chain A, Plasma kallikrein [Homo sapiens]</Hit_def>
  <Hit_accession>6I44_A</Hit_accession>
  <Hit_len>627</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.7373</Hsp_bit-score>
      <Hsp_score>221</Hsp_score>
      <Hsp_evalue>4.85184e-22</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>524</Hsp_hit-from>
      <Hsp_hit-to>610</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDAGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI</Hsp_hseq>
      <Hsp_midline>LQ+ ++PL++N  C K+Y   KI   M+CAG    G  +C GD+GGPLVCK NG W LVGI SWG        PGVY +V   ++W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>35</Hit_num>
  <Hit_id>pdb|1AKS|B</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF THE FIRST ACTIVE AUTOLYSATE FORM OF THE PORCINE ALPHA TRYPSIN [Sus scrofa] &gt;pdb|1EPT|C REFINED 1.8 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF PORCINE EPSILON-TRYPSIN [Sus scrofa]</Hit_def>
  <Hit_accession>1AKS_B</Hit_accession>
  <Hit_len>98</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.8037</Hsp_bit-score>
      <Hsp_score>203</Hsp_score>
      <Hsp_evalue>8.44945e-22</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSCQGDSGGPVVC--NG--QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN</Hsp_hseq>
      <Hsp_midline>P  LQ    P+LSN++CK  +  +I   MIC G    G  SC GDSGGP+VC  NG   L GIVSWG      + PGVY +V   VNW+QQT+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>36</Hit_num>
  <Hit_id>pdb|2F9N|A</Hit_id>
  <Hit_def>Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9N|B Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9N|C Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9N|D Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin [Homo sapiens]</Hit_def>
  <Hit_accession>2F9N_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.2705</Hsp_bit-score>
      <Hsp_score>212</Hsp_score>
      <Hsp_evalue>9.64135e-22</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>101</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAGNSQRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVP</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         I+D M+CAG S   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>37</Hit_num>
  <Hit_id>pdb|2F83|A</Hit_id>
  <Hit_def>Crystal structure at 2.9 Angstroms resolution of human plasma coagulation factor XI zymogen [Homo sapiens]</Hit_def>
  <Hit_accession>2F83_A</Hit_accession>
  <Hit_len>625</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.5817</Hsp_bit-score>
      <Hsp_score>218</Hsp_score>
      <Hsp_evalue>1.37388e-21</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>530</Hsp_hit-from>
      <Hsp_hit-to>624</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>NTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>+ LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>38</Hit_num>
  <Hit_id>pdb|2F9O|A</Hit_id>
  <Hit_def>Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G [Homo sapiens] &gt;pdb|2F9O|B Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G [Homo sapiens] &gt;pdb|2F9O|C Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G [Homo sapiens] &gt;pdb|2F9O|D Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G [Homo sapiens] &gt;pdb|2F9P|A Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9P|B Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9P|C Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin [Homo sapiens] &gt;pdb|2F9P|D Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin [Homo sapiens]</Hit_def>
  <Hit_accession>2F9O_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.8853</Hsp_bit-score>
      <Hsp_score>211</Hsp_score>
      <Hsp_evalue>1.38252e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>101</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAGNSQRDSCKGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVP</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         I+D M+CAG S   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>39</Hit_num>
  <Hit_id>pdb|1AMH|A</Hit_id>
  <Hit_def>Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With Ser (D189s) [Rattus rattus] &gt;pdb|1AMH|B Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With Ser (D189s) [Rattus rattus]</Hit_def>
  <Hit_accession>1AMH_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>1.66376e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKSSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G SSC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>40</Hit_num>
  <Hit_id>pdb|5I25|A</Hit_id>
  <Hit_def>human recombinant coagulation FXI in complex with a peptide derived from human high molecular weight kininogen (HKP) [Homo sapiens] &gt;pdb|6I58|A Allosteric activation of human prekallikrein by apple domain disc rotation [Homo sapiens]</Hit_def>
  <Hit_accession>5I25_A</Hit_accession>
  <Hit_len>607</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.8113</Hsp_bit-score>
      <Hsp_score>216</Hsp_score>
      <Hsp_evalue>2.22621e-21</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>512</Hsp_hit-from>
      <Hsp_hit-to>606</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>NTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>+ LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>41</Hit_num>
  <Hit_id>pdb|5EOD|A</Hit_id>
  <Hit_def>Human Plasma Coagulation FXI with peptide LP2 [Homo sapiens] &gt;pdb|5EOK|A Human Plasma Coagulation Factor XI in complex with peptide P39 [Homo sapiens]</Hit_def>
  <Hit_accession>5EOD_A</Hit_accession>
  <Hit_len>606</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.8113</Hsp_bit-score>
      <Hsp_score>216</Hsp_score>
      <Hsp_evalue>2.33667e-21</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>511</Hsp_hit-from>
      <Hsp_hit-to>605</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>NTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQA</Hsp_hseq>
      <Hsp_midline>+ LQ+A +PL++N  C K+Y G KI   MICAG    G  +C GDSGGPL CK N  W LVGI SWG        PGVY  V   V+W+ +   A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>42</Hit_num>
  <Hit_id>pdb|1UHB|B</Hit_id>
  <Hit_def>Crystal structure of porcine alpha trypsin bound with auto catalyticaly produced native peptide at 2.15 A resolution [Sus scrofa] &gt;pdb|5XW1|B Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRN, at pH10 [Sus scrofa] &gt;pdb|5XW8|B Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRN, at pH 7 [Sus scrofa] &gt;pdb|5XW9|B Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRY, at pH 7 [Sus scrofa] &gt;pdb|5XWA|B Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRY, at pH 10 [Sus scrofa]</Hit_def>
  <Hit_accession>1UHB_B</Hit_accession>
  <Hit_len>98</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.2629</Hsp_bit-score>
      <Hsp_score>199</Hsp_score>
      <Hsp_evalue>2.93338e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVC--NG--QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN</Hsp_hseq>
      <Hsp_midline>P  LQ    P+LS+++CK  +  +I   MIC G    G  SC GDSGGP+VC  NG   L GIVSWG      + PGVY +V   VNW+QQT+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>43</Hit_num>
  <Hit_id>pdb|2TLD|E</Hit_id>
  <Hit_def>Crystal Structure Of An Engineered Subtilisin Inhibitor Complexed With Bovine Trypsin [Bos taurus]</Hit_def>
  <Hit_accession>2TLD_E</Hit_accession>
  <Hit_len>220</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>3.07616e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGLEGGDSCQGDSGGPVVC----SGKLQGIVSWGSG-CAKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG  G  SC GDSGGP+VC    +  L GIVSWGS  C+ + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>44</Hit_num>
  <Hit_id>pdb|2ZEB|A</Hit_id>
  <Hit_def>Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEB|B Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEB|C Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEB|D Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEC|A Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEC|B Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEC|C Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens] &gt;pdb|2ZEC|D Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase [Homo sapiens]</Hit_def>
  <Hit_accession>2ZEB_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.7297</Hsp_bit-score>
      <Hsp_score>208</Hsp_score>
      <Hsp_evalue>4.19495e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         ++D M+CAG +   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>45</Hit_num>
  <Hit_id>pdb|1F7Z|A</Hit_id>
  <Hit_def>Rat Trypsinogen K15a Complexed With Bovine Pancreatic Trypsin Inhibitor [Rattus norvegicus]</Hit_def>
  <Hit_accession>1F7Z_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>4.21596e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>233</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>46</Hit_num>
  <Hit_id>pdb|1A0L|A</Hit_id>
  <Hit_def>Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites Facing A Central Pore [Homo sapiens] &gt;pdb|1A0L|B Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites Facing A Central Pore [Homo sapiens] &gt;pdb|1A0L|C Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites Facing A Central Pore [Homo sapiens] &gt;pdb|1A0L|D Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites Facing A Central Pore [Homo sapiens]</Hit_def>
  <Hit_accession>1A0L_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.7297</Hsp_bit-score>
      <Hsp_score>208</Hsp_score>
      <Hsp_evalue>4.26724e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         ++D M+CAG +   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>47</Hit_num>
  <Hit_id>pdb|1FY8|E</Hit_id>
  <Hit_def>Crystal Structure Of The Deltaile16val17 Rat Anionic Trypsinogen-bpti Complex [Rattus rattus]</Hit_def>
  <Hit_accession>1FY8_E</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>4.28864e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>48</Hit_num>
  <Hit_id>pdb|2BM2|A</Hit_id>
  <Hit_def>human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone [Homo sapiens] &gt;pdb|2BM2|B human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone [Homo sapiens] &gt;pdb|2BM2|C human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone [Homo sapiens] &gt;pdb|2BM2|D human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone [Homo sapiens] &gt;pdb|2FPZ|A Human tryptase with 2-amino benzimidazole [Homo sapiens] &gt;pdb|2FPZ|B Human tryptase with 2-amino benzimidazole [Homo sapiens] &gt;pdb|2FPZ|C Human tryptase with 2-amino benzimidazole [Homo sapiens] &gt;pdb|2FPZ|D Human tryptase with 2-amino benzimidazole [Homo sapiens] &gt;pdb|2FS8|A Human beta-tryptase II with inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FS8|B Human beta-tryptase II with inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FS8|C Human beta-tryptase II with inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FS8|D Human beta-tryptase II with inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FS9|A Human beta tryptase II with inhibitor CRA-28427 [Homo sapiens] &gt;pdb|2FS9|B Human beta tryptase II with inhibitor CRA-28427 [Homo sapiens] &gt;pdb|2FS9|C Human beta tryptase II with inhibitor CRA-28427 [Homo sapiens] &gt;pdb|2FS9|D Human beta tryptase II with inhibitor CRA-28427 [Homo sapiens] &gt;pdb|2FWW|A human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme [Homo sapiens] &gt;pdb|2FWW|B human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme [Homo sapiens] &gt;pdb|2FWW|C human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme [Homo sapiens] &gt;pdb|2FWW|D human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme [Homo sapiens] &gt;pdb|2FXR|A human beta tryptase II complexed with activated ketone inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FXR|B human beta tryptase II complexed with activated ketone inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FXR|C human beta tryptase II complexed with activated ketone inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2FXR|D human beta tryptase II complexed with activated ketone inhibitor CRA-29382 [Homo sapiens] &gt;pdb|2GDD|A Human beta II tryptase with inhibitor CRA-27592 [Homo sapiens] &gt;pdb|2GDD|B Human beta II tryptase with inhibitor CRA-27592 [Homo sapiens] &gt;pdb|2GDD|C Human beta II tryptase with inhibitor CRA-27592 [Homo sapiens] &gt;pdb|2GDD|D Human beta II tryptase with inhibitor CRA-27592 [Homo sapiens] &gt;pdb|2ZA5|A Crystal Structure of human tryptase with potent non-peptide inhibitor [Homo sapiens] &gt;pdb|2ZA5|B Crystal Structure of human tryptase with potent non-peptide inhibitor [Homo sapiens] &gt;pdb|2ZA5|C Crystal Structure of human tryptase with potent non-peptide inhibitor [Homo sapiens] &gt;pdb|2ZA5|D Crystal Structure of human tryptase with potent non-peptide inhibitor [Homo sapiens] &gt;pdb|3V7T|A Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold [Homo sapiens] &gt;pdb|3V7T|B Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold [Homo sapiens] &gt;pdb|3V7T|C Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold [Homo sapiens] &gt;pdb|3V7T|D Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold [Homo sapiens] &gt;pdb|4A6L|A beta-tryptase inhibitor [Homo sapiens] &gt;pdb|4A6L|B beta-tryptase inhibitor [Homo sapiens] &gt;pdb|4A6L|C beta-tryptase inhibitor [Homo sapiens] &gt;pdb|4A6L|D beta-tryptase inhibitor [Homo sapiens] &gt;pdb|4MPU|A Human beta-tryptase co-crystal structure with (6S,8R)-N,N&apos;-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-8-hydroxy-6-(1-hydroxycyclobutyl)-5,7-dioxaspiro[3.4]octane-6,8-dicarboxamide [Homo sapiens] &gt;pdb|4MPU|B Human beta-tryptase co-crystal structure with (6S,8R)-N,N&apos;-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-8-hydroxy-6-(1-hydroxycyclobutyl)-5,7-dioxaspiro[3.4]octane-6,8-dicarboxamide [Homo sapiens] &gt;pdb|4MPV|A Human beta-tryptase co-crystal structure with (2R,4S)-N,N&apos;-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-4-hydroxy-2-(2-hydroxypropan-2-yl)-5,5-dimethyl-1,3-dioxolane-2,4-dicarboxamide [Homo sapiens] &gt;pdb|4MPV|B Human beta-tryptase co-crystal structure with (2R,4S)-N,N&apos;-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-4-hydroxy-2-(2-hydroxypropan-2-yl)-5,5-dimethyl-1,3-dioxolane-2,4-dicarboxamide [Homo sapiens] &gt;pdb|4MPW|A Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzofuran-3,5-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MPW|B Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzofuran-3,5-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MPX|A Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzothiene-4,2-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MPX|B Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzothiene-4,2-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MQA|A Human beta-tryptase co-crystal structure with {(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bis[5-(methylsulfanyl)benzene-3,1-diyl]}bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|4MQA|B Human beta-tryptase co-crystal structure with {(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bis[5-(methylsulfanyl)benzene-3,1-diyl]}bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone) [Homo sapiens] &gt;pdb|5F03|A TRYPTASE B2 IN COMPLEX WITH 5-(3-Aminomethyl-phenoxymethyl)-3-[3-(2-chloro-pyridin-3-ylethynyl)-phenyl]-oxazolidin-2-one; compound with trifluoro-acetic acid [Homo sapiens] &gt;pdb|5F03|B TRYPTASE B2 IN COMPLEX WITH 5-(3-Aminomethyl-phenoxymethyl)-3-[3-(2-chloro-pyridin-3-ylethynyl)-phenyl]-oxazolidin-2-one; compound with trifluoro-acetic acid [Homo sapiens]</Hit_def>
  <Hit_accession>2BM2_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.7297</Hsp_bit-score>
      <Hsp_score>208</Hsp_score>
      <Hsp_evalue>4.43328e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         ++D M+CAG +   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>49</Hit_num>
  <Hit_id>pdb|1AND|A</Hit_id>
  <Hit_def>Anionic Trypsin Mutant With Arg 96 Replaced By His [Rattus rattus]</Hit_def>
  <Hit_accession>1AND_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>4.43494e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>50</Hit_num>
  <Hit_id>pdb|1J14|A</Hit_id>
  <Hit_def>Benzamidine In Complex With Rat Trypsin Mutant X99rt [Rattus norvegicus] &gt;pdb|1QL9|A Factor Xa Specific Inhibitor In Complex With Rat Trypsin Mutant X99rt [Rattus norvegicus]</Hit_def>
  <Hit_accession>1J14_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>4.48244e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>51</Hit_num>
  <Hit_id>pdb|5WI6|A</Hit_id>
  <Hit_def>Human beta-1 tryptase mutant Ile99Cys [Homo sapiens] &gt;pdb|5WI6|B Human beta-1 tryptase mutant Ile99Cys [Homo sapiens] &gt;pdb|5WI6|C Human beta-1 tryptase mutant Ile99Cys [Homo sapiens] &gt;pdb|5WI6|D Human beta-1 tryptase mutant Ile99Cys [Homo sapiens]</Hit_def>
  <Hit_accession>5WI6_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>4.8251e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         ++D M+CAG +   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>52</Hit_num>
  <Hit_id>pdb|1EZS|C</Hit_id>
  <Hit_def>Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a, D70a Bound To Rat Anionic Trypsin Ii [Rattus norvegicus] &gt;pdb|1EZS|D Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a, D70a Bound To Rat Anionic Trypsin Ii [Rattus norvegicus] &gt;pdb|1EZU|C Ecotin Y69f, D70p Bound To D102n Trypsin [Rattus norvegicus] &gt;pdb|1EZU|D Ecotin Y69f, D70p Bound To D102n Trypsin [Rattus norvegicus]</Hit_def>
  <Hit_accession>1EZS_C</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>5.03965e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>53</Hit_num>
  <Hit_id>pdb|1ANE|A</Hit_id>
  <Hit_def>Anionic Trypsin Wild Type [Rattus rattus] &gt;pdb|3FP6|E Anionic trypsin in complex with bovine pancreatic trypsin inhibitor (BPTI) determined to the 1.49 A resolution limit [Rattus norvegicus] &gt;pdb|3TGI|E Wild-Type Rat Anionic Trypsin Complexed With Bovine Pancreatic Trypsin Inhibitor (Bpti) [Rattus norvegicus]</Hit_def>
  <Hit_accession>1ANE_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>5.03965e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>54</Hit_num>
  <Hit_id>pdb|1TRM|A</Hit_id>
  <Hit_def>THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS [Rattus rattus] &gt;pdb|1TRM|B THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS [Rattus rattus] &gt;pdb|2TRM|A THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS [Rattus norvegicus]</Hit_def>
  <Hit_accession>1TRM_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>5.09362e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>55</Hit_num>
  <Hit_id>pdb|1CO7|E</Hit_id>
  <Hit_def>R117H mutant rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) [Rattus norvegicus]</Hit_def>
  <Hit_accession>1CO7_E</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>5.1415e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>245</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>56</Hit_num>
  <Hit_id>pdb|1SLU|B</Hit_id>
  <Hit_def>Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin [Rattus norvegicus] &gt;pdb|1SLV|B Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin; Copper- Bound [Rattus norvegicus] &gt;pdb|1SLX|B Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin; Zinc-Bound [Rattus norvegicus]</Hit_def>
  <Hit_accession>1SLU_B</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>5.14816e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NHPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>57</Hit_num>
  <Hit_id>pdb|1SLW|B</Hit_id>
  <Hit_def>Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin; Nickel- Bound [Rattus norvegicus]</Hit_def>
  <Hit_accession>1SLW_B</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>5.37223e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NHPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>58</Hit_num>
  <Hit_id>pdb|6P0P|A</Hit_id>
  <Hit_def>Human beta-tryptase co-crystal structure with 5-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-2-(3&apos;-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-[1,1&apos;-biphenyl]-3-yl)-2-hydroxy-2H-1,3,2-benzodioxaborol-2-uide [Homo sapiens] &gt;pdb|6P0P|B Human beta-tryptase co-crystal structure with 5-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-2-(3&apos;-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-[1,1&apos;-biphenyl]-3-yl)-2-hydroxy-2H-1,3,2-benzodioxaborol-2-uide [Homo sapiens]</Hit_def>
  <Hit_accession>6P0P_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.7297</Hsp_bit-score>
      <Hsp_score>208</Hsp_score>
      <Hsp_evalue>6.18731e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>172</Hsp_hit-from>
      <Hsp_hit-to>271</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         ++D M+CAG +   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>59</Hit_num>
  <Hit_id>pdb|6O1F|A</Hit_id>
  <Hit_def>Complex between soybean trypsin inhibitor beta1-tryptase and a humanized fab [Homo sapiens]</Hit_def>
  <Hit_accession>6O1F_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>6.29039e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         ++D M+CAG +   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>60</Hit_num>
  <Hit_id>pdb|1PYT|C</Hit_id>
  <Hit_def>Ternary Complex Of Procarboxypeptidase A, Proproteinase E, And Chymotrypsinogen C [Bos taurus]</Hit_def>
  <Hit_accession>1PYT_C</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.3445</Hsp_bit-score>
      <Hsp_score>207</Hsp_score>
      <Hsp_evalue>6.31996e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>253</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>65</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKY--WGTKIKDAMICAGASGVSSCMGDSGGPLVCK-KNGAWTLVGIVSWGSST-CST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDKLQEALLPVVDYEHCSQYDWWGITVKKTMVCAGGDTRSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDWINETIASN</Hsp_hseq>
      <Hsp_midline>PD+LQ+A LP++   +C +Y  WG  +K  M+CAG    S C GDSGGPL C   +G+W + G+ S+ S+  C+T   P V+ RV+A ++W+ +T+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>61</Hit_num>
  <Hit_id>pdb|6VVU|A</Hit_id>
  <Hit_def>Chain A, Tryptase alpha/beta-1 [Homo sapiens] &gt;pdb|6VVU|B Chain B, Tryptase alpha/beta-1 [Homo sapiens] &gt;pdb|6VVU|C Chain C, Tryptase alpha/beta-1 [Homo sapiens] &gt;pdb|6VVU|D Chain D, Tryptase alpha/beta-1 [Homo sapiens]</Hit_def>
  <Hit_accession>6VVU_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>84.7297</Hsp_bit-score>
      <Hsp_score>208</Hsp_score>
      <Hsp_evalue>6.38506e-21</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>172</Hsp_hit-from>
      <Hsp_hit-to>271</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         ++D M+CAG +   SC GDSGGPLVCK NG W   G+VSWG      + PG+Y RVT  ++W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>62</Hit_num>
  <Hit_id>pdb|4H4F|A</Hit_id>
  <Hit_def>Crystal structure of human chymotrypsin C (CTRC) bound to inhibitor eglin c from Hirudo medicinalis [Homo sapiens]</Hit_def>
  <Hit_accession>4H4F_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.9593</Hsp_bit-score>
      <Hsp_score>206</Hsp_score>
      <Hsp_evalue>7.54871e-21</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>65</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGV-SSCMGDSGGPLVCK-KNGAWTLVGIVSWGSST-CST-STPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>DKLQQGLQPVVDHATCSRIDWWGFRVKKTMVCAGGDGVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYIDWINEKM</Hsp_hseq>
      <Hsp_midline>D+LQQ   P++ +  C +  +WG ++K  M+CAG  GV S+C GDSGGPL C+ +NG+W + GIVS+GS   C+T   P VY RV+A ++W+ + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>63</Hit_num>
  <Hit_id>pdb|3TGJ|E</Hit_id>
  <Hit_def>S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin Inhibitor (Bpti) [Rattus norvegicus]</Hit_def>
  <Hit_accession>3TGJ_E</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.5741</Hsp_bit-score>
      <Hsp_score>205</Hsp_score>
      <Hsp_evalue>9.96468e-21</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>233</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDAGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GD+GGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>64</Hit_num>
  <Hit_id>pdb|1FMG|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.04% POLYDOCANOL [Sus scrofa] &gt;pdb|1FN6|A CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.1% POLYDOCANOL [Sus scrofa] &gt;pdb|1FNI|A CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.01% POLYDOCANOL [Sus scrofa] &gt;pdb|1MCT|A THE REFINED 1.6 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PORCINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY [Sus scrofa] &gt;pdb|1QQU|A Crystal Structure Of Porcine Beta Trypsin With Bound Acetate Ion [Sus scrofa]</Hit_def>
  <Hit_accession>1FMG_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.1889</Hsp_bit-score>
      <Hsp_score>204</Hsp_score>
      <Hsp_evalue>1.01767e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>48</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSCQGDSGGPVVC--NG--QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN</Hsp_hseq>
      <Hsp_midline>P  LQ    P+LSN++CK  +  +I   MIC G    G  SC GDSGGP+VC  NG   L GIVSWG      + PGVY +V   VNW+QQT+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>65</Hit_num>
  <Hit_id>pdb|1LTO|A</Hit_id>
  <Hit_def>Human alpha1-tryptase [Homo sapiens] &gt;pdb|1LTO|B Human alpha1-tryptase [Homo sapiens] &gt;pdb|1LTO|C Human alpha1-tryptase [Homo sapiens] &gt;pdb|1LTO|D Human alpha1-tryptase [Homo sapiens]</Hit_def>
  <Hit_accession>1LTO_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.5741</Hsp_bit-score>
      <Hsp_score>205</Hsp_score>
      <Hsp_evalue>1.05579e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>101</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTK-------IKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>PFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAGNSQRDSCKGDSGGPLVCKVNGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYLDWIHHYVP</Hsp_hseq>
      <Hsp_midline>P  L+Q  +P++ N  C  K + G         I+D M+CAG S   SC GDSGGPLVCK NG W   G+VSW       + PG+Y RVT  ++W+   + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>66</Hit_num>
  <Hit_id>pdb|1K9O|E</Hit_id>
  <Hit_def>Crystal Structure Of Michaelis Serpin-Trypsin Complex [Rattus norvegicus] &gt;pdb|1YKT|A Trypsin/Bpti complex mutant [Rattus norvegicus] &gt;pdb|1YLC|A Trypsin/BPTI complex mutant [Rattus norvegicus] &gt;pdb|1YLD|A Trypsin/BPTI complex mutant [Rattus norvegicus] &gt;pdb|3FP7|E Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) cleaved at the scissile bond (LYS15-ALA16) determined to the 1.46 A resolution limit [Rattus norvegicus] &gt;pdb|3FP8|E Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) determined to the 1.46 A resolution limit [Rattus norvegicus]</Hit_def>
  <Hit_accession>1K9O_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.8037</Hsp_bit-score>
      <Hsp_score>203</Hsp_score>
      <Hsp_evalue>1.19385e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDAGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GD+GGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>67</Hit_num>
  <Hit_id>pdb|1ANB|A</Hit_id>
  <Hit_def>Anionic Trypsin Mutant With Ser 214 Replaced By Glu [Rattus rattus]</Hit_def>
  <Hit_accession>1ANB_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.8037</Hsp_bit-score>
      <Hsp_score>203</Hsp_score>
      <Hsp_evalue>1.28618e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVEWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIV WG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>68</Hit_num>
  <Hit_id>pdb|1PYT|D</Hit_id>
  <Hit_def>Ternary Complex Of Procarboxypeptidase A, Proproteinase E, And Chymotrypsinogen C [Bos taurus]</Hit_def>
  <Hit_accession>1PYT_D</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>83.5741</Hsp_bit-score>
      <Hsp_score>205</Hsp_score>
      <Hsp_evalue>1.35065e-20</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>156</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNC--KKYWGTKIKDAMICAGASGV-SSCMGDSGGPLVCKKNGAWTLVGIVSWGSS-TCST-STPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>ELQQGLQPVVDYATCSQRDWWGTTVKETMVCAGGDGVISACNGDSGGPLNCQADGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSAYIDWINQKL</Hsp_hseq>
      <Hsp_midline> LQQ   P++    C  + +WGT +K+ M+CAG  GV S+C GDSGGPL C+ +G W + GIVS+GS  +C+T   P V+ RV+A ++W+ Q L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>69</Hit_num>
  <Hit_id>pdb|3W94|A</Hit_id>
  <Hit_def>Structure of Oryzias latipes enteropeptidase light chain [Oryzias latipes] &gt;pdb|3W94|B Structure of Oryzias latipes enteropeptidase light chain [Oryzias latipes]</Hit_def>
  <Hit_accession>3W94_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.8037</Hsp_bit-score>
      <Hsp_score>203</Hsp_score>
      <Hsp_evalue>1.52821e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>92</Hsp_query-to>
      <Hsp_hit-from>141</Hsp_hit-from>
      <Hsp_hit-to>233</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTK-IKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQT</Hsp_qseq>
      <Hsp_hseq>PDILQEAEVPLVDQDECQRLLPEYTFTSSMLCAGYPEGGVDSCQGDSGGPLMCLEDARWTLIGVTSFGVGCGRPERPGAYARVSAFTSWIAET</Hsp_hseq>
      <Hsp_midline>PD LQ+A +PL+    C++         +M+CAG    GV SC GDSGGPL+C ++  WTL+G+ S+G        PG YARV+A  +W+ +T</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>70</Hit_num>
  <Hit_id>pdb|1ANC|A</Hit_id>
  <Hit_def>Anionic Trypsin Mutant With Ser 214 Replaced By Lys [Rattus rattus]</Hit_def>
  <Hit_accession>1ANC_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.4185</Hsp_bit-score>
      <Hsp_score>202</Hsp_score>
      <Hsp_evalue>1.73261e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVKWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIV WG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>71</Hit_num>
  <Hit_id>pdb|1F5R|A</Hit_id>
  <Hit_def>Rat Trypsinogen Mutant Complexed With Bovine Pancreatic Trypsin Inhibitor [Rattus norvegicus]</Hit_def>
  <Hit_accession>1F5R_A</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.8037</Hsp_bit-score>
      <Hsp_score>203</Hsp_score>
      <Hsp_evalue>1.8379e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLKCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD L+    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>72</Hit_num>
  <Hit_id>pdb|3TGK|E</Hit_id>
  <Hit_def>TRYPSINOGEN MUTANT D194N AND DELETION OF ILE 16-VAL 17 COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) [Rattus norvegicus]</Hit_def>
  <Hit_accession>3TGK_E</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.0333</Hsp_bit-score>
      <Hsp_score>201</Hsp_score>
      <Hsp_evalue>2.83982e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGNSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC G+SGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>73</Hit_num>
  <Hit_id>pdb|1DPO|A</Hit_id>
  <Hit_def>Structure Of Rat Trypsin [Rattus rattus]</Hit_def>
  <Hit_accession>1DPO_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.0333</Hsp_bit-score>
      <Hsp_score>201</Hsp_score>
      <Hsp_evalue>2.88697e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDCGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GD GGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>74</Hit_num>
  <Hit_id>pdb|1AVW|A</Hit_id>
  <Hit_def>Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN Inhibitor, Orthorhombic Crystal Form [Sus scrofa] &gt;pdb|1AVX|A Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN Inhibitor, Tetragonal Crystal Form [Sus scrofa] &gt;pdb|1EJA|A Structure Of Porcine Trypsin Complexed With Bdellastasin, An Antistasin-type Inhibitor [Sus scrofa] &gt;pdb|1H9H|E COMPLEX OF EETI-II WITH PORCINE TRYPSIN [Sus scrofa] &gt;pdb|1H9I|E COMPLEX OF EETI-II MUTANT WITH PORCINE TRYPSIN [Sus scrofa] &gt;pdb|1LDT|T COMPLEX OF LEECH-DERIVED TRYPTASE INHIBITOR WITH PORCINE TRYPSIN [Sus scrofa] &gt;pdb|1S5S|A Porcine trypsin complexed with guanidine-3-propanol inhibitor [Sus scrofa] &gt;pdb|1S6F|A PORCINE TRYPSIN COVALENT COMPLEX WITH BORATE AND GUANIDINE-3 INHIBITOR [Sus scrofa] &gt;pdb|1S6H|A PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR [Sus scrofa] &gt;pdb|1S81|A PORCINE TRYPSIN WITH NO INHIBITOR BOUND [Sus scrofa] &gt;pdb|1S82|A PORCINE TRYPSIN COMPLEXED WITH BORATE AND ETHYLENE GLYCOL [Sus scrofa] &gt;pdb|1S83|A PORCINE TRYPSIN COMPLEXED WITH 4-AMINO PROPANOL [Sus scrofa] &gt;pdb|1S84|A PORCINE TRYPSIN COVALENT COMPLEX WITH 4-AMINO BUTANOL, BORATE AND ETHYLENE GLYCOL [Sus scrofa] &gt;pdb|1S85|A PORCINE TRYPSIN COMPLEXED WITH P-HYDROXYMETHYL BENZAMIDINE AND BORATE [Sus scrofa] &gt;pdb|1TFX|A Complex Of The Second Kunitz Domain Of Tissue Factor Pathway Inhibitor With Porcine Trypsin [Sus scrofa] &gt;pdb|1TFX|B Complex Of The Second Kunitz Domain Of Tissue Factor Pathway Inhibitor With Porcine Trypsin [Sus scrofa] &gt;pdb|1TX6|A trypsin:BBI complex [Sus scrofa] &gt;pdb|1TX6|B trypsin:BBI complex [Sus scrofa] &gt;pdb|1TX6|C trypsin:BBI complex [Sus scrofa] &gt;pdb|1TX6|D trypsin:BBI complex [Sus scrofa] &gt;pdb|1V6D|A The crystal structure of the trypsin complex with synthetic heterochiral peptide [Sus scrofa] &gt;pdb|1YF4|A Crystal Structure of trypsin-vasopressin complex [Sus scrofa] &gt;pdb|1Z7K|A Crystal Structure of Trypsin- Ovomucoid turkey egg white inhibitor complex [Sus scrofa] &gt;pdb|2A31|A Trypsin in complex with borate [Sus scrofa] &gt;pdb|2A32|A Trypsin in complex with benzene boronic acid [Sus scrofa] &gt;pdb|4DOQ|A Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI [Sus scrofa] &gt;pdb|4DOQ|C Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI [Sus scrofa] &gt;pdb|4DOQ|E Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI [Sus scrofa]</Hit_def>
  <Hit_accession>1AVW_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.6481</Hsp_bit-score>
      <Hsp_score>200</Hsp_score>
      <Hsp_evalue>3.53334e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVC--NG--QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN</Hsp_hseq>
      <Hsp_midline>P  LQ    P+LS+++CK  +  +I   MIC G    G  SC GDSGGP+VC  NG   L GIVSWG      + PGVY +V   VNW+QQT+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>75</Hit_num>
  <Hit_id>pdb|1AN1|E</Hit_id>
  <Hit_def>Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX [Sus scrofa] &gt;pdb|1C9P|A Complex Of Bdellastasin With Porcine Trypsin [Sus scrofa]</Hit_def>
  <Hit_accession>1AN1_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.6481</Hsp_bit-score>
      <Hsp_score>200</Hsp_score>
      <Hsp_evalue>3.53334e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVC--NG--QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN</Hsp_hseq>
      <Hsp_midline>P  LQ    P+LS+++CK  +  +I   MIC G    G  SC GDSGGP+VC  NG   L GIVSWG      + PGVY +V   VNW+QQT+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>76</Hit_num>
  <Hit_id>pdb|3MYW|A</Hit_id>
  <Hit_def>The Bowman-Birk type inhibitor from mung bean in ternary complex with porcine trypsin [Sus scrofa] &gt;pdb|3MYW|B The Bowman-Birk type inhibitor from mung bean in ternary complex with porcine trypsin [Sus scrofa]</Hit_def>
  <Hit_accession>3MYW_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.6481</Hsp_bit-score>
      <Hsp_score>200</Hsp_score>
      <Hsp_evalue>3.68685e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSLLQCLKAPVLSDSSCKSAYPGQITGNMICVGFLEGGKDSCQGDSGGPVVC--NG--QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN</Hsp_hseq>
      <Hsp_midline>P  LQ    P+LS+++CK  +  +I   MIC G    G  SC GDSGGP+VC  NG   L GIVSWG      + PGVY +V   VNW+QQT+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>77</Hit_num>
  <Hit_id>pdb|1FON|A</Hit_id>
  <Hit_def>Crystal Structure Of Bovine Procarboxypeptidase A-S6 Subunit Iii, A Highly Structured Truncated Zymogen E [Bos taurus] &gt;pdb|1FON|B Crystal Structure Of Bovine Procarboxypeptidase A-S6 Subunit Iii, A Highly Structured Truncated Zymogen E [Bos taurus]</Hit_def>
  <Hit_accession>1FON_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>82.0333</Hsp_bit-score>
      <Hsp_score>201</Hsp_score>
      <Hsp_evalue>3.92428e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>240</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKY--WGTKIKDAMICAGASGVSSCMGDSGGPLVCK-KNGAWTLVGIVSWGSST-CST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDKLQQALLPTVDYEHCSQWDWWGITVKKTMVCAGGDTRSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDWIDETIASN</Hsp_hseq>
      <Hsp_midline>PD+LQQA LP +   +C ++  WG  +K  M+CAG    S C GDSGGPL C   +G+W + G+ S+ S+  C+T   P V+ RV+A ++W+ +T+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>78</Hit_num>
  <Hit_id>pdb|4AN7|A</Hit_id>
  <Hit_def>Kunitz type trypsin inhibitor complex with porcine trypsin [Sus scrofa] &gt;pdb|5XWJ|A Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 7 [Sus scrofa] &gt;pdb|5XWJ|B Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 7 [Sus scrofa] &gt;pdb|5XWL|A Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 10 [Sus scrofa] &gt;pdb|5XWL|B Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 10 [Sus scrofa]</Hit_def>
  <Hit_accession>4AN7_A</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.6481</Hsp_bit-score>
      <Hsp_score>200</Hsp_score>
      <Hsp_evalue>3.94562e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVC--NG--QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN</Hsp_hseq>
      <Hsp_midline>P  LQ    P+LS+++CK  +  +I   MIC G    G  SC GDSGGP+VC  NG   L GIVSWG      + PGVY +V   VNW+QQT+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>79</Hit_num>
  <Hit_id>pdb|3VEQ|B</Hit_id>
  <Hit_def>A binary complex betwwen bovine pancreatic trypsin and a engineered mutant trypsin inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3VEQ_B</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.2629</Hsp_bit-score>
      <Hsp_score>199</Hsp_score>
      <Hsp_evalue>5.23608e-20</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----AGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    A  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>80</Hit_num>
  <Hit_id>pdb|1BRA|A</Hit_id>
  <Hit_def>RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN [Rattus rattus] &gt;pdb|1BRB|E CRYSTAL STRUCTURES OF RAT ANIONIC TRYPSIN COMPLEXED WITH THE PROTEIN INHIBITORS APPI AND BPTI [Rattus norvegicus] &gt;pdb|1BRC|E RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN [Rattus norvegicus]</Hit_def>
  <Hit_accession>1BRA_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>81.2629</Hsp_bit-score>
      <Hsp_score>199</Hsp_score>
      <Hsp_evalue>5.88544e-20</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKGSCQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPDVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+  +  KI D M+C G    G  SC GDSGGP+VC  NG   L GIVSWG        P VY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>81</Hit_num>
  <Hit_id>pdb|1BTP|A</Hit_id>
  <Hit_def>Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4- (Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-N- Allylglycine Methanesulfonate To Bovine Trypsin, Revealed By The Crystal Structure Of The Complex [Bos taurus] &gt;pdb|1BTW|A Episelection: novel KI ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface [Bos taurus] &gt;pdb|1BTX|A Episelection: Novel Ki ~Nanomolar Inhibitors of Serine Proteases Selected by Binding or Chemistry on an Enzyme Surface [Bos taurus] &gt;pdb|1BTY|A Crystal structure of beta-trypsin in complex with benzamidine [Bos taurus] &gt;pdb|1BTZ|A Episelection: novel KI ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface [Bos taurus] &gt;pdb|1TGB|A Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms Resolution. Ii. Crystallographic Refinement, Refined Crystal Structure And Comparison With Bovine Trypsin [Bos taurus] &gt;pdb|1TGC|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|1TGN|A STRUCTURE OF BOVINE TRYPSINOGEN AT 1.9 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|1TGS|Z Three-Dimensional Structure Of The Complex Between Pancreatic Secretory Inhibitor (Kazal Type) And Trypsinogen At 1.8 Angstroms Resolution. Structure Solution, Crystallographic Refinement And Preliminary Structural Interpretation [Bos taurus] &gt;pdb|1TGT|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|1TNG|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNH|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNI|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNJ|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNK|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|1TNL|A PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS [Bos taurus] &gt;pdb|2TGA|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|2TGD|A LACK OF THE TRANSITION STATE STABILIZATION SITE IS A FACTOR IN THE INACTIVITY OF TRYPSINOGEN, A SERINE PROTEASE ZYMOGEN. STRUCTURE OF DFP INHIBITED BOVINE TRYPSINOGEN AT 2.1 ANGSTROMS RESOLUTION [Bos taurus] &gt;pdb|2TGP|Z The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|2TGT|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|2TPI|Z On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|3TPI|Z The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|4TPI|Z The Refined 2.2-angstroms (0.22-nm) X-ray Crystal Structure Of The Ternary Complex Formed By Bovine Trypsinogen, Valine-valine And The Arg15 Analogue Of Bovine Pancreatic Trypsin Inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>1BTP_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.4925</Hsp_bit-score>
      <Hsp_score>197</Hsp_score>
      <Hsp_evalue>1.3749e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>229</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>82</Hit_num>
  <Hit_id>pdb|1Y59|T</Hit_id>
  <Hit_def>Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant [Bos taurus] &gt;pdb|1Y5A|T Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant [Bos taurus] &gt;pdb|1Y5B|T Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant [Bos taurus] &gt;pdb|1Y5U|T Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant [Bos taurus]</Hit_def>
  <Hit_accession>1Y59_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.37676e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>83</Hit_num>
  <Hit_id>pdb|3QK1|A</Hit_id>
  <Hit_def>Crystal Structure of Enterokinase-like Trypsin Variant [Bos taurus]</Hit_def>
  <Hit_accession>3QK1_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.4925</Hsp_bit-score>
      <Hsp_score>197</Hsp_score>
      <Hsp_evalue>1.38955e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>84</Hit_num>
  <Hit_id>pdb|4NIV|A</Hit_id>
  <Hit_def>Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) trigonal form [Bos taurus] &gt;pdb|4NIW|A Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) orthorhombic form [Bos taurus] &gt;pdb|4NIX|A Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) orthorhombic form, zinc-bound [Bos taurus] &gt;pdb|4NIY|A Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin) [Bos taurus] &gt;pdb|4NIY|B Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin) [Bos taurus] &gt;pdb|4NIY|C Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin) [Bos taurus] &gt;pdb|4NIY|D Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin) [Bos taurus]</Hit_def>
  <Hit_accession>4NIV_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.45183e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKKSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>85</Hit_num>
  <Hit_id>pdb|2D8W|A</Hit_id>
  <Hit_def>Structure of HYPER-VIL-trypsin [Bos taurus]</Hit_def>
  <Hit_accession>2D8W_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.45183e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGXLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>86</Hit_num>
  <Hit_id>pdb|2FI5|E</Hit_id>
  <Hit_def>Crystal structure of a BPTI variant (Cys38-&gt;Ser) in complex with trypsin [Bos taurus] &gt;pdb|2FTM|A Crystal structure of trypsin complexed with the BPTI variant (Tyr35-&gt;Gly) [Bos taurus]</Hit_def>
  <Hit_accession>2FI5_E</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.49345e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>133</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>87</Hit_num>
  <Hit_id>pdb|1AQ7|A</Hit_id>
  <Hit_def>Trypsin With Inhibitor Aeruginosin 98-b [Bos taurus] &gt;pdb|1AUJ|A Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor [Bos taurus] &gt;pdb|1AZ8|A Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor [Bos taurus] &gt;pdb|1BJU|A Beta-Trypsin Complexed With Acpu [Bos taurus] &gt;pdb|1BJV|A Beta-Trypsin Complexed With Appu [Bos taurus] &gt;pdb|1C1N|A Chain A, TRYPSIN [Bos taurus] &gt;pdb|1C1O|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1P|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1Q|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1R|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1S|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C1T|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2D|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2E|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2F|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2G|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2H|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2I|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2J|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2K|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2L|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C2M|A RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Bos taurus] &gt;pdb|1C5P|A Chain A, PROTEIN (TRYPSIN) [Bos taurus] &gt;pdb|1C5Q|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5R|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5S|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5T|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5U|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C5V|A STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Bos taurus] &gt;pdb|1C9T|A Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|B Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|C Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|D Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|E Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1C9T|F Complex Of Bdellastasin With Bovine Trypsin [Bos taurus] &gt;pdb|1CE5|A BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE [Bos taurus] &gt;pdb|1D6R|A Crystal Structure Of Cancer Chemopreventive Bowman-birk Inhibitor In Ternary Complex With Bovine Trypsin At 2.3 A Resolution. Structural Basis Of Janus-faced Serine Protease Inhibitor Specificity [Bos taurus] &gt;pdb|1EB2|A Trypsin inhibitor complex (BPO) [Bos taurus] &gt;pdb|1EJM|A CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN [Bos taurus] &gt;pdb|1EJM|C CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN [Bos taurus] &gt;pdb|1EJM|E CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN [Bos taurus] &gt;pdb|1F2S|E Crystal Structure Of The Complex Formed Between Bovine Beta-trypsin And Mcti-a, A Trypsin Inhibitor Of Squash Family At 1.8 A Resolution [Bos taurus] &gt;pdb|1G36|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1G9I|E CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE [Bos taurus] &gt;pdb|1GBT|A Structure Of An Acyl-Enzyme Intermediate During Catalysis: (Guanidinobenzoyl) Trypsin [Bos taurus] &gt;pdb|1GHZ|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI0|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI1|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI2|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI3|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI4|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI5|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GI6|A A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Bos taurus] &gt;pdb|1GJ6|A ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Bos taurus] &gt;pdb|1J8A|A Crystal Structure Of Benzamidine Inhibited Bovine Pancreatic Trypsin At 105k To 1.21a Resolution From Laboratory Source With High Number Of Waters Modelled [Bos taurus] &gt;pdb|1JIR|A Crystal Structure of Trypsin Complex with Amylamine in Cyclohexane [Bos taurus] &gt;pdb|1JRS|A HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN [Bos taurus] &gt;pdb|1JRT|A HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN [Bos taurus] &gt;pdb|1K1I|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1J|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1L|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1M|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1N|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1O|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1K1P|A Bovine Trypsin-Inhibitor Complex [Bos taurus] &gt;pdb|1MAX|A Beta-Trypsin Phosphonate Inhibited [Bos taurus] &gt;pdb|1MAY|A Beta-Trypsin Phosphonate Inhibited [Bos taurus] &gt;pdb|1MTS|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1MTU|A FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN [Bos taurus] &gt;pdb|1MTV|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1MTW|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1N6X|A RIP-phasing on Bovine Trypsin [Bos taurus] &gt;pdb|1N6Y|A RIP-phasing on Bovine Trypsin [Bos taurus] &gt;pdb|1NC6|A Potent, small molecule inhibitors of human mast cell tryptase. Anti-asthmatic action of a dipeptide-based transition state analogue containing benzothiazole ketone [Bos taurus] &gt;pdb|1O2H|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2I|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2J|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2K|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2L|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2M|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2N|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2O|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2P|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2Q|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2R|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2S|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2T|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2U|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2V|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2W|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2X|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2Y|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O2Z|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O30|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O31|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O32|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O33|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O34|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O35|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O36|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O37|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O38|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O39|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3A|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3B|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3C|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3D|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3E|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3F|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3G|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3H|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3I|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3J|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3K|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3L|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3M|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3N|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1O3O|A Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Bos taurus] &gt;pdb|1OX1|A crystal structure of the bovine trypsin complex with a synthetic 11 peptide inhibitor [Bos taurus] &gt;pdb|1OYQ|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1P2I|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2J|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1P2K|A Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin [Bos taurus] &gt;pdb|1PPC|E Geometry Of Binding Of The Benzamidine-and Arginine-based Inhibitors N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-amidinophenylalanyl- Piperidine (napap) And (2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4- Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray Crystallographic Determination Of The Napap-trypsin Complex And Modeling Of Napap- Thrombin And Mqpa-thrombin [Bos taurus] &gt;pdb|1PPE|E The Refined 2.0 Angstroms X-Ray Crystal Structure Of The Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima): Topological Similarity Of The Squash Seed Inhibitors With The Carboxypeptidase A Inhibitor From Potatoes [Bos taurus] &gt;pdb|1PPH|E Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To Thrombin And Trypsin: X- Ray Crystal Structures Of Their Trypsin Complexes And Modeling Of Their Thrombin Complexes [Sus scrofa] &gt;pdb|1QA0|A BOVINE TRYPSIN 2-AMINOBENZIMIDAZOLE COMPLEX [Bos taurus] &gt;pdb|1QB1|A Bovine Trypsin with 1-[2-[5-[amino(imino)methyl]-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid (ZK-806974) [Bos taurus] &gt;pdb|1QB6|A Bovine Trypsin 3,3&apos;-[3,5-Difluoro-4-Methyl-2, 6- Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk- 805623) Complex [Bos taurus] &gt;pdb|1QB9|A Bovine Trypsin 7-[[2-[[1-(1-iminoethyl)piperidin-4-yl]oxy]-9h- Carbozol-9-yl] Methyl]naphthalene-2-carboximidamide (zk-806450) Complex [Bos taurus] &gt;pdb|1QBN|A Bovine Trypsin 2-[amino(imino)methyl]-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridine-4-carboxylic Acid (ZK-806688) Complex [Bos taurus] &gt;pdb|1QBO|A Bovine Trypsin 7-[[6-[[1-(1-iminoethyl)piperidin-4-yl]oxy]-2-methyl- Benzimidazol-1-yl]methyl]naphthalene-2-carboximidamid Zk-806711 Inhibitor Complex [Bos taurus] &gt;pdb|1QCP|A Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta- Trypsin At 1.8 A [Bos taurus] &gt;pdb|1QL7|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1QL8|A Factor Xa Specific Inhibitor In Complex With Bovine Trypsin [Bos taurus] &gt;pdb|1RXP|A Structure Of Trypsin (Orthorhombic) With 1-(4-Tert- Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino- Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid [Bos taurus] &gt;pdb|1S0Q|A Native Bovine Pancreatic Trypsin [Bos taurus] &gt;pdb|1S0R|A Bovine Pancreatic Trypsin inhibited with Benzamidine at Atomic resolution [Bos taurus] &gt;pdb|1SBW|A Crystal Structure Of Mung Bean Inhibitor Lysine Active Fragment Complex With Bovine Beta-Trypsin At 1.8a Resolution [Bos taurus] &gt;pdb|1SFI|A High resolution structure of a potent, cyclic protease inhibitor from sunflower seeds [Bos taurus] &gt;pdb|1SMF|E Studies on an artificial trypsin inhibitor peptide derived from the mung bean inhibitor [Bos taurus] &gt;pdb|1TAB|E Structure Of The Trypsin-Binding Domain Of Bowman-Birk Type Protease Inhibitor And Its Interaction With Trypsin [Bos taurus] &gt;pdb|1TIO|A Chain A, PROTEIN (BETA-TRYPSIN) [Bos taurus] &gt;pdb|1TLD|A Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms Resolution In A Crystal Form With Low Molecular Packing Density. Active Site Geometry, Ion Pairs And Solvent Structure [Bos taurus] &gt;pdb|1TPA|E The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|1TPO|A The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|1TPP|A The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|1TPS|A Atomic Structure Of The Trypsin-A90720a Complex: A Unified Approach To Structure And Function [Bos taurus] &gt;pdb|1TX7|A Bovine Trypsin complexed with p-amidinophenylmethylphosphinic acid (AMPA) [Bos taurus] &gt;pdb|1TX8|A Bovine Trypsin complexed with AMSO [Bos taurus] &gt;pdb|1TYN|A Atomic Structure Of The Trypsin-cyclotheonamide A Complex: Lessons For The Design Of Serine Protease Inhibitors [Bos taurus] &gt;pdb|1XUF|A TRYPSIN-BABIM-ZN+2, PH 8.2 [Bos taurus] &gt;pdb|1XUG|A TRYPSIN-BABIM-ZN+2, PH 8.2 [Bos taurus] &gt;pdb|1XUH|A TRYPSIN-KETO-BABIM-CO+2, PH 8.2 [Bos taurus] &gt;pdb|1XUI|A TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2 [Bos taurus] &gt;pdb|1XUJ|A TRYPSIN-KETO-BABIM-ZN+2, PH 8.2 [Bos taurus] &gt;pdb|1XUK|A TRYPSIN-BABIM-SULFATE, PH 5.9 [Bos taurus] &gt;pdb|1Y3U|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1Y3V|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1Y3W|A TRYPSIN INHIBITOR COMPLEX [Bos taurus] &gt;pdb|1Y3X|A TRYPSIN INHIBITOR COMPLEX [Bos taurus] &gt;pdb|1Y3Y|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1YP9|A Trypsin Inhibitor Complex [Bos taurus] &gt;pdb|1YYY|1 Trypsin inhibitors with rigid tripeptidyl aldehydes [Bos taurus] &gt;pdb|2A7H|A On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength [Bos taurus] &gt;pdb|2AGE|X Succinyl-AAPR-trypsin acyl-enzyme at 1.15 A resolution [Bos taurus] &gt;pdb|2AGG|X succinyl-AAPK-trypsin acyl-enzyme at 1.28 A resolution [Bos taurus] &gt;pdb|2AGI|X The leupeptin-trypsin covalent complex at 1.14 A resolution [Bos taurus] &gt;pdb|2AH4|X guanidinobenzoyl-trypsin acyl-enzyme at 1.13 A resolution [Bos taurus] &gt;pdb|2AYW|A Crystal Structure of the complex formed between trypsin and a designed synthetic highly potent inhibitor in the presence of benzamidine at 0.97 A resolution [Bos taurus] &gt;pdb|2BLV|A Trypsin before a high dose x-ray &apos;burn&apos; [Bos taurus] &gt;pdb|2BLW|A Trypsin after a high dose X-ray &apos;Burn&apos; [Bos taurus] &gt;pdb|2BTC|E Bovine Trypsin In Complex With Squash Seed Inhibitor (Cucurbita Pepo Trypsin Inhibitor Ii) [Bos taurus] &gt;pdb|2BZA|A BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZYLAMINE [Bos taurus] &gt;pdb|2CMY|A Crystal complex between bovine trypsin and Veronica hederifolia trypsin inhibitor [Bos taurus] &gt;pdb|2F3C|E Crystal structure of infestin 1, a Kazal-type serineprotease inhibitor, in complex with trypsin [Bos taurus] &gt;pdb|2FI3|E Crystal structure of a BPTI variant (Cys14-&gt;Ser, Cys38-&gt;Ser) in complex with trypsin [Bos taurus] &gt;pdb|2FX4|A Bovine trypsin bound by 4-piperidinebutyrate to make acylenzyme complex [Bos taurus] &gt;pdb|2FX6|A bovine trypsin complexed with 2-aminobenzamidazole [Bos taurus] &gt;pdb|2G55|A Anomalous substructure of trypsin (P3121) [Bos taurus] &gt;pdb|2G5N|A Indole-amidine Complexes with Bovine Trypsin [Bos taurus] &gt;pdb|2G5V|A Indole-amidine Complexes with Bovine Trypsin [Bos taurus] &gt;pdb|2G81|E Crystal Structure of the Bowman-Birk Inhibitor from Vigna unguiculata Seeds in Complex with Beta-trypsin at 1.55 Angstrons Resolution [Bos taurus] &gt;pdb|2G8T|A Indole-amidine Complexes with Bovine Trypsin [Bos taurus] &gt;pdb|2ILN|A Crystal structure of the Bowman-Birk inhibitor from snail medic seeds in complex with bovine trypsin [Bos taurus] &gt;pdb|2ILN|B Crystal structure of the Bowman-Birk inhibitor from snail medic seeds in complex with bovine trypsin [Bos taurus] &gt;pdb|2J9N|A Robotically harvested Trypsin complexed with Benzamidine containing polypeptide mediated crystal contacts [Bos taurus] &gt;pdb|2O9Q|A The crystal structure of Bovine Trypsin complexed with a small inhibition peptide ORB2K [Bos taurus] &gt;pdb|2OTV|A Crystal structure of the complex formed between bovine trypsin and nicotinamide at 1.56 A resolution [Bos taurus] &gt;pdb|2OXS|A Crystal Structure of the trypsin complex with benzamidine at high temperature (35 C) [Bos taurus] &gt;pdb|2PLX|A Trypsin complexed to a synthetic peptide from Veronica hederifolia [Bos taurus] &gt;pdb|2PTC|E The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|2PTN|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|2QN5|T Crystal Structure and Functional Study of the Bowman-Birk Inhibitor from Rice Bran in Complex with Bovine Trypsin [Bos taurus] &gt;pdb|2QYI|A Crystal structure of a binary complex between an engineered trypsin inhibitor and Bovine trypsin [Bos taurus] &gt;pdb|2QYI|C Crystal structure of a binary complex between an engineered trypsin inhibitor and Bovine trypsin [Bos taurus] &gt;pdb|2TIO|A Low Packing Density Form Of Bovine Beta-Trypsin In Cyclohexane [Bos taurus] &gt;pdb|2UUY|A Structure of a tick tryptase inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|2XTT|B Bovine trypsin in complex with evolutionary enhanced Schistocerca gregaria protease inhibitor 1 (SGPI-1-P02) [Bos taurus] &gt;pdb|2ZDK|A Exploring Trypsin S3 Pocket [Bos taurus] &gt;pdb|2ZDL|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZDM|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZDN|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZFS|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZFT|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZHD|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZQ1|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|2ZQ2|A Exploring trypsin S3 pocket [Bos taurus] &gt;pdb|3A7T|A Crystal Structure of Trypsin complexed with 4-formylbenzimidamide [Bos taurus] &gt;pdb|3A7V|A Crystal Structure of Trypsin complexed with 3-formylbenzimidamide [Bos taurus] &gt;pdb|3A7W|A Crystal Structure of Trypsin complexed with (E)-4-((tetrahydro-2H-pyran-2-yloxyimino)methyl)benzimidamide (soaking 4hours) [Bos taurus] &gt;pdb|3A7X|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 45seconds) [Bos taurus] &gt;pdb|3A7Y|A Crystal Structure of Trypsin complexed with (E)-4-((1-methylpiperidin-3-yloxyimino)methyl)benzimidamide (soaking 2hours) [Bos taurus] &gt;pdb|3A7Z|A Crystal Structure of Trypsin complexed with (E)-4-((1-methylpiperidin-4-yloxyimino)methyl)benzimidamide (soaking 3hours) [Bos taurus] &gt;pdb|3A80|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)-2-methylpropanoic acid (soaking 40seconds) [Bos taurus] &gt;pdb|3A81|A Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 8 hours) [Bos taurus] &gt;pdb|3A82|A Crystal Structure of Trypsin complexed with pre-synthesized (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid [Bos taurus] &gt;pdb|3A83|A Crystal Structure of Trypsin complexed with pre-synthesized (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide [Bos taurus] &gt;pdb|3A84|A Crystal Structure of Trypsin complexed with(E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 5 seconds) [Bos taurus] &gt;pdb|3A85|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 15 seconds) [Bos taurus] &gt;pdb|3A86|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 30 seconds) [Bos taurus] &gt;pdb|3A87|A Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 5 minutes) [Bos taurus] &gt;pdb|3A88|A Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 30 minutes) [Bos taurus] &gt;pdb|3A89|A Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 4 hours) [Bos taurus] &gt;pdb|3A8A|A Crystal Structure of Trypsin complexed with 4-formylbenzimidamide and aniline [Bos taurus] &gt;pdb|3A8B|A Crystal Structure of Trypsin complexed with (E)-4-((4-bromophenylimino)methyl)benzimidamide [Bos taurus] &gt;pdb|3A8C|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking with mixture of [(E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid] and [(E)-2-(4-carbamimidoylbenzylideneaminooxy)-2-methylpropanoic acid]) [Bos taurus] &gt;pdb|3A8D|A Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (under aniline-free condition) [Bos taurus] &gt;pdb|3AAS|A Bovine beta-trypsin bound to meta-guanidino schiff base copper (II) chelate [Bos taurus] &gt;pdb|3AAU|A Bovine beta-trypsin bound to meta-diguanidino schiff base copper (II) chelate [Bos taurus] &gt;pdb|3AAV|A Bovine beta-trypsin bound to meta-diamidino schiff base copper (II) chelate [Bos taurus] &gt;pdb|3AAV|B Bovine beta-trypsin bound to meta-diamidino schiff base copper (II) chelate [Bos taurus] &gt;pdb|3ATI|A Crystal structure of trypsin complexed with (3-methoxyphenyl)methanamine [Bos taurus] &gt;pdb|3ATK|A Crystal structure of trypsin complexed with cycloheptanamine [Bos taurus] &gt;pdb|3ATL|A Crystal structure of trypsin complexed with benzamidine [Bos taurus] &gt;pdb|3ATM|A Crystal structure of trypsin complexed with 2-(1H-indol-3-yl)ethanamine [Bos taurus] &gt;pdb|3BTD|E The Crystal Structures of the Complexes Between the Bovine Beta-Trypsin and Ten P1 Variants of BPTI. [Bos taurus] &gt;pdb|3BTE|E The Crystal Structures of the Complexes Between Bovine Beta-Trypsin and Ten P1 Variants of BPTI. [Bos taurus] &gt;pdb|3BTF|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI. [Bos taurus] &gt;pdb|3BTG|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTH|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTK|E The Crystal Structures Of The Complexes Between Bovine Beta- Trypsin And Ten P1 Variants Of Bpti [Bos taurus] &gt;pdb|3BTM|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTQ|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTT|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3BTW|E THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI [Bos taurus] &gt;pdb|3D65|E Crystal structure of Textilinin-1, a Kunitz-type serine protease inhibitor from the Australian Common Brown snake venom, in complex with trypsin [Bos taurus] &gt;pdb|3E8L|A The Crystal Structure of the Double-headed Arrowhead Protease Inhibitor A in Complex with Two Trypsins [Bos taurus] &gt;pdb|3E8L|B The Crystal Structure of the Double-headed Arrowhead Protease Inhibitor A in Complex with Two Trypsins [Bos taurus] &gt;pdb|3GY2|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY3|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY4|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY5|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY6|A A comparative study on the inhibition of bovine beta-trypsin by the bis-benzamidines diminazene and pentamidine [Bos taurus] &gt;pdb|3GY7|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3GY8|A A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC [Bos taurus] &gt;pdb|3I29|A Crystal structure of a binary complex between an mutant trypsin inhibitor with bovine trypsin [Bos taurus] &gt;pdb|3ITI|A Structure of bovine trypsin with the MAD triangle B3C [Bos taurus] &gt;pdb|3LJJ|A Bovine trypsin in complex with UB-THR 10 [Bos taurus] &gt;pdb|3LJO|A Bovine trypsin in complex with UB-THR 11 [Bos taurus] &gt;pdb|3M35|A Trypsin in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2&apos;-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423) [Bos taurus] &gt;pdb|3M7Q|A Crystal structure of recombinant Kunitz Type serine protease Inhibitor-1 from the Caribbean sea anemone stichodactyla helianthus in complex with bovine pancreatic trypsin [Bos taurus] &gt;pdb|3MFJ|A Bovine trypsin at 0.8 A resolution, restrained refinement [Bos taurus] &gt;pdb|3MI4|A Bovine trypsin at 0.8 A resolution, non-restrained refinement [Bos taurus] &gt;pdb|3NK8|A Trypsin in complex with fluorine-containing fragment [Bos taurus] &gt;pdb|3NKK|A Trypsin in complex with fluorine containing fragment [Bos taurus] &gt;pdb|3OTJ|E A Crystal Structure of Trypsin Complexed with BPTI (Bovine Pancreatic Trypsin Inhibitor) by X-ray/Neutron Joint Refinement [Bos taurus] &gt;pdb|3PTB|A The Geometry Of The Reactive Site And Of The Peptide Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors [Bos taurus] &gt;pdb|3PTN|A On The Disordered Activation Domain In Trypsinogen. Chemical Labelling And Low-Temperature Crystallography [Bos taurus] &gt;pdb|3RDZ|A Crystal Structure of rBTI-trypsin complex at 2.26 angstrom resolution [Bos taurus] &gt;pdb|3RDZ|B Crystal Structure of rBTI-trypsin complex at 2.26 angstrom resolution [Bos taurus] &gt;pdb|3RU4|T Crystal structure of the Bowman-Birk serine protease inhibitor BTCI in complex with trypsin and chymotrypsin [Bos taurus] &gt;pdb|3RXA|A Crystal structure of Trypsin complexed with cycloheptanamine [Bos taurus] &gt;pdb|3RXB|A Crystal structure of Trypsin complexed with 4-guanidinobutanoic acid [Bos taurus] &gt;pdb|3RXC|A Crystal structure of Trypsin complexed with 2-aminopyridine [Bos taurus] &gt;pdb|3RXD|A Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamine [Bos taurus] &gt;pdb|3RXE|A Crystal structure of Trypsin complexed with benzamide [Bos taurus] &gt;pdb|3RXF|A Crystal structure of Trypsin complexed with 4-aminopyridine [Bos taurus] &gt;pdb|3RXG|A Crystal structure of Trypsin complexed with 4-aminocyclohexanol [Bos taurus] &gt;pdb|3RXH|A Crystal structure of Trypsin complexed with 2-(1H-imidazol-4-yl)ethanamine [Bos taurus] &gt;pdb|3RXI|A Crystal structure of Trypsin complexed with 2-(1H-indol-3-yl)ethanamine [Bos taurus] &gt;pdb|3RXJ|A Crystal structure of Trypsin complexed with 4-guanidinobenzoic acid [Bos taurus] &gt;pdb|3RXK|A Crystal structure of Trypsin complexed with methyl 4-amino-1-methyl-pyrrolidine-2-carboxylate [Bos taurus] &gt;pdb|3RXL|A Crystal structure of Trypsin complexed with (2,5-dimethyl-3-furyl)methanamine [Bos taurus] &gt;pdb|3RXM|A Crystal structure of Trypsin complexed with [2-(2-thienyl)thiazol-4-yl]methanamine [Bos taurus] &gt;pdb|3RXO|A Crystal structure of Trypsin complexed with (3-pyrrol-1-ylphenyl)methanamine [Bos taurus] &gt;pdb|3RXP|A Crystal structure of Trypsin complexed with (1,5-dimethylpyrazol-3-yl)methanamine [Bos taurus] &gt;pdb|3RXQ|A Crystal structure of Trypsin complexed with benzamide (F01 and F05, cocktail experiment) [Bos taurus] &gt;pdb|3RXR|A Crystal structure of Trypsin complexed with cycloheptanamine (F01 and F03, cocktail experiment) [Bos taurus] &gt;pdb|3RXS|A Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamine (F04 and A06, cocktail experiment) [Bos taurus] &gt;pdb|3RXT|A Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamin (F04 and F03, cocktail experiment) [Bos taurus] &gt;pdb|3RXU|A Crystal structure of Trypsin complexed with benzamide (F05 and A06, cocktail experiment) [Bos taurus] &gt;pdb|3RXV|A Crystal structure of Trypsin complexed with benzamide (F05 and F03, cocktail experiment) [Bos taurus] &gt;pdb|3T25|A TMAO-grown orthorhombic trypsin (bovine) [Bos taurus] &gt;pdb|3T26|A Orthorhombic trypsin (bovine) in the presence of sarcosine [Bos taurus] &gt;pdb|3T27|A Orthorhombic trypsin (bovine) in the presence of betaine [Bos taurus] &gt;pdb|3T28|A TMAO-grown trypsin (bovine)-previously unreported tetragonal crystal form [Bos taurus] &gt;pdb|3T29|A TMAO-grown trigonal trypsin (bovine) [Bos taurus] &gt;pdb|3UNR|A Bond length analysis of asp, glu and his residues in trypsin at 1.2A resolution [Bos taurus] &gt;pdb|3VPK|A Crystal Structure of 6-Guanidinohexanoyl Trypsin [Bos taurus] &gt;pdb|4AB8|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4AB9|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABA|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABB|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABD|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABE|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABF|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABG|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABH|A Fragments bound to bovine trypsin for the SAMPL challenge [Bos taurus] &gt;pdb|4ABI|A Co-complex structure of bovine trypsin with a modified Bowman-Birk inhibitor (PtA)SFTI-1(1,14), that was 1,4-disubstituted with a 1,2,3- trizol to mimic a trans amide bond [Bos taurus] &gt;pdb|4ABJ|A Co-complex structure of bovine trypsin with a modified Bowman-Birk inhibitor (IcA)SFTI-1(1,14), that was 1,5-disubstituted with 1,2,3- trizol to mimic a cis amide bond [Bos taurus] &gt;pdb|4AOQ|A Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A) [Bos taurus] &gt;pdb|4AOQ|B Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A) [Bos taurus] &gt;pdb|4AOQ|C Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A) [Bos taurus] &gt;pdb|4AOR|A Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III) [Bos taurus] &gt;pdb|4AOR|B Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III) [Bos taurus] &gt;pdb|4AOR|C Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III) [Bos taurus] &gt;pdb|4HGC|A Crystal structure of bovine trypsin complexed with sfti-1 analog containing a peptoid residue at position p1 [Bos taurus] &gt;pdb|4I8G|A Bovine trypsin at 0.8 resolution [Bos taurus] &gt;pdb|4I8H|A Bovine trypsin at 0.75 resolution [Bos taurus] &gt;pdb|4I8J|A Bovine trypsin at 0.87 A resolution [Bos taurus] &gt;pdb|4I8K|A Bovine trypsin at 0.85 resolution [Bos taurus] &gt;pdb|4I8L|A Bovine trypsin at 0.87 resolution [Bos taurus] &gt;pdb|4J2Y|B Crystal structure of a plant trypsin inhibitor EcTI in complex with bovine trypsin. [Bos taurus] &gt;pdb|4KTS|A Bovine trypsin in complex with microviridin J at pH 8.5 [Bos taurus] &gt;pdb|4KTU|A Bovine trypsin in complex with microviridin J at pH 6.5 [Bos taurus] &gt;pdb|4MTB|A Bovine trypsin in complex with small molecule inhibitor [Bos taurus] &gt;pdb|4NCY|A In situ trypsin crystallized on a MiTeGen micromesh with imidazole ligand [Bos taurus] &gt;pdb|4TPY|A High throughput screening using acoustic droplet ejection to combine protein crystals and chemical libraries on crystallization plates at high density [Bos taurus] &gt;pdb|4U2W|A Atomic resolution crystal structure of HV-BBI protease inhibitor from amphibian skin in complex with bovine trypsin [Bos taurus] &gt;pdb|4Y0Y|E Trypsin in complex with with BPTI [Bos taurus] &gt;pdb|4Y0Z|E Trypsin in complex with with BPTI mutant AMINOBUTYRIC ACID [Bos taurus] &gt;pdb|4Y10|E Trypsin in complex with with BPTI mutant (2S)-2-amino-4,4-difluorobutanoic acid [Bos taurus] &gt;pdb|4Y11|E Trypsin in complex with with BPTI mutant (2S)-2-amino-4,4,4-trifluorobutanoic acid [Bos taurus] &gt;pdb|4YTA|A BOND LENGTH ANALYSIS OF ASP, GLU AND HIS RESIDUES IN TRYPSIN AT 1.2A RESOLUTION [Bos taurus] &gt;pdb|5EG4|A BOVINE TRYPSIN IN COMPLEX WITH CYCLIC INHIBITOR [Bos taurus] &gt;pdb|5F6M|A Isotropic Trypsin Model for Comparison of Diffuse Scattering [Bos taurus] &gt;pdb|5GIB|A Succinic acid bound trypsin crystallized as dimer [Bos taurus] &gt;pdb|5GIB|B Succinic acid bound trypsin crystallized as dimer [Bos taurus] &gt;pdb|5GXP|A Cationic Trypsin With GOL/PGE as Dimer at pH 4.6 [Bos taurus] &gt;pdb|5GXP|B Cationic Trypsin With GOL/PGE as Dimer at pH 4.6 [Bos taurus] &gt;pdb|5K7R|A MicroED structure of trypsin at 1.7 A resolution [Bos taurus] &gt;pdb|5LGO|A Trypsin inhibitors for the treatment of pancreatitis - cpd 15 [Bos taurus] &gt;pdb|5LH4|A Trypsin inhibitors for the treatment of pancreatitis - cpd 1 [Bos taurus] &gt;pdb|5LH8|A Trypsin inhibitors for the treatment of pancreatitis - cpd 8 [Bos taurus] &gt;pdb|5MN1|A Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNA|A Cationic trypsin in complex with aniline (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNB|A Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNC|A Cationic trypsin in complex with aniline (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNE|A Cationic trypsin in its apo form (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNF|A Cationic trypsin in its apo form (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNG|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|5MNH|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|5MNK|A Cationic trypsin in complex with benzylamine (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNL|A Cationic trypsin in complex with benzylamine (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNM|A Cationic trypsin in complex with benzylamine (at 295 K) [Bos taurus] &gt;pdb|5MNN|A Cationic trypsin in complex with N-amidinopiperidine (deuterated sample at 100 K) [Bos taurus] &gt;pdb|5MNO|A Cationic trypsin in complex with N-amidinopiperidine (deuterated sample at 295 K) [Bos taurus] &gt;pdb|5MNP|A Cationic trypsin in complex with N-amidinopiperidine (at 295 K) [Bos taurus] &gt;pdb|5MNQ|A Cationic trypsin in complex with a derivative of N-amidinopiperidine [Bos taurus] &gt;pdb|5MNX|A Neutron structure of cationic trypsin in complex with 2-aminopyridine [Bos taurus] &gt;pdb|5MNY|A Neutron structure of cationic trypsin in complex with aniline [Bos taurus] &gt;pdb|5MNZ|A Neutron structure of cationic trypsin in its apo form [Bos taurus] &gt;pdb|5MO0|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|5MO1|A Neutron structure of cationic trypsin in complex with benzylamine [Bos taurus] &gt;pdb|5MO2|A Neutron structure of cationic trypsin in complex with N-amidinopiperidine [Bos taurus] &gt;pdb|5MON|A Joint X-ray/neutron structure of cationic trypsin in complex with 2-aminopyridine [Bos taurus] &gt;pdb|5MOO|A Joint X-ray/neutron structure of cationic trypsin in complex with aniline [Bos taurus] &gt;pdb|5MOP|A Joint X-ray/neutron structure of cationic trypsin in its apo form [Bos taurus] &gt;pdb|5MOQ|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|5MOR|A Joint X-ray/neutron structure of cationic trypsin in complex with benzylamine [Bos taurus] &gt;pdb|5MOS|A Joint X-ray/neutron structure of cationic trypsin in complex with N-amidinopiperidine [Bos taurus] &gt;pdb|5T3H|A bovine trypsin soaked with selenourea for 5 min [Bos taurus] &gt;pdb|6AVL|A Orthorhombic Trypsin (295 K) in the presence of 50% xylose [Bos taurus] &gt;pdb|6B6N|A Orthorhombic trypsin (295 K) in the presence of 50% mpd [Bos taurus] &gt;pdb|6B6O|A Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant [Bos taurus] &gt;pdb|6B6P|A Orthorhombic trypsin cryocooled to 100 K with 30% xylose as cryoprotectant [Bos taurus] &gt;pdb|6B6Q|A Orthorhombic trypsin cryocooled to 100 K with 50% xylose as cryoprotectant [Bos taurus] &gt;pdb|6B6R|A Orthorhombic trypsin cryocooled to 100 K with 50% mpd as cryoprotectant [Bos taurus] &gt;pdb|6B6S|A Orthorhombic trypsin cryocooled to 100 K with 50% ethanol as cryoprotectant [Bos taurus] &gt;pdb|6B6T|A Orthorhombic trypsin cryocooled to 100 K with 50% methanol as cryoprotectant [Bos taurus] &gt;pdb|6BFP|A Bovine trypsin bound to potent inhibitor [Bos taurus] &gt;pdb|6BVH|A Trypsin complexed with a modified sunflower trypsin inhibitor, SFTI-TCTR(N12,N14) [Bos taurus] &gt;pdb|6DWF|A Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|B Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|C Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|D Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|E Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWF|F Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|A Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|B Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|C Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|D Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|E Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWH|F Crystal structure of complex of BBKI and Bovine Trypsin [Bos taurus] &gt;pdb|6DWU|AA Chain AA, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AC Chain AC, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AE Chain AE, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AG Chain AG, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AI Chain AI, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AK Chain AK, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AM Chain AM, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AO Chain AO, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AQ Chain AQ, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AS Chain AS, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|AU Chain AU, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BA Chain BA, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BC Chain BC, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BE Chain BE, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BG Chain BG, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BI Chain BI, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BK Chain BK, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BM Chain BM, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BO Chain BO, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BQ Chain BQ, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BS Chain BS, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|BU Chain BU, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CA Chain CA, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CC Chain CC, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CE Chain CE, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CG Chain CG, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CI Chain CI, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CK Chain CK, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CM Chain CM, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CO Chain CO, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CQ Chain CQ, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CS Chain CS, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|CU Chain CU, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DA Chain DA, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DC Chain DC, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DE Chain DE, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DG Chain DG, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DI Chain DI, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DK Chain DK, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DM Chain DM, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DO Chain DO, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DQ Chain DQ, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DS Chain DS, Cationic trypsin [Bos taurus] &gt;pdb|6DWU|DU Chain DU, Cationic trypsin [Bos taurus] &gt;pdb|6DZF|A Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant [Bos taurus] &gt;pdb|6E5M|A Crystallographic structure of the cyclic nonapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 32 2 1 [Bos taurus] &gt;pdb|6EAT|A Crystallographic structure of the cyclic nonapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21. [Bos taurus] &gt;pdb|6EAU|A Crystallographic structure of the octapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21. [Bos taurus] &gt;pdb|6EAV|A Crystallographic structure of the cyclic heptapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 4(1) 2(1) 2 [Bos taurus] &gt;pdb|6EAW|A Crystallographic structure of the cyclic heptapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21 [Bos taurus] &gt;pdb|6EAX|A Crystallographic structure of the cyclic hexapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21 [Bos taurus] &gt;pdb|6FID|A Bovine trypsin solved by S-SAD on ID30B [Bos taurus] &gt;pdb|6QIH|A Pancreatic Bovine Trypsin with a boronic acid inhibitor [Bos taurus] &gt;pdb|6SUX|A Terahertz irradiated structure of bovine trypsin (even frames of crystal x37) [Bos taurus] &gt;pdb|6SV0|A Non-terahertz irradiated structure of bovine trypsin (odd frames of crystal x37) [Bos taurus] &gt;pdb|6SV6|A Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x38) [Bos taurus] &gt;pdb|6SV8|A Terahertz irradiated structure of bovine trypsin (odd frames of crystal x38) [Bos taurus] &gt;pdb|6SV9|A Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x40) [Bos taurus] &gt;pdb|6SVB|A Terahertz irradiated structure of bovine trypsin (odd frames of crystal x40) [Bos taurus] &gt;pdb|6SVD|A Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x41) [Bos taurus] &gt;pdb|6SVG|A Terahertz irradiated structure of bovine trypsin (odd frames of crystal x41) [Bos taurus] &gt;pdb|6SVI|A Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x42) [Bos taurus] &gt;pdb|6SVJ|A Terahertz irradiated structure of bovine trypsin (odd frames of crystal x42) [Bos taurus] &gt;pdb|6SVN|A Reference structure of bovine trypsin (even frames of crystal x28) [Bos taurus] &gt;pdb|6SVR|A Reference structure of bovine trypsin (odd frames of crystal x28) [Bos taurus] &gt;pdb|6SVU|A Reference structure of bovine trypsin (even frames of crystal x30) [Bos taurus] &gt;pdb|6SVV|A Reference structure of bovine trypsin (odd frames of crystal x30) [Bos taurus] &gt;pdb|6SVW|A Reference structure of bovine trypsin (even frames of crystal x33) [Bos taurus] &gt;pdb|6SVX|A Reference structure of bovine trypsin (odd frames of crystal x33) [Bos taurus] &gt;pdb|6SVZ|A Reference structure of bovine trypsin (even frames of crystal x34) [Bos taurus] &gt;pdb|6SW0|A Reference structure of bovine trypsin (odd frames of crystal x34) [Bos taurus] &gt;pdb|6U22|A Crystal structure of SFTI-triazole inhibitor in complex with beta-trypsin [Bos taurus] &gt;pdb|6VXY|A Triazole bridged SFTI1 inhibitor in complex with beta-trypsin [Bos taurus] &gt;pdb|6XYG|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6XYK|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6YIT|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YIU|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YIV|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YIW|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6YIX|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YIY|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6YZA|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6YZC|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus] &gt;pdb|6ZFJ|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6ZFK|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|6ZQ2|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7AYS|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRV|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRW|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRX|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRY|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BRZ|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS0|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS1|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS2|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS3|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS4|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS5|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS6|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS7|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS8|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BS9|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7BSA|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|B Chain B, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|C Chain C, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|D Chain D, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|E Chain E, Cationic trypsin [Bos taurus] &gt;pdb|7JR1|F Chain F, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|B Chain B, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|C Chain C, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|D Chain D, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|E Chain E, Cationic trypsin [Bos taurus] &gt;pdb|7JR2|F Chain F, Cationic trypsin [Bos taurus] &gt;pdb|7JWX|A Chain A, Cationic trypsin [Bos taurus] &gt;pdb|7JWX|B Chain B, Cationic trypsin [Bos taurus] &gt;pdb|7JWX|C Chain C, Cationic trypsin [Bos taurus] &gt;pdb|7JWX|D Chain D, Cationic trypsin [Bos taurus]</Hit_def>
  <Hit_accession>1AQ7_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.49882e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>88</Hit_num>
  <Hit_id>pdb|1G3B|A</Hit_id>
  <Hit_def>BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE MAGNESIUM(II) CHELATE [Bos taurus] &gt;pdb|1G3C|A BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF BASE IRON(III) CHELATE [Bos taurus] &gt;pdb|1G3D|A BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE COPPER (II) CHELATE [Bos taurus] &gt;pdb|1G3E|A BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF-BASE COPPER (II) CHELATE [Bos taurus]</Hit_def>
  <Hit_accession>1G3B_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.50254e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>137</Hsp_hit-from>
      <Hsp_hit-to>228</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>89</Hit_num>
  <Hit_id>pdb|1NTP|A</Hit_id>
  <Hit_def>USE OF THE NEUTRON DIFFRACTION H/D EXCHANGE TECHNIQUE TO DETERMINE THE CONFORMATIONAL DYNAMICS OF TRYPSIN [Bos taurus]</Hit_def>
  <Hit_accession>1NTP_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.51482e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>90</Hit_num>
  <Hit_id>pdb|2FI4|E</Hit_id>
  <Hit_def>Crystal structure of a BPTI variant (Cys14-&gt;Ser) in complex with trypsin [Bos taurus] &gt;pdb|2FTL|E Crystal structure of trypsin complexed with BPTI at 100K [Bos taurus]</Hit_def>
  <Hit_accession>2FI4_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.56385e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>91</Hit_num>
  <Hit_id>pdb|1ZZZ|A</Hit_id>
  <Hit_def>Trypsin inhibitors with rigid tripeptidyl aldehydes [Bos taurus]</Hit_def>
  <Hit_accession>1ZZZ_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.82414e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>146</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>92</Hit_num>
  <Hit_id>pdb|1UTQ|A</Hit_id>
  <Hit_def>Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Bos taurus]</Hit_def>
  <Hit_accession>1UTQ_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.94725e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>243</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>93</Hit_num>
  <Hit_id>pdb|1EZX|C</Hit_id>
  <Hit_def>Crystal Structure Of A Serpin:protease Complex [Bos taurus] &gt;pdb|1F0T|A Bovine Trypsin Complexed With Rpr131247 [Bos taurus] &gt;pdb|1F0U|A Bovine Trypsin Complexed With Rpr128515 [Bos taurus] &gt;pdb|1LQE|A Crystal Structure Of Trypsin In Complex With 79. [Bos taurus] &gt;pdb|2BY5|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BY6|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BY7|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BY8|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BY9|X Chain X, CATIONIC TRYPSIN [Bos taurus] &gt;pdb|2BYA|X Chain X, CATIONIC TRYPSIN [Bos taurus]</Hit_def>
  <Hit_accession>1EZX_C</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>1.96791e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>243</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>94</Hit_num>
  <Hit_id>pdb|1UTN|A</Hit_id>
  <Hit_def>Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Bos taurus] &gt;pdb|1UTO|A Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Bos taurus] &gt;pdb|1UTP|A Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Bos taurus]</Hit_def>
  <Hit_accession>1UTN_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>2.00987e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>243</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>95</Hit_num>
  <Hit_id>pdb|4GUX|A</Hit_id>
  <Hit_def>Crystal structure of trypsin:MCoTi-II complex [Bos taurus] &gt;pdb|4GUX|B Crystal structure of trypsin:MCoTi-II complex [Bos taurus] &gt;pdb|4GUX|C Crystal structure of trypsin:MCoTi-II complex [Bos taurus] &gt;pdb|4XOJ|A Structure of bovine trypsin in complex with analogues of sunflower inhibitor 1 (SFTI-1) [Bos taurus] &gt;pdb|5FXL|A Structure of trypsin solved by MR from data collected by Direct Data Collection (DDC) using the ESRF RoboDiff goniometer [Bos taurus] &gt;pdb|5JYI|A Trypsin bound with succinic acid at 1.9A [Bos taurus] &gt;pdb|6QL0|A Cationic Trypsin in Complex with a D-Phe-Pro-p-aminopyridine derivative [Bos taurus] &gt;pdb|6SWV|AAA Chain AAA, Cationic trypsin [Bos taurus] &gt;pdb|6SY3|A Cationic Trypsin in Complex with a D-DiPhe-Pro-pyridine derivative [Bos taurus] &gt;pdb|6T0M|A Cationic Trypsin in Complex with a D-Phe-Pro-diaminopyridine derivative [Bos taurus] &gt;pdb|6T0P|A Cationic Trypsin in Complex with a D-Phe-Pro-2-aminopyridine derivative [Bos taurus] &gt;pdb|6T5W|A Cationic Trypsin in Complex with a D-Phe-Pro-p-aminopyridine Derivative (cocrystallizaton at 291 K) [Bos taurus] &gt;pdb|6T9U|A Chain A, Cationic Trypsin [Bos taurus] &gt;pdb|6T9V|A Chain A, Cationic Trypsin [Bos taurus] &gt;pdb|6YDY|A Chain A, Cationic Trypsin [Bos taurus] &gt;pdb|6YIS|A Trypsin inhibitor in complex with bovine trypsin [Bos taurus]</Hit_def>
  <Hit_accession>4GUX_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.1073</Hsp_bit-score>
      <Hsp_score>196</Hsp_score>
      <Hsp_evalue>2.02016e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>96</Hit_num>
  <Hit_id>pdb|1HIA|B</Hit_id>
  <Hit_def>Kallikrein Complexed With Hirustasin [Sus scrofa] &gt;pdb|1HIA|Y Kallikrein Complexed With Hirustasin [Sus scrofa] &gt;pdb|2KAI|B Refined 2.5 Angstroms X-Ray Crystal Structure Of The Complex Formed By Porcine Kallikrein A And The Bovine Pancreatic Trypsin Inhibitor. Crystallization, Patterson Search, Structure Determination, Refinement, Structure And Comparison With Its Components And With The Bovine Trypsin- Pancreatic Trypsin Inhibitor Complex [Sus scrofa] &gt;pdb|2PKA|B Refined 2 Angstroms X-Ray Crystal Structure Of Porcine Pancreatic Kallikrein A, A Specific Trypsin-Like Serine Proteinase. Crystallization, Structure Determination, Crystallographic Refinement, Structure And Its Comparison With Bovine Trypsin [Sus scrofa] &gt;pdb|2PKA|Y Refined 2 Angstroms X-Ray Crystal Structure Of Porcine Pancreatic Kallikrein A, A Specific Trypsin-Like Serine Proteinase. Crystallization, Structure Determination, Crystallographic Refinement, Structure And Its Comparison With Bovine Trypsin [Sus scrofa]</Hit_def>
  <Hit_accession>1HIA_B</Hit_accession>
  <Hit_len>152</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>2.29409e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>59</Hsp_hit-from>
      <Hsp_hit-to>151</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDEIQCVQLTLLQNTFCADAHPDKVTESMLCAGYLPGGKDTCMGDSGGPLIC--NGMWQ--GITSWGHTPCGSANKPSIYTKLIFYLDWIDDTITEN</Hsp_hseq>
      <Hsp_midline>PD +Q   L LL NT C      K+ ++M+CAG    G  +CMGDSGGPL+C  NG W   GI SWG + C S + P +Y ++   ++W+  T+  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>97</Hit_num>
  <Hit_id>pdb|6MRQ|A</Hit_id>
  <Hit_def>Structure of ToPI1 inhibitor from Tityus obscurus scorpion venom in complex with trypsin [Bos taurus]</Hit_def>
  <Hit_accession>6MRQ_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>79.7221</Hsp_bit-score>
      <Hsp_score>195</Hsp_score>
      <Hsp_evalue>2.37579e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>98</Hit_num>
  <Hit_id>pdb|1BRU|P</Hit_id>
  <Hit_def>STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH THE ELASTASE INHIBITOR GR143783 [Sus scrofa]</Hit_def>
  <Hit_accession>1BRU_P</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>79.7221</Hsp_bit-score>
      <Hsp_score>195</Hsp_score>
      <Hsp_evalue>3.03244e-19</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>141</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>101</Hsp_align-len>
      <Hsp_qseq>TPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASG-VSSCMGDSGGPLVCK-KNGAWTLVGIVSWGSST-CS-TSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>SPDILQQGQLLVVDYATCSKPGWWGSTVKTNMICAGGDGIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSNYIDWINSVIANN</Hsp_hseq>
      <Hsp_midline>+PD LQQ  L ++    C K  +WG+ +K  MICAG  G +SSC GDSGGPL C+  NG W + GIVS+GSS  C+    P V+ RV+  ++W+   +A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>99</Hit_num>
  <Hit_id>pdb|1O5E|H</Hit_id>
  <Hit_def>Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1O5F|H Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1P57|B Extracellular domain of human hepsin [Homo sapiens]</Hit_def>
  <Hit_accession>1O5E_H</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>79.7221</Hsp_bit-score>
      <Hsp_score>195</Hsp_score>
      <Hsp_evalue>3.38173e-19</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>245</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCK----KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIKTH</Hsp_hseq>
      <Hsp_midline>LQ+A +P++SN  C    ++G +IK  M CAG    G+ +C GDSGGP VC+    +   W L GIVSWG+       PGVY +V+    W+ Q +  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>100</Hit_num>
  <Hit_id>pdb|1TAW|A</Hit_id>
  <Hit_def>BOVINE TRYPSIN COMPLEXED TO APPI [Bos taurus] &gt;pdb|1ZR0|A Crystal Structure of Kunitz Domain 1 of Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin [Bos taurus] &gt;pdb|1ZR0|C Crystal Structure of Kunitz Domain 1 of Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin [Bos taurus]</Hit_def>
  <Hit_accession>1TAW_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>79.337</Hsp_bit-score>
      <Hsp_score>194</Hsp_score>
      <Hsp_evalue>3.39362e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSTSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS ++CK  +  +I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>101</Hit_num>
  <Hit_id>pdb|5DJ7|A</Hit_id>
  <Hit_def>S. erythraea trypsin acyl-enzyme [Saccharopolyspora erythraea] &gt;pdb|5DKM|A S. erythraea trypsin Michaelis-Menten complex [Saccharopolyspora erythraea] &gt;pdb|5KWM|A S. erythraea trypsin long construct apoenzyme [Saccharopolyspora erythraea]</Hit_def>
  <Hit_accession>5DJ7_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.9518</Hsp_bit-score>
      <Hsp_score>193</Hsp_score>
      <Hsp_evalue>4.67733e-19</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DHLQKATVPVNSDDTCKQAYGEYTPDAMVCAGVPEGGVDTCQGDSGGPMVVNNK----LIGVTSWGEGCARPGKPGVYARVGAYYDVLMEQINA</Hsp_hseq>
      <Hsp_midline>D LQ+A++P+ S+  CK+ +G    DAM+CAG    GV +C GDSGGP+V        L+G+ SWG        PGVYARV A  + + + + A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>102</Hit_num>
  <Hit_id>pdb|1J15|A</Hit_id>
  <Hit_def>Benzamidine In Complex With Rat Trypsin Mutant X99175190RT [Rattus norvegicus] &gt;pdb|1J16|A Benzamidine In Complex With Rat Trypsin Mutant X99175190RT [Rattus norvegicus] &gt;pdb|1J17|T Factor Xa Specific Inhibitor In Complex With Rat Trypsin Mutant X99175190RT [Rattus norvegicus]</Hit_def>
  <Hit_accession>1J15_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.9518</Hsp_bit-score>
      <Hsp_score>193</Hsp_score>
      <Hsp_evalue>4.76511e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NEPDLLQCLDAPLLPQADCEASSSFIITDNMVCVGFLEGGKDACQGDSGGPVVC--NG--ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN</Hsp_hseq>
      <Hsp_midline>N PD LQ    PLL   +C+      I D M+C G    G  +C GDSGGP+VC  NG   L GIVSWG        PGVY +V   V+W+Q T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>103</Hit_num>
  <Hit_id>pdb|4M7G|A</Hit_id>
  <Hit_def>Streptomyces Erythraeus Trypsin [Saccharopolyspora erythraea]</Hit_def>
  <Hit_accession>4M7G_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.9518</Hsp_bit-score>
      <Hsp_score>193</Hsp_score>
      <Hsp_evalue>4.99616e-19</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DHLQKATVPVNSDDTCKQAYGEYTPDAMVCAGVPEGGVDTCQGDSGGPMVVNNK----LIGVTSWGEGCARPGKPGVYARVGAYYDVLMEQINA</Hsp_hseq>
      <Hsp_midline>D LQ+A++P+ S+  CK+ +G    DAM+CAG    GV +C GDSGGP+V        L+G+ SWG        PGVYARV A  + + + + A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>104</Hit_num>
  <Hit_id>pdb|5PTP|A</Hit_id>
  <Hit_def>STRUCTURE OF HYDROLASE (SERINE PROTEINASE) [Bos taurus]</Hit_def>
  <Hit_accession>5PTP_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.5666</Hsp_bit-score>
      <Hsp_score>192</Hsp_score>
      <Hsp_evalue>5.35467e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDXGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GD GGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>105</Hit_num>
  <Hit_id>pdb|2EEK|A</Hit_id>
  <Hit_def>Crystal structure of Atlantic cod trypsin complexed with benzamidine [Gadus morhua]</Hit_def>
  <Hit_accession>2EEK_A</Hit_accession>
  <Hit_len>220</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.5666</Hsp_bit-score>
      <Hsp_score>192</Hsp_score>
      <Hsp_evalue>5.41624e-19</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>DKLQCLSLPILSHADCANSYPGMITQSMFCAGYLEGGKDSCQGDSGGPVVC--NG--VLQGVVSWGYGCAERDHPGVYAKVCVLSGWVRDTMA</Hsp_hseq>
      <Hsp_midline>D+LQ  SLP+LS+ +C   +   I  +M CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V  L  WV+ T+A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>106</Hit_num>
  <Hit_id>pdb|1OPH|B</Hit_id>
  <Hit_def>Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And S195a Trypsin [Bos taurus]</Hit_def>
  <Hit_accession>1OPH_B</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.9518</Hsp_bit-score>
      <Hsp_score>193</Hsp_score>
      <Hsp_evalue>5.47214e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>243</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDAGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK  +  +I   M CAG    G  SC GD+GGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>107</Hit_num>
  <Hit_id>pdb|3T2N|A</Hit_id>
  <Hit_def>Human hepsin protease in complex with the Fab fragment of an inhibitory antibody [Homo sapiens] &gt;pdb|3T2N|B Human hepsin protease in complex with the Fab fragment of an inhibitory antibody [Homo sapiens] &gt;pdb|5CE1|A Crystal Structure of Serine protease Hepsin in complex with Inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>3T2N_A</Hit_accession>
  <Hit_len>372</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.4925</Hsp_bit-score>
      <Hsp_score>197</Hsp_score>
      <Hsp_evalue>5.54249e-19</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>264</Hsp_hit-from>
      <Hsp_hit-to>362</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCK----KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIKTH</Hsp_hseq>
      <Hsp_midline>LQ+A +P++SN  C    ++G +IK  M CAG    G+ +C GDSGGP VC+    +   W L GIVSWG+       PGVY +V+    W+ Q +  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>108</Hit_num>
  <Hit_id>pdb|1Z8G|A</Hit_id>
  <Hit_def>Crystal structure of the extracellular region of the transmembrane serine protease hepsin with covalently bound preferred substrate. [Homo sapiens]</Hit_def>
  <Hit_accession>1Z8G_A</Hit_accession>
  <Hit_len>372</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>80.4925</Hsp_bit-score>
      <Hsp_score>197</Hsp_score>
      <Hsp_evalue>5.77033e-19</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>264</Hsp_hit-from>
      <Hsp_hit-to>362</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCK----KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIKTH</Hsp_hseq>
      <Hsp_midline>LQ+A +P++SN  C    ++G +IK  M CAG    G+ +C GDSGGP VC+    +   W L GIVSWG+       PGVY +V+    W+ Q +  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>109</Hit_num>
  <Hit_id>pdb|1FXY|A</Hit_id>
  <Hit_def>COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE [Homo sapiens]</Hit_def>
  <Hit_accession>1FXY_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.5666</Hsp_bit-score>
      <Hsp_score>192</Hsp_score>
      <Hsp_evalue>6.62099e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>134</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVC--NG--QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD LQ    P+LS   C+  +  KI   M C G    G  SC GDSGGP+VC  NG   L G+VSWG      + PGVY +V   V W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>110</Hit_num>
  <Hit_id>pdb|1QRZ|A</Hit_id>
  <Hit_def>Catalytic Domain Of Plasminogen [Homo sapiens] &gt;pdb|1QRZ|B Catalytic Domain Of Plasminogen [Homo sapiens] &gt;pdb|1QRZ|C Catalytic Domain Of Plasminogen [Homo sapiens] &gt;pdb|1QRZ|D Catalytic Domain Of Plasminogen [Homo sapiens]</Hit_def>
  <Hit_accession>1QRZ_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.5666</Hsp_bit-score>
      <Hsp_score>192</Hsp_score>
      <Hsp_evalue>7.85872e-19</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVLRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  L  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>111</Hit_num>
  <Hit_id>pdb|1TRN|A</Hit_id>
  <Hit_def>Crystal Structure Of Human Trypsin 1: Unexpected Phosphorylation Of Tyrosine 151 [Homo sapiens] &gt;pdb|1TRN|B Crystal Structure Of Human Trypsin 1: Unexpected Phosphorylation Of Tyrosine 151 [Homo sapiens]</Hit_def>
  <Hit_accession>1TRN_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>8.59264e-19</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DXPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVC--NG--QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD LQ    P+LS   C+  +  KI   M C G    G  SC GDSGGP+VC  NG   L G+VSWG      + PGVY +V   V W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>112</Hit_num>
  <Hit_id>pdb|6DWR|A</Hit_id>
  <Hit_def>Trypsin serine protease modified with the protease inhibitor cyanobenzylsulfonylfluoride [Bos taurus]</Hit_def>
  <Hit_accession>6DWR_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>9.9025e-19</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDXSCKSAYPGQITSNMFCAGYLEGGKDSCQGDXGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+ +CK  +  +I   M CAG    G  SC GD GGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>113</Hit_num>
  <Hit_id>pdb|5LHN|A</Hit_id>
  <Hit_def>The catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody Nb7 [Mus musculus] &gt;pdb|5LHP|A The p-aminobenzamidine active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody Nb7 [Mus musculus] &gt;pdb|5LHQ|A The EGR-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody Nb7 [Mus musculus] &gt;pdb|5LHR|A The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody Nb22 [Mus musculus] &gt;pdb|5LHS|A The ligand free catalytic domain of murine urokinase-type plasminogen activator [Mus musculus] &gt;pdb|5LHS|B The ligand free catalytic domain of murine urokinase-type plasminogen activator [Mus musculus] &gt;pdb|5LHS|C The ligand free catalytic domain of murine urokinase-type plasminogen activator [Mus musculus] &gt;pdb|5LHS|D The ligand free catalytic domain of murine urokinase-type plasminogen activator [Mus musculus] &gt;pdb|6A8G|A The crystal structure of muPAin-1-IG in complex with muPA-SPD at pH8.5 [Mus musculus] &gt;pdb|6A8G|B The crystal structure of muPAin-1-IG in complex with muPA-SPD at pH8.5 [Mus musculus] &gt;pdb|6A8N|A The crystal structure of muPAin-1-IG-2 in complex with muPA-SPD at pH8.5 [Mus musculus] &gt;pdb|6A8N|B The crystal structure of muPAin-1-IG-2 in complex with muPA-SPD at pH8.5 [Mus musculus]</Hit_def>
  <Hit_accession>5LHN_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>1.34971e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASG--VSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PKNLKMSVVKLVSHEQCMQPHYYGSEINYKMLCAADPEWKTDSCKGDSGGPLICNIEGRPTLSGIVSWGRGCAEKNKPGVYTRVSHFLDWIQSHI</Hsp_hseq>
      <Hsp_midline>P  L+ + + L+S+  C +  Y+G++I   M+CA        SC GDSGGPL+C   G  TL GIVSWG      + PGVY RV+  ++W+Q  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>114</Hit_num>
  <Hit_id>pdb|4ZKN|U</Hit_id>
  <Hit_def>The crystal structure of upain-1-W3A in complex with uPA at pH5.5 [Homo sapiens] &gt;pdb|4ZKO|U The crystal structure of upain-1-W3A in complex with uPA at pH7.4 [Homo sapiens] &gt;pdb|4ZKR|U The crystal structure of upain-1-W3A in complex with uPA at pH9.0 [Homo sapiens]</Hit_def>
  <Hit_accession>4ZKN_U</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>1.36397e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>115</Hit_num>
  <Hit_id>pdb|4H42|U</Hit_id>
  <Hit_def>Synthesis of a Weak Basic uPA Inhibitor and Crystal Structure of Complex with uPA [Homo sapiens]</Hit_def>
  <Hit_accession>4H42_U</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>1.39899e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>116</Hit_num>
  <Hit_id>pdb|4GLY|A</Hit_id>
  <Hit_def>Human urokinase-type plasminogen activator uPA in complex with the two-disulfide bridge peptide UK504 [Homo sapiens] &gt;pdb|4JK5|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4JK6|A Human urokinase-type Plasminogen Activator (uPA) in complex with a bicyclic peptide inhibitor (UK18-D-Aba) [Homo sapiens] &gt;pdb|4MNV|A Crystal structure of bicyclic peptide UK729 bound as an acyl-enzyme intermediate to urokinase-type plasminogen activator (uPA) [Homo sapiens] &gt;pdb|4MNW|A Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK749 [Homo sapiens] &gt;pdb|4MNX|A Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK811 [Homo sapiens] &gt;pdb|4MNY|A Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK903 [Homo sapiens] &gt;pdb|4MNY|B Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK903 [Homo sapiens] &gt;pdb|4OS1|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS2|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS4|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS5|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS6|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|4OS7|A Chain A, Urokinase-type plasminogen activator [Homo sapiens] &gt;pdb|5Z1C|U The crystal structure of uPA in complex with 4-Iodobenzylamine at pH7.4 [Homo sapiens] &gt;pdb|6AG7|U The crystal structure of uPA in complex with HMA-55F [Homo sapiens] &gt;pdb|7DZD|U Chain U, Urokinase-type plasminogen activator [Homo sapiens]</Hit_def>
  <Hit_accession>4GLY_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.40995e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>117</Hit_num>
  <Hit_id>pdb|1W0Z|U</Hit_id>
  <Hit_def>Urokinase type plasminogen activator [Homo sapiens] &gt;pdb|1W10|U Urokinase type plasminogen activator [Homo sapiens] &gt;pdb|1W11|U UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1W12|U UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1W13|U UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1W14|U UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|3MHW|U The complex crystal Structure of Urokianse and 2-Aminobenzothiazole [Homo sapiens]</Hit_def>
  <Hit_accession>1W0Z_U</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.45276e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>118</Hit_num>
  <Hit_id>pdb|6JYP|U</Hit_id>
  <Hit_def>Crystal structure of uPA_H99Y in complex with 3-azanyl-5-(azepan-1-yl)-N-[bis(azanyl)methylidene]-6-chloranyl-pyrazine-2-carboxamide [Homo sapiens] &gt;pdb|6JYQ|U Crystal structure of uPA_H99Y in complex with 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(furan-2-yl)pyrazine-2-carboxamide [Homo sapiens]</Hit_def>
  <Hit_accession>6JYP_U</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.47712e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>119</Hit_num>
  <Hit_id>pdb|4X0W|U</Hit_id>
  <Hit_def>The crystal structure of mupain-1-17 in complex with murinised human uPA [Homo sapiens] &gt;pdb|4X1N|U The crystal structure of mupain-1-16 in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4X1P|U The crystal structure of mupain-1-17 in complex with murinised human uPA at pH4.6 [Homo sapiens] &gt;pdb|4X1Q|U The crystal structure of mupain-1 in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4X1R|U The crystal structure of mupain-1-12 in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4X1S|U The crystal structure of mupain-1-16-D9A in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4ZHL|U The crystal structure of mupain-1-IG in complex with murinised human uPA at pH7.4 [Homo sapiens] &gt;pdb|4ZHM|U The crystal structure of mupain-1--16-IG in complex with murinised human uPA at pH7.4 [Homo sapiens]</Hit_def>
  <Hit_accession>4X0W_U</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.48362e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>120</Hit_num>
  <Hit_id>pdb|1FV9|A</Hit_id>
  <Hit_def>Crystal structure of human microurokinase in complex with 2-amino-5-hydroxy-benzimidazole [Homo sapiens]</Hit_def>
  <Hit_accession>1FV9_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.48608e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>121</Hit_num>
  <Hit_id>pdb|1SC8|U</Hit_id>
  <Hit_def>Urokinase Plasminogen Activator B-Chain-J435 Complex [Homo sapiens] &gt;pdb|1VJ9|U Urokinase Plasminogen Activator B-Chain-JT464 Complex [Homo sapiens] &gt;pdb|1VJA|U Urokinase Plasminogen Activator B-Chain-JT463 Complex [Homo sapiens]</Hit_def>
  <Hit_accession>1SC8_U</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>1.48881e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>166</Hsp_hit-from>
      <Hsp_hit-to>257</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>122</Hit_num>
  <Hit_id>pdb|3MWI|U</Hit_id>
  <Hit_def>The complex crystal Structure of Urokianse and 5-nitro-1H-indole-2-amidine [Homo sapiens]</Hit_def>
  <Hit_accession>3MWI_U</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.49273e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>123</Hit_num>
  <Hit_id>pdb|1OWE|A</Hit_id>
  <Hit_def>Substituted 2-Naphthamidine inhibitors of urokinase [Homo sapiens] &gt;pdb|1OWH|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1SQA|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1SQO|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens]</Hit_def>
  <Hit_accession>1OWE_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.50179e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>124</Hit_num>
  <Hit_id>pdb|2NWN|A</Hit_id>
  <Hit_def>New Pharmacophore for Serine Protease Inhibition Revealed by Crystal Structure of Human Urokinase-type Plasminogen Activator Complexed with a Cyclic Peptidyl Inhibitor, upain-1 [Homo sapiens] &gt;pdb|2O8T|A Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q) in complex with Inhibitors [Homo sapiens] &gt;pdb|3KGP|A Crystal Structures of Urokinase-type Plasminogen Activator in Complex with 4-(Aminomethyl) Benzoic Acid and 4-(Aminomethyl-phenyl)-methanol [Homo sapiens] &gt;pdb|3KHV|A Crystal Structures of Urokinase-type Plasminogen Activator in Complex with 4-(Aminomethyl) Benzoic Acid and 4-(Aminomethyl-phenyl)-methanol [Homo sapiens] &gt;pdb|3KID|U The Crystal Structures of 2-Aminobenzothiazole-based Inhibitors in Complexes with Urokinase-type Plasminogen Activator [Homo sapiens] &gt;pdb|3M61|U Crystal structure of complex of urokinase and a upain-1 variant(W3A) in pH4.6 condition [Homo sapiens] &gt;pdb|3OX7|U The crystal structure of uPA complex with peptide inhibitor MH027 at pH4.6 [Homo sapiens] &gt;pdb|3OY5|U The crystal structure of uPA complex with peptide inhibitor MH027 at pH7.4 [Homo sapiens] &gt;pdb|3OY6|U The crystal structure of uPA complex with peptide inhibitor MH036 at pH4.6 [Homo sapiens] &gt;pdb|3QN7|A Potent and selective bicyclic peptide inhibitor (UK18) of human urokinase-type plasminogen activator(uPA) [Homo sapiens] &gt;pdb|5WXF|U Crystal structure of uPA in complex with upain-2-2 [Homo sapiens] &gt;pdb|5WXO|U Crystal structure of uPA in complex with upain-2-2-W3A [Homo sapiens] &gt;pdb|5WXP|U Crystal structure of uPA in complex with upain-2-3-W3A [Homo sapiens] &gt;pdb|5WXQ|U Crystal structure of uPA in complex with upain-2-4 [Homo sapiens] &gt;pdb|5WXR|U Crystal structure of uPA in complex with upain-2-4-W3A [Homo sapiens] &gt;pdb|5WXS|U Crystal structure of uPA in complex with S2444 [Homo sapiens] &gt;pdb|5ZA7|U uPA-HMA [Homo sapiens] &gt;pdb|5ZA8|U uPA-BB2-27F [Homo sapiens] &gt;pdb|5ZA9|U uPA-BB2-50F [Homo sapiens] &gt;pdb|5ZAE|U uPA-6F-HMA [Homo sapiens] &gt;pdb|5ZAF|U uPA-BB2-28F [Homo sapiens] &gt;pdb|5ZAG|U uPA-BB2-94F [Homo sapiens] &gt;pdb|5ZAH|U uPA-BB2-30F [Homo sapiens] &gt;pdb|5ZAJ|U uPA-31F [Homo sapiens] &gt;pdb|5ZC5|U uPA-NU-09F [Homo sapiens] &gt;pdb|6AG2|U uPA-HMA [Homo sapiens] &gt;pdb|6AG3|U Crystal structure of uPA in complex with 3,5-bis(azanyl)-N-carbamimidoyl-6-(2,4-dimethoxypyrimidin-5-yl)pyrazine-2-carboxamide [Homo sapiens] &gt;pdb|6AG9|U Crystal structure of uPA in complex with 3,5-bis(azanyl)-6-(1-benzofuran-2-yl)-N-carbamimidoyl-pyrazine-2- carboxamide [Homo sapiens] &gt;pdb|6XVD|U Crystal structure of complex of urokinase and a upain-1 variant(W3F) in pH7.4 condition [Homo sapiens]</Hit_def>
  <Hit_accession>2NWN_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>1.50465e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>125</Hit_num>
  <Hit_id>pdb|4DVA|U</Hit_id>
  <Hit_def>The crystal structure of human urokinase-type plasminogen activator catalytic domain [Homo sapiens] &gt;pdb|4DW2|U The crystal structure of uPA in complex with the Fab fragment of mAb-112 [Homo sapiens] &gt;pdb|4FU7|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FU8|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FU9|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUB|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUC|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUD|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUE|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUF|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUG|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUH|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUI|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|4FUJ|A Crystal Structure of the Urokinase [Homo sapiens] &gt;pdb|5HGG|A Crystal structure of uPA in complex with a camelid-derived antibody fragment [Homo sapiens] &gt;pdb|5HGG|B Crystal structure of uPA in complex with a camelid-derived antibody fragment [Homo sapiens] &gt;pdb|5XG4|U Crystal structure of uPA in complex with quercetin [Homo sapiens] &gt;pdb|5YC6|U The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH4.6 [Homo sapiens] &gt;pdb|5YC7|U The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH7.4 [Homo sapiens]</Hit_def>
  <Hit_accession>4DVA_U</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.50851e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>126</Hit_num>
  <Hit_id>pdb|1OWD|A</Hit_id>
  <Hit_def>Substituted 2-Naphthamidine inhibitors of urokinase [Homo sapiens] &gt;pdb|1OWI|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1OWJ|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1OWK|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1SQT|A Substituted 2-Naphthamidine Inhibitors of Urokinase [Homo sapiens] &gt;pdb|1U6Q|A Substituted 2-Naphthamadine inhibitors of Urokinase [Homo sapiens]</Hit_def>
  <Hit_accession>1OWD_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.51766e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>127</Hit_num>
  <Hit_id>pdb|6D3X|A</Hit_id>
  <Hit_def>Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma [Homo sapiens] &gt;pdb|6D3X|B Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma [Homo sapiens]</Hit_def>
  <Hit_accession>6D3X_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.54056e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>128</Hit_num>
  <Hit_id>pdb|1GI7|B</Hit_id>
  <Hit_def>A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GI8|B A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GI9|B A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens]</Hit_def>
  <Hit_accession>1GI7_B</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.54992e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>129</Hit_num>
  <Hit_id>pdb|3UIR|A</Hit_id>
  <Hit_def>Crystal structure of the plasmin-textilinin-1 complex [Homo sapiens] &gt;pdb|3UIR|B Crystal structure of the plasmin-textilinin-1 complex [Homo sapiens] &gt;pdb|6D3Y|A Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma [Homo sapiens]</Hit_def>
  <Hit_accession>3UIR_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.58018e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>153</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>130</Hit_num>
  <Hit_id>pdb|6L04|U</Hit_id>
  <Hit_def>Crystal structure of uPA_H99Y in complex with 31F [Homo sapiens] &gt;pdb|6L05|U Crystal structure of uPA_H99Y in complex with 50F [Homo sapiens]</Hit_def>
  <Hit_accession>6L04_U</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.58287e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>131</Hit_num>
  <Hit_id>pdb|5UGD|A</Hit_id>
  <Hit_def>Protease Inhibitor [Homo sapiens] &gt;pdb|5UGG|A Protease Inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>5UGD_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.65806e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>251</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>132</Hit_num>
  <Hit_id>pdb|1EJN|A</Hit_id>
  <Hit_def>Urokinase Plasminogen Activator B-chain Inhibitor Complex [Homo sapiens] &gt;pdb|1F5K|U Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1F5L|A Urokinase Plasminogen Activator B-Chain-Amiloride Complex [Homo sapiens] &gt;pdb|1F92|A Urokinase Plasminogen Activator B Chain-Uki-1d Complex [Homo sapiens] &gt;pdb|2R2W|U Urokinase plasminogen activator B-chain-GPPE complex [Homo sapiens] &gt;pdb|2VIN|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIO|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIP|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIQ|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIV|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens] &gt;pdb|2VIW|A Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator [Homo sapiens]</Hit_def>
  <Hit_accession>1EJN_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.67102e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>133</Hit_num>
  <Hit_id>pdb|1LMW|B</Hit_id>
  <Hit_def>LMW U-PA Structure complexed with EGRCMK (GLU-GLY-ARG Chloromethyl Ketone) [Homo sapiens] &gt;pdb|1LMW|D LMW U-PA Structure complexed with EGRCMK (GLU-GLY-ARG Chloromethyl Ketone) [Homo sapiens]</Hit_def>
  <Hit_accession>1LMW_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.68864e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>134</Hit_num>
  <Hit_id>pdb|6Q1U|A</Hit_id>
  <Hit_def>Structure of plasmin and peptide complex [Homo sapiens] &gt;pdb|6Q1U|B Structure of plasmin and peptide complex [Homo sapiens]</Hit_def>
  <Hit_accession>6Q1U_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.7152e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>135</Hit_num>
  <Hit_id>pdb|3IG6|B</Hit_id>
  <Hit_def>Low molecular weigth human Urokinase type Plasminogen activator 2-[6-(3&apos;-Aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic acid complex [Homo sapiens] &gt;pdb|3IG6|D Low molecular weigth human Urokinase type Plasminogen activator 2-[6-(3&apos;-Aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic acid complex [Homo sapiens]</Hit_def>
  <Hit_accession>3IG6_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.72443e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>136</Hit_num>
  <Hit_id>pdb|6D40|A</Hit_id>
  <Hit_def>Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma [Homo sapiens]</Hit_def>
  <Hit_accession>6D40_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.74432e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>154</Hsp_hit-from>
      <Hsp_hit-to>248</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>137</Hit_num>
  <Hit_id>pdb|1C5W|B</Hit_id>
  <Hit_def>STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5X|B STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5Y|B STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5Z|B Chain B, PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR) [Homo sapiens] &gt;pdb|1GJ7|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJ8|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJ9|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJA|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJB|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJC|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1GJD|B ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS [Homo sapiens] &gt;pdb|1O3P|B Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>1C5W_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.76097e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>138</Hit_num>
  <Hit_id>pdb|2VNT|A</Hit_id>
  <Hit_def>Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|B Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|C Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|D Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|E Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens] &gt;pdb|2VNT|F Urokinase-Type Plasminogen Activator Inhibitor Complex With A 1-(7-Sulphoamidoisoquinolinyl)guanidine [Homo sapiens]</Hit_def>
  <Hit_accession>2VNT_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>1.78456e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>174</Hsp_hit-from>
      <Hsp_hit-to>265</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>139</Hit_num>
  <Hit_id>pdb|1BUI|A</Hit_id>
  <Hit_def>Structure of the ternary microplasmin-staphylokinase-microplasmin complex: a proteinase-cofactor-substrate complex in action [Homo sapiens] &gt;pdb|1BUI|B Structure of the ternary microplasmin-staphylokinase-microplasmin complex: a proteinase-cofactor-substrate complex in action [Homo sapiens]</Hit_def>
  <Hit_accession>1BUI_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>1.79608e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>156</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>140</Hit_num>
  <Hit_id>pdb|6NMB|A</Hit_id>
  <Hit_def>Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator [Homo sapiens] &gt;pdb|6NMB|B Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator [Homo sapiens] &gt;pdb|6NMB|C Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator [Homo sapiens] &gt;pdb|6NMB|D Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator [Homo sapiens]</Hit_def>
  <Hit_accession>6NMB_A</Hit_accession>
  <Hit_len>281</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>78.1814</Hsp_bit-score>
      <Hsp_score>191</Hsp_score>
      <Hsp_evalue>1.83774e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>179</Hsp_hit-from>
      <Hsp_hit-to>270</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>141</Hit_num>
  <Hit_id>pdb|1HAX|B</Hit_id>
  <Hit_def>Snapshots of serine protease catalysis: (A) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 at pH 5 [Sus scrofa] &gt;pdb|1HAY|B Snapshots of serine protease catalysis: (B) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 10 for 10 seconds [Sus scrofa] &gt;pdb|1HB0|B Snapshots of serine protease catalysis: (D) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 10 for 2 minutes [Sus scrofa]</Hit_def>
  <Hit_accession>1HAX_B</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.411</Hsp_bit-score>
      <Hsp_score>189</Hsp_score>
      <Hsp_evalue>1.94923e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>240</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSS-CMGDSGGPLVCKKNGAWTLVGIVSWGSST-CS-TSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN</Hsp_hseq>
      <Hsp_midline>LQQA LP +    C    YWG+ +K++M+CAG  GV S C GDSGGPL C  NG + + G+ S+ S   C+ T  P V+ RV+A ++W+   +A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>142</Hit_num>
  <Hit_id>pdb|1C1M|A</Hit_id>
  <Hit_def>PORCINE ELASTASE UNDER XENON PRESSURE (8 BAR) [Sus scrofa] &gt;pdb|1EAI|A Complex Of Ascaris Chymotrpsin/elastase Inhibitor With Porcine Elastase [Sus scrofa] &gt;pdb|1EAI|B Complex Of Ascaris Chymotrpsin/elastase Inhibitor With Porcine Elastase [Sus scrofa] &gt;pdb|1FZZ|A The Crystal Structure Of The Complex Of Non-peptidic Inhibitor Ono- 6818 And Porcine Pancreatic Elastase. [Sus scrofa] &gt;pdb|1GWA|A Triiodide derivative of porcine pancreas elastase [Sus scrofa] &gt;pdb|1HV7|A Porcine Pancreatic Elastase Complexed With Gw311616a [Sus scrofa] &gt;pdb|1L0Z|A The Structure Of Porcine Pancreatic Elastase Complexed With Xenon And Bromide, Cryoprotected With Dry Paraffin Oil [Sus scrofa] &gt;pdb|1L1G|A The Structure of Porcine Pancreatic Elastase Complexed with Xenon and Bromide, Cryoprotected with Glycerol [Sus scrofa] &gt;pdb|1LKA|A Porcine Pancreatic Elastase/Ca-Complex [Sus scrofa] &gt;pdb|1LKB|A Porcine Pancreatic Elastase/Na-Complex [Sus scrofa] &gt;pdb|1MCV|A Crystal Structure Analysis of a Hybrid Squash Inhibitor in Complex with Porcine Pancreatic Elastase [Sus scrofa] &gt;pdb|1MMJ|N Porcine pancreatic elastase complexed with a potent peptidyl inhibitor, FR136706 [Sus scrofa] &gt;pdb|1QNJ|A THE STRUCTURE OF NATIVE PORCINE PANCREATIC ELASTASE AT ATOMIC RESOLUTION (1.1 A) [Sus scrofa] &gt;pdb|1UO6|A PORCINE PANCREATIC ELASTASE/Xe-COMPLEX [Sus scrofa] &gt;pdb|1UVO|A Structure Of The Complex Of Porcine Pancreatic Elastase In Complex With Cadmium Refined At 1.85 A Resolution (Crystal A) [Sus scrofa] &gt;pdb|1UVP|A Structure Of The Complex Of Porcine Pancreatic Elastase In Complex With Cadmium Refined At 1.85 A Resolution (Crystal B) [Sus scrofa] &gt;pdb|2A7C|A On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength [Sus scrofa] &gt;pdb|2A7J|A On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength [Sus scrofa] &gt;pdb|2BLO|A Elastase before a high dose x-ray &apos;burn&apos; [Sus scrofa] &gt;pdb|2BLQ|A Elastase After A High Dose X-Ray &apos;Burn&apos; [Sus scrofa] &gt;pdb|2CV3|A Crystal structure of porcine pancreatic elastase complexed with a macroclyclic peptide inhibitor [Sus scrofa] &gt;pdb|2D26|C Active site distortion is sufficient for proteinase inhibit second crystal structure of covalent serpin-proteinase complex [Sus scrofa] &gt;pdb|2DE8|A Crystal structure of porcine pancreatic elastase with a unique conformation induced by Tris [Sus scrofa] &gt;pdb|2DE9|A Crystal structure of porcine pancreatic elastase complexed with Tris after soaking a tris-free solution [Sus scrofa] &gt;pdb|2G4T|A anomalous substructure of porcine pancreatic elastase (Na) [Sus scrofa] &gt;pdb|2G4U|A Anomalous substructure of porcine pancreatic elastaase (Ca) [Sus scrofa] &gt;pdb|2IOT|A Clavulanic Acid bound to Elastase [Sus scrofa] &gt;pdb|2OQU|A High Pressure Cryocooling of Capillary Sample Cryoprotection and Diffraction Phasing at Long Wavelengths [Sus scrofa] &gt;pdb|2V0B|A SAD Structure solution porcine pancreatic elastase from a Selenate derivative [Sus scrofa] &gt;pdb|2V35|A Porcine Pancreatic Elastase in complex with inhibitor JM54 [Sus scrofa] &gt;pdb|3HGN|A Structure of porcine pancreatic elastase complexed with a potent peptidyl inhibitor FR130180 determined by neutron crystallography [Sus scrofa] &gt;pdb|3HGP|A Structure of porcine pancreatic elastase complexed with a potent peptidyl inhibitor FR130180 determined by high resolution crystallography [Sus scrofa] &gt;pdb|3UOU|A Crystal structure of the Kunitz-type protease inhibitor ShPI-1 Lys13Leu mutant in complex with pancreatic elastase [Sus scrofa] &gt;pdb|4YM9|A Crystal structure of Porcine Pancreatic Elastase (PPE) in complex with the novel inhibitor JM102 [Sus scrofa] &gt;pdb|6Q8S|A Elastase (PPE) under 2 kbar of argon [Sus scrofa] &gt;pdb|6QBU|A Crystal structure of Porcine Pancreatic Elastase (PPE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC188 [Sus scrofa] &gt;pdb|6QEN|A Crystal structure of Porcine Pancreatic Elastase (PPE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC240 [Sus scrofa] &gt;pdb|6QEO|A Crystal structure of Porcine Pancreatic Elastase (PPE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC269 [Sus scrofa] &gt;pdb|6TH7|A Structure of porcine pancreatic elastase in complex with tutuilamide [Sus scrofa] &gt;pdb|6TH7|B Structure of porcine pancreatic elastase in complex with tutuilamide [Sus scrofa]</Hit_def>
  <Hit_accession>1C1M_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.411</Hsp_bit-score>
      <Hsp_score>189</Hsp_score>
      <Hsp_evalue>1.99072e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>240</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSS-CMGDSGGPLVCKKNGAWTLVGIVSWGSST-CS-TSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN</Hsp_hseq>
      <Hsp_midline>LQQA LP +    C    YWG+ +K++M+CAG  GV S C GDSGGPL C  NG + + G+ S+ S   C+ T  P V+ RV+A ++W+   +A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>143</Hit_num>
  <Hit_id>pdb|1B0E|A</Hit_id>
  <Hit_def>Crystal Structure Of Porcine Pancreatic Elastase With Mdl 101,146 [Sus scrofa] &gt;pdb|1BMA|A Benzyl Methyl Aminimide Inhibitor Complexed To Porcine Pancreatic Elastase [Sus scrofa] &gt;pdb|1BTU|A Porcine Pancreatic Elastase Complexed With (3s, 4r)-1- Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic Acid [Sus scrofa] &gt;pdb|1E34|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para- Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid) Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute [Sus scrofa] &gt;pdb|1E35|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-para- Toluenesulphonyl -3-ethyl-4-(carboxylic Acid)pyrrolidin-2-one Soaked In Ph 9 Buffer For Two Minutes [Sus scrofa] &gt;pdb|1E36|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-para- Nitrobenzenesulphonyl -3-ethyl-4-(carboxylic Acid)pyrrolidin-2-one [Sus scrofa] &gt;pdb|1E37|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para- Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid) Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute [Sus scrofa] &gt;pdb|1E38|B Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para- Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid) Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes [Sus scrofa] &gt;pdb|1EAS|A Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3. Design, Synthesis, X-Ray Crystallographic Analysis, And Structure-Activity Relationships For A Series Of Orally Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl Ketones [Sus scrofa] &gt;pdb|1EAT|A Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5. Design, Synthesis, And X-Ray Crystallography Of A Series Of Orally Active 5- Amino-Pyrimidin-6-One-Containing Trifluoromethylketones [Sus scrofa] &gt;pdb|1EAU|A Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6. Design Of A Potent, Intratracheally Active, Pyridone-Based Trifluoromethyl Ketone [Sus scrofa] &gt;pdb|1ELA|A Analogous inhibitors of elastase do not always bind analogously [Sus scrofa] &gt;pdb|1ELB|A Analogous inhibitors of elastase do not always bind analogously [Sus scrofa] &gt;pdb|1ELC|A Analogous inhibitors of elastase do not always bind analogously [Sus scrofa] &gt;pdb|1ELD|E Structural analysis of the active site of porcine pancreatic elastase based on the x-ray crystal structures of complexes with trifluoroacetyl-dipeptide-anilide inhibitors [Sus scrofa] &gt;pdb|1ELE|E Structural Analysis Of The Active Site Of Porcine Pancreatic Elastase Based On The X-Ray Crystal Structures Of Complexes With Trifluoroacetyl-Dipeptide-Anilide Inhibitors [Sus scrofa] &gt;pdb|1ELF|A Nature Of The Inactivation Of Elastase By N-Peptidyl-O- Aroyl Hydroxylamine As A Function Of Ph [Sus scrofa] &gt;pdb|1ELG|A Nature Of The Inactivation Of Elastase By N-Peptidyl-O- Aroyl Hydroxylamine As A Function Of Ph [Sus scrofa] &gt;pdb|1ESA|A Direct Structure Observation Of An Acyl-Enzyme Intermediate In The Hydrolysis Of An Ester Substrate By Elastase [Sus scrofa] &gt;pdb|1ESB|A Direct Structure Observation Of An Acyl-Enzyme Intermediate In The Hydrolysis Of An Ester Substrate By Elastase [Sus scrofa] &gt;pdb|1EST|A The Atomic Structure Of Crystalline Porcine Pancreatic Elastase At 2.5 Angstroms Resolution. Comparisons With The Structure Of Alpha- Chymotrypsin [Sus scrofa] &gt;pdb|1FLE|E Crystal Structure Of Elafin Complexed With Porcine Pancreatic Elastase [Sus scrofa] &gt;pdb|1GVK|B Porcine pancreatic elastase acyl enzyme at 0.95 A resolution [Sus scrofa] &gt;pdb|1H9L|B PORCINE PANCREATIC ELASTASE COMPLEXED WITH ACETYL-VAL-GLU-PRO-ILE-COOH [Sus scrofa] &gt;pdb|1HAZ|B Snapshots of serine protease catalysis: (C) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 9 for 1 minute [Sus scrofa] &gt;pdb|1INC|A Crystal Structures Of The Complex Of Porcine Pancreatic Elastase With Two Valine-Derived Benzoxazinone Inhibitors [Sus scrofa domesticus] &gt;pdb|1JIM|A Stereospecific Reaction Of 3-Methoxy-4-Chloro-7- Aminoisocoumarin With Crystalline Porcine Pancreatic Elastase [Sus scrofa domesticus] &gt;pdb|1LVY|A Porcine Elastase [Sus scrofa] &gt;pdb|1NES|E Structure Of The Product Complex Of Acetyl-ala-pro-ala With Porcine Pancreatic Elastase At 1.65 Angstroms Resolution [Sus scrofa] &gt;pdb|1OKX|A Binding Structure of Elastase Inhibitor Scyptolin A [Sus scrofa] &gt;pdb|1OKX|B Binding Structure of Elastase Inhibitor Scyptolin A [Sus scrofa] &gt;pdb|1QGF|A PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3R, 4S)N-PARA-TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE [Sus scrofa] &gt;pdb|1QIX|B Porcine pancreatic elastase complexed with human beta-casomorphin-7 [Sus scrofa] &gt;pdb|1QR3|E Structure of porcine pancreatic elastase in complex with FR901277, a novel macrocyclic inhibitor of elastases at 1.6 angstrom resolution [Sus scrofa] &gt;pdb|2BB4|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Asp-Phe at pH 5.0 [Sus scrofa] &gt;pdb|2BD2|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 [Sus scrofa] &gt;pdb|2BD3|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ala-NH2 at pH 5.0 [Sus scrofa] &gt;pdb|2BD4|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ser at pH 5.0 [Sus scrofa] &gt;pdb|2BD5|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ser at pH 5 and immersed in pH 9 buffer for 30 seconds [Sus scrofa] &gt;pdb|2BD7|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak) [Sus scrofa] &gt;pdb|2BD8|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak) and immersed in pH 9 buffer for 30 seconds [Sus scrofa] &gt;pdb|2BD9|A Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak) and immersed in pH 9 buffer for 28 seconds (2nd pH jump) [Sus scrofa] &gt;pdb|2BDA|A Porcine pancreatic elastase complexed with N-acetyl-NPI and Ala-Ala at pH 5.0 [Sus scrofa] &gt;pdb|2BDB|A Porcine pancreatic elastase complexed with Asn-Pro-Ile and Ala-Ala at pH 5.0 [Sus scrofa] &gt;pdb|2BDC|A Porcine pancreatic elastase complexed with Asn-Pro-Ile at pH 5.0 [Sus scrofa] &gt;pdb|2EST|E Crystallographic study of the binding of a trifluoroacetyl dipeptide anilide inhibitor with elastase [Sus scrofa] &gt;pdb|2FO9|A Structure of porcine pancreatic elastase in 95% acetone [Sus scrofa] &gt;pdb|2FOA|A Structure of porcine pancreatic elastase in 40/50/10 % benzene [Sus scrofa] &gt;pdb|2FOB|A Structure of porcine pancreatic elastase in 40/50/10 cyclohexane [Sus scrofa] &gt;pdb|2FOC|A Structure of porcine pancreatic elastase in 55% dimethylformamide [Sus scrofa] &gt;pdb|2FOD|A Structure of porcine pancreatic elastase in 80% ethanol [Sus scrofa] &gt;pdb|2FOE|A Structure of porcine pancreatic elastase in 80% hexane [Sus scrofa] &gt;pdb|2FOF|A Structure of porcine pancreatic elastase in 80% isopropanol [Sus scrofa] &gt;pdb|2FOG|A Structure of porcine pancreatic elastase in 40% trifluoroethanol [Sus scrofa] &gt;pdb|2FOH|A Structure of porcine pancreatic elastase in 40% trifluoroethanol [Sus scrofa] &gt;pdb|2H1U|A Porcine pancreatic elastase complexed with MetPheLeuGlu at pH 5.0 [Sus scrofa] &gt;pdb|3E3T|A Structure of porcine pancreatic elastase with the magic triangle I3C [Sus scrofa] &gt;pdb|3EST|A Structure Of Native Porcine Pancreatic Elastase At 1.65 Angstroms Resolution [Sus scrofa] &gt;pdb|3MNB|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. First stage of radiation damage [Sus scrofa] &gt;pdb|3MNC|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Second stage of radiation damage [Sus scrofa] &gt;pdb|3MNS|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Third stage of radiation damage [Sus scrofa] &gt;pdb|3MNX|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Fourth stage of radiation damage [Sus scrofa] &gt;pdb|3MO3|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Fifth stage of radiation damage [Sus scrofa] &gt;pdb|3MO6|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Sixth stage of radiation damage [Sus scrofa] &gt;pdb|3MO9|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Seventh stage of radiation damage [Sus scrofa] &gt;pdb|3MOC|A Investigation of global and local effects of radiation damage on porcine pancreatic elastase. Eighth stage of radiation damage [Sus scrofa] &gt;pdb|3MTY|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region A of the crystal. First step of radiation damage [Sus scrofa] &gt;pdb|3MU0|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region A of the crystal. Third step of radiation damage [Sus scrofa] &gt;pdb|3MU1|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region A of the crystal. Fifth step of radiation damage [Sus scrofa] &gt;pdb|3MU4|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region B of the crystal. First step of radiation damage [Sus scrofa] &gt;pdb|3MU5|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region B of the crystal. Third step of radiation damage [Sus scrofa] &gt;pdb|3MU8|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region B of the crystal. Fifth step of radiation damage [Sus scrofa] &gt;pdb|3ODD|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region B of the crystal. Second step of radiation damage [Sus scrofa] &gt;pdb|3ODF|A Comparison of the character and the speed of X-ray-induced structural changes of porcine pancreatic elastase at two temperatures, 100 and 15K. The data set was collected from region A of the crystal. Second step of radiation damage [Sus scrofa] &gt;pdb|4EST|E CRYSTAL STRUCTURE OF THE COVALENT COMPLEX FORMED BY A PEPTIDYL ALPHA,ALPHA-DIFLUORO-BETA-KETO AMIDE WITH PORCINE PANCREATIC ELASTASE AT 1.78-ANGSTROMS RESOLUTION [Sus scrofa] &gt;pdb|4GVU|A Lyngbyastatin 7-Porcine Pancreatic Elastase Co-crystal Structure [Sus scrofa] &gt;pdb|5AVD|A The 0.86 angstrom structure of elastase crystallized in high-strength agarose hydrogel [Sus scrofa] &gt;pdb|5EST|E Crystallographic analysis of the inhibition of porcine pancreatic elastase by a peptidyl boronic acid: structure of a reaction intermediate [Sus scrofa] &gt;pdb|6EST|A Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla) With Porcine Pancreatic Elastase. X-Ray Studies At 1.8 Angstroms [Sus scrofa] &gt;pdb|7EST|E Interaction of the peptide CF3-LEU-ALA-NH-C6H4-CF3(TFLA) with porcine pancreatic elastase. X-ray studies at 1.8 Angstroms [Sus scrofa] &gt;pdb|8EST|E Reaction Of Porcine Pancreatic Elastase With 7-substituted 3-alkoxy-4-chloroisocoumarins: Design Of Potent Inhibitors Using The Crystal Structure Of The Complex Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin [Sus scrofa] &gt;pdb|9EST|A Structural Study Of Porcine Pancreatic Elastase Complexed With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A Nonreactivatable Doubly Covalent Enzyme-Inhibitor Complex [Sus scrofa]</Hit_def>
  <Hit_accession>1B0E_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.411</Hsp_bit-score>
      <Hsp_score>189</Hsp_score>
      <Hsp_evalue>2.0118e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>240</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSS-CMGDSGGPLVCKKNGAWTLVGIVSWGSST-CS-TSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN</Hsp_hseq>
      <Hsp_midline>LQQA LP +    C    YWG+ +K++M+CAG  GV S C GDSGGPL C  NG + + G+ S+ S   C+ T  P V+ RV+A ++W+   +A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>144</Hit_num>
  <Hit_id>pdb|4WXV|A</Hit_id>
  <Hit_def>Human cationic trypsin K97D mutant in complex with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|4WXV|B Human cationic trypsin K97D mutant in complex with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens]</Hit_def>
  <Hit_accession>4WXV_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>2.325e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDAGGPVVC--NG--QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD LQ    P+LS   C+  +  KI   M C G    G  SC GD+GGP+VC  NG   L G+VSWG      + PGVY +V   V W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>145</Hit_num>
  <Hit_id>pdb|2RA3|A</Hit_id>
  <Hit_def>Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|2RA3|B Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens]</Hit_def>
  <Hit_accession>2RA3_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>2.42554e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDAGGPVVC--NG--QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD LQ    P+LS   C+  +  KI   M C G    G  SC GD+GGP+VC  NG   L G+VSWG      + PGVY +V   V W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>146</Hit_num>
  <Hit_id>pdb|6QFG|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK144 [Homo sapiens] &gt;pdb|6QFG|B Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK144 [Homo sapiens] &gt;pdb|6SKC|A Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3448330A [Homo sapiens] &gt;pdb|6SKC|B Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3448330A [Homo sapiens] &gt;pdb|6SKD|A Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3397892A [Homo sapiens] &gt;pdb|6SKD|B Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3397892A [Homo sapiens]</Hit_def>
  <Hit_accession>6QFG_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>2.67984e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>129</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDH----LRGLVSWGNYPCGSKEKPGVYTNVCRYTNWIQKTIQAK</Hsp_hseq>
      <Hsp_midline>+ PD +Q A + L+S   C+  +  +I   M+CAG    G  SC GDSGGPLVC  +    L G+VSWG+  C S   PGVY  V    NW+Q+T+ A </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>147</Hit_num>
  <Hit_id>pdb|6QFH|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK144. [Homo sapiens] &gt;pdb|6QFH|B Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK144. [Homo sapiens]</Hit_def>
  <Hit_accession>6QFH_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>3.02408e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>129</Hsp_hit-from>
      <Hsp_hit-to>222</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDH----LRGLVSWGDYPCGSKERPGVYTNVCRYTNWIQKTIQA</Hsp_hseq>
      <Hsp_midline>+ PD +Q A + L+S   C+  +  +I   M+CAG    G  SC GDSGGPLVC  +    L G+VSWG   C S   PGVY  V    NW+Q+T+ A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>148</Hit_num>
  <Hit_id>pdb|1RJX|B</Hit_id>
  <Hit_def>Human PLASMINOGEN CATALYTIC DOMAIN, K698M MUTANT [Homo sapiens]</Hit_def>
  <Hit_accession>1RJX_B</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>3.29634e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>153</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LMEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L +A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>149</Hit_num>
  <Hit_id>pdb|5DK1|A</Hit_id>
  <Hit_def>S. erythraea trypsin mixed catalytic intermediate [Saccharopolyspora erythraea]</Hit_def>
  <Hit_accession>5DK1_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>3.37651e-18</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DHLQKATVPVNSDDTCKQAYGEYTPNAMVCAGVPEGGVDTCQGDSGGPMVVNNK----LIGVTSWGEGCARPGKPGVYARVGAYYDVLMEQINA</Hsp_hseq>
      <Hsp_midline>D LQ+A++P+ S+  CK+ +G    +AM+CAG    GV +C GDSGGP+V        L+G+ SWG        PGVYARV A  + + + + A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>150</Hit_num>
  <Hit_id>pdb|4ZKS|U</Hit_id>
  <Hit_def>The crystal structure of upain-1-W3A in complex with inactive uPA (uPA-S195A) at pH7.4 [Homo sapiens]</Hit_def>
  <Hit_accession>4ZKS_U</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>3.5477e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GD+GGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>151</Hit_num>
  <Hit_id>pdb|6D3Z|A</Hit_id>
  <Hit_def>Protease SFTI complex [Homo sapiens]</Hit_def>
  <Hit_accession>6D3Z_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>3.60822e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GD+GGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>152</Hit_num>
  <Hit_id>pdb|1SGF|A</Hit_id>
  <Hit_def>Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (serine Proteinases) [Mus musculus] &gt;pdb|1SGF|X Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (serine Proteinases) [Mus musculus]</Hit_def>
  <Hit_accession>1SGF_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>3.66574e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>239</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDDLQCVNLKLLPNEDCDKAHEMKVTDAMLCAGEMDGGSYTCEHDSGGPLICDG----ILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIRETMANN</Hsp_hseq>
      <Hsp_midline>PD LQ  +L LL N +C K    K+ DAM+CAG    G  +C  DSGGPL+C       L GI SWG   C   T P VY ++    +W+++T+A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>153</Hit_num>
  <Hit_id>pdb|1L2E|A</Hit_id>
  <Hit_def>Human Kallikrein 6 (hK6) Active Form with benzamidine inhibitor [Homo sapiens] &gt;pdb|1LO6|A Human Kallikrein 6 (hK6) active form with benzamidine inhibitor at 1.56 A resolution [Homo sapiens]</Hit_def>
  <Hit_accession>1L2E_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>3.75999e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>129</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDH----LRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK</Hsp_hseq>
      <Hsp_midline>+ PD +Q A + L+S   C+  +  +I   M+CAG    G  SC GDSGGPLVC  +    L G+VSWG+  C S   PGVY  V    NW+Q+T+ A </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>154</Hit_num>
  <Hit_id>pdb|1DDJ|A</Hit_id>
  <Hit_def>Crystal Structure Of Human Plasminogen Catalytic Domain [Homo sapiens] &gt;pdb|1DDJ|B Crystal Structure Of Human Plasminogen Catalytic Domain [Homo sapiens] &gt;pdb|1DDJ|C Crystal Structure Of Human Plasminogen Catalytic Domain [Homo sapiens] &gt;pdb|1DDJ|D Crystal Structure Of Human Plasminogen Catalytic Domain [Homo sapiens]</Hit_def>
  <Hit_accession>1DDJ_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>3.8182e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>153</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GD+GGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>155</Hit_num>
  <Hit_id>pdb|3VFE|A</Hit_id>
  <Hit_def>Virtual Screening and X-Ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group [Homo sapiens] &gt;pdb|4D8N|A Human Kallikrein 6 Inhibitors with a para-Amidobenzylanmine P1 Group Carry a High Binding Efficiency [Homo sapiens] &gt;pdb|5NX1|A Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy [Homo sapiens] &gt;pdb|5NX3|A Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy [Homo sapiens] &gt;pdb|6QH9|A Crystal Structure of Human Kallikrein 6 in complex with GSK3239861A [Homo sapiens] &gt;pdb|6QH9|B Crystal Structure of Human Kallikrein 6 in complex with GSK3239861A [Homo sapiens] &gt;pdb|6QHA|A Crystal Structure of Human Kallikrein 6 in complex with GSK3205388B [Homo sapiens] &gt;pdb|6QHA|B Crystal Structure of Human Kallikrein 6 in complex with GSK3205388B [Homo sapiens] &gt;pdb|6QHB|A Crystal Structure of Human Kallikrein 6 in complex with GSK578724A [Homo sapiens] &gt;pdb|6QHB|B Crystal Structure of Human Kallikrein 6 in complex with GSK578724A [Homo sapiens] &gt;pdb|6QHC|A Crystal Structure of Human Kallikrein 6 in complex with GSK358180B [Homo sapiens] &gt;pdb|6QHC|B Crystal Structure of Human Kallikrein 6 in complex with GSK358180B [Homo sapiens]</Hit_def>
  <Hit_accession>3VFE_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>3.88126e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>129</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDH----LRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK</Hsp_hseq>
      <Hsp_midline>+ PD +Q A + L+S   C+  +  +I   M+CAG    G  SC GDSGGPLVC  +    L G+VSWG+  C S   PGVY  V    NW+Q+T+ A </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>156</Hit_num>
  <Hit_id>pdb|1GVL|A</Hit_id>
  <Hit_def>Human prokallikrein 6 (hK6)/ prozyme/ proprotease M/ proneurosin [Homo sapiens]</Hit_def>
  <Hit_accession>1GVL_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>3.88126e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDH----LRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQA</Hsp_hseq>
      <Hsp_midline>+ PD +Q A + L+S   C+  +  +I   M+CAG    G  SC GDSGGPLVC  +    L G+VSWG+  C S   PGVY  V    NW+Q+T+ A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>157</Hit_num>
  <Hit_id>pdb|2O8U|A</Hit_id>
  <Hit_def>Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in complex with Inhibitors [Homo sapiens] &gt;pdb|2O8W|A Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in complex with Inhibitors [Homo sapiens] &gt;pdb|3PB1|E Crystal Structure of a Michaelis Complex between Plasminogen Activator Inhibitor-1 and Urokinase-type Plasminogen Activator [Homo sapiens] &gt;pdb|5WXT|U Crystal structure of uPA-S195A in complex with S2444 [Homo sapiens]</Hit_def>
  <Hit_accession>2O8U_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>3.98813e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GD+GGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>158</Hit_num>
  <Hit_id>pdb|1L4D|A</Hit_id>
  <Hit_def>Crystal Structure Of Microplasminogen-streptokinase Alpha Domain Complex [Homo sapiens]</Hit_def>
  <Hit_accession>1L4D_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>4.18522e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GD+GGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>159</Hit_num>
  <Hit_id>pdb|1O5A|B</Hit_id>
  <Hit_def>Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1O5B|B Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1O5C|B Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens]</Hit_def>
  <Hit_accession>1O5A_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>4.2468e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDACQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        +C GDSGGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>160</Hit_num>
  <Hit_id>pdb|1L4Z|A</Hit_id>
  <Hit_def>X-Ray Crystal Structure Of The Complex Of Microplasminogen With Alpha Domain Of Streptokinase In The Presence Cadmium Ions [Homo sapiens]</Hit_def>
  <Hit_accession>1L4Z_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>4.25749e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>154</Hsp_hit-from>
      <Hsp_hit-to>248</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GD+GGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>161</Hit_num>
  <Hit_id>pdb|1BML|A</Hit_id>
  <Hit_def>COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE [Homo sapiens] &gt;pdb|1BML|B COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE [Homo sapiens]</Hit_def>
  <Hit_accession>1BML_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>4.29009e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>156</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GD+GGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>162</Hit_num>
  <Hit_id>pdb|6QFF|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 6 in complex with GSK144 [Homo sapiens] &gt;pdb|6QFF|B Crystal Structure of Human Kallikrein 6 in complex with GSK144 [Homo sapiens]</Hit_def>
  <Hit_accession>6QFF_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>4.33401e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>129</Hsp_hit-from>
      <Hsp_hit-to>222</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDH----LRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQA</Hsp_hseq>
      <Hsp_midline>+ PD +Q A + L+S   C+  +  +I   M+CAG    G  SC GDSGGPLVC  +    L G+VSWG+  C S   PGVY  V    NW+Q+T+ A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>163</Hit_num>
  <Hit_id>pdb|2R0L|A</Hit_id>
  <Hit_def>Short Form HGFA with Inhibitory Fab75 [Homo sapiens]</Hit_def>
  <Hit_accession>2R0L_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>5.53406e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>238</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC--KKYWGTKIKDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDRI</Hsp_hseq>
      <Hsp_midline>L++A +PL+++  C   + +G  I   M+CAG     S  C GDSGGPL C+KNG   L GI+SWG        PGVY RV   V+W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>164</Hit_num>
  <Hit_id>pdb|6SKB|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK3496783A [Homo sapiens] &gt;pdb|6SKB|B Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK3496783A [Homo sapiens] &gt;pdb|6SKB|C Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK3496783A [Homo sapiens]</Hit_def>
  <Hit_accession>6SKB_A</Hit_accession>
  <Hit_len>289</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.0258</Hsp_bit-score>
      <Hsp_score>188</Hsp_score>
      <Hsp_evalue>5.78824e-18</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>195</Hsp_hit-from>
      <Hsp_hit-to>289</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDH----LRGLVSWGDYPCGSKERPGVYTNVCRYTNWIQKTIQAK</Hsp_hseq>
      <Hsp_midline>+ PD +Q A + L+S   C+  +  +I   M+CAG    G  SC GDSGGPLVC  +    L G+VSWG   C S   PGVY  V    NW+Q+T+ A </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>165</Hit_num>
  <Hit_id>pdb|2WUB|A</Hit_id>
  <Hit_def>Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp [Homo sapiens] &gt;pdb|2WUB|C Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp [Homo sapiens] &gt;pdb|2WUC|A Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp and Ac-KQLR-chloromethylketone [Homo sapiens] &gt;pdb|3K2U|A Crystal structure of HGFA in complex with the allosteric inhibitory antibody Fab40 [Homo sapiens]</Hit_def>
  <Hit_accession>2WUB_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>6.27031e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>238</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC--KKYWGTKIKDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDRI</Hsp_hseq>
      <Hsp_midline>L++A +PL+++  C   + +G  I   M+CAG     S  C GDSGGPL C+KNG   L GI+SWG        PGVY RV   V+W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>166</Hit_num>
  <Hit_id>pdb|4XSK|U</Hit_id>
  <Hit_def>Structure of PAItrap, an uPA mutant [Homo sapiens]</Hit_def>
  <Hit_accession>4XSK_U</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>7.36652e-18</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>PEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGLGCALKDKPGVYTRVSHFLPWIR</Hsp_hseq>
      <Hsp_midline>P++L+   + L+S+  C++  Y+G+++   M+CA        SC GD+GGPLVC   G  TL GIVSWG        PGVY RV+  + W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>167</Hit_num>
  <Hit_id>pdb|3GYL|B</Hit_id>
  <Hit_def>Structure of Prostasin at 1.3 Angstroms resolution in complex with a Calcium Ion. [Homo sapiens] &gt;pdb|3GYM|A Structure of Prostasin in Complex with Aprotinin [Homo sapiens] &gt;pdb|3GYM|B Structure of Prostasin in Complex with Aprotinin [Homo sapiens]</Hit_def>
  <Hit_accession>3GYL_B</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>7.65268e-18</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>238</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>TPDRLQQASLPLLSNTNCKKYWGTK--------IKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>TPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQ</Hsp_hseq>
      <Hsp_midline>TP  LQQ  +PL+S   C   +           +++ M+CAG    G  +C GDSGGPL C   G W L GIVSWG +  + + PGVY   ++  +W+Q</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>168</Hit_num>
  <Hit_id>pdb|4A5T|S</Hit_id>
  <Hit_def>Structural Basis For The Conformational Modulation [Homo sapiens] &gt;pdb|4DUR|A The X-ray Crystal Structure of Full-Length type II Human Plasminogen [Homo sapiens] &gt;pdb|4DUR|B The X-ray Crystal Structure of Full-Length type II Human Plasminogen [Homo sapiens] &gt;pdb|4DUU|A The X-ray Crystal Structure of Full-Length type I Human Plasminogen [Homo sapiens]</Hit_def>
  <Hit_accession>4A5T_S</Hit_accession>
  <Hit_len>791</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>77.7962</Hsp_bit-score>
      <Hsp_score>190</Hsp_score>
      <Hsp_evalue>7.88936e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>697</Hsp_hit-from>
      <Hsp_hit-to>791</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN</Hsp_hseq>
      <Hsp_midline>L++A LP++ N  C +Y     +++   +CAG  A G  SC GDSGGPLVC +   + L G+ SWG      + PGVY RV+  V W++  +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>169</Hit_num>
  <Hit_id>pdb|1YBW|A</Hit_id>
  <Hit_def>Protease domain of HGFA with no inhibitor [Homo sapiens] &gt;pdb|1YBW|B Protease domain of HGFA with no inhibitor [Homo sapiens] &gt;pdb|1YC0|A short form HGFA with first Kunitz domain from HAI-1 [Homo sapiens] &gt;pdb|2R0K|A Protease domain of HGFA with inhibitor Fab58 [Homo sapiens]</Hit_def>
  <Hit_accession>1YBW_A</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.6406</Hsp_bit-score>
      <Hsp_score>187</Hsp_score>
      <Hsp_evalue>8.1115e-18</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>182</Hsp_hit-from>
      <Hsp_hit-to>273</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC--KKYWGTKIKDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDRI</Hsp_hseq>
      <Hsp_midline>L++A +PL+++  C   + +G  I   M+CAG     S  C GDSGGPL C+KNG   L GI+SWG        PGVY RV   V+W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>170</Hit_num>
  <Hit_id>pdb|3E0N|B</Hit_id>
  <Hit_def>The X-ray structure of Human Prostasin in complex with DFFR-chloromethyl ketone inhibitor [Homo sapiens] &gt;pdb|3E0P|B The X-ray structure of Human Prostasin in complex with a covalent benzoxazole inhibitor [Homo sapiens] &gt;pdb|3E16|B Chain B, Prostasin [Homo sapiens] &gt;pdb|3E1X|B The Crystal Structure of Apo Prostasin at 1.7 Angstroms Resolution [Homo sapiens] &gt;pdb|3FVF|B The Crystal Structure of Prostasin Complexed with Camostat at 1.6 Angstroms Resolution [Homo sapiens]</Hit_def>
  <Hit_accession>3E0N_B</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>8.67949e-18</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>238</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>TPDRLQQASLPLLSNTNCKKYWGTK--------IKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>TPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQ</Hsp_hseq>
      <Hsp_midline>TP  LQQ  +PL+S   C   +           +++ M+CAG    G  +C GDSGGPL C   G W L GIVSWG +  + + PGVY   ++  +W+Q</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>171</Hit_num>
  <Hit_id>pdb|3DFJ|A</Hit_id>
  <Hit_def>Crystal structure of human Prostasin [Homo sapiens] &gt;pdb|3DFL|A Crystal structure of human Prostasin complexed to 4-guanidinobenzoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>3DFJ_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>76.2554</Hsp_bit-score>
      <Hsp_score>186</Hsp_score>
      <Hsp_evalue>9.47464e-18</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>238</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>TPDRLQQASLPLLSNTNCKKYWGTK--------IKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>TPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQ</Hsp_hseq>
      <Hsp_midline>TP  LQQ  +PL+S   C   +           +++ M+CAG    G  +C GDSGGPL C   G W L GIVSWG +  + + PGVY   ++  +W+Q</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>172</Hit_num>
  <Hit_id>pdb|4WWY|A</Hit_id>
  <Hit_def>human cationic trypsin G193R mutant in complex with bovine pancreatic trypsin inhibitor [Homo sapiens] &gt;pdb|4WWY|B human cationic trypsin G193R mutant in complex with bovine pancreatic trypsin inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>4WWY_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.0998</Hsp_bit-score>
      <Hsp_score>183</Hsp_score>
      <Hsp_evalue>1.18466e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQRDSGGPVVC--NG--QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD LQ    P+LS   C+  +  KI   M C G    G  SC  DSGGP+VC  NG   L G+VSWG      + PGVY +V   V W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>173</Hit_num>
  <Hit_id>pdb|1SPJ|A</Hit_id>
  <Hit_def>Structure Of Mature Human Tissue Kallikrein (Human Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With Vacant Active Site [Homo sapiens]</Hit_def>
  <Hit_accession>1SPJ_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.485</Hsp_bit-score>
      <Hsp_score>184</Hsp_score>
      <Hsp_evalue>1.21772e-17</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDG----VLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAEN</Hsp_hseq>
      <Hsp_midline>PD LQ   L +L N  CKK    K+ D M+C G    G  +C+GDSGGPL+C       L G+ SWG   C T + P V  RV + V W++ T+A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>174</Hit_num>
  <Hit_id>pdb|4NFE|A</Hit_id>
  <Hit_def>Human kallikrein-related peptidase 2 in complex with benzamidine [Homo sapiens] &gt;pdb|4NFF|A Human kallikrein-related peptidase 2 in complex with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>4NFE_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.485</Hsp_bit-score>
      <Hsp_score>184</Hsp_score>
      <Hsp_evalue>1.25121e-17</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>144</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCS-TSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PRSLQCVSLHLLSNDMCARAYSEKVTEFMLCAGLWTGGKDTCGGDSGGPLVC--NG--VLQGITSWGPEPCALPEKPAVYTKVVHYRKWIKDTIAAN</Hsp_hseq>
      <Hsp_midline>P  LQ  SL LLSN  C + +  K+ + M+CAG    G  +C GDSGGPLVC  NG   L GI SWG   C+    P VY +V     W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>175</Hit_num>
  <Hit_id>pdb|2PSX|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 5 in complex with Leupeptin [Homo sapiens] &gt;pdb|2PSY|A Crystal Structure of Human Kallikrein 5 in complex with Leupeptin and Zinc [Homo sapiens] &gt;pdb|6QFE|A Crystal Structure of Human Kallikrein 5 in complex with GSK144 [Homo sapiens] &gt;pdb|6QFE|B Crystal Structure of Human Kallikrein 5 in complex with GSK144 [Homo sapiens]</Hit_def>
  <Hit_accession>2PSX_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.0998</Hsp_bit-score>
      <Hsp_score>183</Hsp_score>
      <Hsp_evalue>1.4715e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>133</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>58</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>HFPKVLQCLNISVLSQKRCEDAYPRQIDDTMFCAGDKAGRDSCQGDSGGPVVC--NG--SLQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETIQAN</Hsp_hseq>
      <Hsp_midline>+ P  LQ  ++ +LS   C+  +  +I D M CAG  +G  SC GDSGGP+VC  NG  +L G+VSWG   C+  + PGVY  +     W+Q+T+ AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>176</Hit_num>
  <Hit_id>pdb|1SGF|G</Hit_id>
  <Hit_def>Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (serine Proteinases) [Mus musculus] &gt;pdb|1SGF|Z Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (serine Proteinases) [Mus musculus]</Hit_def>
  <Hit_accession>1SGF_G</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>75.0998</Hsp_bit-score>
      <Hsp_score>183</Hsp_score>
      <Hsp_evalue>1.56037e-17</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DDLYCVNLKLLPNEDCAKAHIEKVTDAMLCAGEMDGGKDTCKGDSGGPLICDG----VLQGITSWGHTPCGEPDMPGVYTKLNKFTSWIKDTMAKN</Hsp_hseq>
      <Hsp_midline>D L   +L LL N +C K    K+ DAM+CAG    G  +C GDSGGPL+C       L GI SWG + C     PGVY ++    +W++ T+A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>177</Hit_num>
  <Hit_id>pdb|2TBS|A</Hit_id>
  <Hit_def>Cold-Adaption Of Enzymes: Structural Comparison Between Salmon And Bovine Trypsins [Salmo salar]</Hit_def>
  <Hit_accession>2TBS_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>74.7146</Hsp_bit-score>
      <Hsp_score>182</Hsp_score>
      <Hsp_evalue>1.67772e-17</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>221</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DKLQCLNIPILSYSDCNDSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFSDWLTSTMAS</Hsp_hseq>
      <Hsp_midline>D+LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>178</Hit_num>
  <Hit_id>pdb|5TP0|A</Hit_id>
  <Hit_def>Human mesotrypsin in complex with diminazene [Homo sapiens]</Hit_def>
  <Hit_accession>5TP0_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>74.7146</Hsp_bit-score>
      <Hsp_score>182</Hsp_score>
      <Hsp_evalue>1.98754e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSCQRDSGGPVVC--NG--QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD L+    P+L+   CK  +  KI ++M C G    G  SC  DSGGP+VC  NG   L G+VSWG      + PGVY +V   V+W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>179</Hit_num>
  <Hit_id>pdb|5MS3|A</Hit_id>
  <Hit_def>Kallikrein-related peptidase 8 calcium complex [Homo sapiens] &gt;pdb|5MS4|A Kallikrein-related peptidase 8 leupeptin inhibitor complex [Homo sapiens] &gt;pdb|5MS4|B Kallikrein-related peptidase 8 leupeptin inhibitor complex [Homo sapiens] &gt;pdb|5MS4|C Kallikrein-related peptidase 8 leupeptin inhibitor complex [Homo sapiens] &gt;pdb|5MS4|D Kallikrein-related peptidase 8 leupeptin inhibitor complex [Homo sapiens]</Hit_def>
  <Hit_accession>5MS3_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>74.7146</Hsp_bit-score>
      <Hsp_score>182</Hsp_score>
      <Hsp_evalue>2.00828e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>134</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS-GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NFPDTLNCAEVKIFPQKKCEDAYPGQITDGMVCAGSSKGADTCQGDSGGPLVC--DGA--LQGITSWGSDPCGRSDKPGVYTNICRYLDWIKKIIGSK</Hsp_hseq>
      <Hsp_midline>N PD L  A + +     C+  +  +I D M+CAG+S G  +C GDSGGPLVC  +GA  L GI SWGS  C  S  PGVY  +   ++W+++ + + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>180</Hit_num>
  <Hit_id>pdb|1H4W|A</Hit_id>
  <Hit_def>Structure of human trypsin IV (brain trypsin) [Homo sapiens]</Hit_def>
  <Hit_accession>1H4W_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>74.7146</Hsp_bit-score>
      <Hsp_score>182</Hsp_score>
      <Hsp_evalue>2.07326e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSCQRDSGGPVVC--NG--QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD L+    P+L+   CK  +  KI ++M C G    G  SC  DSGGP+VC  NG   L G+VSWG      + PGVY +V   V+W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>181</Hit_num>
  <Hit_id>pdb|2ZPR|A</Hit_id>
  <Hit_def>Crystal structure of anionic trypsin isoform 2 from chum salmon [Oncorhynchus keta] &gt;pdb|2ZPR|B Crystal structure of anionic trypsin isoform 2 from chum salmon [Oncorhynchus keta]</Hit_def>
  <Hit_accession>2ZPR_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.9442</Hsp_bit-score>
      <Hsp_score>180</Hsp_score>
      <Hsp_evalue>3.03105e-17</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>DKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA</Hsp_hseq>
      <Hsp_midline>D+LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>182</Hit_num>
  <Hit_id>pdb|2ZPS|A</Hit_id>
  <Hit_def>Crystal structure of anionic trypsin isoform 3 from chum salmon [Oncorhynchus keta]</Hit_def>
  <Hit_accession>2ZPS_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.559</Hsp_bit-score>
      <Hsp_score>179</Hsp_score>
      <Hsp_evalue>4.24908e-17</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>NKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNNWLTSTMA</Hsp_hseq>
      <Hsp_midline>++LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    NW+  T+A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>183</Hit_num>
  <Hit_id>pdb|2R9P|A</Hit_id>
  <Hit_def>Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) [Homo sapiens] &gt;pdb|2R9P|B Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) [Homo sapiens] &gt;pdb|2R9P|C Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) [Homo sapiens] &gt;pdb|2R9P|D Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI) [Homo sapiens] &gt;pdb|3L33|A Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) [Homo sapiens] &gt;pdb|3L33|B Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) [Homo sapiens] &gt;pdb|3L33|C Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) [Homo sapiens] &gt;pdb|3L33|D Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) [Homo sapiens] &gt;pdb|3L3T|A Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K) [Homo sapiens] &gt;pdb|3L3T|B Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K) [Homo sapiens] &gt;pdb|3L3T|C Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K) [Homo sapiens] &gt;pdb|3L3T|D Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K) [Homo sapiens] &gt;pdb|3P92|A Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (BPTI-K15R/R17G) [Homo sapiens] &gt;pdb|3P95|A Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (BPTI-K15R/R17D) [Homo sapiens] &gt;pdb|4U30|A Human mesotrypsin complexed with bikunin Kunitz domain 2 [Homo sapiens] &gt;pdb|4U30|B Human mesotrypsin complexed with bikunin Kunitz domain 2 [Homo sapiens] &gt;pdb|4U30|C Human mesotrypsin complexed with bikunin Kunitz domain 2 [Homo sapiens] &gt;pdb|4U30|D Human mesotrypsin complexed with bikunin Kunitz domain 2 [Homo sapiens] &gt;pdb|4U32|A Human mesotrypsin complexed with HAI-2 Kunitz domain 1 [Homo sapiens] &gt;pdb|5C67|A Human Mesotrypsin in complex with amyloid precursor protein inhibitor variant APPI-M17G/I18F/F34V [Homo sapiens] &gt;pdb|5C67|B Human Mesotrypsin in complex with amyloid precursor protein inhibitor variant APPI-M17G/I18F/F34V [Homo sapiens] &gt;pdb|5JBT|A Mesotrypsin in complex with cleaved amyloid precursor like protein 2 inhibitor (APLP2) [Homo sapiens] &gt;pdb|6BX8|A Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C) [Homo sapiens] &gt;pdb|6BX8|C Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C) [Homo sapiens] &gt;pdb|6BX8|E Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C) [Homo sapiens] &gt;pdb|6BX8|G Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C) [Homo sapiens] &gt;pdb|6GFI|A Structure of Human Mesotrypsin in complex with APPI variant T11V/M17R/I18F/F34V [Homo sapiens] &gt;pdb|6GFI|B Structure of Human Mesotrypsin in complex with APPI variant T11V/M17R/I18F/F34V [Homo sapiens] &gt;pdb|6HAR|A Crystal structure of Mesotrypsin in complex with APPI-M17C/I18F/F34C [Homo sapiens]</Hit_def>
  <Hit_accession>2R9P_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.559</Hsp_bit-score>
      <Hsp_score>179</Hsp_score>
      <Hsp_evalue>4.38528e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSCQRDAGGPVVC--NG--QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD L+    P+L+   CK  +  KI ++M C G    G  SC  D+GGP+VC  NG   L G+VSWG      + PGVY +V   V+W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>184</Hit_num>
  <Hit_id>pdb|4DG4|A</Hit_id>
  <Hit_def>Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|4DG4|B Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|4DG4|D Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens] &gt;pdb|4DG4|G Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI) [Homo sapiens]</Hit_def>
  <Hit_accession>4DG4_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.559</Hsp_bit-score>
      <Hsp_score>179</Hsp_score>
      <Hsp_evalue>4.57422e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSCQRDAGGPVVC--NG--QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAAN</Hsp_hseq>
      <Hsp_midline>+ PD L+    P+L+   CK  +  KI ++M C G    G  SC  D+GGP+VC  NG   L G+VSWG      + PGVY +V   V+W++ T+AAN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>185</Hit_num>
  <Hit_id>pdb|1A0J|A</Hit_id>
  <Hit_def>Crystal Structure Of A Non-Psychrophilic Trypsin From A Cold-Adapted Fish Species. [Salmo salar] &gt;pdb|1A0J|B Crystal Structure Of A Non-Psychrophilic Trypsin From A Cold-Adapted Fish Species. [Salmo salar] &gt;pdb|1A0J|C Crystal Structure Of A Non-Psychrophilic Trypsin From A Cold-Adapted Fish Species. [Salmo salar] &gt;pdb|1A0J|D Crystal Structure Of A Non-Psychrophilic Trypsin From A Cold-Adapted Fish Species. [Salmo salar]</Hit_def>
  <Hit_accession>1A0J_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.559</Hsp_bit-score>
      <Hsp_score>179</Hsp_score>
      <Hsp_evalue>4.6477e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NYPDTLRCLDLPILSSSSCNSAYPGQITSNMFCAGFMEGGKDSCQGDSGGPVVC--NG--QLQGVVSWGYGCAQRNKPGVYTKVCNYRSWISSTMSSN</Hsp_hseq>
      <Hsp_midline>N PD L+   LP+LS+++C   +  +I   M CAG    G  SC GDSGGP+VC  NG   L G+VSWG      + PGVY +V    +W+  T+++N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>186</Hit_num>
  <Hit_id>pdb|1NPM|A</Hit_id>
  <Hit_def>Neuropsin, A Serine Protease Expressed In The Limbic System Of Mouse Brain [Mus musculus] &gt;pdb|1NPM|B Neuropsin, A Serine Protease Expressed In The Limbic System Of Mouse Brain [Mus musculus]</Hit_def>
  <Hit_accession>1NPM_A</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>6.17572e-17</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>134</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS-GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>NFPNTLNCAEVKIYSQNKCERAYPGKITEGMVCAGSSNGADTCQGDSGGPLVCDG----MLQGITSWGSDPCGKPEKPGVYTKICRYTTWIKKTM</Hsp_hseq>
      <Hsp_midline>N P+ L  A + + S   C++ +  KI + M+CAG+S G  +C GDSGGPLVC       L GI SWGS  C     PGVY ++     W+++T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>187</Hit_num>
  <Hit_id>pdb|1A5H|A</Hit_id>
  <Hit_def>CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE [Homo sapiens] &gt;pdb|1A5H|B CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE [Homo sapiens] &gt;pdb|1RTF|B COMPLEX OF BENZAMIDINE WITH THE CATALYTIC DOMAIN OF HUMAN TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR [(TC)-T-PA] [Homo sapiens]</Hit_def>
  <Hit_accession>1A5H_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>73.1738</Hsp_bit-score>
      <Hsp_score>178</Hsp_score>
      <Hsp_evalue>1.11517e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC--KKYWGTKIKDAMICAG--------ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>ERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM</Hsp_hseq>
      <Hsp_midline>+RL++A + L  ++ C  +      + D M+CAG        A+   +C GDSGGPLVC  +G  TLVGI+SWG        PGVY +VT  ++W++  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>188</Hit_num>
  <Hit_id>pdb|1HJ8|A</Hit_id>
  <Hit_def>Chain A, TRYPSIN I [Salmo salar]</Hit_def>
  <Hit_accession>1HJ8_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.4034</Hsp_bit-score>
      <Hsp_score>176</Hsp_score>
      <Hsp_evalue>1.2591e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>221</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>NKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMAS</Hsp_hseq>
      <Hsp_midline>++LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>189</Hit_num>
  <Hit_id>pdb|1BZX|E</Hit_id>
  <Hit_def>The Crystal Structure Of Anionic Salmon Trypsin In Complex With Bovine Pancreatic Trypsin Inhibitor [Salmo salar] &gt;pdb|2STA|E Anionic Salmon Trypsin In Complex With Squash Seed Inhibitor (Cucurbita Maxima Trypsin Inhibitor I) [Salmo salar] &gt;pdb|2STB|E Anionic Salmon Trypsin In Complex With Squash Seed Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii) [Salmo salar]</Hit_def>
  <Hit_accession>1BZX_E</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.4034</Hsp_bit-score>
      <Hsp_score>176</Hsp_score>
      <Hsp_evalue>1.29955e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>221</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>NKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMAS</Hsp_hseq>
      <Hsp_midline>++LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>190</Hit_num>
  <Hit_id>pdb|1BDA|A</Hit_id>
  <Hit_def>Catalytic Domain Of Human Single Chain Tissue Plasminogen Activator In Complex With Dansyl-Egr-Cmk (Dansyl-Glu-Gly-Arg Chloromethyl Ketone) [Homo sapiens] &gt;pdb|1BDA|B Catalytic Domain Of Human Single Chain Tissue Plasminogen Activator In Complex With Dansyl-Egr-Cmk (Dansyl-Glu-Gly-Arg Chloromethyl Ketone) [Homo sapiens]</Hit_def>
  <Hit_accession>1BDA_A</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.7886</Hsp_bit-score>
      <Hsp_score>177</Hsp_score>
      <Hsp_evalue>1.46454e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>164</Hsp_hit-from>
      <Hsp_hit-to>263</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC--KKYWGTKIKDAMICAG--------ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>ERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM</Hsp_hseq>
      <Hsp_midline>+RL++A + L  ++ C  +      + D M+CAG        A+   +C GDSGGPLVC  +G  TLVGI+SWG        PGVY +VT  ++W++  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>191</Hit_num>
  <Hit_id>pdb|1BIT|A</Hit_id>
  <Hit_def>THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN A SECOND CRYSTAL FORM [Salmo salar]</Hit_def>
  <Hit_accession>1BIT_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.4034</Hsp_bit-score>
      <Hsp_score>176</Hsp_score>
      <Hsp_evalue>1.60399e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>NKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NG--ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMAS</Hsp_hseq>
      <Hsp_midline>++LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>192</Hit_num>
  <Hit_id>pdb|2ZPQ|A</Hit_id>
  <Hit_def>Crystal structure of anionic trypsin isoform 1 from chum salmon [Oncorhynchus keta] &gt;pdb|2ZPQ|B Crystal structure of anionic trypsin isoform 1 from chum salmon [Oncorhynchus keta]</Hit_def>
  <Hit_accession>2ZPQ_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>1.78265e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>NKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA</Hsp_hseq>
      <Hsp_midline>++LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>193</Hit_num>
  <Hit_id>pdb|1MBQ|A</Hit_id>
  <Hit_def>Anionic Trypsin from Pacific Chum Salmon [Oncorhynchus keta]</Hit_def>
  <Hit_accession>1MBQ_A</Hit_accession>
  <Hit_len>220</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>1.80287e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>NKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA</Hsp_hseq>
      <Hsp_midline>++LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>194</Hit_num>
  <Hit_id>pdb|1DST|A</Hit_id>
  <Hit_def>Mutant Of Factor D With Enhanced Catalytic Activity [Homo sapiens]</Hit_def>
  <Hit_accession>1DST_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>1.93072e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>228</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>RRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVC----GGVLEGVVSWGSRVCGNRKKPGIYTRVASYAAWIDSVLA</Hsp_hseq>
      <Hsp_midline>  PD LQ   LP+L    C +  +    I + ++CA ++   SC GDSGGPLVC       L G+VSWGS  C +   PG+Y RV +   W+   LA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>195</Hit_num>
  <Hit_id>pdb|1UTJ|A</Hit_id>
  <Hit_def>Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Salmo salar]</Hit_def>
  <Hit_accession>1UTJ_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.4034</Hsp_bit-score>
      <Hsp_score>176</Hsp_score>
      <Hsp_evalue>1.94801e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>NKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMAS</Hsp_hseq>
      <Hsp_midline>++LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>196</Hit_num>
  <Hit_id>pdb|1UTK|A</Hit_id>
  <Hit_def>Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Salmo salar] &gt;pdb|1UTL|M Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Salmo salar] &gt;pdb|1UTM|A Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements [Salmo salar]</Hit_def>
  <Hit_accession>1UTK_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.4034</Hsp_bit-score>
      <Hsp_score>176</Hsp_score>
      <Hsp_evalue>2.03121e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>152</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>NKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVC--NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMAS</Hsp_hseq>
      <Hsp_midline>++LQ  ++P+LS ++C   +   I +AM CAG    G  SC GDSGGP+VC  NG   L G+VSWG        PGVYA+V    +W+  T+A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>197</Hit_num>
  <Hit_id>pdb|2ZCH|P</Hit_id>
  <Hit_def>Crystal structure of human prostate specific antigen complexed with an activating antibody [Homo sapiens] &gt;pdb|2ZCK|P Crystal structure of a ternary complex between PSA, a substrat-acyl intermediate and an activating antibody [Homo sapiens] &gt;pdb|2ZCL|P Crystal structure of human prostate specific antigen complexed with an activating antibody [Homo sapiens] &gt;pdb|3QUM|P Crystal structure of human prostate specific antigen (PSA) in Fab sandwich with a high affinity and a PCa selective antibody [Homo sapiens] &gt;pdb|3QUM|Q Crystal structure of human prostate specific antigen (PSA) in Fab sandwich with a high affinity and a PCa selective antibody [Homo sapiens]</Hit_def>
  <Hit_accession>2ZCH_P</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>2.21945e-16</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>TPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCS-TSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>TPKKLQCVDLHVISNDVCAQVHPQKVTKFMLCAGRWTGGKSTCSGDSGGPLVC--NG--VLQGITSWGSEPCALPERPSLYTKVVHYRKWIKDTIVAN</Hsp_hseq>
      <Hsp_midline>TP +LQ   L ++SN  C +    K+   M+CAG    G S+C GDSGGPLVC  NG   L GI SWGS  C+    P +Y +V     W++ T+ AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>198</Hit_num>
  <Hit_id>pdb|6KD5|B</Hit_id>
  <Hit_def>Chain B, Transmembrane protease serine 13 [Homo sapiens]</Hit_def>
  <Hit_accession>6KD5_B</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>72.0182</Hsp_bit-score>
      <Hsp_score>175</Hsp_score>
      <Hsp_evalue>3.41185e-16</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKY--WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LREVQVNLIDFKKCNDYLVYDSYLTPRMMCAGDLRGGRDSCQGDSGGPLVCEQNNRWYLAGVTSWGTGCGQRNKPGVYTKVTEVLPWIYSKMEVR</Hsp_hseq>
      <Hsp_midline>L++  + L+    C  Y  + + +   M+CAG    G  SC GDSGGPLVC++N  W L G+ SWG+     + PGVY +VT ++ W+   +   </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>199</Hit_num>
  <Hit_id>pdb|5ZLZ|E</Hit_id>
  <Hit_def>Structure of tPA and PAI-1 [Homo sapiens]</Hit_def>
  <Hit_accession>5ZLZ_E</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>71.633</Hsp_bit-score>
      <Hsp_score>174</Hsp_score>
      <Hsp_evalue>3.61146e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC--KKYWGTKIKDAMICAG--------ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>ERLKEAHVRLYPSSRCTSQHLLQRTVTDNMLCAGDTRSGGPQANLHDACQGDAGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM</Hsp_hseq>
      <Hsp_midline>+RL++A + L  ++ C  +      + D M+CAG        A+   +C GD+GGPLVC  +G  TLVGI+SWG        PGVY +VT  ++W++  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>200</Hit_num>
  <Hit_id>pdb|5BRR|E</Hit_id>
  <Hit_def>Michaelis complex of tPA-S195A:PAI-1 [Homo sapiens]</Hit_def>
  <Hit_accession>5BRR_E</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>71.633</Hsp_bit-score>
      <Hsp_score>174</Hsp_score>
      <Hsp_evalue>3.9738e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC--KKYWGTKIKDAMICAG--------ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>ERLKEAHVRLYPSSRCTSQHLLQRTVTDNMLCAGDTRSGGPQANLHDACQGDAGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM</Hsp_hseq>
      <Hsp_midline>+RL++A + L  ++ C  +      + D M+CAG        A+   +C GD+GGPLVC  +G  TLVGI+SWG        PGVY +VT  ++W++  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>201</Hit_num>
  <Hit_id>pdb|1ELT|A</Hit_id>
  <Hit_def>STRUCTURE OF NATIVE PANCREATIC ELASTASE FROM NORTH ATLANTIC SALMON AT 1.61 ANGSTROMS RESOLUTION [Salmo salar]</Hit_def>
  <Hit_accession>1ELT_A</Hit_accession>
  <Hit_len>236</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>8.44509e-16</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSST-CSTS-TPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>DSLKQAWLPSVDHATCSSSGWWGSTVKTTMVCAGGGANSGCNGDSGGPLNCQVNGSYYVHGVTSFVSSSGCNASKKPTVFTRVSAYISWMNGIM</Hsp_hseq>
      <Hsp_midline>D L+QA LP + +  C    +WG+ +K  M+CAG    S C GDSGGPL C+ NG++ + G+ S+ SS+ C+ S  P V+ RV+A ++W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>202</Hit_num>
  <Hit_id>pdb|4D9Q|A</Hit_id>
  <Hit_def>Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D [Macaca mulatta] &gt;pdb|4D9Q|B Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D [Macaca mulatta]</Hit_def>
  <Hit_accession>4D9Q_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>9.13114e-16</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>228</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>RRPDRLQHVLLPVLDRATCNRRTHHDGAITQRMMCAESNRRDSCKGDSGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA</Hsp_hseq>
      <Hsp_midline>  PDRLQ   LP+L    C +  +    I   M+CA ++   SC GDSGGPLVC       L G+V+ GS  C +   PG+Y RV +   W+   LA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>203</Hit_num>
  <Hit_id>pdb|1HJ9|A</Hit_id>
  <Hit_def>Atomic resolution structures of trypsin provide insight into structural radiation damage [Bos taurus]</Hit_def>
  <Hit_accession>1HJ9_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>9.24165e-16</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICA-GASGV-SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSXCKXAYPGQITXNMFCAYGLEGKGDSXQGDSGGPVVC----SGKLQGIVSWGSGCQAKNKPGVYTKVCNYVXWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS++ CK  +  +I   M CA G  G   S  GDSGGP+VC    +  L GIVSWGS   + + PGVY +V   V W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>204</Hit_num>
  <Hit_id>pdb|6B74|B</Hit_id>
  <Hit_def>Structures of the two-chain human plasma Factor XIIa co-crystallized with potent inhibitors [Homo sapiens] &gt;pdb|6B77|B Structures of the two-chain human plasma factor XIIa co-crystallized with potent inhibitors [Homo sapiens] &gt;pdb|6L63|A Human Coagulation Factor XIIa (FXIIa) bound with the macrocyclic peptide F3 containing two (1S,2S)-2-ACHC residues [Homo sapiens] &gt;pdb|6L63|C Human Coagulation Factor XIIa (FXIIa) bound with the macrocyclic peptide F3 containing two (1S,2S)-2-ACHC residues [Homo sapiens]</Hit_def>
  <Hit_accession>6B74_B</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>9.75138e-16</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>239</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGA---WTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIRE</Hsp_hseq>
      <Hsp_midline>LQ+A +P LS   C      G+ I   M+CAG    G  +C GDSGGPLVC+   A    TL GI+SWGS     + PGVY  V   + W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>205</Hit_num>
  <Hit_id>pdb|4XDE|A</Hit_id>
  <Hit_def>Coagulation Factor XII protease domain crystal structure [Homo sapiens]</Hit_def>
  <Hit_accession>4XDE_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>1.04087e-15</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>149</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGA---WTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIRE</Hsp_hseq>
      <Hsp_midline>LQ+A +P LS   C      G+ I   M+CAG    G  +C GDSGGPLVC+   A    TL GI+SWGS     + PGVY  V   + W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>206</Hit_num>
  <Hit_id>pdb|4XE4|A</Hit_id>
  <Hit_def>Coagulation Factor XII protease domain crystal structure [Homo sapiens]</Hit_def>
  <Hit_accession>4XE4_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>1.04929e-15</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>239</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGA---WTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIRE</Hsp_hseq>
      <Hsp_midline>LQ+A +P LS   C      G+ I   M+CAG    G  +C GDSGGPLVC+   A    TL GI+SWGS     + PGVY  V   + W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>207</Hit_num>
  <Hit_id>pdb|6GT6|B</Hit_id>
  <Hit_def>Crystal structure of recombinant coagulation factor beta-XIIa [Homo sapiens]</Hit_def>
  <Hit_accession>6GT6_B</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>1.07962e-15</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>239</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGA---WTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIRE</Hsp_hseq>
      <Hsp_midline>LQ+A +P LS   C      G+ I   M+CAG    G  +C GDSGGPLVC+   A    TL GI+SWGS     + PGVY  V   + W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>208</Hit_num>
  <Hit_id>pdb|4Z6A|H</Hit_id>
  <Hit_def>Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor [Homo sapiens]</Hit_def>
  <Hit_accession>4Z6A_H</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>1.1659e-15</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>144</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS--SCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>ELMVLNVPRLMTQDCEASYPGKITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSE</Hsp_hseq>
      <Hsp_midline> L   ++P L   +C+  +  KI + M CAG S  S  SC GDSGGP      G W L GIVSWG    +    GVY RV+  + W+Q+ + + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>209</Hit_num>
  <Hit_id>pdb|6X0S|A</Hit_id>
  <Hit_def>Chain A, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0S|B Chain B, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0S|C Chain C, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0T|A Chain A, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0T|B Chain B, Coagulation factor XII [Homo sapiens] &gt;pdb|6X0T|C Chain C, Coagulation factor XII [Homo sapiens]</Hit_def>
  <Hit_accession>6X0S_A</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.4774</Hsp_bit-score>
      <Hsp_score>171</Hsp_score>
      <Hsp_evalue>1.20568e-15</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>163</Hsp_hit-from>
      <Hsp_hit-to>255</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGA---WTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIRE</Hsp_hseq>
      <Hsp_midline>LQ+A +P LS   C      G+ I   M+CAG    G  +C GDSGGPLVC+   A    TL GI+SWGS     + PGVY  V   + W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>210</Hit_num>
  <Hit_id>pdb|4YLQ|H</Hit_id>
  <Hit_def>Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor [Homo sapiens]</Hit_def>
  <Hit_accession>4YLQ_H</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>1.48083e-15</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>144</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS--SCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>ELMVLNVPRLMTQDCEASFPGKITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSE</Hsp_hseq>
      <Hsp_midline> L   ++P L   +C+  +  KI + M CAG S  S  SC GDSGGP      G W L GIVSWG    +    GVY RV+  + W+Q+ + + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>211</Hit_num>
  <Hit_id>pdb|6QF7|B</Hit_id>
  <Hit_def>Crystal structures of the recombinant beta-Factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics [Homo sapiens] &gt;pdb|6QF7|D Crystal structures of the recombinant beta-Factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics [Homo sapiens]</Hit_def>
  <Hit_accession>6QF7_B</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>69.3218</Hsp_bit-score>
      <Hsp_score>168</Hsp_score>
      <Hsp_evalue>2.74919e-15</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>162</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDR-RLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIRE</Hsp_hseq>
      <Hsp_midline>LQ+A +P LS   C      G+ I   M+CAG    G  +C GDSGGPLVC+     TL GI+SWGS     + PGVY  V   + W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>212</Hit_num>
  <Hit_id>pdb|6R2W|H</Hit_id>
  <Hit_def>Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor [Homo sapiens]</Hit_def>
  <Hit_accession>6R2W_H</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>68.9366</Hsp_bit-score>
      <Hsp_score>167</Hsp_score>
      <Hsp_evalue>3.77079e-15</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>144</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS--SCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>ELMVLNVPRVMTQDCEASYPGKITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSE</Hsp_hseq>
      <Hsp_midline> L   ++P +   +C+  +  KI + M CAG S  S  SC GDSGGP      G W L GIVSWG    +    GVY RV+  + W+Q+ + + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>213</Hit_num>
  <Hit_id>pdb|7MEQ|A</Hit_id>
  <Hit_def>Chain A, Transmembrane protease serine 2 [Homo sapiens]</Hit_def>
  <Hit_accession>7MEQ_A</Hit_accession>
  <Hit_len>395</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>70.0922</Hsp_bit-score>
      <Hsp_score>170</Hsp_score>
      <Hsp_evalue>3.89214e-15</Hsp_evalue>
      <Hsp_query-from>2</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>284</Hsp_hit-from>
      <Hsp_hit-to>382</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>TPDRLQQASLPLLSNTNC--KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>TSEVLNAAKVLLIETQRCNSRYVYDNLITPAMICAGFLQGNVDSCQGDSGGPLVTSKNNIWWLIGDTSWGSGCAKAYRPGVYGNVMVFTDWIYRQMRAD</Hsp_hseq>
      <Hsp_midline>T + L  A + L+    C  +  +   I  AMICAG     V SC GDSGGPLV  KN  W L+G  SWGS       PGVY  V    +W+ + + A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>214</Hit_num>
  <Hit_id>pdb|2OQ5|A</Hit_id>
  <Hit_def>Crystal structure of DESC1, a new member of the type II transmembrane serine proteinases family [Homo sapiens]</Hit_def>
  <Hit_accession>2OQ5_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>68.5514</Hsp_bit-score>
      <Hsp_score>166</Hsp_score>
      <Hsp_evalue>4.98574e-15</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>NHLRQAQVTLIDATTCNEPQAYNDAITPRMLCAGSLEGKTDACQGDSGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWI</Hsp_hseq>
      <Hsp_midline>+ L+QA + L+  T C +   +   I   M+CAG+      +C GDSGGPLV       W L GIVSWG      + PGVY RVTAL +W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>215</Hit_num>
  <Hit_id>pdb|1V2U|T</Hit_id>
  <Hit_def>Benzamidine in complex with bovine trypsin varinat X(SSAI)bT.D1 [Bos taurus] &gt;pdb|1V2V|T Benzamidine in complex with bovine trypsin variant X(SSAI)bT.C1 [Bos taurus] &gt;pdb|1V2W|T Trypsin inhibitor in complex with bovine trypsin variant X(SSAI)bT.B4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2U_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>68.1662</Hsp_bit-score>
      <Hsp_score>165</Hsp_score>
      <Hsp_evalue>5.79598e-15</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSAIITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>216</Hit_num>
  <Hit_id>pdb|1V2J|T</Hit_id>
  <Hit_def>BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)bT.C1 [Bos taurus] &gt;pdb|1V2R|T Trypsin inhibitor in complex with bovine trypsin variant X(SSRI)bT.B4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2J_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>6.57237e-15</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSRIITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>217</Hit_num>
  <Hit_id>pdb|1V2O|T</Hit_id>
  <Hit_def>Trypsin inhibitor in complex with bovine trypsin variant X(SSYI)bT.B4 [Bos taurus] &gt;pdb|1V2P|T Trypsin inhibitor in complex with bovine trypsin variant X(SSYI)bT.A4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2O_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>7.22206e-15</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSYIITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>218</Hit_num>
  <Hit_id>pdb|4ZMA|H</Hit_id>
  <Hit_def>Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor [Homo sapiens]</Hit_def>
  <Hit_accession>4ZMA_H</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>1.03079e-14</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>144</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS--SCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>ELMVLNVPRLMTQDCEASSPGKITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSE</Hsp_hseq>
      <Hsp_midline> L   ++P L   +C+     KI + M CAG S  S  SC GDSGGP      G W L GIVSWG    +    GVY RV+  + W+Q+ + + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>219</Hit_num>
  <Hit_id>pdb|3GOV|B</Hit_id>
  <Hit_def>Crystal structure of the catalytic region of human MASP-1 [Homo sapiens] &gt;pdb|4DJZ|B Catalytic fragment of masp-1 in complex with its specific inhibitor developed by directed evolution on sgci scaffold [Homo sapiens] &gt;pdb|4DJZ|D Catalytic fragment of masp-1 in complex with its specific inhibitor developed by directed evolution on sgci scaffold [Homo sapiens]</Hit_def>
  <Hit_accession>3GOV_B</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>1.14489e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>92</Hsp_query-to>
      <Hsp_hit-from>150</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWG---TKIKDAMICAGAS--GVSSCMGDSGGPLVC--KKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQT</Hsp_qseq>
      <Hsp_hseq>PETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRV</Hsp_hseq>
      <Hsp_midline>P+ L +  +P++ ++ C+K +     K+   MICAG    G  +C GDSGGP+V   ++ G W LVG VSWG         GVY+ +    +W+Q+ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>220</Hit_num>
  <Hit_id>pdb|1YM0|A</Hit_id>
  <Hit_def>Chain A, fibrinotic enzyme component B [Eisenia fetida]</Hit_def>
  <Hit_accession>1YM0_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.3958</Hsp_bit-score>
      <Hsp_score>163</Hsp_score>
      <Hsp_evalue>1.19988e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>238</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKK-YWGTKIKDAMICA----GASGVSSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PAVLRYVTLNITTNAFCDAVYTSDTIYDDMICATDNTGMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIG-CASGYPGVYSRVGFHAGWITDTITNN</Hsp_hseq>
      <Hsp_midline>P  L+  +L + +N  C   Y    I D MICA    G +   SC GDSGGPL  K  +G ++LVGIVSWG   C++  PGVY+RV     W+  T+  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>221</Hit_num>
  <Hit_id>pdb|1THP|B</Hit_id>
  <Hit_def>STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE [Homo sapiens] &gt;pdb|3S7H|B Structure of thrombin mutant Y225P in the E* form [Homo sapiens] &gt;pdb|3S7K|B Structure of thrombin mutant Y225P in the E form [Homo sapiens] &gt;pdb|3S7K|D Structure of thrombin mutant Y225P in the E form [Homo sapiens]</Hit_def>
  <Hit_accession>1THP_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>1.32555e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKPGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG        PG Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>222</Hit_num>
  <Hit_id>pdb|2XWA|A</Hit_id>
  <Hit_def>Crystal Structure of Complement Factor D Mutant R202A [Homo sapiens] &gt;pdb|2XWA|B Crystal Structure of Complement Factor D Mutant R202A [Homo sapiens] &gt;pdb|4CBN|A Crystal structure of Complement Factor D mutant R202A after conventional refinement [Homo sapiens] &gt;pdb|4CBN|B Crystal structure of Complement Factor D mutant R202A after conventional refinement [Homo sapiens] &gt;pdb|4CBO|A Crystal structure of Complement Factor D mutant R202A after ensemble refinement [Homo sapiens] &gt;pdb|4CBO|B Crystal structure of Complement Factor D mutant R202A after ensemble refinement [Homo sapiens]</Hit_def>
  <Hit_accession>2XWA_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.0106</Hsp_bit-score>
      <Hsp_score>162</Hsp_score>
      <Hsp_evalue>1.46148e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>228</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>RRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVC----GGVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDSVLA</Hsp_hseq>
      <Hsp_midline>  PD LQ   LP+L    C +  +    I + ++CA ++   SC GDSGGPLVC       L G+V+ GS+ C +   PG+Y RV +   W+   LA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>223</Hit_num>
  <Hit_id>pdb|1V2N|T</Hit_id>
  <Hit_def>Potent factor XA inhibitor in complex with bovine trypsin variant X(99/175/190)bT [Bos taurus]</Hit_def>
  <Hit_accession>1V2N_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>1.73963e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>224</Hit_num>
  <Hit_id>pdb|5FBE|A</Hit_id>
  <Hit_def>Complement Factor D In Complex With Compound2 [Homo sapiens] &gt;pdb|5FBI|A COMPLEMENT FACTOR D IN COMPLEX WITH COMPOUND 3b [Homo sapiens] &gt;pdb|5FCK|A Complement Factor D In Complex With Compound 5 [Homo sapiens] &gt;pdb|5MT0|A COMPLEMENT FACTOR D IN COMPLEX WITH A REVERSIBLE INDOLE CARBOXYLIC ACID BASED INHIBITOR [Homo sapiens] &gt;pdb|5MT4|A Complement Factor D In Complex With A Reversible Benzoic Acid Based Inhibitor [Homo sapiens] &gt;pdb|5NAR|A Complement factor D in complex with the inhibitor (S)-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1H-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens] &gt;pdb|5NAT|A Complement factor D in complex with the inhibitor (S)-Pyrrolidine-1,2-dicarboxylic acid 1-[(1-methyl-1H-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens] &gt;pdb|5NAW|A Complement factor D in complex with the inhibitor (1R,3S,5R)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic acid 2-[(1-carbamoyl-1H-indol-3-yl)-amide] 3-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens] &gt;pdb|5NB6|A Complement factor D in complex with the inhibitor (2S,4S)-4-Amino-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1H-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens] &gt;pdb|6FTY|A COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 5 [Homo sapiens] &gt;pdb|6FTZ|A COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 6 [Homo sapiens] &gt;pdb|6FUG|A Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|B Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|C Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|D Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|E Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUG|F Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUH|A Complement factor D in complex with the inhibitor (4-((3-(aminomethyl)phenyl)amino)quinazolin-2-yl)-L-valine [Homo sapiens] &gt;pdb|6FUI|A Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol [Homo sapiens] &gt;pdb|6FUJ|A Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|B Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|C Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|D Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|E Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUJ|F Complement factor D in complex with the inhibitor N-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-yl)-3-methylbutanamide [Homo sapiens] &gt;pdb|6FUT|A Complement factor D in complex with the inhibitor (S)-3&apos;-(aminomethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-[1,1&apos;-biphenyl]-3-carboxamide [Homo sapiens]</Hit_def>
  <Hit_accession>5FBE_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.0106</Hsp_bit-score>
      <Hsp_score>162</Hsp_score>
      <Hsp_evalue>1.81747e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>229</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>RRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLAS</Hsp_hseq>
      <Hsp_midline>  PD LQ   LP+L    C +  +    I + ++CA ++   SC GDSGGPLVC       L G+V+ GS  C +   PG+Y RV +   W+   LA+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>225</Hit_num>
  <Hit_id>pdb|1V2S|T</Hit_id>
  <Hit_def>Benzamidine in complex with bovine trypsin variant X(SSFI.Glu)bT.D1 [Bos taurus] &gt;pdb|1V2T|T Trypsin inhibitor in complex with bovine trypsin variant X(SSFI.Glu)bT.B4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2S_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>1.9314e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  SC GDSGGP+VC    +  L GIVSWG      + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>226</Hit_num>
  <Hit_id>pdb|5JBB|S</Hit_id>
  <Hit_def>Crystal structure of factor IXa variant V16I K98T Y177T I213V in complex with EGR-chloromethylketone [Homo sapiens] &gt;pdb|5JBC|S Crystal structure of factor IXa variant V16I K98T Y177T I213V in complex with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>5JBB_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.0106</Hsp_bit-score>
      <Hsp_score>162</Hsp_score>
      <Hsp_evalue>2.00782e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIVSWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GIVSWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>227</Hit_num>
  <Hit_id>pdb|1FDP|A</Hit_id>
  <Hit_def>Proenzyme Of Human Complement Factor D, Recombinant Profactor D [Homo sapiens] &gt;pdb|1FDP|B Proenzyme Of Human Complement Factor D, Recombinant Profactor D [Homo sapiens] &gt;pdb|1FDP|C Proenzyme Of Human Complement Factor D, Recombinant Profactor D [Homo sapiens] &gt;pdb|1FDP|D Proenzyme Of Human Complement Factor D, Recombinant Profactor D [Homo sapiens]</Hit_def>
  <Hit_accession>1FDP_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.05004e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>RRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA</Hsp_hseq>
      <Hsp_midline>  PD LQ   LP+L    C +  +    I + ++CA ++   SC GDSGGPLVC       L G+V+ GS  C +   PG+Y RV +   W+   LA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>228</Hit_num>
  <Hit_id>pdb|1FN8|A</Hit_id>
  <Hit_def>FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1FY4|A FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1FY5|A Fusarium oxysporum trypsin at atomic resolution [Fusarium oxysporum] &gt;pdb|1GDN|A FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1GDQ|A FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1XVM|A Trypsin from Fusarium oxysporum- room temperature to atomic resolution [Fusarium oxysporum] &gt;pdb|1XVO|A Trypsin from Fusarium oxysporum at pH 6 [Fusarium oxysporum]</Hit_def>
  <Hit_accession>1FN8_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.06233e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>221</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTK-IKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>STPVNLLKVTVPIVSRATCRAQYGTSAITNQMFCAGVSSGGKDSCQGDSGGPIVDSSN---TLIGAVSWGNGCARPNYSGVYASVGALRSFID</Hsp_hseq>
      <Hsp_midline>+TP  L + ++P++S   C+  +GT  I + M CAG S  G  SC GDSGGP+V   N   TL+G VSWG+     +  GVYA V AL +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>229</Hit_num>
  <Hit_id>pdb|5NB7|A</Hit_id>
  <Hit_def>Complement factor D [Homo sapiens] &gt;pdb|5NBA|A Complement factor D in complex with the inhibitor (2S,4R)-4-Fluoro-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1H-indol-3-yl)-amide] 2-[(3-trifluoromethoxy-phenyl)-amide] [Homo sapiens]</Hit_def>
  <Hit_accession>5NB7_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.07211e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>229</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>RRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLAS</Hsp_hseq>
      <Hsp_midline>  PD LQ   LP+L    C +  +    I + ++CA ++   SC GDSGGPLVC       L G+V+ GS  C +   PG+Y RV +   W+   LA+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>230</Hit_num>
  <Hit_id>pdb|1BIO|A</Hit_id>
  <Hit_def>Human Complement Factor D In Complex With Isatoic Anhydride Inhibitor [Homo sapiens] &gt;pdb|1DFP|A Factor D Inhibited By Diisopropyl Fluorophosphate [Homo sapiens] &gt;pdb|1DFP|B Factor D Inhibited By Diisopropyl Fluorophosphate [Homo sapiens] &gt;pdb|1DIC|A Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D [Homo sapiens] &gt;pdb|1DSU|A Human Factor D, Complement Activating Enzyme [Homo sapiens] &gt;pdb|1DSU|B Human Factor D, Complement Activating Enzyme [Homo sapiens] &gt;pdb|1HFD|A Human Complement Factor D In A P21 Crystal Form [Homo sapiens] &gt;pdb|4D9R|A Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D [Homo sapiens] &gt;pdb|4D9R|B Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D [Homo sapiens] &gt;pdb|5TCA|A Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|B Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|C Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|D Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|E Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|F Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCA|G Complement Factor D inhibited with JH3 [Homo sapiens] &gt;pdb|5TCC|A Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|B Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|C Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|D Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|E Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|F Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|5TCC|G Complement Factor D inhibited with JH4 [Homo sapiens] &gt;pdb|6VMJ|W Chain W, Complement factor D [Homo sapiens] &gt;pdb|6VMJ|X Chain X, Complement factor D [Homo sapiens] &gt;pdb|6VMJ|Y Chain Y, Complement factor D [Homo sapiens] &gt;pdb|6VMJ|Z Chain Z, Complement factor D [Homo sapiens] &gt;pdb|6VMK|C Chain C, Complement factor D [Homo sapiens] &gt;pdb|6VMK|F Chain F, Complement factor D [Homo sapiens] &gt;pdb|6VMK|I Chain I, Complement factor D [Homo sapiens] &gt;pdb|6VMK|N Chain N, Complement factor D [Homo sapiens] &gt;pdb|6VMK|Q Chain Q, Complement factor D [Homo sapiens] &gt;pdb|6VMK|T Chain T, Complement factor D [Homo sapiens] &gt;pdb|6VMK|W Chain W, Complement factor D [Homo sapiens] &gt;pdb|6VMK|X Chain X, Complement factor D [Homo sapiens] &gt;pdb|6VMK|a Chain a, Complement factor D [Homo sapiens] &gt;pdb|6VMK|d Chain d, Complement factor D [Homo sapiens] &gt;pdb|6VMK|g Chain g, Complement factor D [Homo sapiens] &gt;pdb|6VMK|j Chain j, Complement factor D [Homo sapiens] &gt;pdb|6VMK|m Chain m, Complement factor D [Homo sapiens] &gt;pdb|6VMK|p Chain p, Complement factor D [Homo sapiens] &gt;pdb|6VMK|s Chain s, Complement factor D [Homo sapiens] &gt;pdb|6VMK|v Chain v, Complement factor D [Homo sapiens]</Hit_def>
  <Hit_accession>1BIO_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.15031e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>228</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>RRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA</Hsp_hseq>
      <Hsp_midline>  PD LQ   LP+L    C +  +    I + ++CA ++   SC GDSGGPLVC       L G+V+ GS  C +   PG+Y RV +   W+   LA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>231</Hit_num>
  <Hit_id>pdb|1GDU|A</Hit_id>
  <Hit_def>FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION [Fusarium oxysporum] &gt;pdb|1PQ5|A Trypsin at pH 5, 0.85 A [Fusarium oxysporum] &gt;pdb|1PQ7|A Trypsin at 0.8 A, pH5 / borax [Fusarium oxysporum] &gt;pdb|1PQ8|A Trypsin at pH 4 at atomic resolution [Fusarium oxysporum] &gt;pdb|1TRY|A STRUCTURE OF INHIBITED TRYPSIN FROM FUSARIUM OXYSPORUM AT 1.55 ANGSTROMS [Fusarium oxysporum] &gt;pdb|2G51|A anomalous substructure of trypsin (p1) [Fusarium oxysporum] &gt;pdb|2G52|A Anomalous substructure of trypsin (P21) [Fusarium oxysporum] &gt;pdb|2VU8|E Crystal structure of an insect inhibitor with a fungal trypsin [Fusarium oxysporum]</Hit_def>
  <Hit_accession>1GDU_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.17295e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>221</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTK-IKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>STPVNLLKVTVPIVSRATCRAQYGTSAITNQMFCAGVSSGGKDSCQGDSGGPIVDSSN---TLIGAVSWGNGCARPNYSGVYASVGALRSFID</Hsp_hseq>
      <Hsp_midline>+TP  L + ++P++S   C+  +GT  I + M CAG S  G  SC GDSGGP+V   N   TL+G VSWG+     +  GVYA V AL +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>232</Hit_num>
  <Hit_id>pdb|3UQV|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3UQV_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.23584e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PG Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>233</Hit_num>
  <Hit_id>pdb|3PLB|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PLP|A Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PM3|A Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PMJ|A Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3PLB_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.40557e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GDSGGP+VC    +  L GIVSWGS     + PG+Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>234</Hit_num>
  <Hit_id>pdb|3PLK|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3PLK_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.2402</Hsp_bit-score>
      <Hsp_score>160</Hsp_score>
      <Hsp_evalue>2.45639e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GDSGGP+VC    +  L GIVSWGS     + PG+Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>235</Hit_num>
  <Hit_id>pdb|1V2Q|T</Hit_id>
  <Hit_def>Trypsin inhibitor in complex with bovine trypsin variant X(SSWI)bT.B4 [Bos taurus]</Hit_def>
  <Hit_accession>1V2Q_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.2402</Hsp_bit-score>
      <Hsp_score>160</Hsp_score>
      <Hsp_evalue>2.56126e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSWIITSNMFCAGYLEGGKDSCQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  SC GDSGGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>236</Hit_num>
  <Hit_id>pdb|2WPM|S</Hit_id>
  <Hit_def>factor IXa superactive mutant, EGR-CMK inhibited [Homo sapiens]</Hit_def>
  <Hit_accession>2WPM_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.57722e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>237</Hit_num>
  <Hit_id>pdb|5ZFH|A</Hit_id>
  <Hit_def>Mouse Kallikrein 7 [Mus musculus] &gt;pdb|5ZFI|A Mouse kallikrein 7 in complex with 6-benzyl-1,4-diazepan-7-one derivative [Mus musculus] &gt;pdb|6AHS|A Mouse Kallikrein 7 in complex with imidazolinylindole derivative [Mus musculus]</Hit_def>
  <Hit_accession>5ZFH_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.2402</Hsp_bit-score>
      <Hsp_score>160</Hsp_score>
      <Hsp_evalue>2.62258e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>131</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSDLMCSDVKLISSRECKKVYKDLLGKTMLCAGIPDSKTNTCNGDSGGPLVCND----TLQGLVSWGTYPCGQPNDPGVYTQVCKYKRWVMETMKTH</Hsp_hseq>
      <Hsp_midline>P  L  + + L+S+  CKK +   +   M+CAG   S  ++C GDSGGPLVC      TL G+VSWG+  C   + PGVY +V     WV +T+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>238</Hit_num>
  <Hit_id>pdb|6X5L|A</Hit_id>
  <Hit_def>Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>6X5L_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.62681e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>239</Hit_num>
  <Hit_id>pdb|2WPH|S</Hit_id>
  <Hit_def>factor IXa superactive triple mutant [Homo sapiens] &gt;pdb|2WPJ|S factor IXa superactive triple mutant, NaCl-soaked [Homo sapiens] &gt;pdb|2WPK|S factor IXa superactive triple mutant, ethylene glycol-soaked [Homo sapiens] &gt;pdb|2WPL|S factor IXa superactive triple mutant, EDTA-soaked [Homo sapiens]</Hit_def>
  <Hit_accession>2WPH_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.6589e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>240</Hit_num>
  <Hit_id>pdb|1RFN|A</Hit_id>
  <Hit_def>Human Coagulation Factor Ixa In Complex With P-Amino Benzamidine [Homo sapiens] &gt;pdb|3LC3|A Benzothiophene Inhibitors of Factor IXa [Homo sapiens] &gt;pdb|3LC3|C Benzothiophene Inhibitors of Factor IXa [Homo sapiens] &gt;pdb|3LC5|A Selective Benzothiophine Inhibitors of Factor IXa [Homo sapiens] &gt;pdb|6MV4|H CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR IXa [Homo sapiens] &gt;pdb|6X5J|A Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors [Homo sapiens] &gt;pdb|7AHV|H Chain H, Coagulation factor IX [Homo sapiens]</Hit_def>
  <Hit_accession>1RFN_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.71478e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>241</Hit_num>
  <Hit_id>pdb|5JB8|S</Hit_id>
  <Hit_def>Crystal structure of factor IXa variant K98T in complex with EGR-chloromethylketone [Homo sapiens] &gt;pdb|5JB9|S Crystal structure of factor IXa K98T variant in complex with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>5JB8_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>2.77183e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>242</Hit_num>
  <Hit_id>pdb|2WPI|S</Hit_id>
  <Hit_def>factor IXa superactive double mutant [Homo sapiens]</Hit_def>
  <Hit_accession>2WPI_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.2402</Hsp_bit-score>
      <Hsp_score>160</Hsp_score>
      <Hsp_evalue>2.83008e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>243</Hit_num>
  <Hit_id>pdb|6RFK|S</Hit_id>
  <Hit_def>Crystal structure of EGRCK-inhibited Gla-domainless fIXa (K148Q, R150Q variant) [Homo sapiens]</Hit_def>
  <Hit_accession>6RFK_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.2402</Hsp_bit-score>
      <Hsp_score>160</Hsp_score>
      <Hsp_evalue>2.88955e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>244</Hit_num>
  <Hit_id>pdb|1BBR|E</Hit_id>
  <Hit_def>Chain E, EPSILON-THROMBIN [Bos taurus] &gt;pdb|1UCY|E Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7- 19). Three Complexes, One With Epsilon-Thrombin And Two With Alpha-Thrombin [Bos taurus] &gt;pdb|1VIT|G Thrombin:hirudin 51-65 Complex [Bos taurus] &gt;pdb|1YCP|M The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y) Bound To Bovine Thrombin Explains Why The Mutation Of Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At Arginine-16 [Bos taurus]</Hit_def>
  <Hit_accession>1BBR_E</Hit_accession>
  <Hit_len>109</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>2.89498e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>104</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LPL+    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>245</Hit_num>
  <Hit_id>pdb|4YZU|A</Hit_id>
  <Hit_def>Rapid development of two Factor IXa inhibitors from Hit to Lead [Homo sapiens] &gt;pdb|4Z0K|A Rapid development of two Factor IXa inhibitors from Hit to Lead [Homo sapiens] &gt;pdb|4ZAE|A Development of a novel class of potent and selective FIXa inhibitors [Homo sapiens] &gt;pdb|5EGM|A Development of a novel tricyclic class of potent and selective FIXa inhibitors [Homo sapiens] &gt;pdb|5TNO|A Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors [Homo sapiens] &gt;pdb|5TNT|A Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors [Homo sapiens] &gt;pdb|6X5P|A Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>4YZU_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.2402</Hsp_bit-score>
      <Hsp_score>160</Hsp_score>
      <Hsp_evalue>2.98111e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>246</Hit_num>
  <Hit_id>pdb|1BHX|F</Hit_id>
  <Hit_def>X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229-357 [Homo sapiens] &gt;pdb|1RIW|C Thrombin in complex with natural product inhibitor Oscillarin [Homo sapiens] &gt;pdb|2HNT|F Crystallographic Structure Of Human Gamma-Thrombin [Homo sapiens]</Hit_def>
  <Hit_accession>1BHX_F</Hit_accession>
  <Hit_len>105</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.12897e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>100</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>247</Hit_num>
  <Hit_id>pdb|2PKS|C</Hit_id>
  <Hit_def>Thrombin in complex with inhibitor [unidentified] &gt;pdb|3PO1|C Thrombin in complex with Benzothiazole Guanidine [Homo sapiens]</Hit_def>
  <Hit_accession>2PKS_C</Hit_accession>
  <Hit_len>102</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.14e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>100</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>248</Hit_num>
  <Hit_id>pdb|4IGD|A</Hit_id>
  <Hit_def>Crystal structure of the zymogen catalytic region of Human MASP-1 [Homo sapiens]</Hit_def>
  <Hit_accession>4IGD_A</Hit_accession>
  <Hit_len>406</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.3958</Hsp_bit-score>
      <Hsp_score>163</Hsp_score>
      <Hsp_evalue>3.24503e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>305</Hsp_hit-from>
      <Hsp_hit-to>400</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWG---TKIKDAMICAGAS--GVSSCMGDSGGPLVC--KKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>PETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQR</Hsp_hseq>
      <Hsp_midline>P+ L +  +P++ ++ C+K +     K+   MICAG    G  +C GDSGGP+V   ++ G W LVG VSWG         GVY+ +    +W+Q+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>249</Hit_num>
  <Hit_id>pdb|6QMR|A</Hit_id>
  <Hit_def>Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|B Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|C Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|D Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|E Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMR|F Complement factor D in complex with the inhibitor (S)-2-(2-((3&apos;-(1-amino-2-hydroxyethyl)-[1,1&apos;-biphenyl]-3-yl)methoxy)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMT|A Complement factor D in complex with the inhibitor 2-(2-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-carboxamido)phenyl)acetic acid [Homo sapiens] &gt;pdb|6QMT|B Complement factor D in complex with the inhibitor 2-(2-(3&apos;-(aminomethyl)-[1,1&apos;-biphenyl]-3-carboxamido)phenyl)acetic acid [Homo sapiens]</Hit_def>
  <Hit_accession>6QMR_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.6254</Hsp_bit-score>
      <Hsp_score>161</Hsp_score>
      <Hsp_evalue>3.25265e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>160</Hsp_hit-from>
      <Hsp_hit-to>253</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>RRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLAS</Hsp_hseq>
      <Hsp_midline>  PD LQ   LP+L    C +  +    I + ++CA ++   SC GDSGGPLVC       L G+V+ GS  C +   PG+Y RV +   W+   LA+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>250</Hit_num>
  <Hit_id>pdb|1TON|A</Hit_id>
  <Hit_def>RAT SUBMAXILLARY GLAND SERINE PROTEASE, TONIN. STRUCTURE SOLUTION AND REFINEMENT AT 1.8 ANGSTROMS RESOLUTION [Rattus rattus]</Hit_def>
  <Hit_accession>1TON_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>66.2402</Hsp_bit-score>
      <Hsp_score>160</Hsp_score>
      <Hsp_evalue>3.6321e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>234</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQCVNIHLLSNEKCIETYKDNVTDVMLCAGEMEGGKDTCAGDSGGPLICDG----VLQGITSGGATPCAKPKTPAIYAKLIKFTSWIKKVMKEN</Hsp_hseq>
      <Hsp_midline>LQ  ++ LLSN  C + +   + D M+CAG    G  +C GDSGGPL+C       L GI S G++ C+   TP +YA++    +W+++ +  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>251</Hit_num>
  <Hit_id>pdb|4B1T|A</Hit_id>
  <Hit_def>Structure of the factor Xa-like trypsin variant triple-Ala (TA) in complex with eglin C [Bos taurus] &gt;pdb|4B1T|C Structure of the factor Xa-like trypsin variant triple-Ala (TA) in complex with eglin C [Bos taurus]</Hit_def>
  <Hit_accession>4B1T_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>4.22895e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>57</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVVC----SGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GD+GGP+VC    +  L GIVSWGS     + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>252</Hit_num>
  <Hit_id>pdb|1V2K|T</Hit_id>
  <Hit_def>Factor XA specific Inhibitor in complex with bovine trypsin variant X(triple.Glu)bT.D2 [Bos taurus] &gt;pdb|1V2L|T Benzamidine in complex with bovine trypsin variant X(triple.Glu)bT.D1 [Bos taurus] &gt;pdb|1V2M|T Benzamidine in complex with bovine trypsin variant X(triple.Glu)bT.A1 [Bos taurus]</Hit_def>
  <Hit_accession>1V2K_T</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>4.27334e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GDSGGP+VC    +  L GIVSWG      + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>253</Hit_num>
  <Hit_id>pdb|2QXG|A</Hit_id>
  <Hit_def>Crystal Structure of Human Kallikrein 7 in Complex with Ala-Ala-Phe-chloromethylketone [Homo sapiens] &gt;pdb|2QXG|B Crystal Structure of Human Kallikrein 7 in Complex with Ala-Ala-Phe-chloromethylketone [Homo sapiens] &gt;pdb|2QXH|A Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone [Homo sapiens] &gt;pdb|2QXI|A High resolution structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone [Homo sapiens] &gt;pdb|2QXJ|A Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone and Copper [Homo sapiens] &gt;pdb|5Y9L|A Human kallikrein 7 in complex with 1,3,6-trisubstituted 1,4-diazepane-7-one [Homo sapiens] &gt;pdb|5YJK|A Human kallikrein 7 in complex with 1,4-diazepane-7-one 1-acetamide derivative [Homo sapiens] &gt;pdb|6SHH|A Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|B Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|C Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|D Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|E Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|F Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|G Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHH|H Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|A Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|B Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|C Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|D Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|E Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|F Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|G Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SHI|H Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|A Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|B Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|C Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|D Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|E Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|F Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|G Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6SJU|H Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57 [Homo sapiens] &gt;pdb|6Y4S|A Human kallikrein-related peptidase 7 (KLK7) in the unliganded state [Homo sapiens] &gt;pdb|6Y4S|B Human kallikrein-related peptidase 7 (KLK7) in the unliganded state [Homo sapiens] &gt;pdb|6Y4S|C Human kallikrein-related peptidase 7 (KLK7) in the unliganded state [Homo sapiens]</Hit_def>
  <Hit_accession>2QXG_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>4.70621e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>131</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRG----TLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKH</Hsp_hseq>
      <Hsp_midline>P  L    + L+S  +C K +   ++++M+CAG   S  ++C GDSGGPLVC+     TL G+VSWG+  C   + PGVY +V     W+  T+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>254</Hit_num>
  <Hit_id>pdb|3F6U|H</Hit_id>
  <Hit_def>Crystal structure of human Activated Protein C (APC) complexed with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>3F6U_H</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>4.93905e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>149</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGASG--VSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>LNFIKIPVVPHNECSEVMSNMVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIH</Hsp_hseq>
      <Hsp_midline>L    +P++ +  C +     + + M+CAG  G    +C GDSGGP+V   +G W LVG+VSWG         GVY +V+  ++W+ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>255</Hit_num>
  <Hit_id>pdb|2XW9|A</Hit_id>
  <Hit_def>Crystal Structure of Complement Factor D mutant S183A [Homo sapiens] &gt;pdb|2XWB|I Crystal Structure of Complement C3b in complex with Factors B and D [Homo sapiens] &gt;pdb|2XWB|J Crystal Structure of Complement C3b in complex with Factors B and D [Homo sapiens]</Hit_def>
  <Hit_accession>2XW9_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.4698</Hsp_bit-score>
      <Hsp_score>158</Hsp_score>
      <Hsp_evalue>5.10861e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>228</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK--YWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>RRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDAGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA</Hsp_hseq>
      <Hsp_midline>  PD LQ   LP+L    C +  +    I + ++CA ++   SC GD+GGPLVC       L G+V+ GS  C +   PG+Y RV +   W+   LA</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>256</Hit_num>
  <Hit_id>pdb|5JBA|S</Hit_id>
  <Hit_def>Crystal structure of factor IXa variant V16I K98T Y177T I212V in complex with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>5JBA_S</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.855</Hsp_bit-score>
      <Hsp_score>159</Hsp_score>
      <Hsp_evalue>5.22507e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGVISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GDSGGP V +  G   L G++SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>257</Hit_num>
  <Hit_id>pdb|3UNS|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UOP|A Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UQO|A Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3UNS_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.4698</Hsp_bit-score>
      <Hsp_score>158</Hsp_score>
      <Hsp_evalue>5.54775e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GDSGGP+VC    +  L GIVSWGS     + PG Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>258</Hit_num>
  <Hit_id>pdb|3PWB|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PWC|A Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3PYH|A Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3Q00|A Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3PWB_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.4698</Hsp_bit-score>
      <Hsp_score>158</Hsp_score>
      <Hsp_evalue>6.15804e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGEGCAQKNKPGIYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GDSGGP+VC    +  L GIVSWG      + PG+Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>259</Hit_num>
  <Hit_id>pdb|1AUT|C</Hit_id>
  <Hit_def>Human activated protein C [Homo sapiens] &gt;pdb|6M3B|A hAPC-c25k23 Fab complex [Homo sapiens] &gt;pdb|6M3C|A hAPC-h1573 Fab complex [Homo sapiens] &gt;pdb|6M3C|C hAPC-h1573 Fab complex [Homo sapiens] &gt;pdb|6M3C|G hAPC-h1573 Fab complex [Homo sapiens]</Hit_def>
  <Hit_accession>1AUT_C</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.4698</Hsp_bit-score>
      <Hsp_score>158</Hsp_score>
      <Hsp_evalue>6.69749e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>149</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGASG--VSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>LNFIKIPVVPHNECSEVMSNMVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIH</Hsp_hseq>
      <Hsp_midline>L    +P++ +  C +     + + M+CAG  G    +C GDSGGP+V   +G W LVG+VSWG         GVY +V+  ++W+ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>260</Hit_num>
  <Hit_id>pdb|3KCG|H</Hit_id>
  <Hit_def>Crystal structure of the antithrombin-factor IXa-pentasaccharide complex [Homo sapiens]</Hit_def>
  <Hit_accession>3KCG_H</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.4698</Hsp_bit-score>
      <Hsp_score>158</Hsp_score>
      <Hsp_evalue>6.84456e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDAGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I + M CAG    G  SC GD+GGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>261</Hit_num>
  <Hit_id>pdb|1PPZ|A</Hit_id>
  <Hit_def>Trypsin complexes at atomic and ultra-high resolution [Fusarium oxysporum] &gt;pdb|1PQA|A Trypsin with PMSF at atomic resolution [Fusarium oxysporum]</Hit_def>
  <Hit_accession>1PPZ_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.0846</Hsp_bit-score>
      <Hsp_score>157</Hsp_score>
      <Hsp_evalue>6.9233e-14</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>221</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTK-IKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>STPVNLLKVTVPIVSRATCRAQYGTSAITNQMFCAGVSSGGKDSCQGDXGGPIVDSSN---TLIGAVSWGNGCARPNYSGVYASVGALRSFID</Hsp_hseq>
      <Hsp_midline>+TP  L + ++P++S   C+  +GT  I + M CAG S  G  SC GD GGP+V   N   TL+G VSWG+     +  GVYA V AL +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>262</Hit_num>
  <Hit_id>pdb|1PFX|C</Hit_id>
  <Hit_def>PORCINE FACTOR IXA [Sus scrofa] &gt;pdb|1X7A|C Porcine Factor IXa Complexed to 1-{3-[amino(imino)methyl]phenyl}-N-[4-(1H-benzimidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide [Sus scrofa]</Hit_def>
  <Hit_accession>1PFX_C</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.4698</Hsp_bit-score>
      <Hsp_score>158</Hsp_score>
      <Hsp_evalue>7.28443e-14</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYLKVPLVDRATCLRSTKFTIYSNMFCAGFHEGGKDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAVKGKYGIYTKVSRYVNWIKE</Hsp_hseq>
      <Hsp_midline>LQ   +PL+    C +     I   M CAG    G  SC GDSGGP V +  G   L GI+SWG         G+Y +V+  VNW+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>263</Hit_num>
  <Hit_id>pdb|3BSQ|A</Hit_id>
  <Hit_def>Crystal structure of human kallikrein 7 produced as a secretion protein in E.coli [Homo sapiens] &gt;pdb|3BSQ|B Crystal structure of human kallikrein 7 produced as a secretion protein in E.coli [Homo sapiens] &gt;pdb|3BSQ|C Crystal structure of human kallikrein 7 produced as a secretion protein in E.coli [Homo sapiens]</Hit_def>
  <Hit_accession>3BSQ_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>65.0846</Hsp_bit-score>
      <Hsp_score>157</Hsp_score>
      <Hsp_evalue>7.57391e-14</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>131</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRG----TLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTM</Hsp_hseq>
      <Hsp_midline>P  L    + L+S  +C K +   ++++M+CAG   S  ++C GDSGGPLVC+     TL G+VSWG+  C   + PGVY +V     W+  T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>264</Hit_num>
  <Hit_id>pdb|4B2A|A</Hit_id>
  <Hit_def>Structure of the factor Xa-like trypsin variant triple-Ala (TGA) in complex with eglin C [Bos taurus] &gt;pdb|4B2A|C Structure of the factor Xa-like trypsin variant triple-Ala (TGA) in complex with eglin C [Bos taurus]</Hit_def>
  <Hit_accession>4B2A_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.6994</Hsp_bit-score>
      <Hsp_score>156</Hsp_score>
      <Hsp_evalue>1.16345e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVVC----SGKLQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GD+GGP+VC    +  L GIVSWG      + PGVY +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>265</Hit_num>
  <Hit_id>pdb|3UNQ|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UPE|A Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UUZ|A Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UUZ|B Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3UNQ_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.3142</Hsp_bit-score>
      <Hsp_score>155</Hsp_score>
      <Hsp_evalue>1.46325e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGSGCAQKNKPGFYTKLCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GDSGGP+VC    +  L GIVSWGS     + PG Y ++   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>266</Hit_num>
  <Hit_id>pdb|4B2C|A</Hit_id>
  <Hit_def>Structure of the factor Xa-like trypsin variant triple-Ala (TPA) in complex with eglin C [Bos taurus] &gt;pdb|4B2C|C Structure of the factor Xa-like trypsin variant triple-Ala (TPA) in complex with eglin C [Bos taurus]</Hit_def>
  <Hit_accession>4B2C_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.3142</Hsp_bit-score>
      <Hsp_score>155</Hsp_score>
      <Hsp_evalue>1.47858e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVVC----SGKLQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GD+GGP+VC    +  L GIVSWGS     + PG Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>267</Hit_num>
  <Hit_id>pdb|5MJT|H</Hit_id>
  <Hit_def>Thrombin Mutant A190S in complex with (S) -1 - ((R) -2-amino-3,3-diphenylpropanoyl) -N- (3-chlorobenzyl) pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5MLS|H Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(3-chlorobenzyl)pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5MM6|H Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide [Homo sapiens]</Hit_def>
  <Hit_accession>5MJT_H</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.6994</Hsp_bit-score>
      <Hsp_score>156</Hsp_score>
      <Hsp_evalue>1.59677e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDSCEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          SC GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>268</Hit_num>
  <Hit_id>pdb|1AO5|A</Hit_id>
  <Hit_def>Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme) [Mus musculus] &gt;pdb|1AO5|B Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme) [Mus musculus]</Hit_def>
  <Hit_accession>1AO5_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.3142</Hsp_bit-score>
      <Hsp_score>155</Hsp_score>
      <Hsp_evalue>1.65566e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>144</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDDLQCVFITLLPNENCAKVYLQKVTDVMLCAGEMGGGKDTCRDDSGGPLICDG----ILQGTTSYGPVPCGKPGVPAIYTNLIKFNSWIKDTMMKN</Hsp_hseq>
      <Hsp_midline>PD LQ   + LL N NC K +  K+ D M+CAG    G  +C  DSGGPL+C       L G  S+G   C     P +Y  +    +W++ T+  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>269</Hit_num>
  <Hit_id>pdb|1TWX|B</Hit_id>
  <Hit_def>Crystal structure of the thrombin mutant D221A/D222K [Homo sapiens]</Hit_def>
  <Hit_accession>1TWX_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.3142</Hsp_bit-score>
      <Hsp_score>155</Hsp_score>
      <Hsp_evalue>1.9009e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCARKGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>270</Hit_num>
  <Hit_id>pdb|5FAH|A</Hit_id>
  <Hit_def>Kallikrein-7 In Complex With Compound1 [Homo sapiens]</Hit_def>
  <Hit_accession>5FAH_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>2.29414e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>131</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PSDLMCVDVKLISPQDCTKVRKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRG----TLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKH</Hsp_hseq>
      <Hsp_midline>P  L    + L+S  +C K     ++++M+CAG   S  ++C GDSGGPLVC+     TL G+VSWG+  C   + PGVY +V     W+  T+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>271</Hit_num>
  <Hit_id>pdb|1A5I|A</Hit_id>
  <Hit_def>Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva Plasminogen Activator In Complex With Egr-Cmk (Glu-Gly-Arg Chloromethyl Ketone) [Desmodus rotundus]</Hit_def>
  <Hit_accession>1A5I_A</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.3142</Hsp_bit-score>
      <Hsp_score>155</Hsp_score>
      <Hsp_evalue>2.33491e-13</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>164</Hsp_hit-from>
      <Hsp_hit-to>263</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC--KKYWGTKIKDAMICAGASG--------VSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>EQLKEGHVRLYPSSRCAPKFLFNKTVTNNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMNDNHMTLLGIISWGVGCGEKDVPGVYTKVTNYLGWIRDNM</Hsp_hseq>
      <Hsp_midline>++L++  + L  ++ C  K  +   + + M+CAG +           +C GDSGGPLVC  +   TL+GI+SWG        PGVY +VT  + W++  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>272</Hit_num>
  <Hit_id>pdb|1MKW|K</Hit_id>
  <Hit_def>The Co-Crystal Structure Of Unliganded Bovine Alpha- Thrombin And Prethrombin-2: Movement Of The Yppw Segment And Active Site Residues Upon Ligand Binding [Bos taurus] &gt;pdb|1MKX|K The Co-Crystal Structure Of Unliganded Bovine Alpha- Thrombin And Prethrombin-2: Movement Of The Yppw Segment And Active Site Residues Upon Ligand Binding [Bos taurus]</Hit_def>
  <Hit_accession>1MKW_K</Hit_accession>
  <Hit_len>308</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>64.6994</Hsp_bit-score>
      <Hsp_score>156</Hsp_score>
      <Hsp_evalue>2.58508e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>206</Hsp_hit-from>
      <Hsp_hit-to>303</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LPL+    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>273</Hit_num>
  <Hit_id>pdb|1BTH|H</Hit_id>
  <Hit_def>STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR &gt;pdb|1BTH|K STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR</Hit_def>
  <Hit_accession>1BTH_H</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>2.72118e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>274</Hit_num>
  <Hit_id>pdb|2BVR|H</Hit_id>
  <Hit_def>Human thrombin complexed with fragment-based small molecules occupying the S1 pocket [Homo sapiens]</Hit_def>
  <Hit_accession>2BVR_H</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.03945e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>150</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>275</Hit_num>
  <Hit_id>pdb|1WBG|B</Hit_id>
  <Hit_def>Active site thrombin inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>1WBG_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.04578e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>276</Hit_num>
  <Hit_id>pdb|6FJT|H</Hit_id>
  <Hit_def>4-chloro-benzamidine in complex with thrombin [Homo sapiens]</Hit_def>
  <Hit_accession>6FJT_H</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.07339e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>150</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>277</Hit_num>
  <Hit_id>pdb|1VZQ|H</Hit_id>
  <Hit_def>Complex of thrombin with designed inhibitor 7165 [Homo sapiens]</Hit_def>
  <Hit_accession>1VZQ_H</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.10746e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>150</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>278</Hit_num>
  <Hit_id>pdb|3GIC|B</Hit_id>
  <Hit_def>Structure of thrombin mutant delta(146-149e) in the free form [Homo sapiens]</Hit_def>
  <Hit_accession>3GIC_B</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.23794e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>148</Hsp_hit-from>
      <Hsp_hit-to>245</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>279</Hit_num>
  <Hit_id>pdb|1SGT|A</Hit_id>
  <Hit_def>REFINED CRYSTAL STRUCTURE OF STREPTOMYCES GRISEUS TRYPSIN AT 1.7 ANGSTROMS RESOLUTION [Streptomyces griseus]</Hit_def>
  <Hit_accession>1SGT_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.26208e-13</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>128</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTK-IKDAMICAG---ASGVSSCMGDSGGPLVCKKNG-AWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LLKANVPFVSDAACRSAYGNELVANEEICAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAI</Hsp_hseq>
      <Hsp_midline>L +A++P +S+  C+  +G + + +  ICAG     GV +C GDSGGP+  K N   W  VGIVSWG        PGVY  V+   + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>280</Hit_num>
  <Hit_id>pdb|1OS8|A</Hit_id>
  <Hit_def>Recombinant Streptomyces Griseus Trypsin [Streptomyces griseus]</Hit_def>
  <Hit_accession>1OS8_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.3655e-13</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>128</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTK-IKDAMICAG---ASGVSSCMGDSGGPLVCKKNG-AWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LLKANVPFVSDAACRSAYGNELVANEEICAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAI</Hsp_hseq>
      <Hsp_midline>L +A++P +S+  C+  +G + + +  ICAG     GV +C GDSGGP+  K N   W  VGIVSWG        PGVY  V+   + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>281</Hit_num>
  <Hit_id>pdb|1H8I|H</Hit_id>
  <Hit_def>X-ray crystal structure of human alpha-thrombin with a tripeptide phosphonate inhibitor. [Homo sapiens] &gt;pdb|6ROT|H Thrombin in complex with MI2105 [Homo sapiens]</Hit_def>
  <Hit_accession>1H8I_H</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.47037e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>151</Hsp_hit-from>
      <Hsp_hit-to>248</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>282</Hit_num>
  <Hit_id>pdb|1D3D|B</Hit_id>
  <Hit_def>Crystal Structure Of Human Alpha Thrombin In Complex With Benzothiophene Inhibitor 4 [Homo sapiens] &gt;pdb|1EB1|H Complex structure of human thrombin with N-methyl-arginine inhibitor [Homo sapiens] &gt;pdb|1GHV|H A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GHW|H A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GHX|H A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1GHY|H A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE [Homo sapiens] &gt;pdb|1QUR|H Human Alpha-Thrombin In Complex With Bivalent, Benzamidine-Based Synthetic Inhibitor [Homo sapiens] &gt;pdb|1YPE|H Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1YPG|H Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1YPJ|H Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1YPK|H Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1YPL|H X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue RA-1008 [Homo sapiens] &gt;pdb|1YPM|H X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue RA-1014 [Homo sapiens] &gt;pdb|2ANM|H Ternary complex of an orally active thrombin inhibitor with human thrombin and a c-terminal hirudin derived exo-sit inhibitor [Homo sapiens] &gt;pdb|2CF8|H Complex of recombinant human thrombin with an inhibitor [Homo sapiens] &gt;pdb|2CF9|H Complex of recombinant human thrombin with an inhibitor [Homo sapiens] &gt;pdb|2CN0|H Complex of Recombinant Human Thrombin with a Designed Inhibitor [Homo sapiens] &gt;pdb|2V3H|H Thrombin with 3-cycle no F [Homo sapiens] &gt;pdb|2V3O|H Thrombin with 3-cycle with F [Homo sapiens] &gt;pdb|3BIU|H Human thrombin-in complex with UB-THR10 [Homo sapiens] &gt;pdb|3BIV|H Human thrombin-in complex with UB-THR11 [Homo sapiens] &gt;pdb|4AX9|H Human thrombin complexed with Napsagatran, RO0466240 [Homo sapiens] &gt;pdb|4AYV|B Human thrombin - inhibitor complex [Homo sapiens] &gt;pdb|4AYY|B Human thrombin - inhibitor complex [Homo sapiens] &gt;pdb|4AZ2|B Human thrombin - inhibitor complex [Homo sapiens] &gt;pdb|4LOY|H Crystal Structure Analysis of thrombin in complex with compound D57, 5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2- oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1- yl)-3-oxopropyl]amide (SAR107375) [Homo sapiens] &gt;pdb|6GWE|A Crystal structure of Thrombin bound to P2 macrocycle [Homo sapiens]</Hit_def>
  <Hit_accession>1D3D_B</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.48958e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>283</Hit_num>
  <Hit_id>pdb|1ID5|H</Hit_id>
  <Hit_def>Crystal Structure Of Bovine Thrombin Complex With Protease Inhibitor Ecotin [Bos taurus]</Hit_def>
  <Hit_accession>1ID5_H</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.53018e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LPL+    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>284</Hit_num>
  <Hit_id>pdb|1A0H|B</Hit_id>
  <Hit_def>The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1: KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN INTERACTIONS AND Location Of The Linker Chain [Bos taurus] &gt;pdb|1A0H|E The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1: KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN INTERACTIONS AND Location Of The Linker Chain [Bos taurus] &gt;pdb|1AVG|H Thrombin Inhibitor From Triatoma Pallidipennis [Bos taurus] &gt;pdb|1BBR|K Chain K, EPSILON-THROMBIN [Bos taurus] &gt;pdb|1BBR|N Chain N, EPSILON-THROMBIN [Bos taurus] &gt;pdb|1ETR|H REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS [Bos taurus] &gt;pdb|1ETS|H REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS [Bos taurus] &gt;pdb|1ETT|H REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS [Bos taurus] &gt;pdb|1HRT|H The Structure Of A Complex Of Bovine Alpha-Thrombin And Recombinant Hirudin At 2.8 Angstroms Resolution [Bos taurus] &gt;pdb|1MKW|H The Co-Crystal Structure Of Unliganded Bovine Alpha- Thrombin And Prethrombin-2: Movement Of The Yppw Segment And Active Site Residues Upon Ligand Binding [Bos taurus] &gt;pdb|1MKX|H The Co-Crystal Structure Of Unliganded Bovine Alpha- Thrombin And Prethrombin-2: Movement Of The Yppw Segment And Active Site Residues Upon Ligand Binding [Bos taurus] &gt;pdb|1TBQ|H CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN [Bos taurus] &gt;pdb|1TBQ|K CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN [Bos taurus] &gt;pdb|1TBR|H CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN [Bos taurus] &gt;pdb|1TBR|K CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN [Bos taurus] &gt;pdb|1TOC|B STRUCTURE OF SERINE PROTEINASE [Bos taurus] &gt;pdb|1TOC|D STRUCTURE OF SERINE PROTEINASE [Bos taurus] &gt;pdb|1TOC|F STRUCTURE OF SERINE PROTEINASE [Bos taurus] &gt;pdb|1TOC|H STRUCTURE OF SERINE PROTEINASE [Bos taurus] &gt;pdb|1UCY|K Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7- 19). Three Complexes, One With Epsilon-Thrombin And Two With Alpha-Thrombin [Bos taurus] &gt;pdb|1UCY|N Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7- 19). Three Complexes, One With Epsilon-Thrombin And Two With Alpha-Thrombin [Bos taurus] &gt;pdb|1UVT|H Bovine Thrombin--Bm14.1248 Complex [Bos taurus] &gt;pdb|1UVU|H Bovine Thrombin--Bm12.1700 Complex [Bos taurus] &gt;pdb|1VIT|H Thrombin:hirudin 51-65 Complex [Bos taurus] &gt;pdb|1YCP|H The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y) Bound To Bovine Thrombin Explains Why The Mutation Of Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At Arginine-16 [Bos taurus] &gt;pdb|2A1D|B Staphylocoagulase bound to bovine thrombin [Bos taurus] &gt;pdb|2A1D|F Staphylocoagulase bound to bovine thrombin [Bos taurus] &gt;pdb|2ODY|B Chain B, Prothrombin (EC 3.4.21.5) [Bos taurus] &gt;pdb|2ODY|D Chain D, Prothrombin (EC 3.4.21.5) [Bos taurus] &gt;pdb|3PMA|B 2.2 Angstrom crystal structure of the complex between Bovine Thrombin and Sucrose Octasulfate [Bos taurus] &gt;pdb|3PMA|D 2.2 Angstrom crystal structure of the complex between Bovine Thrombin and Sucrose Octasulfate [Bos taurus] &gt;pdb|3PMB|B 2.9 Angstrom crystal structure of bovine thrombin in tetragonal spacegroup [Bos taurus] &gt;pdb|3PMB|D 2.9 Angstrom crystal structure of bovine thrombin in tetragonal spacegroup [Bos taurus] &gt;pdb|7A0D|HHH Chain HHH, Prothrombin [Bos taurus] &gt;pdb|7A0E|HHH Chain HHH, Prothrombin [Bos taurus] &gt;pdb|7A0F|HHH Chain HHH, Prothrombin [Bos taurus]</Hit_def>
  <Hit_accession>1A0H_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.58808e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LPL+    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>285</Hit_num>
  <Hit_id>pdb|2A0Q|B</Hit_id>
  <Hit_def>Structure of thrombin in 400 mM potassium chloride [Homo sapiens] &gt;pdb|2A0Q|D Structure of thrombin in 400 mM potassium chloride [Homo sapiens]</Hit_def>
  <Hit_accession>2A0Q_B</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.6356e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>286</Hit_num>
  <Hit_id>pdb|1GJ4|H</Hit_id>
  <Hit_def>SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN [Homo sapiens] &gt;pdb|1GJ5|H SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN [Homo sapiens] &gt;pdb|1SB1|H Novel Non-Covalent Thrombin Inhibitors Incorporating P1 4,5,6,7-Tetrahydrobenzothiazole Arginine Side Chain Mimetics [Homo sapiens] &gt;pdb|2PW8|H Crystal structure of sulfo-hirudin complexed to thrombin [Homo sapiens] &gt;pdb|3DD2|H Crystal structure of an RNA aptamer bound to human thrombin [Homo sapiens] &gt;pdb|4UDW|H Thrombin in complex with 1-(2R)-2-amino-3-phenyl-propanoyl-N-(2, 5dichlorophenyl)methylpyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|4UE7|H Thrombin in complex with 1-amidinopiperidine [Homo sapiens] &gt;pdb|4UEH|H Thrombin in complex with benzamidine [Homo sapiens] &gt;pdb|4UFD|H Thrombin in complex with 4-(((1-((2S)-1-((2R)-2-(benzylsulfonylamino)- 3-phenyl-propanoyl)pyrrolidin-2-yl)-1-oxo-ethyl)amino)methyl) benzamidine [Homo sapiens] &gt;pdb|4UFE|H Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-butyl)-3-phenyl-propanamide [Homo sapiens] &gt;pdb|4UFF|H Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-ethyl)-N-methyl-3-phenyl- propanamide [Homo sapiens] &gt;pdb|4UFG|H Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-((1S)-2-((4- carbamimidoylphenyl)methylamino)-1-methyl-2-oxo-ethyl)-N-methyl-3- phenyl-propanamide ethane [Homo sapiens] &gt;pdb|5A2M|H Thrombin Inhibitor [Homo sapiens] &gt;pdb|5AF9|H Thrombin in complex with 4-Methoxy-N-(2-pyridinyl)benzamide [Homo sapiens] &gt;pdb|5AFY|H Thrombin in complex with 3-chloro-benzamide [Homo sapiens] &gt;pdb|5AFZ|H Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-propyl)-3-phenyl-propanamide [Homo sapiens] &gt;pdb|5AHG|H Thrombin in complex with ((4-chlorophenyl)sulfamoyl))diemethylamine [Homo sapiens] &gt;pdb|5DO4|H Thrombin-RNA aptamer complex [Homo sapiens] &gt;pdb|6GWE|H Crystal structure of Thrombin bound to P2 macrocycle [Homo sapiens] &gt;pdb|6ZUG|H Crystal Structure of Thrombin in complex with compound10 [Homo sapiens]</Hit_def>
  <Hit_accession>1GJ4_H</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.66784e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>287</Hit_num>
  <Hit_id>pdb|1A2C|H</Hit_id>
  <Hit_def>Structure of thrombin inhibited by AERUGINOSIN298-A from a BLUE-GREEN ALGA [Homo sapiens] &gt;pdb|1A3B|H Complex Of Human Alpha-Thrombin With The Bifunctional Boronate Inhibitor Borolog1 [Homo sapiens] &gt;pdb|1A3E|H Complex Of Human Alpha-Thrombin With The Bifunctional Boronate Inhibitor Borolog2 [Homo sapiens] &gt;pdb|1A46|H Thrombin Complexed With Hirugen And A Beta-Strand Mimetic Inhibitor [Homo sapiens] &gt;pdb|1A4W|H Crystal Structures Of Thrombin With Thiazole-Containing Inhibitors: Probes Of The S1&apos; Binding Site [Homo sapiens] &gt;pdb|1A5G|H Human Thrombin Complexed With Novel Synthetic Peptide Mimetic Inhibitor And Hirugen [Homo sapiens] &gt;pdb|1A61|H Thrombin Complexed With A Beta-Mimetic Thiazole-Containing Inhibitor [Homo sapiens] &gt;pdb|1ABI|H Structure Of The Hirulog 3-Thrombin Complex And Nature Of The S&apos; Subsites Of Substrates And Inhibitors [Homo sapiens] &gt;pdb|1ABJ|H Structure Of The Hirulog 3-Thrombin Complex And Nature Of The S&apos; Subsites Of Substrates And Inhibitors [Homo sapiens] &gt;pdb|1AD8|H Complex Of Thrombin With And Inhibitor Containing A Novel P1 Moiety [Homo sapiens] &gt;pdb|1AE8|H Human Alpha-Thrombin Inhibition By Eoc-D-Phe-Pro-Azalys-Onp [Homo sapiens] &gt;pdb|1AFE|H Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp [Homo sapiens] &gt;pdb|1AHT|H Crystal Structure Of Human Alpha-Thrombin Complexed With Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms Resolution [Homo sapiens] &gt;pdb|1AI8|H Human Alpha-Thrombin Ternary Complex With The Exosite Inhibitor Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Borompg [Homo sapiens] &gt;pdb|1AIX|H Human Alpha-Thrombin Ternary Complex With Exosite Inhibitor Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Boroval [Homo sapiens] &gt;pdb|1AWF|H NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT [Homo sapiens] &gt;pdb|1AWH|B NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT [Homo sapiens] &gt;pdb|1AWH|D NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT [Homo sapiens] &gt;pdb|1AY6|H Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based Macrocyclic Tripeptide Motif [Homo sapiens] &gt;pdb|1B5G|H Human Thrombin Complexed With Novel Synthetic Peptide Mimetic Inhibitor And Hirugen [Homo sapiens] &gt;pdb|1BA8|B Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes [Homo sapiens] &gt;pdb|1BB0|B Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes [Homo sapiens] &gt;pdb|1BCU|H ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN [Homo sapiens] &gt;pdb|1BMM|H Human Alpha-Thrombin Complexed With [s-(R,R)]-4-[(Aminoiminomethyl) Amino]-N-[[1-[3-Hydroxy-2-[(2-Naphthalenylsulfonyl)amino]-1- Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide (Bms-186282) [Homo sapiens] &gt;pdb|1BMN|H Human Alpha-Thrombin Complexed With [s-(R,R)]-1-(Aminoiminomethyl)- N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-Pyrrolidinyl]methyl]-3- Piperidenecarboxamide (Bms-189090) [Homo sapiens] &gt;pdb|1C1U|H RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Homo sapiens] &gt;pdb|1C1V|H RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Homo sapiens] &gt;pdb|1C1W|H RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES [Homo sapiens] &gt;pdb|1C4U|2 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. [Homo sapiens] &gt;pdb|1C4V|2 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. [Homo sapiens] &gt;pdb|1C4Y|2 SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS [Homo sapiens] &gt;pdb|1C5L|H STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5N|H STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens] &gt;pdb|1C5O|H Chain H, Thrombin heavy chain [Homo sapiens] &gt;pdb|1CA8|B Thrombin inhibitors with rigid tripeptidyl aldehydes [Homo sapiens] &gt;pdb|1D3P|B Crystal Structure Of Human Aplha-Thrombin In Complex With Benzo[b]thiophene Inhibitor 3 [Homo sapiens] &gt;pdb|1D3Q|B Crystal Structure Of Human Alpha Thrombin In Complex With Benzo[b]thiophene Inhibitor 2 [Homo sapiens] &gt;pdb|1D3T|B Crystal Structure Of Human Alpha Thrombin In Complex With Benzo[b]thiophene Inhibitor 1 [Homo sapiens] &gt;pdb|1D4P|B Chain B, ALPHA-THROMBIN [Homo sapiens] &gt;pdb|1DE7|H Interaction Of Factor Xiii Activation Peptide With Alpha-Thrombin: Crystal Structure Of The Enzyme-Substrate Complex [Homo sapiens] &gt;pdb|1DE7|K Interaction Of Factor Xiii Activation Peptide With Alpha-Thrombin: Crystal Structure Of The Enzyme-Substrate Complex [Homo sapiens] &gt;pdb|1DIT|H Complex Of A Divalent Inhibitor With Thrombin [Homo sapiens] &gt;pdb|1DWB|H Crystallographic Analysis At 3.0-angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-directed Inhibitors [Homo sapiens] &gt;pdb|1DWC|H Crystallographic Analysis At 3.0-Angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-Directed Inhibitors [Homo sapiens] &gt;pdb|1DWD|H Crystallographic Analysis At 3.0-Angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-Directed Inhibitors [Homo sapiens] &gt;pdb|1DWE|H Crystallographic analysis at 3.0-Angstroms resolution of the binding to human thrombin of four active site-directed inhibitors [Homo sapiens] &gt;pdb|1FPC|H Active Site Mimetic Inhibition Of Thrombin [Homo sapiens] &gt;pdb|1FPH|H The Interaction Of Thrombin With Fibrinogen: A Structural Basis For Its Specificity [Homo sapiens] &gt;pdb|1G30|B THROMBIN INHIBITOR COMPLEX [Homo sapiens] &gt;pdb|1G32|B Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1HAH|H THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN [Homo sapiens] &gt;pdb|1HAI|H THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN [Homo sapiens] &gt;pdb|1HAO|H Complex Of Human Alpha-thrombin With A 15mer Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of Dna) [Homo sapiens] &gt;pdb|1HAP|H Complex Of Human Alpha-Thrombin With A 15mer Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of Dna) [Homo sapiens] &gt;pdb|1HBT|H Human alpha-thrombin complexed with a peptidyl pyridinium methyl ketone containing bivalent inhibitor [Homo sapiens] &gt;pdb|1HDT|H Structure Of A Retro-Binding Peptide Inhibitor Complexed With Human Alpha-Thrombin [Homo sapiens] &gt;pdb|1HGT|H STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN [Homo sapiens] &gt;pdb|1HLT|H THE STRUCTURE OF A NONADECAPEPTIDE OF THE FIFTH EGF DOMAIN OF THROMBOMODULIN COMPLEXED WITH THROMBIN [Homo sapiens] &gt;pdb|1HLT|K THE STRUCTURE OF A NONADECAPEPTIDE OF THE FIFTH EGF DOMAIN OF THROMBOMODULIN COMPLEXED WITH THROMBIN [Homo sapiens] &gt;pdb|1HUT|H The Structure Of Alpha-Thrombin Inhibited By A 15-Mer Single-Stranded Dna Aptamer [Homo sapiens] &gt;pdb|1HXE|H Serine Protease [Homo sapiens] &gt;pdb|1HXF|H Human Thrombin Complex With Hirudin Variant [Homo sapiens] &gt;pdb|1IHS|H Crystal Structure Of The Complex Of Human Alpha-thrombin And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 And Hirutonin-6 [Homo sapiens] &gt;pdb|1IHT|H Crystal Structure Of The Complex Of Human Alpha-Thrombin And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 And Hirutonin-6 [Homo sapiens] &gt;pdb|1K21|H Human Thrombin-Inhibitor Complex [Homo sapiens] &gt;pdb|1K22|H Human Thrombin-inhibitor Complex [Homo sapiens] &gt;pdb|1KTS|B Thrombin Inhibitor Complex [Homo sapiens] &gt;pdb|1KTT|B Thrombin inhibitor complex [Homo sapiens] &gt;pdb|1LHC|H Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boroarg-Oh [Homo sapiens] &gt;pdb|1LHD|H Human Alpha-thrombin Complexed With Ac-(d)phe-pro-borolys-oh [Homo sapiens] &gt;pdb|1LHE|H Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N- Butyl-Amidino-Glycine-Oh [Homo sapiens] &gt;pdb|1LHF|H Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro- Homolys-Oh [Homo sapiens] &gt;pdb|1LHG|H Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro- Boroornithine-Oh [Homo sapiens] &gt;pdb|1MU6|B Chain B, THROMBIN [Homo sapiens] &gt;pdb|1MU8|B Chain B, THROMBIN [Homo sapiens] &gt;pdb|1MUE|B Thrombin-Hirugen-L405,426 [Homo sapiens] &gt;pdb|1NO9|H Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies. [Homo sapiens] &gt;pdb|1NRN|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NRO|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NRP|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NRQ|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NRR|H Crystallographic structures of Thrombin complexed with Thrombin receptor peptides: Existence of expected and novel binding modes [Homo sapiens] &gt;pdb|1NRS|H Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes [Homo sapiens] &gt;pdb|1NU7|B Staphylocoagulase-Thrombin Complex [Homo sapiens] &gt;pdb|1NU7|F Staphylocoagulase-Thrombin Complex [Homo sapiens] &gt;pdb|1NY2|2 Human alpha thrombin inhibited by RPPGF and hirugen [Homo sapiens] &gt;pdb|1NZQ|H D-Phe-Pro-Arg-Type Thrombin Inhibitor [Homo sapiens] &gt;pdb|1O0D|H Human Thrombin complexed with a d-Phe-Pro-Arg-type Inhibitor and a C-terminal Hirudin derived exo-site inhibitor [Homo sapiens] &gt;pdb|1O2G|H Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors [Homo sapiens] &gt;pdb|1O5G|H Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1OOK|B Crystal Structure of the Complex of Platelet Receptor GPIb-alpha and Human alpha-Thrombin [Homo sapiens] &gt;pdb|1OYT|H Complex Of Recombinant Human Thrombin With A Designed Fluorinated Inhibitor [Homo sapiens] &gt;pdb|1P8V|C Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a [Homo sapiens] &gt;pdb|1PPB|H The Refined 1.9 Angstroms Crystal Structure Of Human Alpha-Thrombin: Interaction With D-Phe-Pro-Arg Chloromethylketone And Significance Of The Tyr-Pro-Pro-Trp Insertion Segment [Homo sapiens] &gt;pdb|1QBV|H Crystal Structure Of Thrombin Complexed With An Guanidine-mimetic Inhibitor [Homo sapiens] &gt;pdb|1QHR|B NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS [Homo sapiens] &gt;pdb|1QJ1|B Novel Covalent Active Site Thrombin Inhibitors [Homo sapiens] &gt;pdb|1QJ6|B Novel Covalent Active Site Thrombin Inhibitors [Homo sapiens] &gt;pdb|1QJ7|B Novel Covalent Active Site Thrombin Inhibitors [Homo sapiens] &gt;pdb|1SR5|C ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE [Homo sapiens] &gt;pdb|1T4U|H Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin [Homo sapiens] &gt;pdb|1T4V|H Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin [Homo sapiens] &gt;pdb|1TBZ|H Human Thrombin With Active Site N-Methyl-D Phenylalanyl-N-[5- (Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl] Butyl]-L- Prolinamide Trifluroacetate And Exosite-Hirugen [Homo sapiens] &gt;pdb|1THR|H Structures Of Thrombin Complexes With A Designed And A Natural Exosite Inhibitor [Homo sapiens] &gt;pdb|1THS|H Structures Of Thrombin Complexes With A Designed And A Natural Exosite Inhibitor [Homo sapiens] &gt;pdb|1TMB|H Molecular Basis For The Inhibition Of Human Alpha-thrombin By The Macrocyclic Peptide Cyclotheonamide A [Homo sapiens] &gt;pdb|1TMT|H CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS [Homo sapiens] &gt;pdb|1TMU|H Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms [Homo sapiens] &gt;pdb|1TOM|H Alpha-Thrombin Complexed With Hirugen [Homo sapiens] &gt;pdb|1UMA|H Alpha-Thrombin (Hirugen) Complexed With Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine [Homo sapiens] &gt;pdb|1UVS|H BOVINE THROMBIN--BM51.1011 COMPLEX [Homo sapiens] &gt;pdb|1W7G|H Alpha-thrombin complex with sulfated hirudin (residues 54-65) and L- Arginine template inhibitor CS107 [Homo sapiens] &gt;pdb|1WAY|B Active site thrombin inhibitors [Homo sapiens] &gt;pdb|1XMN|B Crystal structure of thrombin bound to heparin [Homo sapiens] &gt;pdb|1XMN|D Crystal structure of thrombin bound to heparin [Homo sapiens] &gt;pdb|1XMN|F Crystal structure of thrombin bound to heparin [Homo sapiens] &gt;pdb|1XMN|H Crystal structure of thrombin bound to heparin [Homo sapiens] &gt;pdb|2A2X|H Orally Active Thrombin Inhibitors in Complex with Thrombin Inh12 [Homo sapiens] &gt;pdb|2A45|B Crystal structure of the complex between thrombin and the central &apos;E&apos; region of fibrin [Homo sapiens] &gt;pdb|2A45|E Crystal structure of the complex between thrombin and the central &apos;E&apos; region of fibrin [Homo sapiens] &gt;pdb|2AFQ|B 1.9 angstrom crystal structure of wild-type human thrombin in the sodium free state [Homo sapiens] &gt;pdb|2AFQ|D 1.9 angstrom crystal structure of wild-type human thrombin in the sodium free state [Homo sapiens] &gt;pdb|2ANK|H orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide [Homo sapiens] &gt;pdb|2BVS|H Human thrombin complexed with fragment-based small molecules occupying the S1 pocket [Homo sapiens] &gt;pdb|2BVX|H Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker [Homo sapiens] &gt;pdb|2BXT|H Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker [Homo sapiens] &gt;pdb|2BXU|H Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker [Homo sapiens] &gt;pdb|2C8W|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C8X|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C8Y|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C8Z|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C90|B thrombin inhibitors [Homo sapiens] &gt;pdb|2C93|B thrombin inhibitors [Homo sapiens] &gt;pdb|2FEQ|H orally active thrombin inhibitors [Homo sapiens] &gt;pdb|2FES|H Orally active thrombin inhibitors [Homo sapiens] &gt;pdb|2GDE|H Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|2H9T|H Crystal structure of human alpha-thrombin in complex with suramin [Homo sapiens] &gt;pdb|2HGT|H STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN [Homo sapiens] &gt;pdb|2HPP|H Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin [Homo sapiens] &gt;pdb|2HPQ|H Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin [Homo sapiens] &gt;pdb|2JH0|D Human Thrombin Hirugen Inhibitor complex [Homo sapiens] &gt;pdb|2JH5|D Human Thrombin Hirugen Inhibitor complex [Homo sapiens] &gt;pdb|2JH6|D Human Thrombin Hirugen Inhibitor complex [Homo sapiens] &gt;pdb|2R2M|B 2-(2-Chloro-6-Fluorophenyl)Acetamides as Potent Thrombin Inhibitors [Homo sapiens] &gt;pdb|2UUF|B Thrombin-hirugen binary complex at 1.26A resolution [Homo sapiens] &gt;pdb|2UUJ|B Thrombin-hirugen-gw473178 ternary complex at 1.32A resolution [Homo sapiens] &gt;pdb|2UUK|B Thrombin-hirugen-gw420128 ternary complex at 1.39A resolution [Homo sapiens] &gt;pdb|2ZC9|H Thrombin in complex with Inhibitor [Homo sapiens] &gt;pdb|2ZDA|H Exploring Thrombin S1 pocket [Homo sapiens] &gt;pdb|2ZDV|H Exploring Thrombin S1 pocket [Homo sapiens] &gt;pdb|2ZF0|H Exploring Thrombin S1 Pocket [Homo sapiens] &gt;pdb|2ZFF|H Exploring Thrombin S1-pocket [Homo sapiens] &gt;pdb|2ZFP|H Thrombin Inibition [Homo sapiens] &gt;pdb|2ZFQ|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZFR|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZG0|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZGB|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZGX|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZHE|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZHF|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZHQ|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZHW|H Exploring thrombin S3 pocket [Homo sapiens] &gt;pdb|2ZI2|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZIQ|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZNK|H Thrombin Inhibition [Homo sapiens] &gt;pdb|2ZO3|H Bisphenylic Thrombin Inhibitors [Homo sapiens] &gt;pdb|3B23|B Crystal structure of thrombin-variegin complex: Insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors [Homo sapiens] &gt;pdb|3BF6|H Thrombin:suramin complex [Homo sapiens] &gt;pdb|3C27|B Cyanofluorophenylacetamides as Orally Efficacious Thrombin Inhibitors [Homo sapiens] &gt;pdb|3D49|H Thrombin Inhibition [Homo sapiens] &gt;pdb|3DA9|B Crystal structure of thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|3DHK|H Bisphenylic Thrombin Inhibitors [Homo sapiens] &gt;pdb|3DT0|H Understanding Thrombin Inhibition [Homo sapiens] &gt;pdb|3DUX|H Understanding Thrombin Inhibition [Homo sapiens] &gt;pdb|3E6P|H Crystal structure of human meizothrombin desF1 [Homo sapiens] &gt;pdb|3EGK|H KNOBLE Inhibitor [Homo sapiens] &gt;pdb|3EQ0|H Thrombin Inhibitor [Homo sapiens] &gt;pdb|3F68|H Thrombin Inhibition [Homo sapiens] &gt;pdb|3HAT|H Active Site Mimetic Inhibition Of Thrombin [Homo sapiens] &gt;pdb|3HTC|H The Structure Of A Complex Of Recombinant Hirudin And Human Alpha-Thrombin [Homo sapiens] &gt;pdb|3LDX|H Discovery and Clinical Evaluation of RWJ-671818, a Thrombin Inhibitor with an Oxyguanidine P1 Motif [Homo sapiens] &gt;pdb|3P17|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3P6Z|B Structural basis of thrombin mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P6Z|H Structural basis of thrombin mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P70|B Structural basis of thrombin-mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P70|D Structural basis of thrombin-mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P70|F Structural basis of thrombin-mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3P70|H Structural basis of thrombin-mediated factor V activation: essential role of the hirudin-like sequence Glu666-Glu672 for processing at the heavy chain-B domain junction [Homo sapiens] &gt;pdb|3PMH|B Mechanism of Sulfotyrosine-Mediated Glycoprotein Ib Interaction with Two Distinct alpha-Thrombin Sites [Homo sapiens] &gt;pdb|3QLP|H X-ray structure of the complex between human alpha thrombin and a modified thrombin binding aptamer (mTBA) [Homo sapiens] &gt;pdb|3QTO|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3QTV|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3QWC|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3QX5|H Thrombin Inhibition by Pyridin Derivatives [Homo sapiens] &gt;pdb|3RLW|H Human Thrombin in complex with MI328 [Homo sapiens] &gt;pdb|3RLY|H Human Thrombin in complex with MI329 [Homo sapiens] &gt;pdb|3RM0|H Human Thrombin in complex with MI354 [Homo sapiens] &gt;pdb|3RM2|H Human Thrombin in complex with MI003 [Homo sapiens] &gt;pdb|3RML|H Human Thrombin in complex with MI331 [Homo sapiens] &gt;pdb|3RMM|H Human Thrombin in complex with MI332 [Homo sapiens] &gt;pdb|3RMN|H Human Thrombin in complex with MI341 [Homo sapiens] &gt;pdb|3RMO|H Human Thrombin in complex with MI004 [Homo sapiens] &gt;pdb|3SHA|H Human Thrombin In Complex With UBTHR97 [Homo sapiens] &gt;pdb|3SHC|H Human Thrombin In Complex With UBTHR101 [Homo sapiens] &gt;pdb|3SI3|H Human Thrombin In Complex With UBTHR103 [Homo sapiens] &gt;pdb|3SI4|H Human Thrombin In Complex With UBTHR104 [Homo sapiens] &gt;pdb|3SV2|H Human Thrombin In Complex With UBTHR105 [Homo sapiens] &gt;pdb|3T5F|H Human Thrombin In Complex With MI340 [Homo sapiens] &gt;pdb|3TU7|H Human alpha-thrombin complexed with N-(methylsulfonyl)-D-phenylalanyl-N-((1-carbamimidoyl-4-piperidinyl)methyl)-l-prolinamide (BMS-189664) [Homo sapiens] &gt;pdb|3U69|H Unliganded wild-type human thrombin [Homo sapiens] &gt;pdb|3U8O|H Human thrombin complexed with D-Phe-Pro-D-Arg-D-Thr [Homo sapiens] &gt;pdb|3U8R|H Human thrombin complexed with D-Phe-Pro-D-Arg-Ile [Homo sapiens] &gt;pdb|3U8T|H Human thrombin complexed with D-Phe-Pro-D-Arg-Cys [Homo sapiens] &gt;pdb|3U98|H Human Thrombin In Complex With MI001 [Homo sapiens] &gt;pdb|3U9A|H Human Thrombin In Complex With MI330 [Homo sapiens] &gt;pdb|3UTU|H High affinity inhibitor of human thrombin [Homo sapiens] &gt;pdb|3UWJ|H Human Thrombin In Complex With MI353 [Homo sapiens] &gt;pdb|3VXE|H Human alpha-thrombin-Bivalirudin complex at PD5.0 [Homo sapiens] &gt;pdb|3VXF|H X/N Joint refinement of Human alpha-thrombin-Bivalirudin complex PD5 [Homo sapiens] &gt;pdb|4BAH|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAK|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAM|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAN|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAO|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BAQ|B Thrombin in complex with inhibitor [Homo sapiens] &gt;pdb|4BOH|A Madanins (MEROPS I53) are cleaved by thrombin and factor Xa [Homo sapiens] &gt;pdb|4BOH|H Madanins (MEROPS I53) are cleaved by thrombin and factor Xa [Homo sapiens] &gt;pdb|4CH2|B Low-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH2|D Low-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH8|B High-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH8|D High-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH8|F High-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4CH8|H High-salt crystal structure of a thrombin-GpIbalpha peptide complex [Homo sapiens] &gt;pdb|4DIH|H X-ray structure of the complex between human alpha thrombin and thrombin binding aptamer in the presence of sodium ions [Homo sapiens] &gt;pdb|4DII|H X-ray structure of the complex between human alpha thrombin and thrombin binding aptamer in the presence of potassium ions [Homo sapiens] &gt;pdb|4E05|H Anophelin from the malaria vector inhibits thrombin through a novel reverse-binding mechanism [Homo sapiens] &gt;pdb|4E06|H Anophelin from the malaria vector inhibits thrombin through a novel reverse-binding mechanism [Homo sapiens] &gt;pdb|4E7R|G Thrombin in complex with 3-amidinophenylalanine inhibitor [Homo sapiens] &gt;pdb|4E7R|H Thrombin in complex with 3-amidinophenylalanine inhibitor [Homo sapiens] &gt;pdb|4HTC|H THE REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX [Homo sapiens] &gt;pdb|4I7Y|H Crystal Structure of Human Alpha Thrombin in Complex with a 27-mer Aptamer Bound to Exosite II [Homo sapiens] &gt;pdb|4LXB|H Crystal Structure Analysis of thrombin in complex with compound D58 [Homo sapiens] &gt;pdb|4LZ1|H X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 12 nucleobase [Homo sapiens] &gt;pdb|4LZ4|B X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 3 nucleobase [Homo sapiens] &gt;pdb|4LZ4|D X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 3 nucleobase [Homo sapiens] &gt;pdb|4THN|H The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv Complex Reveals A Novel Specificity Site Recognition Mode. [Homo sapiens] &gt;pdb|4UD9|H Thrombin in complex with 5-chlorothiophene-2-carboxamide [Homo sapiens] &gt;pdb|4YES|B Thrombin in complex with (S)-(4-chloro-2-((1-(5-methyl-1H-pyrrole-2-carbonyl)pyrrolidine-2-carboxamido)methyl)phenyl)methanaminium [Homo sapiens] &gt;pdb|5CMX|H X-ray structure of the complex between human alpha thrombin and a duplex/quadruplex 31-mer DNA aptamer [Homo sapiens] &gt;pdb|5E8E|H Crystal structure of thrombin bound to an exosite 1-specific IgA Fab [Homo sapiens] &gt;pdb|5EW1|H Human thrombin sandwiched between two DNA aptamers: HD22 and HD1-deltaT3 [Homo sapiens] &gt;pdb|5EW2|H Human thrombin sandwiched between two DNA aptamers: HD22 and HD1-deltaT12 [Homo sapiens] &gt;pdb|5GDS|H Hirunorms Are True Hirudin Mimetics. The Crystal Structure Of Human Alpha-Thrombin:hirunorm V Complex [Homo sapiens] &gt;pdb|5GIM|B Crystal structure of thrombin-avathrin complex [Homo sapiens] &gt;pdb|5JFD|H Thrombin in complex with (S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-D-arginyl)pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5JZY|H Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5L6N|H Disulfated madanin-thrombin complex [Homo sapiens] &gt;pdb|5LCE|H Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(5-chloro-2-(hydroxymethyl)benzy l)pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5LPD|H Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(2-(aminomethyl)-5-chlorobenzyl) pyrrolidine-2-carboxamide [Homo sapiens] &gt;pdb|5NHU|A HUMAN ALPHA THROMBIN COMPLEXED WITH ANOPHELES GAMBIAE cE5 ANTICOAGULANT [Homo sapiens] &gt;pdb|5NHU|C HUMAN ALPHA THROMBIN COMPLEXED WITH ANOPHELES GAMBIAE cE5 ANTICOAGULANT [Homo sapiens] &gt;pdb|5NHU|H HUMAN ALPHA THROMBIN COMPLEXED WITH ANOPHELES GAMBIAE cE5 ANTICOAGULANT [Homo sapiens] &gt;pdb|6CYM|A Reversible Covalent Direct Thrombin Inhibitors [Homo sapiens] &gt;pdb|6CYM|C Reversible Covalent Direct Thrombin Inhibitors [Homo sapiens] &gt;pdb|6EO6|H X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(2-(1H-indol-3-yl)acetamide-N-yl)-1-propen-1-yl)-2&apos;-deoxyuridine residue [Homo sapiens] &gt;pdb|6EO7|H X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(acetamide-N-yl)-1-propen-1-yl)-2&apos;-deoxyuridine residue [Homo sapiens] &gt;pdb|6EO8|H Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor [Homo sapiens] &gt;pdb|6EO9|H Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor [Homo sapiens] &gt;pdb|6EVV|H X-ray structure of the complex between human alpha thrombin and NU172, a duplex/quadruplex 26-mer DNA aptamer, in the presence of potassium ions. [Homo sapiens] &gt;pdb|6GBW|H Thrombin in complex with MI2100 ((S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-L-arginyl)pyrrolidine-2-carboxamide) [Homo sapiens] &gt;pdb|6GN7|H X-ray structure of the complex between human alpha thrombin and NU172, a duplex/quadruplex 26-mer DNA aptamer, in the presence of sodium ions. [Homo sapiens] &gt;pdb|6HSX|H Thrombin in Complex with a D-Phe-Pro-diaminopyridine derivative [Homo sapiens] &gt;pdb|6I51|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6T3M|H Thrombin in Complex with a D-Phe-Pro-p-phenol derivative [Homo sapiens] &gt;pdb|6T3Q|H Thrombin in Complex with a D-Phe-Pro-2-aminopyridine derivative [Homo sapiens] &gt;pdb|6T4A|H Thrombin in Complex with a D-Phe-Pro-p-aminopyridine derivative [Homo sapiens] &gt;pdb|6T52|H Thrombin in Complex with a D-Phe-Pro-imidazole derivative [Homo sapiens] &gt;pdb|6T53|H Thrombin in Complex with a D-Phe-Pro-p-benzylamine derivative [Homo sapiens] &gt;pdb|6T54|H Thrombin in Complex with a D-Phe-Pro-2-bromothiophene Derivative [Homo sapiens] &gt;pdb|6T55|H Thrombin in Complex with Methylbenzylamine [Homo sapiens] &gt;pdb|6T56|H Thrombin in Complex with Benzylamine [Homo sapiens] &gt;pdb|6T57|H Thrombin in Complex with a D-Phe-Pro-N-amidinopiperidine Derivative [Homo sapiens] &gt;pdb|6T7H|A Chain A, Prothrombin [Homo sapiens] &gt;pdb|6T7H|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6T89|H Thrombin in complex with (S)-N-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2&apos;,4&apos;-dimethoxy-[1,1&apos;-biphenyl])-3-sulfonamido)propanoyl)piperazine-1-carboxamide (MI-498) [Homo sapiens] &gt;pdb|6T8A|H Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((S)-1-((R)-3-cyclohexyl 2-((phenylmethyl)sulfonamido)propanoyl)pyrrolidine-2-carboxamido)methyl)phosphonate (MI-492) [Homo sapiens] &gt;pdb|6TDT|H Thrombin in Complex with a D-DiPhe-Pro-p-pyridine derivative [Homo sapiens] &gt;pdb|6TKG|H Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 12keV [Homo sapiens] &gt;pdb|6TKH|H Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 7keV [Homo sapiens] &gt;pdb|6TKI|H Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 12.7keV [Homo sapiens] &gt;pdb|6TKJ|H Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 7keV [Homo sapiens] &gt;pdb|6TKL|H Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin [Homo sapiens] &gt;pdb|6Y02|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6Y9H|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YB6|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YHG|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YHJ|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YMP|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YN3|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YQV|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YSJ|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6YSX|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6Z8V|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6Z8W|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6Z8X|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6ZGO|H Chain H, Prothrombin [Homo sapiens] &gt;pdb|6ZUH|H Crystal Structure of Thrombin in complex with compound17 [Homo sapiens] &gt;pdb|6ZUN|H Crystal Structure of Thrombin in complex with compound20a [Homo sapiens] &gt;pdb|6ZUU|H Crystal structure of Thrombin in complex with compound30 [Homo sapiens] &gt;pdb|6ZUW|H Crystal Structure of Thrombin in complex with compound40 [Homo sapiens] &gt;pdb|6ZUX|H Crystal Structure of Thrombin in complex with compound42a [Homo sapiens] &gt;pdb|6ZV7|H Crystal Structure of Thrombin in complex with compound42b [Homo sapiens] &gt;pdb|6ZV8|H Crystal Structure of Thrombin in complex with compound51 [Homo sapiens] &gt;pdb|7KME|H CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2711. [Homo sapiens] &gt;pdb|7NTU|B Chain B, Prothrombin [Homo sapiens] &gt;pdb|7NTU|D Chain D, Prothrombin [Homo sapiens] &gt;pdb|8KME|2 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770. [Homo sapiens]</Hit_def>
  <Hit_accession>1A2C_H</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.70001e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>288</Hit_num>
  <Hit_id>pdb|4B2B|A</Hit_id>
  <Hit_def>Structure of the factor Xa-like trypsin variant triple-Ala (TGPA) in complex with eglin C [Bos taurus] &gt;pdb|4B2B|C Structure of the factor Xa-like trypsin variant triple-Ala (TGPA) in complex with eglin C [Bos taurus]</Hit_def>
  <Hit_accession>4B2B_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>3.73444e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVVC----SGKLQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M CAG    G  +C GD+GGP+VC    +  L GIVSWG      + PG Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>289</Hit_num>
  <Hit_id>pdb|3R3G|B</Hit_id>
  <Hit_def>Structure of human thrombin with residues 145-150 of murine thrombin. [Homo sapiens]</Hit_def>
  <Hit_accession>3R3G_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.73809e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>290</Hit_num>
  <Hit_id>pdb|2THF|B</Hit_id>
  <Hit_def>Structure Of Human Alpha-thrombin Y225f Mutant Bound To D-phe-pro-arg- Chloromethylketone [Homo sapiens]</Hit_def>
  <Hit_accession>2THF_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.81542e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKFGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>291</Hit_num>
  <Hit_id>pdb|1SFQ|B</Hit_id>
  <Hit_def>Fast form of thrombin mutant R(77a)A bound to PPACK [Homo sapiens] &gt;pdb|1SFQ|E Fast form of thrombin mutant R(77a)A bound to PPACK [Homo sapiens] &gt;pdb|1SG8|B Crystal structure of the procoagulant fast form of thrombin [Homo sapiens] &gt;pdb|1SG8|E Crystal structure of the procoagulant fast form of thrombin [Homo sapiens] &gt;pdb|1SGI|B Crystal structure of the anticoagulant slow form of thrombin [Homo sapiens] &gt;pdb|1SGI|E Crystal structure of the anticoagulant slow form of thrombin [Homo sapiens] &gt;pdb|1SHH|B Slow form of Thrombin Bound with PPACK [Homo sapiens] &gt;pdb|1SHH|E Slow form of Thrombin Bound with PPACK [Homo sapiens] &gt;pdb|2HWL|B Crystal structure of thrombin in complex with fibrinogen gamma&apos; peptide [Homo sapiens] &gt;pdb|2HWL|D Crystal structure of thrombin in complex with fibrinogen gamma&apos; peptide [Homo sapiens] &gt;pdb|3BV9|B Structure of Thrombin Bound to the Inhibitor FM19 [Homo sapiens]</Hit_def>
  <Hit_accession>1SFQ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.85469e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>292</Hit_num>
  <Hit_id>pdb|2GP9|B</Hit_id>
  <Hit_def>Crystal structure of the slow form of thrombin in a self-inhibited conformation [Homo sapiens] &gt;pdb|3BEF|B Crystal structure of thrombin bound to the extracellular fragment of PAR1 [Homo sapiens] &gt;pdb|3BEF|E Crystal structure of thrombin bound to the extracellular fragment of PAR1 [Homo sapiens] &gt;pdb|3BEI|B Crystal structure of the slow form of thrombin in a self_inhibited conformation [Homo sapiens] &gt;pdb|3QDZ|B Crystal structure of the human thrombin mutant D102N in complex with the extracellular fragment of human PAR4. [Homo sapiens] &gt;pdb|3QDZ|D Crystal structure of the human thrombin mutant D102N in complex with the extracellular fragment of human PAR4. [Homo sapiens] &gt;pdb|4MLF|B Crystal structure for the complex of thrombin mutant D102N and hirudin [Homo sapiens]</Hit_def>
  <Hit_accession>2GP9_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.85469e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>293</Hit_num>
  <Hit_id>pdb|1DX5|M</Hit_id>
  <Hit_def>Crystal structure of the thrombin-thrombomodulin complex [Homo sapiens] &gt;pdb|1DX5|N Crystal structure of the thrombin-thrombomodulin complex [Homo sapiens] &gt;pdb|1DX5|O Crystal structure of the thrombin-thrombomodulin complex [Homo sapiens] &gt;pdb|1DX5|P Crystal structure of the thrombin-thrombomodulin complex [Homo sapiens] &gt;pdb|1E0F|D Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor [Homo sapiens] &gt;pdb|1E0F|E Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor [Homo sapiens] &gt;pdb|1E0F|F Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>1DX5_M</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.85469e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>294</Hit_num>
  <Hit_id>pdb|5JDU|B</Hit_id>
  <Hit_def>Crystal structure for human thrombin mutant D189A [Homo sapiens] &gt;pdb|5JDU|D Crystal structure for human thrombin mutant D189A [Homo sapiens]</Hit_def>
  <Hit_accession>5JDU_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.89435e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGV-----SSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGAACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG         ++C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>295</Hit_num>
  <Hit_id>pdb|3JZ1|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin mutant N143P in E:Na+ form [Homo sapiens] &gt;pdb|3JZ2|B Crystal structure of human thrombin mutant N143P in E* form [Homo sapiens] &gt;pdb|3QGN|B The allosteric E*-E equilibrium is a key property of the trypsin fold [Homo sapiens]</Hit_def>
  <Hit_accession>3JZ1_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.97491e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>296</Hit_num>
  <Hit_id>pdb|6PXJ|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin mutant I16T [Homo sapiens] &gt;pdb|6PXJ|H Crystal structure of human thrombin mutant I16T [Homo sapiens]</Hit_def>
  <Hit_accession>6PXJ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>3.97491e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>297</Hit_num>
  <Hit_id>pdb|1D6W|A</Hit_id>
  <Hit_def>Structure Of Thrombin Complexed With Selective Non-electrophilic Inhibitors Having Cyclohexyl Moieties At P1 [Homo sapiens] &gt;pdb|1G37|A CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE [Homo sapiens]</Hit_def>
  <Hit_accession>1D6W_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>3.99653e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>187</Hsp_hit-from>
      <Hsp_hit-to>284</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>298</Hit_num>
  <Hit_id>pdb|1NM6|A</Hit_id>
  <Hit_def>thrombin in complex with selective macrocyclic inhibitor at 1.8A [Homo sapiens] &gt;pdb|1NT1|A thrombin in complex with selective macrocyclic inhibitor [Homo sapiens] &gt;pdb|1SL3|A crystal structue of Thrombin in complex with a potent P1 heterocycle-Aryl based inhibitor [Homo sapiens] &gt;pdb|1TA2|A Crystal structure of thrombin in complex with compound 1 [Homo sapiens] &gt;pdb|1TA6|A Crystal structure of thrombin in complex with compound 14b [Homo sapiens] &gt;pdb|1Z71|A thrombin and P2 pyridine N-oxide inhibitor complex structure [Homo sapiens] &gt;pdb|1ZGI|A thrombin in complex with an oxazolopyridine inhibitor 21 [Homo sapiens] &gt;pdb|1ZGV|A Thrombin in complex with an oxazolopyridine inhibitor 2 [Homo sapiens] &gt;pdb|1ZRB|A Thrombin in complex with an azafluorenyl inhibitor 23b [Homo sapiens] &gt;pdb|3C1K|A Crystal structure of thrombin in complex with inhibitor 15 [Homo sapiens]</Hit_def>
  <Hit_accession>1NM6_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>4.03716e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>186</Hsp_hit-from>
      <Hsp_hit-to>283</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>299</Hit_num>
  <Hit_id>pdb|1MH0|A</Hit_id>
  <Hit_def>Crystal structure of the anticoagulant slow form of thrombin [Homo sapiens] &gt;pdb|1MH0|B Crystal structure of the anticoagulant slow form of thrombin [Homo sapiens]</Hit_def>
  <Hit_accession>1MH0_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>4.03716e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>187</Hsp_hit-from>
      <Hsp_hit-to>284</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>300</Hit_num>
  <Hit_id>pdb|1D9I|A</Hit_id>
  <Hit_def>Structure Of Thrombin Complexed With Selective Non-electophilic Inhibitors Having Cyclohexyl Moieties At P1 [Homo sapiens]</Hit_def>
  <Hit_accession>1D9I_A</Hit_accession>
  <Hit_len>288</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.929</Hsp_bit-score>
      <Hsp_score>154</Hsp_score>
      <Hsp_evalue>4.06261e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>187</Hsp_hit-from>
      <Hsp_hit-to>284</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>301</Hit_num>
  <Hit_id>pdb|1H8D|H</Hit_id>
  <Hit_def>X-ray structure of the human alpha-thrombin complex with a tripeptide phosphonate inhibitor. [Homo sapiens]</Hit_def>
  <Hit_accession>1H8D_H</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>4.17678e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>150</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>302</Hit_num>
  <Hit_id>pdb|1B7X|B</Hit_id>
  <Hit_def>Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D- Phe-Pro-Arg-Chloromethylketone [Homo sapiens]</Hit_def>
  <Hit_accession>1B7X_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>4.31412e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKIGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>303</Hit_num>
  <Hit_id>pdb|2OD3|B</Hit_id>
  <Hit_def>Human thrombin chimera with human residues 184a, 186, 186a, 186b, 186c and 222 replaced by murine thrombin equivalents. [Homo sapiens]</Hit_def>
  <Hit_accession>2OD3_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>4.63453e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>304</Hit_num>
  <Hit_id>pdb|1RD3|B</Hit_id>
  <Hit_def>2.5A Structure of Anticoagulant Thrombin Variant E217K [Homo sapiens] &gt;pdb|1RD3|D 2.5A Structure of Anticoagulant Thrombin Variant E217K [Homo sapiens]</Hit_def>
  <Hit_accession>1RD3_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>4.73037e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>305</Hit_num>
  <Hit_id>pdb|2Y5F|A</Hit_id>
  <Hit_def>FACTOR XA - CATION INHIBITOR COMPLEX [Homo sapiens] &gt;pdb|2Y5G|A FACTOR XA - CATION INHIBITOR COMPLEX [Homo sapiens] &gt;pdb|2Y5H|A FACTOR XA - CATION INHIBITOR COMPLEX [Homo sapiens]</Hit_def>
  <Hit_accession>2Y5F_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>4.95029e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>306</Hit_num>
  <Hit_id>pdb|1FJS|A</Hit_id>
  <Hit_def>Crystal Structure Of The Inhibitor Zk-807834 (ci-1031) Complexed With Factor Xa [Homo sapiens] &gt;pdb|1Z6E|A Factor XA in complex with the inhibitor 1-(3&apos;-amino-1,2-benzisoxazol-5&apos;-yl)-n-(4-(2&apos;-((dimethylamino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (razaxaban; DPC906; BMS-561389) [Homo sapiens] &gt;pdb|2BMG|B Crystal structure of factor Xa in complex with 50 [Homo sapiens] &gt;pdb|2FZZ|A Factor Xa in complex with the inhibitor 1-(3-amino-1,2-benzisoxazol-5-yl)-6-(2&apos;-(((3r)-3-hydroxy-1-pyrrolidinyl)methyl)-4-biphenylyl)-3-(trifluoromethyl)-1,4,5,6-tetrahydro-7h-pyrazolo[3,4-c]pyridin-7-one [Homo sapiens] &gt;pdb|2G00|A Factor Xa in complex with the inhibitor 3-(6-(2&apos;-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-1-yl)benzamide [Homo sapiens] &gt;pdb|2P16|A Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE [Homo sapiens] &gt;pdb|2P93|A Factor xa in complex with the inhibitor 5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide [Homo sapiens] &gt;pdb|2P94|A Factor xa in complex with the inhibitor 3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclohexyl)-1H-indole-6-carboxamide [Homo sapiens] &gt;pdb|2P95|A Factor xa in complex with the inhibitor 5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) cyclopentyl)thiophene-2-carboxamide [Homo sapiens] &gt;pdb|2PHB|A An Orally Efficacious Factor Xa Inhibitor [Homo sapiens] &gt;pdb|2PR3|A Factor XA inhibitor [Homo sapiens] &gt;pdb|2Q1J|A The discovery of glycine and related amino acid-based factor xa inhibitors [Homo sapiens] &gt;pdb|2RA0|A X-ray Structure of FXa in complex with 7-fluoroindazole [Homo sapiens] &gt;pdb|2W26|A Chain A, ACTIVATED FACTOR XA HEAVY CHAIN [Homo sapiens] &gt;pdb|2W3I|A Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2 [Homo sapiens] &gt;pdb|2W3K|A Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1 [Homo sapiens] &gt;pdb|3CEN|A Factor XA in complex with the inhibitor N-(2-(((5-chloro-2-pyridinyl) amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide [Homo sapiens] &gt;pdb|3CS7|A FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one [Homo sapiens] &gt;pdb|3FFG|A Factor XA in complex with the inhibitor (R)-6-(2&apos;-((3- HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN- 7(4H)-ONE [Homo sapiens] &gt;pdb|3KQB|A Factor xa in complex with the inhibitor n-(3-fluoro-2&apos;- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-1h- pyrazole-5-carboxamide [Homo sapiens] &gt;pdb|3KQC|A Factor xa in complex with the inhibitor 6-(2&apos;- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6- dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one [Homo sapiens] &gt;pdb|3KQD|A Factor xa in complex with the inhibitor 1-(3-(5-oxo-4,5- dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2&apos;-(pyrrolidin-1- ylmethyl)biphenyl-4-yl)-3-(trifluoromethyl)-5,6-dihydro- 1h-pyrazolo[3,4-c]pyridin-7(4h)-one [Homo sapiens] &gt;pdb|3KQE|A Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2&apos;- (pyrrolidin-1-ylmethyl)biphenyl-4-yl)-5,6-dihydro-1h- pyrazolo[3,4-c]pyridin-7(4h)-one [Homo sapiens] &gt;pdb|3LIW|A Factor XA in complex with (R)-2-(1-ADAMANTYLCARBAMOYLAMINO)-3-(3-CARBAMIDOYL-PHENYL)-N-PHENETHYL-PROPIONIC ACID AMIDE [Homo sapiens] &gt;pdb|3M36|A Factor XA in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2&apos;-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423) [Homo sapiens] &gt;pdb|3M37|A Factor XA in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2&apos;-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC602) [Homo sapiens] &gt;pdb|5K0H|A Human factor Xa in complex with synthetic inhibitor benzylsulfonyl-dSer(Benzyl)-Gly-4-amidinobenzylamide [Homo sapiens]</Hit_def>
  <Hit_accession>1FJS_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>5.00177e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>307</Hit_num>
  <Hit_id>pdb|1MQ5|A</Hit_id>
  <Hit_def>Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa [Homo sapiens] &gt;pdb|1MQ6|A Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa [Homo sapiens] &gt;pdb|1V3X|A Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine [Homo sapiens] &gt;pdb|1WU1|A Factor Xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine [Homo sapiens] &gt;pdb|2D1J|A Factor Xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide [Homo sapiens] &gt;pdb|2EI6|A FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-cis-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine [Homo sapiens] &gt;pdb|2EI7|A FACTOR XA IN COMPLEX WITH THE INHIBITOR trans-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine [Homo sapiens] &gt;pdb|2EI8|A FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-chloroindol-2-yl)carbonyl]-4-(N,N-dimethylcarbamoyl)-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine [Homo sapiens] &gt;pdb|2H9E|H Crystal Structure of FXa/selectide/NAPC2 ternary complex [Homo sapiens] &gt;pdb|2P3T|B Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide [Homo sapiens] &gt;pdb|2P3U|B Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1H-imidazol-2-yl)methyl]thiophene-2-carboxamide {Pfizer 320663} [Homo sapiens] &gt;pdb|3IIT|A Factor XA in complex with a cis-1,2-diaminocyclohexane derivative [Homo sapiens] &gt;pdb|3Q3K|A Factor Xa in complex with a phenylenediamine derivative [Homo sapiens] &gt;pdb|3TK5|A Factor Xa in complex with D102-4380 [Homo sapiens] &gt;pdb|3TK6|A factor Xa in complex with D46-5241 [Homo sapiens]</Hit_def>
  <Hit_accession>1MQ5_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>5.05092e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>308</Hit_num>
  <Hit_id>pdb|1G2L|A</Hit_id>
  <Hit_def>Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|1G2M|A Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|1IOE|A Human coagulation factor Xa in complex with M55532 [Homo sapiens] &gt;pdb|1IQE|A Human coagulation factor Xa in complex with M55590 [Homo sapiens] &gt;pdb|1IQF|A Human coagulation factor Xa in complex with M55165 [Homo sapiens] &gt;pdb|1IQG|A Human coagulation factor Xa in complex with M55159 [Homo sapiens] &gt;pdb|1IQH|A Human coagulation factor Xa in complex with M55143 [Homo sapiens] &gt;pdb|1IQI|A Human coagulation factor Xa in complex with M55125 [Homo sapiens] &gt;pdb|1IQJ|A Human coagulation factor Xa in complex with M55124 [Homo sapiens] &gt;pdb|1IQK|A Human coagulation factor Xa in complex with M55113 [Homo sapiens] &gt;pdb|1IQL|A Human coagulation factor Xa in complex with M54476 [Homo sapiens] &gt;pdb|1IQM|A Human coagulation factor Xa in complex with M54471 [Homo sapiens] &gt;pdb|1IQN|A Human coagulation factor Xa in complex with M55192 [Homo sapiens] &gt;pdb|1XKA|C Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3&apos;- Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid [Homo sapiens] &gt;pdb|1XKB|C Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3&apos;- Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid [Homo sapiens] &gt;pdb|1XKB|D Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3&apos;- Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid [Homo sapiens] &gt;pdb|2P3F|H Crystal structure of the factor Xa/NAP5 complex [Homo sapiens]</Hit_def>
  <Hit_accession>1G2L_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>5.10874e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>309</Hit_num>
  <Hit_id>pdb|1JWT|A</Hit_id>
  <Hit_def>Crystal Structure Of Thrombin In Complex With A Novel Bicyclic Lactam Inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>1JWT_A</Hit_accession>
  <Hit_len>305</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.5438</Hsp_bit-score>
      <Hsp_score>153</Hsp_score>
      <Hsp_evalue>5.29975e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>193</Hsp_hit-from>
      <Hsp_hit-to>290</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>310</Hit_num>
  <Hit_id>pdb|2BQ6|B</Hit_id>
  <Hit_def>Crystal structure of factor Xa in complex with 21 [Homo sapiens] &gt;pdb|2BQ7|B Crystal structure of factor Xa in complex with 43 [Homo sapiens] &gt;pdb|2BQW|B CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45 [Homo sapiens]</Hit_def>
  <Hit_accession>2BQ6_B</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>5.58731e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>311</Hit_num>
  <Hit_id>pdb|3UWI|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|A Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|B Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|C Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|D Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|E Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|F Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|G Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|H Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|I Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|J Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|K Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|L Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|M Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|N Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|O Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3UY9|P Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3V12|A Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus] &gt;pdb|3V13|A Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3UWI_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>5.71947e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCVGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M C G    G  +C GDSGGP+VC    +  L GIVSWG      + PG Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>312</Hit_num>
  <Hit_id>pdb|3BN9|A</Hit_id>
  <Hit_def>Crystal Structure of MT-SP1 in complex with Fab Inhibitor E2 [Homo sapiens] &gt;pdb|3BN9|B Crystal Structure of MT-SP1 in complex with Fab Inhibitor E2 [Homo sapiens] &gt;pdb|3NCL|A Crystal Structure of MT-SP1 bound to Benzamidine Phosphonate Inhibitor [Homo sapiens] &gt;pdb|3NPS|A Crystal structure of membrane-type serine protease 1 (MT-SP1) in complex with the Fab Inhibitor S4 [Homo sapiens] &gt;pdb|3SO3|A Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition. [Homo sapiens] &gt;pdb|6T9T|A Chain A, Suppressor of tumorigenicity 14 protein [Homo sapiens]</Hit_def>
  <Hit_accession>3BN9_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>5.72752e-13</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>149</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLV-CKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE</Hsp_hseq>
      <Hsp_midline>LQ+  + +++ T C+     +I   M+C G  + GV SC GDSGGPL   + +G     G+VSWG      + PGVY R+    +W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>313</Hit_num>
  <Hit_id>pdb|2BOK|A</Hit_id>
  <Hit_def>Factor Xa - cation [Homo sapiens] &gt;pdb|2JKH|A Factor Xa - cation inhibitor complex [Homo sapiens] &gt;pdb|2VVC|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VVC|B Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VVU|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VVV|A Aminopyrrolidine-related triazole Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWL|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWM|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWM|B Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWN|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2VWO|A Aminopyrrolidine Factor Xa inhibitor [Homo sapiens] &gt;pdb|2XBV|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>2BOK_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>5.72752e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>314</Hit_num>
  <Hit_id>pdb|3V0X|A</Hit_id>
  <Hit_def>Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor [Bos taurus]</Hit_def>
  <Hit_accession>3V0X_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>5.77922e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLKCLKAPILSDSSCKSASSFIITSNMFCVGYLEGGKDACQGDSGGPVVC----SGKLQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIASN</Hsp_hseq>
      <Hsp_midline>PD L+    P+LS+++CK      I   M C G    G  +C GDSGGP+VC    +  L GIVSWG      + PG Y +V   V+W++QT+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>315</Hit_num>
  <Hit_id>pdb|3ENS|B</Hit_id>
  <Hit_def>Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate [Homo sapiens] &gt;pdb|3ENS|D Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate [Homo sapiens] &gt;pdb|3HPT|B Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine [Homo sapiens] &gt;pdb|3HPT|D Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine [Homo sapiens] &gt;pdb|3K9X|B X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE [Homo sapiens] &gt;pdb|3K9X|D X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE [Homo sapiens] &gt;pdb|3SW2|B X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-5,6-dihydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2H,4H,8H)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide [Homo sapiens]</Hit_def>
  <Hit_accession>3ENS_B</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>5.7876e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>316</Hit_num>
  <Hit_id>pdb|1EAW|A</Hit_id>
  <Hit_def>Crystal structure of the MTSP1 (matriptase)-BPTI (aprotinin) complex [Homo sapiens] &gt;pdb|1EAW|C Crystal structure of the MTSP1 (matriptase)-BPTI (aprotinin) complex [Homo sapiens] &gt;pdb|1EAX|A Crystal structure of MTSP1 (matriptase) [Homo sapiens] &gt;pdb|2GV6|A Chain A, Suppressor of tumorigenicity 14 [Homo sapiens] &gt;pdb|2GV7|A Structure of Matriptase in Complex with Inhibitor CJ-672 [Homo sapiens] &gt;pdb|4JYT|A Crystal Structure of Matriptase in complex with Inhibitor [Homo sapiens] &gt;pdb|4JZ1|A Crystal Structure of Matriptase in complex with Inhibitor [Homo sapiens] &gt;pdb|4JZI|A Crystal Structure of Matriptase in complex with Inhibitor&apos;. [Homo sapiens] &gt;pdb|4O97|A Crystal structure of matriptase in complex with inhibitor [Homo sapiens] &gt;pdb|4O9V|A Crystal structure of matriptase in complex with inhibitor [Homo sapiens] &gt;pdb|4R0I|A CRYSTAL STRUCTURE of MATRIPTASE in COMPLEX WITH INHIBITOR [Homo sapiens] &gt;pdb|6N4T|A Crystal structure of Matriptase1 in complex with a peptidomimetic benzothiazole [Homo sapiens]</Hit_def>
  <Hit_accession>1EAW_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>6.03052e-13</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>149</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLV-CKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE</Hsp_hseq>
      <Hsp_midline>LQ+  + +++ T C+     +I   M+C G  + GV SC GDSGGPL   + +G     G+VSWG      + PGVY R+    +W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>317</Hit_num>
  <Hit_id>pdb|1HCG|A</Hit_id>
  <Hit_def>Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms Resolution [Homo sapiens] &gt;pdb|2XBW|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XBX|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XBY|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XC0|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XC4|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|2XC5|A Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor [Homo sapiens] &gt;pdb|3KL6|A Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally active factor Xa inhibitor [Homo sapiens] &gt;pdb|7AHU|C Chain C, Coagulation factor X [Homo sapiens] &gt;pdb|7AHU|E Chain E, Coagulation factor X [Homo sapiens]</Hit_def>
  <Hit_accession>1HCG_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>6.03052e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>318</Hit_num>
  <Hit_id>pdb|1OSS|A</Hit_id>
  <Hit_def>T190p Streptomyces Griseus Trypsin In Complex With Benzamidine [Streptomyces griseus]</Hit_def>
  <Hit_accession>1OSS_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>6.21528e-13</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>128</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTK-IKDAMICAG---ASGVSSCMGDSGGPLVCKKNG-AWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LLKANVPFVSDAACRSAYGNELVANEEICAGYPDTGGVDPCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAI</Hsp_hseq>
      <Hsp_midline>L +A++P +S+  C+  +G + + +  ICAG     GV  C GDSGGP+  K N   W  VGIVSWG        PGVY  V+   + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>319</Hit_num>
  <Hit_id>pdb|3P8F|A</Hit_id>
  <Hit_def>Crystal Structure of MT-SP1 in complex with SFTI-1 [Homo sapiens] &gt;pdb|3P8G|A Crystal Structure of MT-SP1 in complex with benzamidine [Homo sapiens] &gt;pdb|4ISN|A Crystal Structure of Matriptase in complex with its inhibitor HAI-1 [Homo sapiens] &gt;pdb|4ISO|A Crystal Structure of Matriptase in complex with its inhibitor HAI-1 [Homo sapiens]</Hit_def>
  <Hit_accession>3P8F_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>6.21995e-13</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>149</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLV-CKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQKGEIRVIQQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE</Hsp_hseq>
      <Hsp_midline>LQ+  + ++  T C+     +I   M+C G  + GV SC GDSGGPL   + +G     G+VSWG      + PGVY R+    +W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>320</Hit_num>
  <Hit_id>pdb|1EZQ|A</Hit_id>
  <Hit_def>Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr128515 [Homo sapiens] &gt;pdb|1F0R|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr208815 [Homo sapiens] &gt;pdb|1F0S|A Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707 [Homo sapiens] &gt;pdb|1KSN|A Crystal Structure of Human Coagulation Factor XA Complexed with FXV673 [Homo sapiens] &gt;pdb|1LPG|B Crystal Structure Of Fxa In Complex With 79. [Homo sapiens] &gt;pdb|1LPK|B Crystal Structure Of Fxa In Complex With 125. [Homo sapiens] &gt;pdb|1LPZ|B Crystal Structure Of Fxa In Complex With 41. [Homo sapiens] &gt;pdb|1LQD|B Crystal Structure Of Fxa In Complex With 45. [Homo sapiens] &gt;pdb|1NFU|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr132747 [Homo sapiens] &gt;pdb|1NFW|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr209685 [Homo sapiens] &gt;pdb|1NFX|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr208944 [Homo sapiens] &gt;pdb|1NFY|A Crystal Structure Of Human Coagulation Factor Xa Complexed With Rpr200095 [Homo sapiens] &gt;pdb|1P0S|H Crystal Structure of Blood Coagulation Factor Xa in Complex with Ecotin M84R [Homo sapiens] &gt;pdb|2BOH|B Crystal structure of factor Xa in complex with compound &apos;1&apos; [Homo sapiens] &gt;pdb|2CJI|A Crystal structure of a Human Factor Xa inhibitor complex [Homo sapiens] &gt;pdb|2J2U|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J34|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J38|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J4I|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J94|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2J95|A Crystal Structure Of A Human Factor Xa Inhibitor Complex [Homo sapiens] &gt;pdb|2UWL|A Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa [Homo sapiens] &gt;pdb|2UWO|A Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa [Homo sapiens] &gt;pdb|2UWP|A Factor Xa inhibitor complex [Homo sapiens] &gt;pdb|2VH0|A Structure and property based design of factor Xa inhibitors:biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs [Homo sapiens] &gt;pdb|2VH6|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs [Homo sapiens] &gt;pdb|2WYG|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs [Homo sapiens] &gt;pdb|2WYJ|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs [Homo sapiens] &gt;pdb|2Y7X|A The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs [Homo sapiens] &gt;pdb|2Y7Z|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs [Homo sapiens] &gt;pdb|2Y80|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs [Homo sapiens] &gt;pdb|2Y81|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs [Homo sapiens] &gt;pdb|2Y82|A Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs [Homo sapiens] &gt;pdb|4A7I|B Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor [Homo sapiens] &gt;pdb|4BTI|B factor Xa in complex with the dual thrombin-FXa inhibitor 58. [Homo sapiens] &gt;pdb|4BTI|F factor Xa in complex with the dual thrombin-FXa inhibitor 58. [Homo sapiens] &gt;pdb|4BTT|B factor Xa in complex with the dual thrombin-FXa inhibitor 31. [Homo sapiens] &gt;pdb|4BTT|F factor Xa in complex with the dual thrombin-FXa inhibitor 31. [Homo sapiens] &gt;pdb|4BTU|B Factor Xa in complex with the dual thrombin-FXa inhibitor 57. [Homo sapiens] &gt;pdb|4BTU|F Factor Xa in complex with the dual thrombin-FXa inhibitor 57. [Homo sapiens] &gt;pdb|4Y6D|A Factor Xa complex with GTC000101 [Homo sapiens] &gt;pdb|4Y71|A Factor Xa complex with GTC000398 [Homo sapiens] &gt;pdb|4Y76|A Factor Xa complex with GTC000401 [Homo sapiens] &gt;pdb|4Y79|A Factor Xa complex with GTC000406 [Homo sapiens] &gt;pdb|4Y7A|A Factor Xa complex with GTC000422 [Homo sapiens] &gt;pdb|4Y7B|A Factor Xa complex with GTC000441 [Homo sapiens] &gt;pdb|4ZH8|A Factor Xa complex with GTC000006 [Homo sapiens] &gt;pdb|4ZHA|A Factor Xa complex with GTC000102 [Homo sapiens]</Hit_def>
  <Hit_accession>1EZQ_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>6.4145e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>321</Hit_num>
  <Hit_id>pdb|1C5M|D</Hit_id>
  <Hit_def>STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR [Homo sapiens]</Hit_def>
  <Hit_accession>1C5M_D</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>6.47143e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>322</Hit_num>
  <Hit_id>pdb|1FAX|A</Hit_id>
  <Hit_def>COAGULATION FACTOR XA INHIBITOR COMPLEX [Homo sapiens]</Hit_def>
  <Hit_accession>1FAX_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>63.1586</Hsp_bit-score>
      <Hsp_score>152</Hsp_score>
      <Hsp_evalue>6.54734e-13</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>323</Hit_num>
  <Hit_id>pdb|3ELA|H</Hit_id>
  <Hit_def>Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor [Homo sapiens]</Hit_def>
  <Hit_accession>3ELA_H</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>8.03642e-13</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-----KKYWGTKIKDAMICAGASGVS--SCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSE</Hsp_hseq>
      <Hsp_midline>LQ  ++P L   +C     K      I + M CAG S  S  SC GDSGGP      G W L GIVSWG    +    GVY RV+  + W+Q+ + + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>324</Hit_num>
  <Hit_id>pdb|2BDY|A</Hit_id>
  <Hit_def>thrombin in complex with inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>2BDY_A</Hit_accession>
  <Hit_len>289</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>8.80585e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>187</Hsp_hit-from>
      <Hsp_hit-to>284</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>325</Hit_num>
  <Hit_id>pdb|1NU9|A</Hit_id>
  <Hit_def>Staphylocoagulase-Prethrombin-2 complex [Homo sapiens] &gt;pdb|1NU9|D Staphylocoagulase-Prethrombin-2 complex [Homo sapiens]</Hit_def>
  <Hit_accession>1NU9_A</Hit_accession>
  <Hit_len>291</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>8.8186e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>189</Hsp_hit-from>
      <Hsp_hit-to>286</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>326</Hit_num>
  <Hit_id>pdb|4RKJ|B</Hit_id>
  <Hit_def>Crystal structure of thrombin mutant S195T (free form) [Homo sapiens] &gt;pdb|4RKO|B Crystal structure of thrombin mutant S195T bound with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>4RKJ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>9.00914e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDTGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>327</Hit_num>
  <Hit_id>pdb|4H6S|B</Hit_id>
  <Hit_def>Crystal structure of thrombin mutant E14eA/D14lA/E18A/S195A [Homo sapiens]</Hit_def>
  <Hit_accession>4H6S_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>9.28959e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>328</Hit_num>
  <Hit_id>pdb|1JOU|B</Hit_id>
  <Hit_def>Crystal Structure of Native S195A Thrombin with an Unoccupied Active Site [Homo sapiens] &gt;pdb|1JOU|D Crystal Structure of Native S195A Thrombin with an Unoccupied Active Site [Homo sapiens] &gt;pdb|1JOU|F Crystal Structure of Native S195A Thrombin with an Unoccupied Active Site [Homo sapiens] &gt;pdb|1TB6|H 2.5A Crystal Structure of the Antithrombin-Thrombin-Heparin Ternary Complex [Homo sapiens] &gt;pdb|2B5T|B 2.1 Angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic SR123781 and two S195A thrombin molecules [Homo sapiens] &gt;pdb|2B5T|D 2.1 Angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic SR123781 and two S195A thrombin molecules [Homo sapiens] &gt;pdb|3B9F|H 1.6 A structure of the PCI-thrombin-heparin complex [Homo sapiens] &gt;pdb|3GIS|B Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin [Homo sapiens] &gt;pdb|3GIS|D Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin [Homo sapiens] &gt;pdb|3GIS|F Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin [Homo sapiens] &gt;pdb|3LU9|B Crystal structure of human thrombin mutant S195A in complex with the extracellular fragment of human PAR1 [Homo sapiens] &gt;pdb|3LU9|E Crystal structure of human thrombin mutant S195A in complex with the extracellular fragment of human PAR1 [Homo sapiens] &gt;pdb|4DT7|B Crystal structure of thrombin bound to the activation domain QEDQVDPRLIDGKMTRRGDS of protein C [Homo sapiens] &gt;pdb|4DT7|D Crystal structure of thrombin bound to the activation domain QEDQVDPRLIDGKMTRRGDS of protein C [Homo sapiens] &gt;pdb|4DY7|B Crystal structures of protease nexin-1 in complex with S195A thrombin [Homo sapiens] &gt;pdb|4DY7|E Crystal structures of protease nexin-1 in complex with S195A thrombin [Homo sapiens] &gt;pdb|4HFP|B Structure of thrombin mutant S195a bound to the active site inhibitor argatroban [Homo sapiens] &gt;pdb|4HFP|D Structure of thrombin mutant S195a bound to the active site inhibitor argatroban [Homo sapiens] &gt;pdb|6PX5|B CRYSTAL STRUCTURE OF HUMAN MEIZOTHROMBIN DESF1 MUTANT S195A bound with PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>1JOU_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>9.38499e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>329</Hit_num>
  <Hit_id>pdb|1EQ9|A</Hit_id>
  <Hit_def>Crystal Structure Of Fire Ant Chymotrypsin Complexed To Pmsf [Solenopsis invicta] &gt;pdb|1EQ9|B Crystal Structure Of Fire Ant Chymotrypsin Complexed To Pmsf [Solenopsis invicta]</Hit_def>
  <Hit_accession>1EQ9_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>9.60164e-13</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>133</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKK-YWGTKIKDAMICA-GASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>NTPNALQEIELIVHPQKQCERDQW--RVIDSHICTLTKRGEGACHGDSGGPLVA--NGAQ--IGIVSFGSP-CALGEPDVYTRVSSFVSWINANL</Hsp_hseq>
      <Hsp_midline>NTP+ LQ+  L +     C++  W  ++ D+ IC     G  +C GDSGGPLV   NGA   +GIVS+GS  C+   P VY RV++ V+W+   L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>330</Hit_num>
  <Hit_id>pdb|1DM4|B</Hit_id>
  <Hit_def>SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16) [Homo sapiens] &gt;pdb|1JMO|H Crystal Structure of the Heparin Cofactor II-S195A Thrombin Complex [Homo sapiens]</Hit_def>
  <Hit_accession>1DM4_B</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>9.65766e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>158</Hsp_hit-from>
      <Hsp_hit-to>255</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>331</Hit_num>
  <Hit_id>pdb|1VR1|H</Hit_id>
  <Hit_def>Specifity for Plasminogen Activator Inhibitor-1 [Homo sapiens]</Hit_def>
  <Hit_accession>1VR1_H</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>9.73633e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>161</Hsp_hit-from>
      <Hsp_hit-to>258</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICA------GASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAYYKPDEGKRG-DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CA      G  G  +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>332</Hit_num>
  <Hit_id>pdb|1DOJ|A</Hit_id>
  <Hit_def>Crystal structure of human alpha-thrombin*RWJ-51438 complex at 1.7 A [Homo sapiens] &gt;pdb|1HAG|E THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN [Homo sapiens] &gt;pdb|1XM1|A Nonbasic Thrombin Inhibitor Complex [Homo sapiens]</Hit_def>
  <Hit_accession>1DOJ_A</Hit_accession>
  <Hit_len>295</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>9.77202e-13</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>193</Hsp_hit-from>
      <Hsp_hit-to>290</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>333</Hit_num>
  <Hit_id>pdb|1EOJ|A</Hit_id>
  <Hit_def>Design of P1&apos; and P3&apos; residues of trivalent thrombin inhibitors and their crystal structures [Homo sapiens] &gt;pdb|1EOL|A Design of P1&apos; and P3&apos; residues of trivalent thrombin inhibitors and their crystal structures [Homo sapiens]</Hit_def>
  <Hit_accession>1EOJ_A</Hit_accession>
  <Hit_len>289</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.7734</Hsp_bit-score>
      <Hsp_score>151</Hsp_score>
      <Hsp_evalue>1.00397e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>189</Hsp_hit-from>
      <Hsp_hit-to>286</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>334</Hit_num>
  <Hit_id>pdb|5VOE|H</Hit_id>
  <Hit_def>DesGla-XaS195A Bound to Aptamer 11F7t [Homo sapiens] &gt;pdb|5VOF|H DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban [Homo sapiens]</Hit_def>
  <Hit_accession>5VOE_H</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.26777e-12</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GD+GGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>335</Hit_num>
  <Hit_id>pdb|5LPE|A</Hit_id>
  <Hit_def>Kallikrein-related peptidase 10 complex with Zn2+ [Homo sapiens] &gt;pdb|5LPE|B Kallikrein-related peptidase 10 complex with Zn2+ [Homo sapiens] &gt;pdb|5LPF|A Kallikrein-related peptidase 10 [Homo sapiens] &gt;pdb|5LPF|B Kallikrein-related peptidase 10 [Homo sapiens]</Hit_def>
  <Hit_accession>5LPE_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.29442e-12</Hsp_evalue>
      <Hsp_query-from>9</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>149</Hsp_hit-from>
      <Hsp_hit-to>234</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>ASLPLLSNTNCKKYWGTKIKDAMICAGAS-GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>SSITILSPKECEVFYPGVVTNNMICAGLDRGQDPCQSDSGGPLVCDE----TLQGILSWGVYPCGSAQHPAVYTQICKYMSWINKVIRSN</Hsp_hseq>
      <Hsp_midline>+S+ +LS   C+ ++   + + MICAG   G   C  DSGGPLVC +    TL GI+SWG   C S   P VY ++   ++W+ + + +N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>336</Hit_num>
  <Hit_id>pdb|2OCV|B</Hit_id>
  <Hit_def>Structural basis of Na+ activation mimicry in murine thrombin [Mus musculus]</Hit_def>
  <Hit_accession>2OCV_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.3882</Hsp_bit-score>
      <Hsp_score>150</Hsp_score>
      <Hsp_evalue>1.34178e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKAWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>337</Hit_num>
  <Hit_id>pdb|4IS5|A</Hit_id>
  <Hit_def>Crystal Structure of the ligand-free inactive Matriptase [Homo sapiens] &gt;pdb|4ISL|A Crystal Structure of the inactive Matriptase in complex with its inhibitor HAI-1 [Homo sapiens]</Hit_def>
  <Hit_accession>4IS5_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.47747e-12</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>149</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLV-CKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQKGEIRVIQQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDAGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE</Hsp_hseq>
      <Hsp_midline>LQ+  + ++  T C+     +I   M+C G  + GV SC GD+GGPL   + +G     G+VSWG      + PGVY R+    +W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>338</Hit_num>
  <Hit_id>pdb|2GD4|B</Hit_id>
  <Hit_def>Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex [Homo sapiens] &gt;pdb|2GD4|H Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex [Homo sapiens]</Hit_def>
  <Hit_accession>2GD4_B</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.49275e-12</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>232</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>RLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM</Hsp_hseq>
      <Hsp_midline>RL+   +P +   +CK      I   M CAG       +C GD+GGP V +    + + GIVSWG         G+Y +VTA + W+ +++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>339</Hit_num>
  <Hit_id>pdb|5PAB|H</Hit_id>
  <Hit_def>Crystal Structure of Factor VIIa in complex with 1-[[3-[2-hydroxy-3-(1H-pyrrolo[3,2-c]pyridin-2-yl)phenyl]phenyl]methyl]-3-phenylurea [Homo sapiens] &gt;pdb|5PB1|D Crystal Structure of Factor VIIa in complex with benzenecarboximidamide [Homo sapiens]</Hit_def>
  <Hit_accession>5PAB_H</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.51599e-12</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>171</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>39</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>72</Hsp_align-len>
      <Hsp_qseq>IKDAMICAGASGVS--SCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>ITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSE</Hsp_hseq>
      <Hsp_midline>I + M CAG S  S  SC GDSGGP      G W L GIVSWG    +    GVY RV+  + W+Q+ + + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>340</Hit_num>
  <Hit_id>pdb|1CVW|H</Hit_id>
  <Hit_def>Crystal structure of active site-inhibited human coagulation factor VIIA (DES-GLA) [Homo sapiens] &gt;pdb|1DAN|H Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor [Homo sapiens] &gt;pdb|1DVA|H Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA [Homo sapiens] &gt;pdb|1DVA|I Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA [Homo sapiens] &gt;pdb|1FAK|H Human Tissue Factor Complexed With Coagulation Factor Viia Inhibited With A Bpti-Mutant [Homo sapiens] &gt;pdb|1J9C|H Crystal Structure of tissue factor-factor VIIa complex [Homo sapiens] &gt;pdb|1JBU|H Coagulation Factor VII Zymogen (EGF2/Protease) in Complex with Inhibitory Exosite Peptide A-183 [Homo sapiens] &gt;pdb|1KLI|H Cofactor-and substrate-assisted activation of factor VIIa [Homo sapiens] &gt;pdb|1KLJ|H Crystal structure of uninhibited factor VIIa [Homo sapiens] &gt;pdb|1O5D|H Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) [Homo sapiens] &gt;pdb|1QFK|H Structure Of Human Factor Viia And Its Implications For The Triggering Of Blood Coagulation [Homo sapiens] &gt;pdb|1W0Y|H tf7a_3771 complex [Homo sapiens] &gt;pdb|1W2K|H tf7a_4380 complex [Homo sapiens] &gt;pdb|1W7X|H Factor7 - 413 complex [Homo sapiens] &gt;pdb|1W8B|H Factor7 - 413 complex [Homo sapiens] &gt;pdb|1WQV|H Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine [Homo sapiens] &gt;pdb|1WSS|H Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged groups in P2 and P4 [Homo sapiens] &gt;pdb|1WTG|H Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine [Homo sapiens] &gt;pdb|1WUN|H Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine [Homo sapiens] &gt;pdb|1WV7|H Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine [Homo sapiens] &gt;pdb|1YGC|H Short Factor VIIa with a small molecule inhibitor [Homo sapiens] &gt;pdb|1Z6J|H Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor [Homo sapiens] &gt;pdb|2A2Q|H Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+ [Homo sapiens] &gt;pdb|2AEI|H Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid [Homo sapiens] &gt;pdb|2AER|H Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. [Homo sapiens] &gt;pdb|2B7D|H Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy in a Baboon Thrombosis Model [Homo sapiens] &gt;pdb|2B8O|H Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex [Homo sapiens] &gt;pdb|2BZ6|H Orally available Factor7a inhibitor [Homo sapiens] &gt;pdb|2C4F|H crystal structure of factor VII.stf complexed with pd0297121 [Homo sapiens] &gt;pdb|2EC9|H Crystal structure analysis of human Factor VIIa, Souluble tissue factor complexed with BCX-3607 [Homo sapiens] &gt;pdb|2F9B|H Discovery of Novel Heterocyclic Factor VIIa Inhibitors [Homo sapiens] &gt;pdb|2FIR|H Crystal structure of DFPR-VIIa/sTF [Homo sapiens] &gt;pdb|2FLB|H Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor [Homo sapiens] &gt;pdb|2FLR|H Novel 5-Azaindole Factor VIIa Inhibitors [Homo sapiens] &gt;pdb|2PUQ|H Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor [Homo sapiens] &gt;pdb|2ZP0|H Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine [Homo sapiens] &gt;pdb|2ZWL|H Human factor viia-tissue factor complexed with highly selective peptide inhibitor [Homo sapiens] &gt;pdb|2ZZU|H Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine [Homo sapiens] &gt;pdb|3TH2|H Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ [Homo sapiens] &gt;pdb|3TH3|H Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ [Homo sapiens] &gt;pdb|3TH4|H Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ [Homo sapiens] &gt;pdb|4IBL|H Chain H, Coagulation factor VII [Homo sapiens] &gt;pdb|4ISH|H Structure of FACTOR VIIA in complex with the inhibitor BMS-593214 also known as 2&apos;-[(6R,6AR,11BR)-2-CARBAMIMIDOYL-6,6A,7,11B-TETRAHYDRO-5H-INDENO[2,1-C]QUINOLIN-6-YL]-5&apos;-HYDROXY-4&apos;-METHOXYBIPHENYL-4-CARBOXYLIC ACID [Homo sapiens] &gt;pdb|4ISI|H Structure of FACTOR VIIA in complex with the inhibitor (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(CYCLOBUTYLAMINO)-8,8-DIETHYL-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE [Homo sapiens] &gt;pdb|4JYU|H Structure of factor VIIA in complex with the inhibitor (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(PHENYLSULFONYL)ETHANAMIDE [Homo sapiens] &gt;pdb|4JYV|H Structure of factor VIIA in complex with the inhibitor (2R)-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2-(ISOQUINOLIN-6-YLAMINO)-N-[(3-SULFAMOYLPHENYL)SULFONYL]ETHANAMIDE [Homo sapiens] &gt;pdb|4JZD|H Structure of factor VIIA in complex with the inhibitor 2-{2-[(4-carbamimidoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid [Homo sapiens] &gt;pdb|4JZE|H Structure of factor VIIA in complex with the inhibitor 2-{2-[(1-aminoisoquinolin-6-yl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid [Homo sapiens] &gt;pdb|4JZF|H Structure of factor VIIA in complex with the inhibitor 2-{2-[(3-carbamoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid [Homo sapiens] &gt;pdb|4NA9|H Factor VIIa in complex with the inhibitor 3&apos;-amino-5&apos;-[(2s,4r)-6-carbamimidoyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]biphenyl-2-carboxylic acid [Homo sapiens] &gt;pdb|4NG9|H Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-(3-sulfamoylbenzyl)ethanamide [Homo sapiens] &gt;pdb|4NGA|H Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-N-[2-(propan-2-ylsulfonyl)benzyl]ethanamide [Homo sapiens] &gt;pdb|4X8S|H Factor Viia In Complex With The Inhibitor 4-bromo-2-methoxyphenol [Homo sapiens] &gt;pdb|4X8T|H FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 7-chloro-3,4-dihydroisoquinolin-1(2H)-one [Homo sapiens] &gt;pdb|4X8U|H Factor Viia In Complex With The Inhibitor 5-chloro-1h-indole-2- Carboxylic Acid [Homo sapiens] &gt;pdb|4X8V|H FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (methyl {3-[(2R)-1-{(2R)-2-(3,4-dimethoxyphenyl)-2-[(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]acetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}carbamate) [Homo sapiens] &gt;pdb|4YT6|H Factor VIIa in complex with the inhibitor 4-{[(R)-[5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl](4-phenyl-1H-imidazol-2-yl)methyl]amino}benzenecarboximidamide [Homo sapiens] &gt;pdb|4YT7|H Factor VIIa in complex with the inhibitor 2-(2-{(R)-[(4-carbamimidoylphenyl)amino][5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl]methyl}-1H-imidazol-4-yl)benzamide [Homo sapiens] &gt;pdb|4ZXX|H FACTOR VIIA IN COMPLEX WITH THE INHIBITOR N-{3-[(2R)-1-{(2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-phenylacetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}acetamide [Homo sapiens] &gt;pdb|4ZXY|H FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5I46|H Factor VIIA in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-8-fluoro-7-hydroxy-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5L2Y|H Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,20-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6,8,10(21),16,19-hexaen-7-yl] cyclobutane-1-carboxylic acid [Homo sapiens] &gt;pdb|5L2Z|H Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-7-yl]cyclohexane-1-carboxylic acid [Homo sapiens] &gt;pdb|5L30|H Factor VIIa in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-[1-(1H-tetrazol-5-yl)cyclopropyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5PA8|C Crystal Structure of Factor VIIa in complex with cyclohexanamine [Homo sapiens] &gt;pdb|5PA9|C Crystal Structure of Factor VIIa in complex with phenylmethanamine;hydrochloride [Homo sapiens] &gt;pdb|5PAA|C Crystal Structure of Factor VIIa in complex with cyclohexylmethanamine [Homo sapiens] &gt;pdb|5PAC|B human factor VIIa in complex with 5-hydroxy-N-(4-oxo-3H-quinazolin-6-yl)-1-[3-[(phenylcarbamoylamino)methyl]phenyl]pyrazole-4-carboxamide at 1.50A [Homo sapiens] &gt;pdb|5PAE|B Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]propanamide [Homo sapiens] &gt;pdb|5PAF|B Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-[3-[(2-amino-2-oxoethyl)-methylsulfonylamino]-5-chlorophenyl]acetamide;2,2,2-trifluoroacetic acid [Homo sapiens] &gt;pdb|5PAG|B Crystal Structure of Factor VIIa in complex with (2R)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-methylbutanamide;hydrobromide [Homo sapiens] &gt;pdb|5PAI|B human factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-1-[3-[[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]methyl]phenyl]-5-hydroxypyrazole-4-carboxamide at 1.73A [Homo sapiens] &gt;pdb|5PAJ|B Crystal Structure of Factor VIIa in complex with 1-(1-aminoisoquinolin-6-yl)-3-benzylurea [Homo sapiens] &gt;pdb|5PAK|C Crystal Structure of Factor VIIa in complex with N-[[4-(aminomethyl)-2-(2-amino-2-oxoethoxy)phenyl]methyl]-2-(4-hydroxyphenyl)-2-methoxyacetamide;hydrochloride [Homo sapiens] &gt;pdb|5PAM|B Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(5-ethoxy-2-fluorophenyl)-1-(2-phenylpyrrolidin-1-yl)ethanone [Homo sapiens] &gt;pdb|5PAN|B Crystal Structure of Factor VIIa in complex with 5-hydroxy-N-(3-oxo-1,2-dihydroisoindol-5-yl)-1-[3-[(phenylcarbamoylamino)methyl]phenyl]pyrazole-4-carboxamide [Homo sapiens] &gt;pdb|5PAO|C Crystal Structure of Factor VIIa in complex with (2S)-2,3-dihydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]propanamide;hydrobromide [Homo sapiens] &gt;pdb|5PAQ|B Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(3-ethoxy-4-propan-2-yloxyphenyl)-1-(2-phenylpyrrolidin-1-yl)ethanone [Homo sapiens] &gt;pdb|5PAR|C Crystal Structure of Factor VIIa in complex with 1H-benzimidazol-2-amine [Homo sapiens] &gt;pdb|5PAS|C Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylpropanamide [Homo sapiens] &gt;pdb|5PAT|B Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-(3-chlorophenyl)acetamide [Homo sapiens] &gt;pdb|5PAU|C Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-[3-[(2-amino-2-oxoethyl)-methylsulfonylamino]phenyl]acetamide;2,2,2-trifluoroacetic acid [Homo sapiens] &gt;pdb|5PAV|C Crystal Structure of Factor VIIa in complex with N-(6-aminopyridin-3-yl)-5-hydroxy-1-phenylpyrazole-4-carboxamide [Homo sapiens] &gt;pdb|5PAW|B Crystal Structure of Factor VIIa in complex with isoquinoline-1,6-diamine [Homo sapiens] &gt;pdb|5PAX|C Crystal Structure of Factor VIIa in complex with 1-(2,6-difluorophenyl)-3-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]urea [Homo sapiens] &gt;pdb|5PAY|C Crystal Structure of Factor VIIa in complex with 1-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea [Homo sapiens] &gt;pdb|5PB0|B Crystal Structure of Factor VIIa in complex with 2-(4-ethoxy-3-methoxyphenyl)-2-(isoquinolin-6-ylamino)acetic acid [Homo sapiens] &gt;pdb|5PB2|C Crystal Structure of Factor VIIa in complex with 2-phenyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-3-ol [Homo sapiens] &gt;pdb|5PB3|C Crystal Structure of Factor VIIa in complex with 1-[[3-[4-(5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-5-hydroxypyrazol-1-yl]phenyl]methyl]-3-phenylurea [Homo sapiens] &gt;pdb|5PB4|C human factor VIIa in complex with 1-[[3-[5-hydroxy-3-methyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 2.43A [Homo sapiens] &gt;pdb|5PB5|B human factor VIIa in complex with 1-[[3-[5-hydroxy-4-(7H-pyrrolo[2,3-d]pyrimidin-6-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 1.84A [Homo sapiens] &gt;pdb|5PB6|C Crystal Structure of Factor VIIa in complex with N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]pentanamide [Homo sapiens] &gt;pdb|5TQE|H Factor VIIa in complex with the inhibitor (5R)-5-[(1-aminoisoquinolin-6-yl)amino]-19-(cyclopropylsulfonyl)-3-methyl-13-oxa-3,15-diazatricyclo[14.3.1.1~6,10~]henicosa-1(20),6(21),7,9,16,18-hexaene-4,14-dione [Homo sapiens] &gt;pdb|5TQF|H Factor VIIa in complex with the inhibitor (11R)-11-[(1-aminoisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-13-methyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5TQG|H Factor VIIa in complex with the inhibitor (5R,11R)-11-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-7-(2,2-difluoroethoxy)-5,13-dimethyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione [Homo sapiens] &gt;pdb|5U6J|H Factor VIIa in complex with the inhibitor 3-{[(2R)-17-ethyl-4-methyl-3,12-dioxo-7-[(propan-2-yl)sulfonyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-2-yl]amino}benzamide [Homo sapiens]</Hit_def>
  <Hit_accession>1CVW_H</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.5793e-12</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>171</Hsp_hit-from>
      <Hsp_hit-to>242</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>39</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>72</Hsp_align-len>
      <Hsp_qseq>IKDAMICAGASGVS--SCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>ITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSE</Hsp_hseq>
      <Hsp_midline>I + M CAG S  S  SC GDSGGP      G W L GIVSWG    +    GVY RV+  + W+Q+ + + </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>341</Hit_num>
  <Hit_id>pdb|2PUX|B</Hit_id>
  <Hit_def>Crystal structure of murine thrombin in complex with the extracellular fragment of murine PAR3 [Mus musculus] &gt;pdb|2PV9|B Crystal structure of murine thrombin in complex with the extracellular fragment of murine PAR4 [Mus musculus]</Hit_def>
  <Hit_accession>2PUX_B</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.68324e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKASTRIRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKRWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>342</Hit_num>
  <Hit_id>pdb|5LYO|A</Hit_id>
  <Hit_def>Crystal structure of the zymogen matriptase catalytic domain [Homo sapiens] &gt;pdb|5LYO|B Crystal structure of the zymogen matriptase catalytic domain [Homo sapiens] &gt;pdb|5LYO|C Crystal structure of the zymogen matriptase catalytic domain [Homo sapiens]</Hit_def>
  <Hit_accession>5LYO_A</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.86996e-12</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>173</Hsp_hit-from>
      <Hsp_hit-to>261</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLV-CKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQKGEIRVIQQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDAGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE</Hsp_hseq>
      <Hsp_midline>LQ+  + ++  T C+     +I   M+C G  + GV SC GD+GGPL   + +G     G+VSWG      + PGVY R+    +W+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>343</Hit_num>
  <Hit_id>pdb|3SQE|E</Hit_id>
  <Hit_def>Crystal structure of prethrombin-2 mutant S195A in the alternative form [Homo sapiens] &gt;pdb|3SQH|E Crystal structure of prethrombin-2 mutant S195A in the the open form [Homo sapiens] &gt;pdb|4RN6|A Structure of prethrombin-2 mutant s195a bound to the active site inhibitor argatroban [Homo sapiens] &gt;pdb|4RN6|B Structure of prethrombin-2 mutant s195a bound to the active site inhibitor argatroban [Homo sapiens]</Hit_def>
  <Hit_accession>3SQE_E</Hit_accession>
  <Hit_len>290</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>1.98299e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>188</Hsp_hit-from>
      <Hsp_hit-to>285</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>344</Hit_num>
  <Hit_id>pdb|2FMJ|A</Hit_id>
  <Hit_def>220-loop mutant of streptomyces griseus trypsin [Streptomyces griseus]</Hit_def>
  <Hit_accession>2FMJ_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>61.2326</Hsp_bit-score>
      <Hsp_score>147</Hsp_score>
      <Hsp_evalue>2.29579e-12</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>128</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTK-IKDAMICAG--ASGVSSCMGDSGGPLVCKKNG-AWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LLKANVPFVSDAACRSAYGNELVANEEICAGYDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTFASAI</Hsp_hseq>
      <Hsp_midline>L +A++P +S+  C+  +G + + +  ICAG    GV +C GDSGGP+  K N   W  VGIVSWG         GVY  V+   + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>345</Hit_num>
  <Hit_id>pdb|1Z8I|B</Hit_id>
  <Hit_def>Crystal structure of the thrombin mutant G193A bound to PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>1Z8I_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>61.6178</Hsp_bit-score>
      <Hsp_score>148</Hsp_score>
      <Hsp_evalue>2.30426e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C  DSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>346</Hit_num>
  <Hit_id>pdb|3K65|B</Hit_id>
  <Hit_def>Crystal Structure of Prethombin-2/Fragment-2 Complex [Homo sapiens]</Hit_def>
  <Hit_accession>3K65_B</Hit_accession>
  <Hit_len>308</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>2.43658e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>206</Hsp_hit-from>
      <Hsp_hit-to>303</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>347</Hit_num>
  <Hit_id>pdb|3NXP|A</Hit_id>
  <Hit_def>Crystal structure of human prethrombin-1 [Homo sapiens]</Hit_def>
  <Hit_accession>3NXP_A</Hit_accession>
  <Hit_len>424</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>62.003</Hsp_bit-score>
      <Hsp_score>149</Hsp_score>
      <Hsp_evalue>2.55498e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>322</Hsp_hit-from>
      <Hsp_hit-to>419</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>348</Hit_num>
  <Hit_id>pdb|4H6T|A</Hit_id>
  <Hit_def>Crystal structure of prethrombin-2 mutant E14eA/D14lA/E18A/S195A [Homo sapiens]</Hit_def>
  <Hit_accession>4H6T_A</Hit_accession>
  <Hit_len>306</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>61.6178</Hsp_bit-score>
      <Hsp_score>148</Hsp_score>
      <Hsp_evalue>2.75155e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>204</Hsp_hit-from>
      <Hsp_hit-to>301</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>349</Hit_num>
  <Hit_id>pdb|2PGB|B</Hit_id>
  <Hit_def>Inhibitor-free human thrombin mutant C191A-C220A [Homo sapiens] &gt;pdb|2PGQ|B Human thrombin mutant C191A-C220A in complex with the inhibitor PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>2PGB_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>61.2326</Hsp_bit-score>
      <Hsp_score>147</Hsp_score>
      <Hsp_evalue>2.76837e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +  GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>350</Hit_num>
  <Hit_id>pdb|5O32|I</Hit_id>
  <Hit_def>The structure of complement complex [Homo sapiens] &gt;pdb|5O32|J The structure of complement complex [Homo sapiens]</Hit_def>
  <Hit_accession>5O32_I</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.8474</Hsp_bit-score>
      <Hsp_score>146</Hsp_score>
      <Hsp_evalue>3.6383e-12</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKD-AMICAGASG--VSSCMGDSGGPLVCKKNGAWTLV-GIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQWGEVKLISN--CSKFYGNRFYEKEMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWI</Hsp_hseq>
      <Hsp_midline>LQ   + L+SN  C K++G +  +  M CAG     + +C GDSGGPLVC      T V G+VSWG +      PGVY +V    +W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>351</Hit_num>
  <Hit_id>pdb|5FCR|A</Hit_id>
  <Hit_def>Mouse Complement Factor D [Mus musculus] &gt;pdb|5FCR|B Mouse Complement Factor D [Mus musculus] &gt;pdb|5FCR|C Mouse Complement Factor D [Mus musculus] &gt;pdb|5FCR|D Mouse Complement Factor D [Mus musculus]</Hit_def>
  <Hit_accession>5FCR_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.8474</Hsp_bit-score>
      <Hsp_score>146</Hsp_score>
      <Hsp_evalue>3.66835e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC--KKYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVLHQLRVSIMNRTTCNLRTYHDGVVTINMMCAESNRRDTCRGDSGSPLVCGD----AVEGVVTWGSRVCGNGKKPGVYTRVSSYRMWIENITNGN</Hsp_hseq>
      <Hsp_midline>PD L Q  + +++ T C  + Y    +   M+CA ++   +C GDSG PLVC       + G+V+WGS  C     PGVY RV++   W++     N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>352</Hit_num>
  <Hit_id>pdb|1Z8J|B</Hit_id>
  <Hit_def>Crystal structure of the thrombin mutant G193P bound to PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>1Z8J_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.8474</Hsp_bit-score>
      <Hsp_score>146</Hsp_score>
      <Hsp_evalue>4.03582e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C  DSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>353</Hit_num>
  <Hit_id>pdb|2XRC|A</Hit_id>
  <Hit_def>Human complement factor I [Homo sapiens] &gt;pdb|2XRC|B Human complement factor I [Homo sapiens] &gt;pdb|2XRC|C Human complement factor I [Homo sapiens] &gt;pdb|2XRC|D Human complement factor I [Homo sapiens]</Hit_def>
  <Hit_accession>2XRC_A</Hit_accession>
  <Hit_len>565</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>61.6178</Hsp_bit-score>
      <Hsp_score>148</Hsp_score>
      <Hsp_evalue>4.09635e-12</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>466</Hsp_hit-from>
      <Hsp_hit-to>551</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKD-AMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLV-GIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQWGEVKLISN--CSKFYGNRFYEKEMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWI</Hsp_hseq>
      <Hsp_midline>LQ   + L+SN  C K++G +  +  M CAG     + +C GDSGGPLVC      T V G+VSWG +      PGVY +V    +W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>354</Hit_num>
  <Hit_id>pdb|6LZ9|B</Hit_id>
  <Hit_def>t8E4 antibody Fab complexed with the active form of HGF [Homo sapiens]</Hit_def>
  <Hit_accession>6LZ9_B</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.4622</Hsp_bit-score>
      <Hsp_score>145</Hsp_score>
      <Hsp_evalue>5.8462e-12</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKI--KDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LRVAHLYIMGNEKCSQHHRGKVTLQESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKII</Hsp_hseq>
      <Hsp_midline>L+ A L ++ N  C ++   K+  +++ ICAGA  + S  C GD GGPLVC+++    ++G++  G      + PG++ RV     W+ + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>355</Hit_num>
  <Hit_id>pdb|5EDM|A</Hit_id>
  <Hit_def>Crystal structure of prothrombin deletion mutant residues 154-167 (Form I) [Homo sapiens]</Hit_def>
  <Hit_accession>5EDM_A</Hit_accession>
  <Hit_len>568</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.8474</Hsp_bit-score>
      <Hsp_score>146</Hsp_score>
      <Hsp_evalue>6.4153e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>463</Hsp_hit-from>
      <Hsp_hit-to>560</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>356</Hit_num>
  <Hit_id>pdb|5EDK|A</Hit_id>
  <Hit_def>Crystal structure of prothrombin deletion mutant residues 146-167 (Form II). [Homo sapiens]</Hit_def>
  <Hit_accession>5EDK_A</Hit_accession>
  <Hit_len>560</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.8474</Hsp_bit-score>
      <Hsp_score>146</Hsp_score>
      <Hsp_evalue>6.47048e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>455</Hsp_hit-from>
      <Hsp_hit-to>552</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>357</Hit_num>
  <Hit_id>pdb|6PXQ|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin mutant D194A [Homo sapiens]</Hit_def>
  <Hit_accession>6PXQ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.077</Hsp_bit-score>
      <Hsp_score>144</Hsp_score>
      <Hsp_evalue>7.43177e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGASGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C G SGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>358</Hit_num>
  <Hit_id>pdb|4NZQ|A</Hit_id>
  <Hit_def>Crystal structure of Ca2+-free prothrombin deletion mutant residues 146-167 [Homo sapiens] &gt;pdb|4O03|A Crystal structure of Ca2+ bound prothrombin deletion mutant residues 146-167 [Homo sapiens]</Hit_def>
  <Hit_accession>4NZQ_A</Hit_accession>
  <Hit_len>557</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.8474</Hsp_bit-score>
      <Hsp_score>146</Hsp_score>
      <Hsp_evalue>7.63257e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>455</Hsp_hit-from>
      <Hsp_hit-to>552</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>359</Hit_num>
  <Hit_id>pdb|6BJR|A</Hit_id>
  <Hit_def>Crystal structure of prothrombin mutant S101C/A470C [Homo sapiens] &gt;pdb|6C2W|A Crystal structure of human prothrombin mutant S101C/A470C [Homo sapiens] &gt;pdb|6C2W|B Crystal structure of human prothrombin mutant S101C/A470C [Homo sapiens]</Hit_def>
  <Hit_accession>6BJR_A</Hit_accession>
  <Hit_len>582</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.8474</Hsp_bit-score>
      <Hsp_score>146</Hsp_score>
      <Hsp_evalue>7.81091e-12</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>477</Hsp_hit-from>
      <Hsp_hit-to>574</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>360</Hit_num>
  <Hit_id>pdb|3I77|A</Hit_id>
  <Hit_def>35/99/170-loops of FXa in SGT [Streptomyces griseus]</Hit_def>
  <Hit_accession>3I77_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>59.6918</Hsp_bit-score>
      <Hsp_score>143</Hsp_score>
      <Hsp_evalue>7.87408e-12</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWG-TKIKDAMICAG---ASGVSSCMGDSGGPLVCKKNG-AWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LLKANVPFVSDAACRSSSSFILVANEMICAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAI</Hsp_hseq>
      <Hsp_midline>L +A++P +S+  C+       + + MICAG     GV +C GDSGGP+  K N   W  VGIVSWG        PGVY  V+   + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>361</Hit_num>
  <Hit_id>pdb|1FI8|A</Hit_id>
  <Hit_def>Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd] [Rattus norvegicus] &gt;pdb|1FI8|B Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd] [Rattus norvegicus]</Hit_def>
  <Hit_accession>1FI8_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>59.6918</Hsp_bit-score>
      <Hsp_score>143</Hsp_score>
      <Hsp_evalue>9.88397e-12</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDA-MICAGASGV--SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>DTLQEVELTVQEDQKCESYLKNYFDKANEICAGDPKIKRASFRGDSGGPLVCKKVAA----GIVSYGQN--DGSTPRAFTKVSTFLSWIKKTM</Hsp_hseq>
      <Hsp_midline>D LQ+  L +  +  C+ Y       A  ICAG   +  +S  GDSGGPLVCKK  A    GIVS+G +    STP  + +V+  ++W+++T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>362</Hit_num>
  <Hit_id>pdb|1SHY|A</Hit_id>
  <Hit_def>The Crystal Structure of HGF beta-chain in Complex with the Sema Domain of the Met Receptor. [Homo sapiens]</Hit_def>
  <Hit_accession>1SHY_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>59.6918</Hsp_bit-score>
      <Hsp_score>143</Hsp_score>
      <Hsp_evalue>1.05866e-11</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKI--KDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKII</Hsp_hseq>
      <Hsp_midline>L+ A L ++ N  C ++   K+   ++ ICAGA  + S  C GD GGPLVC+++    ++G++  G      + PG++ RV     W+ + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>363</Hit_num>
  <Hit_id>pdb|1SI5|H</Hit_id>
  <Hit_def>Protease-like domain from 2-chain hepatocyte growth factor [Homo sapiens]</Hit_def>
  <Hit_accession>1SI5_H</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>59.6918</Hsp_bit-score>
      <Hsp_score>143</Hsp_score>
      <Hsp_evalue>1.1182e-11</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKI--KDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKII</Hsp_hseq>
      <Hsp_midline>L+ A L ++ N  C ++   K+   ++ ICAGA  + S  C GD GGPLVC+++    ++G++  G      + PG++ RV     W+ + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>364</Hit_num>
  <Hit_id>pdb|4O3T|A</Hit_id>
  <Hit_def>Zymogen HGF-beta/MET with Zymogen Activator Peptide ZAP.14 [Homo sapiens] &gt;pdb|4O3U|A Zymogen HGF-beta/MET with Zymogen Activator Peptide ZAP2.3 [Homo sapiens]</Hit_def>
  <Hit_accession>4O3T_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>59.3066</Hsp_bit-score>
      <Hsp_score>142</Hsp_score>
      <Hsp_evalue>1.21372e-11</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKI--KDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKII</Hsp_hseq>
      <Hsp_midline>L+ A L ++ N  C ++   K+   ++ ICAGA  + S  C GD GGPLVC+++    ++G++  G      + PG++ RV     W+ + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>365</Hit_num>
  <Hit_id>pdb|4HZH|A</Hit_id>
  <Hit_def>Structure of recombinant Gla-domainless prothrombin mutant S525A [Homo sapiens] &gt;pdb|4HZH|B Structure of recombinant Gla-domainless prothrombin mutant S525A [Homo sapiens]</Hit_def>
  <Hit_accession>4HZH_A</Hit_accession>
  <Hit_len>533</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>60.077</Hsp_bit-score>
      <Hsp_score>144</Hsp_score>
      <Hsp_evalue>1.47486e-11</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>431</Hsp_hit-from>
      <Hsp_hit-to>528</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GD+GGP V K   N  W  +GIVSWG         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>366</Hit_num>
  <Hit_id>pdb|1EUF|A</Hit_id>
  <Hit_def>BOVINE DUODENASE(NEW SERINE PROTEASE), CRYSTAL STRUCTURE [Bos taurus]</Hit_def>
  <Hit_accession>1EUF_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.9214</Hsp_bit-score>
      <Hsp_score>141</Hsp_score>
      <Hsp_evalue>1.63816e-11</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>DKLQEVDLEVQSEEKCIARFKNYIPFTQICAGDPSKRKNSFSGDSGGPLVC--NGVAQ--GIVSYGRN--DGTTPDVYTRISSFLSWIHSTM</Hsp_hseq>
      <Hsp_midline>D+LQ+  L + S   C   +   I    ICAG  +   +S  GDSGGPLVC  NG     GIVS+G +    +TP VY R+++ ++W+  T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>367</Hit_num>
  <Hit_id>pdb|1FIZ|A</Hit_id>
  <Hit_def>THREE DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM BOAR SPERMATOZOA [Sus scrofa]</Hit_def>
  <Hit_accession>1FIZ_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.9214</Hsp_bit-score>
      <Hsp_score>141</Hsp_score>
      <Hsp_evalue>2.17222e-11</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>251</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCKKNGA--WTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQEARVALIDLELCNSTRWYNGRIRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTSTWPYLNWIASKIGSN</Hsp_hseq>
      <Hsp_midline>LQ+A + L+    C   +++  +I+   +CAG     + +C GDSGGPL+C+      + +VGI SWG        PGVY      +NW+   + +N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>368</Hit_num>
  <Hit_id>pdb|1TQ0|B</Hit_id>
  <Hit_def>Crystal structure of the potent anticoagulant thrombin mutant W215A/E217A in free form [Homo sapiens] &gt;pdb|1TQ0|D Crystal structure of the potent anticoagulant thrombin mutant W215A/E217A in free form [Homo sapiens] &gt;pdb|1TQ7|B Crystal structure of the anticoagulant thrombin mutant W215A/E217A bound to PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>1TQ0_B</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.9214</Hsp_bit-score>
      <Hsp_score>141</Hsp_score>
      <Hsp_evalue>2.35662e-11</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVS G+        G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>369</Hit_num>
  <Hit_id>pdb|3EE0|B</Hit_id>
  <Hit_def>Crystal Structure of the W215A/E217A Mutant of Human Thrombin (space group P2(1)2(1)2(1)) [Homo sapiens] &gt;pdb|3HKJ|B Crystal structure of human thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 [Homo sapiens] &gt;pdb|3HKJ|E Crystal structure of human thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 [Homo sapiens]</Hit_def>
  <Hit_accession>3EE0_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.9214</Hsp_bit-score>
      <Hsp_score>141</Hsp_score>
      <Hsp_evalue>2.36498e-11</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVS G+        G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>370</Hit_num>
  <Hit_id>pdb|6P9U|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin mutant W215A [Homo sapiens] &gt;pdb|6P9U|D Crystal structure of human thrombin mutant W215A [Homo sapiens] &gt;pdb|6P9U|F Crystal structure of human thrombin mutant W215A [Homo sapiens] &gt;pdb|6P9U|H Crystal structure of human thrombin mutant W215A [Homo sapiens]</Hit_def>
  <Hit_accession>6P9U_B</Hit_accession>
  <Hit_len>273</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.9214</Hsp_bit-score>
      <Hsp_score>141</Hsp_score>
      <Hsp_evalue>2.45138e-11</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGEGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVS G         G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>371</Hit_num>
  <Hit_id>pdb|1BQY|A</Hit_id>
  <Hit_def>Plasminogen activator (TSV-PA) from snake venom [Trimeresurus stejnegeri] &gt;pdb|1BQY|B Plasminogen activator (TSV-PA) from snake venom [Trimeresurus stejnegeri]</Hit_def>
  <Hit_accession>1BQY_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.151</Hsp_bit-score>
      <Hsp_score>139</Hsp_score>
      <Hsp_evalue>3.59043e-11</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>134</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWG-TKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVPHCANINILDHAVCRTAYSWRQVANTTLCAGILQGGRDTCHFDSGGPLIC--NGIFQ--GIVSWGGHPCGQPGEPGVYTKVFDYLDWIKSIIAGN</Hsp_hseq>
      <Hsp_midline>PD    A++ +L +  C+  +   ++ +  +CAG    G  +C  DSGGPL+C  NG +   GIVSWG   C     PGVY +V   ++W++  +A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>372</Hit_num>
  <Hit_id>pdb|1KIG|H</Hit_id>
  <Hit_def>BOVINE FACTOR XA [Bos taurus]</Hit_def>
  <Hit_accession>1KIG_H</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.151</Hsp_bit-score>
      <Hsp_score>139</Hsp_score>
      <Hsp_evalue>3.73279e-11</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>143</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>93</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LKMLEVPYVDRSTCKLSSSFTITPNMFCAGYDTQPEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWIDKIMKAR</Hsp_hseq>
      <Hsp_midline>L+   +P +  + CK      I   M CAG       +C GDSGGP V +    + + GIVSWG         GVY +V+  + W+ + + A </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>373</Hit_num>
  <Hit_id>pdb|1FIW|A</Hit_id>
  <Hit_def>THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA [Ovis aries]</Hit_def>
  <Hit_accession>1FIW_A</Hit_accession>
  <Hit_len>290</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.151</Hsp_bit-score>
      <Hsp_score>139</Hsp_score>
      <Hsp_evalue>4.39743e-11</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>244</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>LQQASLPL--LSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNG--AWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQEARVDLIDLGLCNSTRWYNGRIRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTSTWSYLNWI</Hsp_hseq>
      <Hsp_midline>LQ+A + L  L   N  +++  +I+   +CAG     + +C GDSGGPL+CK +   ++ +VGI SWG        PGVY    + +NW+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>374</Hit_num>
  <Hit_id>pdb|3EDX|B</Hit_id>
  <Hit_def>Crystal structure of the W215A/E217A mutant of murine thrombin [Mus musculus] &gt;pdb|3EDX|D Crystal structure of the W215A/E217A mutant of murine thrombin [Mus musculus] &gt;pdb|3EDX|F Crystal structure of the W215A/E217A mutant of murine thrombin [Mus musculus] &gt;pdb|3HK3|B Crystal structure of murine thrombin mutant W215A/E217A (one molecule in the asymmetric unit) [Mus musculus] &gt;pdb|3HK6|B Crystal structure of murine thrombin mutant W215A/E217A (two molecules in the asymmetric unit) [Mus musculus] &gt;pdb|3HK6|D Crystal structure of murine thrombin mutant W215A/E217A (two molecules in the asymmetric unit) [Mus musculus] &gt;pdb|3HKI|B Crystal structure of murine thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 [Mus musculus] &gt;pdb|3HKI|E Crystal structure of murine thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 [Mus musculus]</Hit_def>
  <Hit_accession>3EDX_B</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>58.151</Hsp_bit-score>
      <Hsp_score>139</Hsp_score>
      <Hsp_evalue>4.49385e-11</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRKGKYGFYTHVFRLKRWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVS G+        G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>375</Hit_num>
  <Hit_id>pdb|1M9U|A</Hit_id>
  <Hit_def>Chain A, Earthworm Fibrinolytic Enzyme [Eisenia fetida] &gt;pdb|1M9U|B Chain B, Earthworm Fibrinolytic Enzyme [Eisenia fetida] &gt;pdb|1M9U|C Chain C, Earthworm Fibrinolytic Enzyme [Eisenia fetida]</Hit_def>
  <Hit_accession>1M9U_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.7658</Hsp_bit-score>
      <Hsp_score>138</Hsp_score>
      <Hsp_evalue>4.53198e-11</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYW----GTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSW----GSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>NLPDILQKSSIPVITTAQCTAAMVGVGGANIWDNHICVQDPAGNTGACNGDSGGPLNCPDGGT-RVVGVTSWVVSSGLGACLPDYPSVYTRVSAYLGWI</Hsp_hseq>
      <Hsp_midline>N PD LQ++S+P+++   C        G  I D  IC    A    +C GDSGGPL C   G   +VG+ SW    G   C    P VY RV+A + W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>376</Hit_num>
  <Hit_id>pdb|1AZZ|A</Hit_id>
  <Hit_def>Fiddler Crab Collagenase Complexed To Ecotin [Leptuca pugilator] &gt;pdb|1AZZ|B Fiddler Crab Collagenase Complexed To Ecotin [Leptuca pugilator]</Hit_def>
  <Hit_accession>1AZZ_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.7658</Hsp_bit-score>
      <Hsp_score>138</Hsp_score>
      <Hsp_evalue>4.58723e-11</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>219</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASG-VSSCMGDSGGPLVCKKNGAWTLVGIVSWGSST-CSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>DVLRQVDVPIMSNADCDAVYGI-VTDGNICIDSTGGKGTCNGDSGGPL--NYNG--LTYGITSFGAAAGCEAGYPDAFTRVTYFLDWIQ</Hsp_hseq>
      <Hsp_midline>D L+Q  +P++SN +C   +G  + D  IC  ++G   +C GDSGGPL    NG     GI S+G++  C    P  + RVT  ++W+Q</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>377</Hit_num>
  <Hit_id>pdb|4GSO|A</Hit_id>
  <Hit_def>structure of Jararacussin-I [Bothrops jararacussu]</Hit_def>
  <Hit_accession>4GSO_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.3806</Hsp_bit-score>
      <Hsp_score>137</Hsp_score>
      <Hsp_evalue>5.82858e-11</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>133</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVPYCANINLVDYEVCQGAYNGLPAKTTLCAGVLEGGKDTCVGDSGGPLIC--NGQFQ--GIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRNIAGN</Hsp_hseq>
      <Hsp_midline>PD    A++ L+    C+  +        +CAG    G  +C+GDSGGPL+C  NG +   GIVS+G+ +C     PG+Y  V    +W+Q+ +A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>378</Hit_num>
  <Hit_id>pdb|2OLG|A</Hit_id>
  <Hit_def>Crystal structure of the serine protease domain of prophenoloxidase activating factor-I in a zymogen form [Holotrichia diomphalia]</Hit_def>
  <Hit_accession>2OLG_A</Hit_accession>
  <Hit_len>278</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>57.3806</Hsp_bit-score>
      <Hsp_score>137</Hsp_score>
      <Hsp_evalue>1.01651e-10</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>185</Hsp_hit-from>
      <Hsp_hit-to>273</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>QQASLPLLSNTNCKKYWG---TKIKDAMICAGASGV-SSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ</Hsp_qseq>
      <Hsp_hseq>QKLAVPVVHAEQCAKTFGAAGVRVRSSQLCAGGEKAKDSCGGDSGGPLLAERANQQFFLEGLVSFGATCGTEGWPGIYTKVGKYRDWIE</Hsp_hseq>
      <Hsp_midline>Q+ ++P++    C K +G    +++ + +CAG      SC GDSGGPL+ ++ N  + L G+VS+G++  +   PG+Y +V    +W++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>379</Hit_num>
  <Hit_id>pdb|4K3J|A</Hit_id>
  <Hit_def>Crystal structure of Onartuzumab Fab in complex with MET and HGF-beta [Homo sapiens]</Hit_def>
  <Hit_accession>4K3J_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>1.58571e-10</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>88</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>221</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>87</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKI--KDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNW</Hsp_qseq>
      <Hsp_hseq>LRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKW</Hsp_hseq>
      <Hsp_midline>L+ A L ++ N  C ++   K+   ++ ICAGA  + S  C GD GGPLVC+++    ++G++  G      + PG++ RV     W</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>380</Hit_num>
  <Hit_id>pdb|3G01|A</Hit_id>
  <Hit_def>Structure of GrC mutant E192R/E193G [Mus musculus] &gt;pdb|3G01|B Structure of GrC mutant E192R/E193G [Mus musculus]</Hit_def>
  <Hit_accession>3G01_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>1.66966e-10</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDA-MICAGASGV--SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PKTLHEVKLTVQKDQVCESQFQSSYNRANEICVGDSKIKGASFRGDSGGPLVCKRAAA----GIVSYGQT--DGSAPQVFTRVLSFVSWIKKTM</Hsp_hseq>
      <Hsp_midline>P  L +  L +  +  C+  + +    A  IC G S +  +S  GDSGGPLVCK+  A    GIVS+G +    S P V+ RV + V+W+++T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>381</Hit_num>
  <Hit_id>pdb|1OP0|A</Hit_id>
  <Hit_def>Crystal Structure of AaV-SP-I, a Glycosylated Snake Venom Serine Proteinase from Agkistrodon acutus [Deinagkistrodon acutus]</Hit_def>
  <Hit_accession>1OP0_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>2.00114e-10</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>134</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKD-AMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGIVQGGKDTCGGDSGGPLIC--NGQFQ--GIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNIAGN</Hsp_hseq>
      <Hsp_midline>PD    A++ LL +  C+  +   + +   +CAG    G  +C GDSGGPL+C  NG +   GIVS+G+  C     PG+Y  V    +W+Q+ +A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>382</Hit_num>
  <Hit_id>pdb|1OP2|A</Hit_id>
  <Hit_def>Crystal Structure of AaV-SP-II, a Glycosylated Snake Venom Serine Proteinase from Agkistrodon acutus [Deinagkistrodon acutus]</Hit_def>
  <Hit_accession>1OP2_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>2.06335e-10</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>134</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>53</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKD-AMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGIVQGGKDTCGGDSGGPLIC--NGQFQ--GIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNIAGN</Hsp_hseq>
      <Hsp_midline>PD    A++ LL +  C+  +   + +   +CAG    G  +C GDSGGPL+C  NG +   GIVS+G+  C     PG+Y  V    +W+Q+ +A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>383</Hit_num>
  <Hit_id>pdb|6BQM|A</Hit_id>
  <Hit_def>Secreted serine protease VesC from Vibrio cholerae [Vibrio cholerae O395]</Hit_def>
  <Hit_accession>6BQM_A</Hit_accession>
  <Hit_len>506</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>2.18256e-10</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--------KYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LHQVQVPFVPLPECKTKGSDQDAKNNYSQLTNNAFCAGSFGKDACSGDAGGPIFFDSNNGRKQMGVVSWGDGCGRANSPGVYTNLSVFNDWL</Hsp_hseq>
      <Hsp_midline>L Q  +P +    CK        K   +++ +   CAG+ G  +C GD+GGP+    N     +G+VSWG      ++PGVY  ++   +W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>384</Hit_num>
  <Hit_id>pdb|5TO3|B</Hit_id>
  <Hit_def>Crystal structure of thrombin mutant W215A/E217A fused to EGF456 of thrombomodulin via a 31-residue linker and bound to PPACK [Homo sapiens]</Hit_def>
  <Hit_accession>5TO3_B</Hit_accession>
  <Hit_len>409</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>3.17615e-10</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N  W  +GIVS G+        G Y  V  L  W+Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>385</Hit_num>
  <Hit_id>pdb|2XXL|A</Hit_id>
  <Hit_def>Crystal structure of drosophila Grass clip serine protease of Toll pathway [Drosophila melanogaster] &gt;pdb|2XXL|B Crystal structure of drosophila Grass clip serine protease of Toll pathway [Drosophila melanogaster]</Hit_def>
  <Hit_accession>2XXL_A</Hit_accession>
  <Hit_len>408</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>3.63949e-10</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>272</Hsp_hit-from>
      <Hsp_hit-to>375</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>104</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-SCMGDSGGPLVCKKN--GAWT----LVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>SSSDVLLQANVPLQPRSACSQAYRRAVPLSQLCVGGGDLQDSCKGDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVTCGQISLPGLYTNVGEYVQWITDTMASN</Hsp_hseq>
      <Hsp_midline>++ D L QA++PL   + C + +   +  + +C G   +  SC GDSGGPL       G +       GIVS G  TC   S PG+Y  V   V W+  T+A+N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>386</Hit_num>
  <Hit_id>pdb|4IW4|E</Hit_id>
  <Hit_def>Crystal structure of the serine protease domain of MASP-3 in complex with ecotin [Homo sapiens] &gt;pdb|4IW4|F Crystal structure of the serine protease domain of MASP-3 in complex with ecotin [Homo sapiens]</Hit_def>
  <Hit_accession>4IW4_E</Hit_accession>
  <Hit_len>279</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.4546</Hsp_bit-score>
      <Hsp_score>132</Hsp_score>
      <Hsp_evalue>5.05573e-10</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>166</Hsp_hit-from>
      <Hsp_hit-to>266</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>101</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTK-----IKDAMICAG--ASGVSSCMGDSGGPLVCKKN--GAWTLVGIVSW-GSSTC-STSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>DVLQYVKLPVVPHAECKTSYESRSGNYSVTENMFCAGYYEGGKDTCLGDSGGAFVIFDDLSQRWVVQGLVSWGGPEECGSKQVYGVYTKVSNYVDWVWEQM</Hsp_hseq>
      <Hsp_midline>D LQ   LP++ +  CK  + ++     + + M CAG    G  +C+GDSGG  V   +    W + G+VSW G   C S    GVY +V+  V+WV + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>387</Hit_num>
  <Hit_id>pdb|3S69|A</Hit_id>
  <Hit_def>Crystal structure of saxthrombin [Gloydius saxatilis]</Hit_def>
  <Hit_accession>3S69_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>54.6842</Hsp_bit-score>
      <Hsp_score>130</Hsp_score>
      <Hsp_evalue>6.01488e-10</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>134</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAM-ICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTS-TPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVPYCAYINLLDDAVCQAGYPELLTEYRTLCAGILEGGKDTCGGDSGGPLIC--NGQFQ--GIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSIIAGN</Hsp_hseq>
      <Hsp_midline>PD    A + LL +  C+  +   + +   +CAG    G  +C GDSGGPL+C  NG +   GIVS+G+  C     PGVY +V    +W+Q  +A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>388</Hit_num>
  <Hit_id>pdb|4QT8|C</Hit_id>
  <Hit_def>Crystal Structure of RON Sema-PSI-IPT1 extracellular domains in complex with MSP beta-chain [Homo sapiens] &gt;pdb|4QT8|D Crystal Structure of RON Sema-PSI-IPT1 extracellular domains in complex with MSP beta-chain [Homo sapiens]</Hit_def>
  <Hit_accession>4QT8_C</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>54.6842</Hsp_bit-score>
      <Hsp_score>130</Hsp_score>
      <Hsp_evalue>7.60645e-10</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>244</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LNVALLNVISNQECNIKHRGRVRESEMCTEGLLAPVGACEGDYGGPLACFTHNSWVLEGIIIPNRVCARSRWPAVFTRVSVFVDWIHKVM</Hsp_hseq>
      <Hsp_midline>L  A L ++SN  C      +++++ +C     + V +C GD GGPL C  + +W L GI+        +  P V+ RV+  V+W+ + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>389</Hit_num>
  <Hit_id>pdb|2ASU|B</Hit_id>
  <Hit_def>Crystal Structure of the beta-chain of HGFl/MSP [Homo sapiens]</Hit_def>
  <Hit_accession>2ASU_B</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>54.299</Hsp_bit-score>
      <Hsp_score>129</Hsp_score>
      <Hsp_evalue>9.21986e-10</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LNVALLNVISNQECNIKHRGRVRESEMCTEGLLAPVGACEGDYGGPLACFTHNSWVLEGIIIPNRVCARSRWPAVFTRVSVFVDWIHKVM</Hsp_hseq>
      <Hsp_midline>L  A L ++SN  C      +++++ +C     + V +C GD GGPL C  + +W L GI+        +  P V+ RV+  V+W+ + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>390</Hit_num>
  <Hit_id>pdb|6NVB|A</Hit_id>
  <Hit_def>Crystal structure of the inhibitor-free form of the serine protease kallikrein-4 [Homo sapiens] &gt;pdb|6NVB|B Crystal structure of the inhibitor-free form of the serine protease kallikrein-4 [Homo sapiens] &gt;pdb|6NVB|C Crystal structure of the inhibitor-free form of the serine protease kallikrein-4 [Homo sapiens] &gt;pdb|6NVB|D Crystal structure of the inhibitor-free form of the serine protease kallikrein-4 [Homo sapiens]</Hit_def>
  <Hit_accession>6NVB_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.9138</Hsp_bit-score>
      <Hsp_score>128</Hsp_score>
      <Hsp_evalue>1.32445e-09</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>148</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>CKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>CSKLYDPLYHPSMFCAGGGQDQKDSCNGDSGGPLIC--NG--YLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKTVQAS</Hsp_hseq>
      <Hsp_midline>C K +      +M CAG       SC GDSGGPL+C  NG   L G+VS+G + C     PGVY  +     W+++T+ A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>391</Hit_num>
  <Hit_id>pdb|2BDG|A</Hit_id>
  <Hit_def>Human Kallikrein 4 complex with nickel and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDG|B Human Kallikrein 4 complex with nickel and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDH|A Human Kallikrein 4 complex with zinc and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDH|B Human Kallikrein 4 complex with zinc and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDH|C Human Kallikrein 4 complex with zinc and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDH|D Human Kallikrein 4 complex with zinc and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|A Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|B Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|C Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|D Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|E Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|F Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|G Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|H Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|I Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|J Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|K Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|L Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|M Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|N Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|O Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|2BDI|P Human Kallikrein 4 complex with cobalt and p-aminobenzamidine [Homo sapiens] &gt;pdb|4K1E|A Atomic resolution crystal structures of Kallikrein-Related Peptidase 4 complexed with a modified SFTI inhibitor FCQR [Homo sapiens] &gt;pdb|4K8Y|A Atomic resolution crystal structures of Kallikrein-Related Peptidase 4 complexed with Sunflower Trypsin Inhibitor (SFTI-1) [Homo sapiens] &gt;pdb|4KEL|A Atomic resolution crystal structure of Kallikrein-Related Peptidase 4 complexed with a modified SFTI inhibitor FCQR(N) [Homo sapiens] &gt;pdb|4KGA|A Crystal structure of kallikrein-related peptidase 4 [Homo sapiens] &gt;pdb|4KGA|B Crystal structure of kallikrein-related peptidase 4 [Homo sapiens] &gt;pdb|6O21|A Crystal Structure of Human KLK4 in Complex With Cleaved SFTI-FCQR(Asn14)[1,14] Inhibitor [Homo sapiens] &gt;pdb|7JOD|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOE|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|A Chain A, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|C Chain C, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|G Chain G, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|I Chain I, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|K Chain K, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOS|M Chain M, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JOW|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens] &gt;pdb|7JQV|E Chain E, Kallikrein 4 (Prostase, enamel matrix, prostate), isoform CRA_a [Homo sapiens]</Hit_def>
  <Hit_accession>2BDG_A</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>1.41121e-09</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>148</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>80</Hsp_align-len>
      <Hsp_qseq>CKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>CSKLYDPLYHPSMFCAGGGQDQKDSCNGDSGGPLIC--NG--YLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKTVQA</Hsp_hseq>
      <Hsp_midline>C K +      +M CAG       SC GDSGGPL+C  NG   L G+VS+G + C     PGVY  +     W+++T+ A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>392</Hit_num>
  <Hit_id>pdb|1GVZ|A</Hit_id>
  <Hit_def>Prostate Specific Antigen (PSA) from stallion seminal plasma [Equus caballus]</Hit_def>
  <Hit_accession>1GVZ_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>1.54783e-09</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPG-VYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LQCVELRLQSNEKCARAYPEKMTEFVLCATHRDDSGSICLGDSGGALIC--DGVFQ--GITSWGYSECADFNDNFVFTKVMPHKKWIKETIEKN</Hsp_hseq>
      <Hsp_midline>LQ   L L SN  C + +  K+ + ++CA     S   C+GDSGG L+C  +G +   GI SWG S C+      V+ +V     W+++T+  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>393</Hit_num>
  <Hit_id>pdb|3FZZ|A</Hit_id>
  <Hit_def>Structure of GrC [Mus musculus] &gt;pdb|3FZZ|B Structure of GrC [Mus musculus]</Hit_def>
  <Hit_accession>3FZZ_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>1.59583e-09</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDA-MICAGASGV--SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PKTLHEVKLTVQKDQVCESQFQSSYNRANEICVGDSKIKGASFEEDSGGPLVCKRAAA----GIVSYGQT--DGSAPQVFTRVLSFVSWIKKTM</Hsp_hseq>
      <Hsp_midline>P  L +  L +  +  C+  + +    A  IC G S +  +S   DSGGPLVCK+  A    GIVS+G +    S P V+ RV + V+W+++T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>394</Hit_num>
  <Hit_id>pdb|7MO7|A</Hit_id>
  <Hit_def>Chain A, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MO7|D Chain D, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MO8|A Chain A, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MO9|A Chain A, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MO9|D Chain D, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MOA|A Chain A, Hepatocyte growth factor [Homo sapiens] &gt;pdb|7MOA|D Chain D, Hepatocyte growth factor [Homo sapiens]</Hit_def>
  <Hit_accession>7MO7_A</Hit_accession>
  <Hit_len>728</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.9138</Hsp_bit-score>
      <Hsp_score>128</Hsp_score>
      <Hsp_evalue>1.65581e-09</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>629</Hsp_hit-from>
      <Hsp_hit-to>720</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKI--KDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKII</Hsp_hseq>
      <Hsp_midline>L+ A L ++ N  C ++   K+   ++ ICAGA  + S  C GD GGPLVC+++    ++G++  G      + PG++ RV     W+ + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>395</Hit_num>
  <Hit_id>pdb|6KBR|A</Hit_id>
  <Hit_def>Crystal structure of Human KLK4 and SPINK2 derived KLK4 inhibitor complex [Homo sapiens]</Hit_def>
  <Hit_accession>6KBR_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>2.91359e-09</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>162</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASG--VSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PTVLQCVNVSVVSEEVCSKLYDPLYHPSMFCAGGGHDQKDSCNGDSGGPLIC--NG--YLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKTVQAS</Hsp_hseq>
      <Hsp_midline>P  LQ  ++ ++S   C K +      +M CAG       SC GDSGGPL+C  NG   L G+VS+G + C     PGVY  +     W+++T+ A+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>396</Hit_num>
  <Hit_id>pdb|3I78|A</Hit_id>
  <Hit_def>35/99/170/186/220-loops of FXa in SGT [Streptomyces griseus]</Hit_def>
  <Hit_accession>3I78_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.7582</Hsp_bit-score>
      <Hsp_score>125</Hsp_score>
      <Hsp_evalue>3.10453e-09</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>135</Hsp_hit-from>
      <Hsp_hit-to>222</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWG-TKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNG-AWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LLKANVPFVSDAACRSSSSFILVANEMICAGYDTKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAI</Hsp_hseq>
      <Hsp_midline>L +A++P +S+  C+       + + MICAG       +C GDSGGP+  K N   W  VGIVSWG         GVY  V+   + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>397</Hit_num>
  <Hit_id>pdb|3BEU|A</Hit_id>
  <Hit_def>Na+-Dependent Allostery Mediates Coagulation Factor Protease Active Site Selectivity [Streptomyces griseus] &gt;pdb|3BEU|B Na+-Dependent Allostery Mediates Coagulation Factor Protease Active Site Selectivity [Streptomyces griseus]</Hit_def>
  <Hit_accession>3BEU_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.373</Hsp_bit-score>
      <Hsp_score>124</Hsp_score>
      <Hsp_evalue>3.86096e-09</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>130</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>88</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWG-TKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNG-AWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LLKANVPFVSDAACRSSSSFILVANEMICAGYDTKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAI</Hsp_hseq>
      <Hsp_midline>L +A++P +S+  C+       + + MICAG       +C GDSGGP+  K N   W  VGIVSWG         GVY  V+   + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>398</Hit_num>
  <Hit_id>pdb|4F4O|C</Hit_id>
  <Hit_def>Structure of the Haptoglobin-Haemoglobin Complex [Sus scrofa] &gt;pdb|4F4O|F Structure of the Haptoglobin-Haemoglobin Complex [Sus scrofa] &gt;pdb|4F4O|I Structure of the Haptoglobin-Haemoglobin Complex [Sus scrofa] &gt;pdb|4F4O|L Structure of the Haptoglobin-Haemoglobin Complex [Sus scrofa]</Hit_def>
  <Hit_accession>4F4O_C</Hit_accession>
  <Hit_len>347</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.7582</Hsp_bit-score>
      <Hsp_score>125</Hsp_score>
      <Hsp_evalue>3.88719e-09</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>232</Hsp_hit-from>
      <Hsp_hit-to>347</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>54</Hsp_positive>
      <Hsp_gaps>22</Hsp_gaps>
      <Hsp_align-len>117</Hsp_align-len>
      <Hsp_qseq>NTPDRLQQASLPLLSNTNCKKYW---------------GTK--IKDAMICAGASGV--SSCMGDSGGPLVC--KKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>NFTEHLKYVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDAGSAFAVHDKDDDTWYAAGILSFDKS-CRTAEYGVYVRVTSILDWIQTTIADN</Hsp_hseq>
      <Hsp_midline>N  + L+   LP+     C +Y+               G +  + +   CAG S     +C GD+G       K +  W   GI+S+  S C T+  GVY RVT++++W+Q T+A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>399</Hit_num>
  <Hit_id>pdb|2B9L|A</Hit_id>
  <Hit_def>Crystal structure of prophenoloxidase activating factor-II from the beetle Holotrichia diomphalia [Holotrichia diomphalia]</Hit_def>
  <Hit_accession>2B9L_A</Hit_accession>
  <Hit_len>394</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.7582</Hsp_bit-score>
      <Hsp_score>125</Hsp_score>
      <Hsp_evalue>4.8477e-09</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>284</Hsp_hit-from>
      <Hsp_hit-to>384</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>46</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>101</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK-----KYWGTK--IKDAMICAGA-SGVSSCMGDSGGPLVC---KKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>LKKIQLPTVDRDKCQADLRNTRLGLKFVLDQTFVCAGGEQGKDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDENVPGVYANVAHFRNWIDQEMQA</Hsp_hseq>
      <Hsp_midline>L++  LP +    C+        G K  +    +CAG   G  +C GD G PL C   +    +  +GIV+WG      + PGVYA V    NW+ Q + A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>400</Hit_num>
  <Hit_id>pdb|5XRF|A</Hit_id>
  <Hit_def>Crystal structure of Da-36, a thrombin-like enzyme from Deinagkistrodon acutus [Deinagkistrodon acutus]</Hit_def>
  <Hit_accession>5XRF_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.373</Hsp_bit-score>
      <Hsp_score>124</Hsp_score>
      <Hsp_evalue>5.25917e-09</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>233</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>96</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNC-KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>PDVPHCANINLLNYMECVAHYPDVPETTRLLCAGVLEGGIDTCNQDSGGPLIC--DGQFQ--GIVFFGKYPCAQPNKPGLYTRVSNYNDWIQNIIA</Hsp_hseq>
      <Hsp_midline>PD    A++ LL+   C   Y        ++CAG    G+ +C  DSGGPL+C  +G +   GIV +G   C+  + PG+Y RV+   +W+Q  +A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>401</Hit_num>
  <Hit_id>pdb|4KKD|A</Hit_id>
  <Hit_def>The X-ray crystal structure of Mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the 3MC syndrome [Homo sapiens] &gt;pdb|4KKD|B The X-ray crystal structure of Mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the 3MC syndrome [Homo sapiens]</Hit_def>
  <Hit_accession>4KKD_A</Hit_accession>
  <Hit_len>433</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>52.373</Hsp_bit-score>
      <Hsp_score>124</Hsp_score>
      <Hsp_evalue>5.51613e-09</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>320</Hsp_hit-from>
      <Hsp_hit-to>420</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>101</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTK-----IKDAMICAG--ASGVSSCMGDSGGPLVCKKN--GAWTLVGIVSW-GSSTC-STSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>DVLQYVKLPVVPHAECKTSYESRSGNYSVTENMFCAGYYEGGKDTCLGDSGEAFVIFDDLSQRWVVQGLVSWGGPEECGSKQVYGVYTKVSNYVDWVWEQM</Hsp_hseq>
      <Hsp_midline>D LQ   LP++ +  CK  + ++     + + M CAG    G  +C+GDSG   V   +    W + G+VSW G   C S    GVY +V+  V+WV + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>402</Hit_num>
  <Hit_id>pdb|6V64|B</Hit_id>
  <Hit_def>Crystal structure of human thrombin bound to ppack with tryptophans replaced by 5-F-tryptophan [Homo sapiens]</Hit_def>
  <Hit_accession>6V64_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.6026</Hsp_bit-score>
      <Hsp_score>122</Hsp_score>
      <Hsp_evalue>9.05323e-09</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>157</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVS-----SCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRXYQMGIVSXGEGCDRDGKYGFYTHVFRLKKXIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N     +GIVS G         G Y  V  L   +Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>403</Hit_num>
  <Hit_id>pdb|4E7N|A</Hit_id>
  <Hit_def>Crystal Structure of AhV_TL-I, a Glycosylated Snake-venom Thrombin-like Enzyme from Agkistrodon halys [Gloydius halys]</Hit_def>
  <Hit_accession>4E7N_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.6026</Hsp_bit-score>
      <Hsp_score>122</Hsp_score>
      <Hsp_evalue>1.01015e-08</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>168</Hsp_hit-from>
      <Hsp_hit-to>231</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>38</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>68</Hsp_align-len>
      <Hsp_qseq>ICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LCAGILEGGKDTCKGDSGGPLIC--NGQFQ--GIASWGDDPCAQPHKPAAYTKVFDHLDWIENIIAGN</Hsp_hseq>
      <Hsp_midline>+CAG    G  +C GDSGGPL+C  NG +   GI SWG   C+    P  Y +V   ++W++  +A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>404</Hit_num>
  <Hit_id>pdb|5UBM|A</Hit_id>
  <Hit_def>Crystal structure of human C1s in complex with inhibitor gigastasin [Homo sapiens]</Hit_def>
  <Hit_accession>5UBM_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>2.18325e-08</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>145</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>105</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTK-IKDA--------MICAGAS-GVSSCMGDSGGPLVCK---KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>RLKAARLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQ-CGTY--GLYTRVKNYVDWIMKTMQEN</Hsp_hseq>
      <Hsp_midline>RL+ A LP+     CK+    K   DA        MICAG   G+ SC GDSGG    +       +   G+VSWG   C T   G+Y RV   V+W+ +T+  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>405</Hit_num>
  <Hit_id>pdb|2AIP|A</Hit_id>
  <Hit_def>Crystal structure of native protein C activator from the venom of copperhead snake Agkistrodon contortrix contortrix [Agkistrodon contortrix contortrix] &gt;pdb|2AIQ|A Crystal structure of benzamidine-inhibited protein C activator from the venom of copperhead snake Agkistrodon contortrix contortrix [Agkistrodon contortrix contortrix]</Hit_def>
  <Hit_accession>2AIP_A</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>2.47879e-08</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>133</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCST-STPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>PDVPHCANINILDYAVCQAAY-KGLAATTLCAGILEGGKDTCKGDSGGPLIC--NGQFQ--GILSVGGNPCAQPRKPGIYTKVFDYTDWIQSIISGN</Hsp_hseq>
      <Hsp_midline>PD    A++ +L    C+  +   +    +CAG    G  +C GDSGGPL+C  NG +   GI+S G + C+    PG+Y +V    +W+Q  ++ N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>406</Hit_num>
  <Hit_id>pdb|1HYL|A</Hit_id>
  <Hit_def>The 1.8 A Structure Of Collagenase From Hypoderma Lineatum [Hypoderma lineatum] &gt;pdb|1HYL|B The 1.8 A Structure Of Collagenase From Hypoderma Lineatum [Hypoderma lineatum] &gt;pdb|2HLC|A Hl Collagenase Structure At 1.7a Resolution [Hypoderma lineatum] &gt;pdb|2HLC|B Hl Collagenase Structure At 1.7a Resolution [Hypoderma lineatum]</Hit_def>
  <Hit_accession>1HYL_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>2.5919e-08</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>91</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC-KKYWGTKIKDAMICAGAS-GVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSST-CSTSTPGVYARVTALVNWVQQ</Hsp_qseq>
      <Hsp_hseq>LQYTYNLVIDNDRCAQEYPPGIIVESTICGDTSDGKSPCFGDSGGPFVLSDKN--LLIGVVSFVSGAGCESGKPVGFSRVTSYMDWIQQ</Hsp_hseq>
      <Hsp_midline>LQ     ++ N  C ++Y    I ++ IC   S G S C GDSGGP V        L+G+VS+ S   C +  P  ++RVT+ ++W+QQ</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>407</Hit_num>
  <Hit_id>pdb|3S9A|A</Hit_id>
  <Hit_def>Russell&apos;s viper venom serine proteinase, RVV-V (closed-form) [Daboia siamensis] &gt;pdb|3S9B|A Russell&apos;s viper venom serine proteinase, RVV-V (open-form) [Daboia siamensis] &gt;pdb|3S9C|A Russell&apos;s viper venom serine proteinase, RVV-V in complex with the fragment (residues 1533-1546) of human factor V [Daboia siamensis] &gt;pdb|3SBK|A Russell&apos;s viper venom serine proteinase, RVV-V (PPACK-bound form) [Daboia siamensis]</Hit_def>
  <Hit_accession>3S9A_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.0618</Hsp_bit-score>
      <Hsp_score>118</Hsp_score>
      <Hsp_evalue>2.84498e-08</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>164</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>38</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>68</Hsp_align-len>
      <Hsp_qseq>ICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTS-TPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LCAGILKGGRDTCHGDSGGPLIC--NGE--MHGIVAGGSEPCGQHLKPAVYTKVFDYNNWIQSIIAGN</Hsp_hseq>
      <Hsp_midline>+CAG    G  +C GDSGGPL+C  NG   + GIV+ GS  C     P VY +V    NW+Q  +A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>408</Hit_num>
  <Hit_id>pdb|4J1Y|A</Hit_id>
  <Hit_def>The X-ray crystal structure of human complement protease C1s zymogen [Homo sapiens] &gt;pdb|4J1Y|B The X-ray crystal structure of human complement protease C1s zymogen [Homo sapiens]</Hit_def>
  <Hit_accession>4J1Y_A</Hit_accession>
  <Hit_len>397</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.447</Hsp_bit-score>
      <Hsp_score>119</Hsp_score>
      <Hsp_evalue>3.03603e-08</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>290</Hsp_hit-from>
      <Hsp_hit-to>391</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>105</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTK-IKDA--------MICAGAS-GVSSCMGDSGGPLVCK---KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>RLKAARLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQ-CGTY--GLYTRVKNYVDWIMKTMQEN</Hsp_hseq>
      <Hsp_midline>RL+ A LP+     CK+    K   DA        MICAG   G+ SC GDSGG    +       +   G+VSWG   C T   G+Y RV   V+W+ +T+  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>409</Hit_num>
  <Hit_id>pdb|7JQK|E</Hit_id>
  <Hit_def>Chain E, Kallikrein-4 [Homo sapiens] &gt;pdb|7JQN|E Chain E, Kallikrein-4 [Homo sapiens]</Hit_def>
  <Hit_accession>7JQK_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>50.0618</Hsp_bit-score>
      <Hsp_score>118</Hsp_score>
      <Hsp_evalue>3.2295e-08</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>148</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>41</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>80</Hsp_align-len>
      <Hsp_qseq>CKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>CSKLYDPLYHPSMFCAGGGQDQKDSCNGDSGGPLIC--NG--YLQGLVSFGKAPXGQVGVPGVYTNLCKFTEWIEKTVQA</Hsp_hseq>
      <Hsp_midline>C K +      +M CAG       SC GDSGGPL+C  NG   L G+VS+G +       PGVY  +     W+++T+ A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>410</Hit_num>
  <Hit_id>pdb|3TVJ|B</Hit_id>
  <Hit_def>Catalytic fragment of MASP-2 in complex with its specific inhibitor developed by directed evolution on SGCI scaffold [Homo sapiens]</Hit_def>
  <Hit_accession>3TVJ_B</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>4.044e-08</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>141</Hsp_hit-from>
      <Hsp_hit-to>240</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC------KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVC--KKNGAWTLVGIVSWGSSTCSTS-TPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>LMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS</Hsp_hseq>
      <Hsp_midline>L    +P++ +  C        Y    +   M+CAG  + G  SC GDSGG LV    +   W + GIVSWGS  C  +   GVY +V   + W++  ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>411</Hit_num>
  <Hit_id>pdb|1Q3X|A</Hit_id>
  <Hit_def>Crystal structure of the catalytic region of human MASP-2 [Homo sapiens] &gt;pdb|1Q3X|B Crystal structure of the catalytic region of human MASP-2 [Homo sapiens]</Hit_def>
  <Hit_accession>1Q3X_A</Hit_accession>
  <Hit_len>328</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>4.86802e-08</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>227</Hsp_hit-from>
      <Hsp_hit-to>326</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC------KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVC--KKNGAWTLVGIVSWGSSTCSTS-TPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>LMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS</Hsp_hseq>
      <Hsp_midline>L    +P++ +  C        Y    +   M+CAG  + G  SC GDSGG LV    +   W + GIVSWGS  C  +   GVY +V   + W++  ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>412</Hit_num>
  <Hit_id>pdb|6TB2|C</Hit_id>
  <Hit_def>Structure of human haptoglobin-hemoglobin bound to S. aureus IsdH [Homo sapiens]</Hit_def>
  <Hit_accession>6TB2_C</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>5.00071e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>267</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>22</Hsp_gaps>
      <Hsp_align-len>114</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC-KKYWGTKI----------------KDAMICAGASGV--SSCMGDSGGPLVCK--KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DHLKYVMLPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFAVHDLEEDTWYATGILSFDKS-CAVAEYGVYVKVTSIQDWVQKTIAEN</Hsp_hseq>
      <Hsp_midline>D L+   LP+     C + Y G+ +                 +   CAG S     +C GD+G        +   W   GI+S+  S C+ +  GVY +VT++ +WVQ+T+A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>413</Hit_num>
  <Hit_id>pdb|4X0L|C</Hit_id>
  <Hit_def>Human haptoglobin-haemoglobin complex [Homo sapiens] &gt;pdb|5HU6|C Structure of the T. brucei haptoglobin-haemoglobin receptor bound to human haptolgobin-haemoglobin [Homo sapiens]</Hit_def>
  <Hit_accession>4X0L_C</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>5.17729e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>147</Hsp_hit-from>
      <Hsp_hit-to>259</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>22</Hsp_gaps>
      <Hsp_align-len>114</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC-KKYWGTKI----------------KDAMICAGASGV--SSCMGDSGGPLVCK--KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DHLKYVMLPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFAVHDLEEDTWYATGILSFDKS-CAVAEYGVYVKVTSIQDWVQKTIAEN</Hsp_hseq>
      <Hsp_midline>D L+   LP+     C + Y G+ +                 +   CAG S     +C GD+G        +   W   GI+S+  S C+ +  GVY +VT++ +WVQ+T+A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>414</Hit_num>
  <Hit_id>pdb|1ZJK|A</Hit_id>
  <Hit_def>Crystal structure of the zymogen catalytic region of human MASP-2 [Homo sapiens]</Hit_def>
  <Hit_accession>1ZJK_A</Hit_accession>
  <Hit_len>403</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>5.73384e-08</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>302</Hsp_hit-from>
      <Hsp_hit-to>401</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC------KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVC--KKNGAWTLVGIVSWGSSTCSTS-TPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>LMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS</Hsp_hseq>
      <Hsp_midline>L    +P++ +  C        Y    +   M+CAG  + G  SC GDSGG LV    +   W + GIVSWGS  C  +   GVY +V   + W++  ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>415</Hit_num>
  <Hit_id>pdb|5YJM|A</Hit_id>
  <Hit_def>Human chymase in complex with 7-oxo-3-(phenoxyimino)-1,4-diazepane derivative [Homo sapiens] &gt;pdb|5YJP|A Human chymase in complex with 3-(ethoxyimino)-7-oxo-1,4-diazepane derivative [Homo sapiens]</Hit_def>
  <Hit_accession>5YJM_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>6.34129e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DTLQEVKLRLMDPQACSHFRDFD-HNLQLCVGNPRKTKSAFKGDSGGPLLC----AGVAQGIVSYGRS--DAKPPAVFTRISHYRPWINQILQAN</Hsp_hseq>
      <Hsp_midline>D LQ+  L L+    C  +      +  +C G      S+  GDSGGPL+C    A    GIVS+G S      P V+ R++    W+ Q L AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>416</Hit_num>
  <Hit_id>pdb|4AFQ|A</Hit_id>
  <Hit_def>Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFQ|B Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFS|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFU|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFU|B Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFZ|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AFZ|B Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AG1|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AG2|A Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4AG2|B Human Chymase - Fynomer Complex [Homo sapiens] &gt;pdb|4KP0|A Crystal Structure of the human Chymase with TJK002 [Homo sapiens]</Hit_def>
  <Hit_accession>4AFQ_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>6.53605e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DTLQEVKLRLMDPQACSHFRDFD-HNLQLCVGNPRKTKSAFKGDSGGPLLC----AGVAQGIVSYGRS--DAKPPAVFTRISHYRPWINQILQAN</Hsp_hseq>
      <Hsp_midline>D LQ+  L L+    C  +      +  +C G      S+  GDSGGPL+C    A    GIVS+G S      P V+ R++    W+ Q L AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>417</Hit_num>
  <Hit_id>pdb|1KLT|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF PMSF-TREATED HUMAN CHYMASE AT 1.9 ANGSTROMS RESOLUTION [Homo sapiens]</Hit_def>
  <Hit_accession>1KLT_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>6.53605e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DTLQEVKLRLMDPQACSHFRDFD-HNLQLCVGNPRKTKSAFKGDSGGPLLC----AGVAQGIVSYGRS--DAKPPAVFTRISHYRPWINQILQAN</Hsp_hseq>
      <Hsp_midline>D LQ+  L L+    C  +      +  +C G      S+  GDSGGPL+C    A    GIVS+G S      P V+ R++    W+ Q L AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>418</Hit_num>
  <Hit_id>pdb|1NN6|A</Hit_id>
  <Hit_def>Human Pro-Chymase [Homo sapiens]</Hit_def>
  <Hit_accession>1NN6_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>6.67715e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>141</Hsp_hit-from>
      <Hsp_hit-to>228</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DTLQEVKLRLMDPQACSHFRDFD-HNLQLCVGNPRKTKSAFKGDSGGPLLC----AGVAQGIVSYGRS--DAKPPAVFTRISHYRPWINQILQAN</Hsp_hseq>
      <Hsp_midline>D LQ+  L L+    C  +      +  +C G      S+  GDSGGPL+C    A    GIVS+G S      P V+ R++    W+ Q L AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>419</Hit_num>
  <Hit_id>pdb|1KYN|A</Hit_id>
  <Hit_def>Cathepsin-G [Homo sapiens] &gt;pdb|1KYN|B Cathepsin-G [Homo sapiens]</Hit_def>
  <Hit_accession>1KYN_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>6.99643e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>137</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDSGGPLLCNNVAH----GIVSYGKS--SGVPPEVFTRVSSFLPWIRTTMRS</Hsp_hseq>
      <Hsp_midline>D L++  L +  +  C + +G+      IC G      ++  GDSGGPL+C         GIVS+G S  S   P V+ RV++ + W++ T+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>420</Hit_num>
  <Hit_id>pdb|1AU8|A</Hit_id>
  <Hit_def>Human Cathepsin G [Homo sapiens] &gt;pdb|1CGH|A Human cathepsin G [Homo sapiens] &gt;pdb|1T32|A A Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase with Therapeutic Efficacy in Animals Models of Inflammation [Homo sapiens] &gt;pdb|6VTM|A Chain A, Cathepsin G [Homo sapiens] &gt;pdb|6VTM|C Chain C, Cathepsin G [Homo sapiens] &gt;pdb|6VTM|D Chain D, Cathepsin G [Homo sapiens] &gt;pdb|6VTM|G Chain G, Cathepsin G [Homo sapiens]</Hit_def>
  <Hit_accession>1AU8_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>7.51605e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>137</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>DTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDSGGPLLCNN----VAHGIVSYGKS--SGVPPEVFTRVSSFLPWIRTTMRS</Hsp_hseq>
      <Hsp_midline>D L++  L +  +  C + +G+      IC G      ++  GDSGGPL+C         GIVS+G S  S   P V+ RV++ + W++ T+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>421</Hit_num>
  <Hit_id>pdb|3N7O|A</Hit_id>
  <Hit_def>X-ray structure of human chymase in complex with small molecule inhibitor. [Homo sapiens]</Hit_def>
  <Hit_accession>3N7O_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>8.15865e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DTLQEVKLRLMDPQACSHFRDFD-HNLQLCVGNPRKTKSAFKGDSGGPLLC----AGAAQGIVSYGRS--DAKPPAVFTRISHYQPWINQILQAN</Hsp_hseq>
      <Hsp_midline>D LQ+  L L+    C  +      +  +C G      S+  GDSGGPL+C    A    GIVS+G S      P V+ R++    W+ Q L AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>422</Hit_num>
  <Hit_id>pdb|1PJP|A</Hit_id>
  <Hit_def>The 2.2 A Crystal Structure Of Human Chymase In Complex With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone [Homo sapiens] &gt;pdb|1T31|A A Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase with Therapeutic Efficacy in Animals Models of Inflammation [Homo sapiens] &gt;pdb|2HVX|A Discovery of Potent, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase by Using Structure-Based Drug Design [Homo sapiens] &gt;pdb|3S0N|A Crystal Structure of Human Chymase with Benzimidazolone Inhibitor [Homo sapiens] &gt;pdb|4K2Y|A Crystal Structure of Human Chymase in Complex with Fragment Inhibitor 6-chloro-1,3-dihydro-2H-indol-2-one [Homo sapiens] &gt;pdb|4K5Z|A Crystal Structure of Human Chymase in Complex with Fragment Inhibitor 6-chloro-2,3-dihydro-1H-isoindol-1-one [Homo sapiens] &gt;pdb|4K60|A Crystal Structure of Human Chymase in Complex with Fragment 6-bromo-1,3-dihydro-2H-indol-2-one [Homo sapiens] &gt;pdb|4K69|A Crystal Structure of Human Chymase in Complex with Fragment Linked Benzimidazolone Inhibitor: (3S)-3-{3-[(6-bromo-2-oxo-2,3-dihydro-1H-indol-4-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}hexanoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>1PJP_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>8.15865e-08</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DTLQEVKLRLMDPQACSHFRDFD-HNLQLCVGNPRKTKSAFKGDSGGPLLC----AGAAQGIVSYGRS--DAKPPAVFTRISHYQPWINQILQAN</Hsp_hseq>
      <Hsp_midline>D LQ+  L L+    C  +      +  +C G      S+  GDSGGPL+C    A    GIVS+G S      P V+ R++    W+ Q L AN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>423</Hit_num>
  <Hit_id>pdb|4FXG|H</Hit_id>
  <Hit_def>Complement C4 in complex with MASP-2 [Homo sapiens] &gt;pdb|4FXG|J Complement C4 in complex with MASP-2 [Homo sapiens] &gt;pdb|5JPM|H Structure of the complex of human complement C4 with MASP-2 rebuilt using iMDFF [Homo sapiens] &gt;pdb|5JPM|J Structure of the complex of human complement C4 with MASP-2 rebuilt using iMDFF [Homo sapiens]</Hit_def>
  <Hit_accession>4FXG_H</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>9.65934e-08</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>94</Hsp_query-to>
      <Hsp_hit-from>141</Hsp_hit-from>
      <Hsp_hit-to>240</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC------KKYWGTKIKDAMICAG--ASGVSSCMGDSGGPLVC--KKNGAWTLVGIVSWGSSTCSTS-TPGVYARVTALVNWVQQTLA</Hsp_qseq>
      <Hsp_hseq>LMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS</Hsp_hseq>
      <Hsp_midline>L    +P++ +  C        Y    +   M+CAG  + G  SC GD+GG LV    +   W + GIVSWGS  C  +   GVY +V   + W++  ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>424</Hit_num>
  <Hit_id>pdb|4LK4|A</Hit_id>
  <Hit_def>Structure of Vibrio cholerae VesB protease [Vibrio cholerae 569B]</Hit_def>
  <Hit_accession>4LK4_A</Hit_accession>
  <Hit_len>357</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.9062</Hsp_bit-score>
      <Hsp_score>115</Hsp_score>
      <Hsp_evalue>9.72827e-08</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>155</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKI----KDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCS-TSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>LQEVDVDLVSQSLCQIVMQHGISSDPNSTNFCAARLTKDSCQGDAGGPIVVKTGREQ--LGIVSWGDEQCAKTGTYGVYTNVSYFRDWI</Hsp_hseq>
      <Hsp_midline>LQ+  + L+S + C+      I         CA      SC GD+GGP+V K       +GIVSWG   C+ T T GVY  V+   +W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>425</Hit_num>
  <Hit_id>pdb|1ELV|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COMPLEMENT C1S PROTEASE [Homo sapiens]</Hit_def>
  <Hit_accession>1ELV_A</Hit_accession>
  <Hit_len>333</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>1.27372e-07</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>226</Hsp_hit-from>
      <Hsp_hit-to>327</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>49</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>105</Hsp_align-len>
      <Hsp_qseq>RLQQASLPLLSNTNCKKYWGTK-IKDA--------MICAGAS-GVSSCMGDSGGPLVCKKNGAWT---LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>RLKAARLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGP---QCGTYGLYTRVKNYVDWIMKTMQEN</Hsp_hseq>
      <Hsp_midline>RL+ A LP+     CK+    K   DA        MICAG   G+ SC GDSGG    +     T     G+VSWG       T G+Y RV   V+W+ +T+  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>426</Hit_num>
  <Hit_id>pdb|6V5T|E</Hit_id>
  <Hit_def>Crystal structure of human prethrombin-2 with tryptophans replaced by 5-F-tryptophan [Homo sapiens]</Hit_def>
  <Hit_accession>6V5T_E</Hit_accession>
  <Hit_len>290</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.521</Hsp_bit-score>
      <Hsp_score>114</Hsp_score>
      <Hsp_evalue>1.35586e-07</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>188</Hsp_hit-from>
      <Hsp_hit-to>285</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>98</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG-----ASGVSSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRXYQMGIVSXGEGCDRDGKYGFYTHVFRLKKXIQKVI</Hsp_hseq>
      <Hsp_midline>P  LQ  +LP++    CK     +I D M CAG          +C GDSGGP V K   N     +GIVS G         G Y  V  L   +Q+ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>427</Hit_num>
  <Hit_id>pdb|2ZGC|A</Hit_id>
  <Hit_def>Crystal Structure of Active Human Granzyme M [Homo sapiens] &gt;pdb|2ZGH|A Crystal Structure of active granzyme M bound to its product [Homo sapiens] &gt;pdb|2ZKS|A Structural insights into the proteolytic machinery of apoptosis-inducing Granzyme M [Homo sapiens]</Hit_def>
  <Hit_accession>2ZGC_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>1.40032e-07</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>92</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMIC--AGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCS-TSTPGVYARVTALVNWVQQT</Hsp_qseq>
      <Hsp_hseq>LRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKGDSGGPLVCGK--GRVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKV</Hsp_hseq>
      <Hsp_midline>L++  L +L    C   ++W   +  +M+C  A +   + C GDSGGPLVC K     L G++S+ S  C+    P V   V   V+W+++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>428</Hit_num>
  <Hit_id>pdb|2ZGJ|A</Hit_id>
  <Hit_def>Crystal Structure of D86N-GzmM Complexed with Its Optimal Synthesized Substrate [Homo sapiens]</Hit_def>
  <Hit_accession>2ZGJ_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>48.1358</Hsp_bit-score>
      <Hsp_score>113</Hsp_score>
      <Hsp_evalue>1.42859e-07</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>92</Hsp_query-to>
      <Hsp_hit-from>138</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK--KYWGTKIKDAMIC--AGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCS-TSTPGVYARVTALVNWVQQT</Hsp_qseq>
      <Hsp_hseq>LRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKGDSGGPLVCGK--GRVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKV</Hsp_hseq>
      <Hsp_midline>L++  L +L    C   ++W   +  +M+C  A +   + C GDSGGPLVC K     L G++S+ S  C+    P V   V   V+W+++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>429</Hit_num>
  <Hit_id>pdb|4GAW|A</Hit_id>
  <Hit_def>Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|B Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|C Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|D Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|E Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|F Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|G Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|H Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|I Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|J Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|K Crystal structure of active human granzyme H [Homo sapiens] &gt;pdb|4GAW|L Crystal structure of active human granzyme H [Homo sapiens]</Hit_def>
  <Hit_accession>4GAW_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>2.81112e-07</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKK-YWGTKIKDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPLVCKDVAQ----GILSYGNK--KGTPPGVYIKVSHFLPWIKRTM</Hsp_hseq>
      <Hsp_midline>LQ+  L +  +  C++ + G   +   IC G    +     GDSGGPLVCK        GI+S+G+     + PGVY +V+  + W+++T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>430</Hit_num>
  <Hit_id>pdb|3TJU|A</Hit_id>
  <Hit_def>Crystal structure of human granzyme H with an inhibitor [Homo sapiens] &gt;pdb|3TJV|A Crystal structure of human granzyme H with a peptidyl substrate [Homo sapiens] &gt;pdb|3TK9|A Crystal structure of human granzyme H [Homo sapiens]</Hit_def>
  <Hit_accession>3TJU_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>47.3654</Hsp_bit-score>
      <Hsp_score>111</Hsp_score>
      <Hsp_evalue>2.9263e-07</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>91</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKK-YWGTKIKDAMICAGASGVSS--CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPLVCKDVAQ----GILSYGNK--KGTPPGVYIKVSHFLPWIKRTM</Hsp_hseq>
      <Hsp_midline>LQ+  L +  +  C++ + G   +   IC G    +     GDSGGPLVCK        GI+S+G+     + PGVY +V+  + W+++T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>431</Hit_num>
  <Hit_id>pdb|7JQO|E</Hit_id>
  <Hit_def>Chain E, Kallikrein-4 [Homo sapiens]</Hit_def>
  <Hit_accession>7JQO_E</Hit_accession>
  <Hit_len>223</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>7.185e-07</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>148</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>40</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>80</Hsp_align-len>
      <Hsp_qseq>CKKYWGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWVQQTLAA</Hsp_qseq>
      <Hsp_hseq>CSKLYDPLYHPSMFCAGGGQDQKDSXNGDSGGPLIC--NG--YLQGLVSFGKAPXGQVGVPGVYTNLCKFTEWIEKTVQA</Hsp_hseq>
      <Hsp_midline>C K +      +M CAG       S  GDSGGPL+C  NG   L G+VS+G +       PGVY  +     W+++T+ A</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>432</Hit_num>
  <Hit_id>pdb|4WJG|2</Hit_id>
  <Hit_def>Chain 2, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|C Chain C, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|H Chain H, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|M Chain M, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|R Chain R, Haptoglobin [Homo sapiens] &gt;pdb|4WJG|W Chain W, Haptoglobin [Homo sapiens]</Hit_def>
  <Hit_accession>4WJG_2</Hit_accession>
  <Hit_len>315</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>1.21391e-06</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>203</Hsp_hit-from>
      <Hsp_hit-to>315</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>22</Hsp_gaps>
      <Hsp_align-len>114</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC-KKYWGTKIKDA----------------MICAGASGVS--SCMGDSGGPLVCK--KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DHLKYVMLPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFAVHDLEEDTWYATGILSFDKS-CAVAEYGVYVKVTSIQDWVQKTIAEN</Hsp_hseq>
      <Hsp_midline>D L+   LP+     C + Y G+ + +                   CAG S     +C GD+G        +   W   GI+S+  S C+ +  GVY +VT++ +WVQ+T+A N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>433</Hit_num>
  <Hit_id>pdb|4Q7X|A</Hit_id>
  <Hit_def>Neutrophil serine protease 4 (PRSS57) apo form 1 [Homo sapiens] &gt;pdb|4Q7X|B Neutrophil serine protease 4 (PRSS57) apo form 1 [Homo sapiens] &gt;pdb|4Q7Y|A Neutrophil serine protease 4 (PRSS57) apo form 2 [Homo sapiens] &gt;pdb|4Q7Z|A Neutrophil serine protease 4 (PRSS57) with phe-phe-arg-chloromethylketone (FFR-cmk) [Homo sapiens] &gt;pdb|4Q80|A Neutrophil serine protease 4 (PRSS57) with val-leu-lys-chloromethylketone (VLK-cmk) [Homo sapiens] &gt;pdb|4Q80|B Neutrophil serine protease 4 (PRSS57) with val-leu-lys-chloromethylketone (VLK-cmk) [Homo sapiens]</Hit_def>
  <Hit_accession>4Q7X_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>1.44003e-06</Hsp_evalue>
      <Hsp_query-from>3</Hsp_query-from>
      <Hsp_query-to>89</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>92</Hsp_align-len>
      <Hsp_qseq>PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSS----CMGDSGGPLVCKKNGAWTLVGIVSWGSSTC-STSTPGVYARVTALVNWV</Hsp_qseq>
      <Hsp_hseq>PPGLMEAKVRVLDPDVCNSSWKGHLTLTMLCT-RSGDSHRRGFCSADSGGPLVCRNRAH----GLVSFSGLWCGDPKTPDVYTQVSAFVAWI</Hsp_hseq>
      <Hsp_midline>P  L +A + +L    C   W   +   M+C   SG S     C  DSGGPLVC+        G+VS+    C    TP VY +V+A V W+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>434</Hit_num>
  <Hit_id>pdb|3RP2|A</Hit_id>
  <Hit_def>THE STRUCTURE OF RAT MAST CELL PROTEASE II AT 1.9-ANGSTROMS RESOLUTION [Rattus rattus] &gt;pdb|3RP2|B THE STRUCTURE OF RAT MAST CELL PROTEASE II AT 1.9-ANGSTROMS RESOLUTION [Rattus rattus]</Hit_def>
  <Hit_accession>3RP2_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.2838</Hsp_bit-score>
      <Hsp_score>103</Hsp_score>
      <Hsp_evalue>3.33259e-06</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>141</Hsp_hit-from>
      <Hsp_hit-to>223</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGASGV--SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LREVELRIMDEKACVDYRYYEYK-FQVCVGSPTTLRAAFMGDSGGPLLC----AGVAHGIVSYGHP--DAKPPAIFTRVSTYVPWINAVI</Hsp_hseq>
      <Hsp_midline>L++  L ++    C  Y   + K   +C G+     ++ MGDSGGPL+C    A    GIVS+G        P ++ RV+  V W+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>435</Hit_num>
  <Hit_id>pdb|1MZA|A</Hit_id>
  <Hit_def>crystal structure of human pro-granzyme K [Homo sapiens] &gt;pdb|1MZD|A crystal structure of human pro-granzyme K [Homo sapiens]</Hit_def>
  <Hit_accession>1MZA_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.5134</Hsp_bit-score>
      <Hsp_score>101</Hsp_score>
      <Hsp_evalue>7.76645e-06</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>234</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNC--KKYWGTK--IKDAMICAG-ASGV-SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVN-WVQQTL</Hsp_qseq>
      <Hsp_hseq>DTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVCAGDAKGQKDSCKGDAGGPLICK----GVFHAIVSGGHECGVATKPGIYTLLTKKYQTWIKSNL</Hsp_hseq>
      <Hsp_midline>D L++ ++ +LS   C  + Y+     I   M+CAG A G   SC GD+GGPL+CK         IVS G      + PG+Y  +T     W++  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>436</Hit_num>
  <Hit_id>pdb|1IAU|A</Hit_id>
  <Hit_def>Human Granzyme B In Complex With Ac-Iepd-Cho [Homo sapiens]</Hit_def>
  <Hit_accession>1IAU_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>8.76022e-06</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC----KKYWGTKIKDAMICAGASGV--SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LQEVKMTVQEDRKCESDLRHYYDSTIE---LCVGDPEIKKTSFKGDSGGPLVCNK----VAQGIVSYGRN--NGMPPRACTKVSSFVHWIKKTM</Hsp_hseq>
      <Hsp_midline>LQ+  + +  +  C    + Y+ + I+   +C G   +  +S  GDSGGPLVC K       GIVS+G +  +   P    +V++ V+W+++T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>437</Hit_num>
  <Hit_id>pdb|1FQ3|A</Hit_id>
  <Hit_def>Crystal Structure Of Human Granzyme B [Homo sapiens] &gt;pdb|1FQ3|B Crystal Structure Of Human Granzyme B [Homo sapiens]</Hit_def>
  <Hit_accession>1FQ3_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>9.02521e-06</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>140</Hsp_hit-from>
      <Hsp_hit-to>224</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>50</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>94</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNC----KKYWGTKIKDAMICAGASGV--SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LQEVKMTVQEDRKCESDLRHYYDSTIE---LCVGDPEIKKTSFKGDSGGPLVCNK----VAQGIVSYGRN--NGMPPRACTKVSSFVHWIKKTM</Hsp_hseq>
      <Hsp_midline>LQ+  + +  +  C    + Y+ + I+   +C G   +  +S  GDSGGPLVC K       GIVS+G +  +   P    +V++ V+W+++T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>438</Hit_num>
  <Hit_id>pdb|1GPZ|A</Hit_id>
  <Hit_def>THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R [Homo sapiens] &gt;pdb|1GPZ|B THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R [Homo sapiens]</Hit_def>
  <Hit_accession>1GPZ_A</Hit_accession>
  <Hit_len>399</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>3.50849e-05</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>301</Hsp_hit-from>
      <Hsp_hit-to>395</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTK-----IKDAMICAGASGVS--SCMGDSGGPLVCK--KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIG-CSRGY-GFYTKVLNYVDWIKKEM</Hsp_hseq>
      <Hsp_midline>L+   LP+ +   C+ +   K         M CAG   +   +C GDSGG    +      W   GIVSWG   CS    G Y +V   V+W+++ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>439</Hit_num>
  <Hit_id>pdb|2QY0|B</Hit_id>
  <Hit_def>Active dimeric structure of the catalytic domain of C1r reveals enzyme-product like contacts [Homo sapiens] &gt;pdb|2QY0|D Active dimeric structure of the catalytic domain of C1r reveals enzyme-product like contacts [Homo sapiens]</Hit_def>
  <Hit_accession>2QY0_B</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.2022</Hsp_bit-score>
      <Hsp_score>95</Hsp_score>
      <Hsp_evalue>4.17408e-05</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>144</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTK-----IKDAMICAGASGV--SSCMGDSGGPLVCKK--NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>LRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIG-CSRGY-GFYTKVLNYVDWIKKEMEEE</Hsp_hseq>
      <Hsp_midline>L+   LP+ +   C+ +   K         M CAG   +   +C GDSGG    +      W   GIVSWG   CS    G Y +V   V+W+++ +   </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>440</Hit_num>
  <Hit_id>pdb|1MD8|A</Hit_id>
  <Hit_def>Monomeric structure of the active catalytic domain of complement protease C1r [Homo sapiens]</Hit_def>
  <Hit_accession>1MD8_A</Hit_accession>
  <Hit_len>329</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.2022</Hsp_bit-score>
      <Hsp_score>95</Hsp_score>
      <Hsp_evalue>4.66822e-05</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>233</Hsp_hit-from>
      <Hsp_hit-to>327</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTK-----IKDAMICAGASGVS--SCMGDSGGPLVCK--KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIG-CSRGY-GFYTKVLNYVDWIKKEM</Hsp_hseq>
      <Hsp_midline>L+   LP+ +   C+ +   K         M CAG   +   +C GDSGG    +      W   GIVSWG   CS    G Y +V   V+W+++ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>441</Hit_num>
  <Hit_id>pdb|4BXS|A</Hit_id>
  <Hit_def>Crystal Structure of the Prothrombinase Complex from the Venom of Pseudonaja Textilis [Pseudonaja textilis] &gt;pdb|4BXW|A Crystal Structure of the Prothrombinase Complex from the Venom of Pseudonaja Textilis [Pseudonaja textilis] &gt;pdb|4BXW|B Crystal Structure of the Prothrombinase Complex from the Venom of Pseudonaja Textilis [Pseudonaja textilis]</Hit_def>
  <Hit_accession>4BXS_A</Hit_accession>
  <Hit_len>423</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.817</Hsp_bit-score>
      <Hsp_score>94</Hsp_score>
      <Hsp_evalue>6.53127e-05</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>320</Hsp_hit-from>
      <Hsp_hit-to>409</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>24</Hsp_identity>
      <Hsp_positive>38</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>90</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTKIKDAMICAGASGV--SSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LKVLKVPYVDRHTCMVSSETPITPNMFCAGYDTLPRDACQGDSGGPHTTVYRDTHFITGIVSSGEGCARNGKYGNYTKLSKFIPWIKRIM</Hsp_hseq>
      <Hsp_midline>L+   +P +    C     T I   M CAG   +   +C GDSGGP          + GIVS G         G Y +++  + W+++ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>442</Hit_num>
  <Hit_id>pdb|1MD7|A</Hit_id>
  <Hit_def>Monomeric structure of the zymogen of complement protease C1r [Homo sapiens]</Hit_def>
  <Hit_accession>1MD7_A</Hit_accession>
  <Hit_len>328</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.4318</Hsp_bit-score>
      <Hsp_score>93</Hsp_score>
      <Hsp_evalue>0.000113382</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>233</Hsp_hit-from>
      <Hsp_hit-to>327</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>97</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCKKYWGTK-----IKDAMICAGASGVS--SCMGDSGGPLVCK--KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDAGGVFAVRDPNTDRWVATGIVSWGIG-CSRGY-GFYTKVLNYVDWIKKEM</Hsp_hseq>
      <Hsp_midline>L+   LP+ +   C+ +   K         M CAG   +   +C GD+GG    +      W   GIVSWG   CS    G Y +V   V+W+++ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>443</Hit_num>
  <Hit_id>pdb|1DLE|A</Hit_id>
  <Hit_def>FACTOR B SERINE PROTEASE DOMAIN [Homo sapiens] &gt;pdb|1DLE|B FACTOR B SERINE PROTEASE DOMAIN [Homo sapiens]</Hit_def>
  <Hit_accession>1DLE_A</Hit_accession>
  <Hit_len>298</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.6614</Hsp_bit-score>
      <Hsp_score>91</Hsp_score>
      <Hsp_evalue>0.000198398</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>215</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>42</Hsp_align-len>
      <Hsp_qseq>ICAGASGVS------SCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>LCTG--GVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>+C G  GVS      +C GDSGGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>444</Hit_num>
  <Hit_id>pdb|6QSW|AAA</Hit_id>
  <Hit_def>Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6QSW|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6QSW|CCC Chain CCC, Complement factor B [Homo sapiens] &gt;pdb|6QSX|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6QSX|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6RAV|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6RAV|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6T8U|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6T8U|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6T8U|CCC Chain CCC, Complement factor B [Homo sapiens] &gt;pdb|6T8V|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6T8V|BBB Chain BBB, Complement factor B [Homo sapiens] &gt;pdb|6T8W|AAA Chain AAA, Complement factor B [Homo sapiens] &gt;pdb|6T8W|BBB Chain BBB, Complement factor B [Homo sapiens]</Hit_def>
  <Hit_accession>6QSW_AAA</Hit_accession>
  <Hit_len>291</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.6614</Hsp_bit-score>
      <Hsp_score>91</Hsp_score>
      <Hsp_evalue>0.00019944</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>208</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>42</Hsp_align-len>
      <Hsp_qseq>ICAGASGVS------SCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>LCTG--GVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>+C G  GVS      +C GDSGGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>445</Hit_num>
  <Hit_id>pdb|2WIN|I</Hit_id>
  <Hit_def>C3 convertase (C3bBb) stabilized by SCIN [Homo sapiens] &gt;pdb|2WIN|J C3 convertase (C3bBb) stabilized by SCIN [Homo sapiens] &gt;pdb|2WIN|K C3 convertase (C3bBb) stabilized by SCIN [Homo sapiens] &gt;pdb|2WIN|L C3 convertase (C3bBb) stabilized by SCIN [Homo sapiens]</Hit_def>
  <Hit_accession>2WIN_I</Hit_accession>
  <Hit_len>507</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.2762</Hsp_bit-score>
      <Hsp_score>90</Hsp_score>
      <Hsp_evalue>0.000236482</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>422</Hsp_hit-from>
      <Hsp_hit-to>461</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>42</Hsp_align-len>
      <Hsp_qseq>ICAGASGVS------SCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>LCTG--GVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>+C G  GVS      +C GDSGGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>446</Hit_num>
  <Hit_id>pdb|1RRK|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of the Bb segment of Factor B [Homo sapiens] &gt;pdb|1RS0|A Crystal Structure Analysis of the Bb segment of Factor B complexed with Di-isopropyl-phosphate (DIP) [Homo sapiens] &gt;pdb|1RTK|A Crystal Structure Analysis of the Bb segment of Factor B complexed with 4-guanidinobenzoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>1RRK_A</Hit_accession>
  <Hit_len>497</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.2762</Hsp_bit-score>
      <Hsp_score>90</Hsp_score>
      <Hsp_evalue>0.00024543</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>414</Hsp_hit-from>
      <Hsp_hit-to>453</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>42</Hsp_align-len>
      <Hsp_qseq>ICAGASGVS------SCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>LCTG--GVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>+C G  GVS      +C GDSGGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>447</Hit_num>
  <Hit_id>pdb|2RDL|A</Hit_id>
  <Hit_def>Hamster Chymase 2 [Mesocricetus auratus] &gt;pdb|2RDL|B Hamster Chymase 2 [Mesocricetus auratus]</Hit_def>
  <Hit_accession>2RDL_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.891</Hsp_bit-score>
      <Hsp_score>89</Hsp_score>
      <Hsp_evalue>0.000345684</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>96</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>226</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>42</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>95</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASG--VSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN</Hsp_qseq>
      <Hsp_hseq>DTLQEVKMRILDPQACKHFEDFH-QEPQLCVGNPKKIRNVYKGDSGGPLLC----AGIAQGIASY--VLRNAKPPSVFTRISHYRPWINKILREN</Hsp_hseq>
      <Hsp_midline>D LQ+  + +L    CK +     ++  +C G      +   GDSGGPL+C    A    GI S+     +   P V+ R++    W+ + L  N</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>448</Hit_num>
  <Hit_id>pdb|1FUJ|A</Hit_id>
  <Hit_def>Pr3 (Myeloblastin) [Homo sapiens] &gt;pdb|1FUJ|B Pr3 (Myeloblastin) [Homo sapiens] &gt;pdb|1FUJ|C Pr3 (Myeloblastin) [Homo sapiens] &gt;pdb|1FUJ|D Pr3 (Myeloblastin) [Homo sapiens]</Hit_def>
  <Hit_accession>1FUJ_A</Hit_accession>
  <Hit_len>221</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.000388707</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>172</Hsp_hit-from>
      <Hsp_hit-to>220</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>21</Hsp_identity>
      <Hsp_positive>29</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>53</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CFGDSGGPLICDG----IIQGIDSFVIWGCATRLFPDFFTRVALYVDWIRSTL</Hsp_hseq>
      <Hsp_midline>C GDSGGPL+C       + GI S+    C+T   P  + RV   V+W++ TL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>449</Hit_num>
  <Hit_id>pdb|6RUR|J</Hit_id>
  <Hit_def>Structure of the SCIN stabilized C3bBb convertase bound to properdin [Homo sapiens] &gt;pdb|6RUR|L Structure of the SCIN stabilized C3bBb convertase bound to properdin [Homo sapiens] &gt;pdb|6RUV|J Structure of the SCIN stabilized C3bBb convertase bound to Properdin and a the non-inhibitory nanobody hFPNb1 [Homo sapiens] &gt;pdb|6RUV|L Structure of the SCIN stabilized C3bBb convertase bound to Properdin and a the non-inhibitory nanobody hFPNb1 [Homo sapiens]</Hit_def>
  <Hit_accession>6RUR_J</Hit_accession>
  <Hit_len>505</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.00060293</Hsp_evalue>
      <Hsp_query-from>32</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>422</Hsp_hit-from>
      <Hsp_hit-to>461</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>42</Hsp_align-len>
      <Hsp_qseq>ICAGASGVS------SCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>LCTG--GVSPYADPNTCRGDAGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>+C G  GVS      +C GD+GGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>450</Hit_num>
  <Hit_id>pdb|2XWB|F</Hit_id>
  <Hit_def>Crystal Structure of Complement C3b in complex with Factors B and D [Homo sapiens] &gt;pdb|2XWB|H Crystal Structure of Complement C3b in complex with Factors B and D [Homo sapiens]</Hit_def>
  <Hit_accession>2XWB_F</Hit_accession>
  <Hit_len>732</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.000651325</Hsp_evalue>
      <Hsp_query-from>40</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>659</Hsp_hit-from>
      <Hsp_hit-to>686</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>14</Hsp_identity>
      <Hsp_positive>20</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>28</Hsp_align-len>
      <Hsp_qseq>SSCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>NTCRGDSGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>++C GDSGGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>451</Hit_num>
  <Hit_id>pdb|3H7O|A</Hit_id>
  <Hit_def>Crystal structure of scabies mite inactivated protease paralogue S-I1 (SMIPP-S-I1) [Sarcoptes scabiei] &gt;pdb|3H7O|B Crystal structure of scabies mite inactivated protease paralogue S-I1 (SMIPP-S-I1) [Sarcoptes scabiei]</Hit_def>
  <Hit_accession>3H7O_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.000670654</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>142</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>43</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>LQQASLPLLSNTNCK-KYWGTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>LKSAQLTVVDLDECRTKYGPIFLSLQVFCAQKVGVSLESGDAGDPTVQQD----TLVGVAAYFPKR-PEGAPEVFTKVGSYVSWIQDII</Hsp_hseq>
      <Hsp_midline>L+ A L ++    C+ KY    +   + CA   GVS   GD+G P V +     TLVG+ ++         P V+ +V + V+W+Q  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>452</Hit_num>
  <Hit_id>pdb|2XWJ|I</Hit_id>
  <Hit_def>Crystal Structure of Complement C3b in Complex with Factor B [Homo sapiens] &gt;pdb|2XWJ|J Crystal Structure of Complement C3b in Complex with Factor B [Homo sapiens] &gt;pdb|2XWJ|K Crystal Structure of Complement C3b in Complex with Factor B [Homo sapiens] &gt;pdb|2XWJ|L Crystal Structure of Complement C3b in Complex with Factor B [Homo sapiens] &gt;pdb|3HRZ|D Cobra Venom Factor (CVF) in complex with human factor B [Homo sapiens] &gt;pdb|3HS0|D Cobra Venom Factor (CVF) in complex with human factor B [Homo sapiens] &gt;pdb|3HS0|I Cobra Venom Factor (CVF) in complex with human factor B [Homo sapiens]</Hit_def>
  <Hit_accession>2XWJ_I</Hit_accession>
  <Hit_len>741</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.000725624</Hsp_evalue>
      <Hsp_query-from>40</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>668</Hsp_hit-from>
      <Hsp_hit-to>695</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>14</Hsp_identity>
      <Hsp_positive>20</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>28</Hsp_align-len>
      <Hsp_qseq>SSCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>NTCRGDSGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>++C GDSGGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>453</Hit_num>
  <Hit_id>pdb|7JTN|A</Hit_id>
  <Hit_def>Chain A, Complement factor B [Homo sapiens] &gt;pdb|7JTN|C Chain C, Complement factor B [Homo sapiens] &gt;pdb|7JTQ|A Chain A, Complement factor B [Homo sapiens] &gt;pdb|7JTQ|C Chain C, Complement factor B [Homo sapiens]</Hit_def>
  <Hit_accession>7JTN_A</Hit_accession>
  <Hit_len>764</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.000763292</Hsp_evalue>
      <Hsp_query-from>40</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>693</Hsp_hit-from>
      <Hsp_hit-to>720</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>14</Hsp_identity>
      <Hsp_positive>20</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>28</Hsp_align-len>
      <Hsp_qseq>SSCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>NTCRGDSGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>++C GDSGGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>454</Hit_num>
  <Hit_id>pdb|2OK5|A</Hit_id>
  <Hit_def>Human Complement factor B [Homo sapiens]</Hit_def>
  <Hit_accession>2OK5_A</Hit_accession>
  <Hit_len>752</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.000800668</Hsp_evalue>
      <Hsp_query-from>40</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>678</Hsp_hit-from>
      <Hsp_hit-to>705</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>14</Hsp_identity>
      <Hsp_positive>20</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>28</Hsp_align-len>
      <Hsp_qseq>SSCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>NTCRGDSGGPLIVHKRSRFIQVGVISWG</Hsp_hseq>
      <Hsp_midline>++C GDSGGPL+  K   +  VG++SWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>455</Hit_num>
  <Hit_id>pdb|1OP8|A</Hit_id>
  <Hit_def>Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|B Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|C Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|D Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|E Crystal Structure of Human Granzyme A [Homo sapiens] &gt;pdb|1OP8|F Crystal Structure of Human Granzyme A [Homo sapiens]</Hit_def>
  <Hit_accession>1OP8_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.7354</Hsp_bit-score>
      <Hsp_score>86</Hsp_score>
      <Hsp_evalue>0.000857275</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>48</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKY----WGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWG-SSTCSTST-PGVYARVT-ALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>DTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRDSCNGDSGSPLLCE----GVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMTI</Hsp_hseq>
      <Hsp_midline>D L++ ++ ++    C       +   I   M+CAG+   G  SC GDSG PL+C+        G+ S+G  + C     PGVY  ++   +NW+  T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>456</Hit_num>
  <Hit_id>pdb|1ORF|A</Hit_id>
  <Hit_def>The Oligomeric Structure of Human Granzyme A Reveals the Molecular Determinants of Substrate Specificity [Homo sapiens]</Hit_def>
  <Hit_accession>1ORF_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.7354</Hsp_bit-score>
      <Hsp_score>86</Hsp_score>
      <Hsp_evalue>0.000891574</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>136</Hsp_hit-from>
      <Hsp_hit-to>230</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>47</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>DRLQQASLPLLSNTNCKKY----WGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWG-SSTCSTST-PGVYARVT-ALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>DTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRDSCNGDSGSPLLCE----GVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMTI</Hsp_hseq>
      <Hsp_midline>D L++  + ++    C       +   I   M+CAG+   G  SC GDSG PL+C+        G+ S+G  + C     PGVY  ++   +NW+  T+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>457</Hit_num>
  <Hit_id>pdb|7CBK|B</Hit_id>
  <Hit_def>Structure of Human Neutrophil Elastase Ecotin complex [Homo sapiens] &gt;pdb|7CBK|D Structure of Human Neutrophil Elastase Ecotin complex [Homo sapiens]</Hit_def>
  <Hit_accession>7CBK_B</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.1946</Hsp_bit-score>
      <Hsp_score>82</Hsp_score>
      <Hsp_evalue>0.00307527</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>198</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>21</Hsp_identity>
      <Hsp_positive>28</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>53</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CFGDSGSPLVC--NG--LIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII</Hsp_hseq>
      <Hsp_midline>C GDSG PLVC  NG   + GI S+    C++   P  +A V   VNW+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>458</Hit_num>
  <Hit_id>pdb|1HNE|E</Hit_id>
  <Hit_def>Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-angstroms resolution [Homo sapiens]</Hit_def>
  <Hit_accession>1HNE_E</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.8094</Hsp_bit-score>
      <Hsp_score>81</Hsp_score>
      <Hsp_evalue>0.00360264</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>169</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>21</Hsp_identity>
      <Hsp_positive>28</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>53</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CFGDSGSPLVC--NG--LIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII</Hsp_hseq>
      <Hsp_midline>C GDSG PLVC  NG   + GI S+    C++   P  +A V   VNW+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>459</Hit_num>
  <Hit_id>pdb|1PPF|E</Hit_id>
  <Hit_def>X-Ray Crystal Structure Of The Complex Of Human Leukocyte Elastase (Pmn Elastase) And The Third Domain Of The Turkey Ovomucoid Inhibitor [Homo sapiens]</Hit_def>
  <Hit_accession>1PPF_E</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.8094</Hsp_bit-score>
      <Hsp_score>81</Hsp_score>
      <Hsp_evalue>0.00363818</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>169</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>21</Hsp_identity>
      <Hsp_positive>28</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>53</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CFGDSGSPLVC--NG--LIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII</Hsp_hseq>
      <Hsp_midline>C GDSG PLVC  NG   + GI S+    C++   P  +A V   VNW+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>460</Hit_num>
  <Hit_id>pdb|1B0F|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146 [Homo sapiens]</Hit_def>
  <Hit_accession>1B0F_A</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.8094</Hsp_bit-score>
      <Hsp_score>81</Hsp_score>
      <Hsp_evalue>0.00367406</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>169</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>21</Hsp_identity>
      <Hsp_positive>28</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>53</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CFGDSGSPLVC--NG--LIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII</Hsp_hseq>
      <Hsp_midline>C GDSG PLVC  NG   + GI S+    C++   P  +A V   VNW+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>461</Hit_num>
  <Hit_id>pdb|1H1B|A</Hit_id>
  <Hit_def>Crystal structure of human neutrophil elastase complexed with an inhibitor (GW475151) [Homo sapiens] &gt;pdb|1H1B|B Crystal structure of human neutrophil elastase complexed with an inhibitor (GW475151) [Homo sapiens] &gt;pdb|1PPG|E The refined 2.3 angstroms crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor [Homo sapiens] &gt;pdb|2Z7F|E Crystal structure of the complex of human neutrophil elastase with 1/2SLPI [Homo sapiens] &gt;pdb|3Q76|A Structure of human neutrophil elastase (uncomplexed) [Homo sapiens] &gt;pdb|3Q76|B Structure of human neutrophil elastase (uncomplexed) [Homo sapiens] &gt;pdb|3Q77|A Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|4NZL|A Chain A, Neutrophil elastase [Homo sapiens] &gt;pdb|4WVP|E Crystal structure of an activity-based probe HNE complex [Homo sapiens] &gt;pdb|5A09|A Chain A, NEUTROPHIL ELASTASE [Homo sapiens] &gt;pdb|5A0A|E Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A0B|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A0C|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A0C|B Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A8X|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A8Y|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5A8Z|A Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor [Homo sapiens] &gt;pdb|5ABW|A Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases [Homo sapiens] &gt;pdb|6E69|A Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments [Homo sapiens] &gt;pdb|6E69|B Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments [Homo sapiens] &gt;pdb|6E69|C Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments [Homo sapiens] &gt;pdb|6E69|D Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments [Homo sapiens] &gt;pdb|6F5M|A Crystal structure of highly glycosylated human leukocyte elastase in complex with a thiazolidinedione inhibitor [Homo sapiens] &gt;pdb|6F5M|B Crystal structure of highly glycosylated human leukocyte elastase in complex with a thiazolidinedione inhibitor [Homo sapiens] &gt;pdb|6SMA|A Crystal structure of Human Neutrophil Elastase (HNE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC249 [Homo sapiens] &gt;pdb|6SMA|B Crystal structure of Human Neutrophil Elastase (HNE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC249 [Homo sapiens] &gt;pdb|6SMA|C Crystal structure of Human Neutrophil Elastase (HNE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC249 [Homo sapiens]</Hit_def>
  <Hit_accession>1H1B_A</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.8094</Hsp_bit-score>
      <Hsp_score>81</Hsp_score>
      <Hsp_evalue>0.00367406</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>169</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>21</Hsp_identity>
      <Hsp_positive>28</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>53</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CFGDSGSPLVC--NG--LIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII</Hsp_hseq>
      <Hsp_midline>C GDSG PLVC  NG   + GI S+    C++   P  +A V   VNW+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>462</Hit_num>
  <Hit_id>pdb|2RG3|A</Hit_id>
  <Hit_def>Covalent complex structure of elastase [Homo sapiens]</Hit_def>
  <Hit_accession>2RG3_A</Hit_accession>
  <Hit_len>218</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.2686</Hsp_bit-score>
      <Hsp_score>77</Hsp_score>
      <Hsp_evalue>0.0134014</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>169</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>20</Hsp_identity>
      <Hsp_positive>27</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>53</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTST-PGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CFGDXGSPLVC--NG--LIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII</Hsp_hseq>
      <Hsp_midline>C GD G PLVC  NG   + GI S+    C++   P  +A V   VNW+   +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>463</Hit_num>
  <Hit_id>pdb|2ODP|A</Hit_id>
  <Hit_def>Complement component C2a, the catalytic fragment of C3- and C5-convertase of human complement [Homo sapiens] &gt;pdb|2ODQ|A Complement component C2a, the catalytic fragment of C3- and C5-convertase of human complement [Homo sapiens]</Hit_def>
  <Hit_accession>2ODP_A</Hit_accession>
  <Hit_len>509</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.113</Hsp_bit-score>
      <Hsp_score>74</Hsp_score>
      <Hsp_evalue>0.0415054</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>416</Hsp_hit-from>
      <Hsp_hit-to>457</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>15</Hsp_identity>
      <Hsp_positive>24</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>42</Hsp_align-len>
      <Hsp_qseq>IKDAMICAGAS-GVSSCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>VTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWG</Hsp_hseq>
      <Hsp_midline>+ D  +C+G     S C G+SGG +  ++   +  VG+VSWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>464</Hit_num>
  <Hit_id>pdb|2I6Q|A</Hit_id>
  <Hit_def>Complement component C2a [Homo sapiens] &gt;pdb|2I6S|A Complement component C2a [Homo sapiens]</Hit_def>
  <Hit_accession>2I6Q_A</Hit_accession>
  <Hit_len>517</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.7278</Hsp_bit-score>
      <Hsp_score>73</Hsp_score>
      <Hsp_evalue>0.046718</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>67</Hsp_query-to>
      <Hsp_hit-from>424</Hsp_hit-from>
      <Hsp_hit-to>465</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>15</Hsp_identity>
      <Hsp_positive>24</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>42</Hsp_align-len>
      <Hsp_qseq>IKDAMICAGAS-GVSSCMGDSGGPLVCKKNGAWTLVGIVSWG</Hsp_qseq>
      <Hsp_hseq>VTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWG</Hsp_hseq>
      <Hsp_midline>+ D  +C+G     S C G+SGG +  ++   +  VG+VSWG</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>465</Hit_num>
  <Hit_id>pdb|1FY3|A</Hit_id>
  <Hit_def>[G175Q]HBP, A mutant of human heparin binding protein (CAP37) [Homo sapiens]</Hit_def>
  <Hit_accession>1FY3_A</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>28.8758</Hsp_bit-score>
      <Hsp_score>63</Hsp_score>
      <Hsp_evalue>1.05136</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>171</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>52</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CNGDQGTPLVCE----GLAHGVASFSLGPCGRG-PDFFTRVALFRDWIDGVL</Hsp_hseq>
      <Hsp_midline>C GD G PLVC+        G+ S+    C    P  + RV    +W+   L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>466</Hit_num>
  <Hit_id>pdb|1A7S|A</Hit_id>
  <Hit_def>Atomic Resolution Structure Of Hbp [Homo sapiens] &gt;pdb|1AE5|A Human Heparin Binding Protein [Homo sapiens]</Hit_def>
  <Hit_accession>1A7S_A</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>28.4906</Hsp_bit-score>
      <Hsp_score>62</Hsp_score>
      <Hsp_evalue>1.26508</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>171</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>52</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CNGDGGTPLVCE----GLAHGVASFSLGPCGRG-PDFFTRVALFRDWIDGVL</Hsp_hseq>
      <Hsp_midline>C GD G PLVC+        G+ S+    C    P  + RV    +W+   L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>467</Hit_num>
  <Hit_id>pdb|1FY1|A</Hit_id>
  <Hit_def>[r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein (Cap37) [Homo sapiens]</Hit_def>
  <Hit_accession>1FY1_A</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>28.4906</Hsp_bit-score>
      <Hsp_score>62</Hsp_score>
      <Hsp_evalue>1.27746</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>171</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>52</Hsp_align-len>
      <Hsp_qseq>CMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL</Hsp_qseq>
      <Hsp_hseq>CNGDGGTPLVCE----GLAHGVASFSLGPCGRG-PDFFTRVALFRDWIDGVL</Hsp_hseq>
      <Hsp_midline>C GD G PLVC+        G+ S+    C    P  + RV    +W+   L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>468</Hit_num>
  <Hit_id>pdb|5VLB|A</Hit_id>
  <Hit_def>Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with Imidazole [Medicago truncatula] &gt;pdb|5VLB|B Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with Imidazole [Medicago truncatula] &gt;pdb|5VLB|C Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with Imidazole [Medicago truncatula] &gt;pdb|5VLB|D Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with Imidazole [Medicago truncatula] &gt;pdb|5VLB|E Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with Imidazole [Medicago truncatula] &gt;pdb|5VLB|F Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with Imidazole [Medicago truncatula] &gt;pdb|5VLC|A Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidinol [Medicago truncatula] &gt;pdb|5VLC|B Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidinol [Medicago truncatula] &gt;pdb|5VLC|C Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidinol [Medicago truncatula] &gt;pdb|5VLC|D Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidinol [Medicago truncatula] &gt;pdb|5VLC|E Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidinol [Medicago truncatula] &gt;pdb|5VLC|F Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidinol [Medicago truncatula] &gt;pdb|5VLD|A Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidine and NAD+ [Medicago truncatula] &gt;pdb|5VLD|B Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidine and NAD+ [Medicago truncatula] &gt;pdb|5VLD|C Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidine and NAD+ [Medicago truncatula] &gt;pdb|5VLD|D Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidine and NAD+ [Medicago truncatula] &gt;pdb|5VLD|E Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidine and NAD+ [Medicago truncatula] &gt;pdb|5VLD|F Crystal Structure of Medicago truncatula L-Histidinol Dehydrogenase in Complex with L-Histidine and NAD+ [Medicago truncatula]</Hit_def>
  <Hit_accession>5VLB_A</Hit_accession>
  <Hit_len>446</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>26.9498</Hsp_bit-score>
      <Hsp_score>58</Hsp_score>
      <Hsp_evalue>5.46691</Hsp_evalue>
      <Hsp_query-from>24</Hsp_query-from>
      <Hsp_query-to>71</Hsp_query-to>
      <Hsp_hit-from>171</Hsp_hit-from>
      <Hsp_hit-to>208</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>13</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>48</Hsp_align-len>
      <Hsp_qseq>GTKIKDAMICAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTC</Hsp_qseq>
      <Hsp_hseq>GTTCKEVLYCAKKAGVTHLL----------KAGGAQAISAMAWGTETC</Hsp_hseq>
      <Hsp_midline>GT  K+ + CA  +GV+  +          K G    +  ++WG+ TC</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
</Iteration_hits>
  <Iteration_stat>
    <Statistics>
      <Statistics_db-num>130881</Statistics_db-num>
      <Statistics_db-len>34844698</Statistics_db-len>
      <Statistics_hsp-len>63</Statistics_hsp-len>
      <Statistics_eff-space>877773435</Statistics_eff-space>
      <Statistics_kappa>0.041</Statistics_kappa>
      <Statistics_lambda>0.267</Statistics_lambda>
      <Statistics_entropy>0.14</Statistics_entropy>
    </Statistics>
  </Iteration_stat>
</Iteration>
</BlastOutput_iterations>
</BlastOutput>

